<SEC-DOCUMENT>0001213900-21-026626.txt : 20210517
<SEC-HEADER>0001213900-21-026626.hdr.sgml : 20210517
<ACCEPTANCE-DATETIME>20210517060335
ACCESSION NUMBER:		0001213900-21-026626
CONFORMED SUBMISSION TYPE:	F-4
PUBLIC DOCUMENT COUNT:		21
FILED AS OF DATE:		20210517

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			China Jo-Jo Drugstores Holdings, Inc.
		CENTRAL INDEX KEY:			0001856084
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		F-4
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-256176
		FILM NUMBER:		21927268

	BUSINESS ADDRESS:	
		STREET 1:		HAI WAI HAI TONGXIN MANSION FLOOR 6
		STREET 2:		GONG SHU DISTRICT
		CITY:			HANGZHOU CITY
		STATE:			F4
		ZIP:			310008
		BUSINESS PHONE:		8657188219579

	MAIL ADDRESS:	
		STREET 1:		HAI WAI HAI TONGXIN MANSION FLOOR 6
		STREET 2:		GONG SHU DISTRICT
		CITY:			HANGZHOU CITY
		STATE:			F4
		ZIP:			310008
</SEC-HEADER>
<DOCUMENT>
<TYPE>F-4
<SEQUENCE>1
<FILENAME>ea140501-f4_chinajojodrug.htm
<DESCRIPTION>REGISTRATION STATEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-indent: 0; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border: white 1pt solid"><B>As filed with the
Securities and Exchange Commission on May 17, 2021</B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No. 333-</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="border-top: Black 2pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 5pt 0pt 0pt; text-align: center"><B>United States<BR>
Securities and Exchange Commission<BR>
Washington, D.C. 20549</B></P>

<DIV STYLE="border: white 1pt solid; margin-right: 0in; margin-left: 5.75pt; padding: 0in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>FORM
F-4<BR>
Registration Statement<BR>
<I>Under<BR>
The Securities Act of 1933</I>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>China
Jo-Jo Drugstores Holdings, Inc.</B></FONT></P>

</DIV>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Exact name of registrant
as specified in its Charter)</B>&nbsp;</P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-right: 3pt; padding-left: 3pt; text-align: center; width: 32%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Cayman
    Islands</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; padding-right: 3pt; padding-left: 3pt; text-align: center; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-right: 3pt; padding-left: 3pt; text-align: center; width: 32%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>5912</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; padding-right: 3pt; padding-left: 3pt; text-align: center; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-right: 3pt; padding-left: 3pt; text-align: center; width: 32%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>N/A</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(State
    or other jurisdiction of<BR>
    incorporation or organization)</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(Primary
    Standard Industrial<BR>
    Classification Code Number)</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 3pt; padding-left: 3pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 3pt; padding-left: 3pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(I.R.S.
    Employer<BR>
    Identification Number)</B></FONT></TD></TR>
  </TABLE>
<DIV STYLE="border: white 1pt solid; margin-right: 0in; margin-left: 6pt; padding: 0in"></DIV>

<DIV STYLE="border: white 1pt solid; padding: 9pt 0in 3pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Hai Wai Hai Tongxin Mansion Floor 6</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Gong Shu District, Hangzhou City</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>People&rsquo;s Republic of China 310008</B></P>

</DIV>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>+86-571-88219579</B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Address, including
zip code, and telephone number, including area code, of registrant&rsquo;s principal executive offices)</B>&nbsp;</P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<DIV STYLE="border: white 1pt solid; margin-right: 0in; margin-left: 5.75pt; padding: 0in">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Elizabeth F. Chen, Esq.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pryor Cashman LLP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>7 Times Square</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>New York, New York 10036</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(212) 326-0199 </B></P>

</DIV>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Name, address, including
zip code, and telephone number, including area code, of agent for service)</B>&nbsp;</P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;<FONT STYLE="font-size: 10pt"><B><I>Copies
to:</I></B>&nbsp;</FONT></FONT></P>

<DIV STYLE="border: white 1pt solid; padding: 0in; margin-right: 0in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Elizabeth F. Chen, Esq.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Michael T. Campoli, Esq.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pryor Cashman LLP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>7 Times Square</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>New York, New York 10036</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>(212)
326-0199</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

</DIV>

<DIV STYLE="border: white 1pt solid; margin-right: 0in; padding-right: 0in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>Approximate date of commencement of proposed
sale to the public:</B> As soon as practicable after this Registration Statement becomes effective and the satisfaction or waiver of
all other conditions under the Merger Agreement described herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the
flowing box and list the Securities Act Registration Statement number of the earliest effective registration statement for the same
offering. &#9744;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">If applicable, place an X in the box to designate
the appropriate rule provision relied upon in conducting this transaction:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exchange
Act Rule 13e-4(i) (Cross-Border Issuer Tender Offer) &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exchange
Act Rule 14d-l(d) (Cross-Border Third-Party Tender Offer) &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Indicate by check mark whether the registrant is
an emerging growth company as defined in Rule 405 of the Securities Act of 1933. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Emerging growth company &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">If an emerging growth company that prepares its
financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards&dagger; provided pursuant to Section 7(a)(2)(B) of the Securities
Act .</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&dagger; The term &ldquo;new or revised financial
accounting standard&rdquo; refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification
after April 5, 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CALCULATION OF REGISTRATION FEE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Title of each class of securities to be registered</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount to be<BR> Registered<SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Proposed maximum<BR> offering price<BR> per share</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Proposed maximum<BR> Aggregate<BR> offering price</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount of<BR> registration&nbsp;fee</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%">Ordinary Shares</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">41,751,790</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">0.94</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">39,246,682.60</TD><TD STYLE="width: 1%; text-align: left"><SUP>(2)</SUP></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">4,281.81</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">Ordinary Shares</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">8,257,009</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">0.94</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">7,761,588.46</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><SUP>(3)</SUP></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">846.79</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">47,008,271.06</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">5,128.60</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><BR></B></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 4%; text-align: left">(1)</TD><TD STYLE="text-align: justify; width: 96%">Relates to ordinary shares,
                                            $0.001 par value per share, of China Jo-Jo Drugstores Holdings, Inc. (&ldquo;CJJD Cayman&rdquo;)
                                            issuable to holders of common stock, $0.001 par value per share, of China Jo-Jo Drugstores,
                                            Inc., a company incorporated in the State of Nevada, or CJJD, in the proposed redomicile
                                            merger of CJJD, whereby CJJD will merge with and into CJJD Cayman and in which holders of
                                            CJJD common stock shall receive CJJD Cayman ordinary shares. The number of CJJD Cayman ordinary
                                            shares to be registered is based on the maximum number that is expected to be issued pursuant
                                            to the redomicile merger. The actual number of ordinary shares issued pursuant to the redomicile
                                            merger may be less than the number of ordinary shares being registered.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 4%; text-align: left">(2)</TD><TD STYLE="text-align: justify; width: 96%">Pursuant to Rule 457 under the Securities Act of 1933, as amended and solely for
the purpose of calculating the registration fee, the proposed maximum aggregate offering price was calculated as the product of $0.94
(the average high and low price of CJJD common stock on May 11, 2021) and 41,751,790 ordinary shares representing the maximum number of
shares of CJJD common stock outstanding as of May 11, 2021.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 4%; text-align: left">(3)</TD><TD STYLE="text-align: justify; width: 96%">Pursuant to Rule 457 under the Securities Act of 1933, as amended, and solely for
the purpose of calculating the registration fee, the proposed maximum aggregate offering price was calculated as the product of $0.94
(the average high and low price of CJJD common stock on May 11, 2021) and 8,257,009 ordinary shares representing the maximum number of
shares of CJJD common stock issuable upon the exercise of outstanding warrants prior to the effective time of the merger.</TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp; &nbsp;</P>


<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><B>The
registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the
registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act of 1933 or until this Registration Statement shall become effective on such date
as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="color: Red">The information in this
proxy statement/prospectus is not complete and may be changed. We may not sell these securities or accept any offers to buy these securities
until the registration statement filed with the Securities and Exchange Commission is effective. This proxy statement/prospectus is not
an offer to sell these securities and it is not soliciting an offer to buy these securities, nor shall there be any sale of these securities,
in any jurisdiction where such offer, solicitation or sale is not permitted or would be unlawful prior to registration or qualification
under the securities laws of any such jurisdiction</FONT>.<BR>
&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Subject to completion, dated May 17,
2021</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="logo.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CHINA JO-JO DRUGSTORES, INC.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Hai Wai Hai Tongxin Mansion Floor 6</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Gong Shu District, Hangzhou City</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>People&rsquo;s Republic of China 310008</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>__________, 2021 </B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Stockholder:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">You are cordially invited
to the special meeting of stockholders (the &ldquo;Special Meeting&rdquo;) of China Jo-Jo Drugstores, Inc., a Nevada corporation (the
&ldquo;Company&rdquo;), to be held on __________, __________, 2021, at 10:00 a.m., Beijing time, at the principal office of the Company
located at Hai Wai Hai Tongxin Mansion Floor 6, Gong Shu District, Hangzhou City, People&rsquo;s Republic of China 310008. Only stockholders
of record at the close of business on _______, 2021 are entitled to notice of and to vote at the Special Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">At the Special Meeting, you
will be asked to vote on the important matters described in the notice of Special Meeting of stockholders and proxy statement/prospectus
accompanying this letter. You will also have an opportunity to ask questions and receive information about the Company&rsquo;s business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Included with the proxy statement/prospectus
is a copy of the Company&rsquo;s 2020 Annual Report (the &ldquo;Annual Report&rdquo;). We encourage you to read the Annual Report. It
includes information on the Company&rsquo;s operations as well as the Company&rsquo;s audited financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">At the Special Meeting, you will be asked to vote on the adoption of
an agreement and plan of merger, dated as of May 14, 2021 (the &ldquo;Merger Agreement&rdquo;), which included a plan of merger required
to be filed with the Register of Companies of the Cayman Islands, substantially in the form as attached as Annex A to the Merger Agreement
(the &ldquo;Plan of Merger&rdquo;) which provides for a redomicile of the Company to the Cayman Islands through a merger (the &ldquo;Redomicile
Merger&rdquo;) that would result in each share of the Company&rsquo;s common stock being converted into the right to receive one ordinary
share in the capital of China Jo-Jo Drugstores Holdings, Inc., an exempted company incorporated under the laws of the Cayman Islands with
registration number of 373821 (&ldquo;CJJD Cayman&rdquo;), and CJJD Cayman shall issue to each holder of such right that number of ordinary
shares in CJJD Cayman to which such holder is entitled. Upon the completion of the Redomicile Merger, the former stockholders of the Company
will become the legal owners of the shares of CJJD Cayman, and CJJD Cayman, together with its subsidiaries, will own and continue to conduct
our business in substantially the same manner as is currently being conducted by the Company and its subsidiaries. CJJD Cayman will also
be managed by the same board of directors and executive officers that manage the Company today.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">As further explained in the
accompanying proxy statement/prospectus, our Board of Directors expects that the reorganization of the Company&rsquo;s corporate structure,
which will be facilitated by the approval of the Redomicile Merger, will result in the following benefits:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">reduction of
                                            our operational, administrative, legal and accounting costs over the long term through the
                                            reduction of our reporting obligations and related expenses because CJJD Cayman is expected
                                            to qualify as a &ldquo;foreign private issuer&rdquo; under the rules and regulations of the
                                            Securities and Exchange Commission (&ldquo;SEC&rdquo;) and be exempt from certain rules under
                                            the Securities Exchange Act of 1934, as amended (&ldquo;Exchange Act&rdquo;), that would
                                            otherwise apply if CJJD Cayman were a company incorporated in the United States or did not
                                            meet the other conditions to qualify as a foreign private issuer, which is in line with the
                                            Company&rsquo;s current business and operations which are almost all conducted outside of
                                            the United States;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">alignment of
                                            our structure with our international corporate strategy, which structure would more closely
                                            align with those of other companies operating in the same industry in China; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">potential regulatory
                                            benefits in China, which has a strictly regulated pharmaceutical industry that officially
                                            or unofficially may favor companies that are incorporated in jurisdictions that are not politically
                                            and economically perceived to be in competition with China.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>


<DIV STYLE="border: white 1pt solid; margin-right: 0in; padding-right: 0in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15.1pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We have chosen to redomicile
under the laws of the Cayman Islands because of its political and economic stability, effective judicial system, absence of exchange
control or currency restrictions and availability of professional and support services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15.1pt"></P></DIV>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="margin-right: 0in; padding-right: 0in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The Redomicile Merger cannot
be completed unless proposal to adopt the Merger Agreement and the Plan of Merger is approved by the holders of a majority of the Company&rsquo;s
outstanding shares of common stock. There are a number of risks which you should be aware of in considering whether to vote in favor
of the proposal to approve the Merger Agreement and the Plan of Merger. The accompanying proxy statement/prospectus contains important
information about the Merger Agreement and the Plan of Merger and related Redomicile Merger and the risks associated thereto and we encourage
you to read it. In particular, you should carefully consider the discussion in the section of the proxy statement/prospectus entitled
&ldquo;Risk Factors and Caution Regarding Forward-Looking Statements&rdquo; beginning on page 24.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We intend the Redomicile
Merger to qualify as a reorganization for U.S. federal income tax purposes, and it is a condition to our obligation to complete the Redomicile
Merger that we receive an opinion (the &ldquo;Tax Opinion&rdquo;) from our tax counsel substantially to this effect. The Tax Opinion
does not bind the IRS or prevent the IRS from adopting a contrary position. Based on the Tax Opinion, after the Redomicile Merger, CJJD
Cayman, as successor to the Company, will be treated as a U.S. domestic corporation for U.S. federal income tax purposes. If the Redomicile
Merger qualifies as a reorganization, stockholders of the Company will not recognize any gain or loss for U.S. federal income tax purposes
solely due to the receipt of CJJD Cayman ordinary shares in the Redomicile Merger. For a more detailed discussion of U.S. federal income
tax considerations for stockholders, please see the section entitled &ldquo;Tax Opinion&rdquo; beginning on page 81. We urge you to consult
your own tax advisor regarding the particular tax consequences of the Redomicile Merger for you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></P>

</DIV>

<DIV STYLE="border: white 1pt solid; margin-right: 0in; padding-right: 0in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our Board of Directors has
determined that the Redomicile Merger is advisable and in the best interests of the Company and our stockholders and, as such, has unanimously
approved the Redomicile Merger, the Merger Agreement and the Plan of Merger. Our Board of Directors recommends that you vote &ldquo;FOR&rdquo;
the proposal to adopt the Merger Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Your vote is important.
Whether or not you plan to attend the Special Meeting, we hope that you will vote as soon as possible. You may vote your shares by either
completing, signing and returning the accompanying proxy card or casting your vote via a toll-free telephone number or over the Internet.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B></B>&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">Sincerely,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Lei Liu</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;&nbsp;</P>

<DIV STYLE="border: white 1pt solid; margin-right: 0in; padding-right: 0in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>NEITHER THE SECURITIES AND EXCHANGE COMMISSION
NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THE SECURITIES TO BE ISSUED UNDER THIS PROXY STATEMENT/PROSPECTUS
OR PASSED UPON THE ADEQUACY OR ACCURACY OF THIS PROXY STATEMENT/PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

</DIV>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>This proxy statement/prospectus
is dated _______, 2021 and is being first mailed to</B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>China Jo-Jo Drugstores,
Inc. stockholders on or about _______, 2021</B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><BR STYLE="clear: both">
CHINA JO-JO DRUGSTORES, INC.<BR>
<BR>
NOTICE OF SPECIAL MEETING OF STOCKHOLDERS<BR>
to be held on _______, 2021</B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">NOTICE
IS HEREBY GIVEN that the Special Meeting of stockholders (the &ldquo;Special Meeting&rdquo;) of China Jo-Jo Drugstores, Inc., a Nevada
corporation (the &ldquo;Company&rdquo;), will be held on _______, _______, 2021, at 10:00 a.m., Beijing time, at the principal office
of the Company located at Hai Wai Hai Tongxin Mansion Floor 6, Gong Shu District, Hangzhou City, People&rsquo;s Republic of China 310008,
for the following purposes:</P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: justify">to approve and adopt the agreement and plan of merger (the &ldquo;Merger Agreement&rdquo;)
by and between the Company and China Jo-Jo Drugstores Holdings, Inc., an exempted company incorporated under the laws of the Cayman Islands
and a wholly owned subsidiary of the Company (&ldquo;CJJD Cayman&rdquo;), which included a plan of merger required to be filed with the
Register of Companies of the Cayman Islands, substantially in the form as attached as Annex A to the Merger Agreement (the &ldquo;Plan
of Merger&rdquo;), pursuant to which the Company will merge with and into CJJD Cayman, with CJJD Cayman as the surviving company upon
the merger becoming effective, and whereby each issued and outstanding share of the common stock of the Company will be converted into
the right to receive one ordinary share of CJJD Cayman (the &ldquo;Redomicile Merger&rdquo;); and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left">2.</TD><TD STYLE="text-align: justify">to transact such other business as may properly come before the Special Meeting or any adjournment
or postponement thereof.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<DIV STYLE="border: white 1pt solid; margin-right: 0in; padding-right: 0in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">If you owned our common stock
at the close of business on _______, 2021, you may attend and vote at the Special Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">A proxy statement/prospectus
describing the matters to be considered at the Special Meeting is attached to this Notice. Our 2020 Annual Report accompanies this Notice,
but it is not deemed to be part of the proxy statement/prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><B>Your vote is important.
Whether or not you plan to attend the Special Meeting, we hope that you will vote as soon as possible. You may vote your shares by either
completing, signing and returning the accompanying proxy card or casting your vote via a toll-free telephone number or over the Internet.</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">By Order of the Board of Directors</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">/s/ <FONT STYLE="font-size: 10pt">Lei Liu</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Lei Liu</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">_______, 2021</FONT></TD></TR>
  </TABLE>

</DIV>

<P STYLE="border: white 1pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>IMPORTANT
NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE STOCKHOLDER MEETING TO BE HELD ON __________, 2021</B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">This
Notice and proxy statement/prospectus are available online at <I>https://www.iproxydirect.com/CJJD.</I>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<DIV STYLE="border: white 1pt solid; padding: 9pt 0in 3pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

</DIV>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top; width: 92%"><A HREF="#main_001"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 7%; text-align: center">ii</TD>
    </TR>
  <TR STYLE="background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><A HREF="#main_002"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">USE OF TERMS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">iii</FONT></TD>
    </TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><A HREF="#main_003"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">INFORMATION ABOUT THE SPECIAL MEETING AND THE PROPOSED REDOMICILE MERGER</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">iv</FONT></TD>
    </TR>
  <TR STYLE="background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><A HREF="#main_004"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">SUMMARY</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">4</TD>
    </TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><A HREF="#main_005"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">MARKET FOR THE COMPANY&rsquo;S COMMON STOCK</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">6</TD>
    </TR>
  <TR STYLE="background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><A HREF="#main_006"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">MANAGEMENT&rsquo;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">7</FONT></TD>
    </TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><A HREF="#main_007"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">RISK FACTORS AND CAUTION REGARDING FORWARD-LOOKING STATEMENTS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD>
    </TR>
  <TR STYLE="background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><A HREF="#main_008"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">BUSINESS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</FONT></TD>
    </TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><A HREF="#main_009"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">DIRECTORS AND EXECUTIVE OFFICERS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</FONT></TD>
    </TR>
  <TR STYLE="background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><A HREF="#main_010"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">CORPORATE GOVERNANCE</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">67</FONT></TD>
    </TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><A HREF="#main_011"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">EXECUTIVE COMPENSATION</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">69</FONT></TD>
    </TR>
  <TR STYLE="background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><A HREF="#main_012"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">72</TD>
    </TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><A HREF="#main_013"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">TRANSACTIONS WITH RELATED PERSONS, PROMOTERS AND CERTAIN CONTROL PERSONS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">73</TD>
    </TR>
  <TR STYLE="background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><A HREF="#main_014"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">PROPOSAL NO. 1 ADOPTION OF THE MERGER AGREEMENT</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">74</TD>
    </TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><A HREF="#main_015"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">DESCRIPTION OF SHARE CAPITAL OF CJJD CAYMAN</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">85</TD>
    </TR>
  <TR STYLE="background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><A HREF="#main_016"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">COMPARISON OF RIGHTS UNDER NEVADA AND CAYMAN ISLANDS LAWS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">89</TD>
    </TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><A HREF="#main_017"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">ENFORCEABILITY OF CIVIL LIABILITIES</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">96</TD>
    </TR>
  <TR STYLE="background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><A HREF="#main_018"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">LEGAL MATTERS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">96</TD>
    </TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><A HREF="#main_019"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">EXPERTS</FONT></A></TD>
    <TD STYLE="vertical-align: bottom"></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">96</TD>
    </TR>
  <TR STYLE="background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><A HREF="#main_020"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">WHERE YOU CAN FIND MORE INFORMATION</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">97</TD>
    </TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; vertical-align: top"><A HREF="#main_022"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Annex A</FONT></A></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">A-1</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="main_001"></A>CAUTIONARY STATEMENT
REGARDING FORWARD LOOKING STATEMENTS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">This proxy statement/prospectus
contains or incorporates by reference forward looking statements within the meaning of the private securities litigation reform act of
1995 with respect to the restructuring and our financial condition, results of operations and business. This act protects public companies
from liability for forward looking statements in private securities litigation if the forward looking statement is identified and is
accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materially from
the forward looking statements. Forward looking statements by their nature involve a degree of risk and uncertainty, including, but not
limited to, the risks and uncertainties referred to under &ldquo;Risk Factors&rdquo; and elsewhere herein or in the documents incorporated
by reference. All statements regarding the expected benefits of the restructuring are forward looking statements. The forward looking
statements may include statements for the period following completion of the Redomicile Merger. You can find many of these statements
by looking for words such as &ldquo;believes,&rdquo; &ldquo;expects,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;estimates,&rdquo; &ldquo;continues,&rdquo;
&ldquo;may,&rdquo; &ldquo;can,&rdquo; &ldquo;continue,&rdquo; &ldquo;potential,&rdquo; &ldquo;should,&rdquo; &ldquo;will,&rdquo; &ldquo;could,&rdquo;
&ldquo;intends,&rdquo; &ldquo;plans&rdquo; or similar expressions in this proxy statement/prospectus or in the documents incorporated
by reference. You should be aware that any forward looking statements in this proxy statement/prospectus reflect only current expectations
and are not guarantees of performance. Many possible events or factors could affect our future financial results and performance. This
could cause our results or performance to differ materially from those we express in our forward looking statements. You should consider
these risks when deciding how to vote. Also, as you make your decision how to vote, please take into account that forward looking statements
speak only as of the date of this proxy statement/prospectus or, in the case of documents incorporated by reference, the date of any
such document, or in certain cases, as of a specified date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We have identified factors
that could cause actual plans or results to differ materially from those included in any forward looking statements. These factors include,
but are not limited to, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">an inability to realize expected benefits of the restructuring within the anticipated time
frame, or at all;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">changes in tax law, tax treaties or tax regulations or the interpretation or enforcement
thereof, including taxing authorities not agreeing with our assessment of the effects of such laws, treaties and regulations;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">an inability to execute any of our business strategies;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">costs or difficulties related to the Redomicile Merger and related restructuring transactions,
which could be greater than expected; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">such other risk factors as may be discussed in our reports filed with the SEC.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We
disclaim any obligation or undertaking to disseminate any updates or revisions to our statements, forward looking or otherwise, to reflect
changes in our expectations or any change in events, conditions or circumstances on which any such statements are based.</P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="main_002"></A>USE OF TERMS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Except as otherwise indicated
by the context and for the purposes of this prospectus only, references in this prospectus to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">&ldquo;China Jo-Jo Drugstores,&rdquo; &ldquo;CJJD&rdquo;, &ldquo;we,&rdquo; &ldquo;us,&rdquo;
&ldquo;our company,&rdquo; or &ldquo;our&rdquo; are to China Jo-Jo Drugstores, Inc., a Nevada corporation, and, unless the context requires
otherwise, its direct and indirect subsidiaries;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">&ldquo;China&rdquo; or &ldquo;PRC&rdquo; are to the People&rsquo;s Republic of China, excluding,
for the purposes of this prospectus only, Taiwan and the special administrative regions of Hong Kong and Macau;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">&ldquo;Exchange Act&rdquo; are to the Securities Exchange Act of 1934, as amended;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">&ldquo;RMB&rdquo; are to the legal currency of China;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">&ldquo;SEC&rdquo; are to the Securities and Exchange Commission;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">&ldquo;Securities Act&rdquo; are to the Securities Act of 1933, as amended;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">&ldquo;U.S. dollars&rdquo; or &ldquo;$&rdquo; are to the legal currency of the United States.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="main_003"></A>INFORMATION ABOUT
THE SPECIAL MEETING AND THE PROPOSED REDOMICILE MERGER</B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The Board of Directors (the
&ldquo;Board&rdquo;) of China Jo-Jo Drugstores, Inc., a Nevada corporation (the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo;
&ldquo;our&rdquo; or &ldquo;CJJD&rdquo;), is furnishing this proxy statement/prospectus and the accompanying proxy to you to solicit
your proxy for the Special Meeting of Stockholders (the &ldquo;Special Meeting&rdquo;). The Special Meeting will be held on _______,
_______, 2021, at 10:00 a.m., Beijing time, at the principal office of the Company located at Hai Wai Hai Tongxin Mansion Floor 6, Gong
Shu District, Hangzhou City, People&rsquo;s Republic of China 310008.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">It is anticipated that the
proxy materials will be mailed to stockholders on or about _______, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The following questions and
answers are intended to address briefly some commonly asked questions regarding the Special Meeting and, in particular, the proposed
Redomicile Merger. These questions and answers may not address all issues that may be important to you. Please refer to the more detailed
information contained elsewhere in this proxy statement/prospectus, its annexes and the documents referred to.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>



<DIV STYLE="border: white 1pt solid; padding-right: 0in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>What is this proxy statement/prospectus?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I></I></B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">You
have received this proxy statement/prospectus and our 2020 annual report (the &ldquo;Annual Report&rdquo;) because our Board is soliciting
your proxy to vote your shares at the Special Meeting. This proxy statement/prospectus includes information that we are required to provide
to you under the rules of the Securities and Exchange Commission (&ldquo;SEC&rdquo;) and that is designed to assist you in voting your
shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>What is the purpose of the Special
Meeting?</I></B></P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">At
the Special Meeting, our stockholders will act upon the matters described in this proxy statement/prospectus. These actions include the
adoption of the Merger Agreement and approval of the Redomicile Merger. An additional purpose of the Special Meeting is to transact any
other business that may properly come before the Special Meeting and any and all adjournments or postponements of the Special Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Who can attend the Special Meeting?</I></B></P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">All
stockholders of record at the close of business on _______, 2021 (the &ldquo;Record Date&rdquo;), or their duly appointed proxies, may
attend the Special Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>What proposals will be voted on at
the Special Meeting?</I></B></P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Stockholders
will vote on one proposal at the Special Meeting:</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">the approval and adoption of the agreement and plan of merger (the &ldquo;Merger Agreement&rdquo;)
by and between the Company and China Jo-Jo Drugstores Holdings, Inc., an exempted company incorporated under the laws of the Cayman Islands
and a wholly owned subsidiary of the Company (&ldquo;CJJD Cayman&rdquo;), which included a plan of merger required to be filed with the
Register of Companies of the Cayman Islands, substantially in the form as attached as Annex A to the Merger Agreement (the &ldquo;Plan
of Merger&rdquo;), pursuant to which the Company will merge with and into CJJD Cayman, with CJJD Cayman as the surviving company upon
the merger becoming effective, and whereby each issued and outstanding share of the common stock of the Company will be converted into
the right to receive one ordinary share of CJJD Cayman (the &ldquo;Redomicile Merger&rdquo;).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>What are the Board&rsquo;s recommendations?
</I></B></P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our Board recommends that
you vote:</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><B>FOR</B> adoption of the Merger Agreement and approval of the Redomicile Merger.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Will there be any other business on
the agenda?</I></B></P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The
Board knows of no other matters that are likely to be brought before the Special Meeting. If any other matters properly come before the
Special Meeting, however, the persons named in the enclosed proxy, or their duly appointed substitute acting at the Special Meeting,
will be authorized to vote or otherwise act on those matters in accordance with their judgment.</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Who is entitled to vote?</I></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Only
stockholders of record at the close of business on _______, 2021, which we refer to as the Record Date, are entitled to notice of, and
to vote at, the Special Meeting. Holders of common stock as of the Record Date are entitled to one vote for each share held for each
of the proposals. No other class of voting securities is outstanding on the date of mailing of this proxy statement/prospectus.</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>What is the difference between holding
shares as a stockholder of record and as a beneficial owner?</I></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><I>Stockholder of Record.
</I>If your shares are registered directly in your name with our transfer
agent, you are considered, with respect to those shares, the &ldquo;stockholder of record.&rdquo; This proxy statement/prospectus and
our Annual Report have been sent directly to you by us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><I>Beneficial Owner.</I> If
your shares are held in a stock brokerage account or by a bank or other nominee, you are considered the &ldquo;beneficial owner&rdquo;
of shares held in street name. This proxy statement/prospectus and the Annual Report have been forwarded to you by your broker, bank
or nominee who is considered, with respect to those shares, the stockholder of record. As the beneficial owner, you have the right to
direct your broker, bank or nominee how to vote your shares by using the voting instructions included in with your proxy materials.</P>








<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>How do I vote my shares?</I></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Whether you hold shares directly
as a registered stockholder of record or beneficially in street name, you may vote without attending the Special Meeting. You may vote
by granting a proxy or, for shares held beneficially in street name, by submitting voting instructions to your stockbroker, trustee or
nominee. In most cases, you will be able to do this by using the Internet or telephone or by mail, if you received a printed set of the
proxy materials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">By Internet &mdash; If you
have Internet access, you may submit your proxy via the Internet by following the instructions provided in the Notice of Special Meeting
of Stockholders accompanying this proxy statement/prospectus (the &ldquo;Notice&rdquo;), or if you received a printed version of the
proxy materials by mail, by following the instructions provided with your proxy materials and on your proxy card or voting instruction
card.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">By Telephone or Mail &mdash;
If you received printed proxy materials, you may submit your proxy by telephone by following the instructions provided on your proxy
card or voting instruction card. If you received a Notice, you may submit your proxy by telephone after accessing the proxy materials
via the Internet. You may also submit your proxy by mail by signing your proxy card if your shares are registered or, for shares held
beneficially in street name, by following the voting instructions included by your stockbroker, trustee or nominee, and mailing it in
the envelope provided. If you provide specific voting instructions, your shares will be voted as you have instructed. Voting by telephone
is not available to persons outside of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Telephone and Internet voting
facilities for stockholders of record will be available 24 hours a day and will close at 11:59 p.m., Beijing time, on _______, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">If you vote by proxy, the
individuals named on the proxy card (your &ldquo;proxies&rdquo;) will vote your shares in the manner you indicate. You may specify how
your shares should be voted for each of the proposals. If you grant a proxy without indicating your instructions, your shares will be
voted as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">FOR adoption of the Merger Agreement and approval of the Redomicile Merger.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Each share of common stock
is entitled to one vote.</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;&nbsp;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>What constitutes a quorum?</I></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">A
quorum is the presence, in person or by proxy, of the holders of a majority of the shares of the common stock entitled to vote. Under
Nevada law, an abstaining vote and a broker &ldquo;non-vote&rdquo; are counted as present and are, therefore, included for purposes of
determining whether a quorum of shares is present at the Special Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>What is a broker &ldquo;non-vote&rdquo;
and what is its effect on voting?</I></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">If
you are a beneficial owner of shares held in street name and do not provide the organization that holds your shares with specific voting
instructions, under the rules of various national and regional securities exchanges, the organization that holds your shares may generally
vote on routine matters but cannot vote on non-routine matters. If the organization that holds your shares does not receive instructions
from you on how to vote your shares on a non-routine matter, the organization that holds your shares does not have the authority to vote
on the matter with respect to those shares. This is generally referred to as a &ldquo;broker non-vote.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<DIV STYLE=" padding-right: 0in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>What is required to approve each item?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">For Proposal No. 1 (adoption
of the Merger Agreement), the majority of the outstanding shares of our common stock must vote &ldquo;For&rdquo; the proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">For
the purpose of determining whether the stockholders have approved matters, abstentions are treated as shares present or represented and
voting, so abstaining has the same effect as a negative vote. If stockholders hold their shares through a broker, bank or other nominee
and do not instruct them how to vote, the broker has authority to vote the shares for routine matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>How will shares of common stock represented
by properly executed proxies be voted?</I></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">All
shares of common stock represented by proper proxies will, unless such proxies have previously been revoked, be voted in accordance with
the instructions indicated in such proxies. If you do not provide voting instructions, your shares will be voted in accordance with the
Board&rsquo;s recommendations as set forth herein. In addition, if any other matters properly come before the Special Meeting, the persons
named in the enclosed proxy, or their duly appointed substitute acting at the Special Meeting, will be authorized to vote or otherwise
act on those matters in accordance with their judgment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Can I change my vote or revoke my proxy?</I></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Any stockholder executing
a proxy has the power to revoke such proxy at any time prior to your shares being voted. You may revoke your proxy prior to your shares
being voted by calling 1-866-752-VOTE (8683), or by accessing the Internet website <I>https://www.iproxydirect.com/CJJD</I>, or in writing
by execution of a subsequently dated proxy, or by a written notice of revocation, sent to the attention of the Corporate Secretary at
China Jo-Jo Drugstores, Inc., Hai Wai Hai Tongxin Mansion Floor 6, Gong Shu District, Hangzhou City, People&rsquo;s Republic of China
310008, or by attending and voting in person at the Special Meeting. Unless revoked, the shares represented by timely received proxies
will be voted in accordance with the directions given therein. Your most current proxy card or telephone or Internet proxy is the one
that is counted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">If the Special Meeting is
postponed or adjourned for any reason, at any subsequent reconvening of the Special Meeting, all proxies granted according to the instructions
set forth herein will be voted in the same manner as the proxies would have been voted at the previously convened Special Meeting (except
for any proxies that have at that time effectively been revoked or withdrawn), even if the proxies had been effectively voted on the
same or any other matter at a previous Special Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>



<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>How are proxies solicited?</I></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In
addition to the mail solicitation of proxies, our officers, directors, employees and agents may solicit proxies by written communication,
telephone or personal call. These persons will receive no special compensation for any solicitation activities. We will reimburse banks,
brokers and other persons holding common stock for their expenses in forwarding proxy solicitation materials to beneficial owners of
our common stock.</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Who paid for this proxy solicitation?</I></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The
cost of preparing, printing, assembling and mailing this proxy statement/prospectus and other material furnished to stockholders in connection
with the solicitation of proxies is borne by us.</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>What is &ldquo;householding&rdquo;?</I></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The SEC has adopted rules
that allow a company to deliver a single proxy statement or annual report to an address shared by two or more of its stockholders. This
method of delivery, known as &ldquo;householding&rdquo;, permits us to realize significant cost savings, reduces the amount of duplicate
information stockholders receive, and reduces the environmental impact of printing and mailing documents to you. Under this process,
certain stockholders of record who do not participate in electronic delivery of proxy materials will receive only one copy of our proxy
materials and any additional proxy materials that are delivered until such time as one or more of these stockholders notify us that they
want to receive separate copies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Any stockholders who wish
to opt out of, or wish to begin, householding may contact our Corporate Secretary through one of the following methods:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">by sending a written request by mail to:</TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.48in">China Jo-Jo Drugstores, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.48in">Hai Wai Hai Tongxin Mansion Floor 6</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.48in">Gong Shu District, Hangzhou City</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.48in">People&rsquo;s Republic of China 310008</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.48in">Attention: Corporate Secretary</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.48in">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">by calling our Corporate Secretary, at (+86) 571-88219579.</TD>
</TR></TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vi<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Are there any rules regarding admission to the Special Meeting?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I></I></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Yes.
You are entitled to attend the Special Meeting only if you were, or you hold a valid legal proxy naming you to act for, one of our stockholders
on the Record Date. Before we admit you to the Special Meeting, we must be able to confirm:</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">Your identity by reviewing a valid form of photo identification, such as your passport; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">You were, or are validly acting for, a stockholder of record on the Record Date by:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">verifying your name and stock ownership against our list of registered stockholders, if you
are the record holder of your shares;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">reviewing other evidence of your stock ownership, such as your most recent brokerage or bank
statement, if you hold your shares in street name; or</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">reviewing a written proxy that shows your name and is signed by the stockholder you are representing,
in which case either the stockholder must be a registered stockholder of record or you must have a brokerage or bank statement for that
stockholder as described above.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">If you do not have a valid
form of photo identification and proof that you owned, or are legally authorized to act as proxy for someone who owned shares of our
common stock on _______, 2021, you will not be admitted to the Special Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">At the entrance to the Special
Meeting, we will verify that your name appears in our stock records or will inspect your brokerage or bank statement, as your proof of
ownership, and any written proxy you present as the representative of a stockholder. We will decide in our sole discretion whether the
documentation you present for admission to the Special Meeting meets the requirements described above.</P>



<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>How do I learn the results of the voting
at the Special Meeting?</I></B></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The
preliminary voting results will be announced at the Special Meeting. The final results will be published in our current report on Form
8-K to be filed with the SEC within four business days after the date of the Special Meeting, provided that the final results are available
at such time. In the event the final results are not available within such time period, the preliminary voting results will be published
in our current report on Form 8-K to be filed within such time period, and the final results will be published in an amended current
report on Form 8-K/A to be filed within four business days after the final results are available.</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Can I receive
future stockholder communications electronically through the Internet?</I></B></P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Yes. You may elect to receive
future notices of meetings, proxy materials and annual reports electronically through the Internet. To consent to electronic delivery,
vote your shares using the Internet. At the end of the Internet voting procedure, the on-screen Internet voting instructions will tell
you how to request future stockholder communications be sent to you electronically.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Once you consent to electronic
delivery, you must vote your shares using the Internet and your consent will remain in effect until withdrawn. You may withdraw this
consent at any time during the voting process and resume receiving stockholder communications in print form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<DIV STYLE=" padding: 3pt 0in 3pt 3pt; margin-right: 0in; margin-left: 3pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

</DIV>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Whom may I contact for further assistance?
</I></B></P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If you have any questions
about giving your proxy or require any assistance, please contact our Corporate Secretary:</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">by mail to:</TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.48in">China Jo-Jo Drugstores, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.48in">Hai Wai Hai Tongxin Mansion Floor 6</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.48in">Gong Shu District, Hangzhou City</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.48in">People&rsquo;s Republic of China 310008</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.48in">Attention: Corporate Secretary</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">by telephone at (+86) 571-88219579</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>



<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>QUESTIONS AND ANSWERS ABOUT THE REDOMICILE
MERGER </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>What is the Redomicile Merger?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Under
the Merger Agreement and Plan of Merger, the Company will merge with and into CJJD Cayman, with CJJD Cayman as the surviving company
and changing its name to China Jo-Jo Drugstores, Inc. upon the Redomicile Merger becoming effective. Upon consummation of the Redomicile
Merger, each share of the Company&rsquo;s common stock will be converted into the right to receive one ordinary share of CJJD Cayman,
which ordinary shares will be issued by CJJD Cayman in connection with the Redomicile Merger. Following the Redomicile Merger, CJJD Cayman,
together with its subsidiaries, will own and continue to conduct our business in substantially the same manner as it is currently being
conducted by the Company and its subsidiaries. CJJD Cayman will also be managed by substantially the same board of directors and executive
officers that manage the Company today.</P>



<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Why does the Company want to engage
in the Redomicile Merger?</I></B></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We
expect that the Redomicile Merger will, among other things, result in a reduction in operational, administrative, legal and accounting
costs over the long term, more closely align our structure with our international corporate strategy and potentially provide regulatory
benefits. However, there can be no assurance that following the Redomicile Merger we will be able to realize these expected benefits
for the reasons discussed in the section entitled &ldquo;Risk Factors and Caution Regarding Forward-Looking Statements-Risks Relating
to the Redomicile Merger &mdash; The expected benefits of the Redomicile Merger may not be realized.&rdquo;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Will the Redomicile
Merger affect current or future operations?</I></B></P>



<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We
expect that the Redomicile Merger will not have a material impact on how we conduct day-to-day operations and the new corporate structure
will not change our future operational plans to grow our business. We expect that the Redomicile Merger, by aligning our structure with
our international corporate strategy and moving our jurisdiction of incorporation outside the U.S., may improve our ability to grow both
internationally and as well as in China which has a strictly regulated pharmaceutical industry that may officially or unofficially may
favor companies that are incorporated in jurisdictions that are not politically and economically perceived to be in competition with
China. The location of future operations will depend on the needs of the business, which will be determined without regard to our jurisdiction
of incorporation.</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Will CJJD Cayman
be treated differently from the Company for U.S. federal income tax purposes?</I></B></P>



<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Based
on the Tax Opinion, after the Redomicile Merger, CJJD Cayman, as successor to the Company, will be treated as a U.S. domestic corporation
for U.S. federal income tax purposes, will be subject to U.S. federal income taxes, and dividends paid by CJJD Cayman to its non-U.S.
stockholders will be subject to U.S. withholding taxes. The Tax Opinion does not bind the IRS or prevent the IRS from adopting a contrary
position. For a more detailed discussion of U.S. federal income tax considerations of the Redomicile Merger, please see the section entitled
&ldquo;Tax Opinion&rdquo; beginning on page 81.</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Is the Redomicile Merger taxable to
me?</I></B></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We intend the Redomicile
Merger to qualify as a reorganization for U.S. federal income tax purposes, and it is a condition to our obligation to complete the Redomicile
Merger that the Tax Opinion is substantially to this effect. The Tax Opinion does not bind the IRS or prevent the IRS from adopting a
contrary position. If the Redomicile Merger qualifies as a reorganization: (i) a U.S. Holder (as defined in the section titled &ldquo;Taxation
&mdash; United States Taxation&rdquo;) will not recognize any gain or loss for U.S. federal income tax purposes solely due to the receipt
of CJJD Cayman ordinary shares in the Redomicile Merger, (ii) a U.S. Holder&rsquo;s adjusted tax basis in the CJJD Cayman ordinary shares
received in the Redomicile Merger will be the same as such U.S. Holder&rsquo;s adjusted tax basis in the Company common stock surrendered
in the Redomicile Merger, and (iii) such U.S. Holder&rsquo;s holding period in the CJJD Cayman ordinary shares received in the Redomicile
Merger will include such U.S. Holder&rsquo;s holding period in the Company common stock surrendered in the Redomicile Merger; provided
that, if a U.S. Holder acquired different blocks of Company common stock at different times or at different prices, the CJJD Cayman ordinary
shares received in the Redomicile Merger will be allocated pro rata to each block of Company common stock, and the basis and holding
period of each block of CJJD Cayman ordinary shares received will be determined on a block-for-block basis depending on the basis and
holding period of the blocks of Company common stock exchanged for such block of CJJD Cayman ordinary shares. For a more detailed discussion
of U.S. federal income tax considerations for stockholders, please see the section entitled &ldquo;Tax Opinion&rdquo; beginning on page
81. We urge you to consult your own tax advisor regarding the particular tax consequences of the Redomicile Merger for you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">THE TAX TREATMENT OF THE
REDOMICILE MERGER UNDER STATE OR LOCAL LAW WILL DEPEND ON THE JURISDICTION. WE URGE YOU TO CONSULT YOUR OWN TAX ADVISOR PRIOR TO CONSENTING
REGARDING THE PARTICULAR TAX CONSEQUENCES OF THE REDOMICILE MERGER TO YOU.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15.1pt"></P>

<!-- Field: Page; Sequence: 13; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15.1pt">&nbsp;</P>



<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Has the U.S. Internal Revenue Service
rendered a ruling on any aspects of the Redomicile Merger?</I></B></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">No
ruling has been requested from the U.S. Internal Revenue Service (the &ldquo;IRS&rdquo;), in connection with the Redomicile Merger.</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>When do you expect to complete the
Redomicile Merger?</I></B></P>



<P STYLE=" text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">If
the adoption of the Merger Agreement is approved by our stockholders, we anticipate that the Redomicile Merger will become effective
promptly following such approval, although the Redomicile Merger may be abandoned by our board of directors prior to its completion.
Please see the section entitled &ldquo;Risk Factors and Caution Regarding Forward-Looking Statements-Risks Relating to the Redomicile
Merger &mdash; Our Board of Directors may choose to defer or abandon the Redomicile Merger.&rdquo;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>What types of
information and reports will CJJD Cayman make available to shareholders following the Redomicile Merger?</I></B></P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Following
completion of the Redomicile Merger, CJJD Cayman is expected to qualify as a &ldquo;foreign private issuer&rdquo; under the rules and
regulations of the SEC. CJJD Cayman will remain subject to the provisions of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act.
However, as a foreign private issuer, CJJD Cayman will be exempt from certain rules under the Securities Exchange Act of 1934, as amended
(&ldquo;Exchange Act&rdquo;), that would otherwise apply if CJJD Cayman were a company incorporated in the United States or did not meet
the other conditions to qualify as a foreign private issuer. For example:</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">CJJD Cayman may include in its SEC filings financial statements prepared in accordance with
generally accepted accounting principles in the United States, or U.S. GAAP, or with the International Financial Reporting Standards,
or IFRS, as issued by the International Accounting Standards Board, or IASB, without reconciliation to U.S. GAAP;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">CJJD Cayman will not be required to provide as many Exchange Act reports, or as frequently
or as promptly, as U.S. companies with securities registered under the Exchange Act. For example, CJJD Cayman will not be required to
file current reports on Form 8-K within four business days from the occurrence of specific material events. Instead, CJJD Cayman will
need to promptly furnish reports on Form 6-K any information that CJJD Cayman (a) makes or is required to make public under the laws
of the Cayman Islands, (b) files or is required to file under the rules of any stock exchange, or (c) otherwise distributes or is required
to distribute to its shareholders. Unlike Form 8-K, there is no precise deadline by which Form 6-K must be furnished. In addition, CJJD
Cayman will not be required to file its annual report on Form 10-K, which may be due as soon as 60 days after its fiscal year end. As
a foreign private issuer, CJJD Cayman will be required to file an annual report on Form 20-F within four months after its fiscal year
end;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">CJJD Cayman will not be required to provide the same level of disclosure on certain issues,
such as executive compensation;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">CJJD Cayman will be exempt from filing quarterly reports under the Exchange Act with the
SEC; however, as a Nasdaq listed foreign private issuer, CJJD Cayman will be required to publish on a Form 6-K an interim balance sheet
and income statement as of the end of its second quarter no later than six months following the end of such quarter;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">CJJD Cayman will not be subject to the requirement to comply with Regulation FD, which imposes
certain restrictions on the selected disclosure of material information;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">CJJD Cayman will not be required to comply with the sections of the Exchange Act regulating
the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: right"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">CJJD Cayman will not be required to comply with Section 16 of the Exchange Act requiring
insiders to file public reports of their stock ownership and trading activities and establishing insider liability for profits realized
from any &ldquo;short-swing&rdquo; trading transaction.</TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Accordingly, after the completion
of the Redomicile Merger, if you hold CJJD Cayman shares, you may receive less information about CJJD Cayman and its business than you
currently receive with respect to the Company and be afforded less protection under the U.S. federal securities laws than you are entitled
to currently.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">If CJJD Cayman loses its status
as a foreign private issuer at some future time, then it will no longer be exempt from such rules and, among other things, will be required
to file periodic reports and financial statements as if it were a company incorporated in the U.S. The costs (including operational,
administrative, legal and accounting costs) incurred in fulfilling these additional regulatory requirements could be substantial. Please
see the sections entitled &ldquo;Risk Factors and Caution Regarding Forward-Looking Statements-Risks Relating to the Redomicile Merger
&mdash; The expected benefits of the redomicile merger may not be realized&rdquo; and &ldquo;Risk Factors and Caution Regarding Forward-Looking
Statements &mdash; Risks Relating to the Redomicile Merger.&rdquo;</P>



<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B><I>Do I have to take
any action to exchange my common stock in the Company to receive ordinary shares of CJJD Cayman?</I></B></P>



<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Each share of the Company&rsquo;s
common stock registered in your name or which you beneficially own through your broker will be converted into the right to receive one
CJJD Cayman ordinary shares and such ordinary shares will be registered in your name (or your broker&rsquo;s name, as applicable) in
CJJD Cayman&rsquo;s register of members upon completion of the Redomicile Merger. Upon completion of the Redomicile Merger, only registered
shareholders reflected in CJJD Cayman&rsquo;s register of members will have and be entitled to exercise any voting and other rights with
respect to and to receive any dividend and other distributions upon CJJD Cayman ordinary shares registered in their respective names.
Any attempted transfer of the Company&rsquo;s common stock prior to the Redomicile Merger that is not properly documented and reflected
in the stock records maintained by the Company&rsquo;s transfer agent as of immediately prior to the Effective Time will not be reflected
in holdings of CJJD Cayman&rsquo;s ordinary shares upon completion of the Redomicile Merger. If you hold your shares of the Company&rsquo;s
common stock in an account with a broker or other securities intermediary, you will receive delivery of ordinary shares in your account
with that same broker or other securities intermediary. Under Cayman Islands law, a Cayman Islands company such as CJJD Cayman may pay
a dividend on its shares out of either profit or share premium amount, provided that in no circumstances may a dividend be paid if this
would result in the company being unable to pay its debts due in the ordinary course of business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">If you hold the Company&rsquo;s
common stock in certificated form, you may exchange your common stock certificates of the Company for CJJD Cayman ordinary shares in
certificated form following the Redomicile Merger. We will request that all of the Company&rsquo;s stock certificates be returned to
CJJD Cayman&rsquo;s transfer agent following the Redomicile Merger. Soon after the closing of the Redomicile Merger, you will be sent
a letter of transmittal from our exchange agent. It is expected that, prior to the Effective Time, Securities Transfer Corporation will
be appointed as our exchange agent for the Redomicile Merger. The letter of transmittal will contain instructions explaining the procedure
for surrendering your stock certificates in the Company to receive CJJD Cayman ordinary shares in certificated form. YOU SHOULD NOT RETURN
STOCK CERTIFICATES WITH THE ENCLOSED PROXY CARD. CJJD Cayman&rsquo;s current transfer agent is American Stock Transfer &amp; Trust Company,
which will continue to serve as the transfer agent for CJJD Cayman ordinary shares after the Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>





<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>What happens to the Company&rsquo;s
stock options and other equity awards at the effective time of the Redomicile Merger?</I></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">At
the Effective Time, all outstanding options to purchase shares of the Company&rsquo;s common stock granted or issued prior to the Effective
Time and all other outstanding equity awards granted under our equity compensation plans to directors, employees and consultants, as
applicable, will entitle the holder to purchase or receive, or receive payment based on, as applicable, an equal number of CJJD Cayman
ordinary shares. Immediately prior to the Effective Time, all existing equity compensation plans of the Company, as may be amended, will
be adopted and assumed by CJJD Cayman. We do not anticipate an increase to the total number of shares underlying options and awards outstanding
under our assumed equity compensation plans or shares otherwise issuable thereunder. Future awards would be subject to and governed by
the terms of our assumed equity compensation plans and any agreements entered into pursuant thereto.</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Can I trade my common stock in the
Company before the Redomicile Merger is completed?</I></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Yes.
Common stock in the Company will continue to be listed on the NASDAQ Capital Market through the last trading day prior to the date of
completion of the Redomicile Merger, which is anticipated to take place promptly following the approval of the Redomicile Merger.</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>After the Redomicile Merger, where
can I trade my CJJD Cayman ordinary shares?</I></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The
Company and CJJD Cayman are in the process of applying for listing of the ordinary shares of CJJD Cayman with the NASDAQ Capital Market
and hope to complete that process concurrent with or shortly after the consummation of the Redomicile Merger.</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>How will my rights
as a shareholder of CJJD Cayman change after the Redomicile Merger relative to my rights as a stockholder of the Company prior to the
Redomicile Merger?</I></B></P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Because
of differences between Nevada law and Cayman Islands law and differences between the governing documents of the Company and the constitutional
documents of CJJD Cayman, we are unable to adopt governing documents for CJJD Cayman that are identical to the governing documents for
the Company. CJJD Cayman&rsquo;s amended and restated memorandum and articles of association differ from the Company&rsquo;s bylaws and
articles of incorporation, both in form and substance, and the rights of shareholders of CJJD Cayman will change relative to your rights
as a stockholder of the Company as a result of the Redomicile Merger and you may not be afforded as many rights as a shareholder of CJJD
Cayman under applicable laws and CJJD Cayman&rsquo;s amended and restated memorandum and articles of association as you had as a stockholder
of the Company under applicable laws and the Company&rsquo;s articles of incorporation and bylaws. Please see the sections entitled &ldquo;Risk
Factors and Caution Regarding Forward-Looking Statements-Risks Relating to the Redomicile Merger &mdash; Your rights as a stockholder
of the Company will change as a result of the Redomicile Merger and you may not be afforded as many rights as a shareholder of CJJD Cayman
under applicable laws and CJJD Cayman&rsquo;s amended and restated memorandum and articles of association as you were as a stockholder
of the Company under applicable laws and the Company&rsquo;s articles of incorporation and bylaws,&rdquo; &ldquo;Description of Share
Capital of CJJD Cayman&rdquo;, and &ldquo;Comparison of Rights under Nevada and Cayman Islands Laws.&rdquo; Additionally, as a foreign
private issuer, CJJD Cayman will be permitted to follow corporate governance practices in accordance with Cayman Islands laws. However,
we do not intend to initially rely on any NASDAQ exemptions or accommodations for foreign private issuers following the merger.</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Do I have Dissenters&rsquo; Rights?
</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In connection with the Redomicile Merger, our stockholders
will not have dissenters&rsquo; rights under the Nevada Revised Statutes (&ldquo;NRS&rdquo;). Please see the section entitled &ldquo;Comparison
of Rights under Nevada and Cayman Islands Laws.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="main_004"></A>SUMMARY </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt; text-align: justify; text-indent: 0.25in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><I>The following summary
highlights selected information from this proxy statement/prospectus and may not contain all of the information that is important to
you. To better understand the Merger Agreement, including the Redomicile Merger and other transactions contemplated thereby, you should
carefully read this entire proxy statement/prospectus, including the Merger Agreement attached as Annex A to this proxy statement/prospectus
and the Plan of Merger attached as Annex A to the Merger Agreement. For purposes of this proxy statement/prospectus, the term &ldquo;Merger
Agreement&rdquo; will refer to the Merger Agreement, as the same may be amended.</I>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>The Redomicile Merger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>The Parties to the Merger Agreement and the Plan of Merger</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><I>China Jo-Jo
Drugstores, Inc., a Nevada incorporated corporation, the Company or CJJD Nevada. </I>The Company is a retailer and distributor of pharmaceutical
and other healthcare products typically found in retail pharmacies in the PRC. The Company currently has one hundred and eighteen (118)
store locations under the store brand &ldquo;Jiuzhou Grand Pharmacy&rdquo; in Hangzhou city and its adjacent town Lin&rsquo;an. The Company
currently operates in four business segments in China: (1) retail drugstores, (2) online pharmacy, (3) wholesale business selling products
similar to those we carry in our pharmacies, and (4) farming and selling herbs used for traditional Chinese medicine (&ldquo;TCM&rdquo;).
All of the above business are performed in China with no other international sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.9pt; text-align: justify; text-indent: 15.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><I>China Jo-Jo
Drugstores Holdings, Inc. a Cayman incorporated company, or CJJD Cayman.</I> CJJD Cayman is a newly formed exempted company incorporated
under the laws of the Cayman Islands and currently a wholly-owned subsidiary of the Company. An &ldquo;exempted&rdquo; company under
the laws of the Cayman Islands is one which receives such registration as a result of satisfying the Registrar of Companies in the Cayman
Islands that it conducts its operations mainly outside of the Cayman Islands and is as a result exempted from complying with certain
provisions of the Companies Act (2021 Revision) (the &ldquo;Companies Act&rdquo;) of the Cayman Islands, such as the general requirement
to file an annual return of its shareholders with the Registrar of Companies, and is permitted flexibility in certain matters, such as
the ability to register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands upon satisfying certain
requirements of the Companies Act as it pertains to continuation and/or deregistration. CJJD Cayman does not have a significant amount
of assets or liabilities and has not engaged in any business since its incorporation other than activities associated with its anticipated
participation in the Redomicile Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.9pt; text-align: justify; text-indent: 15.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The principal
executive offices of each of the Company and CJJD Cayman are located at Hai Wai Hai Tongxin Mansion Floor 6, Gong Shu District, Hangzhou
City, People&rsquo;s Republic of China 310008; Telephone: +86 571-88219579. The registered office for CJJD Cayman is in the Cayman Islands
located at Cricket Square, Hutchins Drive, PO Box 2681, Grand Cayman, KY1-1111, Cayman Islands, and the phone number of the registered
office is +1 345 945 3901.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.9pt; text-indent: 15.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Background and Reasons for the Redomicile Merger </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We believe that the
Redomicile Merger, which would change our place of incorporation from Nevada to the Cayman Islands, (i) would allow us to reduce operational,
administrative, legal and accounting costs over the long term because CJJD is expected to qualify as a foreign private issuer and be
exempt from certain rules under the Exchange Act, which is in line with the Company&rsquo;s current business and operations which are
almost all conducted outside of the United States, (ii) will more closely align our structure with our international corporate strategy
and (iii) may improve our ability to grow both internationally and as well as in China which has a strictly regulated biopharmaceutical
industry that may officially or unofficially may favor companies that are incorporated in jurisdictions that are not politically and
economically perceived to be in competition with China. With our headquarters in Hangzhou City, China and substantially all of our executive
team and members of our board of directors residing outside the United States, we believe that it is advisable to move our place of incorporation
outside the United States. In reaching its decision to approve the Merger Agreement, our Board of Directors identified several potential
benefits to our stockholders, which are described under &ldquo;The Merger Agreement &mdash; Background and Reasons for the Redomicile
Merger.&rdquo; Please also see the section entitled &ldquo;Risk Factors and Caution Regarding Forward-Looking Statements &mdash; Risks
Relating to the Redomicile Merger&rdquo; for a description of certain risks associated with the merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>The Merger Agreement </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">A copy of the Merger
Agreement and Plan of Merger is attached as Annex A to this proxy statement/prospectus. The Company encourages you to read the entire
Merger Agreement and Plan of Merger carefully they are the principal documents governing the Redomicile Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>CJJD Cayman Ordinary Shares </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">If the Redomicile
Merger is completed, each share of the Company&rsquo;s common stock shall convert into the right to receive one ordinary share in the
capital of CJJD Cayman, which ordinary shares will be issued by CJJD Cayman in connection with the Redomicile Merger. Following the Redomicile
Merger, the former stockholders of the Company will become holders of CJJD Cayman ordinary shares, and CJJD Cayman, together with its
subsidiaries, will own and continue to conduct our business in substantially the same manner as is currently being conducted by the Company
and its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I></I></B></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Treatment of the Company&rsquo;s Options, Warrants and Convertible
Securities </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In connection with
the Redomicile Merger, each outstanding option, warrant or convertible security exercisable or convertible into common stock of the Company
will be assumed by CJJD Cayman and will become an option, warrant or convertible security exercisable or convertible into an equal number
of ordinary shares in the capital of CJJD Cayman under the same terms and conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Overview of the Merger Agreement </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The Company and CJJD
Cayman are required to complete the Redomicile Merger only if certain customary conditions are satisfied or waived, including, among
others, the registration statement on Form F-4, of which this proxy statement/prospectus is a part, being declared effective by the SEC,
and the Merger Agreement and Plan of Merger being approved by the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Board of Directors; Management of the CJJD Cayman Following
the Redomicile Merger </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Following the Redomicile
Merger, CJJD Cayman will be managed by substantially the same board of directors and executive officers that manage the Company. Under
Cayman Islands law, all directors owe three types of duties: (i) statutory duties, (ii) fiduciary duties, and (iii) common law duties.
The Companies Act (2021 Revision), as amended, of the Cayman Islands imposes a number of statutory duties on a director. A Cayman Islands
director&rsquo;s fiduciary duties are not codified, however the courts of the Cayman Islands have held that a director owes the following
fiduciary duties: (a) a duty to act in what the director bona fide considers to be in the best interests of the company, (b) a duty to
exercise their powers for the purposes they were conferred, (c) a duty to avoid fettering his or her discretion in the future and (d)
a duty to avoid conflicts of interest and of duty. The common law duties owed by a director are those to act with skill, care and diligence
that may reasonably be expected of a person carrying out the same functions as are carried out by that director in relation to the company
and, also, to act with the skill, care and diligence in keeping with a standard of care commensurate with any particular skill they have
which enables them to meet a higher standard than a director without those skills. In fulfilling their duty of care, the directors must
ensure compliance with the amended articles of association, as amended and restated from time to time. There is a right to seek damages
if a duty owed by any of director is breached.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Accounting Treatment </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The Redomicile Merger
will be accounted for as a legal reorganization with no change in ultimate ownership interest immediately before and after the transaction.
Accordingly, all assets and liabilities will be recorded at historical cost as an exchange between entities under common control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Material U.S. Federal Income Tax Consequences </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We intend the Redomicile
Merger to qualify as a reorganization within the meaning of Section 368(a) of the Internal Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;),
and it is a condition to our obligation to complete the Redomicile Merger that the Tax Opinion is substantially to this effect. The Tax
Opinion does not bind the IRS or prevent the IRS from adopting a contrary position. Based on the Tax Opinion, after the Redomicile Merger,
CJJD Cayman, as successor to the Company, will be treated as a U.S. domestic corporation for U.S. federal income tax purposes. If the
Redomicile Merger qualifies as a reorganization: (i) a U.S. Holder (as defined in the section titled &ldquo;Taxation &mdash; United States
Taxation&rdquo;) will not recognize any gain or loss for U.S. federal income tax purposes solely due to the receipt of CJJD Cayman ordinary
shares in the Redomicile Merger, (ii) a U.S. Holder&rsquo;s adjusted tax basis in the CJJD Cayman ordinary shares received in the Redomicile
Merger will be the same as such U.S. Holder&rsquo;s adjusted tax basis in the Company common stock surrendered in the Redomicile Merger,
and (iii) such U.S. Holder&rsquo;s holding period in the CJJD Cayman ordinary shares received in the Redomicile Merger will include such
U.S. Holder&rsquo;s holding period in the Company common stock surrendered in the Redomicile Merger; provided that, if a U.S. Holder
acquired different blocks of Company common stock at different times or at different prices, the CJJD Cayman ordinary shares received
in the Redomicile Merger will be allocated pro rata to each block of Company common stock, and the basis and holding period of each block
of CJJD Cayman ordinary shares received will be determined on a block-for-block basis depending on the basis and holding period of the
blocks of Company common stock exchanged for such block of CJJD Cayman ordinary shares. For a more detailed discussion of U.S. federal
income tax considerations for stockholders, please see the section entitled &ldquo;Tax Opinion&rdquo; beginning on page 81. We urge you
to consult your own tax advisor regarding the particular tax consequences of the Redomicile Merger for you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>Comparison of Stockholder/Shareholder Rights
</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Upon consummation
of the Redomicile Merger, the holders of issued and outstanding common stock of the Company will be entitled to receive CJJD Cayman ordinary
shares. The rights of the holders of the Company&rsquo;s common stock are governed by the Company&rsquo;s articles of incorporation and
bylaws and by the Nevada Revised Statutes, while the rights of holders of CJJD Cayman&rsquo;s ordinary shares are generally governed
by CJJD Cayman&rsquo;s amended and restated memorandum and articles of association and the Companies Act of the Cayman Islands and the
common law of the Cayman Islands. There are differences in rights afforded by under Nevada law and Cayman Islands law. Please see the
section entitled &ldquo;Comparison of Rights under Nevada and Cayman Islands Laws.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Risks Associated with the Redomicile Merger </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Holders of the Company&rsquo;s
common stock and, assuming consummation of the Redomicile Merger, CJJD Cayman&rsquo;s ordinary shares, will be subject to various risks
associated with CJJD Cayman&rsquo;s business and industries. These risks are discussed in greater detail under the section entitled &ldquo;Risk
Factors and Caution Regarding Forward-Looking Statements&rdquo; in this proxy statement/prospectus. The Company encourages you to read
and consider all of these risks carefully.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="main_005"></A>MARKET FOR THE COMPANY&rsquo;S COMMON STOCK
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Market Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our common stock trades on
the NASDAQ Capital Market under the symbol &ldquo;CJJD&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Based on the records of our
transfer agent, we had ________ shares of common stock issued and outstanding as of the Record Date for the Special Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We and CJJD Cayman
are in the process of applying for listing of CJJD Cayman&rsquo;s ordinary shares with the Nasdaq Capital Market and hope to complete
that process concurrent with or shortly after the consummation of the Redomicile Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Holders</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Based on the records of our
transfer agent, there were ____ stockholders of record of our common stock as of the Record Date for the Special Meeting (not including
beneficial owners who hold shares at broker/dealers in &ldquo;street name&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Transfer Agent</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our transfer agent is American
Stock Transfer &amp; Trust Company, LLC, whose address is 6201, 15th Avenue, Brooklyn, New York 11219, and whose telephone number is
(718) 921-8206.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dividends</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">While there are no restrictions
that limit our ability to pay dividends, we have not paid, and following the approval and completion of the Redomicile Merger do not
currently intend to pay, cash dividends on our common stock in the foreseeable future. Our policy is to retain all earnings, if any,
to provide funds for the operation and expansion of our business. The declaration of dividends, if any, will be subject to the discretion
of our Board of Directors, who may consider such factors as our results of operations, financial condition, capital needs and acquisition
strategy, among others, in making its determination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.9pt; text-align: justify; text-indent: 15.1pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="main_006"></A>MANAGEMENT&rsquo;S DISCUSSION AND ANALYSIS
OF<BR>
FINANCIAL CONDITION AND RESULTS OF OPERATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><I>The following discussion
and analysis of our results of operations and financial condition for the fiscal years ended March 31, 2020 and 2019, and for the three
and nine months ended December 31, 2020, should be read in conjunction with our financial statements and the notes to those financial
statements that are included elsewhere in this prospectus. Our discussion includes forward-looking statements based upon current expectations
that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Actual results and the timing of events
could differ materially from those anticipated in these forward-looking statements as a result of a number of factors, including those
set forth under the &ldquo;Risk Factors&rdquo; and &ldquo;Business&rdquo; sections and elsewhere in this prospectus. We use words such
as &ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo; &ldquo;plan,&rdquo; &ldquo;project,&rdquo; &ldquo;continuing,&rdquo; &ldquo;ongoing,&rdquo;
&ldquo;expect,&rdquo; &ldquo;believe,&rdquo; &ldquo;intend,&rdquo; &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo; &ldquo;could,&rdquo;
&ldquo;predict&rdquo; and similar expressions to identify forward-looking statements. Although we believe the expectations expressed
in these forward-looking statements are based on reasonable assumptions within the bound of our knowledge of our business, our actual
results could differ materially from those discussed in these statements. Factors that could contribute to such differences include,
but are not limited to, those discussed in the &ldquo;Risk Factors&rdquo; section of this prospectus. We undertake no obligation to update
publicly any forward-looking statements for any reason even if new information becomes available or other events occur in the future
other than in compliance with the SEC rules and regulations.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><I>Our financial statements
are prepared in U.S. Dollars and in accordance with accounting principles generally accepted in the United States. See &ldquo;Exchange
Rates&rdquo; at the end of this section for information concerning the exchanges rates at which Renminbi (&ldquo;RMB&rdquo;) were translated
into U.S. Dollars (&ldquo;USD&rdquo; or &ldquo;$&rdquo;) at various pertinent dates and for pertinent periods.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Overview </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We currently operate in four
business segments in China: (1) retail drugstores, (2) online pharmacy, (3) wholesale of products similar to those that we carry in our
pharmacies, and (4) farming and selling herbs used for traditional Chinese medicine (&ldquo;TCM&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our drugstores offer customers
a wide variety of pharmaceutical products, including prescription and over-the-counter (&ldquo;OTC&rdquo;) drugs, nutritional supplements,
TCM, personal and family care products, medical devices, and convenience products, including consumable, seasonal, and promotional items.
Additionally, we have licensed doctors of both western medicine and TCM on site for consultation, examination and treatment of common
ailments at scheduled hours. As of December 31, 2020, we had 115 pharmacies in Hangzhou city and its adjacent town Lin&rsquo;an under
the store brand of &ldquo;Jiuzhou Grand Pharmacy&rdquo; and 4 independent pharmacies controlled by Jiuzhou Pharmacy. During the nine
months ended December 31, 2020, we dissolved four pharmacies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Since May 2010, we have also
been selling certain OTC drugs, medical devices, nutritional supplements and other sundry products online. Our online pharmacy sells
through several third-party platforms such as Alibaba&rsquo;s Tmall, JD.com, Amazon.com and the Company&rsquo;s own platform all over
China. Our sales through our own platform are primarily generated by customers who use their private commercial medical insurances packages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We operate a wholesale business
through Jiuxin Medicine distributing third-party pharmaceutical products (similar to those carried by our pharmacies) primarily to trading
companies throughout China. We also planted gingko trees but have not incurred sales in the nine months ended December 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Amidst the COVID-19 outbreak,
we experienced a decline in the number of customer visits. To avoid face-to-face contact, customers tend to shop online. In order to
keep pace with customers&rsquo; change in their ways of shopping, we strengthened our O2O service team, which takes orders online, i.e.
via mobile phone app, and delivers products to local community from our stores. The spread of the disease has been effectively controlled
in China in the past few months. The number of the new infected daily has become limited. People tend to work and live as usual. As a
result, we believe the negative impacts on our operations are temporary. However, the extent to which the COVID-19 impacts our operations
will depend on its future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of
the outbreak, new information which may emerge concerning the severity of the coronavirus and the actions to contain the coronavirus
or minimize its harm, among others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Critical Accounting Policies and Estimates</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In preparing our audited
consolidated financial statements in accordance with accounting principles generally accepted in the United States of America, we are
required to make judgments, estimates and assumptions that affect: (i) the reported amounts of our assets and liabilities; (ii) the disclosure
of our contingent assets and liabilities at the end of each reporting period; and (iii) the reported amounts of revenue and expenses
during each reporting period. We continually evaluate these estimates based on our own historical experience, knowledge and assessment
of current business and other conditions, our expectations regarding the future based on available information and reasonable assumptions,
which together form our basis for making judgments about matters that are not readily apparent from other sources. Since the use of estimates
is an integral component of the financial reporting process, our actual results could differ materially from those estimates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We believe that any reasonable
deviation from those judgments and estimates would not have a material impact on our financial condition or results of operations. To
the extent that the estimates used differ from actual results, however, adjustments to the statement of operations and corresponding
balance sheet accounts would be necessary. These adjustments would be made in future financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">When reading our financial
statements, you should consider: (i) our critical accounting policies; (ii) the judgment and other uncertainties affecting the application
of such policies; and (iii) the sensitivity of reported results to changes in conditions and assumptions. The critical accounting policies
and related judgments and estimates used to prepare our financial statements are identified in Note 2 to our audited consolidated financial
statements accompanying in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Revenue recognition</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In May 2014, the FASB issued
ASU No. 2014-09, which creates Topic 606, Revenue from Contracts with Customers. The new guidance outlines a single comprehensive model
for entities to use in accounting for revenue arising from contracts with customers. The core principle of the guidance is that an entity
should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration
to which the entity expects to be entitled in exchange for those goods and services. Additionally, the guidance requires improved disclosure
to help users of financial statements better understand the nature, amount, timing, and uncertainty of revenue that is recognized. The
new guidance supersedes most current revenue recognition guidance, including industry-specific guidance. The standard is effective for
annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period, and permits early
adoption on a limited basis. The update permits the use of either the retrospective or cumulative effect transition method. On April
1, 2018, we adopted the guidance in ASC 606 and all the related amendments and applied the new revenue standard to all contracts using
the modified retrospective method. Based on the new standard our revenue recognition policies related to membership rewards programs
has changed. Membership rewards, usually membership points, are accumulated by customers based on their historical spending levels. The
Company has determined that there is an additional performance obligation to those customers at the time of the initial transaction.
The customers can then redeem these points against the prices of merchandises they purchase in the future. At the end of each period,
unredeemed membership rewards are reflected as a contract liability. The adoption of the new revenue standard was not material and is
not expected to be material to our net income on an ongoing basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Impairment of definite-lived intangible assets</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The Company evaluates the
recoverability of definite-lived intangible assets whenever events or changes in circumstances indicate that the carrying value of an
asset may not be recoverable. These long-lived assets are grouped and evaluated for impairment at the lowest level at which individual
cash flows can be identified. When evaluating these long-lived assets for potential impairment, the Company first compares the carrying
amount of the asset group to the asset group&rsquo;s estimated future cash flows (undiscounted and without interest charges). If the
estimated future cash flows are less than that carrying amount of the asset group, an impairment loss calculation is prepared. The impairment
loss calculation compares the carrying amount of the asset group to the asset group&rsquo;s estimated future cash flows (discounted and
with interest charges). If required, an impairment loss is recorded for the portion of the asset group&rsquo;s carrying value that exceeds
the asset group&rsquo;s estimated future cash flows (discounted and with interest charges).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The long-lived asset impairment
loss calculation contains uncertainty since management must use judgment to estimate each asset group&rsquo;s future sales, profitability
and cash flows. When preparing these estimates, the Company considers historical results and current operating trends and consolidated
sales, profitability and cash flow results and forecasts. These estimates can be affected by a number of factors including, but not limited
to, general economic and regulatory conditions, efforts of third party organizations to reduce their prescription drug costs and/or increased
member co-payments, the continued efforts of competitors to gain market share and consumer spending patterns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In the year ended March 31,
2020, we evaluated the licenses of insurance applicable drugstores acquired in the past based on their discounted positive cash value.
Due to the stricter government insurance policy in fiscal year 2021, the value of these licenses has declined. As a result, we recorded
an impairment of $628,192 as of March 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Results of Operations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Comparison of years ended March 31, 2020
and 2019</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The following table summarizes
our results of operations for the years ended March 31, 2020 and 2019:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="14" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Years
    ended March 31,</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2020</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2019</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Amount</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Percentage<BR>
    of total<BR> revenue</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Amount</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Percentage<BR>
    of total<BR> revenue</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%">Revenue</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">117,327,689</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">100.0</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">107,551,012</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">100.0</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Cost of goods sold</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">91,801,259</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">78.2</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">82,442,969</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">76.7</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Gross profit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">25,526,430</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21.8</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">25,108,043</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23.3</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Selling expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">23,793,603</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20.3</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">24,265,184</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22.6</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">General and administrative expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">8,108,377</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.9</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,718,989</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.6</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Impairment of long-lived assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">628,192</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.5</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Loss from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(7,003,742</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6.0</TD><TD STYLE="text-align: left">)%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(876,130</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(0.8</TD><TD STYLE="text-align: left">)%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other Income(expense), net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">562,323</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.5</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(306,876</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(0.3</TD><TD STYLE="text-align: left">)%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Change in fair value of derivative liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">401,158</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(0.3</TD><TD STYLE="text-align: left">)%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(326,452</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(0.3</TD><TD STYLE="text-align: left">)%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Income tax expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">16,258</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.0</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">134,763</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.1</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Net loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(6,457,677</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5.5</TD><TD STYLE="text-align: left">)%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(1,317,769</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1.2</TD><TD STYLE="text-align: left">)%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Revenue</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Primarily due to the rise
in our online pharmacy and wholesale business, revenue increased by $9,776,677 or 9.1% for the year ended March 31, 2020, as compared
to the year ended March 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Revenue by Segment</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table breaks
down the revenue for our four business segments for the year ended March 31, 2020 and 2019:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="14" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">For
    the year ended March 31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Amount</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">%
    of total<BR> revenue</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Amount</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">%
    of total<BR> revenue</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Variance
    by<BR> amount</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">%
    of<BR> change</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; text-align: left; padding-left: 0.25pt">Revenue from retail drugstores</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">74,081,237</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">63.1</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">72,334,409</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">67.3</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1,746,828</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">2.4</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25pt">Revenue from online sales</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,541,215</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11.6</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,784,459</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,756,756</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">54.1</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; text-align: left; text-indent: -10pt; padding-left: 10.25pt">Revenue from wholesale business</TD><TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: right">29,705,237</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: right">25.3</TD><TD STYLE="white-space: nowrap; text-align: left">%</TD><TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: right">26,432,144</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: right">24.6</TD><TD STYLE="white-space: nowrap; text-align: left">%</TD><TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: right">3,273,093</TD><TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: right">12.4</TD><TD STYLE="white-space: nowrap; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25pt">Revenue from farming business</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt; padding-left: 0.25pt">Total revenue</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">117,327,689</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">100.0</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">107,551,012</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">100.0</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">9,776,677</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">9.1</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Retail drugstores sales,
which accounted for approximately 63.1% of total revenue for the year ended March 31, 2020, increased by $1,746,828, or 2.4% compared
to the year ended March 31, 2019, to $74,081,237. Same-store sales increased by approximately $2,021,002, or 2.9%, while new stores contributed
approximately $53,241 in revenue in the year ended March 31, 2020. Excluding the RMB depreciation effect, the same store sales increased
by approximately 6.9% period over period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The increase in our retail
drugstore sales is primarily due to consumer-facing benefits such as emphasis on on-site medical care, chronic disease management services,
incremental DTP (Direct-to-Patient) business caused by continuous hospital medical reform, and maturing of stores opened a year ago.
Convenient on-site medical support at our pharmacies has been our hallmark from the beginning of our business. Suitable medical support
from our doctors has proven to be critical to our superior store sales. Linking doctor care with drug sales has become our business guidance
for the future. By adding more doctor-provided services at stores, we have been able to promote our store sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">As the PRC medical reform
goes on, more and more drug prescriptions have flowed out of hospitals. DTP drugs are usually new medicines with low profit margins.
As part of such medical reform package, local governments require the revenue percentage from drug sales at public hospitals to decline
year by year. In order to achieve lower drug sales percentage out of their total revenue, the public hospitals chose to abandon sales
of low profit margin DTP products first. As a result, the DTP drug manufacturers or vendors switched to local drugstores to explore the
market. As a large drugstore network in Hangzhou City, quite a few of our stores are located adjacent to local hospitals. Additionally,
we have actively approached local vendors of certain DTP products, which we have not sold at our stores in the past. By opening special
counters at some stores and selling more DTP products, sales in our drugstores increased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Furthermore, since fiscal
year 2018, we have accelerated our expansion of new stores, which is expected to generate more retail drugstore revenues. Eighteen stores
have become qualified for municipal government insurance reimbursement after about two years&rsquo; operation. Sales reimbursed from
municipal government insurance program usually account for more than 50% of our total sales at maturing stores. As these stores gained
such qualifications, their sales increased quickly as compared to the previous year. Our store count is 121 at March, 2019 and 117 at
March 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our online pharmacy sales
increased by approximately $4,756,756, or 54.1% for the year ended March 31, 2020, as compared to the year ended March 31, 2019. The
increase was caused by both an increase in sales via e-commerce platforms such as Tmall and an increase in sales via our official site.
Popular products at reasonable prices are key to success in online business. In order to promote our sales, we focused on the selection
of medical equipment suitable to local customers. For example, sales of blood glucose meters and contact lens contributed significantly
to our revenue in the year ended March 31, 2020 as compared to the same period a year ago. Additionally, we maintained a membership care
program targeted at chronic disease customers. We have closely interacted with our members via WeChat by providing healthcare knowledge
and reminding our customers to refill medicine. By implementing a personalized customer care program, we were able to promote our sales.
As a result, our sales via these e-commerce platforms increased by 58.3% period over period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The sales via our official
website were primarily made by certain pharmacy benefit management providers and insurance companies. For example, we have signed a service
contract with Yingda Taihe Life Insurance Co. Ltd. (&ldquo;Yingda&rdquo;), a national insurance company. State Grid Corporation of China
has bought health insurance package for its employees from Yingta. In the year ended March 31, 2020, we served a local factory of State
Grid and sold healthcare products to its employees who used their insurance card to make payments. The sales from these customers contributed
significantly to our official website sales. Additionally, in the first quarter of calendar 2020, at the outbreak of COVID-19, we sold
a large quantity of health protective products such as masks. Our official website sales increased by 847,899 or 40.8% year over year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Wholesale revenue increased
by $3,273,093 or 12.4%, primarily as a result of our ability to resell certain products, which our retail stores made large order on,
to other vendors. As our retail drugstores achieved large quantity sales of certain brand name products, we were able to bargain for
lower purchase prices than the market level on these merchandises. As a result, vendors who were unable to obtain a better price than
ours, turned to us for these products, causing the increase in the wholesale volume. However, hospitals are still the dominant drug retailers
in China. Local hospitals usually have strong ties with their existing suppliers and we have not been able to make significant progress
in becoming a major supplier to local hospitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In the year ended March 31,
2020 and 2019, we have not harvested and generated revenue from our farming business. We planted ginkgo trees during the year ended March
31, 2013. A ginkgo tree may have a growth period of up to twenty years before it is mature enough for harvest. Usually, the longer it
grows the more valuable it becomes. We plan to continue cultivating the trees in order to maximize their market value in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Gross Profit</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Gross profit increased by
$418,387 or 1.7% period over period primarily as a result of an increase in gross profit provided by both wholesale business and online
sale, which increased significantly in the year ended March 31, 2020. At the same time, gross margin decreased from 23.3% to 21.8% due
to lower online and offline retail profit margins. The average gross margins for each of our four business segments are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Year ended<BR> March 31,</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2020</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2019</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; padding-left: 0.25pt">Average gross margin for retail drugstores</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">28.1</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">29.2</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25pt">Average gross margin for online sales</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10.6</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11.8</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25pt">Average gross margin for wholesale business</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11.0</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11.3</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25pt">Average gross margin for farming business</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">N/A</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">N/A</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Retail gross margins decreased
primarily because of price restriction from local government on sale of drugs reimbursed by the National Public Health Insurance Program
and rising proportion of sales DTP (&ldquo;Direct-to-Patient&rdquo;) medicine with low profit margin. In order to control increasing
budget on medical insurance spending, government has drafted and executed a series of policies to reduce the price of drugs reimbursed
by its insurance program. For example, the government has invited bidders, usually manufacturers, for the drugs used in large quantity
every year. In exchange for large quantity, manufacturers have to surrender a low price. These drugs are usually prescription drugs primarily
used at hospitals. However, our drugstores also sell some of these drugs. As a result, our profit margin decreased. Additionally, as
we described above, DTP drug sales have taken a larger proportion of our sales at stores. DTP drugs have extremely low profit margins.
Hence, our retail profit margin decreased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Gross margin of online pharmacy
sales decreased primarily due to intense market competition. We conduct our business either through certain e-commerce platforms such
as Tmall and JD.com or via our own official online pharmacy website, www.dada360.com. The online prices of healthcare products are transparent
as customers can easily compare prices from websites. In order to promote our sales through e-commerce platforms, we have to lower our
prices leading to lower profit margin. As a way to retain new customers from insurance companies, we also kept low prices on our official
online pharmacy websites. As a result, our profit margin for online sales decreased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Wholesale gross margin decreased
primarily due to various products with different profit margins we carried and sold to certain pharmaceutical vendors. In the year ended
March 31, 2020, certain prescription drugs we sold are at low profit margin. As a result, the overall profit margin is lower as compared
to the same period last year. Although we have attempted to market our products to major local hospitals and other pharmacies, we have
not been able to make significant progress. Until we are able to obtain status as a provincial or national exclusive sale agent for certain
popular drugs or have sales access to large local hospitals, we may have to maintain low profit margins in order to drive sales on our
wholesale business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Selling and Marketing Expenses</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Sales and marketing expenses
decreased by $471,581 or 1.9% year over year, primarily due to decrease in rent. As we closed several stores, rent expense went down.
Additionally, we have closely monitored our marketing expense such as small gifts. As a result, our sale and marketing expense declined
slightly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>General and Administrative Expenses</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">General and administrative
expenses increased by $6,389,388 or 371.7% period over period. Such expenses as a percentage of revenue increased to 6.9% from 1.6% for
the same period a year ago. In the year ended March 31, 2020, we recorded bad debt expense of $455,159 as compared to a reduction in
the allowance for bad debts of $3,346,886 in FY2019. Additionally, we incurred additional labor cost of approximately $1.5 million as
we have expanded certain business. For example, we have been operating two Linjia Clinics and hired more doctors. In addition, in order
to obtain business from commercial health insurance providers, we formed a marketing team. Although these business have not contributed
significantly to our revenue, they incurred labor costs. Excluding such an effect, general and administrative expenses increased by approximately
$1.1 million, which reflects the increase in management cost as a result of our business expansion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Impairment of Long-lived Assets</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We recorded an impairment
of long-lived assets of $628,192 and $0 for the year ended March 31, 2020 and 2019. In the year ended March 31, 2020, we evaluated the
licenses of insurance applicable drugstores acquired in the past based on their discounted positive cash value. Due to the stricter government
insurance policy in fiscal year 2021, the value of these licenses has declined. As a result, we recorded an impairment of $628,192 as
of March 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Loss from Operations</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">As a result of the above,
we had loss from operations of $7,003,742, as compared to loss from operations of $876,130 a year ago. Our operating margin for the year
ended March 31, 2020 and 2019 was (6.0)% and (0.8)%, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Other Income (Expense), Net</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In the year ended March 31,
2020, other income is $(204,064) as compared to other income of $(93,311) in the year ended March 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Income Taxes</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our income tax expense decreased
by $118,505 period over period due to a decrease in the effective rate resulting from a decline in profits in several business lines.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Net Loss</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">As a result of the foregoing,
net loss is $6,457,677 in the year ended March 31, 2020 as compared to a net loss of $1,317,769 in the year ended March 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Accounts receivable</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Accounts receivable, which
are unsecured, are stated at the amount we expect to collect. We continuously monitor collections and payments from our customers (our
distributors) and maintain a provision for estimated credit losses. To prepare for potential loss in such accounts, we made corresponding
reserves.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our accounts receivable aging was as follows for
the periods described below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">From
    date of invoice to customer</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Retail<BR>
    drugstores</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Online<BR>
    Pharmacy</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Drug<BR>
    wholesale</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Herb<BR>
    farming</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Total<BR>
    amount</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; padding-left: 0.25pt">1- 3 months</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">7,097,422</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">766,988</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">541,975</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">8,406,385</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25pt">4- 6 months</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">77,195</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,531,512</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,608,707</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25pt">7- 12 months</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,848</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,149</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,997</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25pt">Over one year</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,919,409</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,873</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,355</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,005,637</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25pt">Allowance for doubtful accounts</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,752,952</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(68,542</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(442,576</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,264,070</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt; padding-left: 0.25pt">Total accounts receivable</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">7,351,922</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">759,319</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,659,415</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">9,770,656</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Accounts receivable from
our retail business mainly consist of reimbursements from local government health insurance bureaus and commercial health insurance programs.
In the year ended March 31, 2020, we wrote off an approximately $212,338 collectible from provincial and Hangzhou City government insurance,
as such amounts have been determined by the health insurance bureaus to be unqualified for reimbursement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Accounts receivables from
our online pharmacy business mainly consist of receivables from insurance company and a service company handling with insurance companies.
As we continue to expand our business with commercial insurance company, our receivables from them increased. Additionally, certain receivables
are from third-party platforms such as JD.com where we sell products. Usually the third-party platforms will collect from customers ordering
on their platforms and then reimburse us at a later date, such reimbursement periods times ranging from several days to a month after
orders are placed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Accounts receivable from
our drug wholesale business consist of receivables from our customers such as pharmaceutical distributors and local drugstores primarily
in Zhejiang Province. In fiscal 2019, we accelerated collection of certain aged accounts from customers which we no longer or rarely
sold products to. By doing so, we are able to take better use of our cash. As a result, the overall reserve on wholesale accounts receivables
decreased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Subsequent to March 31, 2020
and through May 31, 2020, we collected approximately $5.3 million in receivables relating to our drugstore business, approximately $0.5
million in receivables relating to our online pharmacy business, approximately $1.7 million relating to our wholesale business, and $0
relating to our herb farming business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Advances to suppliers</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Advances to suppliers are
mainly prepayments to secure certain products or services at favorable pricing. The aging of our advances to suppliers is as follows
for the periods described below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid">From date of cash prepayment to suppliers</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Retail<BR> drugstores</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Online<BR> Pharmacy</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Drug<BR> wholesale</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Herb<BR> farming</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Total<BR> amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; padding-left: 0.25pt">1- 3 months</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">41,889</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">480,417</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">522,306</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25pt">4- 6 months</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">104,131</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">245,407</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">349,538</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25pt">7- 12 months</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">198,397</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">300,033</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">498,430</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25pt">Over one year</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">82,357</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">746,232</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">828,589</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25pt">Allowance for doubtful accounts</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(140,743</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(883,320</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,024,063</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt; padding-left: 0.25pt">Total advances to suppliers</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">286,031</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">888,769</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,174,800</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Since the acquisition of
Jiuxin Medicine, we have gradually transferred almost all logistics services of our retail drugstores to Jiuxin Medicine. Jiuzhou Pharmacy
only purchases certain non-medical products such as sundry. As a result, our retail chain made few advances to suppliers as of March
31, 2020. At the end of 2019 we had outstanding advances to suppliers with which we have ceased doing business. These advances have been
fully reserved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Advances to suppliers for
our drug wholesale business consist of prepayments to our vendors such as pharmaceutical manufacturers and other distributors. We typically
receive products from vendors within three to nine months after making prepayments. We continuously monitor delivery from and payments
to our vendors while maintaining a provision for estimated credit losses based upon past experience and any supplier-specific issues
such as the discontinuation of inventory supply that have been identified. If we are having difficulty receiving products from a vendor,
we take the following steps: cease purchasing products from the vendor, ask for return of our prepayment promptly, and if necessary,
take legal action. If all of these steps are unsuccessful, management then determines whether or not the prepayments should be reserved
or written off. In fiscal 2019, in order to use our cash more efficiently, we accelerated the collection of deposits from quite a few
suppliers, especially aged accounts. We chose to only leave deposits with critical suppliers who supply large quantities of merchandise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">As a result, the outstanding
advances to suppliers decreased dramatically.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Comparison of the three months ended December
31, 2020 and 2019</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table summarizes
our results of operations for the three months ended December 31, 2020 and 2019:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Three months ended December 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Percentage<BR> of total<BR> revenue</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Percentage<BR> of total<BR> revenue</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: justify">Revenue</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">35,538,759</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">100.0</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">33,363,282</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">100.0</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Gross profit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">8,087,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22.8</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">7,283,372</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21.8.</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Selling expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">8,262,590</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23.2</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5,676,400</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17.0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">General and administrative expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">6,192,294</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17.4</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,054,060</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.2</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Loss(gain) from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(6,367,634</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(17.9</TD><TD STYLE="text-align: left">)%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">552,912</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.7</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Other Income(expense), net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">39,786</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(29,635</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(0.1</TD><TD STYLE="text-align: left">)%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Change in fair value of derivative liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">36,306</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(65,172</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(0.2</TD><TD STYLE="text-align: left">)%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Income tax expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,976</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(0.0</TD><TD STYLE="text-align: left">)%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,184</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Net loss(gain)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(6,293,518</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(17.7</TD><TD STYLE="text-align: left">)%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">455,921</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.4</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Revenue</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Due to the growth in our online
pharmacy, revenue increased by $2,175,477 or 6.5% for the three months ended December 31, 2020, as compared to the three months ended
December 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Revenue by Segment</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table breaks
down the revenue of our four business segments for the three months ended December 31, 2020 and 2019:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="text-align: center; border-bottom: Black 1.5pt solid">For the three months ended December 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">% of total<BR> &nbsp;&nbsp;revenue</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">% of total<BR> revenue</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Variance<BR> by&nbsp;amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">% of<BR> change</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; text-align: left; text-indent: -9pt; padding-left: 9pt">Revenue from retail drugstores</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">20,066,840</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">56.5</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">21,575,965</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">64.7</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(1,509,125</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(7.0</TD><TD STYLE="width: 1%; text-align: left">)%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Revenue from online sales</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,599,138</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18.5</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,965,023</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11.9</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,634,115</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">66.4</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Revenue from wholesale business</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,872,781</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25.0</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,822,294</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23.4</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,050,487</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13.4</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Revenue from farming business</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt; text-indent: -9pt; padding-left: 9pt">Total revenue</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">35,538,759</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">100.0</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">33,363,282</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">100.0</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">2,175,477</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">6.5</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Retail drugstores sales, which
accounted for approximately 56.5% of total revenue for the three months ended December 31, 2020, decreased by $1,509,125, or 7.0% compared
to the three months ended December 31, 2019, to $20,066,840. After removing the impact of exchange rate fluctuation, the retail drugstores
sales decreased by 12.6%. Same-store sales decreased by approximately $2,382,523, or 11.4%, while new stores contributed approximately
$859,525 in revenue in the three months ended December 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The decrease in our retail
drugstore sales is primarily due the negative effect on the overall economy from COVID-19, and also to our strategic decision to cease
selling certain low-profit margin products that are eligible for reimbursement by National Healthcare Security Administration (&ldquo;NHSA&rdquo;
hereafter) since September 1, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In the first half of 2020,
to boost our sales, we promoted sale of DTP (Direct-to-Patient) drugs. DTP drugs are usually new medicines not sold at hospitals with
low profit margin. As part of the PRC&rsquo;s recent medical reform package, local governments require public hospitals to reduce their
revenue percentage from drug sales. In order to achieve such goal, public hospitals first cease to sell low-profit-margin DTP products.
As the biggest local drugstore network in Hangzhou City, Jiuzhou Pharmacy has a few stores located adjacent to local hospitals. Additionally,
we have actively contacted local vendors for certain DTP products that we were previously not selling and were able to sell these DTP
products in our stores. By setting special counters selling DTP products at our stores, our sales have increased especially in the first
half of Calendar 2020. However, sales of a few DTP drugs are reimbursed by local NHSA. If we continue to sell large quantity of products
reimbursed by the NHSA, the agency may refuse to pay us due to its limited budget. As a result, we chose to actively control sales of
certain low-profit margin products covered by NHSA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In order to further balance
its budget, the local NHSA announced to eliminate a variety of medicines, including nutritional supplements, from its list of reimbursed
drugs beginning from September 1, 2020. Certain eliminated items are quite popular at the market. As these products are not reimbursed
by their insurance program, customers usually choose to order less on these products. As a result, our overall sales were affected. However,
as we quickly searched for substitute products favored by our customers, we expect to recover our sales in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Although local economy has
quickly recovered from COVID-19, the economy growth has slowed down in general. Local people have become more conservative in consumption.
It appears that COVID-19 has become more contagious in the winter. Once the spread of COVID-19 is effectively controlled, we expect the
local consumption will surge again in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our online pharmacy sales
increased by approximately $2,634,115, or 66.4% for the three months ended December 31, 2020, as compared to the three months ended December
31, 2019. The increase was primarily caused by an increase in sales of prescription drugs via e-commerce platforms such as Tmall. In the
past, prescription drugs cannot be sold online due to safety concern. However, because the nation has lifted the ban order, online prescription
drug sales become popular. As a result, the sale of prescription drugs was $2,227,332 in the three months ended December 31, 2020 as compared
to none in the three month ended December 31, 2019. Additionally, we maintained a membership care program targeted at chronic disease
customers. We have closely interacted with our members via WeChat by providing healthcare knowledge and reminding our customers to refill
medicine. By implementing a personalized customer care program, we were able to promote our sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Wholesale revenue increased
by $1,050,487 or 13.4%. The sale of our wholesale business may vary based on customer&rsquo;s need. Usually we resell certain products,
which our retail stores made large order on, to other vendors. As our retail drugstores achieved large quantity sales of certain brand
name products, we were able to bargain for lower purchase prices on these merchandises. As a result, vendors who were unable to obtain
a better price than ours, turned to us for these products. On the other hand, hospitals are still the dominant drug retailers in China.
Local hospitals usually have strong ties with their existing suppliers and we have not been able to make significant progress in becoming
a major supplier to local hospitals.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In the three months ended
December 31, 2020 and 2019, we have not generated revenue from our farming business. We planted ginkgo and maidenhair trees during the
year ended March 31, 2013, more than seven years ago. A ginkgo tree may have a growth period of up to twenty years before it is mature
enough for harvest. Usually, the longer a ginkgo tree grows the more valuable it becomes. Therefore, we have not yet harvested our ginkgo
trees. We plan to continue cultivating the trees in order to maximize their market value in the future. We will continue to grow ginkgo
trees in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Gross Profit</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Gross profit increased by
$803,878 or 11.0% period over period primarily as a result of an increase in gross profit provided by retail pharmacy business and online
pharmacy sales, which increased significantly in the three months ended December 31, 2020. At the same time, gross margin increased slightly
from 21.8% to 22.8% due to lower online pharmacy profit margins. The average gross margins for each of our four business segments are
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">For the three months ended<BR> December&nbsp;31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Average gross margin for retail drugstores</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">32.6</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">28.7</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Average gross margin for online sales</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.2</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Average gross margin for wholesale business</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11.4</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9.9</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Average gross margin for farming business</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Retail gross margins increased
primarily because of the control on sale of low profit margin products reimbursed by NHSA, introducing certain popular products with high
profit margin, and renegotiating prices with our suppliers continuously. As described above, in order to meet the NHSA budget, we chose
to actively control sales of certain low-profit margin products covered by NHSA. In order to promote our sales and profits, we specifically
selected a series of popular products, which we believe are suitable to local community. As a result, we were able to keep up with our
sales profit margin. Additionally, we continuously renegotiate with our vendors and press price down to acceptable levels. For example,
we explore more suppliers to search for lower prices. We also try to directly purchase from manufacturers instead of local vendors to
cut off middle-man expenses. We expect to keep our profit margin at a reasonable level in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Gross margin of online pharmacy
sales decreased primarily due to intense market competition. We conduct our business either through certain e-commerce platforms such
as Tmall and JD.com or via our own official online pharmacy website, www.dada360.com. The online prices of healthcare products are transparent
as customers can easily compare prices from websites. In order to promote our sales through e-commerce platforms, we have to lower our
prices leading to lower profit margin. As a way to retain new customers from insurance companies, we also kept low prices on our official
online pharmacy websites. As a result, our profit margin for online sales decreased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Wholesale gross margin increased
primarily due to various products with different profit margin we carried and sold to certain pharmaceutical vendors. Although we have
attempted to market our products to major local hospitals and other pharmacies, we have not been able to make significant progress. Until
we are able to obtain status as a provincial or national exclusive sale agent for certain popular drugs or have sales access to large
local hospitals, we may have to maintain low profit margins in order to drive sales on our wholesale business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Selling and Marketing Expenses</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Selling and marketing expenses
increased by $2,586,190, or 45.6%, as compared to the same period of last fiscal year, primarily due to increase in annual employee compensation
and online sales service fee as a result of sale increase in our online pharmacy. To cope with intense competition in retail pharmacy
business, it is important to retain key operation staff such as store managers and marketing and merchandise analysts. In addition, our
fast growing online pharmacy business requires more experienced staff. To retain these staff, we incurred $1.6 million more labor expenses.
On the other side, our online pharmacy sales increased more than 60% in the three months ended December 31, 2020 as compared to the same
period last year. As a result, we incurred additional service fee of $0.5 million from third-party platforms such as Tmall and JD.com,
which usually charge their fee based on a proportion of our sales via their platforms. Overall, such expenses as a percentage of our revenue
were 23.2% and 17.0% respectively, in the three months ended December 31, 2020 and 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>General and Administrative Expenses</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">General and administrative
expenses increased by $5,138,234, or 487.5%, as compared to the same period of last year. Such expenses as a percentage of revenue increased
to 17.4% from 3.2% for the same period of last year. On December 21, 2020, we issued 3,790,000 shares of common stock according to our
employee stock reward incentive plan and recorded stock-based compensation of $3,941,600. Additionally, for the three months ended December
31, 2020, bad debt direct write-off and provision amounted to $293,141, an increase of $1,089,429, as compared to reversal of bad debt
allowance of $796,288 for the same period a year ago. Excluding such effect, the general and administrative expenses increased by $109,016
period over period, which reflects the increase in staff and administration expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Loss (income) from Operations</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As a result of the above,
we had loss from operations of $6,367,634 in the quarter ended December 31, 2020, as compared to income from operations of $552,912 a
year ago. Our operating margin for the three months ended December 31, 2020 and 2019 was (17.9)% and 1.7%, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Income Taxes</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our income tax expense decreased
by $208 period over period due to a decrease in overall profit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Net Loss (income)</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As a result of the foregoing,
net loss is $6,293,518 in the three months ended December 31, 2020 as compared to a net income of $455,921 in the three months ended December
31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Comparison of the nine months ended December
31, 2020 and 2019</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table summarizes
our results of operations for the nine months ended December 31, 2020 and 2019:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Nine months ended December 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Percentage<BR> of total<BR> revenue</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Percentage<BR> of total<BR> revenue</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: justify">Revenue</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">97,435,616</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">100.0</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">86,997,845</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">100.0</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Gross profit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">23,080,221</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23.7</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">20,038,174</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23.0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Selling expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">21,010,509</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21.6</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">18,130,799</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20.8</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">General and administrative expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">10,374,019</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10.6</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5,729,607</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.6</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Loss from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(8,304,307</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8.5</TD><TD STYLE="text-align: left">)%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(3,822,232</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4.4</TD><TD STYLE="text-align: left">)%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Other Income, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">71,487</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">224,042</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.3</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Change in fair value of derivative liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">64,090</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">345,248</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.4</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Income tax expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">40,571</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.0</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">16,274</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Net loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(8,209,301</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8.4</TD><TD STYLE="text-align: left">)%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(3,269,216</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3.8</TD><TD STYLE="text-align: left">)%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Revenue</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Due to the growth in our retail
drugstores business, online pharmacy and wholesale business, revenue increased by $10,437,771 or 12.0% for the nine months ended December
31, 2020, as compared to the nine months ended December 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Revenue by Segment</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table breaks
down the revenue of our four business segments for the nine months ended December 31, 2020 and 2019:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="text-align: center; border-bottom: Black 1.5pt solid">For the nine months ended December 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">% of total<BR> &nbsp;&nbsp;revenue</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">% of total<BR> revenue</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Variance<BR> by&nbsp;amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">% of<BR> change</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; text-align: left; text-indent: -9pt; padding-left: 9pt">Revenue from retail drugstores</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">56,807,810</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">58.3</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">56,312,226</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">64.7</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">495,584</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0.9</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Revenue from online sales</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,858,984</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17.3</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,759,892</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,099,092</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">92.5</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Revenue from wholesale business</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,768,822</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24.4</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,925,727</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25.2</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,843,095</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.4</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Revenue from farming business</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Retail drugstores sales, which
accounted for approximately 58.3% of total revenue for the nine months ended December 31, 2020, increased by $495,584, or 0.9% compared
to the nine months ended December 31, 2019, to $56,312,226. However, after removing the impact of exchange rate fluctuation, the actual
retail drugstores sales decreased 0.8%. Same-store sales decreased by approximately $1,791,766, or 3.3%, while new stores contributed
approximately $2,064,353 in revenue in the nine months ended December 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The actual decrease in our
retail drugstore sales is primarily due to the negative effect on the overall economy from COVID-19, and also to our strategic decision
to cease selling certain low-profit margin products that are eligible for reimbursement by NHSA since September 1, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In the first half of Calendar
2020, to boost our sales, we promoted sale of DTP (Direct-to-Patient) drugs. DTP drugs are usually new medicines not sold at hospitals
with low profit margin. As part of the PRC&rsquo;s recent medical reform package, local governments require local hospitals to reduce
the revenue percentage from drug sales. In order to achieve such goal, the public hospitals first chose to case to sell low-profit-margin
DTP products. As the biggest local drugstore network in Hangzhou City, Jiuzhou Pharmacy has a few stores located adjacent to local hospitals.
Additionally, we have actively contacted local vendors of certain DTP products that we were previously not selling and were able to sell
these DTP products in our stores. By setting special counters selling DTP products at our stores, sales in our drugstores have increased
especially in the first half of Calendar 2020. However, sales of a few DTP drugs are reimbursed by local NHSA. If we continue to sell
large quantity of products reimbursed by the NHSA, the agency may refuse to pay us due to its limited budget. As a result, we chose to
actively control sales of certain low-profit margin products covered by NHSA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In order to further balance
its budget, the local NHSA announced to eliminate a variety of medicines, including nutritional supplements, from its list of reimbursed
drugs beginning from September 1, 2020. Certain eliminated items are quite popular at the market. As these products are not reimbursed
by their insurance program, customers usually choose to order less on these products. As a result, our overall sales were affected. However,
as we quickly searched for substitute products favored by our customers, we expect to recover our sales in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Although local economy has
quickly recovered from COVID-19, the economy growth has slowed down in general. Local people have become more conservative in consumption.
It appears that COVID-19 has become more <FONT STYLE="background-color: white">contagious</FONT> in the winter. Once the spread of COVID-19
is effectively controlled, we expect the local consumption will surge again in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Furthermore, from fiscal years
2018 to 2020, we have accelerated our expansion of new stores, which have generated more retail drugstore revenues. Among the new stores,
forty-six stores have become qualified for municipal government insurance reimbursement after operation of a year or more. Sales reimbursed
from municipal government insurance program usually account for more than 50% of our total sales at maturing stores. As these stores gained
such qualifications, their sales increased quickly compared to the previous year. Our store count is 115 at December 31, 2020 and 114
at December 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our online pharmacy sales
increased by approximately $8,099,092, or 92.5% for the nine months ended December 31, 2020, as compared to the nine months ended December
31, 2019. The increase was primarily caused by an increase in sales of prescription drugs via e-commerce platforms such as Tmall. In the
past, prescription drugs cannot be sold online due to safety concern. However, because the nation has lifted the ban order, online prescription
drug sales become popular. As a result, the sale of prescription drugs was $5,855,491 in the nine months ended December 31, 2020 as compared
to none in the nine month ended December 31, 2019. Additionally, we maintained a membership care program targeted at chronic disease customers.
We have closely interacted with our members via WeChat by providing healthcare knowledge and reminding our customers to refill medicine.
By implementing a personalized customer care program, we were able to promote our sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Wholesale revenue increased
by $1,843,095 or 8.4% primarily as a result of our ability to resell certain products, which our retail stores made large order on, to
other vendors. As our retail drugstores achieved large quantity sales of certain brand name products, we were able to bargain for lower
purchase prices than the market level on these merchandises. As a result, vendors who were unable to obtain a better price than ours,
turned to us for these products, causing the increase in the wholesale volume. Although in August and September, the sales slowed down
due to the absence of a key salesperson, we believe the sales volume will recover in the future. However, hospitals are still the dominant
drug retailers in China. Local hospitals usually have strong ties with their existing suppliers and we have not been able to make significant
progress in becoming a major supplier to local hospitals.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In the nine months ended December
31, 2020 and 2019, we have not generated revenue from our farming business. We planted ginkgo and maidenhair trees during the year ended
March 31, 2013, more than seven years ago. A ginkgo tree may have a growth period of up to twenty years before it is mature enough for
harvest. Usually, the longer a ginkgo tree grows the more valuable it becomes. Therefore, we have not yet harvested our ginkgo trees.
We plan to continue cultivating the trees in order to maximize their market value in the future. We will continue to grow ginkgo trees
in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Gross Profit</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Gross profit increased by
$3,042,047 or 15.2% period over period primarily as a result of an increase in gross profit provided by retail pharmacy business, which
increased significantly in the nine months ended December 31, 2020. At the same time, gross margin increased slightly from 23.0% to 23.7%
due to higher retail pharmacy profit margins. The average gross margins for each of our four business segments are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">For the nine months ended<BR> December&nbsp;31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Average gross margin for retail drugstores</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">32.7</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">29.8</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Average gross margin for online sales</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10.8</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11.3</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Average gross margin for wholesale business</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11.4</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10.4</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Average gross margin for farming business</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Retail gross margins increased
primarily because of introducing certain popular products with high profit margin, and renegotiating prices with our suppliers continuously.
In order to promote our sales and profits, we specifically selected a series of popular products such as radix bupleuri, which we believe
are suitable to local community. As a result, we were able to keep up with our sales profit margin. Additionally, we continuously renegotiate
with our vendors and press price down to acceptable levels. For example, we explore more suppliers to search for lower prices. We also
try to directly purchase from manufacturers instead of local vendors to cut off middle-man expenses. We expect to keep our profit margin
at a reasonable level in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Gross margin of online pharmacy
sales decreased primarily due to intense market competition. We conduct our business either through certain e-commerce platforms such
as Tmall and JD.com or via our own official online pharmacy website, www.dada360.com. The online prices of healthcare products are transparent
as customers can easily compare prices from websites. In order to promote our sales through e-commerce platforms, we have to lower our
prices leading to lower profit margin. As a way to retain new customers from insurance companies, we also kept low prices on our official
online pharmacy websites. As a result, our profit margin for online sales decreased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Wholesale gross margin increased
primarily due to various products with different profit margin we carried and sold to certain pharmaceutical vendors. Although we have
attempted to market our products to major local hospitals and other pharmacies, we have not been able to make significant progress. Until
we are able to obtain status as a provincial or national exclusive sale agent for certain popular drugs or have sales access to large
local hospitals, we may have to maintain low profit margins in order to drive sales on our wholesale business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Selling and Marketing Expenses</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Selling and marketing expenses
increased by $2,879,710, or 15.9%, as compared to the same period of last fiscal year, primarily due to increase in fee charged by various
platforms as a result of sale increase in our online pharmacy. To cope with intense competition in retail pharmacy business, it is important
to retain key operation staff such as store managers and marketing &amp; merchandise analysts. In addition, our fast-growing online pharmacy
business requires more experienced staff. To retain these staff, we incurred $1.0 million more labor expense. On the other hand, our online
pharmacy sales increased more than 60% in the three months ended December 31, 2020 as compared to the same period last year. As a result,
we incurred additional service fee of $1 million from third-party platforms such as Tmall and JD.com, which usually charge their fee based
on a proportion of our sales via their platforms. Overall, such expenses as a percentage of our revenue were 21.6% and 20.8% respectively,
in the nine months ended December 31, 2020 and 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>General and Administrative Expenses</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">General and administrative
expenses increased by $4,644,412, or 81.1%, as compared to the same period of last year. Such expenses as a percentage of revenue decreased
to 10.6% from 6.6% for the same period of last year. On December 21, 2020, we issued 3,790,000 shares of common stock according to our
employee stock reward incentive plan and recorded stock-based compensation of $3,941,600. Excluding such an effect, the general and administrative
expenses increased by $702,812 period over period, which reflects the increases in staff and administration expense as our online business
grew.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Loss from Operations</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As a result of the above,
we had loss from operations of $8,304,307 in the quarter ended December 31, 2020, as compared to loss from operations of $3,822,232 a
year ago. Our operating margin for the nine months ended December 31, 2020 and 2019 was (8.5)% and (4.4)%, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Income Taxes</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our income tax expense increased
by $24,297 period over period due to an increase in overall profit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Net Loss</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As a result of the foregoing,
net loss is $8,209,301 in the nine months ended December 31, 2020 as compared to a net loss of $3,269,216 in the nine months ended December
31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Accounts receivable</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Accounts receivable, which
are unsecured, are stated at the amount we expect to collect. We continuously monitor collections and payments from our customers (our
distributors) and maintain a provision for estimated credit losses. To prepare for potential loss in such accounts, we made corresponding
reserves.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our accounts receivable aging
was as follows for the periods described below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">From date of invoice to customer</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Retail<BR> drugstores</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Online<BR> Pharmacy</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Drug<BR> wholesale</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Herb<BR> farming</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Total<BR> amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: justify">1- 3 months</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">9,872,323</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">680,476</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">483,786</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">11,036,585</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">4- 6 months</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">78,816</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,189</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">343,413</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">429,418</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">7- 12 months</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,440</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">61</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">195,948</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">209,449</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Over one year</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,890,196</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">66,080</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">383,760</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,340,036</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Allowance for doubtful accounts</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,935,724</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(73,628</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(484,148</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,493,500</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total accounts receivable</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">9,919,051</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">680,178</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">922,759</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">11,521,988</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Accounts receivable from our
retail business mainly consist of reimbursements from government health insurance bureaus and commercial health insurance programs. In
the nine months ended December 31, 2020, we wrote off an approximately $71,856 collectible from provincial and Hangzhou City government
insurance, as such amount has been determined by the health insurance bureaus to be unqualified for reimbursement.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Accounts receivables from
our online pharmacy business mainly consist of receivables from insurance company and a service company handling with insurance companies.
As we continue to expand our business with commercial insurance company, our receivables from them increased. Additionally, certain receivables
are from third-party platforms such as JD.com where we sell products. Usually the third-party platforms will collect from customers ordering
on their platforms and then reimburse us at a later date. Such reimbursement periods range from several days to a month after orders are
placed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Accounts receivable from our
drug wholesale business consist of receivables from our customers such as pharmaceutical distributors and local drugstores primarily in
Zhejiang Province. In fiscal 2019, we accelerated collection of certain aged accounts from customers who we no longer or rarely sold products
to. By doing so, we are able to improve our cash flow. However, as our wholesale business kept growing in a steady rate, receivable from
wholesale customers increased accordingly. We usually put reserve on new accounts based on historical collection experience. As a result,
the overall reserve on wholesale accounts receivables increased slightly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Subsequent to December 31,
2020 and through January 31, 2021, we collected approximately $3.1 million in receivables relating to our drugstore business, approximately
$0.4 million in receivables relating to our online pharmacy business, approximately $0.8 million relating to our wholesale business, and
$0 relating to our herb farming business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Advances to suppliers</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Advances to suppliers are
mainly prepayments to secure certain products or services at favorable pricing. The aging of our advances to suppliers is as follows for
the periods described below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid">From date of cash prepayment to suppliers</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Retail<BR> drugstores</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Online<BR> Pharmacy</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Drug<BR> wholesale</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Herb<BR> farming</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Total<BR> amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: justify">1- 3 months</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">600,873</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">3,973,097</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">4,573,970</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">4- 6 months</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,872</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">316,291</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">343,163</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">7- 12 months</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100,320</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">235,579</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">335,899</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Over one year</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">36,343</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">305,816</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">342,159</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Allowance for doubtful accounts</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(165,025</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(918,345</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,083,370</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total advances to suppliers</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">599,383</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">3,912,438</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">4,511,821</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Since the acquisition of Jiuxin
Medicine, we have gradually transferred almost all logistics services of our retail drugstores to Jiuxin Medicine. Jiuzhou Pharmacy only
makes purchases of certain non-medical products. As a result, our retail chain had little advances to suppliers as of December 31, 2020.
In the nine months ended December 31, 2020, we had outstanding advances to suppliers with which we have ceased doing business. These advances
have been fully reserved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Advances to suppliers for
our drug wholesale business consist of prepayments to our vendors such as pharmaceutical manufacturers and other distributors.&nbsp;We
typically receive products from vendors within three to nine months after making prepayments.&nbsp;We continuously monitor delivery from
and payments to our vendors while maintaining a provision for estimated credit losses based upon past experience and any supplier-specific
issues such as the discontinuation of inventory supply that have been identified.&nbsp;If we are having difficulty receiving products
from a vendor, we take the following steps: ceasing purchasing products from the vendor, asking for prompt return of our prepayment, and
if necessary, taking legal actions.&nbsp;If all of these steps are unsuccessful, management then determines whether or not the prepayments
should be reserved or written off.&nbsp; The increase in advance to suppliers is primarily due to deposits made to purchase Ejiao. Ejiao
is a traditional chinese nutritional supplement, which is popular in the local market. In order to retain the sufficient quantity for
our stores, we advanced approximately $3.06 million purchase deposits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Comparison of the nine months ended December
31, 2020 and 2019</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes our results of
operations for the nine months ended December 31, 2020 and 2019:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Nine months ended December 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Percentage<BR> of total<BR> revenue</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Percentage<BR> of total<BR> revenue</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: justify">Revenue</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">97,435,616</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">100.0</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">86,997,845</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">100.0</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Gross profit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">23,080,221</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23.7</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">20,038,174</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23.0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Selling expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">21,010,509</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21.6</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">18,130,799</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20.8</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">General and administrative expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">10,374,019</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10.6</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5,729,607</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.6</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Loss from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(8,304,307</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8.5</TD><TD STYLE="text-align: left">)%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(3,822,232</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4.4</TD><TD STYLE="text-align: left">)%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Other Income, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">71,487</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">224,042</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.3</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Change in fair value of derivative liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">64,090</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">345,248</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.4</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Income tax expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">40,571</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.0</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">16,274</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Net loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(8,209,301</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8.4</TD><TD STYLE="text-align: left">)%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(3,269,216</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3.8</TD><TD STYLE="text-align: left">)%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Revenue</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Due to the growth in our retail
drugstores business, online pharmacy and wholesale business, revenue increased by $10,437,771 or 12.0% for the nine months ended December
31, 2020, as compared to the nine months ended December 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Revenue by Segment</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table breaks
down the revenue of our four business segments for the nine months ended December 31, 2020 and 2019:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="text-align: center; border-bottom: Black 1.5pt solid">For the nine months ended December 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">% of total<BR> &nbsp;&nbsp;revenue</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">% of total<BR> revenue</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Variance<BR> by&nbsp;amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">% of<BR> change</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; text-align: left; text-indent: -9pt; padding-left: 9pt">Revenue from retail drugstores</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">56,807,810</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">58.3</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">56,312,226</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">64.7</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">495,584</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0.9</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Revenue from online sales</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,858,984</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17.3</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,759,892</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,099,092</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">92.5</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Revenue from wholesale business</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,768,822</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24.4</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,925,727</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25.2</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,843,095</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.4</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Revenue from farming business</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Comparison of the nine months ended December
31, 2020 and 2019</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table summarizes
our results of operations for the nine months ended December 31, 2020 and 2019:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Nine months ended December 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Percentage<BR> of total<BR> revenue</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Percentage<BR> of total<BR> revenue</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: justify">Revenue</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">97,435,616</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">100.0</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">86,997,845</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">100.0</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Gross profit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">23,080,221</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23.7</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">20,038,174</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23.0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Selling expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">21,010,509</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21.6</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">18,130,799</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20.8</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">General and administrative expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">10,374,019</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10.6</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5,729,607</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.6</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Loss from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(8,304,307</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8.5</TD><TD STYLE="text-align: left">)%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(3,822,232</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4.4</TD><TD STYLE="text-align: left">)%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Other Income, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">71,487</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">224,042</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.3</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Change in fair value of derivative liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">64,090</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">345,248</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.4</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Income tax expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">40,571</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.0</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">16,274</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Net loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(8,209,301</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8.4</TD><TD STYLE="text-align: left">)%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(3,269,216</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3.8</TD><TD STYLE="text-align: left">)%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Revenue</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Due to the growth in our retail
drugstores business, online pharmacy and wholesale business, revenue increased by $10,437,771 or 12.0% for the nine months ended December
31, 2020, as compared to the nine months ended December 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Revenue by Segment</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table breaks
down the revenue of our four business segments for the nine months ended December 31, 2020 and 2019:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="text-align: center; border-bottom: Black 1.5pt solid">For the nine months ended December 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">% of total<BR> &nbsp;&nbsp;revenue</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">% of total<BR> revenue</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Variance<BR> by&nbsp;amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">% of<BR> change</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; text-align: left; text-indent: -9pt; padding-left: 9pt">Revenue from retail drugstores</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">56,807,810</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">58.3</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">56,312,226</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">64.7</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">495,584</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">0.9</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Revenue from online sales</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,858,984</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17.3</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,759,892</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,099,092</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">92.5</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Revenue from wholesale business</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,768,822</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24.4</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,925,727</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25.2</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,843,095</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.4</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">Revenue from farming business</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Gross Profit</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Gross profit increased by
$3,042,047 or 15.2% period over period primarily as a result of an increase in gross profit provided by retail pharmacy business, which
increased significantly in the nine months ended December 31, 2020. At the same time, gross margin increased slightly from 23.0% to 23.7%
due to higher retail pharmacy profit margins. The average gross margins for each of our four business segments are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">For the nine months ended<BR> December&nbsp;31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Average gross margin for retail drugstores</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">32.7</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">29.8</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Average gross margin for online sales</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10.8</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11.3</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Average gross margin for wholesale business</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11.4</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10.4</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Average gross margin for farming business</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Retail gross margins increased
primarily because of introducing certain popular products with high profit margin, and renegotiating prices with our suppliers continuously.
In order to promote our sales and profits, we specifically selected a series of popular products such as radix bupleuri, which we believe
are suitable to local community. As a result, we were able to keep up with our sales profit margin. Additionally, we continuously renegotiate
with our vendors and press price down to acceptable levels. For example, we explore more suppliers to search for lower prices. We also
try to directly purchase from manufacturers instead of local vendors to cut off middle-man expenses. We expect to keep our profit margin
at a reasonable level in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Gross margin of online pharmacy
sales decreased primarily due to intense market competition. We conduct our business either through certain e-commerce platforms such
as Tmall and JD.com or via our own official online pharmacy website, www.dada360.com. The online prices of healthcare products are transparent
as customers can easily compare prices from websites. In order to promote our sales through e-commerce platforms, we have to lower our
prices leading to lower profit margin. As a way to retain new customers from insurance companies, we also kept low prices on our official
online pharmacy websites. As a result, our profit margin for online sales decreased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Wholesale gross margin increased
primarily due to various products with different profit margin we carried and sold to certain pharmaceutical vendors. Although we have
attempted to market our products to major local hospitals and other pharmacies, we have not been able to make significant progress. Until
we are able to obtain status as a provincial or national exclusive sale agent for certain popular drugs or have sales access to large
local hospitals, we may have to maintain low profit margins in order to drive sales on our wholesale business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Selling and Marketing Expenses</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Selling and marketing expenses
increased by $2,879,710, or 15.9%, as compared to the same period of last fiscal year, primarily due to increase in fee charged by various
platforms as a result of sale increase in our online pharmacy. To cope with intense competition in retail pharmacy business, it is important
to retain key operation staff such as store managers and marketing &amp; merchandise analysts. In addition, our fast-growing online pharmacy
business requires more experienced staff. To retain these staff, we incurred $1.0 million more labor expense. On the other hand, our online
pharmacy sales increased more than 60% in the three months ended December 31, 2020 as compared to the same period last year. As a result,
we incurred additional service fee of $1 million from third-party platforms such as Tmall and JD.com, which usually charge their fee based
on a proportion of our sales via their platforms. Overall, such expenses as a percentage of our revenue were 21.6% and 20.8% respectively,
in the nine months ended December 31, 2020 and 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>General and Administrative Expenses</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">General and administrative
expenses increased by $4,644,412, or 81.1%, as compared to the same period of last year. Such expenses as a percentage of revenue decreased
to 10.6% from 6.6% for the same period of last year. On December 21, 2020, we issued 3,790,000 shares of common stock according to our
employee stock reward incentive plan and recorded stock-based compensation of $3,941,600. Excluding such an effect, the general and administrative
expenses increased by $702,812 period over period, which reflects the increases in staff and administration expense as our online business
grew.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Loss from Operations</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As a result of the above,
we had loss from operations of $8,304,307 in the quarter ended December 31, 2020, as compared to loss from operations of $3,822,232 a
year ago. Our operating margin for the nine months ended December 31, 2020 and 2019 was (8.5)% and (4.4)%, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Income Taxes</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our income tax expense increased
by $24,297 period over period due to an increase in overall profit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Net Loss</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As a result of the foregoing,
net loss is $8,209,301 in the nine months ended December 31, 2020 as compared to a net loss of $3,269,216 in the nine months ended December
31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Accounts receivable</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Accounts receivable, which
are unsecured, are stated at the amount we expect to collect. We continuously monitor collections and payments from our customers (our
distributors) and maintain a provision for estimated credit losses. To prepare for potential loss in such accounts, we made corresponding
reserves.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our accounts receivable aging
was as follows for the periods described below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">From date of invoice to customer</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Retail<BR> drugstores</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Online<BR> Pharmacy</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Drug<BR> wholesale</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Herb<BR> farming</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Total<BR> amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: justify">1- 3 months</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">9,872,323</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">680,476</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">483,786</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">11,036,585</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">4- 6 months</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">78,816</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,189</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">343,413</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">429,418</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">7- 12 months</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,440</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">61</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">195,948</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">209,449</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Over one year</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,890,196</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">66,080</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">383,760</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,340,036</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Allowance for doubtful accounts</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,935,724</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(73,628</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(484,148</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,493,500</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total accounts receivable</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">9,919,051</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">680,178</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">922,759</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">11,521,988</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Accounts receivable from our
retail business mainly consist of reimbursements from government health insurance bureaus and commercial health insurance programs. In
the nine months ended December 31, 2020, we wrote off an approximately $71,856 collectible from provincial and Hangzhou City government
insurance, as such amount has been determined by the health insurance bureaus to be unqualified for reimbursement.&nbsp;</P>

<P STYLE="text-indent: -0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Accounts receivables from
our online pharmacy business mainly consist of receivables from insurance company and a service company handling with insurance companies.
As we continue to expand our business with commercial insurance company, our receivables from them increased. Additionally, certain receivables
are from third-party platforms such as JD.com where we sell products. Usually the third-party platforms will collect from customers ordering
on their platforms and then reimburse us at a later date. Such reimbursement periods range from several days to a month after orders are
placed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Accounts receivable from our
drug wholesale business consist of receivables from our customers such as pharmaceutical distributors and local drugstores primarily in
Zhejiang Province. In fiscal 2019, we accelerated collection of certain aged accounts from customers who we no longer or rarely sold products
to. By doing so, we are able to improve our cash flow. However, as our wholesale business kept growing in a steady rate, receivable from
wholesale customers increased accordingly. We usually put reserve on new accounts based on historical collection experience. As a result,
the overall reserve on wholesale accounts receivables increased slightly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Subsequent to December 31,
2020 and through January 31, 2021, we collected approximately $3.1 million in receivables relating to our drugstore business, approximately
$0.4 million in receivables relating to our online pharmacy business, approximately $0.8 million relating to our wholesale business, and
$0 relating to our herb farming business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Advances to suppliers</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Advances to suppliers are
mainly prepayments to secure certain products or services at favorable pricing. The aging of our advances to suppliers is as follows for
the periods described below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid">From date of cash prepayment to suppliers</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Retail<BR> drugstores</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Online<BR> Pharmacy</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Drug<BR> wholesale</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Herb<BR> farming</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Total<BR> amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: justify">1- 3 months</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">600,873</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">3,973,097</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">4,573,970</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">4- 6 months</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,872</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">316,291</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">343,163</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">7- 12 months</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100,320</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">235,579</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">335,899</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Over one year</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">36,343</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">305,816</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">342,159</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Allowance for doubtful accounts</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(165,025</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(918,345</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,083,370</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total advances to suppliers</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">599,383</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">3,912,438</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">4,511,821</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Since the acquisition of Jiuxin
Medicine, we have gradually transferred almost all logistics services of our retail drugstores to Jiuxin Medicine. Jiuzhou Pharmacy only
makes purchases of certain non-medical products. As a result, our retail chain had little advances to suppliers as of December 31, 2020.
In the nine months ended December 31, 2020, we had outstanding advances to suppliers with which we have ceased doing business. These advances
have been fully reserved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Advances to suppliers for
our drug wholesale business consist of prepayments to our vendors such as pharmaceutical manufacturers and other distributors.&nbsp;We
typically receive products from vendors within three to nine months after making prepayments.&nbsp;We continuously monitor delivery from
and payments to our vendors while maintaining a provision for estimated credit losses based upon past experience and any supplier-specific
issues such as the discontinuation of inventory supply that have been identified.&nbsp;If we are having difficulty receiving products
from a vendor, we take the following steps: ceasing purchasing products from the vendor, asking for prompt return of our prepayment, and
if necessary, taking legal actions.&nbsp;If all of these steps are unsuccessful, management then determines whether or not the prepayments
should be reserved or written off.&nbsp; The increase in advance to suppliers is primarily due to deposits made to purchase Ejiao. Ejiao
is a traditional chinese nutritional supplement, which is popular in the local market. In order to retain the sufficient quantity for
our stores, we advanced approximately $3.06 million purchase deposits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Liquidity and Capital Resources</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our cash flows for the periods
indicated are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">For the nine months ended<BR> December&nbsp;31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Net cash used in operating activities</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(12,448,468</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(11,274,690</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Net cash used in investing activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(1,824,601</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(1,714,176</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Net cash provided by financing activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5,422,085</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">12,698,032</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For the nine months ended
December 31, 2020, cash used in operating activities amounted to $(12,448,468), as compared to $(11,274,690) for the same period a year
ago. The change is primarily attributable to a decrease in net loss of $4,940,085, a decrease in cash provided by inventories and biological
assets of $4,042,571, a decrease in cash provided by advances to suppliers of $2,827,970 offset by an increase of $3,907,040 in stock
compensation, an increase of $1,978,751 in other receivables, and an increase in other current assets of $1,678,682.</P>

<P STYLE="text-indent: -0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For the nine months ended
December 31, 2020, net cash used in investing activities amounted to $(1,824,601), as compared to $(1,714,176) provided by investing activities
for the same period a year ago. The change is primarily attributable to a decrease in cash provided by investment in a joint venture of
$1,458,633, offset by an increase in additions to leasehold improvements and increase intangible assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For the nine months ended
December 31, 2020, net cash provided by financing activities amounted to $5,422,085, as compared to $12,698,032 net cash used in financing
activities for the same period a year ago. The change is primarily due to repayment of notes payable and proceeds from equity financing.
Additionally, we borrowed a one-year loan of $727,855 from the Beijing Bank.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of December 31, 2020, we
had cash of approximately $25,041,724. Our total current assets as of December 31, 2020, were $63,085,365 and total current liabilities
were $55,875,718, which resulted in a working capital of $7,209,647.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Contractual Obligations and Off-Balance Sheet
Arrangements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Contractual Obligations</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="background-color: white">The
following table summarizes our contractual obligations:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid">Contractual obligations</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="18" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Payments due by period</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Less than<BR> 1 year</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">1-3 years</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">3-5 years</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">More than<BR> 5 years</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: justify">Short-term loan payable</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">2,296,155</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">2,296,155</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,736,161</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,736,161</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Long-term loan payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,069,907</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,480,264</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,589,643</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Long-Term Debt Obligations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Capital Lease Obligations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Operating Lease Obligations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,643,599</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,650,085</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,443,287</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,073,077</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,477,150</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Purchase Obligations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Other Long-Term Liabilities Reflected on the Registrant&rsquo;s Balance Sheet under GAAP*</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">52,745,822</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">32,162,665</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">13,032,930</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">5,073,077</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">2,477,150</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="width: 97%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This refers to warrants to purchase shares of common stock issued to an institutional investor and a placement agent (See Note 19).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Off-balance Sheet Arrangements</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We do not have any outstanding
financial guarantees or commitments to guarantee the payment obligations of any third parties. We have not entered into any derivative
contracts that are indexed to our shares and classified as stockholder&rsquo;s equity or that are not reflected in our consolidated financial
statements. Furthermore, we do not have any retained or contingent interest in assets transferred to an unconsolidated entity that serves
as credit, liquidity or market risk support to such entity. We do not have any variable interest in any unconsolidated entity that provides
financing, liquidity, market risk or credit support to us or engages in leasing, hedging or research and development services with us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Exchange Rates</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our subsidiaries and affiliated
companies in the PRC maintain their books and records in RMB, the lawful currency of the PRC. In general, for consolidation purposes,
we translate their assets and liabilities into USD using the applicable exchange rates prevailing at the balance sheet date, and the statement
of income is translated at average exchange rates during the reporting period. Adjustments resulting from the translation of their financial
statements are recorded as accumulated other comprehensive income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The exchange rates used to
translate amounts in RMB into USD for the purposes of preparing the audited consolidated financial statements or otherwise disclosed in
this report were as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center">December&nbsp;31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center">March&nbsp;31, <BR> 2020</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; width: 76%; text-align: left; text-indent: -9pt; padding-left: 9pt">Balance sheet items, except for the registered and paid-up capital, as of end of period</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: center">USD1: RMB 0.1531</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: center">USD1: RMB 0.1410</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left; text-indent: -9pt; padding-left: 9pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: left; text-indent: -9pt; padding-left: 9pt">Amounts included in the statement of Operations and statement of cash flows for the period ended</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">USD1: RMB 0.1456</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">USD1: RMB 0.1436</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Inflation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We believe that inflation has not had a material
effect on our operations to date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="main_007"></A>RISK FACTORS AND CAUTION REGARDING FORWARD-LOOKING
STATEMENTS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In considering whether to consent
to the proposal to adopt the Merger Agreement in connection with the Redomicile Merger, you should consider carefully the following risks
or investment considerations, in addition to the other information in this proxy statement/prospectus. In addition, please note that this
proxy statement/prospectus contains or incorporates by reference &ldquo;forward-looking statements&rdquo; and &ldquo;forward-looking information&rdquo;
under applicable securities laws. These forward-looking statements include, but are not limited to, statements about the Redomicile Merger
and our plans, objectives, expectations and intentions with respect to future operations, including the benefits or impact described in
this proxy statement/prospectus that we expect to achieve as a result of the Redomicile Merger. You can find many of these statements
by looking for words such as &ldquo;believes,&rdquo; &ldquo;expects,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;estimates,&rdquo; &ldquo;continues,&rdquo;
&ldquo;may,&rdquo; &ldquo;intends,&rdquo; &ldquo;plans&rdquo; or similar expressions in this proxy statement/prospectus. Any forward-looking
statements in this proxy statement/prospectus reflect only expectations that are current as of the date of this proxy statement/prospectus,
are not guarantees of performance, and are inherently subject to significant business, economic and competitive uncertainties and contingencies,
many of which are difficult to predict and generally beyond our ability to control. Further, these forward-looking statements are based
on assumptions with respect to business strategies and decisions that are subject to change. Actual results or performance may differ
materially from those we express in our forward-looking statements. Except as may be required by applicable securities laws, we disclaim
any obligation or undertaking to disseminate any updates or revisions to our statements, forward-looking or otherwise, to reflect changes
in our expectations or any change in events, conditions or circumstances on which any such statements are based.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Set forth below, we have identified
the factors, among others, that you should consider before making a decision on whether or not to consent to adopt the Merger Agreement,
and we have identified certain of the risks that could cause our actual plans or results to differ materially from those included in the
forward-looking statements contained or incorporated by reference herein. You should consider these risks when deciding whether to adopt
the Merger Agreement. In addition, you should also review carefully the risks affecting our business generally that could also cause our
actual plans or results to differ materially from those included in the forward-looking statements contained or incorporated by reference
herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Summary of Risk Factors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Relating to the Redomicile Merger </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify"><TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
                                            rights as a stockholder of the Company will change as a result of the Redomicile Merger and
                                            you may not be afforded as many rights as a shareholder of CJJD Cayman.</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">&nbsp;</TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            laws of the Cayman Islands may not provide CJJD Cayman shareholders with benefits comparable
                                            to those provided to shareholders of corporations incorporated in the United States.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            a result of different shareholder voting requirements in the Cayman Islands relative to Nevada,
                                            we will have less flexibility with respect to our ability to amend our constitutional documents
                                            and enter into certain business combinations than we now have.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            expected benefits of the Redomicile Merger may not be realized.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD
                                            Cayman will continue to be treated as a U.S. corporation for U.S. federal income tax purposes.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            a foreign private issuer, CJJD Cayman will not be required to provide its shareholders with
                                            the same information as the Company would if the Company remained a U.S. public issuer. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we prepare our financial statements in accordance with IFRS following the Redomicile Merger,
                                            there may be a significant effect on our reported financial results.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            enforcement of civil liabilities against CJJD Cayman may be more difficult.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Relating to Our Business in General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top"><TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            face significant competition, and if we do not compete successfully against existing and
                                            new competitors, our revenue and profitability could be materially and adversely affected.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
                                            in economic conditions and consumer confidence in China may influence the drugstore industry,
                                            consumer preferences and spending patterns.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            have significant cash deposits with our suppliers and landlords, which we may not be able
                                            to recover in the event of bankruptcy by our suppliers or landlords or other events beyond
                                            our control.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            we are unable to optimize management of our procurement and distribution activities, we may
                                            be unable to meet customer demand while increasing the burden on managing our supply chain.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            depend substantially on the continuing efforts of the Key Personnel, and our business and
                                            prospects may be severely disrupted if we lose their services.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            retail and wholesale operations require a number of permits and licenses in order to carry
                                            on their business.</FONT></TD></TR></TABLE>

<DIV STYLE="border: white 1pt solid; margin-right: 0in; margin-left: 0pt; padding: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Relating to Our Pharmacy Operations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</DIV>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            continued penetration of counterfeit products into the pharmaceutical market in China may
                                            damage our reputation and have a material adverse effect on our business, financial condition,
                                            results of operations and prospects.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            a distributor of pharmaceutical and other healthcare products, we are exposed to inherent
                                            risks relating to product liability and personal injury claims.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may be subject to fines and penalties if we fail to comply with the applicable PRC laws and
                                            regulations governing sales of medicines under China&rsquo;s National Medical Insurance Program.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Relating to Our Medical Services</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            provision of medical services is heavily regulated in the PRC and failure to comply with
                                            those regulations could result in penalties, loss of licensure, additional compliance costs
                                            or other adverse consequences.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            a provider of medical services, we are exposed to inherent risks relating to malpractice
                                            claims.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Herb Farming</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            herb farming business is subject to the volatility of prices for raw TCM herbs.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unforeseen
                                            and severe weather can reduce cultivation activities and lead to a decrease in anticipated
                                            harvest.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Risks
Related to Our Online Sales</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            operation results of our online business fluctuates and we cannot assure our efforts for
                                            alternative vendors will result in the stable increase in revenues from online pharmacy in
                                            the coming years</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Risks
Related to Our Corporate Structure</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chinese
                                            regulations limit foreign ownership of any pharmacy operator with thirty (30) or more stores,
                                            and limit foreign ownership of medical clinics to Sino-foreign joint venture. The entities
                                            that operate our pharmacies and clinics are controlled by us through contractual arrangements.
                                            The validity of such contractual arrangements is uncertain. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may be adversely affected by complexity, uncertainties and changes in Chinese regulation
                                            of drugstores and the practice of medicine.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            contractual arrangements with HJ Group and the Key Personnel may not be as effective in providing
                                            control over these entities as direct ownership.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
                                            we rely on contractual arrangements to control HJ Group and for substantially all of our
                                            revenue, the termination of our contractual arrangements to control HJ Group will severely
                                            and detrimentally affect our continuing business viability under our current corporate structure.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Doing Business in China</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            rely on contractual arrangements with our VIE for our operations, which may not be as effective
                                            in providing control over these entities as direct ownership.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                            may experience difficulties in effecting service of legal process, enforcing foreign judgments
                                            or bringing original actions in China against us or our management based on United States
                                            or other foreign laws.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            may need to obtain additional governmental approvals to open new drugstores. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            advent of recent healthcare reform directives from China&rsquo;s central government may increase
                                            both competition and our cost of doing business.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiuzhou
                                            Pharmacy, Jiuzhou Clinic and Jiuzhou Service are subject to restrictions on making payments
                                            to us.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
                                            we receive from our subsidiaries located in the PRC may be subject to PRC withholding tax.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            face risks related to disease epidemics and other outbreaks.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            auditor is not permitted to be subject to inspection by Public Company Accounting Oversight
                                            Board.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to an Investment in Our Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            market price of our common stock has fluctuated and may continue to fluctuate in the future,
                                            and we may not pay dividends on our common stock.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Techniques
                                            employed by manipulative short sellers in Chinese small-cap stocks may drive down the market
                                            price of our common stock.</FONT></TD></TR></TABLE>

<DIV STYLE="border: white 1pt solid; padding-right: 0in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">Our officers and directors own a substantial portion
of our outstanding common stock, which will enable them to influence many significant corporate actions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Risk Factors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Relating to the Redomicile Merger </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Your rights as a stockholder of the Company
will change as a result of the Redomicile Merger and you may not be afforded as many rights as a shareholder of CJJD Cayman under applicable
laws and CJJD Cayman&rsquo;s amended and restated memorandum and articles of association as you were as a stockholder of the Company under
applicable laws and the Company&rsquo;s articles of incorporation and bylaws. </I></B></P>

</DIV>

<DIV STYLE="border: white 1pt solid; margin-right: 0in; padding-right: 0in">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">Because of differences between
Nevada law and Cayman Islands law and differences between the governing documents of the Company and the constitutional documents of CJJD
Cayman, we are unable to adopt governing documents for CJJD Cayman that are identical to the governing documents for the Company, but
we have attempted to preserve in the amended and restated memorandum and articles of association of CJJD Cayman the same allocation of
material rights and powers between the shareholders and our Board of Directors that exists under the Company&rsquo;s bylaws and articles
of incorporation to the extent permitted by Cayman Islands law. Nevertheless, CJJD Cayman&rsquo;s amended and restated memorandum and
articles of association differ from the Company&rsquo;s bylaws and article of incorporation, both in form and substance, and your rights
as a shareholder will change. For example:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

</DIV>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Under the Nevada Revised Statutes, a corporation
may not engage in a business in combination with an interested stockholder for a period of three years after the time of the transaction
in which the person became an interested stockholder. However, there is no equivalent provision under the Companies Act or CJJD Cayman&rsquo;s
articles of association prohibiting business combinations with interested stockholders.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Under the Nevada Revised Statutes, any stockholder
may, upon written demand under oath stating the purpose thereof, inspect the corporation&rsquo;s books and records for a proper purpose
during the usual hours for business. However, shareholders of a Cayman Islands exempted company do not have any general rights to inspect
corporate records of a company, and CJJD Cayman&rsquo;s articles of association provide that the directors have the discretion as to whether,
to what extent, when, where and under what conditions or regulations the accounts and books of the company may be open to the inspection
of shareholders who are not directors.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
                                            the Nevada Revised Statutes, a stockholder may bring a derivative suit provided the requirements
                                            to do so under the Nevada Revised Statutes have been met. However, for a Cayman Islands company,
                                            the decision to institute proceedings on behalf of a company is generally taken by the company&rsquo;s
                                            board of directors, rather than the shareholders, and a shareholder of CJJD Cayman would
                                            be entitled to bring a derivative action on behalf of CJJD Cayman only in certain limited
                                            circumstances.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>



<DIV STYLE="border: white 1pt solid; padding-right: 0in; padding-bottom: 0pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For a detailed discussion
of these and other material differences, please see the comparison chart of your rights as a common stockholder of the Company against
your rights as an ordinary shareholder of CJJD Cayman under the section entitled &ldquo;Comparison of Rights under Nevada and Cayman Islands
Laws.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The laws of the Cayman Islands may not provide
CJJD Cayman shareholders with benefits comparable to those provided to shareholders of corporations incorporated in the United States.
</I></B></P>

</DIV>

<DIV STYLE="border: white 1pt solid; margin-right: 0in; padding-right: 0in">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&nbsp;</P>

<P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">CJJD Cayman&rsquo;s corporate
affairs are governed by its amended and restated memorandum and articles of association, as amended and restated from time to time, by
the Companies Act, and by the common law of the Cayman Islands. The rights of shareholders to take action against CJJD Cayman&rsquo;s
directors, actions by minority shareholders and the fiduciary duties of CJJD Cayman&rsquo;s directors to CJJD Cayman under Cayman Islands
law are to a large extent governed by the common law of the Cayman Islands. The common law of the Cayman Islands is derived in part from
comparatively limited judicial precedent in the Cayman Islands and from English common law, the decisions of whose courts are of persuasive
authority but are not binding on a court in the Cayman Islands. The rights of CJJD Cayman&rsquo;s shareholders and the fiduciary duties
of its directors, although clearly established under Cayman Islands law, are not specifically prescribed in statute or a particular document
in the same way that they are in certain statutes or judicial precedents in some jurisdictions of the United States. In particular, the
Cayman Islands has a less developed body of securities laws relative to the United States. Therefore, CJJD Cayman&rsquo;s shareholders
may have more difficulty in protecting their interests in the face of actions by CJJD Cayman&rsquo;s management, directors or controlling
shareholders than would shareholders of a corporation incorporated in a jurisdiction in the United States. In addition, shareholders
of Cayman Islands companies may not have standing to initiate a shareholder derivative action before the federal courts of the United
States. The Cayman Island courts are also unlikely to impose liability against CJJD Cayman, in original actions brought in the Cayman
Islands, based on certain civil liabilities provisions of U.S. securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt; text-align: justify">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border: white 1pt solid"><B><I>As a result of
different shareholder voting requirements in the Cayman Islands relative to Nevada, we will have less flexibility with respect to our
ability to amend our constitutional documents and enter into certain business combinations than we now have. </I></B></P>

<DIV STYLE="border: white 1pt solid; margin-right: 0in; padding-right: 0in">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under Nevada law and our current
bylaws and articles of incorporation, our bylaws and articles of incorporation may be amended by the vote of a majority of shares of common
stock entitled to vote on the matter to approve the amendment, unless the articles of incorporation requires the vote of a greater number
of shares. Cayman Islands law requires a special resolution of not less than two-thirds of the votes cast by those shareholders entitled
to vote who are present in person or by proxy at a general meeting for any amendment to the amended and restated memorandum and articles
of association of CJJD Cayman. As a result of this Cayman Islands law requirement, situations may arise where the flexibility we now have
under Nevada law would have provided benefits to our shareholders that will not be available in the Cayman Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, under Cayman Islands
law, certain corporate transactions, such as a merger, require the approval of a special resolution of not less than two-thirds of the
votes cast at a general meeting by those shareholders entitled to vote who are present in person or by proxy. By contrast, a merger under
Nevada law would only require a simple majority of the outstanding stock of the company entitled to vote thereon. The increased shareholder
approval requirements may limit our flexibility to enter into or complete certain business combinations that may be beneficial to shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For a detailed discussion of
the differences in shareholder voting requirements in the Cayman Islands relative to Nevada, please see the section entitled &ldquo;Comparison
of Rights under Nevada and Cayman Islands Laws.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt"><B><I>The expected benefits
of the Redomicile Merger may not be realized. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">We have presented in this proxy
statement/prospectus the anticipated benefits of the Redomicile Merger. Please see the section entitled &ldquo;Adoption of the Merger
Agreement &mdash; Background and Reasons for the Redomicile Merger.&rdquo; We cannot be assured that all of the goals of the Redomicile
Merger will be achievable, and some or all of the anticipated benefits of the Redomicile Merger may not occur, particularly as the achievement
of the benefits are in many important respects subject to factors that we do not control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">These factors would include
such things as the reactions of third parties with whom we enter into contracts and do business and the reactions of investors and analysts.
In addition, the anticipated reduction of SEC reporting requirements and related expenses may not be achieved in the event of changes
to the SEC rules applicable to foreign private issuers or if we fail to qualify as a foreign private issuer. While we expect the Redomicile
Merger will enable us to reduce our operational, administrative, legal and accounting costs over the long term, these benefits may not
be achieved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><B><I>CJJD Cayman will continue to be treated
as a U.S. corporation for U.S. federal income tax purposes. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt; text-align: justify; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Based on the Tax Opinion,
after the Redomicile Merger, CJJD Cayman, as successor to the Company, will be treated as a U.S. domestic corporation for U.S. federal
income tax purposes, will be subject to U.S. federal income taxes as if it were a U.S. domestic corporation, and dividends paid by CJJD
Cayman to non-U.S. stockholders will generally be subject to U.S. withholding tax at a 30% rate (or a reduced rate specified by an applicable
income tax treaty). While the Redomicile Merger is not anticipated to have any material impact on our effective tax rate, changes in
U.S. tax laws could adversely affect our results of operations and profitability. The Tax Opinion does not bind the IRS or prevent the
IRS from adopting a contrary position. For a more detailed discussion of U.S. federal income tax considerations with respect to the Redomicile
Merger, please see the section entitled &ldquo;Tax Opinion&rdquo; beginning on page 81.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt; text-align: justify; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt; text-align: justify; text-indent: 15pt"></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3pt; text-align: justify; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border: white 1pt solid"><B><I>As a foreign private
issuer, CJJD Cayman will not be required to provide its shareholders with the same information as the Company would if the Company remained
a U.S. public issuer and, as a result, you may not receive as much information about CJJD Cayman as you did about the Company and you
may not be afforded the same level of protection as a beneficial owner of CJJD Cayman under applicable laws and CJJD Cayman&rsquo;s amended
and restated memorandum and articles of association as you were as a shareholder of the Company under applicable laws and the Company&rsquo;s
articles of incorporation and bylaws. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Following the completion of
the Redomicile Merger, CJJD Cayman is expected to qualify as a &ldquo;foreign private issuer&rdquo; under the rules and regulations of
the SEC. CJJD Cayman will remain subject to the mandates of the Sarbanes-Oxley Act. However, as a foreign private issuer, CJJD Cayman
will be exempt from certain rules under the Exchange Act that would otherwise apply if CJJD Cayman were a company incorporated in the
United States or did not meet the other conditions to qualify as a foreign private issuer. For example:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD Cayman may include in its SEC filings financial statements prepared in accordance with U.S. GAAP or with the International Financial Reporting Standards, or IFRS, as issued by the International Accounting Standards Board, or IASB as issued by the IASB without reconciliation to U.S. GAAP;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD Cayman will not be required to provide as many Exchange Act reports, or as frequently or as promptly, as U.S. companies with securities registered under the Exchange Act. For example, CJJD Cayman will not be required to file current reports on Form 8-K within four business days from the occurrence of specific material events. Instead, CJJD Cayman will need to promptly furnish reports on Form 6-K any information that CJJD Cayman (a) makes or is required to make public under the laws of the Cayman Islands, (b) files or is required to file under the rules of any stock exchange, or (c) otherwise distributes or is required to distribute to its shareholders. Unlike Form 8-K, there is no precise deadline by which Form 6-K must be furnished. In addition, CJJD Cayman will not be required to file its annual report on Form 10-K. As a foreign private issuer, CJJD Cayman will be required to file an annual report on Form 20-F within four months after its fiscal year end;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD Cayman will not be required to provide the same level of disclosure on certain issues, such as executive compensation;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD Cayman will be exempt from filing quarterly reports under the Exchange Act with the SEC; however, as a Nasdaq listed foreign private issuer, CJJD Cayman will be required to publish on a Form 6-K an interim balance sheet and income statement as of the end of its second quarter no later than six months following the end of such quarter;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD Cayman will not be subject to the requirement to comply with Regulation FD, which imposes certain restrictions on the selected disclosure of material information;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD Cayman will not be required to comply with the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&#9679;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD Cayman will not be required to comply with Section 16 of the Exchange Act requiring insiders to file public reports of their stock ownership and trading activities and establishing insider liability for profits realized from any &ldquo;short-swing&rdquo; trading transaction.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&nbsp;</P>









<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Thus, you may not be afforded the same protections
or information under applicable laws and CJJD Cayman&rsquo;s amended and restated memorandum and articles of association which would be
made available to you if we remain a U.S. corporation with publicly traded securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If CJJD Cayman fails to qualify as a foreign
private issuer upon completion of the Redomicile Merger, or loses its status as a foreign private issuer at some future time, CJJD Cayman
would be required to comply fully with the reporting requirements of the Exchange Act applicable to U.S. domestic issuers and would incur
significant operational, administrative, legal and accounting costs that it would not incur as a foreign private issuer.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Following completion of the Redomicile Merger,
CJJD Cayman is expected to qualify as a &ldquo;foreign private issuer&rdquo; under the rules and regulations of the SEC. As a foreign
private issuer, CJJD Cayman will be exempt from certain rules under the Exchange Act that would otherwise apply if CJJD Cayman were a
company incorporated in the United States or did not meet the other conditions to qualify as a foreign private issuer. As a foreign private
issuer, CJJD Cayman will not be required to provide its shareholders with the same information as the Company would if the Company remained
a U.S. public issuer and, as a result, you may not receive as much information about CJJD Cayman as you did about the Company and you
may not be afforded the same level of protection as a shareholder of CJJD Cayman under applicable laws and CJJD Cayman&rsquo;s amended
and restated memorandum and articles of association as you were as a shareholder of the Company under applicable laws and the Company&rsquo;s
articles of incorporation and bylaws. While CJJD Cayman is expected to qualify as a foreign private issuer following the completion of
the Redomicile Merger, if CJJD Cayman fails to qualify as a foreign private issuer upon completion of the Redomicile Merger, or loses
its status as a foreign private issuer at some future time, CJJD Cayman will be required to comply fully with the reporting requirements
of the Exchange Act applicable to U.S. domestic issuers and would incur significant operational, administrative, legal and accounting
costs that it would not incur as a foreign private issuer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If we prepare our financial statements in
accordance with IFRS following the Redomicile Merger, there may be a significant effect on our reported financial results.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The SEC permits foreign private issuers to file
financial statements in accordance with IFRS as issued by IASB. At any time in the future, as a foreign private issuer, we may decide
to prepare our financial statements in accordance with IFRS as issued by the IASB. The application by us of different accounting standards,
a change in the rules of IFRS as issued by the IASB, or in the SEC&rsquo;s acceptance of such rules, could have a significant effect on
our reported financial results. Additionally, U.S. GAAP is subject to interpretation by the Financial Accounting Standards Board, the
American Institute of Certified Public Accountants, the SEC, and various bodies formed to promulgate and interpret appropriate accounting
principles. IFRS are subject to interpretation by the IASB and the SEC, although the SEC does not publish Staff Accounting Bulletins (SAB&rsquo;s)
on IFRS. A change in these principles or interpretations could have a significant effect on our reported financial results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Changes in domestic and foreign laws, including
tax law changes, could adversely affect CJJD Cayman, its subsidiaries and its shareholders, and our effective tax rate may increase whether
we effect the Redomicile Merger or not.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Changes in tax laws, regulations or treaties or
the interpretation or enforcement thereof, in both or either of the U.S. or Cayman Islands, could adversely affect the tax consequences
of the Redomicile Merger to CJJD Cayman and its shareholders and/or our effective tax rates (whether associated with the Redomicile Merger
or otherwise). While the Redomicile Merger is not anticipated to have any material impact on our effective tax rate, there is uncertainty
regarding the tax policies of the jurisdictions where we operate, and our effective tax rate may increase and any such increase may be
material.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The enforcement of civil liabilities against
CJJD Cayman may be more difficult.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">After the Redomicile Merger, substantially all
of our executive officers and directors will reside outside of the United States. As a result, it may be difficult to serve legal process
within the United States upon any of these persons and it may also be difficult to enforce, both in and outside of the United States,
judgments you may obtain in the U.S. courts against these persons in any action, including actions based upon the civil liability provisions
of U.S. federal or state securities laws. Because CJJD Cayman is a Cayman Islands company, investors could also experience more difficulty
enforcing judgments obtained against CJJD Cayman in U.S. courts than would currently be the case for U.S. judgments obtained against the
Company. In addition, it may be more difficult (or impossible) to bring some types of claims against CJJD Cayman in Cayman Islands courts
than it would be to bring similar claims against a U.S. company in a U.S. court.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The market for CJJD Cayman shares may differ
from the market for the Company&rsquo;s shares.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Although it is expected that the CJJD Cayman ordinary
shares will be authorized for listing on NASDAQ under the symbol &ldquo;CJJD,&rdquo; as a company incorporated under the laws of the Cayman
Islands, shares of CJJD Cayman may appeal to different institutional investors, or impact the level of investment by current investors
who may prefer or be required by internal guidelines to invest in companies that are incorporated in the United States. Accordingly, the
redomicile may impact our institutional investor base, or the level of their respective investments in our securities, and may result
in a change in the market prices, trading volume and volatility of the CJJD Cayman ordinary shares from those of the Company&rsquo;s shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We expect to incur transaction costs and
adverse financial consequences in the year of completion of the Redomicile Merger.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We expect to incur significant transaction costs
in connection with the Redomicile Merger, which have been and will continue to be expensed as incurred. The substantial majority of these
costs will be incurred regardless of whether the Redomicile Merger is completed and prior to your vote on the proposal. We expect to incur
costs and expenses, including professional fees, to comply with the Cayman Islands corporate and other laws. In addition, we expect to
incur attorneys&rsquo; fees, accountants&rsquo; fees, filing fees, mailing expenses, solicitation fees and financial printing expenses
in connection with the Redomicile Merger, even if the Redomicile Merger is not approved or completed. The Redomicile Merger also may negatively
affect us by diverting attention of our management and employees from our operating business during the period of implementation and by
increasing other administrative costs and expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our Board of Directors may choose to defer
or abandon the Redomicile Merger.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Completion of the Redomicile Merger may be deferred
or abandoned, at any time, by action of our Board of Directors, whether before or after the deadline to submit consents. While we currently
expect the Redomicile Merger to take place promptly after the proposal to adopt the Merger Agreement is approved, our Board of Directors
may defer completion or may abandon the Redomicile Merger because of, among other reasons, changes in existing or proposed laws, our determination
that the Redomicile Merger would involve tax or other risks that outweigh their benefits, our determination that the level of expected
benefits associated with the Redomicile Merger would otherwise be reduced, a dispute with the taxation authorities over the Redomicile
Merger (or certain aspects thereof), an unexpected increase in the costs to complete the Redomicile Merger or any other determination
by our Board of Directors that the Redomicile Merger would not be in the best interests of the Company or its stockholders or that the
Redomicile Merger would have material adverse consequences to the Company or its stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Relating to Our Business in General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Future acquisitions are expected to be a
part of our growth strategy, and could expose us to significant business risks.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have grown our business,
in part, through the acquisition of stores over the years. One of our strategies going forward is to continue our growth by acquiring
additional drugstores. However, we cannot provide assurance that we will be able to identify and secure suitable acquisition opportunities.
Our ability to consummate and integrate effectively any future acquisitions on terms that are favorable to us may be limited by the number
of attractive acquisition targets, internal demands on our resources and, to the extent necessary, our ability to obtain any necessary
financing for larger acquisitions on terms that are satisfactory to us. Moreover, if an acquisition target is identified, the third parties
with whom we seek to cooperate may not select us as a potential partner or we may not be able to enter into arrangements on commercially
reasonable terms. The negotiation and completion of potential acquisitions, whether or not ultimately consummated, could also significantly
divert management&rsquo;s time and resources and may potentially disrupt our existing business. Furthermore, we cannot provide any assurance
that the expected synergies from future acquisitions will actually materialize. Additionally, future acquisitions could result in the
incurrence of additional indebtedness, costs, and contingent liabilities, causing us to significantly increase our interest expense, leverage
and debt service requirements if we incur additional debt to pay for an acquisition or investment, issue common stock that would dilute
our current shareholders&rsquo; percentage ownership, or incur write-offs and restructuring and other related expenses. Future acquisitions
may also expose us to potential risks, including risks associated with:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the integration of new operations, services and personnel;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">unforeseen or hidden liabilities;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">the diversion of financial or other resources from our existing businesses;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">difficulties in entering markets or lines of business in which we have no
or limited direct prior experience;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">our inability to generate sufficient revenue to recover costs and expenses
of the acquisitions; and</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">potential loss of, or harm to, relationships with employees or customers.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Any of the above could significantly
disrupt our ability to manage our business and materially and adversely affect our business, financial condition and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We face significant competition, and if
we do not compete successfully against existing and new competitors, our revenue and profitability could be materially and adversely affected.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Both the drugstore, online
pharmacy and wholesale pharmaceutical distribution industries in China are highly competitive, and we expect competition to intensify
in the future. Our primary drugstore competitors include other drugstore chains and independent drugstores. Increasingly, we also face
competition from discount stores, convenience stores and supermarkets as we expand our offering of non-drug convenience products and services.
We compete for customers and revenue primarily on the basis of store location, merchandise selection, price, services offered, and our
brand name. Our online pharmacy competitors include other online pharmaceutical vendors. As more large traditional drugstore chain companies
entered into the online sales, we face competition ranging from prices to service. Our primary wholesale competitors include regional
and national players. In addition, we may be subject to additional competition from new entrants to both industries in China. We could
also face increased competition from foreign companies if the Chinese government removes the restrictions on the entry of foreign companies
into these industries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Some of our larger competitors
may enjoy competitive advantages, such as:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">greater financial and other resources;</FONT></TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
                                                                                                                                                                                                                                                         </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">larger variety of products;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">more extensive and advanced supply chain management systems;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">greater pricing flexibility;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">larger economies of scale and purchasing power;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">more extensive advertising and marketing efforts;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">greater knowledge of local market conditions;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">stronger brand recognition; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">larger sales and distribution networks.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As a result of the aforementioned
advantages, we may be unable to offer products similar to, or more desirable than, those offered by our competitors, market our products
as effectively as our competitors, or otherwise respond successfully to competitive pressures. As competition increases in the markets
in which we operate, a significant increase in general pricing pressures could occur, which could require us to reevaluate our pricing
structures to remain competitive. Our competitors may be able to offer larger discounts on competing products, and we may not be able
to profitably match those discounts. Furthermore, our competitors may offer products that are more attractive to our customers or that
render our products uncompetitive. In addition, the timing of the introduction of competing products into the market could affect the
market acceptance and market share of our products. Our failure to successfully compete could materially and adversely affect our business,
financial condition, results of operation, and prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Changes in economic conditions and consumer
confidence in China may influence the drugstore industry, consumer preferences and spending patterns.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our business and revenue growth
primarily depend on the size of the pharmaceutical market in China. As a result, our revenue and profitability may be negatively affected
by changes in national, regional or local economic conditions and consumer confidence in China. In particular, as we focus on our expansion
of pharmacies in metropolitan markets, where living standards and consumer purchasing power are relatively high, we are especially susceptible
to changes in economic conditions, consumer confidence and customer preferences of the urban Chinese population. External factors beyond
our control that affect consumer confidence include unemployment rates, levels of personal disposable income, national, regional or local
economic conditions, and acts of war or terrorism. Changes in economic conditions and consumer confidence could adversely affect consumer
preferences, purchasing power and spending patterns. A decrease in overall consumer spending as a result of changes in economic conditions
could adversely affect our front-end and pharmacy sales and negatively impact our profitability. In addition, acts of war or terrorism
may cause damage to our facilities, disrupt the supply of the products and services we offer in our stores, or adversely impact consumer
demand. Any of these factors could have a material adverse effect on our business, financial condition and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We may not be able to timely identify or
otherwise effectively respond to changing customer preferences, and we may fail to optimize our product offering and inventory position.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The pharmaceutical industry
in China is rapidly evolving and is subject to rapidly changing customer preferences that are difficult to predict. Our success depends
on our ability to anticipate and identify customer preferences, and adapt our product selection to meet these preferences. In particular,
we must optimize our product selection and inventory positions based on sales trends. We cannot provide assurance that our product selection,
especially our selection of nutritional supplements and food products, will accurately reflect customer preferences at any given time.
If we fail to accurately anticipate either the market for our products or customers&rsquo; purchasing habits or fail to respond to customers&rsquo;
changing preferences promptly and effectively, we may not be able to adapt our product selection to customer preferences or make appropriate
adjustments to our inventory positions, which could significantly reduce our revenue and have a material adverse effect on our business,
financial condition and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our success depends on our ability to establish
effective advertising, marketing and promotional programs.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our success depends on our
ability to establish effective advertising, marketing and promotional programs, including pricing strategies implemented in response to
competitive pressures and/or to drive demand for our products. Our advertisements are designed to promote our brand, our corporate image
and the prices of products available for sale in our stores. Our pricing strategies and value propositions must be appropriate for our
target customers. If we are not able to maintain and increase the awareness of our pharmacy&rsquo;s brand and the products and services
we provide, we may not be able to attract and retain customers and our reputation may also suffer. We expect to incur substantial expenses
in our marketing and promotional efforts to both attract and retain customers. However, our marketing and promotional activities may be
less successful than we anticipate, and may not be effective at building our brand awareness and customer base. In addition, the government
may impose restrictions on how marketing and promotional activities can be conducted. We cannot provide assurance that our current and
proposed budget for marketing activities will be adequate to support our future growth. Failure to successfully execute our advertising,
marketing and promotional programs may result in material decreases in our revenue and profitability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our ability to grow our business may be
constrained by our inability to find suitable new store locations at acceptable prices or by the expiration of our current leases.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our ability to grow our business
may be constrained if suitable new store locations cannot be identified with lease terms or purchase prices that are acceptable to us.
We compete with other retailers and businesses for suitable locations for our stores. Local land use regulations and other regulations
applicable to the kinds of stores we seek to construct may impact our ability to find suitable locations and influence the cost of constructing
our stores. The expiration of leases at existing store locations may adversely affect us if the renewal terms of those leases are unacceptable
to us and we are forced to close or relocate stores. Furthermore, changing local demographics at existing store locations could materially
and adversely affect revenue and profitability levels at those stores, and overall our business, financial condition, results of operation,
and prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We have significant cash deposits with our
suppliers and landlords in order to obtain and maintain our inventory and maintain and establish store locations, which we may not be
able to recover in the event of bankruptcy by our suppliers or landlords or other events beyond our control.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our ability to obtain products
and maintain inventory at, and to establish and maintain leases for, our pharmacies, is dependent upon our ability to post and maintain
significant cash deposits with our suppliers and landlords. Many vendors in China are unwilling to ship merchandise on credit and instead
require cash deposits, and landlords may require security deposits consisting of the equivalent of twelve (12) months of rent. As of March
31, 2020, we had approximately $2.2 million deposited with suppliers and approximately $2.8 million deposited with landlords for our pharmacies.
If we are unable or unwilling to establish such advances and deposits, our ability to generate sales and expand our business could be
adversely affected. In general, we expect the amounts required for advances and deposits to increase as we undertake our expansion plans,
complete store openings and expand our business through acquisitions or otherwise. We do not generally receive interest on the deposits
made to suppliers or landlords, and such deposits are subject to the risk of loss as a result of the creditworthiness or bankruptcy of
the party who holds our funds, as well as the risk from any illegal acts associated with the third party, such as conversion, fraud, theft
or dishonesty. If these circumstances were to arise, we could find it difficult or impossible, due to the unpredictability of legal proceedings
in China, to recover all or a portion of the amount on deposit with our vendors or landlords.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If we are unable to optimize management
of our procurement and distribution activities, we may be unable to meet customer demand while increasing the burden on managing our supply
chain.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Since May 2011, we have been
using Jiuxin Medicine&rsquo;s facility as our distribution center for both our retail and wholesale businesses. Starting from March 31,
2018, we outsourced our logistic service to Astro Boy Cloud Pan (Hangzhou) Storage and Logistic Co. Ltd (&ldquo;Astro Boy Logistic&rdquo;).
As a result, Jiuxin Medicine&rsquo;s warehouse lease has been terminated. Astro Boy Logistic provides us with a facility with approximately
14,000 square meters located approximately eighteen (18) miles from our headquarters, which served as our central distribution center.
Astro Boy Logistic&rsquo;s staff and vehicles make regular deliveries to our pharmacies and wholesale customers. Our ability to meet customer
demand may be significantly limited if we do not successfully and efficiently conduct our distribution activities, or if Astro Boy Logistic&rsquo;s
facility is destroyed or shut down for any reason, including as the result of natural disasters. Any disruption in the operation of our
distribution activities could result in higher costs or longer lead times associated with distributing our products. Since it is difficult
to predict accurate sales volume in our industry, we may be unable to optimize our distribution activities, which may result in excess
or insufficient inventory, warehousing, fulfillment or distribution capacity. Furthermore, failure to effectively control product damage
during the distribution process could decrease our operating margins and reduce our profitability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">All product procurement is
handled through our corporate headquarters. Such centralization is intended to reduce the cost of goods sold as a result of volume purchase
benefits. However, we may be less successful than anticipated in achieving these volume purchase benefits. In addition, such centralization
is expected to increase the complexity of tracking inventory and could place additional burdens on the management of our supply chain.
If we cannot successfully reduce our costs through centralizing procurement, our profitability and prospects could be materially and adversely
affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Failure to maintain optimal inventory levels
could increase our inventory holding costs or cause us to lose sales, either of which could have a material adverse effect on our business,
financial condition and results of operations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We need to maintain sufficient
inventory levels to operate both of our retail and wholesale businesses successfully as well as meet customer expectations. However, we
must also guard against the risk of accumulating excess inventory. We are exposed to inventory risks as a result of rapid changes in product
life cycles, changing consumer preferences, uncertainty of the success of product launches, seasonality, and manufacturer backorders and
other vendor-related problems. We cannot provide assurance that we can accurately predict these trends and events and avoid over-stocking
or under-stocking products. In addition, demand for products could change significantly between the time product inventory is ordered
and the time it is available for sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">When we begin selling a new
product, it is particularly difficult to accurately forecast product demand. The purchase of certain types of inventory may require significant
lead-time. As we carry a broad selection of products and maintain significant inventory levels for a substantial portion of our merchandise,
we may be unable to sell such inventory in sufficient quantities or during the relevant selling seasons. Carrying excess inventory could
increase our inventory holding costs, and failure to have inventory in stock when a customer orders or purchases it could cause us to
lose that order or that customer, either of which could have a material adverse effect on our business, financial condition and results
of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We rely on computer software and hardware
systems in managing our operations, the capacity of which may restrict our growth and the failure of which could adversely affect our
business, financial condition and results of operations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are dependent upon our
integrated information management system to monitor daily operations of our retail and wholesale businesses, and to maintain accurate
and up-to-date operating and financial data for the compilation of management information. In addition, we rely on our computer hardware
and network for the storage, delivery and transmission of the data of our retail and wholesale systems. If our computer software and hardware
systems fail to meet the increasing needs of our expanding operations, our ability to grow may be constrained. Furthermore, any system
failure which causes interruptions to the input, retrieval and transmission of data or causes lags in service time could disrupt our normal
operations. Although we believe that our computer software and hardware systems are up to date and that our disaster recovery plan is
adequate in handling potential failures, we cannot provide assurance that we can effectively carry out this disaster recovery plan and
that we will be able to restore our operation within a sufficiently short time frame to avoid our business being disrupted. Furthermore,
our systems are subject to damage or interruption from power outages, computer and telecommunications failures, computer viruses, security
breaches, vandalism, natural disasters, catastrophic events and human error, and our disaster recovery planning cannot account for all
eventualities. If any of our computer software and/or hardware systems are damaged, fail to function properly or otherwise become unavailable,
we may incur substantial costs to repair or replace them, and may experience loss or corruption of critical data and interruptions or
delays in our ability to perform critical functions. Due to the limited coverage of business interruption insurance policies offered in
China, we do not carry business interruption insurance and, as a result, any business disruption or natural disaster could severely disrupt
our business and operations and, in turn, significantly decrease our revenue and profitability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We depend substantially on the continuing
efforts of the Key Personnel, and our business and prospects may be severely disrupted if we lose their services.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our future success is dependent
on the continued services of the Key Personnel but we do not maintain key-man insurance. If we lose the services of any one of the Key
Personnel, we may not be able to locate suitable or qualified replacements, which could severely disrupt our business and prospects. Each
of the Key Personnel has entered into confidentiality and non-competition agreements with us. However, if any disputes arise between us
and the Key Personnel, we cannot provide assurance, in light of uncertainties associated with the PRC legal system, that any of these
agreements can be enforced in China, the jurisdiction in which the Key Personnel reside and hold some of their assets. See &ldquo;<I>Risks
Related to Doing Business in China - You may experience difficulties in effecting service of legal process, enforcing foreign judgments
or bringing original actions in China based on United States or other foreign laws against us or our management.</I> &rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We depend on the continued service of, and
on the ability to attract, motivate and retain a sufficient number of qualified and skilled personnel for our business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The implementation of our
business strategy and our future success also depend in large part on our continued ability to attract and retain highly qualified and
skilled personnel. We cannot provide assurance that we will be able to attract, hire and retain sufficient numbers of skilled personnel
necessary to continue to develop and grow our business. We face competition for personnel from both retail and wholesale pharmaceutical
distribution operators. This competition could require us to offer higher compensation and other benefits in order to attract and retain
qualified individuals, which could materially and adversely affect our financial condition and results of operations. On the other hand,
we may be unable to attract or retain the personnel required to achieve our business objectives, and that failure could severely disrupt
our business and prospects. The process of hiring suitably qualified personnel is often lengthy. If our recruitment and retention efforts
are unsuccessful in the future, it may be more difficult for us to execute our business strategy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our retail and wholesale operations require
a number of permits and licenses in order to carry on their business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are required to obtain
certain permits and licenses from various PRC governmental authorities, including a Drug Distribution Permit and a GSP certification.
We are also required to obtain food hygiene certificates for the distribution of nutritional supplements and food products. We cannot
provide any assurance that we can maintain all required licenses, permits and certifications to carry on our business at all times, and
from time to time we may have not been in the past, or may not be in the future, in compliance with all such required licenses, permits
and certifications. Moreover, these licenses, permits and certifications are subject to periodic renewal and/or reassessment by the relevant
PRC governmental authorities and the standards of such renewal or reassessment may change from time to time. We intend to apply for renewal
of these licenses, permits and certifications when required by applicable laws and regulations. Any failure by us to obtain and maintain
all licenses, permits and certifications necessary to carry on our business at any time could have a material adverse effect on our business,
financial condition and results of operations. In addition, any inability to renew any of these licenses, permits and certifications could
severely disrupt our business, and prevent us from continuing to carry on our business. Any changes in the standards used by governmental
authorities in considering whether to renew or reassess our business licenses, permits and certifications, as well as any enactment of
new regulations that may restrict the conduct of our business, may also decrease our revenue and/or increase our costs, materially reducing
our profitability and prospects. Furthermore, if the interpretation or implementation of existing laws and regulations changes or if new
regulations come into effect requiring us to obtain any additional licenses, permits or certifications that were previously not required
to operate our existing businesses, we cannot provide assurance that we can successfully obtain such licenses, permits or certifications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We may need additional capital, and the
sale of equity securities could result in dilution to our stockholders, while debts may require us to make covenants restricting how we
operate.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We believe that the aggregate
amount of our current cash, anticipated cash flow from operations, available borrowings under our existing bank facilities, and personal
loans from our principal shareholders should be sufficient to meet our anticipated cash needs for the near future. We may, however, require
additional cash resources due to changed business conditions or other future developments. If our resources are insufficient to satisfy
our cash requirements, we may seek to sell additional equity or debt securities or obtain credit facilities. The sale of additional equity
securities could result in the dilution of our existing stockholders. We cannot guarantee that we will be able to obtain any additional
financing on terms that are acceptable to us, or at all. Even if we are able to obtain any requisite financing, the incurrence of additional
indebtedness would result in increased debt service obligations, and could result in further operating and financing covenants that would
restrict our freedom to operate our business, such as conditions that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">limit our ability to pay dividends or require us to seek consent for the
payment of dividends;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18.05pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">increase our vulnerability to general adverse economic and industry conditions;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18.05pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">require us to dedicate a portion of our cash flow from operations to payments
on our debt, thereby reducing the availability of our cash flow to fund capital expenditures, working capital and other general corporate
purposes; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18.05pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">limit our flexibility in planning for, or reacting to, changes in our business
and our industry.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Relating to Our Pharmacy Operations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our brand names, trade secrets and other
intellectual property are valuable assets. If we are unable to protect them from infringement, our business and prospects may be harmed.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We consider our pharmacy
brand names to be valuable assets. We may be unable to prevent third parties from using such brand names without authorization, which
may adversely affect our business and reputation, including the perceived quality and reliability of our products and services. We have
five (5) registered trademarks. We also own three (3) domain names that we actively use in our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We rely on trade secrets
to protect our know-how and other proprietary information, including pricing, purchasing, promotional strategies, customer lists and/or
suppliers lists. As a result, our employees are required to sign employment agreements that contain confidentiality provisions as a condition
of their employment with us. However, trade secrets are difficult to protect. While we believe we use reasonable efforts to protect our
trade secrets, our employees, consultants, contractors or advisors may unintentionally or willfully disclose our information to competitors.
In addition, confidentiality agreements executed by the aforementioned individuals may not be enforceable or provide meaningful protection
for our trade secrets or other proprietary information in the event of unauthorized use or disclosure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If we were to enforce a claim
that a third party had illegally obtained and was using our trade secrets, such efforts could be expensive and time-consuming, and the
outcome unpredictable. Additionally, if our competitors independently develop information that is equivalent to our trade secrets or other
proprietary information, we have little recourse to enforce our rights, and our business and prospects could be harmed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Litigation may be necessary
in the future to enforce our intellectual property rights or to determine the validity and scope of the intellectual property rights of
others. However, since the validity, enforceability and scope of protection of intellectual property rights in the PRC are uncertain and
still evolving, we may not be successful in prosecuting these cases. In addition, any litigation, proceeding or other efforts to protect
our intellectual property rights could result in substantial costs and diversion of our resources, and could seriously harm our business
and operating results. Furthermore, the degree of future protection of our proprietary rights is uncertain and may not adequately protect
our rights or permit us to gain or keep our competitive advantage. If we are unable to protect our trade names, trade secrets and other
propriety information from infringement, our business, financial condition and results of operations may be materially and adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We may be exposed to intellectual property
infringement and other claims by third parties which, if successful, could disrupt our business and have a material adverse effect on
our financial condition and results of operations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our success depends, in large
part, on our ability to use our proprietary information and know-how without infringing third party intellectual property rights. As litigation
becomes more common in China, we face a higher risk of being the subject of claims for intellectual property infringement, invalidity
or indemnification relating to other parties&rsquo; proprietary rights. Our current or potential competitors, many of whom have substantial
resources, may have or may obtain intellectual property protection that will prevent, limit or interfere with our ability to conduct our
business in China. Moreover, the defense of intellectual property suits, including trademark infringement suits and related legal and
administrative proceedings, can be both costly and time consuming and may significantly divert the efforts and resources of our management
personnel. Furthermore, an adverse determination in any such litigation or proceeding to which we may become a party could cause us to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">pay damage awards;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18.05pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">seek licenses from third parties;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18.05pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">pay ongoing royalties;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18.05pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">redesign our product offerings; or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18.05pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">be restricted by injunctions,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Each of which could effectively
prevent us from pursuing some or all of our business and result in our customers or potential customers deferring or limiting their purchase
from our stores, which could have a material adverse effect on our financial condition and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The continued penetration of counterfeit
products into the pharmaceutical market in China may damage our reputation and have a material adverse effect on our business, financial
condition, results of operations and prospects.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Counterfeit products have
continued to make their way into the Chinese pharmaceutical market. Counterfeit products are generally sold at lower prices compared to
their authentic counterparts due to their low production costs, and in some cases may be very similar in appearance to their authentic
counterparts. Counterfeit pharmaceuticals may or may not have the same chemical content as their authentic counterparts, and are typically
manufactured without proper licenses or approvals as well as fraudulently mislabeled with respect to their content and/or manufacturer.
Although China&rsquo;s central government has been increasingly active in combating counterfeit pharmaceutical and other products, China
does not yet have effective regulatory control or an enforcement system over counterfeit pharmaceutical products. Although we have implemented
a series of quality control procedures in our procurement process, we cannot provide assurance that we may not be inadvertently selling
counterfeit pharmaceutical products. Any unintentional sale of counterfeit products may subject us to negative publicity, fines and/or
other administrative penalties, or may even result in litigation against us. Moreover, the increased distribution of counterfeit products
and other products in recent years may reinforce the negative image of drug distributors among consumers in China. The continued proliferation
of counterfeit products in China could have a material adverse effect on our business financial condition, and results of operation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>As a distributor of pharmaceutical and other
healthcare products, we are exposed to inherent risks relating to product liability and personal injury claims.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Distributors of pharmaceutical
and other healthcare products are exposed to risks inherent in the packaging and distribution of such products. Such risks include unintentional
distribution of counterfeit, mislabeled or contaminated drugs, and, with respect to our pharmacies, improper filling of prescriptions,
labeling of prescriptions and adequacy of warnings. Errors in the packaging or dispensing of pharmaceuticals could lead to serious injury
or death. Furthermore, the applicable PRC laws, rules and regulations require our in-store pharmacists to offer counseling to our customers,
without additional charge, about medication, dosage, delivery systems, common side effects, and other information the in-store pharmacists
deem significant. Our in-store pharmacists sometimes also have a duty to warn customers regarding any potential negative effects of a
prescription drug if the warning could reduce or negate these effects, and we may be liable for claims arising from any advice given by
our in-store pharmacists. Product liability or personal injury claims may be asserted against us with respect to any of the products or
pharmaceuticals we sell or services we provide, and we may be required to pay for substantial monetary damages for any successful product
liability or personal injury claim against us. We may, however, in product liability claims, have the right under applicable PRC laws,
rules and regulations to recover from the relevant manufacturer any compensation we paid to our customers in connection with such claim.
Even if we successfully defend ourselves against this type of claim, we could be required to spend significant management, financial and
other resources in the process, which could disrupt our business. Our reputation and our brand names may also suffer as a result of any
product liability or personal injury claims against us. Like many other similar companies in China, we do not carry product liability
insurance. A product recall or damage to our reputation in the event of a product liability or personal injury claim or judgment against
us could have a material adverse effect on our business, financial condition and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We may be subject to fines and penalties
if we fail to comply with the applicable PRC laws and regulations governing sales of medicines under China&rsquo;s National Medical Insurance
Program.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Eligible participants in
China&rsquo;s national medical insurance program, mainly consisting of urban residents in China, are entitled to buy medicines using their
medical insurance cards from an authorized pharmacy, provided that the medicines they purchase have been included in the national or provincial
medical insurance catalogs. The pharmacy, in turn, obtains reimbursement from the relevant government social security bureaus. Moreover,
the applicable PRC laws, rules and regulations prohibit pharmacies from selling goods other than pre-approved medicines when purchases
are made with medical insurance cards. We have established procedures to prohibit our drugstores from selling unauthorized goods to customers
who make purchases with medical insurance cards. However, we cannot provide assurance that those procedures will be strictly followed
by all of our employees in all of our stores.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Relating to Our Medical Services</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If we do not attract and retain qualified
physicians and other medical personnel, our ability to provide medical services would be adversely affected.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The success of our medical
services will, in part, be dependent upon the number and quality of doctors, nurses and other medical support personnel that we employ
and our ability to maintain good relationships with them. Our medical staff may terminate their employment with us at any time. If we
are unable to successfully maintain good relationships with them, our ability to provide medical services may be adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The provision of medical services is heavily
regulated in the PRC and failure to comply with those regulations could result in penalties, loss of licensure, additional compliance
costs or other adverse consequences.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Healthcare providers in China,
as in most other populous countries, are required to comply with many laws and regulations at the national and local government levels.
These laws and regulations relate to: licensing; the conduct of operations; the ownership of facilities; the addition of facilities and
services; advertising; confidentiality, maintenance and security issues associated with medical records; billing for services; and prices
for services. If we fail to comply with applicable laws and regulations, we could suffer penalties, including the loss of our licenses
to operate. In addition, further healthcare legislative reform is likely, and could materially and adversely affect our business and results
of operations in the event that we do not comply or if the cost of compliance is prohibitive. The above list of certain regulated areas
is not exhaustive, and it is not possible to anticipate the exact nature of future healthcare legislative reform in China. Depending on
the priorities set by the Chinese Ministry of Health, the political climate at any given time, the continued development of the Chinese
healthcare system and many other factors, future legislative reforms may be highly comprehensive, including stringent infection control
policies, improved rural healthcare facilities, increased regulation of the distribution of pharmaceuticals, and numerous other policy
matters. Consequently, the implications of these future reforms could result in penalties, loss of licensure, additional compliance costs
or other adverse consequences we cannot foresee at the present time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>As a provider of medical services, we are
exposed to inherent risks relating to malpractice claims.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As a provider of medical
services, any misdiagnosis or improper treatment may result in negative publicity regarding us or our services, which would harm our reputation.
If we are found liable for malpractice, we may be required to pay substantial monetary damages. Furthermore, even if we successfully defend
ourselves against a malpractice claim, we could be required to spend significant management, financial and other resources in the process,
which could disrupt our business, and our reputation and brand name may also suffer. Since malpractice claims are not common in China,
we do not carry malpractice insurance. As a result, any imposition of malpractice liability could materially harm our business, financial
condition and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We face competition that could adversely
affect our results of operations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our clinics compete with
a large number and variety of healthcare facilities in their respective markets. There are numerous government-run and private hospitals
and clinics available to the general populace. There can be no assurance that these or other clinics, hospitals or other facilities will
not commence or expand such operations, which would increase their competitive position. Furthermore, there can be no assurance that a
healthcare organization that having greater resources in the provision or management of healthcare services will not decide to engage
in operations similar to those being conducted by us in Hangzhou.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Related to Our Herb Farming</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our herb farming business is subject to
the volatility of prices for raw TCM herbs.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We currently planted gingko
trees in our leased farm land. However, in the future, we may continue to cultivate and sell certain herbs in bulk to third-party vendors,
based on local market prices primarily determined by TCM manufacturers and trading companies. Such market prices have increased significantly
in recent years in response to changes in the supply of and demand for raw herbs, market uncertainty and a variety of additional factors
that are beyond our control, including inflation, changes in weather, disease outbreaks, domestic government regulation, market speculation
and overall economic conditions. There can be no assurance that market prices, which historically have fluctuated widely, will continue
to increase or remain stable, and any future declines in prices may negatively impact the viability of our herb farming business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Unforeseen and severe weather can reduce
cultivation activities and lead to a decrease in anticipated harvest.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Seasonal climate change and
weather variations such as levels of rainfall and temperature may, among other things, affect the quality, overall supply and availability
of raw herbs. Sustained adverse weather conditions in Zhejiang Province in general and in Lin&rsquo;an in particular where our herbs are
planted, such as rain, extreme cold or snow, could disrupt or curtail cultivation activities. This in turn could reduce our anticipated
harvest yields, delay the timing of our anticipated harvest and distribution, and negatively affect the quality of our harvest. In addition,
natural disasters such as fires, earthquakes, snowstorms, floods or droughts, or natural conditions such as crop disease, pests or soil
erosion, may also negatively impact our cultivation and harvest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, the actual climatic
conditions of Zhejiang Province and of Lin&rsquo;an in particular may not conform to historical patterns and may be affected by variations
in weather patterns, including any potential impact of climate change. The effects of climate change may produce more unpredictable weather
events that may adversely affect our ability to cultivate and harvest successfully.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The occurrence of any of
these may materially harm our herb farming business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We have limited control over the availability
and the quality of the local farmers with whom we cooperate because we do not employ them directly.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We rely on local farmers
to farm and harvest our herbs, but do not employ them directly. Instead, they are recruited and employed by the local villagers&rsquo;
committees with whom we negotiate. We have limited control over the availability and the quality of this labor force. A shortage of suitable
laborers may adversely affect our harvest yields.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Related to Our Online Sales</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We rely on computer software and hardware
systems in managing our online sales, the capacity of which may restrict our growth and the failure of which could adversely affect our
business, financial condition and results of operations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are dependent upon our
electronic commerce system to carry out our online sales. Any system failure which causes interruptions to the input, retrieval and transmission
of data, or increases in service time could disrupt our normal operations. Although we believe we have a disaster recovery plan that can
handle the failure of our computer software and hardware systems, we cannot provide assurance that we can effectively carry out this disaster
recovery plan and that we will be able to restore our operation within a sufficiently short time frame to avoid disruption to our business.
Any failure in our computer software and/or hardware systems could have a material adverse effect on our business, financial condition
and results of operations. In addition, if the capacity of our computer software and hardware systems fails to meet the increasing needs
of our operations, our ability to grow may be constrained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The operation results of our online business
fluctuates and we cannot assure our efforts for alternative vendors will result in the stable increase in revenues from online pharmacy
in the coming years</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our online pharmacy sales
increased by approximately $4,756,756, or 54.1% for the year ended March 31, 2020, as compared to the year ended March 31, 2019. The increase
was caused by both an increase in sales via e-commerce platforms such as Tmall and an increase in sales via our official site. Popular
products at reasonable prices are key to success in online business. In order to promote our sales, we focused on the selection of medical
equipment suitable to local customers. For example, sales of blood glucose meters and contact lens contributed significantly to our revenue
in the year ended March 31, 2020 as compared to the same period a year ago. Additionally, we maintained a membership care program which
targeted at chronic disease customers. We have closely interacted with our members via WeChat by providing healthcare knowledge and reminding
our customers to refill medicine. By implementing a personalized customer care program, we were able to promote our sales. As a result,
our sales via these e-commerce platforms increased by 58.3% period over period. The sales via our official website were primarily made
by certain pharmacy benefit management providers and insurance companies. There can be of no assurance that our online pharmacy sales
will continue to increase in the future despite of our relentless efforts. If our online pharmacy sales do not grow as we expect in the
future, our operation results may be materially impacted in a negative manner.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If our online business fails to obtain and
maintain the requisite assets, licenses, qualified personnel and approvals required under the complex regulatory environment for Internet-based
businesses in China, the business prospects for such business may be materially and adversely affected.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Internet-based businesses
in China are highly regulated by China&rsquo;s central government, and numerous regulatory authorities are empowered to issue and implement
regulations governing various aspects of these businesses. Our online business is operated by our PRC subsidiary, Jiuzhou Pharmacy, which
is required to obtain and maintain certain assets relevant to its business, such as computers and other electrical equipment, as well
as applicable licenses or approvals from different regulatory authorities. These assets and licenses are essential to the operation of
an e-commerce business and are generally subject to annual review by the relevant governmental authorities. Furthermore, we may be required
to obtain additional licenses. If we fail to obtain or maintain any of the required assets, licenses or approvals, our Internet business
may be deemed illegal and it may be subject to various penalties, such as confiscation of illegal income, fines, and/or the discontinuation
or restriction of its operations. Any such disruption may materially and adversely affect the prospects of our online business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Related to Our Corporate Structure</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Chinese regulations limit foreign ownership
of any pharmacy operator with thirty (30) or more stores, and limit foreign ownership of medical clinics to Sino-foreign joint venture.
The entities that operate our pharmacies and clinics are controlled by us through contractual arrangements. The validity of such contractual
arrangements is uncertain. If the Chinese government determines that these contractual arrangements do not comply with applicable regulations,
we could be subject to severe penalties and our business could be adversely affected. In addition, changes in the relevant Chinese laws
and regulations may materially and adversely affect our business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Current PRC regulations limit
foreign ownership of a pharmacy operator to forty nine percent (49%) if such operator owns interests in thirty (30) or more drugstores
in China that sell a variety of branded pharmaceutical products sourced from different suppliers. Since we do not own any equity interests
in Jiuzhou Pharmacy (or its subsidiary Jiuxin Medicine), but instead control it through contractual arrangements, we do not believe that
the regulations limiting foreign ownership apply to us even if Jiuzhou Pharmacy or Jiuxin Medicine expands beyond thirty (30) stores.
In fact, Jiuzhou Pharmacy has expanded to one hundred and eighteen (118) stores as of March 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Similarly, PRC regulations
restrict foreign ownership of medical practices in China to Sino-foreign joint ventures. Since we do not have any actual equity interest
in Jiuzhou Clinic or Jiuzhou Service, but control these entities through contractual arrangements, we do not believe that such PRC regulations
are applicable to us or our structure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">There are, however, uncertainties
regarding the interpretation and application of PRC laws, rules and regulations, including but not limited to the laws, rules and regulations
governing the validity and enforcement of our contractual arrangements. Although the structures for operating our business in China (including
our corporate structure and contractual arrangements with Jiuzhou Pharmacy, Jiuzhou Clinic, Jiuzhou Service and the Key Personnel) comply
with all applicable PRC laws, rules and regulations, and do not violate, breach, contravene or otherwise conflict with any applicable
PRC laws, rules or regulations, we cannot provide assurance that a regulatory authority will not determine that our corporate structure
and contractual arrangements violate PRC laws, rules or regulations. If any such authority determines that our contractual arrangements
are in violation of applicable PRC laws, rules or regulations, our contractual arrangements may become invalid or unenforceable, and we
may not be able to consolidate the operations of HJ Group with our results of operations. In addition, new PRC laws, rules and regulations
may be introduced from time to time to impose additional requirements that may be applicable to our contractual arrangements. For example,
pursuant to the PRC Property Rights Law that became effective on October 1, 2007 (the &ldquo;Property Law&rdquo;), the pledge of any equity
interests of a PRC private entity shall become effective once it is duly registered with the local branches of the SAIC. Following the
promulgation of the Property Law, the SAIC further issued the <I>Administrative Measures for Registrations of Share Pledge</I> on September
1, 2008, which provided detailed procedural guidance for the local SAIC offices to handle the registrations of pledged shares. The Equity
Pledge Agreement that forms a part of the contractual arrangements creates a legally binding obligation on the parties upon the execution
date; however, the pledge established under such agreement does not become effective until due registration with the local SAIC office.
On May 18, 2010, registration of the pledged equity interests in Jiuzhou Pharmacy was completed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Chinese government has
broad discretion in dealing with violations of laws and regulations, including levying fines, revoking business and other licenses, and
requiring actions necessary for compliance. In particular, licenses and permits issued or granted to us by the relevant governmental bodies
may be revoked at a later time by higher regulatory bodies. We cannot predict the effect of the interpretation of existing or new Chinese
laws or regulations on our businesses. We cannot provide assurance that our current ownership and operating structure will not be found
in violation of any current or future Chinese laws or regulations. As a result, we may be subject to sanctions, including fines, and could
be required to restructure our operations or cease the provision of certain services. Any of these or similar actions could significantly
disrupt our business operations or restrict us from conducting a substantial portion of our business operations, which could materially
and adversely affect our business, financial condition and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If we are determined to be
in violation of any existing or future PRC laws, rules or regulations, or fail to obtain or maintain any of the required governmental
permits or approvals, the relevant PRC regulatory authorities would have broad discretion in dealing with such violations, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">revoking the business and operating licenses of the HJ Group entities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 13.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">discontinuing or restricting the operations of the HJ Group entities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 13.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">imposing conditions or requirements with which we or the HJ Group entities
may not be able to comply;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 13.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">requiring us or the HJ Group entities to restructure the relevant ownership
structure or operations; and/or</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 13.55pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">imposing fines.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The imposition of any of these
penalties would severely disrupt our ability to conduct business and have a material adverse effect on our financial condition, results
of operations and prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We may be adversely affected by complexity,
uncertainties and changes in Chinese regulation of drugstores and the practice of medicine.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Chinese government regulates
drugstores and the practice of medicine, including foreign ownership and requirements for licenses and permits. These laws and regulations
are relatively new and evolving, and their interpretation and enforcement involve significant uncertainty. As a result, in certain circumstances
it may be difficult to determine what actions or omissions may be deemed to be a violation of applicable laws and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The interpretation and application
of existing Chinese laws, regulations and policies and possible new laws, regulations or policies have created substantial uncertainties
regarding the legality of existing and future foreign investments in, and the businesses and activities of, pharmaceutical businesses
in China, including our business. We currently only have contractual control over the HJ Group entities, and do not own them due to the
restrictions on foreign ownership of such companies. However, changes to laws in the PRC may force us to restructure our ownership structure
or our operations, which would severely disrupt our ability to conduct business and have a material adverse effect on our financial condition,
results of operations and prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Uncertainties relating to
the regulation of drugstores and medical practice in China also extend to evolving licensing practices, which means that permits, licenses
or operations at our company may be subject to challenge. This may disrupt our business or subject us to sanctions, requirements to increase
capital, or other conditions or enforcement. In turn, this could compromise enforceability of related contractual arrangements, or have
other harmful effects on us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our contractual arrangements with HJ Group
and the Key Personnel may not be as effective in providing control over these entities as direct ownership.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We have no equity ownership
interest in HJ Group, and rely on contractual arrangements to control and operate the HJ Group companies and their businesses. These contractual
arrangements may not be as effective in providing control over these companies as direct ownership. For example, any one of them could
fail to take actions required for our business despite its contractual obligation to do so. Under such circumstances, we may have to rely
on legal remedies under Chinese law, which may not be effective in providing us any relief. In addition, we cannot provide assurance that
the Key Personnel will act in our best interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Since we rely on contractual arrangements
to control HJ Group and for substantially all of our revenue, the termination of such agreements will severely and detrimentally affect
our continuing business viability under our current corporate structure.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Since we do not own equity
interests of HJ Group, the termination of our contractual arrangements with them would sever our ability to continue receiving payments
from them under our current holding company structure. We cannot provide assurance that there will not be any event or reason that may
cause the contractual arrangements to terminate. In the event that the contractual arrangements terminate, we will lose our control over
them and their business operations and, as a result, over our primary sources of revenue. This may have a severe and detrimental effect
on our continuing business viability under our current corporate structure, which in turn may affect the value of your investment. Should
this occur, we may seek to acquire control of HJ Group through other means, although we cannot guarantee that we will do so, nor can we
guarantee that we will be successful if we do.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We rely principally on dividends paid by
our consolidated operating entities to fund any cash and financing requirements we may have, and any limitation on the ability of our
consolidated PRC entities to pay dividends to us could have a material adverse effect on our ability to conduct our business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are a holding company
and rely principally on dividends paid by our consolidated PRC operating entities for cash requirements, including the funds required
to service any debt we may incur, which are passed on to us through Jiuxin Management. If any of the consolidated operating entities incurs
debt in its own name in the future, the instruments governing the debt may restrict dividends or other distributions on our equity interest
to us. In addition, the PRC tax authorities may require us to adjust our taxable income under the contractual arrangements in a manner
that would materially and adversely affect our ability to pay dividends and other distributions on our equity interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Furthermore, applicable PRC
laws, rules and regulations permit payment of dividends by our consolidated PRC entities only out of their retained earnings, if any,
determined in accordance with PRC accounting standards. Under PRC laws, rules and regulations, our consolidated PRC entities are required
to set aside at least ten percent (10%) of their after-tax profit each year, based on PRC accounting standards, into their statutory surplus
reserve funds until the accumulative amount of such reserves reaches fifty percent (50%) of their respective registered capital. As a
result, our consolidated PRC entities are restricted in their ability to transfer a portion of their net income to us whether in the form
of dividends, loans or advances. As of March 31, 2020, our restricted reserves totaled $1,309,109(RMB 9,460,695). Our restricted reserves
are not distributable as cash dividends. Any limitation on the ability of our consolidated operating entities to pay dividends to us could
materially and adversely limit our ability to grow, make investments or acquisitions that could be beneficial to our businesses, pay dividends,
or otherwise fund and conduct our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Certain management members of HJ Group have
potential conflicts of interest with us, which may adversely affect our business and your ability for recourse.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Mr. Lei Liu, our Chief Executive
Officer and Chairman of our Board of Directors, is also the executive director of Jiuzhou Pharmacy, a general partner of Jiuzhou Clinic,
and the supervising director of Jiuzhou Service. In addition, Mr. Liu has also lent us money out of his personal funds to help facilitate
our payments of expenses in the U.S., as well as to purchase a land use right. Ms. Li Qi, our Corporate Secretary and a member of our
Board of Directors, is the general manager of each of Jiuzhou Pharmacy, Jiuzhou Clinic and Jiuzhou Service, and a general partner of Jiuzhou
Clinic. Conflicts of interests between their respective duties to our company and HJ Group may arise. As our directors and executive officers,
they have a duty of loyalty and care to us under U.S. and Hong Kong law when there are any potential conflicts of interests between our
company and HJ Group. We cannot provide assurance, however, that when any conflicts of interest arise, both of them will act completely
in our interests or that conflicts of interests will be resolved in our favor. For example, they may determine that it is in HJ Group&rsquo;s
interests to sever the contractual arrangements with Jiuxin Management, irrespective of the effect such action may have on us. In addition,
either one of them could violate his or her legal duties by diverting business opportunities from us to others, thereby affecting the
amount of payment that HJ Group is obligated to remit to us under the Consulting Services Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In the event that you believe
that your rights have been infringed under securities laws or otherwise as a result of any one of the circumstances described above, it
may be difficult or impossible for you to bring an action against HJ Group, or our officers or directors who are members of the management,
all of whom reside within China. Even if you are successful in bringing an action, the laws of China may render you unable to enforce
a judgment against the assets of HJ Group and its management, all of which are located in China.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Related to Doing Business in China</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We rely on contractual arrangements with
our VIE for our operations, which may not be as effective in providing control over these entities as direct ownership.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our operations and financial
results are dependent on our VIEs, Jiuzhou Pharmacy (including its subsidiaries and controlled entities), Jiuzhou Clinic and Jiuzhou Service,
in which we have no equity ownership interest and must rely on contractual arrangements to control and operate the businesses of our VIEs.
These contractual arrangements are not as effective in providing control over the VIEs as direct ownership. For example, the VIEs may
be unwilling or unable to perform its contractual obligations under our commercial agreements. Consequently, we would not be able to conduct
our operations in the manner currently planned. In addition, the VIEs may seek to renew its agreements on terms that are disadvantageous
to us. Although we have entered into a series of agreements that provide us with substantial ability to control the VIEs, we may not succeed
in enforcing our rights under them insofar as our contractual rights and legal remedies under PRC law are inadequate. In addition, if
we are unable to renew these agreements on favorable terms when these agreements expire or enter into similar agreements with other parties,
our business may not be able to operate or expand, and our operating expenses may significantly increase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In January 2015, China&rsquo;s
Ministry of Commerce released draft legislation (&ldquo;2015 Draft FIL&rdquo;) that could change how the government regulates corporate
structures, especially for VIEs controlled by foreign investments. Instead of looking at &ldquo;ownership&rdquo;, the draft law focused
on the entities or individuals hold control of a VIE. If a VIE is deemed to be controlled by foreign investors, it may be barred from
operating in restricted sectors or the prohibited sectors listed on a &ldquo;negative list&rdquo;, where only companies controlled by
Chinese nationals could operate, even if structured as VIEs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">In
March 2019, the PRC National People&rsquo;s Congress promulgated the PRC Foreign Investment Law, and in December 2019, the State Council
promulgated the Implementing Rules of PRC Foreign Investment Law, or the Implementing Rules, to further clarify and elaborate the relevant
provisions of the PRC Foreign Investment Law. The PRC Foreign Investment Law and the Implementing Rules both became effective from January&nbsp;1,
2020 and replaced the major previous laws and regulations governing foreign investments in the PRC. Pursuant to the PRC Foreign Investment
Law, &ldquo;foreign investments&rdquo; refer to investment activities conducted by foreign investors (including foreign natural persons,
foreign enterprises or other foreign organizations) directly or indirectly in the PRC, which include any of the following circumstances:
(i)&nbsp;foreign investors setting up foreign-invested enterprises in the PRC solely or jointly with other investors, (ii)&nbsp;foreign
investors obtaining shares, equity interests, property portions or other similar rights and interests of enterprises within the PRC, (iii)&nbsp;foreign
investors investing in new projects in the PRC solely or jointly with other investors, and (iv)&nbsp;investment in other methods as specified
in laws, administrative regulations, or as stipulated by the State Council. The PRC Foreign Investment Law and the Implementing Rules
do not introduce the concept of &ldquo;control&rdquo; in determining whether a company would be considered as a foreign-invested enterprise,
nor do they explicitly provide whether the VIE structure would be deemed as a method of foreign investment. However, the PRC Foreign Investment
Law has a&nbsp;catch-all&nbsp;provision that includes into the definition of &ldquo;foreign investments&rdquo; made by foreign investors
in China in other methods as specified in laws, administrative regulations, or as stipulated by the State Council, and as the PRC Foreign
Investment Law and the Implementing Rules are newly adopted and relevant government authorities may promulgate more laws, regulations
or rules on the interpretation and implementation of the PRC Foreign Investment Law, the possibility cannot be ruled out that the concept
of &ldquo;control&rdquo; as stated in the 2015 Draft FIL may be embodied in, or the VIE structure adopted by us may be deemed as a method
of foreign investment by, any of such future laws, regulations and rules. If our consolidated VIE was deemed as a foreign-invested enterprise
under any of such future laws, regulations and rules, and any of the businesses that we operate would be in any &ldquo;negative list&rdquo;
for foreign investment and therefore be subject to any foreign investment restrictions or prohibitions, further actions required to be
taken by us under such laws, regulations and rules may materially and adversely affect our business, financial condition and results of
operations. Furthermore, if future laws, administrative regulations or provisions mandate further actions to be taken by companies with
respect to existing contractual arrangements, we may face substantial uncertainties as to whether we can complete such actions in a timely
manner, or at all. Failure to take timely and appropriate measures to cope with any of these or similar regulatory compliance challenges
could materially and adversely affect our current corporate structure, business, financial condition and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Changes in the policies of the PRC government
could have a significant impact upon the business we may be able to conduct in the PRC and the profitability of such business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Policies of the PRC government
can have significant effects on economic conditions in China. Our interests may be adversely affected by changes in policies by the PRC
government, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">changes in laws, regulations or their interpretation;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18.05pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">confiscatory taxation;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18.05pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">restrictions on currency conversion, imports or sources of supplies and export
tariff; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18.05pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">expropriation or nationalization of private enterprises.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Although the PRC government
has been pursuing economic reform policies for more than two (2) decades, we cannot assure you that the government will continue to pursue
such policies or that such policies may not be significantly altered, especially in the event of a change in leadership, social or political
disruption, or other circumstances affecting the PRC&rsquo;s political, economic and social life.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Uncertainties with respect to the Chinese
legal system could adversely affect us.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We conduct our business through
our subsidiaries and controlled companies in the PRC. Our operations in China are governed by Chinese laws and regulations. We are generally
subject to laws and regulations applicable to foreign investments in China and, in particular, laws applicable to WFOE. The Chinese legal
system is based on written statutes. Prior court decisions may be cited for reference but have limited precedential value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Since 1979, Chinese legislation
and regulations have significantly enhanced the protections afforded to various forms of foreign investments in China. However, China
has not developed a fully integrated legal system and recently enacted laws and regulations may not sufficiently cover all aspects of
economic activities in China. In particular, because these laws and regulations are relatively new, and because of the limited volume
of published decisions and their nonbinding nature, the interpretation and enforcement of these laws and regulations involve uncertainties.
In addition, the Chinese legal system is based in part on government policies and internal rules (some of which are not published on a
timely basis or at all) that may have a retroactive effect. As a result, we may not be aware of our violation of these policies and rules
until sometime after the violation. In addition, any litigation in China may be protracted and result in substantial costs and diversion
of our resources and our management&rsquo;s attention.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>You may experience difficulties in effecting
service of legal process, enforcing foreign judgments or bringing original actions in China against us or our management based on United
States or other foreign laws.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are a holding company
and conduct our business through our subsidiaries and controlled companies in the PRC. In addition, all of our operating assets are located
in, and all of our other senior executive officers reside within, China. As a result, it may not be possible to effect service of process
within the United States or elsewhere outside China upon those of our senior executive officers and directors that do not reside in the
United States, including with respect to matters arising under U.S. federal securities laws or applicable state securities laws. Moreover,
our Chinese counsel has advised us that China does not have treaties with the United States or many other countries providing for the
reciprocal recognition and enforcement of judgment of courts. As a result, our public shareholders may face substantially more difficulty
in protecting their interests through actions against our management or directors than would shareholders of a corporation with assets
and management located in the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We may need to obtain additional governmental
approvals to open new drugstores. Our inability to obtain such approvals will have a material adverse effect on our business and growth.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">According to the <I>Measures
on the Administration of Foreign Investment in the Commercial Sector</I> (the &ldquo;Measures&rdquo;) promulgated by China&rsquo;s Ministry
of Commerce (the &ldquo;MOC&rdquo;), which became effective on June 1, 2004, a company that is directly owned by a foreign invested enterprise
needs to obtain relevant governmental approvals before it opens new retail stores. However, there are no specific laws, rules or regulations
with respect to whether such approvals are necessary for a company that is contractually controlled by a foreign invested enterprise.
In addition, the Measures state that the MOC will promulgate a detailed implementation regulation to govern foreign invested enterprises
engaging in drug sale. However, such implementation regulation has not yet been promulgated. Therefore, we cannot provide assurance that
the MOC will not require such approvals to be obtained, or as to when any regulation of such requirements may be implemented. If additional
governmental approvals are deemed to be necessary and we are unable to obtain such approvals on a timely basis or at all, our business,
financial condition, results of operations and prospects, as well as the trading price of our common stock, will be materially and adversely
affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The advent of recent healthcare reform directives
from China&rsquo;s central government may increase both competition and our cost of doing business.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under the auspices of the
Healthy China 2020 program (the &ldquo;Program&rdquo;), published by China&rsquo;s National Development and Reform Commission in October
2008, the central government has set in motion a series of policies in fairly rapid succession aimed to improve China&rsquo;s healthcare
system. Such policies include (1) discouraging hospitals from both prescribing and dispensing medication, (2) the unveiling in April 2009
of formal healthcare reform guidelines aimed at improving the availability of and subsidies for &ldquo;essential&rdquo; drugs, and (3)
the announcement in August 2009 of China&rsquo;s National Essential Drugs List (&ldquo;NEDL&rdquo;), initially listing approximately three
hundred (300) medicines to be sold at government-controlled prices. While an underlying goal of these policies is to make drugs more accessible
to China&rsquo;s poorer population, these policies also serve to create opportunities that in turn will intensify business competition
in the Chinese retail drugstore industry, as well as competition for skilled labor and retail spaces. Additionally, we expect the NEDL
to result in a rise in the number of government-subsidized community healthcare service centers, which in turn may erode the convenience
and price advantage that our drugstores traditionally enjoy against hospitals.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The PRC&rsquo;s labor law restricts our
ability to reduce our workforce in the PRC in the event of an economic downturn and may increase our production costs.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In June 2007, the National
People&rsquo;s Congress of the PRC enacted new labor law legislation called the Labor Contract Law, which became effective on January
1, 2008 (the &ldquo;LC Law&rdquo;). The LC Law formalized workers&rsquo; rights concerning overtime hours, pensions, layoffs, employment
contracts and the role of trade unions. Considered one of the strictest labor laws in the world, among other things, the LC Law provides
for specific standards and procedures for the termination of an employment contract and places the burden of proof on the employer. In
addition, the law requires the payment of a statutory severance pay upon the termination of an employment contract in most cases, including
the case of the expiration of a fixed-term employment contract. Further, the LC Law requires an employer to conclude an &ldquo;employment
contract without a fixed-term&rdquo; with any employee who either has worked for the same employer for ten (10) consecutive years or more
or has had two (2) consecutive fixed-term contracts with the same employer. An &ldquo;employment contract without a fixed term&rdquo;
can no longer be terminated on the ground of the expiration of the contract, although it can still be terminated pursuant to the standards
and procedures set forth under the new law. Because of the lack of implementing rules for the LC Law and the precedents for the enforcement
of such a law, the standards and procedures set forth under the LC Law in relation to the termination of an employment contract have raised
concerns among foreign investment enterprises in the PRC that such &ldquo;employment contract without a fixed term&rdquo; might in fact
become a &ldquo;lifetime, permanent employment contract.&rdquo; Finally, under the LC Law, downsizing of either more than twenty (20)
people or more than ten percent (10%) of the workforce may occur only under specified circumstances, such as a restructuring undertaken
pursuant to the PRC&rsquo;s Enterprise Bankruptcy Law, or where a company suffers serious difficulties in production and/or business operations,
or where there has been a material change in the objective economic circumstances relied upon by the parties at the time of the conclusion
of the employment contract, thereby making the performance of such employment contract impossible. To date, there has been very little
guidance and precedent as to how such specified circumstances for downsizing will be interpreted and enforced by the relevant PRC authorities.
All of our employees working for us exclusively within the PRC are covered by the LC Law and thus, our ability to adjust the size of our
operations when necessary in periods of recession or less severe economic downturns may be curtailed. Accordingly, if we face future periods
of decline in business activity generally or adverse economic periods specific to our business, the LC Law can be expected to exacerbate
the adverse effect of the economic environment on our results of operations and financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We cannot be certain that the Chinese regulatory
authorities will not impose more stringent restrictions on the convertibility of the Renminbi, especially with respect to foreign exchange
transactions.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Fluctuations in the value
of the Renminbi may have a material and adverse effect on your investment. The change in value of the Renminbi against the U.S. dollar
is affected by, among other things, changes in PRC&rsquo;s political and economic conditions. We receive substantially all of our revenues
in RMB. Under our current structure, our income is primarily derived from payments from the three (3) HJ Group companies. Shortages in
the availability of foreign currency may restrict the ability of our subsidiaries and our PRC affiliated entities to remit sufficient
foreign currency to pay dividends or other payments to us, or otherwise satisfy their foreign currency denominated obligations. Under
existing Chinese foreign exchange regulations, payments of current account items, including profit distributions, interest payments and
expenditures from trade-related transactions, can be made in foreign currencies without prior approval from SAFE by complying with certain
procedural requirements. However, approval from appropriate government authorities is required where RMB is to be converted into foreign
currency and remitted out of China to pay capital expenses, such as the repayment of bank loans denominated in foreign currencies. The
Chinese government may also, at its discretion, restrict access in the future to foreign currencies for current account transactions.
If the foreign exchange control system prevents us from obtaining sufficient foreign currency to satisfy our currency demands, we may
not be able to pay dividends in foreign currencies to our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">From 1995 until July 2005,
the People&rsquo;s Bank of China intervened in the foreign exchange market to maintain an exchange rate of approximately Renminbi 8.3
per U.S. dollar. On July 21, 2005, the PRC government changed this policy and began allowing modest appreciation of the Renminbi versus
the U.S. dollar. Under the new policy, the Renminbi was permitted to fluctuate within a narrow and managed band against a basket of certain
foreign currencies. This change in policy caused the Renminbi to appreciate approximately 21.5% against the U.S. dollar over the following
three years. As a consequence, the Renminbi has fluctuated sharply since July 2008 against other freely traded currencies, in tandem with
the U.S. dollar. It is difficult to predict how long the current situation may last and when and how it may change again. There remains
significant international pressure on the PRC government to adopt a substantial liberalization of its currency policy, which could result
in a further and more significant appreciation in the value of the Renminbi against the U.S. dollar. Significant revaluation of the Renminbi
may have a material and adverse effect on your investment. For example, to the extent that we need to convert U.S. dollars we receive
from securities offering into Renminbi for our operations, appreciation of the Renminbi against the U.S. dollar would have an adverse
effect on the Renminbi amount we would receive from the conversion. Conversely, if we decide to convert our Renminbi into U.S. dollars
for the purpose of making payments for dividends on our common stock or for other business purposes, appreciation of the U.S. dollar against
the Renminbi would have a negative effect on the U.S. dollar amount available to us. In August 2015, the PRC Government devalued its currency
by approximately 3%, represented the largest yuan depreciation for 20 years. Concerns remain that China&rsquo;s slowing economy, and in
particular its exports, will need a stimulus that can only come from further cuts in the exchange rate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Fluctuations in the value of RMB may have
a material adverse effect on your investment.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The value of RMB against
the U.S. dollar and other currencies may fluctuate and is affected by, among other things, changes in political and economic conditions.
Our revenues, costs, and financial assets are mostly denominated in RMB, while our reporting currency is the U.S. dollar. Accordingly,
this may result in gains or losses from currency translation on our financial statements. We rely entirely on fees paid to us by our affiliated
entities in China. Therefore, any significant fluctuation in the value of RMB may materially and adversely affect our cash flows, revenues,
earnings, financial position, and the value of, and any dividends payable on, our stock in U.S. dollars. For example, an appreciation
of RMB against the U.S. dollar would, to the extent that we need to convert U.S. dollars into RMB for such purposes, make any new RMB
denominated investments or expenditures more costly to us. An appreciation of RMB against the U.S. dollar would result in foreign currency
translation gains for financial reporting purposes when we translate our RMB denominated financial assets into U.S. dollars, as the U.S.
dollar is our reporting currency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In addition, appreciation
or depreciation in the value of the Renminbi relative to the U.S. dollar would affect our financial results reported in U.S. dollars without
giving effect to any underlying change in our business or results of operations. The income statements of our operations are translated
into U.S. dollars at the average exchange rates in each applicable period. To the extent the U.S. dollar strengthens against foreign currencies,
the translation of these foreign currencies denominated transactions results in reduced revenue, operating expenses and net income for
our international operations. Similarly, to the extent the U.S. dollar weakens against foreign currencies, the translation of these foreign
currency denominated transactions results in increased revenue, operating expenses and net income for our international operations. We
are also exposed to foreign exchange rate fluctuations as we convert the financial statements of our foreign subsidiaries into U.S. dollars
in consolidation. If there is a change in foreign currency exchange rates, the conversion of the foreign subsidiaries&rsquo; financial
statements into U.S. dollars will lead to a translation gain or loss, which is recorded as a component of other comprehensive income.
Very limited hedging transactions are available in China to reduce our exposure to exchange rate fluctuations. To date, we have not entered
into any hedging transactions. While we may enter into hedging transactions in the future, the availability and effectiveness of these
transactions may be limited, and we may not be able to successfully hedge our exposure at all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our management will
have broad discretion over the use of the proceeds we receive from our financing activities and might not apply the proceeds in ways that
increase the value of your investment.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our management will have
broad discretion to use the net proceeds from any offerings we may conduct from time to time, and the shareholders will be relying on
the judgment of our management regarding the application of these proceeds. Except as described in our offering books, the net proceeds
received by us from our offerings will be added to our general funds and will be used for general corporate purposes. Our management might
not apply the net proceeds from offerings of our securities in ways that increase the value of your investment and might not be able to
yield a significant return, if any, on any investment of such net proceeds. You may not have the opportunity to influence our decisions
on how to use such proceeds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Jiuzhou Pharmacy, Jiuzhou Clinic and Jiuzhou
Service are subject to restrictions on making payments to us.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We rely substantially on
our contractual arrangements with Jiuzhou Pharmacy, Jiuzhou Clinic and Jiuzhou Service for our revenue. The Chinese government also imposes
controls on the conversion of RMB into foreign currencies and the remittance of currencies out of China. We may experience difficulties
in completing the administrative procedures necessary to obtain and remit foreign currency. Furthermore, if these companies incur debt
on their own in the future, the instruments governing the debt may restrict their ability to make payments. If we are unable to receive
all of the revenues from our operations through these contractual arrangements, we may be unable to pay dividends on our common shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Dividends we receive from our subsidiaries
located in the PRC may be subject to PRC withholding tax.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The EIT Law provides that
a maximum income tax rate of twenty percent (20%) is applicable to dividends payable to non-PRC investors that are &ldquo;non-resident
enterprises,&rdquo; to the extent such dividends are derived from sources within the PRC. However, the State Council has reduced such
rate to ten percent (10%) through the implementation regulations. We are a Nevada holding company and substantially all of our income
is derived from our subsidiaries and controlled companies located in the PRC. Therefore, dividends paid to us from China may be subject
to the ten percent (10%) income tax if we are considered a &ldquo;non-resident enterprise&rdquo; under the EIT Law. If we are required
to pay income tax for any dividends we receive from our PRC subsidiaries under the EIT Law and its implementation regulations, it may
have a material and adverse effect on our net income and materially reduce the amount of dividends, if any, we may pay to our shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We face risks related to disease epidemics
and other outbreaks.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our business could be adversely
affected by the effects of a widespread outbreak of contagious disease, including the current outbreak of respiratory illness caused by
the novel coronavirus. Any outbreak of contagious diseases, and other adverse public health developments, particularly in China, could
have a material and adverse effect on our business operations. These could include disruptions or restrictions on our ability to travel
or to distribute our products, as well as temporary closures of our facilities or the facilities of our suppliers or customers. Any disruption
or delay of our suppliers, manufacturers or customers would likely impact our sales and operating results. In addition, a significant
outbreak of contagious diseases in the human population could result in a widespread health crisis that could adversely affect the economies
and financial markets of China and many other countries, resulting in an economic downturn that could affect demand for our products and
significantly impact our operating results. Amidst the COVID-19 outbreak, we experienced a decline in the number of customer visits during
the first three months of calendar 2020 due to the implementation of the lockdown policy in China. In addition, because some of our employees
could not come to the workplace, we were short of staff which slowed down our logistic service and impacted our customer service at stores.
However, as China is gradually controlling the spread of COVID-19, we believe these negative impacts are temporary. Currently we are unable
to accurately predict the future impact of COVID-19 due to the developing circumstances and uncertainty surrounding this current pandemic,
including the ultimate geographic spread of COVID-19, the severity of the disease, the duration of the outbreak, and effectiveness of
the actions that may be taken by governmental authorities. The management has been closely monitoring the impact caused by COVID-19 and
we will continue to operate our business as steadily and safely as we can.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Failure to comply with the U.S. Foreign
Corrupt Practices Act could subject us to penalties and other adverse consequences.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are required to comply
with the United States Foreign Corrupt Practices Act, which generally prohibits United States companies from engaging in bribery or other
prohibited payments to foreign officials for the purpose of obtaining or retaining business. Foreign companies, including some that may
compete with us, are not subject to these prohibitions, and therefore may have a competitive advantage over us. Corruption, extortion,
bribery, pay-offs, theft and other fraudulent practices may occur in the PRC. If our competitors engage in these practices, they may receive
preferential treatment in the PRC, giving them an advantage in securing business, which would put us at a disadvantage. We cannot provide
assurance that our employees or other agents will not engage in such conduct for which we might be held responsible. If our employees
or other agents are found to have engaged in such practices, we could suffer severe penalties and other consequences that may have a material
adverse effect on our business, financial condition and results of operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If relations between the United States and
China worsen, investors may be unwilling to hold or buy our stock and our stock price may decrease.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">At various times in recent
years, the United States and China have had significant disagreements over political and economic issues. Controversies may arise in the
future between the two countries. Any political or trade controversies between the United States and China, whether or not directly related
to our business, could reduce the price of our common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our auditor, like other independent registered
public accounting firms operating in China, is not permitted to be subject to inspection by Public Company Accounting Oversight Board,
and consequently investors may be deprived of the benefits of such inspection.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our independent registered
public accounting firm issued an audit opinion on the financial statements included in our annual reports filed with the SEC. Our independent
registered public accounting firm&rsquo;s audit documentation related to their audit reports included in our annual reports is located
in China, and audit procedures take place within China&rsquo;s borders. As auditors of companies that are traded publicly in the United
States and a firm registered with the Public Company Accounting Oversight Board, or the PCAOB, our auditor is required by the laws of
the United States to undergo regular inspections by the PCAOB. However, work papers located in China are not currently inspected by the
PCAOB because the PCAOB is currently unable to conduct inspections without the approval of the PRC authorities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Inspections of certain other
firms that the PCAOB has conducted outside of China have identified deficiencies in those firms&rsquo; audit procedures and quality control
procedures, which may be addressed as part of the inspection process to improve future audit quality. However, the PCAOB is currently
unable to inspect an auditor&rsquo;s audit work related to a company&rsquo;s operations in China and where such documentation of the audit
work is located in China. As a result, our investors may be deprived of the benefits of the PCAOB&rsquo;s oversight of auditors that are
located in China through such inspections.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On December 7, 2018, the
SEC and the PCAOB issued a joint statement highlighting continued challenges faced by the U.S. regulators in their oversight of financial
statement audits of U.S.-listed companies with significant operations outside United States, especially in China. On April 21, 2020, the
SEC and the PCAOB issued another joint statement highlighting the significant disclosure, financial reporting and other risks associated
with emerging market investments, including the PCAOB&rsquo;s continued inability to inspect audit work papers in China. These joint statements
reflect a heightened interest in an issue that has vexed U.S. regulators in recent years. However, it remains unclear what further actions
the SEC and the PCAOB will take to address the problem and its impact on Chinese companies listed in the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The inability of the PCAOB
to conduct inspections of an auditor&rsquo;s work papers in China makes it more difficult to evaluate the effectiveness of any of our
auditor&rsquo;s audit procedures or quality control procedures that may be located in China as compared to auditors outside of China that
are subject to PCAOB inspections. Investors may consequently lose confidence in our reported financial information and procedures and
the quality of our financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In June 2019, a bipartisan
group of lawmakers introduced bills in both houses of the U.S. Congress, and passed requiring the SEC to maintain a list of issuers for
which the PCAOB is not able to inspect or investigate an auditor report issued by a foreign public accounting firm. The proposed Ensuring
Quality Information and Transparency for Abroad-Based Listings on our Exchanges (EQUITABLE) Act prescribes increased disclosure requirements
for these issuers and, beginning in 2025, the delisting from U.S. national securities exchanges of issuers included on the SEC&rsquo;s
list for three consecutive years. On May 20, 2020, the U.S. Senate passed the Holding Foreign Companies Accountable Act, which in effect
would prohibit securities of any registrant from being listed on any of the U.S. securities exchanges or traded &ldquo;over-the-counter&rdquo;
if registrant&rsquo;s financial statements have, for a period of three years, been audited by an accounting firm branch or office that
is not subject to PCAOB inspection. Enactment of any of such legislations or other efforts to increase U.S. regulatory access to audit
information could cause investor uncertainty for affected issuers, including us, and the stock price could be adversely affected. There
is uncertainty as to whether and when these bills or legislations will be enacted in the proposed form, or at all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The slowing economic growth in China may
assert a negative impact on our operation and financial results.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">According to several articles
published by the Wall Street Journal, CNN, and BBC News in January 2016, after experiencing rapid growth for more than a decade, China&rsquo;s
economy has been hit by shrinking foreign and domestic demand, weak investment, factory overcapacity and oversupply in the property market,
and has experienced a painful slowdown in the last two years. In 2016, China&rsquo;s economy grew by 6.7%, compared with 6.9% a year earlier,
marking its slowest growth in a quarter of a century. As the government tried to shift the growth engine away from manufacturing and debt-fueled
investment toward the services sector and consumer spending, the outlook of the Chinese economy is uncertain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In the next two to three
years, China&rsquo;s growth performance could deteriorate because of the overhang of its real estate bubble, massive manufacturing overcapacity,
and the lack of new growth engines. The International Monetary Fund expected China&rsquo;s economy to grow by 6.4% in 2018-2020. If China&rsquo;s
economy slows down further, it may negatively affect our business operation and financial results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks Related to an Investment in Our Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>To date, we have not paid any cash dividends
and no cash dividends will be paid in the foreseeable future.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We do not anticipate paying
cash dividends on our common stock in the foreseeable future and we may not have sufficient funds legally available to pay dividends.
Even if the funds are legally available for distribution, we may nevertheless decide not to pay any dividends. We intend to retain all
earnings for our operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>NASDAQ may delist our common stock from
trading on the NASDAQ Capital Market for failing to maintain a minimum bid price of $1.00, which could limit investors&rsquo; ability
to effect transactions in our common stock and subject us to additional trading restrictions.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On May 9, 2013, we received
a letter from The NASDAQ Stock Market LLC (&ldquo;NASDAQ&rdquo;), notifying us of our failure to maintain a minimum closing bid price
of $1.00 over the then preceding thirty (30) consecutive trading days for its common stock, as required by NASDAQ Listing Rule 5550(a)(2)
(the &ldquo;Bid Price Rule&rdquo;). The letter stated that the company had until November 5, 2013, to demonstrate compliance by maintaining
a minimum closing bid price of at least $1.00 for a minimum of ten (10) consecutive trading days. In the meantime, we were included in
a list of non-compliant companies posted on NASDAQ&rsquo;s website commencing on May 16, 2013.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On November 6, 2013, NASDAQ
granted us an additional 180-day period, or until May 5, 2014, to remain listed on the NASDAQ Capital Market and to regain compliance
with the Bid Price Rule. Under NASDAQ Listing Rules, we were granted this extension because we met the continued listing requirement for
market value of publicly held shares and all other applicable NASDAQ listing requirements, except the bid price requirement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On January 16, 2014, we received
a letter from NASDAQ notifying us that we had regained compliance with the Bid Price Rule, as the closing bid price of our common stock
had been at or above $1.00 per share for at least 10 consecutive trading days. However, we cannot provide assurance that we will remain
compliant with the Bid Price Rule in the future. In the year ended March 31, 2020, our stock prices range from $1.01 to $3.35. If NASDAQ
delists our common stock from trading on its exchange, we could face significant material adverse consequences including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">a limited availability of market quotations for our common stock;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18.05pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">a limited amount of news and analyst coverage for our company; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18.05pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">a decreased ability to issue additional securities or obtain additional financing
in the future.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></DIV>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Although publicly traded, the trading market
in our common stock may be substantially less liquid than the average stock quoted on the NASDAQ Capital Market, and such low trading
volume may adversely affect the price of our common stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Although our common stock
has been listed on the NASDAQ Capital Market since April 22, 2010, the historical trading volume of our common stock has generally been
low. Limited trading volume will subject our shares of common stock to greater price volatility and may make it difficult for you to sell
your shares of common stock at a price that is attractive to you.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The market price for our stock may be volatile,
and such volatility may subject us to securities litigation.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The market price for our
stock may be volatile and, when compared to seasoned issuers, subject to wide fluctuations in response to various factors, many of which
are beyond our control, including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0pt; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">actual
    or anticipated fluctuations in our quarterly operating results;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">changes
    in financial estimates by securities research analysts;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">conditions
    in the retail pharmacy markets;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">changes
    in the economic performance or market valuations of other retail pharmacy operators;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">announcements
    by us or our competitors of new products, acquisitions, strategic partnerships, joint ventures or capital commitments;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">addition
    or departure of key personnel;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">fluctuations
    of exchange rates between RMB and the U.S. dollar;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">intellectual
    property litigation; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">general
    economic or political conditions in China.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In addition, the securities
market has from time to time experienced significant price and volume fluctuations that are not related to the operating performance
of particular companies. These market fluctuations may also materially and adversely affect the market price of our stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In the past, plaintiffs have
often initiated securities class action litigation against a company following periods of volatility in the market price of its securities.
We may, in the future, be the target of similar litigation. Securities litigation could result in substantial costs and liabilities and
could divert management&rsquo;s attention and resources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Techniques employed by manipulative short
sellers in Chinese small-cap stocks may drive down the market price of our common stock.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Short selling is the practice
of selling securities that the seller does not own but rather has borrowed from a third party with the intention of buying identical
securities back at a later date to return to the lender. The short seller hopes to profit from the difference in the sale price of the
borrowed securities and the purchase price of the replacement shares. As it is therefore in the short seller&rsquo;s best interests for
the price of the stock to decline, there have been incidents of short sellers publishing, or arranging to publish negative opinions in
order to create negative market momentum. While traditionally these disclosed shorts have been limited in their ability to access mainstream
business media or to otherwise create negative market rumors, the rise of the Internet and technological advancements regarding document
creation, videotaping and publication by weblog (&ldquo;blogging&rdquo;) have allowed many disclosed shorts to publicly attack a company&rsquo;s
credibility, strategy and veracity by means of so-called research reports that mimic the type of investment analysis performed by large
Wall Street firms and independent research analysts. These short attacks have, in the past, resulted in the selling of shares in the
market, on occasion on a large scale and broad base. Issuers with business operations based in the PRC, that have limited trading volumes
and that are susceptible to higher volatility levels than U.S. domestic large-cap stocks can be particularly vulnerable to such short
attacks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">These short seller publications
are not regulated by any governmental, self-regulatory organization or other official authority in the U.S., are not subject to the certification
requirements imposed by the SEC in Regulation Analyst Certification and, accordingly, the opinions they express may be based on distortion
of the actual facts or, in some cases, fabrication of the facts. In light of the limited risks involved in publishing such information,
and the enormous profit that can be made from running just one successful short attack, unless the short sellers become subject to significant
penalties, it is more likely than not that disclosed shorts will continue to issue such reports.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">While we intend to strongly
defend our public filings against any such short seller attacks, oftentimes we are constrained, either by principles of freedom of speech,
applicable state law (often called Anti-SLAPP statutes), or issues of commercial confidentiality, in the manner in which we can proceed
against the relevant short seller. You should be aware that in light of the relative freedom to operate that such persons enjoy &ndash;
oftentimes blogging from outside the U.S. with little or no assets or identity requirements &ndash; should we be targeted for such an
attack and the rumors not dismissed by market participants, our stock will likely suffer from a temporary, or possibly long term, decline
in market price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our officers and directors own a substantial
portion of our outstanding common stock, which will enable them to influence many significant corporate actions and in certain circumstances
may prevent a change in control that would otherwise be beneficial to our shareholders.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">As of June 11, 2020, our
directors and executive officers collectively controlled approximately 9,433,482 or 28.4% of our outstanding shares of stock entitled
to vote on all corporate actions. These stockholders, acting together, could have a substantial impact on matters requiring the vote
of the shareholders, including the election of our directors and most of our corporate actions. This control could delay, defer or prevent
others from initiating a potential merger, takeover or other change in our control, even if these actions would benefit us and our shareholders.
This control could adversely affect the voting and other rights of our other shareholders and could depress the market price of our common
stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The elimination of monetary liability against
our directors, officers and employees under Nevada law and the existence of indemnification rights for our directors, officers and employees
may result in substantial expenditures by us and may discourage lawsuits against our directors, officers and employees.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our bylaws contain specific
provisions that eliminate the liability of our directors for monetary damages to our company and shareholders, and we are prepared to
give such indemnification to our directors and officers to the extent provided by Nevada law. We may also have contractual indemnification
obligations under our employment agreements with our officers. The foregoing indemnification obligations could result in our company
incurring substantial expenditures to cover the cost of settlement or damage awards against directors and officers, which we may be unable
to recoup. These provisions and any costs resulting therefrom may also discourage our company from bringing a lawsuit against directors
and officers for breaches of their fiduciary duties, and may similarly discourage the filing of derivative litigation by our shareholders
against our directors and officers even though such actions, if successful, might otherwise benefit our company and shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Legislative actions, potential new accounting
pronouncements and higher insurance costs may impact our future financial position and results of operations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Over the last decade or so,
there have been many regulatory changes, including the Sarbanes-Oxley Act of 2002 (the &ldquo;Sarbanes-Oxley Act&rdquo;) and the Dodd-Frank
Wall Street Reform and Consumer Protection Act of 2010. There may potentially be new accounting pronouncements or regulatory rulings
or changes that will have an impact on our future financial position and results of operations. In addition, insurers are likely to increase
premiums as a result of high claims rates over the past several years, which we expect will increase our premiums for insurance policies.
These and other potential changes could materially increase the expenses we report under generally accepted accounting principles, and
adversely affect our operating results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>If we fail to maintain an effective system
of internal controls, we may not be able to accurately report our financial results or prevent fraud.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We are subject to reporting
obligations under U.S. securities laws. The SEC, as required by Section 404 of the Sarbanes-Oxley Act, as amended, adopted rules requiring
every public company to include a management report on such company&rsquo;s internal controls over financial reporting in its annual
report, which contains management&rsquo;s assessment of the effectiveness of our internal controls over financial reporting. We reported
certain material weaknesses involving control activities, specifically internal control weaknesses relating to finance personnel, in
light of the continuing lack of sufficient experience by our accounting staff in U.S. GAAP-based reporting and SEC rules and regulations.
Such material weaknesses were noted for the past five (5) fiscal years, based on factors including: (i) the number of adjustments proposed
by our independent auditors during our quarterly review and annual audit processes; (ii) the significance of the audit adjustments and
their impact on the overall financial statements; (iii) how appropriately we complied with U.S. GAAP on transactions; and (iv) how accurately
we prepared supporting information to provide to our independent auditors on a quarterly and annual basis. As such, we did not maintain
effective controls and did not implement adequate and proper supervisory review to ensure that significant internal control deficiencies
could be detected and/or prevented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Although we believe that
we have made significant efforts to address the foregoing weaknesses, we believe that our efforts to date have not yet been sufficient
to fully remediate such weaknesses. We will continue our efforts during the current fiscal year, although there can be no assurance that
compliance will be achieved in this time frame.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our reporting obligations
as a public company will place a significant strain on our management, operational and financial resources and systems for the foreseeable
future. Effective internal controls, particularly those related to revenue recognition, are necessary for us to produce reliable financial
reports and are important to help prevent fraud. As a result, our failure to achieve and maintain effective internal controls over financial
reporting could result in the loss of investor confidence in the reliability of our financial statements, which in turn could harm our
business and negatively impact the trading price of our common stock. Furthermore, we anticipate that we will incur considerable costs
and use significant management time and other resources in an effort to comply with Section 404 and other requirements of the Sarbanes-Oxley
Act.</P>


<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B><A NAME="main_008"></A>BUSINESS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Set forth below is a description
of the business of the Company. CJJD Cayman does not have any operations or assets. Accordingly, a separate discussion of its business
is not included in this proxy statement/prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Overview </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We are a retailer and distributor
of pharmaceutical and other healthcare products typically found in retail pharmacies in the People&rsquo;s Republic of China (&ldquo;PRC&rdquo;
or &ldquo;China&rdquo;). Prior to acquiring Zhejiang Jiuxin Medicine Co., Ltd. (&ldquo;Jiuxin Medicine&rdquo;) in August 2011 (see &ldquo;<I>Our
Corporate History and Structure - HJ Group</I>&rdquo; below), we were primarily a retail pharmacy operator. We currently have one hundred
and eighteen (118) store locations under the store brand &ldquo;Jiuzhou Grand Pharmacy&rdquo; in Hangzhou city and its adjacent town
Lin&rsquo;an. During the year ended March 31, 2020, the Company dissolved eight independent pharmacies. Among the eight dissolved pharmacies,
two stores had merged into Jiuzhou Pharmacy, as defined below, and became Jiuzhou Pharmacy stores in Hangzhou. The other six stores&rsquo;
licenses of government medical insurance, which qualify the stores for reimbursement from government, were transferred to six Jiuzhou
Pharmacy stores in Hangzhou City. Additionally, we acquired a local drugstore chain with ten stores in January 2020. Then we dissolved
the chain and transferred its certificates to Jiuzhou Pharmacy stores. Furthermore, we closed three stores in calendar 2019 due to their
underperformance and opened a new store in April 2020. Amidst the COVID-19 outbreak, we experienced a decline in the number of customer
visits during the first three months of calendar 2020 due to the implementation of the lockdown policy in China. However, as China is
gradually controlling the spread of COVID-19, we believe these negative impacts are temporary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We currently operate in four
business segments in China: (1) retail drugstores, (2) online pharmacy, (3) wholesale business selling products similar to those we carry
in our pharmacies, and (4) farming and selling herbs used for traditional Chinese medicine (&ldquo;TCM&rdquo;). All of the above business
are performed in China with no other international sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our stores provide customers
with a wide variety of pharmaceutical products, including prescription and over-the-counter (&ldquo;OTC&rdquo;) drugs, nutritional supplements,
TCM, personal and family care products, and medical devices, as well as convenience products, including consumable, seasonal, and promotional
items. Additionally, we have doctors licensed in both western medicine and TCM on site for consultation, examination and treatment of
common ailments at scheduled hours. Three (3) stores have adjacent medical clinics offering urgent care (to provide treatment for minor
ailments such as sprains, minor lacerations, and dizziness that can be treated on an outpatient basis), TCM (including acupuncture, therapeutic
massage, and cupping) and minor outpatient surgical treatments (such as suturing). Our stores vary in size, but presently average close
to 200 square meters per store. We attempt to tailor each store&rsquo;s product offerings, physician access, and operating hours to suit
the community where the store is located.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We operate our pharmacies
(including the medical clinics) through the following companies in China that we control through contractual arrangements (refer to &ldquo;<I>Contractual
Arrangements with HJ Group and the Key Personnel&rdquo; below in this prospectus regarding the details of contractual arrangements</I>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Hangzhou Jiuzhou
    Grand Pharmacy Chain Co., Ltd. (&ldquo;Jiuzhou Pharmacy&rdquo;), which we control contractually, operates our &ldquo;Jiuzhou Grand
    Pharmacy&rdquo; stores;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Hangzhou
    Jiuzhou Clinic of Integrated Traditional and Western Medicine (General Partnership) (&ldquo;Jiuzhou Clinic&rdquo;), which we control
    contractually, operates one (1) of our three (3) medical clinics; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Hangzhou
    Jiuzhou Medical &amp; Public Health Service Co., Ltd. (&ldquo;Jiuzhou Service&rdquo;), which we control contractually, operates our
    other medical clinics.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In addition, we operate pharmacies
through Lin&rsquo;An Jiuzhou Pharmacy Co., Ltd (&ldquo;Lin&rsquo;An Jiuzhou&rdquo;), which are directly held by Jiuxin Investments Management
Co. Ltd. We have also opened two clinics adjacent to our drugstores under Zhejiang Jiuzhou Linjia Medical Investment and Management Co.
Ltd. (&ldquo;Linjia Medical&rdquo;), which are controlled by Jiuzhou Pharmacy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We also offer OTC drugs and
nutritional supplements for sale through a website (<U>www.dada360.com</U>) operated by Jiuzhou Pharmacy. For the fiscal year ended March
31, 2020, retail revenue, including pharmacies, medical clinics accounted for approximately 63.1% of our total revenue, while online
pharmacy revenue accounted for 11.6% of our total revenue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Since August 2011, we have
operated a wholesale business through Zhejiang Jiuxin Medicine Co., Ltd. (&ldquo;Jiuxin Medicine&rdquo;), distributing third-party pharmaceutical
products (similar to those carried by our pharmacies) primarily to trading companies throughout China. Jiuxin Medicine is wholly owned
by Jiuzhou Pharmacy. For the fiscal year March 31, 2020, wholesale revenue accounted for approximately 25.3% of our total revenue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We also have an herb farming
business cultivating and wholesaling herbs used for TCM. This business is conducted through Hangzhou Qianhong Agriculture Development
Co., Ltd. (&ldquo;Qianhong Agriculture&rdquo;), a wholly-owned subsidiary. During the fiscal year ended March 31, 2020, we generated
no revenue from our herb farming business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Throughout this prospectus,
we will sometimes refer to Jiuzhou Pharmacy, Jiuzhou Clinic and Jiuzhou Service, Lin&rsquo;An Jiuzhou, as well as the subsidiaries of
Jiuzhou Pharmacy, collectively as &ldquo;HJ Group.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our Corporate History and Structure</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We were incorporated in Nevada
on December 19, 2006, under the name &ldquo;Kerrisdale Mining Corporation,&rdquo; with a principal business objective to acquire and
develop mineral properties. Although we had acquired certain mining claims, we were not operational.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">On July 14, 2008, we amended
our Articles of Incorporation to increase our authorized capital stock from 75,000,000 shares of common stock, par value $0.001 per share,
to 500,000,000 shares of common stock, par value $0.001 per share, and authorized the issuance of 10,000,000 shares of &ldquo;blank check&rdquo;
preferred stock, par value $0.001 per share. With respect to the preferred shares, our Board of Directors has the right to set its designations,
preferences, limitations, privileges, qualifications, dividend, conversion, voting, and other special or relative rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">On September 17, 2009, we
acquired control of Renovation Investment (Hong Kong) Co., Ltd., a limited liability company incorporated in Hong Kong on September 2,
2008 (&ldquo;Renovation&rdquo;), pursuant to a share exchange agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">On September 24, 2009, we
amended our Articles of Incorporation to change our name from &ldquo;Kerrisdale Mining Corporation&rdquo; to &ldquo;China Jo-Jo Drugstores,
Inc.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">On April 9, 2010, we implemented
a 1-for-2 reverse stock split of our issued and outstanding shares of common stock and a proportional reduction of our authorized shares
of common stock, by filing a Certificate of Change pursuant to Nevada Revised Statutes 78.209 with the Nevada Secretary of State on April
6, 2010. All share information in this prospectus takes into account this reverse stock split.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">On April 28, 2010, we completed
a registered public offering of 3,500,000 shares of our common stock at a price of $5.00 per share, resulting in gross proceeds to us,
prior to deducting underwriting discounts, commissions and offering expenses, of approximately $17,500,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">On July 24, 2015, we closed
a registered direct offering of 1.2 million shares of common stock at $2.50 per share with gross proceeds of approximately $3 million
from our effective shelf registration statement on Form S-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">On January 23, 2017, we completed
a private offering of 4,840,000 shares of the common stock at a price of $2.20 per share with gross proceeds of $10,648,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">On April 15, 2019, we closed
a registered direct offering of 4,000,008 shares of common stock at $2.50 per share with gross proceeds of $10,000,020 from our effective
shelf registration statement on Form S-3. In a concurrent private placement we issued to the investors unregistered warrants to purchase
up to an aggregate of 3,000,006 shares of common stock at an exercise price of $3.00 per share. The placement agent receives warrants
to purchase up to 240,000 shares of the common stock with an exercise price of $3.125 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">On June 3, 2020, we closed
a registered direct offering of 5,000,004 shares of common stock at $2.00 per share with gross proceeds of $10,000,008 from our effective
shelf registration statement on Form S-3. In a concurrent private placement we issued to the investors unregistered warrants to purchase
up to an aggregate of 3,750,003 shares of common stock at an exercise price of $2.60 per share. The placement agent receives warrants
to purchase up to 300,000 shares of the common stock with an exercise price of $2.57 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Renovation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Renovation was formed by
the owners of HJ Group, as defined below, as a special purpose vehicle to raise capital overseas, in accordance with the requirements
of China&rsquo;s State Administration of Foreign Exchange (&ldquo;SAFE&rdquo;). SAFE issued the <I>Notice on Relevant Issues Concerning
Foreign Exchange Administration for Financing and Round-Trip Investment Undertaken by Domestic Residents Through Overseas Special-Purpose
Vehicles</I> (&ldquo;Circular No. 75&rdquo;) on October 21, 2005. To further clarify the implementation of Circular 75, on May 31, 2007,
SAFE issued a supplementary official notice known as <I>Hui ZhongFa [2007] No. 106</I> (&ldquo;Circular 106&rdquo;). Circular 75 and
Circular 106 require the owners of any Chinese company to obtain SAFE&rsquo;s approval before establishing any offshore holding company
structure for foreign financing as well as subsequent acquisition matters in China. Accordingly, the owners of HJ Group submitted their
applications to SAFE on July 25, 2008. On August 16, 2008, SAFE approved the applications, permitting these Chinese nationals to establish
Renovation as an offshore, special purpose vehicle which was permitted to have foreign ownership and participate in foreign capital raising
activities. After SAFE&rsquo;s approval, the owners of HJ Group became holders of one hundred percent (100%) of Renovation&rsquo;s issued
and outstanding capital stock on September 2, 2008. See &ldquo;<I>Relevant PRC Regulations - SAFE Registration</I>&rdquo; below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Jiuxin Management</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Zhejiang Jiuxin Investment
Management Co., Ltd. (&ldquo;Jiuxin Management&rdquo;) was organized in the PRC on October 14, 2008. Since all of its issued and outstanding
capital stock is held by Renovation, a Hong Kong company, Jiuxin Management is deemed a &ldquo;wholly foreign owned enterprise&rdquo;
(&ldquo;WFOE&rdquo;) under applicable PRC laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Jiutong Medical</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Hangzhou Jiutong Medical
Technology Co., Ltd. (&ldquo;Jiutong Medical&rdquo;) was organized in the PRC on December 20, 2011. Like Jiuxin Management, Jiutong Medical
is also deemed a WFOE because it is wholly owned by Renovation. In November 2013, Jiutong Medical acquired the right to use of a piece
of land, for which we intended to establish a herb processing plant. However, as our herb business has not grown, we have not started
constructing the plant as of March 31, 2020. In the future, we may sell the land.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Shouantang Technology</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Shouantang Technology was
organized in the PRC on July 16, 2010. Like Jiuxin Management and Jiutong Medical, it is also deemed a WFOE because it is wholly owned
by Renovation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In November 2010, Shouantang
Technology acquired one hundred percent (100%) of Quannuo Technology and its wholly-owned subsidiary, Hangzhou Quannuo Grand Pharmacy
Co., Ltd. (&ldquo;Hangzhou Quannuo&rdquo;), pursuant to an equity ownership transfer agreement. Quannuo Technology was organized in the
PRC on July 7, 2009, and Hangzhou Quannuo was established on July 8, 2010. Hangzhou Quannuo has terminated its State Administration of
Industry and Commerce (&ldquo;SAIC&rdquo;) license in April 2015 and currently has no operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In November 2015, we sold
all of the equity interests of Quannuo Technology to six individuals for approximately $17,121 (RMB107,074). Quannuo Technology previously
provided technical support to our online pharmacy and incurred accumulated losses over the last five years of its operations. After the
sale, its technical support function has been transferred back to Jiuzhou Pharmacy, which hosts our online pharmacy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Qianhong Agriculture</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Qianhong Agriculture was
organized in the PRC on August 10, 2010 for our herb farming business. We planted ginkgo, also known as maidenhair, trees during the
year ended March 31, 2013. A ginkgo tree may have a growth period of up to twenty years before it is mature enough for harvest. Usually,
the longer it grows the more valuable it becomes. As of March 31, 2020, we have not harvested or sold any herbs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Shouantang Bio</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">On October 11, 2014, the
Company, through Jiuzhou Pharmacy, formed Shouantang Bio-technology Co., Ltd. (&ldquo;Shouantang Bio&rdquo;) by contributing $0.16 million
(RMB1 million) as its registered capital. Shouantang Bio was formed to sell nutritional supplements under its own brand name, Shouantang.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Jiuyi Technology</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">On September 10, 2015, Renovation
set up an entity named Hangzhou Jiuyi Medical Technology Co. Ltd, (&ldquo;Jiuyi Technology&rdquo;) with registered capital of $5 million,
which was originally intended to provide additional technical support such as webpage development to our online pharmacy business. Later
on, we decided to move online technical supports back to Jiuzhou Pharmacy, so Jiuyi Technology had no significant online technical operations.
Jiuyi Technology is located in Hangzhou, China. As it now has no operation, we may close it in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Lin&rsquo;an Jiuzhou</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">On March 31, 2017, the Company,
through Jiuxin Management, formed Lin&rsquo;an Jiuzhou Grand Pharmacy Co. Ltd, (&ldquo;Lin&rsquo;an Jiuzhou&rdquo;) with registered capital
of $725,570 (RMB 5 million), to expand our retail pharmacies in Lin&rsquo;an City. On February 4, 2021, Lin&rsquo;an Jiuzhou was sold
to a local online medicine operator fora total proceeds of $130,135 (RMB850,000). Lin&rsquo;An Jiuzhou has suffered an accumulated loss
of $833,831 as of January 31, 2021. After spinning off its Lin&rsquo;an subsidiary, the Company will focus more on its Hangzhou pharmacies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Linjia Medical</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">On September 27, 2017, the
Company, through Jiuzhou Pharmacy, formed and held 51% of Zhejiang Jiuzhou Linjia Medical Investment and Management Co. Ltd. with registered
capital of $2,979,460 (RMB20 million), to expand our clinics network adjacent to our drugstores. After extensive market research, Linjia
Medical started operation of its clinics in late calendar year 2018. However, Linjia Medical has not been profitable. As of December
31, 2020, Linjia Medical has ceased its operation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Ayi Health</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">On March 29, 2019, the Company, through Jiuzhou
Pharmacy, formed and currently holds 51% of the equity of Zhejiang AyiGe Medical Health Management Co., Ltd.(&ldquo;Ayi Health&rdquo;),
which is intended to provide technical support such as IT and customer support to our health management business in the future. However,
as the health management business did not progress as planned, on November 19, 2020, Ayi Health was dissolved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>HJ Group</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Jiuzhou Pharmacy is a PRC
limited liability company established on September 9, 2003 by Mr. Lei Liu (55%), Mr. Chong&rsquo;an Jin (23%) and Ms. Li Qi (22%). Hangzhou
Kuaileren Grand Pharmacy Co., Ltd. (&ldquo;Kuaileren&rdquo;), originally a subsidiary of Jiuzhou Pharmacy, was dissolved on April 9,
2011. Prior to its dissolution, Kuaileren operated a &ldquo;Kuaileren Grand Pharmacy&rdquo; store, which is now a &ldquo;Jiuzhou Grand
Pharmacy&rdquo; store. On July 1, 2014, Mr. Chong&rsquo;an Jin transferred all of the equity interests he held in Jiuzhou Pharmacy to
Mr. Lei Liu and Ms. Li Qi. As a result of this transfer, Mr. Lei Liu held 61% and Ms. Li Qi held 39% equity interests of Jiuzhou Pharmacy.
On August 21, 2017, after Mr. Lei Liu transferred certain shares to Ms. Li Qi, Mr. Lei Liu held 56.7% and Ms. Li Qi held 43.3%. On April
25, 2018, Mr. Wei Chen, who is associated with CareRetail Holdings Limited, agreed to invest RMB200,000 and hold 1% of Jiuzhou Pharmacy.
As a result, Mr. Lei Liu held 56.13% and Ms. Li Qi has held 42.87% equity interests of Jiuzhou Pharmacy. Mr. Lei Liu and Ms. Li Qi are
from time to time referred to in this prospectus as Key Personnel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Jiuzhou Pharmacy currently
has one subsidiary, Jiuxin Medicine, which was organized in the PRC on December 31, 2003. In April 2011, Jiuzhou Pharmacy entered into
an equity ownership transfer agreement with the owners of Jiuxin Medicine, and its business license was transferred to Jiuzhou Pharmacy,
although no consideration was paid. On August 25, 2011, the acquisition of Jiuxin Medicine was completed for $4.7 million (RMB 30 million).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Jiuzhou Clinic is a PRC general
partnership established on October 10, 2003 by Mr. Liu (39%), Mr. Jin (31%) and Ms. Qi (30%). Jiuzhou Clinic is a medical practice currently
operating adjacent to the &ldquo;Jiuzhou Grand Pharmacy&rdquo; store in Daguan, providing primary, urgent, minor surgical, and traditional
medical care services. Additionally, Jiuzhou Clinic&rsquo;s physicians consult with and examine patients at other &ldquo;Jiuzhou Grand
Pharmacy&rdquo; stores.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Jiuzhou Service is a PRC
limited liability company established on November 2, 2005 by Mr. Liu (39%), Mr. Jin (31%) and Ms. Qi (30%). Jiuzhou Service is licensed
as a healthcare management company and currently manages the medical clinic operating adjacent to the &ldquo;Jiuzhou Grand Pharmacy&rdquo;
stores in Wenhua and Xiasha, providing services similar to those at the Daguan clinic. In November 30, 2017, Mr. Jin transferred his
shares to Mr. Liu and Ms. Qi. After the transfer, Mr. Liu owns 56.7% and Ms. Qi owns 43.3% of the Jiuzhou Service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We control HJ Group through
contractual arrangements. See &ldquo;<I>Contractual Arrangements with HJ Group and the Key Personnel</I>&rdquo; below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Contractual Arrangements with HJ Group
and the Key Personnel</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our relationships with HJ
Group and the Key Personnel are governed by a series of contractual arrangements that they have entered into with Jiuxin Management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">PRC regulations on foreign
investment currently permit foreign companies to establish or invest in WFOEs or joint ventures that engage in wholesale or retail sales
of pharmaceuticals in China. For retail sales, however, these regulations restrict the number and size of pharmacies that a foreign investor
may own. If a chain operates more than thirty (30) stores and sells branded pharmaceutical products from different suppliers, a foreign
investor may own only up to forty nine percent (49%) of such chain. The contractual arrangements with Jiuzhou Pharmacy render such restrictions
inapplicable to us, since neither we nor our subsidiaries own equity interests in Jiuzhou Pharmacy, while at the same time we retain
control of its drugstore chain by virtue of the contractual arrangements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Similarly, PRC regulations
place certain restrictions on foreign ownership of medical practices. Foreign investors can only acquire ownership interests through
a Sino-foreign joint venture and not through a WFOE. Since we do not have actual equity interests in Jiuzhou Clinic or Jiuzhou Service,
and instead control these entities through contractual arrangements, such regulations do not apply to us or our structure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Under PRC laws, Jiuxin Management,
Jiuzhou Pharmacy, Jiuzhou Service and Jiuzhou Clinic are each independent business entities not exposed or subject to the liabilities
incurred by any of the other three (3) entities. The contractual arrangements constitute valid and binding obligations of the parties
to such agreements. Each of the contractual arrangements, and the rights and obligations of the parties thereto, are enforceable and
valid in accordance with the laws of the PRC. These contractual arrangements, as amended and in effect, include the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Consulting Services Agreements.
Pursuant to certain exclusive consulting services agreements (the &ldquo;Consulting Services Agreements&rdquo;), Jiuxin Management has
the exclusive right to provide Jiuzhou Pharmacy, Jiuzhou Service and Jiuzhou Clinic with general business operation services, including
advisory and strategic planning services, as well as consulting services related to their current and future operations (the &ldquo;Services&rdquo;).
Additionally, Jiuxin Management owns the intellectual property rights developed or discovered through research and development, in the
course of providing the Services, or derived from the provision of the Services. Jiuzhou Pharmacy, Jiuzhou Service and Jiuzhou Clinic
must each pay a quarterly consulting services fee in RMB to Jiuxin Management that is equal to its profits for such quarter. This agreement
is in effect until and unless terminated by written notice of a party to the agreement in the event that: (a) a party becomes bankrupt,
insolvent, is the subject of proceedings or arrangements for liquidation or dissolution, ceases to carry on business, or becomes unable
to pay its debts as they become due; (b) Jiuxin Management terminates its operations; or (c) circumstances arise which would materially
and adversely affect the performance or the objectives of the agreement. Jiuxin Management may also terminate the agreement with any
of Jiuzhou Pharmacy, Jiuzhou Service or Jiuzhou Clinic if one of them breaches the terms of the agreement, or without cause.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Operating Agreements. Pursuant
to certain operating agreements (the &ldquo;Operating Agreements&rdquo;), Jiuxin Management agrees to guarantee the contractual performance
by Jiuzhou Pharmacy, Jiuzhou Service and Jiuzhou Clinic of their agreements with any third party. In return, the Key Personnel must appoint
designees of Jiuxin Management to the boards of directors and senior management of Jiuzhou Pharmacy, Jiuzhou Service and Jiuzhou Clinic.
In addition, each of Jiuzhou Pharmacy, Jiuzhou Service and Jiuzhou Clinic agrees to pledge its accounts receivable and all of its assets
to Jiuxin Management. Moreover, without the prior consent of Jiuxin Management, Jiuzhou Pharmacy, Jiuzhou Service and Jiuzhou Clinic
cannot engage in any transactions that could materially affect their respective assets, liabilities, rights or operations, including,
without limitation, incurrence or assumption of any indebtedness, sale or purchase of any assets or rights, incurrence of any encumbrance
on any of their assets or intellectual property rights in favor of a third party, or transfer of any agreements relating to their business
operations to any third party. They must also abide by corporate policies set by Jiuxin Management with respect to their daily operations,
financial management and employment issues. The term of this agreement is from August 1, 2009 until the maximum period of time permitted
by law. Jiuzhou Pharmacy, Jiuzhou Service and Jiuzhou Clinic cannot terminate this agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Equity Pledge Agreements.
Pursuant to certain equity pledge agreements (the &ldquo;Equity Pledge Agreement&rdquo;), the Key Personnel have pledged all of their
equity interests in Jiuzhou Pharmacy, Jiuzhou Service and Jiuzhou Clinic to Jiuxin Management in order to guarantee these companies&rsquo;
performance of their respective obligations under the Consulting Services Agreement. If these companies or the Key Personnel breach their
respective contractual obligations, Jiuxin Management, as pledgee, will be entitled to certain rights, including the right to sell the
pledged equity interests. The Key Personnel have also agreed that upon occurrence of any event of default, Jiuxin Management shall be
granted an exclusive, irrevocable power of attorney to take actions in the place and stead of the Key Personnel to carry out the security
provisions of this agreement, and to take any action and execute any instrument that Jiuxin Management may deem necessary or advisable
to accomplish the purposes of this agreement. The Key Personnel agree not to dispose of the pledged equity interests or take any actions
that would prejudice Jiuxin Management&rsquo;s interests. This agreement will expire two (2) years after the obligations of Jiuzhou Pharmacy,
Jiuzhou Service and Jiuzhou Clinic under the Consulting Services Agreement have been fulfilled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Option Agreements. Pursuant
to the option agreements, the Key Personnel irrevocably grant Jiuxin Management or its designee an exclusive option to purchase, to the
extent permitted under PRC law, all or part of their equity interests in Jiuzhou Pharmacy, Jiuzhou Service and Jiuzhou Clinic for the
cost of the initial contributions to the registered capital or the minimum amount of consideration permitted by applicable PRC law. Jiuxin
Management or its designee has sole discretion to decide when to exercise the option, whether in part or in full. The term of this agreement
commenced from August 1, 2009 and continues for the maximum period of time permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 63; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Voting Rights Proxy Agreements.
Pursuant to the voting rights proxy agreements, the Key Personnel irrevocably grant a designee of Jiuxin Management the right to exercise
the voting and other ownership rights of the Key Personnel in Jiuzhou Pharmacy, Jiuzhou Service and Jiuzhou Clinic, including the rights
to (i) attend any meeting of the Key Personnel (or participate by written consent in lieu of such meeting) in accordance with applicable
laws and each company&rsquo;s incorporating documents, (ii) sell or transfer all or any of the equity interests of the Key Personnel
in these companies, and (iii) appoint and vote for the companies&rsquo; directors. The proxy agreement may be terminated by mutual consent
of the parties or upon thirty (30) days&rsquo; written notice from Jiuxin Management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Other than as pursuant to
the foregoing contractual arrangements, Jiuzhou Pharmacy, Jiuzhou Service and Jiuzhou Clinic cannot transfer any funds generated from
their respective operations. The contractual arrangements were originally entered into on August 1, 2009, and amended on October 27,
2009.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our Current Corporate Structure</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The following diagram illustrates
our current corporate structure as of March 31, 2021:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The table below summarizes
the status of the registered capital of our PRC subsidiaries and controlled companies as of the date of this prospectus:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; width: 35%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entity
    Name</FONT></TD>
    <TD STYLE="width: 1%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 15%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entity<BR>
    Type</FONT></TD>
    <TD STYLE="width: 1%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 15%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered<BR>
    Capital</FONT></TD>
    <TD STYLE="width: 1%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 15%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registered
    <BR>
    Capital Paid</FONT></TD>
    <TD STYLE="width: 1%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 16%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
    Date for <BR>
    Unpaid Registered <BR>
    Capital</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Jiutong
    Medical</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Subsidiary</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">USD
    2,600,000</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">USD
    2,600,000</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">N/A</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Jiuzhou
    Clinic</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">VIE</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">N/A</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">N/A</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">N/A</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Jiuzhou
    Pharmacy</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">VIE</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">USD
    733,500</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">USD
    733,500</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">N/A</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Jiuzhou
    Service</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">VIE</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">USD
    73,350</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">USD
    73,350</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">N/A</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Jiuxin
    Management</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Subsidiary</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">USD
    14,500,000</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">USD
    14,500,000</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">N/A</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Jiuxin
    Medicine</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">VIE</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">USD
    1,564,000</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">USD
    1,564,000</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">N/A</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Qianhong
    Agriculture</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Subsidiary</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">USD
    1,497,000</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">USD
    1,497,000</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">N/A</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Shouantang
    Technology</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Subsidiary</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">USD
    11,000,000</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">USD
    11,000,000</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">N/A</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Shouantang
    Bio</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Subsidiary</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">USD
    162,900</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">USD
    162,900</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">N/A</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Jiuyi
    Technology</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Subsidiary</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">USD
    5,000,000</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">USD
    2,500,000</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">September
    25, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Lin&rsquo;an
    Jiuzhou</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Subsidiary</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">USD
    725,570</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">USD
    72,557</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">March
    31, 2027</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Linjia
    Medical</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">VIE</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">USD
    2,979,460</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">USD
    1,489,730</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">N/A</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 64; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Our Business</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Pharmacies</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">As of December 31, 2020,
we currently have one hundred and eighteen (115) pharmacies throughout Hangzhou, the provincial capital of Zhejiang and neighborhood
cities. Pharmacy sales accounted for approximately 84.5% of our retail revenue, and 63.1% of our total revenue, for the fiscal year ended
March 31, 2020. We offer primarily third-party products at our pharmacies, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Approximately
    1,469 prescription drugs (295 of which require a physician&rsquo;s prescription and the remainder requiring customer personal information
    registration only), sales of which accounted for approximately 35.2% of our retail revenue for the fiscal year ended March 31, 2020;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Approximately
    1,704 OTC drugs, sales of which accounted for approximately 42.6% of our retail revenue for the fiscal year ended March 31, 2020;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Approximately
    482 nutritional supplements, including a variety of healthcare supplements, vitamin, mineral and dietary products, sales of which
    accounted for approximately 8.1% of our retail revenue for the fiscal year ended March 31, 2020;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">TCM,
    including drinkable herbal remedies and pre-packaged herbal mixtures for making soup, sales of which accounted for approximately
    7.2% of our retail revenue for the fiscal year ended March 31, 2020;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Sundry
    products (i.e., personal care products such as skin care, hair care and beauty products, convenience products such as soft drinks,
    packaged snacks, and other consumable, cleaning agents, stationeries, and seasonal and promotional items tailored to local consumer
    demand for convenience and quality), sales of which accounted for approximately 1.8% of our retail revenue for the fiscal year ended
    March 31, 2020; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Medical
    devices (i.e., family planning and birth control products, early pregnancy test products, portable electronic diagnostic apparatus,
    rehabilitation equipment, and surgical tools such as hemostats, needle forceps and surgical scissors), sales of which accounted for
    approximately 5.2% of our retail revenue for the fiscal year ended March 31,2020.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We favor retail locations
in well-established residential communities with relatively concentrated consumer purchasing power or are located in close proximity
to local hospitals, and evaluate potential store sites to assess consumer traffic, visibility and convenience. Depending on its size,
each drugstore has between two (2) to twenty-five (25) pharmacists on staff, all of whom are properly licensed. We only accept prescriptions
from licensed health care providers, and verify the validity, accuracy, and completeness of all prescriptions. We also ask all prescription
customers to disclose their drug allergies, current medical conditions, and current medications. Most pharmacies also maintain a TCM
counter staffed by licensed herbalists.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">After opening, a location
without SHI coverage may take up to one year to achieve our projected revenue goals for that particular location. Various factors influence
individual store revenue including, but not limited to: location, nearby competition, local population demographics, square footage,
and government insurance coverage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">All of our one hundred and
eighteen (118) of our drugstores are located in Hangzhou city and its adjacent town Lin&rsquo;an.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">To enhance our customers&rsquo;
experience, we have licensed physicians available at several of our &ldquo;Jiuzhou Grand Pharmacy&rdquo; locations for consultation,
examination and treatment of common ailments at scheduled hours. In addition, our Daguan, Wenhua, Xiasha and Yueming stores have adjoining
medical clinics that provide urgent care (for conditions such as sprains, minor lacerations, and dizziness), TCM treatments (including
acupuncture, therapeutic massage, moxibustion, and cupping), and minor outpatient surgical treatments (such as suturing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">To ensure quality and personal
attention for patients, we employ only licensed doctors and certified nurses and technicians. Patient treatment at our four (4) Jiuzhou
Clinics and Jiuzhou Service, and all Linjia Clinics follow nationally established clinical practice guidelines from China&rsquo;s Ministry
of Health. We currently have eighty-two (82) physicians and sixty-one (61) clinic staff. In-store consultations and examinations by our
physicians are provided free-of-charge to ensure that customers are being prescribed and taking the appropriate medication for their
ailments, and to afford customers convenience.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We view our medical services
as more consumer-driven than other health care specialties, because consumers requiring the types of medical services that we provide
often seek treatment on their own accord. We have developed our medical services to respond to the public need for convenient access
to medical consultations and/or care and the significant savings that we can provide as compared to a more traditional medical setting
such as a hospital. Many of our patients often need immediate access to medical services, do not have a regular physician, or may lack
suitable alternatives. Patient flow is derived from the physical presence of our drugstores, not from pre-existing doctor-patient relationships
or referrals from other healthcare providers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We generate limited revenue
directly from our clinics. However, our clinic brings patients into our stores, where they then purchase medical products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<!-- Field: Page; Sequence: 65; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Online Sales</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Since May 2010, we have been
retailing OTC drugs and nutritional supplements on the Internet at <U>www.dada360.com</U>. Before November 2015, our subsidiary Quannuo
Technology operated and maintained the website pursuant to the Internet Pharmaceutical Transaction Service Qualification Certificate
issued by the State Food and Drug Administration (the &ldquo;SFDA&rdquo;) of Zhejiang Province, which allows us to engage in online retail
pharmaceutical sales throughout China. As we sold all our equity interests in Quannuo Technology in November 2015, we have transferred
our online pharmacy operation function to Jiuzhou Pharmacy. We have established payment methods with banks and online intermediaries
such as Alipay, and are cooperating with business-to-consumer online vendors such as Taobao. By using Taobao&rsquo;s platform in addition
to our own website as mentioned above, we can be exposed to a wider range of customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Online sales accounted for
approximately 11.6% of our total revenue, for the fiscal year ended March 31, 2020. Online sales accounted for approximately 10.8% of
our retail revenue, and 8.1% of our total revenue, for the fiscal year ended March 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Wholesale</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Since acquiring Jiuxin Medicine
in August 2011, we have been distributing third-party products primarily to drug distributors throughout China, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Approximately
    1,455 prescription drugs, the sales of which accounted for approximately 83.7% of our wholesale revenue for the fiscal year ended
    March 31, 2020 as compared to approximately 1,154 prescription drugs, the sales of which accounted for approximately 63.4% of our
    wholesale revenue for the fiscal year ended March 31, 2019;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Approximately
    1,662 OTC drugs, the sales of which accounted for approximately 14.1% of our wholesale revenue for the fiscal year ended March 31,
    2020 as compared to approximately 1,282 OTC drugs, the sales of which accounted for approximately 33.9% of our wholesale revenue
    for the fiscal year ended March 31, 2019;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Approximately
    350 nutritional supplements, the sales of which accounted for approximately 0.7% of our wholesale revenue for the fiscal year ended
    March 31, 2020 as compared to approximately 307 nutritional supplements, the sales of which accounted for approximately 1.1% of our
    wholesale revenue for the fiscal year ended March 31, 2019;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">TCM
    products, the sales of which accounted for approximately 1.1% of our wholesale revenue for the fiscal year ended March 31, 2020,
    as compared to TCM products, the sales of which accounted for approximately 1.0% of our wholesale revenue for the fiscal year ended
    March 31, 2019;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Sundry
    products, the sales of which accounted for approximately 0.1% of our wholesale revenue for the fiscal year ended March 31, 2020 as
    compared to Sundry products, the sales of which accounted for approximately 0.1% of our wholesale revenue for the fiscal year ended
    March 31, 2019; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Medical
    devices, the sales of which accounted for approximately 0.3% and 0.5%, of our wholesale revenue for the fiscal year ended March 31,
    2020 and 2019, respectively.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Wholesale revenue increased
primarily as a result of our ability to resell certain products, which our retail stores made large orders on, to other vendors. As our
retail drugstores achieved large quantity sales of certain brand name merchandise, we were able to negotiate for lower purchase prices
than the market level on such merchandise. As a result, certain vendors who were unable to obtain better prices than ours, will turn
to us for such merchandise, leading the wholesale volume to grow. On the other side, we have been trying to act as a local agent for
well-known health products in Zhejiang Province. For example, we signed a strategic cooperation agreement with Dong&rsquo;a Gelatin (DEEJ)
and act as its local sale agent in Zhejiang Province. Until we can establish a new customer base and secure the status to serve as provincial
or national exclusive sale agent for certain popular drugs, we do not expect our wholesale business to increase significantly in the
immediate future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Herb Farming</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">From 2010 to the third quarter
of fiscal 2013, we had been cultivating and harvested ten (10) types of herbs, such as fructusrubi (used in TCM to promote blood circulation),
white atractylodes rhizome (used in TCM to treat physical and mental fatigue), atractylodesmacrocephala (used in TCM to control sweating),
ginkgo seeds (used in TCM to treat asthma), and ginkgo trees used for TCM on approximately forty eight (48) acres of leased land in Lin&rsquo;an,
approximately thirty (30) miles from Hangzhou.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We planted ginkgo trees during
the year ended March 31, 2013. A ginkgo tree may have a growth period of up to twenty years before it is mature enough to harvest. Typically,
the longer the plant grows, the more valuable it becomes. We plan to continue cultivating the trees in order to maximize their market
value in the future. We may continue growing trees and cultivating other herbs in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Herb farming revenue accounted
for no revenue for the fiscal year ended March 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 66; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our Customers</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Retail Customers</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">For the fiscal year ended
March 31, 2020, our pharmacies collectively served an average of 13,475 customers per day. We periodically conduct qualitative customer
surveys to help us build a stronger understanding of our market position and our customers&rsquo; purchasing habits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Pharmacy customers pay by
cash, debit or credit cards, mobile devices or medical insurance cards under Hangzhou and Zhejiang&rsquo;s medical insurance programs.
During the fiscal year ended March 31, 2020, approximately 15% of our pharmacy revenue came from cash sales, 50% from Hangzhou&rsquo;s
medical insurance cards (where most of our pharmacies are located), and 35% from debit and credit cards, Zhejiang&rsquo;s medical insurance
cards, Alipay and other charge cards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We maintain strict cash control
procedures at our pharmacies. Our integrated information management system records the details of each sale, which we control from our
headquarters. Depending on each location&rsquo;s sales activities, cash may be deposited daily or several times per week in designated
bank accounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">For sales made to eligible
participants in the national medical insurance program, we generally obtain payments from the relevant government social security bureaus
on a monthly basis. See &ldquo;<I>Relevant PRC Regulations - Reimbursement under the National Medical Insurance Program.</I>&rdquo; According
to relevant regulations, a drugstore usually needs to operate for at least one (1) year before it can apply to be licensed to accept
Hangzhou&rsquo;s medical insurance cards. As of the date of this prospectus, one hundred and five (105) of our one hundred and eighteen
(118) &ldquo;Jiuzhou Grand Pharmacy&rdquo; stores are licensed to accept medical insurance cards. Those of our stores that accept medical
insurance cards are designated as such by clear signage on their storefront windows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Online Sales Customers</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our online customers consist
primarily of consumers between the ages of 20 and 40. While our website is accessible throughout China, approximately thirty percent
(30%) of our online sales during the fiscal year ended March 31, 2020, were from Zhejiang and neighboring Jiangsu and Shanghai.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Wholesale Customers</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our wholesale customers are
primarily third-party trading companies that purchase from us to resell to pharmacies throughout China. We also supply some hospitals
and pharmacies, although they collectively make up less than 10.0% of our wholesale customers currently.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Herb Farming Customers</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our farming customers primarily
include local herb vendors. For the fiscal year ended March, 31, 2020, we had not harvested or sold any herbs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Marketing and Promotion</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our marketing and promotion
efforts are focused on our retail segment, specifically, our pharmacies, and our strategy is to build brand recognition, increase customer
flow, build strong customer loyalty, maximize repetitive customer visits, and develop incremental revenue opportunities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our marketing department
designs chain-wide marketing efforts while each store designs local promotions based on local demographics and market conditions. We
also launch single store promotional campaigns and community activities in connection with the opening of new stores. Our store managers
and staff are also encouraged to propose their own advertising and promotional plans, including holiday promotions, posters and billboards.
In addition, we offer special discounts and gift promotions for selected merchandise periodically in conjunction with our suppliers&rsquo;
marketing programs. We also provide ancillary services such as providing free blood pressure readings in our stores.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Many of our promotional programs
are designed to encourage manufacturers to invest resources to market their brands within our stores. We charge manufacturers promotional
fees in exchange for the right to promote and display their products in our stores during promotional periods. We also allow manufacturers
and distributors to station salespeople in our stores to promote their products, for which we receive a fee. Since manufacturers provide
purchasing incentives and information to help customers make informed purchase decisions, we believe that manufacturer-led promotions
improve our customers&rsquo; shopping experience. We work to maintain strong inventory positions for merchandise featured in our promotions,
as we believe this increases the effectiveness of our spending on promotional activities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We regularly run advertisements
in selected newspapers to promote our brands and the products carried in our stores. Under our agreements with certain newspapers, we
run one-page weekly and monthly advertisements, as applicable, and the newspapers publish healthcare-related feature articles relating
to our advertised products on or around the dates of our advertisements. We also promote our brands and products using billboards and
radio and television commercials. Depending on our agreement with a particular manufacturer, advertising expenses are borne either by
us, the manufacturer of the products being advertised, or are shared as a joint expense. Our advertisements are designed to promote our
brands, our corporate image and the prices of products available for sale in our stores.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">As part of our marketing
campaign, we offer rewards cards to customers, which provide certain exclusive discounts. After a customer signs up for the rewards card,
we communicate via the customer&rsquo;s preferred method: e-mail, traditional mail or text messages. For the fiscal year ended March
31, 2020, approximately 69.7% of our customers used their rewards cards to make purchases. We intend to further extend this program to
enhance the customer experience and for customer retention. For every 10 Yuan spent at our stores, we award 1 membership point. Every
20 points can be exchanged for a 1 Yuan coupon, redeemable towards merchandise purchased at our stores. The reward points never expire,
but cannot be applied towards products reimbursed by the local SIC agent. As a result, we recorded unused membership points as accrued
expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our clinic staff also regularly
offers free seminars and outreach programs covering various health issues that are topical to the communities where our stores are located.
Such events are designed not only to raise public health awareness, but to reach potential customers for our drugstores.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">To promote our online business,
we are cooperating with Taobao, the largest online vendor in China, to help raise awareness among potential customers. Taobao lists our
products on its platform, which then directs consumers back to our website to make their purchases.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Logistics</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Before March 31, 2018, we
used Jiuxin Medicine&rsquo;s resources to support our logistics needs in Hangzhou. Beginning March 31, 2018, we outsourced our logistics
service to Astro Boy Cloud Pan (Hangzhou) Storage and Logistic Co. Ltd (&ldquo;Astro Boy Logistic&rdquo;). As a result, Jiuxin Medicine&rsquo;s
warehouse lease has been terminated. Astro Boy Logistic provides us with approximately 14,000 square meters facility located approximately
eighteen (18) miles from our headquarters, which served as our central distribution center. Astro Boy Logistics&rsquo; staff and vehicles
make regular deliveries to our pharmacies and wholesale customers. Jiuxin Medicine, however, continues to negotiate with various suppliers
and make orders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We employ third-party logistics
companies for deliveries to wholesale customers outside Hangzhou. We believe that reliable logistics providers are readily available
and can be replaced without any material interruptions to our business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Suppliers</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We currently source retail
products from approximately 120 suppliers, including trading companies and direct manufacturers. We source wholesale products from approximately
340 suppliers, including many of those that provide our retail products. For the fiscal year ended March 31, 2020, one supplier, HuaDong
Pharmaceutical Co., Ltd. accounted for more than twenty-eight and half percent (28.5%) and twenty-six and point two percent (26.2%) of
our total purchases and total purchase deposits. The suppliers are neither related to nor affiliated with us. For the fiscal year ended
March 31, 2019, one supplier, HuaDong Pharmaceutical Co., Ltd. accounted for more than twenty-two percent (22.0%) and twenty-two and
point seven percent (22.7%) of our total purchases and total purchase deposits. The suppliers are neither related to nor affiliated with
us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 68; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We believe that competitive
sources are readily available for substantially all of the products we require for our retail and wholesale businesses. As such, we believe
that we can change suppliers without any material interruption to our business. To date, we have not experienced any significant difficulty
in sourcing our suppliers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Quality Control</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We strongly emphasize quality
control, which starts with procurement. In addition to their market acceptance and costs, we select products based on Good Manufacturing
Practice and Good Supply Practice (&ldquo;GSP&rdquo;) compliance status of their suppliers. We also assess product quality based on the
manufacturer&rsquo;s facilities and capabilities, including technology, packaging and logistics. We conduct random quality inspections
of each batch of products we procure, and replace any supplier who fails to pass such inspections.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We also enforce strict quality
control measures at our distribution center. All products are screened upon their arrival, and those with evidence of defects or damages
are immediately rejected. Products that pass the screening process are recorded and stored strictly according to each manufacturer&rsquo;s
temperature and other requirements. Products (for both our pharmacies and wholesale customers) are verified against the appropriate delivery
orders prior to leaving the facility. We use vehicles with cold-temperature storage to make deliveries as necessary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">All of our pharmacy employees
participate in a mandatory thirty-six (36) hour training program regarding quality control annually, and we regularly dispatch quality
inspectors to our stores to monitor the service quality of our staff.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Competition</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The drugstore industry in
China is intensely competitive, rapidly evolving and highly fragmented. We compete on the basis of store location, merchandise selection,
prices and brand recognition. Many of our competitors include large, national drugstore chains that may have more financial resources,
stronger brand strength, and management expertise than us, including China Nepstar Chain Drugstore Ltd., LBX Pharmacy, and TianTianHao
Grand Pharmacy. Other competitors include local and independent drugstores and government-operated pharmacies, as well as discount stores,
convenience stores, and supermarkets with respect to sundry and other non-medicinal products that we carry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The wholesale pharmaceutical
distribution industry in China is likewise competitive and highly fragmented. We compete with regional distributors, such as Zhengchen
Pharmaceutical Co., Ltd. and Hangzhou Xiaoran Pharmaceutical Co., Ltd., as well as national operators such as Fengwoda Pharmaceutical
Co., Ltd. and Jiuzhoutong Pharmaceutical Co., Ltd. These competitors have substantially greater logistics capacities and more financial
resources, as well as more industry-relevant experience, than us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The online pharmacy is an
emerging business in China. We are competing with other online vendors that may be supported by major drugstore chains or initiated by
smaller local drugstore chains. In order to compete effectively, we are cooperating with Taobao, the largest online vendor in China.
We also invest significant resources in selecting products we believe are most suitable for online sales, such as those we have the exclusive
right to sell. We have invested significant resources identifying popular products that we believe can drive sales, while simultaneously
controlling costs. In fiscal 2020, we have continued working with large insurance companies in China such as the People&rsquo;s Insurance
Company (Group) of China Limited and Yingda Taihe Life Insurance Co., Ltd., which sell online products to their enrolled insurance customers.
Commercial health insurance has expanded rapidly in recent years in China, especially after the government began restricting its Social
Health Insurance (&ldquo;SHI&rdquo;) budget. We expect the close cooperation with commercial insurance companies and active strategy
on e-commerce platforms will drive up our online sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">China&rsquo;s herb market
is highly specialized. We have not incurred any herb sales in fiscal 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 69; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Intellectual Property</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We currently have the following
trademarks registered with the Trademark Office of the SAIC:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;Jiuzhou
    Tongxin&rdquo; is a Classes 5 and 35 trademark (for pharmaceuticals and advertisement) issued on February 14, 2011 and March 7, 2013
    respectively, registered under Jiuzhou Pharmacy, which we plan to use to brand certain products that we may sell in our stores;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;Jiuzhou&rdquo;
    is a Classes 5, 35 and 44 trademark (for medical services) issued in April and May 2012, registered under Jiuzhou Pharmacy, which
    we plan to use to brand our medical services;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;Shouantang&rdquo;
    a Classes 5, 10, 30, 35 and 44 trademark (for pharmaceuticals, construction, food, advertisement and medical services) issued on
    October 2011, and a Classes 3&#12289;42&#12289;6&#12289;19&#12289;20&#12289;24&#12289;31&#12289;26&#12289;32 and 29 (for oil, diary
    and others) trademark issued in August and October 2015, registered under Jiuzhou Pharmacy, which we are using to brand certain products
    that we sell in our stores; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;Jinyuliangyan&rdquo;
    is a Class 29 trademark (for food and oil) issued in June 2011, registered under Jiuzhou Pharmacy, which we are using to brand certain
    products that we sell in our stores; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;Jiuying&rdquo;
    is a Classes 5, 35 and 44 trademark (for healthcare and nutritional supplement) issued in December 2012 and February 2013, registered
    under Jiuzhou Service, which we are using to brand our service and products that we sell in our clinics.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We own and operate the following
websites: <U>www.dada360.com</U> (for online sales), <U>www.jiuzhou-drugstore.com</U> (our corporate website used in China), and www.jiuzhou360.com
(our English-language corporate website). We also own two (2) inactive domain names. We do not own any patents, nor do we have any pending
patent applications, and we are not a beneficiary of any licenses, franchises, concessions or royalty agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">All of our employees are
required to enter into written employment agreements with us, pursuant to which they are subject to confidentiality obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Employees</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">As of January 31, 2021, we
had 1,025 employees combined in our retail and wholesale operations, consisting of 995 full-time and 30 part-time employees. The number
of employees for each area of operations, and such employees as a percentage of our total workforce, are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center">As of <BR> January 31, <BR>
    2021</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Employees</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Percentage</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Non-pharmacist store staff</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">472</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">46.0</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Pharmacists</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">263</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25.7</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Management - non-pharmacists</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">94</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9.2</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Physicians</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">54</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.6</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Non-physician clinic staff</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">52</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.7</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Wholesale - non-warehouse</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">40</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.9</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Online pharmacy - technicians</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.2</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Online pharmacy - non-technicians</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">48</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4.7</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,025</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">100.00</TD><TD STYLE="padding-bottom: 4pt; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 70; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We strongly emphasize the
quality of our employees at all levels, including in-store pharmacists and store staff who directly interact with our customers. We provide
extensive training for newly recruited employees in the first three (3) months of their employment. The training is designed to encompass
a number of areas, such as knowledge of our products and effective customer service. In addition, we regularly carry out training programs
on medicinal information, nutritional information, and selling skills for our store staff and in-store pharmacists. We believe these
programs have played an important role in strengthening the capabilities of our employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Various drug manufacturers
also pay us to have their representatives in our drugstores, and accordingly, we train them under our store policies and procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Relevant PRC Regulations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>SAFE Registration</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In October 2005, SAFE issued
Circular 75. Circular 75 regulates foreign exchange matters in relation to the use of a special purpose vehicle by PRC residents to seek
offshore equity financing and conduct &ldquo;round trip investment&rdquo; in China. The Key Personnel, who are PRC residents, are in
compliance with Circular 75 and its implementing circulars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Dividend Distribution</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Under current applicable
laws and regulations, each of our consolidated PRC entities, including WFOEs and domestic companies, may pay dividends only out of their
accumulated profits, if any, determined in accordance with PRC accounting standards and regulations. In addition, each of our consolidated
PRC entities is required to deposit at least ten percent (10%) of its after-tax profit based on PRC accounting standards each year into
its statutory surplus reserve fund until the accumulative amount of such reserve reaches fifty percent (50%) of its registered capital.
These reserves are not distributable as cash dividends. As of March 31, 2020 the accumulated balance of our statutory reserve funds reserves
amounted to $1.31 million, and the accumulated losses of our consolidated PRC entities amounted to $20.94 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Taxation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The current PRC Enterprise
Income Tax Law (the &ldquo;EIT Law&rdquo;), and the implementation regulations for the EIT Law issued by China&rsquo;s State Council,
became effective as of January 1, 2008. Under the EIT Law, enterprises are classified as either resident or non-resident enterprises.
An enterprise established outside of China with its &ldquo;de facto management bodies&rdquo; located within China is considered a &ldquo;resident
enterprise,&rdquo; meaning that it can be treated in a manner similar to a Chinese enterprise for enterprise income tax purposes. The
implementing rules of the EIT Law defines a &ldquo;de facto management body&rdquo; as a managing body that in practice exercises &ldquo;substantial
and overall management and control over the production and operations, personnel, accounting, and properties&rdquo; of the enterprise;
however, it remains unclear whether the PRC tax authorities would deem our managing body as being located within China. Due to the relatively
short history of the EIT Law and lack of applicable legal precedents, the PRC tax authorities determine the PRC tax resident treatment
of entities organized under the laws of foreign jurisdictions on a case-by-case basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">If the PRC tax authorities
determine that we are a resident enterprise for PRC enterprise income tax purposes, a number of PRC tax consequences could follow. First,
we may be subject to enterprise income tax at a rate of twenty five percent (25%) on our respective worldwide taxable income, as well
as PRC enterprise income tax reporting obligations. Second, although the EIT Law provides that &ldquo;dividends, bonuses and other equity
investment proceeds between qualified resident enterprises&rdquo; is exempted income, and the implementing rules of the EIT Law refer
to &ldquo;dividends, bonuses and other equity investment proceeds between qualified resident enterprises&rdquo; as the investment proceeds
obtained by a resident enterprise from its direct investment in another resident enterprise, it is still unclear whether the dividends
we receive from Jiuxin Management would be classified as &ldquo;dividends between qualified resident enterprises&rdquo; and therefore
qualify for tax exemption.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 71; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">If we are treated as a non-resident
enterprise under the EIT Law, any dividends that we receive from Jiuxin Management (assuming such dividends are deemed to be sourced
from within the PRC) (i) may be subject to a five percent (5%) PRC withholding tax, provided that we own more than twenty five percent
(25%) of the registered capital of Jiuxin Management incessantly within twelve (12) months immediately prior to obtaining such dividends
from Jiuxin Management, and if the <I>Arrangement between the Mainland of China and the Hong Kong Special Administrative Region for the
Avoidance of Double Taxation and the Prevention of Fiscal Evasion with Respect to Taxes on Income</I> (the &ldquo;Arrangement&rdquo;)
is applicable, or (ii) if the Arrangement does not apply (i.e. the PRC tax authorities may deem us to be a conduit not entitled to treaty
benefits), may be subject to a ten percent (10%) PRC withholding tax. Similarly, if we are treated as a non-resident enterprise, and
Renovation is treated as a resident enterprise, then any dividends that we receive from Renovation (assuming such dividends were considered
sourced within the PRC) may be subject to a ten percent (10%) PRC withholding tax. Any such taxes on dividends could materially reduce
the amount of dividends, if any, that we could pay to our shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Finally, the new &ldquo;resident
enterprise&rdquo; classification could result in a situation in which a ten percent (10%) PRC tax is imposed on dividends we pay to our
investors that are non-resident enterprises so long as such non-resident enterprise investors do not have an establishment or place of
business in China or, despite the existence of such establishment of place of business in China, the relevant income is not effectively
connected with such establishment or place of business in China, to the extent that such dividends have their sources within the PRC.
Similarly, any gain realized on the transfer of our shares by such investors is also subject to a ten percent (10%) PRC income tax if
such gain is regarded as income derived from sources within China. In such event, we may be required to withhold a ten percent (10%)
PRC tax on any dividends paid to our investors that are non-resident enterprises. Our investors that are non-resident enterprises also
may be responsible for paying PRC tax at a rate of ten percent (10%) on any gain realized from the sale or transfer of our common shares
in certain circumstances. We would not, however, have an obligation to withhold PRC tax with respect to such gain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Moreover, the State Administration
of Taxation issued the <I>Notice on Strengthening the Administration of Enterprise Income Tax on Share Transfer Income of Non-Resident
Enterprises No. 698</I> (&ldquo;Circular 698&rdquo;) on December 10, 2009, which reinforces taxation on transfer of non-listed shares
by non-resident enterprises through overseas holding vehicles. Circular 698 applies retroactively and was deemed to be effective as of
January 2008. Pursuant to Circular 698, where (i) a foreign investor who indirectly holds equity interest in a PRC resident enterprise
through an offshore holding company indirectly transfers equity interests in a PRC resident enterprise by selling the shares of the offshore
holding company, and (ii) the offshore holding company is located in a jurisdiction where the effective tax rate is lower than twelve
and a half percent (12.5%) or where the offshore income of its residents is not taxable, the foreign investor is required to provide
the tax authority in charge of that PRC resident enterprise with certain relevant information within thirty (30) days of the transfer.
The tax authorities in charge will evaluate the offshore transaction for tax purposes. In the event that the tax authorities determine
that such transfer is abusing forms of business organization and there is no reasonable commercial purpose other than avoidance of PRC
enterprise income tax, the tax authorities will have the power to conduct a substance-over-form re-assessment of the nature of the equity
transfer. A reasonable commercial purpose may be established when the overall offshore structure is set up to comply with the requirements
of supervising authorities of international capital markets. If the State Administration of Taxation&rsquo;s challenge of a transfer
is successful, they will deny the existence of the offshore holding company that is used for tax planning purposes. Since Circular 698
has a brief history, there is uncertainty as to its application.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>General PRC Government Approval</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">As a wholesale distributor
and retailer of pharmaceutical products, we are subject to regulation and oversight by different levels of the food and drug administration
in China, in particular, the SFDA. The <I>Drug Administration Law of the PRC</I>, as amended, provides the basic legal framework for
the administration of the production and sale of pharmaceutical products in China and governs the manufacturing, distributing, packaging,
pricing, and advertising of pharmaceutical products in China. The corresponding implementation regulations set out detailed rules with
respect to the administration of pharmaceuticals in China. We are also subject to other PRC laws and regulations that are applicable
to business operators, retailers, and foreign-invested companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Distribution of Pharmaceutical Products</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">A distributor of pharmaceutical
products must obtain a distribution permit from the relevant provincial or designated municipal- or county-level SFDA. The grant of such
permit is subject to an inspection of the distributor&rsquo;s facilities, warehouses, hygienic environment, quality control systems,
personnel, and equipment. The distribution permit is valid for five (5) years, and the holder must apply for renewal of the permit within
six (6) months prior to its expiration. In addition, a pharmaceutical product distributor needs to obtain a business license from the
relevant administration for industry and commerce prior to commencing its business. All of our consolidated entities that engage in the
retail pharmaceutical business have obtained necessary pharmaceutical distribution permits, and we do not expect to face any difficulties
in renewing these permits and/or certifications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 72; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In addition, under the <I>Supervision
and Administration Rules on Pharmaceutical Product Distribution</I>, promulgated by the SFDA on January 31, 2007, and effective May 1,
2007, a pharmaceutical product distributor is responsible for its procurement and sales activities and is liable for the actions of its
employees or agents in connection with their conduct of distribution on behalf of the distributor. A retail distributor of pharmaceutical
products is not allowed to sell prescription pharmaceutical products or Tier A OTC pharmaceutical products listed in the national or
provincial medical insurance catalogs without the presence of a certified in-store pharmacist. See &ldquo;<I>Reimbursement under the
National Medical Insurance Program</I>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Restrictions on Foreign Ownership of Wholesale
or Retail Pharmaceutical Business in China</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">PRC regulations on foreign
investment currently permit foreign companies to establish or invest in WFOEs or joint ventures that engage in wholesale or retail sales
of pharmaceuticals in China. For retail sales, these regulations restrict the number and size of pharmacies that a foreign investor may
establish. If a foreign investor owns more than thirty (30) stores that sell a variety of branded pharmaceutical products sourced from
different suppliers, the foreign investor&rsquo;s ownership interests in the stores are limited to forty nine percent (49%).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">In lieu of equity ownership,
our WFOE, Jiuxin Management, has entered into contractual arrangements with Jiuzhou Pharmacy and the Key Personnel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Good Supply Practice Standards</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">GSP standards regulate wholesale
and retail pharmaceutical product distributors to ensure the quality of distribution of pharmaceutical products in China. All wholesale
and retail pharmaceutical product distributors are required to apply for GSP certification within thirty (30) days after obtaining drug
distribution permits. The current applicable GSP standards require pharmaceutical product distributors to implement strict controls on
the distribution of medicine products, including standards regarding staff qualifications, distribution premises, warehouses, inspection
equipment and facilities, management, and quality control. Specifically, the warehouse must be able to store the pharmaceutical products
at various required temperatures and humidity, and handle transport, warehouse entries, delivery, and billing by computerized logistics
management systems. The GSP certificate is usually valid for five (5) years. Currently, Jiuzhou Pharmacy, and Jiuxin Medicine are all
GSP certified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Prescription Administration</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Under the <I>Rules on Administration
of Prescriptions</I> promulgated by the SFDA, effective May 1, 2007, doctors are required to include the chemical ingredients of the
medicine they prescribe in their prescription and are not allowed to include brand names in their prescription. This regulation is designed
to provide consumers with choices among different pharmaceutical products that contain the same chemical ingredients.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Advertisement of Pharmaceutical Products</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Under the <I>Advertising
Law of PRC</I>, the contents of an advertisement must be true, lawful, without falsehood, and must neither deceive nor mislead consumers.
Accordingly, advertisement must be examined by the competent authority prior to its publication or broadcast through any form of media.
In addition, advertisement of pharmaceutical products may only be based on a drug&rsquo;s approved indication of use statement, and may
not contain any assurance of a product&rsquo;s efficiency, treatment efficiency, curative rate, or any other information prohibited by
law. Advertisement for certain drugs should include an admonishment to seek a doctor&rsquo;s advice before purchasing and application.
Advertising is prohibited for certain drugs such as anesthetics and psychotropic drugs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">To further prevent misleading
advertising of pharmaceutical products, the SAIC and the SFDA jointly promulgated the <I>Standards for Examination and Publication of
Advertisements of Pharmaceutical Products</I> and <I>Measures for Examination of Advertisement of Pharmaceutical Products</I> in March
2007. Under these regulations, an approval must be obtained from the provincial level of food and drug administration before a pharmaceutical
product may be advertised. In addition, once approved, an advertisement&rsquo;s content may not be altered without further approval.
Such approval, once obtained, is valid for one (1) year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<!-- Field: Page; Sequence: 73; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Product Liability and Consumers Protection</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Product liability claims
may arise if the products sold have any harmful effect on consumers. The injured party may make a claim for damages or compensation.
The <I>General Principles of the Civil Law of the PRC</I>, which became effective in January 1987, state that manufacturers and sellers
of defective products causing property damage or injury shall incur civil liabilities for such damage or injuries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The <I>Product Quality Law
of the PRC</I> was enacted in 1993 and amended in 2000 to strengthen the quality control of products and protect consumers&rsquo; rights
and interests. Under this law, manufacturers and distributors who produce or sell defective products may be subject to confiscation of
earnings from such sales, revocation of business licenses, imposition of fines, and, in severe circumstances, may be subject to criminal
liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The <I>Administrative Measures
for Drug Recalls</I> was issued by the SFDA in December 2007, and covers two (2) types of drug recalls, namely voluntary recalls and
compulsory recalls. Under such regulation, wholesalers are obliged to assist drug manufacturers with any drug recall. In addition, a
wholesaler must immediately cease to sell any drug that the wholesaler learns has any safety issues, and must immediately notify the
manufacturer or its supplier as well as report the matter to the SFDA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The <I>Law of the PRC on
the Protection of the Rights and Interests of Consumers</I> was promulgated on October 31, 1993 and became effective on January 1, 1994
to protect consumers&rsquo; rights when they purchase or use goods or services. All business operators must comply with this law when
they manufacture or sell goods and/or provide services to customers. In extreme situations, pharmaceutical product manufacturers and
distributors may be subject to criminal liability if their goods or services lead to the death or injuries of customers or other third
parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The <I>Tort Law of the PRC
</I>was promulgated on December 26, 2009 and went into effect on July 1, 2010. The Tort Law provides that manufacturers and distributors
who produce or sell defective products shall be responsible for the damage caused by the defective products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Reimbursement under the National Medical
Insurance Program</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Eligible participants in
the national medical insurance program, consisting primarily of urban residents, are entitled to purchase medicine when presenting their
medical insurance cards in an authorized pharmacy, provided that the medicine they purchase has been included in the national or provincial
medical insurance catalogs. Depending on relevant local regulations, authorized pharmacies can either (i) sell medicine on credit and
obtain reimbursement from relevant government social security bureaus on a monthly basis, or (ii) receive payments from the participants
at the time of their purchases, and the participants in turn obtain reimbursement from relevant government social security bureaus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Medications included in the
national and provincial medical insurance catalogs are divided into two (2) tiers. Purchases of Tier A pharmaceutical products are generally
fully reimbursable, except that certain Tier A pharmaceutical products are only reimbursable to the extent the medications are used specifically
for the purposes stated in the medical insurance catalogs. Purchasers of Tier B pharmaceutical products, which are generally more expensive
than those in Tier A, are required to make a certain percentage of co-payments, with the remaining amount being reimbursable. The percentage
of reimbursement for Tier B OTC products varies in different regions in the PRC. Factors that affect the inclusion of medicine in the
medical insurance catalogs include whether the medicine is consumed in large volumes and commonly prescribed for clinical use in China
and whether it is considered to be important in meeting the basic healthcare needs of the general public.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">China&rsquo;s Ministry of
Labor and Social Security, together with other government authorities, has the power to determine which medicines are included in the
national medical insurance catalog every two (2) years, under which of the two (2) tiers the included medicine falls, and whether an
included medicine should be removed from the catalog.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 74; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Sales of Nutritional Supplements and other
Food Products</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">A distributor of nutritional
supplements and other food products must obtain a food circulation permit from its local Administration of Industry and Commerce. The
grant of such permit is subject to an inspection of the distributor&rsquo;s facilities, warehouses, hygienic environment, quality control
systems, personnel, and equipment. The food circulation permit is valid for three (3) years, and the holder must apply for renewal of
the certificate within thirty (30) days prior to its expiration. Currently, Jiuxin Medicine, Jiuzhou Pharmacy, and our drugstores all
hold a valid Food Circulation Permit, except for our Lin&rsquo;an store and Ren&rsquo;airu store, which do not sell food products and
therefore is not required to hold such a permit. Currently all of our stores hold valid permits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Medical Practice</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Healthcare providers in China
are required to comply with many laws and regulations at the national and local government levels. The laws and regulations applicable
to our medical practice include the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
    must register with and maintain an operating license from the local public health authority for each clinic that we operate, each
    of which is subject to annual review by the public health authority;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
    <I>Licensed Physician Act</I> requires that we only hire PRC licensed physicians;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">All
    waste material from our clinics must be properly collected, sterilized, deposited, transported and disposed of, and we are required
    to keep records of the origin, type and amount of all waste materials that we generate for at least three (3) years;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
    must have at least three (3) physicians, five (5) nurses and one (1) technician on staff at each clinic; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD>
    <TD STYLE="padding-right: 0.8pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">We
    must establish and follow protocols to prevent medical malpractice, which require us to: (i) insure that patients are adequately
    informed before they consent to medical operations or procedures; (ii) maintain complete medical records which are available for
    review by the patient, physicians and the courts; (iii) voluntarily report any event of malpractice to a local government agency;
    and (iv) support and justify the medical services we provide in any administrative investigation or litigation. If we fail to comply
    with applicable laws and regulations, we could suffer penalties, including the loss of our license to operate.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<!-- Field: Page; Sequence: 75; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Interim Regulations on Administration of
Sino-Foreign Joint Venture and Cooperative Medical Institutions</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">As per China&rsquo;s commitments
to the World Trade Organization, &ldquo;Foreign service suppliers are permitted to establish joint venture hospitals or clinics with
local Chinese partners with quantitative limitations in line with China&rsquo;s needs. Foreign majority ownership is permitted.&rdquo;
In accordance with the <I>Interim Regulations on Administration of Sino-Foreign Joint Venture and Cooperative Medical Institutions</I>
issued jointly by the Ministry of Health (&ldquo;MOH&rdquo;) and the Ministry of Commerce (&ldquo;MOFCOM&rdquo;) in 2000, the Chinese
party of Sino-foreign joint ventures and cooperative medical institutions shall hold no less than thirty percent (30%) of shares and
legal rights or interest, which also mean foreign investors are allowed to hold a maximum stake of seventy percent (70%). Such regulations
also specify that the establishment of Sino-foreign joint venture and cooperative medical institutions should be approved respectively
by MOH and MOFCOM. In other words, foreigners are allowed to run hospitals or clinics in the form of equity or co-operative joint ventures
with an equity interest of up to seventy percent (70%) lasting up to twenty (20) years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Internet Pharmaceutical Sales</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">China&rsquo;s central government
regulates Internet access, the distribution of online information and the conduct of online commerce through strict business licensing
requirements and other government regulations. Companies which sell pharmaceutical products to consumers through the Internet are required
to obtain: (1) a drug distribution permit; (2) an Internet pharmaceutical information provider qualification certificate, renewable every
five (5) years; (3) an Internet pharmaceutical transaction service qualification certificate, renewable every five (5) years; (4) a value-added
telecommunication operation permit; and (5) registration with the Administration of Information Industry. Internet pharmacies are not
allowed to distribute prescription drugs. The websites that sell pharmaceutical products must ensure transaction security and enable
the consumers to consult with licensed pharmacists. Also, an Internet-based business in China is required to obtain and maintain certain
assets relevant to its business, such as delivery and storage facilities. Jiuzhou Pharmacy obtained all above-mentioned certificates
and registrations and launched <U>www.dada360.com</U> in May 2010 and renewed the certificates in 2015. During the year ended March 31,
2020, the Company also sold pharmaceutical and other products via certain third-party platforms such as Tmall and JD.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>TCM Manufacturing</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The SFDA has adopted a non-mandatory
licensing process for TCM manufacturers according to Good Agricultural Practice (&ldquo;GAP&rdquo;) for Chinese Crude Drugs. Manufacturers
who meet the government-set requirements will be granted a GAP certificate. Since we do not process the herbs that we harvest and the
GAP certification is not mandatory, we have not applied for such certification, and currently have no plan of doing so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Environmental Matters</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our drugstore and wholesale
operations do not involve any activities subject to specific PRC environmental regulations. Our medical clinics are in compliance with
applicable regulations regarding the administration of medical wastes, including collections, temperate storage, and packaging and labeling
of medical wastes. Pursuant to such regulations, we contract with DadiWeikang Medical Wastes Disposal Center to dispose of all medical
wastes generated by our clinics.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Principal Executive Office</B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our principal executive office
is located at 6<SUP>th</SUP> Floor, Hai Wai Hai Tongxin Mansion, Gong Shu District, Hangzhou City, Zhejiang Province, China. Our main
telephone number is +86-571-88219579, and fax number is +86-571-8821-9579.</P>

<DIV STYLE="border: white 1pt solid; padding: 0pt 0in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>


<!-- Field: Page; Sequence: 76; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="main_009"></A>DIRECTORS AND EXECUTIVE OFFICERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B></B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The
following table identifies our current executive officers and directors as of the date of this proxy/prospectus, their respective offices
and positions, and their respective dates of election or appointment:</P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; width: 20%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Name</B></FONT></TD>
    <TD STYLE="width: 1%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 8%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Age(1)</B></FONT></TD>
    <TD STYLE="width: 1%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 52%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Position</B></FONT></TD>
    <TD STYLE="width: 1%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 17%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Date
    of Appointment</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Lei
    Liu</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">57</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Chief
    Executive Officer and Chairman of the Board of Directors</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">September
    17, 2009</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Ming
    Zhao</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">45</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Chief
    Financial Officer</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">August
    1, 2011</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Li
    Qi</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">48</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Director</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">October
    23, 2009</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Caroline
    Wang (2) (3) (4)</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">33</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Director</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">March
    29, 2017</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Jiangliang
    He (2) (3) (4)</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">58</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Director</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">September
    4, 2018</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Genghua
    Gu (2) (3) (4)</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">71</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Director</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">March
    28, 2014</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Pingfan
    Wu (4)</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">56</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Director</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">October
    26, 2018</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">As of the date
of this prospectus.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Member of the Audit
Committee.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(3)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Member of the Compensation
Committee.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(4)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Member of the Nominating
Committee.</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Biographical Information of Our Current Directors
and Executive Officers </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><B>Lei Liu</B> has served
as our Chief Executive Officer and Chairman of our Board of Directors since September 17, 2009. Mr. Liu is one of the three founders
of Hangzhou Jiuzhou Grand Pharmacy Chain Co., Ltd. (&ldquo;Jiuzhou Pharmacy&rdquo;), Hangzhou Jiuzhou Clinic of Integrated Traditional
and Western Medicine (General Partnership) (&ldquo;Jiuzhou Clinic&rdquo;) and Hangzhou Jiuzhou Service &amp; Public Health Service Co.,
Ltd. (&ldquo;Jiuzhou Service&rdquo;) (Jiuzhou Pharmacy, Jiuzhou Clinic and Jiuzhou Service, as well as the subsidiaries of Jiuzhou Pharmacy,
collectively as &ldquo;HJ Group&rdquo;), and has been the executive director of Jiuzhou Pharmacy since September 2003 and the supervising
director of Jiuzhou Service since November 2005. From December 1997 to August 2003, Mr. Liu worked in Tai He Drugstore as a general manager.
From September 1992 to November 1997, Mr. Liu was an administration official of Hangzhou Medical Junior College, his alma mater, where
he was also a researcher and an anatomy instructor from September 1983 to July 1992. Mr. Liu has been a licensed researcher in the PRC
since September 1988. As the founder and CEO responsible for our vision and direction, Mr. Liu is invaluable to us and our Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><B>Ming Zhao</B> has served
as our Chief Financial Officer since August 2011. From September 2010 to July 2011, Mr. Zhao was a senior manager at CFO Oncall, Inc.,
a financial consulting firm providing CFO services to U.S.-listed, China-based publicly traded companies. From December 2006 through
August 2010, Mr. Zhao was a senior auditor at Sherb &amp; Co., LLP. From January through June 2003, Mr. Zhao worked as a financial analyst
at Microsoft Corporation. Mr. Zhao is a licensed certified public accountant. He graduated with a bachelor&rsquo;s degree in accounting
from Central University of Finance and Economic in Beijing in July 1999, and obtained a master&rsquo;s degree in professional accounting
from the University of Washington in December 2002.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><B>Li Qi</B> is one of the
three founders of HJ Group. Ms. Qi has served as our secretary since October 23, 2009 to September 4, 2018, and is currently the general
manager of both Jiuzhou Pharmacy and Jiuzhou Service. From January 2000 to June 2003, Ms. Qi worked in Zhejiang Yikang Drugstore as a
general manager. From October 1991 to January 2000, Ms. Qi worked in the Branch Hospital of Hangzhou No. 1 People&rsquo;s Hospital as
a nurse. Ms. Qi is a licensed TCM pharmacist in the PRC and is a 1991 graduate of Hangzhou Nurse School. As the founder and secretary
overseeing our day-to-day corporate operations, Ms. Qi is highly qualified to serve on our Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><B>Caroline Wang</B> has
been a member of our Board since March 29, 2017. Ms. Wang has been a project manager with JC Group, a comprehensive industrial financial
group which serves the &ldquo;city management&rdquo;, performing internal audit and projects management for a variety of financial products
since October 2015. Prior to that, Ms. Wang served as a CFO assistant of Kandi Technologies Group, Inc. (NASDAQ:KNDI), a company engaged
in the research, development, manufacturing, and sales of vehicle products. She was mainly responsible for consolidation of financial
reports and internal control audits. From 2012 to 2015, Ms. Wang was an audit department assistant manager with KPMG Huazhen LLP Hangzhou
Branch, conducting financial report audits and internal control audits for listing companies and also providing audit services to pre-IPO
companies. None of these companies are related to or affiliated with the registrant. Ms. Wang holds a master&rsquo;s degree in public
administration from the London School of Economics and Political Science, and a bachelor&rsquo;s degree in finance from Beijing Language
and Culture University. The Board has determined that Ms. Wang has the qualification to serve as a member of the Board given her extensive
financial, accounting and auditing experience, as well as her English and Chinese bilingual capabilities to facilitate the Board&rsquo;s
supervision of the management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B></B></P>

<!-- Field: Page; Sequence: 77; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><B>Jiangliang He</B>, has
extensive experience as a professional attorney. He has served as a partner in Dentons China, a large law firm with a presence in approximately
45 cities in China, since August 2008. From July 1997 to July 2008, he was a partner in the Zhejiang Jiuyao law firm. From July 1984
to June 1997, he was a professor at Hangzhou School of Law. Mr. He received his bachelor&rsquo;s degree in law from Beijing University.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><B>Genghua Gu</B> is a retired
physician, professor and published scientific researcher in the field of stomatology. From 2003 to 2013, Dr. Gu was a member of the Standing
Committee of Zhejiang Province Political Consultative Conference. From 2000 to 2009, Dr. Gu was the Vice President of the Women&rsquo;s
Hospital of Zhejiang University&rsquo;s School of Medicine (the &ldquo;School of Medicine&rdquo;), where, in addition to being a chief
physician, professor and researcher, he was also in charge of logistics and financial control as part of the hospital&rsquo;s management.
From 1998 to 2000, Dr. Gu was the Vice President of the Second Affiliate Hospital of the School of Medicine (the &ldquo;Affiliate Hospital&rdquo;),
where, in addition to his medical, teaching and research duties, he was also in charge of the hospital&rsquo;s logistics. From 1995 to
1998, Dr. Gu served as the Deputy Magistrate with the Shuichang County Government in Zhejiang Province, in charge of the county&rsquo;s
culture, education and hygiene programs. From 1988 to 1995, Dr. Gu was the Head of the Medical Department at the Affiliate Hospital and
was involved in planning and management of the medical department. Dr. Gu served as an oral surgeon from 1977 to 1988 at the Affiliate
Hospital. Dr. Gu graduated from Shanghai Jiaotong University&rsquo;s School of Medicine, Department of Stomatology in 1977. The Board
has determined that Dr. Gu should serve as a director given his extensive medical and scientific research experience, as well as his
government and hospital management and logistics experience.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><B>Pingfan Wu</B> graduated
from Jiangxi Medical College with a major in clinical medicine. After graduation, she worked in a hospital for eight years as a physician
and an attending physician. After that, she joined Sino-American Shike/GlaxoSmithKline for 18 years until 2014. From sales representative
to GSK China Sales/Strategy Director, Ms. Wu was responsible for the sale of multiple prescription drugs/OTC products in Chinese hospitals,
retail markets, government cooperation projects and mergers and acquisitions. Since 2014 Ms. Wu has been working at Cardinal Health China
Pharmaceutical Co., Ltd., which is among the top three largest U.S./foreign drug distribution companies in China (&ldquo;Cardinal China&rdquo;).
She served as its retail COO, responsible for retail channel branding/sales of the distribution products in China and online/offline
business strategy planning and operation management for its Direct-to-Patient (&ldquo;DTP&rdquo;) pharmacy. The DTP pharmacy is mainly
a hospital-side pharmacy and the products are primarily high-value drugs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Family Relationships</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">There are no family relationships
among our officers and directors and those of our subsidiaries and affiliated companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Involvement in Certain Legal Proceedings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">To our knowledge, our directors
and executive officers were not involved in any legal proceedings as described in Item 401(f) of Regulation S-K in the past ten (10)
years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Compliance with Section 16(a) of the Exchange
Act</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Section 16(a) of the Exchange
Act requires our directors, executive officers and persons who own more than ten percent (10%) of a registered class of our equity securities
(&ldquo;Reporting Persons&rdquo;), to file reports of ownership and changes in ownership on Forms 3, 4 and 5 with the SEC. The Reporting
Persons are also required by SEC rules to furnish us with copies of Section 16(a) forms they file. Based upon a review of the filings
made on their behalf during the fiscal year ended March 31, 2020, as well as an examination of the SEC&rsquo;s EDGAR system Form 3, 4,
and 5 filings (including amendments to such forms) and our records, we believe that, for the fiscal year ended March 31, 2020, our directors,
executive officers and holders of ten percent (10%) or more of our common stock complied with Section 16(a) filing requirements applicable
to them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 78; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="main_010"></A>CORPORATE GOVERNANCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our Board currently consists
of six members. Our bylaws provide that our directors will hold office until the Annual Meeting of shareholders or until their successors
have been elected and qualified. Our Board is responsible for the business and affairs of the Company and considers various matters that
require its approval.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Independence of the Board</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">We are required to comply
with The NASDAQ Stock Market (&ldquo;NASDAQ&rdquo;) listing standards, under which a majority of the members of a listed company&rsquo;s
board of directors must qualify as &ldquo;independent,&rdquo; as affirmatively determined by the board of directors. The Board consults
with the Company&rsquo;s counsel to ensure that the Board&rsquo;s determination are consistent with relevant securities and other laws
and regulations regarding the definition of &ldquo;independent,&rdquo; including those set forth in pertinent listing standards of the
NASDAQ, as in effect from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Consistent with these considerations,
after review of all relevant transactions or relationships between each director, or any of his or her family members, and the Company,
our senior management and our independent registered public accounting firm, the Board has affirmatively determined that the following
directors are independent directors within the meaning of the NASDAQ listing standards: Ms. Caroline Wang, Mr. Jiangliang He, Dr. Genghua
Gu, and Ms. Pingfan Wu are independent directors. Mr. Lei Liu and Ms. Li Qi are not independent directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Code of Ethics and Business Conduct</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Our Code of Ethics, which
applies to all officers, directors and employees, was adopted by the Board on March 15, 2010. The Code of Ethics was filed as Exhibit
14 to our Current Report on Form 8-K filed with the SEC on March 23, 2010, a copy of which is available on our website at http://www.chinajojodrugstores.com
under the tabs &ldquo;Investor&rdquo; &ndash; &ldquo;Corporate Governance&rdquo; &ndash; &ldquo;Documents&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Meetings of the Board</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">During the fiscal year ended
March 31, 2020, the Board met one time and took action by unanimous written consent three times.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Information regarding Committees of the Board</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The Board has three committees:
the Audit Committee, the Compensation Committee and the Nominating Committee. The following table provides membership and meeting information
for these committees for the fiscal year ended March 31, 2020:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Audit</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Compensation</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nominating</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Caroline Wang (2)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">X</FONT></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;X</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Jiangliang He</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">X</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Genghua Gu</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">X</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pingfan Wu</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">X</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 64%; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total meetings in year ended
    March 31, 2020</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    actions by unanimous written consent in year ended March 31, 2020</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Committee chairperson.</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;Audit committee
financial expert&rdquo; within the meaning of Item 407(d)(5)(ii) and (iii) of Regulation S-K promulgated under the Exchange Act. Effective
March 29, 2017, Caroline Wang was elected as a member of the Board and is qualified as audit committee financial expert within the meaning
under Regulation S-K.</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Below is a description of
each committee as it is presently constituted. The Board has determined that each current member of each committee meets the applicable
SEC and NASDAQ rules and regulations regarding &ldquo;independence&rdquo; and that each member is free of any relationship that would
impair his or her individual exercise of independent judgment with regard to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Audit Committee</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The Audit Committee was established
in accordance with Section 3(a)(58)(A) of the Exchange Act to oversee the Company&rsquo;s corporate accounting and financial reporting
processes and audits of its financial statements. The Audit Committee operates under a written charter, a copy of which is available
on our website at http://www.jiuzhou360.com under the tabs &ldquo;For Investor&rdquo; &ndash; &ldquo;Corporate Governance&rdquo; -&ldquo;Committee
Charters&rdquo;, and is composed of our three (3) independent directors. Our Board of Directors has determined, based on information
furnished by Ms. Caroline Wang and other available information, that she meets the requirements of an &ldquo;audit committee financial
expert&rdquo; as that term is defined in the rules promulgated under the Securities Act and the Exchange Act, and has accordingly designated
her as such. Our Board of Directors has also appointed her the chairperson of the committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The Audit Committee assists
the Board oversight of (i) the integrity of the Company&rsquo;s financial statements, (ii) the Company&rsquo;s compliance with legal
and regulatory requirements, (iii) the independent auditor&rsquo;s qualifications and independence, and (iv) the performance of the Company&rsquo;s
internal audit function and independent auditor, and prepares the report that the SEC requires to be included in the Company&rsquo;s
annual proxy statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 79; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Report
of the Audit Committee</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee oversees the Company&rsquo;s financial reporting process on behalf of the Board. The Audit Committee operates under a
written charter approved by the Board. The charter provides, among other things, that the Audit Committee has full authority to engage
the independent auditor. In discharging its oversight responsibilities regarding the audit process, the Audit Committee:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewed
    and discussed the audited financial statements with management;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">discussed
    with the independent auditors the matters required to be discussed by the statement on Auditing Standards No. 61, as amended (AICPA,
    <I>Professional Standards</I>, Vol. 1. AU section 380), as adopted by the Public Company Accounting Oversight Board in Rule 3200T;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">received
    the written disclosures and the letter from the independent auditors required by applicable requirements of the Public Company Accounting
    Oversight Board regarding the independent accountant&rsquo;s communications with the Audit Committee concerning independence, and
    discussed with the independent accountant the independent accountant&rsquo;s independence; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">based
    on the review and discussions referred to above, recommended to the Board that the audited financial statements be included in the
    Company&rsquo;s Annual Report on Form 10-K for the fiscal year ended March 31, 2020, as filed with the Securities and Exchange Commission.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Respectfully
submitted,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee of the Board</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Caroline Wang, Chairperson of the Audit Committee</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Jiangliang He, Member of the Audit Committee</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Genghua Gu, Member of the Audit Committee</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
foregoing Audit Committee Report does not constitute soliciting material or to be &ldquo;filed&rdquo; with the Commission or subject
to Regulation 14A or 14C (17 CFR 240.14a-1 through 240.14b-2 or 240.14c-1 through 240.14c-101), other than as provided in Item 407 of
Regulation S-K, or to the liabilities of section 18 of the Exchange Act (15 U.S.C. 78r) and shall not be deemed filed or incorporated
by reference into any other filing of our company under the Securities Act or the Exchange Act, except to the extent we specifically
incorporate this Audit Committee Report by reference therein.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation
Committee</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Compensation Committee operates under a written charter, a copy of which is available on our website at <U>http://www.jiuzhou360.com
</U>under the tabs &ldquo;For Investor&rdquo; &ndash; &ldquo;Corporate Governance&rdquo; &ndash; &ldquo;Committee Charters&rdquo;, and
is made up of our three (3) independent directors. Mr. Jiangliang He chairs our Compensation Committee, leading it to oversee and, as
appropriate, make recommendations to the Board regarding the annual salaries and other compensation of our executive officers and our
employees, and other employee policies. The committee also provides assistance and recommendations with respect to our compensation policies
and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nominating
Committee</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Nominating Committee operates under a written charter, a copy of which is available on our website at <U>http://www.jiuzhou360.com </U>under
the tabs &ldquo;For Investor&rdquo; &ndash; &ldquo;Corporate Governance&rdquo; &ndash; &ldquo;Committee Charters&rdquo;, and is made
up of our four (4) independent directors. Mr. Genghua Gu is the chairperson of the committee. Our Nominating Committee assists the Board
in the selection of director nominees, approves director nominations to be presented for stockholder approval at our annual general meeting,
fills any vacancies on our Board of Directors, considers any nominations of director candidates validly made by stockholders, and reviews
and considers developments in corporate governance practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the six nominees for election as a director named in this proxy statement were unanimously recommended by the Nominating Committee
for submission to the shareholders of the Company as the Board&rsquo;s nominees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shareholder
Communications with the Board</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to the infrequency of communications from shareholders to the Board, our Board has not adopted a formal process by which shareholders
may communicate with the Board. Nevertheless, shareholders or other interested parties may write to the Company&rsquo;s Secretary at
Hai Wai Hai Tongxin Mansion Floor 6, Gong Shu District, Hangzhou City, Zhejiang Province, P. R. China, 310008, and should prominently
indicate on the outside of the envelope that it is intended for the Board or for non-management directors, and the Company&rsquo;s Secretary
will forward the communications to all specified directors. If no director is specified, the communication will be forwarded to the entire
Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 80; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="main_011"></A>EXECUTIVE
COMPENSATION </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary
of Executive Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information concerning all cash and non-cash compensation awarded to, earned by or paid to our principal executive
officer and principal financial officer during the last two (2) fiscal years. No other executive officer received compensation in excess
of $100,000 during the fiscal year ended March 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="37" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Summary
    Compensation Table</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Name
    and Principal Position</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Fiscal<BR>
    Year <BR> ended <BR> March&nbsp;31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Salary
    <BR> ($)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Bonus
    <BR> ($)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Stock
    <BR> Awards <BR> ($)(1)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Option
    <BR> Awards <BR> ($)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Non-Equity
    <BR> Incentive Plan <BR> Compensation <BR> ($)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Nonqualified
    <BR> Deferred <BR> Compensation Earnings <BR> ($)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">All
    Other <BR> Compensation <BR> ($)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Total
    <BR> ($)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 19%; text-align: justify; text-indent: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lei
    Liu,</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68,910</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68,910</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO
    (2)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,676</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,676</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ming
    Zhao,</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">88,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">88,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: 0pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CFO</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">88,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">88,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects
the full fair value of stock issued during the applicable fiscal year for financial statement reporting purposes.</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Salary
as reported is based on interbank exchange rate of RMB 6.7075 to $1.00 on March 31, 2019 and RMB 6.9656 to $1.00 on March 31, 2020.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employment
Agreements, Termination of Employment and Change-in-Control Arrangements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as described below, we currently have no employment agreements with any of our executive officers, nor any compensatory plans or arrangements
resulting from the resignation, retirement or any other termination of any of our executive officers, from a change-in-control, or from
a change in any executive officer&rsquo;s responsibilities following a change-in-control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Agreement
with Ming Zhao</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
entered into an employment agreement with Mr. Zhao dated as of August 1, 2011, under which Mr. Zhao is serving as our Chief Financial
Officer for a term of two years commencing August 1, 2011, for annual compensation of $100,000, payable in monthly installments, as well
as a one-time grant of 40,000 shares of our common stock (the &ldquo;Shares&rdquo;) under our 2010 Equity Incentive Plan. The term of
his employment was extended verbally for another two (2) years with an amended annual compensation of $88,000 starting from October 2012.
The term of this employment was extended verbally for another one (1) years automatically (unless providing prior notice otherwise) with
an annual compensation of $88,000 starting from October 2015. Mr. Zhao is also entitled to expense reimbursement and to be included as
an insured under our directors and officers insurance policy with coverage of $5,000,000. During his employment, Mr. Zhao is subject
to certain restrictive covenants, including (i) prohibition against engaging in any work that competes with us and our business and soliciting
our customers, potential customers and employees, and (ii) requirement to maintain our confidential information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Zhao&rsquo;s employment agreement terminates upon his death or disability. If Mr. Zhao is unable to perform his duties for 60 days during
any 12 month period, we may terminate the employment agreement upon 30-day written notice. We may also terminate the employment agreement
for cause, upon notice if at any time Mr. Zhao commits (a) fraudulent, unlawful or grossly negligent conduct in connection with his employment
duties; (b) willful misconduct; (c) willful and continued failure to perform his duties; (d) any felony or any crime involving moral
turpitude; (e) any violation of any of our material policies; or (f) any material breach of any written agreement with us. Mr. Zhao may
terminate his employment agreement immediately upon written notice if we breach our agreement with him.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Outstanding
Equity Awards at Fiscal Year Ended March 31, 2020</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="19" STYLE="padding: 0pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Option
    Awards</FONT></TD><TD STYLE="padding: 0pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="14" STYLE="padding: 0pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Stock
    Awards</FONT></TD><TD STYLE="padding: 0pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 0pt; font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Name</FONT></TD><TD STYLE="padding: 0pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Number
    of securities underlying unexercised options exercisable</FONT></TD><TD STYLE="padding: 0pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Equity
    incentive plan awards: <BR> number of <BR> securities <BR> underlying <BR> unexercised <BR> options <BR> unexercisable</FONT></TD><TD STYLE="padding: 0pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Equity
    incentive plan awards: number of <BR> securities <BR> underlying <BR> unexercised <BR> unearned <BR> options</FONT></TD><TD STYLE="padding: 0pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Option
    <BR> exercise <BR> price ($)</FONT></TD><TD STYLE="padding: 0pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Option
    <BR> expiration <BR> date</FONT></TD><TD STYLE="padding: 0pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Number
    of shares <BR> or units <BR> of stock that have <BR> not vested</FONT></TD><TD STYLE="padding: 0pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Market
    value of shares or units of stock that <BR> have not vested<BR>
    ($)</FONT></TD><TD STYLE="padding: 0pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Equity
    incentive plan awards: number of unearned shares, units or other rights that have not vested</FONT></TD><TD STYLE="padding: 0pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 0pt; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Equity
    incentive <BR> plan awards: <BR> market or payout <BR> value of unearned <BR> shares, units or other rights that have not vested<BR>
    ($)</FONT></TD><TD STYLE="padding: 0pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0pt; width: 17%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lei
    Liu</FONT></TD><TD STYLE="padding: 0pt; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</FONT></TD><TD STYLE="padding: 0pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</FONT></TD><TD STYLE="padding: 0pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">180,000</FONT></TD><TD STYLE="padding: 0pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</FONT></TD><TD STYLE="padding: 0pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; width: 10%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nov.18,
    2022</FONT></TD><TD STYLE="padding: 0pt; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="padding: 0pt; width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ming Zhao</FONT></TD><TD STYLE="padding: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</FONT></TD><TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</FONT></TD><TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nov.18, 2022</FONT></TD><TD STYLE="padding: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="padding: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Li Qi</FONT></TD><TD STYLE="padding: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">125,000</FONT></TD><TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</FONT></TD><TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nov.18, 2022</FONT></TD><TD STYLE="padding: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="padding: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 81; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Equity
Compensation Plan Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-left: 20pt; text-indent: -20pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Plan
    Category</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Number
    of<BR>
    securities<BR>
    to be issued<BR>
    upon<BR>
    exercise of<BR> outstanding options, warrants<BR> and rights</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Weighted-average<BR>
    exercise price of<BR>
    outstanding<BR>
    options, warrants<BR>
    and rights</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Number
    of securities<BR> remaining available<BR> for future issuance<BR> under equity<BR> compensation plans</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -20pt; width: 64%; text-align: justify; padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    compensation plans approved by security holders</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">967,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,520,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -20pt; text-align: justify; padding-bottom: 1.5pt; padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    compensation plans not approved by security holders</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -20pt; text-align: justify; padding-bottom: 4pt; padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">967,000</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,520,000</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Discussion
of Summary Compensation and Grants of Plan-based Awards Tables</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of certain material terms of our existing compensation plans and arrangements is set forth below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 21, 2010, our Board of Directors approved a stock incentive plan for officers, directors, employees, and consultants entitled
&ldquo;China Jo-Jo Drugstores, Inc. 2010 Equity Incentive Plan&rdquo; (the &ldquo;Plan&rdquo;). The maximum number of shares that may
be issued under the Plan is 2,025,000 shares of our common stock. The Plan was approved by our shareholders at our annual meeting held
on November 2, 2010. On February 24, 2015, our Board of Directors adopted and approved Amendment No. 1 to the Plan to increase the number
of shares of the Company&rsquo;s common stock available for issuance thereunder from 2,025,000 share limit to 4,325,000 shares. Amendment
No. 1 was approved by the stockholders at the annual shareholders meeting on March 23, 2015. On January 27, 2016, our Board of Directors
adopted and approved Amendment No. 2 to the Plan to increase the number of shares of the Company&rsquo;s common stock available for issuance
thereunder from 4,325,000 share limit to 7,175,000 shares. Amendment No. 2 was approved by the stockholders at the annual shareholders
meeting on March 23, 2016. Under the Plan, the Company may issue common stock and/or options to purchase common stock to our officers,
directors, employees and consultants. The Plan is administered either by our Board of Directors or a committee that it designates comprising
of at least two (2) &ldquo;non-employee&rdquo; directors. The board (or the committee, if one is designated) has full and complete authority,
in its discretion, but subject to the express provisions of the Plan, to grant awards, to determine the number of awards to be granted
and the time or times at which awards shall be granted; to establish the terms and conditions upon which awards may be exercised; to
remove or adjust any restrictions and conditions upon awards; to specify, at the time of grant, provisions relating to exercisability
of awards and to accelerate or otherwise modify the exercisability of any awards; and to adopt such rules and regulations and to make
all other determinations deemed necessary or desirable for the administration of the Plan. On February 14, 2017, our Board of Directors
adopted and approved Amendment No. 3 to the Plan to increase the number of shares of the Company&rsquo;s common stock available for issuance
thereunder from 7,175,000 share limit to 9,696,468 shares. Amendment No. 3 was approved by the stockholders at the annual shareholders
meeting on March 29, 2017. On March 26, 2018, the shareholders of the Company approved the Amendment No. 4 to the Plan which increased
the total shares of common stock available for issuance thereunder to 12,196,468. On June 30, 2018, the Compensation Committee of the
Board approved the Amendment No. 5 to the Plan as <FONT STYLE="background-color: white">The Tax Cuts and Jobs Act of 2017 removed the
162(m) qualified performance based compensation exemption to the $1 million cap on deductions for compensation to covered executives.
Section 1.3.2 was in the Plan to permit grants under the Plan to fit within that exemption. As that exemption no longer applies for grants
made in 2018 or thereafter, the Plan had been amended to remove the provisions intended to comply with that exemption, including the
one in Section 1.3.2. of the Plan.</FONT> On March 5, 2020, the shareholders of the Company approved the Amended and Restated 2010 Equity
Incentive Plan, which in addition to the incorporation of the Amendment No. 4 and Amendment No. 5 to the Plan, clarified the term of
the Plan in order to render the Plan being available for incentive stock options grants in the future and approved the proposal of adding
a ten-year term to the Plan. The Plan, effective since November 2, 2010, shall terminate automatically on January 14, 2030 (the tenth
anniversary of the Board&rsquo;s approval of this Plan), unless terminated earlier by the Board, except with respect to Awards then outstanding.
The Plan, as amended and restated, has authorized, with the stockholders&rsquo; approval previously obtained, to reserve a total of 12,196,468
shares of our common stock for issuance under the Plan. As of March 31, 2020, there were 3,840,546 shares of our common stock available
for future issuance under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 82; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides compensation information for our directors during the fiscal year ended March 31, 2020:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="font-style: normal; vertical-align: bottom; font-weight: normal">
    <TD COLSPAN="33" STYLE="font-style: normal; font-weight: normal; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Director
    Compensation Table</FONT></TD></TR>
  <TR STYLE="font-style: normal; vertical-align: bottom; font-weight: normal">
    <TD STYLE="font-style: normal; font-weight: normal; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Name</FONT></TD><TD STYLE="font-style: normal; font-weight: normal; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-style: normal; white-space: nowrap; font-weight: normal; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Fiscal
    <BR> Year <BR> ended <BR> March&nbsp;31,</FONT></TD><TD STYLE="font-style: normal; padding-bottom: 1.5pt; font-weight: normal"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-style: normal; font-weight: normal; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-style: normal; font-weight: normal; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Fees
    Earned <BR> or Paid in <BR> Cash <BR> ($)</FONT></TD><TD STYLE="font-style: normal; padding-bottom: 1.5pt; font-weight: normal"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-style: normal; font-weight: normal; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-style: normal; font-weight: normal; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Stock
    <BR> Awards <BR> ($)(1)</FONT></TD><TD STYLE="font-style: normal; padding-bottom: 1.5pt; font-weight: normal"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-style: normal; font-weight: normal; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-style: normal; font-weight: normal; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Option
    <BR> Awards <BR> ($)</FONT></TD><TD STYLE="font-style: normal; padding-bottom: 1.5pt; font-weight: normal"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-style: normal; font-weight: normal; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-style: normal; font-weight: normal; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Non-Equity
    <BR> Incentive Plan <BR> Compensation <BR> ($)</FONT></TD><TD STYLE="font-style: normal; padding-bottom: 1.5pt; font-weight: normal"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-style: normal; font-weight: normal; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-style: normal; font-weight: normal; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Nonqualified
    <BR> Deferred <BR> Compensation <BR> Earnings <BR> ($)</FONT></TD><TD STYLE="font-style: normal; padding-bottom: 1.5pt; font-weight: normal"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-style: normal; font-weight: normal; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-style: normal; font-weight: normal; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">All
    Other <BR> Compensation <BR> ($)</FONT></TD><TD STYLE="font-style: normal; padding-bottom: 1.5pt; font-weight: normal"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-style: normal; font-weight: normal; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-style: normal; font-weight: normal; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Total
    <BR> ($)</FONT></TD><TD STYLE="font-style: normal; padding-bottom: 1.5pt; font-weight: normal"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; text-align: justify; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lei
    Liu (2)</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68,910</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">--</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68,910</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Li
    Qi (2)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51,682</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51,682</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Caroline
    Wang</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,485</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,485</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Genghua
    Gu</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiangliang
    He</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,168</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,168</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pingfan
    Wu</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,614</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-0-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,614</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reflects
dollar amount expensed by the Company during the applicable fiscal year for financial statement reporting purposes.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation
is reflected in the Summary Compensation Table on page 75 above.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not currently have an established policy to provide compensation to members of our Board of Directors for their services in that capacity,
although we have entered into certain agreements with some of our directors as described below. We intend to develop such a policy in
the near future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Agreement
with Genghua Gu</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 9, 2013, we entered into an agreement with Dr. Gu in the form of a director offer letter, pursuant to which we have agreed to
compensate him $6,000 annually for his services, payable in monthly installments on the last day of each month. Additionally, he is entitled
to be included as an insured under our directors and officers insurance policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Agreement
with Caroline Wang</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 29, 2017, we entered into an agreement with Ms. Wang in the form of a director offer letter pursuant to which we agreed to compensate
her $11,485 (RMB80,000) annually for her services. Additionally, she is entitled to be included as an insured under our directors and
officers insurance policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Agreement
with Jiangliang He</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 4, 2018, we entered into an agreement with Mr. He in the form of a director offer letter pursuant to which we agreed to
compensate her $5,168 (RMB36,000) annually for her services. Additionally, she is entitled to be included as an insured under our directors
and officers insurance policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Agreement
with Pingfan Wu</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of October 26, 2018, we entered into an agreement with Ms. Wu in the form of a director offer letter pursuant to which we agreed to compensate
her $8,614 (RMB60,000) annually for her services. Additionally, she is entitled to be included as an insured under our directors and
officers insurance policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 83; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="main_012"></A>SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Security
Ownership of Certain Beneficial Owners and Management</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information regarding our common stock beneficially owned on March 31, 2021, for (i) each stockholder
known to be the beneficial owner of five percent (5%) or more of our outstanding common stock, (ii) each executive officer and director,
and (iii) all executive officers and directors as a group. To the best of our knowledge, subject to community and marital property laws,
all persons named have sole voting and investment power with respect to such shares, except as otherwise noted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="9" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
                                            Stock Beneficially Owned</FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font-style: normal; vertical-align: bottom; font-weight: normal">
    <TD STYLE="font-style: normal; border-bottom: Black 1.5pt solid; padding: 0pt 0pt 0pt 10pt; text-indent: -10pt; font-weight: normal"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Executive
    officers and directors: <SUP>(1)</SUP></FONT></TD><TD STYLE="font-style: normal; font-weight: normal; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-style: normal; font-weight: normal; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Number
    of<BR>
    Shares<BR>
    beneficially<BR>
    owned (2)</FONT></TD><TD STYLE="font-style: normal; padding-bottom: 1.5pt; font-weight: normal"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-style: normal; font-weight: normal; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-style: normal; font-weight: normal; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Percentage<BR>
    of class<BR>
    beneficially<BR>
    owned (3)</FONT></TD><TD STYLE="font-style: normal; padding-bottom: 1.5pt; font-weight: normal"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD><TD STYLE="font-style: normal; padding-bottom: 1.5pt; font-weight: normal"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt; width: 75%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lei
    Liu, Chief Executive Officer and Chairman of the Board of Directors <SUP>(4)</SUP></FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,825,482</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ming
    Zhao, Chief Financial Officer</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">199,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Li
    Qi, Director <SUP>(4)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,409,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.4</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Caroline
    Wang, Director <SUP>(5)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Genghua
    Gu, Director <SUP>(6)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiangliang,
    He, Director</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pingfan
    Wu, Director</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    directors and executive officers as a group (7 persons)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,433,482</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.6</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5%
    Shareholders: <SUP>(1)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CareRetail
    Holdings Limited <SUP>(7)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,840,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.6</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0pt 0pt 0pt 10pt; text-indent: -10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Super
    Marvel Limited <SUP>(4)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,030,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.4</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less
                                            than 1%.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                            otherwise noted, the address for each of the named beneficial owners is: 6<SUP>th </SUP>Floor,
                                            Hai Wai Hai Tongxin Mansion, Gong Shu District, Hangzhou City, Zhejiang Province, China,
                                            310008.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
                                            Rule 13d-3, a beneficial owner of a security includes any person who, directly or indirectly,
                                            through any contract, arrangement, understanding, relationship, or otherwise has or shares:
                                            (i) voting power, which includes the power to vote, or to direct the voting of shares; and
                                            (ii) investment power, which includes the power to dispose or direct the disposition of shares.
                                            Certain shares may be deemed to be beneficially owned by more than one person (if, for example,
                                            persons share the power to vote or the power to dispose of the shares). In addition, shares
                                            are deemed to be beneficially owned by a person if the person has the right to acquire the
                                            shares (for example, upon exercise of an option) within 60 days of the date as of which the
                                            information is provided. In computing the percentage ownership of any person, the amount
                                            of shares outstanding is deemed to include the amount of shares beneficially owned by such
                                            person (and only such person) by reason of these acquisition rights. As a result, the percentage
                                            of outstanding shares of any person as shown in this table does not necessarily reflect the
                                            person&rsquo;s actual ownership or voting power with respect to the number of shares of common
                                            stock actually outstanding.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
                                            otherwise noted, the number and percentage of outstanding shares of common stock is based
                                            upon&nbsp;41,751,790&nbsp;shares outstanding as of March 31, 2021.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            address of Super Marvel Limited (&ldquo;Super Marvel&rdquo;) is P.O. Box 957, Offshore Incorporations
                                            Centre, Road Town, Tortola, British Virgin Islands. The owners of Super Marvel are Lei Liu
                                            (56.7%) and Li Qi (43.3%). They are also its directors. As such, they are deemed to have
                                            or share investment control over Super Marvel&rsquo;s portfolio.&nbsp;&nbsp;According to
                                            Rule 13d-5, when two or more persons agree to act together for the purpose of acquiring,
                                            holding, voting or disposing of equity securities of an issuer, the group formed thereby
                                            shall be deemed to have acquired beneficial ownership, for purposes of sections 13(d) and
                                            (g) of the Exchange Act, as of the date of such agreement, of all equity securities of that
                                            issuer beneficially owned by any such persons.&nbsp;&nbsp;As a result, 6,030,000 shares of
                                            common stock held by Super Marvel reported herein as beneficially owned by each of Mr. Liu,
                                            Ms. Qi and Mr. Jin, which they in turn own indirectly through their respective ownership
                                            of Super Marvel.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ms.
                                            Wang&rsquo;s address is: 3601B The Center, Changle Road, Xuhui District, Shanghai, China.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
                                            Gu&rsquo;s address is: No.1, Xueshi Road, Hangzhou, China.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            address of CareRetail Holdings Limited is Walkers Corporate Limited, Cayman Corporate Centre,
                                            27 Hospital Road, George Town, Grand Cayman KY1-9008. Hillhouse Capital Management, Ltd.,
                                            an exempted Cayman Islands company (&ldquo;Hillhouse Capital&rdquo;) is hereby deemed to
                                            be the sole beneficial owner of, and to control the voting power of, the shares of our common
                                            stock held by CareRetail. The directors of Hillhouse Capital are Jun Shen and Colm O&rsquo;Connell.
                                            Mr. Shen and Mr. O&rsquo;Connell are employees of Hillhouse Capital and Mr. Lei Zhang is
                                            the President and Chief Investment Officer of Hillhouse Capital.</FONT></TD>
</TR></TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 84; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="main_013"></A>CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Officers and Directors&rsquo; Relationship with Us, Our Subsidiaries and VIE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
operate our pharmacies (including the medical clinics) through the following companies in China that we control through contractual arrangements:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hangzhou Jiuzhou Grand
    Pharmacy Chain Co., Ltd. (&ldquo;Jiuzhou Pharmacy&rdquo;), which we control contractually, operates our &ldquo;Jiuzhou Grand Pharmacy&rdquo;
    stores;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hangzhou Jiuzhou Clinic
    of Integrated Traditional and Western Medicine (General Partnership) (&ldquo;Jiuzhou Clinic&rdquo;), which we control contractually,
    operates one (1) of our three (3) medical clinics; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hangzhou Jiuzhou Medical
    &amp; Public Health Service Co., Ltd. (&ldquo;Jiuzhou Service&rdquo;), which we control contractually, operates our other medical
    clinics.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, we operate pharmacies through &ldquo;Lin&rsquo;An Jiuzhou&rdquo;, which are directly held by Jiuxin Investments Management
Co. Ltd. We also operates nine stores, which are held by Jiuzhou Pharmacy. We tend to expand our clinics network adjacent to our drugstores
through Zhejiang Jiuzhou Linjia Medical Investment and Management Co. Ltd. (&ldquo;Linjia Medical&rdquo;), which are controlled by Jiuzhou
Pharmacy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
control HJ Group (Jiuzhou Pharmacy, Jiuzhou Clinic and Jiuzhou Service, Lin&rsquo;An Jiuzhou, as well as the subsidiaries of Jiuzhou
Pharmacy) through contractual arrangements between Jiuxin Management, our wholly-owned subsidiary, and each of Jiuzhou Pharmacy, Jiuzhou
Medical and Jiuzhou Clinic. HJ Group is owned by Mr. Lei Liu, Ms. Li Qi and Mr. Chong&rsquo;an Jin (the &ldquo;Key Personnel&rdquo;),
two (2) of whom also hold positions as our executive officers and/or directors. Because the Key Personnel also collectively own a substantial
amount of our issued and outstanding common stock, we believe that our interests are aligned with those of HJ Group and the Key Personnel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
Related Party Transactions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&nbsp;31,<BR>
    2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&nbsp;31,<BR>
    2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
    to a director and CEO <SUP>(1)</SUP>:</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">490,218</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">795,179</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 4%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify; width: 96%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
                                            to foreign exchange restrictions, the Company&rsquo;s director and CEO, Mr. Lei Liu personally
                                            lent U.S. dollars to the Company to facilitate its payments of expenses in the United States.</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company leases a retail space from Mr. Lei Liu. The lease will expire in September 2020. The rent for the year ended March 31, 2020 has
not been paid to Mr. Liu as of March 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 28, 2018, 10% of Jiuxin Medicine was sold to Hangzhou Kangzhou Biotech Co. Ltd. for a total proceeds of approximately $75,643(RMB507,760).
Mr. Lei Liu owns 51% of Hangzhou Kangzhou Biotech Co. Ltd.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 85; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="main_014"></A>PROPOSAL
NO. 1<BR>
<BR>
ADOPTION OF THE MERGER AGREEMENT</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Merger Agreement and the Plan of Merger</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
following includes a brief summary of the material provisions of the Merger Agreement, a copy of which is attached as Annex A and incorporated
by reference into this proxy statement/prospectus. We encourage you to read the Merger Agreement and the Plan of Merger in their entirety
for a more complete description of the Redomicile Merger. In the event of any discrepancy between the terms of the Merger Agreement and
the Plan of Merger and the following summary, the Merger Agreement and the Plan of Merger will control.</I>&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Introduction</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement and the Plan of Merger you are being asked to adopt and approve provides for a Redomicile Merger that would result in
each share of common stock of the Company being converted into the right to receive one ordinary share in the capital of CJJD Cayman,
an exempted company incorporated under the laws of the Cayman Islands. Under the Merger Agreement, the Company will merge with and into
CJJD Cayman, with CJJD Cayman as the surviving company and changing its name to China Jo-Jo Drugstores, Inc. upon the Redomicile Merger
becoming effective. If the Merger Agreement and the Plan of Merger are adopted by the stockholders, we anticipate that the Redomicile
Merger will become effective promptly following such approval. Following the Redomicile Merger, CJJD Cayman, together with its subsidiaries,
will own and continue to conduct our business in substantially the same manner as is currently being conducted by the Company and its
subsidiaries. Immediately following the Redomicile Merger, you will own an interest in CJJD Cayman, which will be managed by substantially
the same board of directors and executive officers that managed the Company immediately prior to the Redomicile Merger. Additionally,
the consolidated assets and liabilities of CJJD Cayman will be the same as those of the Company immediately prior to the Redomicile Merger.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Parties to the Redomicile Merger</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>China
                                            Jo-Jo Drugstores, Inc. (a Nevada corporation) </I>The Company is a retailer and distributor
                                            of pharmaceutical and other healthcare products typically found in retail pharmacies in the
                                            PRC. The Company currently has one hundred and eighteen (118) store locations under the store
                                            brand &ldquo;Jiuzhou Grand Pharmacy&rdquo; in Hangzhou city and its adjacent town Lin&rsquo;an.
                                            The Company currently operates in four business segments in China: (1) retail drugstores,
                                            (2) online pharmacy, (3) wholesale business selling products similar to those we carry in
                                            our pharmacies, and (4) farming and selling herbs used for traditional Chinese medicine (&ldquo;TCM&rdquo;).
                                            All of the above business are performed in China with no other international sales.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>China
Jo-Jo Drugstores Holdings, Inc., or CJJD Cayman ( </I> CJJD Cayman is a newly formed exempted company incorporated under the laws of
the Cayman Islands and currently a wholly-owned subsidiary of the Company. An &ldquo;exempted&rdquo; company under the laws of the Cayman
Islands is one which receives such registration as a result of satisfying the Registrar of Companies in the Cayman Islands that it conducts
its operations mainly outside of the Cayman Islands and is as a result exempted from complying with certain provisions of the Companies
Act of the Cayman Islands, such as the general requirement to file an annual return of its shareholders with the Registrar of Companies,
and is permitted flexibility in certain matters, such as the ability to register by way of continuation in another jurisdiction and be
deregistered in the Cayman Islands upon satisfying certain requirements of the Companies Act as it pertains to continuation and/or deregistration.
CJJD Cayman does not have a significant amount of assets or liabilities and has not engaged in any business since its formation other
than activities associated with its anticipated participation in the Redomicile Merger.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
principal executive offices of each of the Company and CJJD Cayman are located at Hai Wai Hai Tongxin Mansion Floor 6, Gong Shu District,
Hangzhou City, People&rsquo;s Republic of China 310008; Telephone: +86 571-88219579. The registered office for CJJD Cayman is in the
Cayman Islands located at Cricket Square, Hutchins Drive, PO Box 2681, Grand Cayman, KY1-1111, Cayman Islands, and the phone number of
the registered office is +1 345 945 3901.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Background
and Reasons for the Redomicile Merger&nbsp;</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe the Redomicile Merger, which would redomicile our entity from Nevada to the Cayman Islands, is consistent with our corporate
strategy of focusing on the China plasma market, including expanding our business in China, and would allow us to reduce operational,
administrative, legal and accounting costs over the long term. Our strategy has been focused on our core strengths and aligned with favorable
long-term market trends relating to plasma-related products in China.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
biopharmaceutical industry in China is strictly regulated and officially or unofficially may favor companies that are incorporated in
jurisdictions that are not politically and economically perceived to be in competition with China. In addition, our assets and operations
have been primarily based in China. Nearly 100% of our sales in 2019 and 2020 were attributable to China and almost all of our long-lived
assets, consisting of property, plant and equipment and our full-time employees were located in China as of December 31, 2020. We currently
have no operations in the United States and we believe that there is no particular business reason to remain incorporated in the United
States. Furthermore, we believe that most overseas incorporated companies whose assets and operations are primarily in China have adopted
a corporate holding structure similar to the structure we propose to adopt in the Redomicile Merger. Therefore, we believe by reorganizing
our structure we will be better able to compete with our competitors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"></P>

<!-- Field: Page; Sequence: 86; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt; margin-right: 0in; margin-left: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have chosen to redomicile under the laws of the Cayman Islands because of its political and economic stability, effective judicial system,
absence of exchange control or currency restrictions and availability of professional and support services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="padding-left: -1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            believe that by reincorporating to a jurisdiction outside the United States, which is in
                                            line with the Company&rsquo;s current business and operations which are almost all conducted
                                            outside of the United States, CJJD Cayman will be able to qualify as a &ldquo;foreign private
                                            issuer&rdquo; under the rules and regulations of the SEC and we expect that the reduced reporting
                                            obligations associated with being a foreign private issuer will reduce operational, administrative,
                                            legal and accounting costs in the long term. CJJD Cayman will remain subject to the mandates
                                            of the Sarbanes-Oxley Act. As a foreign private issuer, CJJD Cayman also will be exempt from
                                            certain rules under the Exchange Act that would otherwise apply if CJJD Cayman were a company
                                            incorporated in the United States or did not meet the other conditions to qualify as a foreign
                                            private issuer. For example: CJJD Cayman may include in its SEC filings financial statements
                                            prepared in accordance with U.S. GAAP or with IFRS as issued by the IASB without reconciliation
                                            to U.S. GAAP;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD
                                            Cayman will not be required to provide as many Exchange Act reports, or as frequently or
                                            as promptly, as U.S. companies with securities registered under the Exchange Act. For example,
                                            CJJD Cayman will not be required to file current reports on Form 8-K within four business
                                            days from the occurrence of specific material events. Instead, CJJD Cayman will need to promptly
                                            furnish reports on Form 6-K any information that CJJD Cayman (a) makes or is required to
                                            make public under the laws of the Cayman Islands, (b) files or is required to file under
                                            the rules of any stock exchange, or (c) otherwise distributes or is required to distribute
                                            to its shareholders. Unlike Form 8-K, there is no precise deadline by which Form 6-K must
                                            be furnished. In addition, CJJD Cayman will not be required to file its annual report on
                                            Form 10-K, which may be due as soon as 60 days after its fiscal year end. As a foreign private
                                            issuer, CJJD Cayman will be required to file an annual report on Form 20-F within four months
                                            after its fiscal year end;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD
                                            Cayman will not be required to provide the same level of disclosure on certain issues, such
                                            as executive compensation;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD
                                            Cayman will not be required to conduct advisory votes on executive compensation;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD
                                            Cayman will be exempt from filing quarterly reports under the Exchange Act with the SEC;however,
                                            as a Nasdaq listed foreign private issuer, CJJD Cayman will be required to publish on a Form
                                            6-K an interim balance sheet and income statement as of the end of its second quarter no
                                            later than six months following the end of such quarter;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD
                                            Cayman will not be subject to the requirement to comply with Regulation FD, which imposes
                                            certain restrictions on the selected disclosure of material information;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD
                                            Cayman will not be required to comply with the sections of the Exchange Act regulating the
                                            solicitation of proxies, consents or authorizations in respect of a security registered under
                                            the Exchange Act; and</FONT></TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD
                                            Cayman will not be required to comply with Section 16 of the Exchange Act requiring insiders
                                            to file public reports of their stock ownership and trading activities and establishing insider
                                            liability for profits realized from any &ldquo;short-swing&rdquo; trading transaction.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD
                                            Cayman expects to take advantage of these exemptions if the Redomicile Merger is effected.
                                            Accordingly, after the completion of the Redomicile Merger, if you hold CJJD Cayman securities,
                                            you may receive less information about CJJD Cayman and its business than you currently receive
                                            with respect to the Company and be afforded less protection under the U.S. federal securities
                                            laws than you are entitled to currently.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
as a foreign private issuer, CJJD Cayman will be permitted to follow corporate governance practices in accordance with Cayman Islands
laws in lieu of certain exchange corporate governance standards, such as the following NASDAQ corporate governance standards requiring
that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the majority of
the board of directors be comprised of independent directors;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">executive compensation
be determined by independent directors or a committee of independent directors;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">director nominees
be selected, or recommended for selection by the board of directors, by independent directors or a committee of independent directors;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an audit committee
be comprised of at least three members, each of whom is an independent director and one of whom has finance and accounting experience;
and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all related party
transactions be reviewed by the audit committee or another independent body of the board of directors.</FONT></TD>
</TR></TABLE>






<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt; margin-right: 0in; margin-left: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></P></DIV>

<!-- Field: Page; Sequence: 87; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt; margin-right: 0in; margin-left: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conyers
                                            Dill Pearman, our Cayman Islands counsel, has advised us that there are no comparable Cayman
                                            Islands laws related to the above corporate governance standards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concurrent
with the process of the Redomicile Merger and thereafter, it is the intent of CJJD Cayman to list its ordinary shares on the NASDAQ Capital
Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe the Redomicile Merger will enhance shareholder value for the reasons discussed above. However, in light of the fact that the
achievement of our objectives depends on many things, including, among other things, future laws and regulations, as well as the development
of our business, we cannot predict what impact, if any, the Redomicile Merger will have in the long term when these factors change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a discussion of the risk factors associated with the Redomicile Merger, please see the section entitled &ldquo;Risk Factors and Caution
Regarding Forward-Looking Statements &mdash; Risks Relating to the Redomicile Merger.&rdquo;</FONT></P></DIV>



<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt; margin-right: 0in; margin-left: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are certain disadvantages that accompany redomicile in the Cayman Islands, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Cayman Islands
has a different body of securities laws and corporate laws as compared to the United States and may provide significantly less protection
to investors;</FONT></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
    <TD>&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman Islands
companies may not have standing to sue before the federal courts of the United States;</FONT></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
    <TD>&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD Cayman&rsquo;s
constitutional documents do not contain provisions requiring that disputes, including those arising under the securities laws of the
United States, between it and our officers, directors and shareholders be arbitrated; and</FONT></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
    <TD>&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD Cayman will
continue to be treated as a U.S. corporation for U.S. federal income tax purposes.</FONT></TD>
</TR></TABLE>




<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT>

<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt; margin-right: 0in; margin-left: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD
                                            Cayman&rsquo;s corporate affairs are governed by CJJD Cayman&rsquo;s amended and restated
                                            memorandum and articles of association, as amended and restated from time to time, the Companies
                                            Act and the common law of the Cayman Islands. The rights of shareholders to take action against
                                            the directors and officers of CJJD Cayman, actions by minority shareholders and the fiduciary
                                            duties of our directors to us under Cayman Islands law are to a large extent governed by
                                            the common law of the Cayman Islands. The common law of the Cayman Islands is derived in
                                            part from comparatively limited judicial precedent in the Cayman Islands, as well as from
                                            English common law, which has persuasive, but not binding, authority on a court in the Cayman
                                            Islands. The rights of our shareholders and the fiduciary duties of our directors, although
                                            clearly established under Cayman Islands law, are not specifically prescribed in statute
                                            or a particular document in the same way that they are in certain statutes or judicial precedent
                                            in some jurisdictions in the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
a significant portion of our operations are conducted in the PRC, and a significant portion of our assets are located in the PRC. After
the Redomicile Merger, substantially all of CJJD Cayman&rsquo;s directors and executive officers will continue to reside outside of the
United States, and all or a substantial portion of such persons&rsquo; assets are or may be located outside the United States. As a result,
it may be difficult for you to effect service of process within the United States upon CJJD Cayman or such persons, or to enforce against
them in courts of the United States, Cayman Islands or PRC, judgments obtained in United States courts, including judgments predicated
upon the civil liability provisions of the securities laws of the United States or any state in the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Redomicile Merger</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            steps that have been taken to date, and that will be taken, to complete the Redomicile Merger
                                            are:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD
Cayman was incorporated with the Company holding the one (and only) ordinary share issued by CJJD Cayman.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the Special Meeting, provided that we have obtained the requisite stockholder approval of the Merger Agreement and the Plan of Merger
and related transaction including the Redomicile Merger, as of the Effective Time (i) the Company will merge with and into CJJD Cayman,
with CJJD Cayman as the surviving company changing its name to China Jo-Jo Drugstores, Inc., and (ii) each share of the Company&rsquo;s
common stock will be converted into the right to receive one ordinary share in the capital of CJJD Cayman and CJJD Cayman shall issue
to each holder of such right that number of ordinary shares in CJJD Cayman to which each such holder is entitled.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the Effective Time, CJJD Cayman will cancel the one ordinary share issued to the Company prior to the Redomicile Merger and all common
stock of the Company will be cancelled.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"></P>




<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt; margin-right: 0in; margin-left: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the Effective Time, all existing equity compensation plans of the Company, as may be amended, will be adopted and assumed by CJJD Cayman.
Each outstanding option and other equity award issued under our equity compensation plans for the purchase or receipt of, or payment
based on, each share of the Company&rsquo;s common stock will represent the right to purchase or receive, or receive payment based on,
one ordinary share in the capital of CJJD Cayman on substantially the same terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
at the Effective Time, CJJD Cayman will adopt and assume the obligations of the Company under or with respect to certain contracts or
agreements as described in the Merger Agreement. The contracts and agreements will become the obligations of CJJD Cayman and will be
performed in the same manner and without interruption until the same are amended or otherwise lawfully altered or terminated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P></DIV>

<!-- Field: Page; Sequence: 88; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt; margin-right: 0in; margin-left: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Merger Agreement and the Plan of Merger may be amended, modified or supplemented at any time before or after it is adopted by the stockholders
of the Company. However, after adoption by the stockholders, no amendment, modification or supplement that requires further approval
by the Company&rsquo;s stockholders may be made or effected without obtaining that approval.</FONT></P></DIV>



<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt; margin-right: 0in; margin-left: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Possible
Abandonment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Merger Agreement, the board of directors of the Company may exercise its discretion to terminate the Merger Agreement, and therefore
abandon the Redomicile Merger, at any time prior to the Effective Time, including after the adoption of the Merger Agreement by the Company&rsquo;s
stockholders. Please see the section entitled &ldquo;Risk Factors and Caution Regarding Forward-Looking Statements &mdash; Risks Relating
to the Redomicile Merger &mdash; Our Board of Directors may choose to defer or abandon the Redomicile Merger.&rdquo;</FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="border: white 1pt solid; text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Additional
Agreements</B></FONT></P>

<P STYLE="border: white 1pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD
Cayman expects to enter into indemnification agreements with those directors, executive officers and other officers and employees (including
those of its subsidiaries) who currently have indemnification agreements with the Company. The CJJD Cayman indemnification agreements
will be substantially similar to the Company&rsquo;s existing indemnification agreements and will generally require that CJJD Cayman
indemnify and hold an indemnitee harmless to the fullest extent permitted by law for liabilities arising out of the indemnitee&rsquo;s
current or past association with CJJD Cayman, any subsidiary of CJJD Cayman or another entity where he or she is or was serving at CJJD
Cayman&rsquo;s request as a director or officer or in a similar capacity that involves services with respect to any employee benefit
plan.</FONT></P>



<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt; margin-right: 0in; margin-left: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
indemnification agreements also provide for the advancement of defense expenses by CJJD Cayman. Please also see the section entitled
&ldquo;Comparison of Rights under Nevada and Cayman Islands Laws &mdash; Indemnification of Directors and Officers&rdquo; for a description
of indemnification of directors and officers under Cayman Islands law and CJJD Cayman&rsquo;s amended and restated memorandum and articles
of association.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conditions
to Completion of the Redomicile Merger</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following conditions must be satisfied or waived, if allowed by law, to complete the Redomicile Merger:</FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Merger Agreement
and the Plan of Merger have been approved and adopted by the requisite vote of stockholders of the Company;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">none of the parties
to the Merger Agreement is subject to any decree, order or injunction that prohibits the consummation of the Redomicile Merger;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the registration
statement of which this proxy statement/prospectus is a part has been declared effective by the SEC and no stop order is in effect;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the CJJD Cayman
ordinary shares to be issued pursuant to the Redomicile Merger have been authorized for listing on the NASDAQ Stock Market, subject to
official notice of issuance and satisfaction of other standard conditions;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Company and
CJJD Cayman receive an opinion from our tax counsel, Pryor Cashman LLP, that the Redomicile Merger will qualify as a reorganization with
the meaning of Section 368(a) of the Code;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="text-align: left; width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all material consents
and authorizations of, filings or registrations with, and notices to, any governmental or regulatory authority required of the Company,
CJJD Cayman or their subsidiaries to consummate the Redomicile Merger have been obtained or made; and</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the representations
and warranties of the parties to the Merger Agreement set forth in the Merger Agreement are true and correct in all material respects,
and the covenants of the parties set forth in the Merger Agreement (other than those to be performed after the Effective Time) have been
performed in all material respects.</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors currently does not anticipate any circumstances in which it would waive the conditions listed above; however, in the
event it determines that a waiver of any such conditions is in the best interests of the Company and our stockholders and that such change
to the terms of the Redomicile Merger does not make the disclosure provided to our stockholders materially misleading (for example, if
a representation in the Merger Agreement is not true but there is otherwise no harm to the Company or our stockholders), our board of
directors will not resolicit stockholder approval of the Redomicile Merger. If a waiver of any condition listed above would make the
disclosure provided to our stockholders materially misleading, our board of directors will resolicit shareholder approval of the Redomicile
Merger. Additionally, our board of directors reserves the right to defer or abandon the Redomicile Merger as well for the reasons described
under &ldquo;Risk Factors and Caution Regarding Forward-Looking Statements &mdash; Risks Relating to the Redomicile Merger &mdash; Our
Board of Directors may choose to defer or abandon the Redomicile Merger.&rdquo;</FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&nbsp;</P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"></P>

<!-- Field: Page; Sequence: 89; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock
Compensation and Benefit Plans and Programs</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of the Redomicile Merger, CJJD Cayman has agreed to assume all of the Company&rsquo;s rights and obligations under the Company&rsquo;s
stock-based benefit and compensation plans and programs at the Effective Time. All rights to purchase or receive, or receive payment
based on, each share of the Company&rsquo;s common stock arising under our equity compensation plans will entitle the holder to purchase
or receive, or receive payment based on, as applicable, one CJJD Cayman ordinary share.</FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Warrants,
Convertible Debentures or Convertible Securities</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, as part of the Redomicile Merger, CJJD Cayman has agreed to assume all of the Company&rsquo;s rights and obligations of any
warrants, convertible debentures or other convertible securities that may convert into the Company&rsquo;s common stock at the Effective
Time. All rights to purchase or receive, or receive payment based on, each share of the Company&rsquo;s common stock arising under our
warrants, convertible debentures or other convertible securities will entitle the holder thereof to purchase or receive, or receive payment
based on, as applicable, one CJJD Cayman ordinary share.</FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Effective
Time</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provided
that we have obtained the requisite stockholder approval, we anticipate that the Redomicile Merger will become effective promptly following
such approval. Our board of directors will have the right, however, to defer or abandon the Redomicile Merger at any time if it concludes
that completion of the Redomicile Merger would not be in the best interests of the Company or our stockholders.</FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Management
of CJJD Cayman</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Immediately
prior to the Effective Time, the directors and officers of the Company at such time will be elected or appointed as the directors and
officers of CJJD Cayman (to the extent the directors and officers of CJJD Cayman and the Company are not already identical), each such
person to have the same office(s) with CJJD Cayman (and the same committee memberships in the case of directors) as he or she held with
the Company, with the directors to serve until the earlier of the next meeting of CJJD Cayman&rsquo;s shareholders at which an election
of directors is required or until their successors are elected or appointed (or their earlier death, disability or retirement).</FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recommendation
and Required Vote</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>



<DIV STYLE="border: white 1pt solid; margin-right: 0in; margin-left: 0pt; padding: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
affirmative vote of the holders of a majority of the outstanding shares of the Company&rsquo;s common stock entitled to vote is required
to approve and adopt the Merger Agreement and the Plan of Merger. Our board of directors believes that the Redomicile Merger, to be effected
by the Merger Agreement and the Plan of Merger, is advisable and in the best interests of the Company and our stockholders.</FONT></P></DIV>



<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt; margin-right: 0in; margin-left: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCORDINGLY,
OUR BOARD OF DIRECTORS HAS UNANIMOUSLY APPROVED THE REDOMICILE MERGER AND THE MERGER AGREEMENT AND THE PLAN OF MERGER. THE BOARD OF DIRECTORS
RECOMMENDS THAT STOCKHOLDERS VOTE &ldquo;FOR&rdquo; THE ADOPTION OF THE MERGER AGREEMENT AND THE PLAN OF MERGER.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

</DIV>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Regulatory
Approvals</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
only governmental or regulatory approvals or actions that are required to complete the Redomicile Merger are compliance with U.S. federal
and state securities laws and Nevada corporate law (including the filing with the Secretary of State of the State of Nevada of articles
of merger).</FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rights
of Dissenting Stockholder</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Nevada Revised Statutes, the stockholders will not have appraisal or dissenting rights in connection with the Redomicile Merger.</FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ownership
in CJJD Cayman</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
                                            share of the Company&rsquo;s common stock registered in your name or which you beneficially
                                            own through your broker will be converted into the right to receive one ordinary share in
                                            the capital of CJJD Cayman and such ordinary share will be registered in your name (or your
                                            broker&rsquo;s name, as applicable) in CJJD Cayman&rsquo;s register of members upon completion
                                            of the Redomicile Merger, without any further action on your part. Upon completion of the
                                            Redomicile Merger, only registered shareholders reflected in CJJD Cayman&rsquo;s register
                                            of members will have and be entitled to exercise any voting and other rights with respect
                                            to and to receive any dividend and other distributions upon CJJD Cayman ordinary shares registered
                                            in their respective names. Any attempted transfer of the Company&rsquo;s stock prior to the
                                            Redomicile Merger that is not properly documented and reflected in the stock records maintained
                                            by the Company&rsquo;s transfer agent as of immediately prior to the Effective Time will
                                            not be reflected in CJJD Cayman&rsquo;s register of members upon completion of the Redomicile
                                            Merger.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"></P>

<!-- Field: Page; Sequence: 90; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">If you hold the Company&rsquo;s
common stock in an account with a broker or other securities intermediary, you will receive delivery of ordinary shares in your account
with that same broker or securities intermediary without any action on your part. If you hold the Company&rsquo;s common stock in certificated
form, you may exchange your stock certificates for new CJJD Cayman share certificates following the Redomicile Merger. We will request
that all Company stock certificates be returned to our exchange agent following the Redomicile Merger. Soon after the closing of the
Redomicile Merger, you will be sent a letter of transmittal from our exchange agent. The letter of transmittal will contain instructions
explaining the procedure for surrendering your stock certificates of the Company for new CJJD Cayman share certificates. YOU SHOULD NOT
RETURN STOCK CERTIFICATES WITH THE ENCLOSED PROXY CARD.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD
Nevada&rsquo;s current transfer agent is American Stock Transfer &amp; Trust Company, LLC, which is expected to continue to serve as
the transfer agent for CJJD Cayman ordinary shares after the Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock
Exchange Listing</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company&rsquo;s common stock is currently listed on NASDAQ under the symbol &ldquo;CJJD.&rdquo;
                                            There is currently no established public trading market for CJJD Cayman&rsquo;s ordinary
                                            shares. However, it is a condition to the completion of the Redomicile Merger that the shares
                                            of CJJD Cayman will be authorized for listing on NASDAQ, subject to official notice of issuance
                                            and satisfaction of other standard conditions. As such, we expect that as of the Effective
                                            Time, CJJD Cayman&rsquo;s ordinary shares will be authorized for listing on NASDAQ, and we
                                            expect that such shares will be traded on the exchange under the symbol &ldquo;CJJD.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is anticipated that CJJD Cayman will qualify as a foreign private issuer in the U.S. following the Redomicile Merger. As a foreign private
issuer, CJJD Cayman will be permitted to follow corporate governance practices in accordance with Cayman Islands laws in lieu of certain
NASDAQ corporate governance standards. However, we do not intend to initially rely on any NASDAQ exemptions or accommodations for foreign
private issuers following the Redomicile Merger.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Accounting
Treatment of the Redomicile Merger </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Redomicile Merger will be accounted for as a legal reorganization with no change in ultimate ownership interest immediately before and
after the transaction. Accordingly, no business combination has occurred and all assets and liabilities will be recorded at historical
cost as an exchange between entities under common control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Taxation
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
following discussion of the material Cayman Islands, People&rsquo;s Republic of China and U.S. federal income tax consequences of the
Redomicile Merger is based upon laws and relevant interpretations thereof effective as of the date of this proxy statement/prospectus,
all of which are subject to change, possibly with retroactive effect. This discussion does not deal with all possible tax consequences
relating to the Redomicile Merger or otherwise, such as the tax consequences under laws of countries other than the Cayman Islands, the
People&rsquo;s Republic of China and the United States or under state and local tax laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Cayman
Islands Taxation </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Cayman Islands government (or any other taxing authority in the Cayman Islands) currently does not levy taxes on individuals or corporations
based upon profits, income, gains or appreciation, and there is no taxation in the Cayman Islands in the nature of inheritance tax or
estate duty. There are no other taxes likely to be material to CJJD Cayman levied by the government of the Cayman Islands except for
stamp duty which may be applicable on instruments executed in, or brought within the jurisdiction of the Cayman Islands. No stamp duties
or other similar taxes or charges are payable under the laws of the Cayman Islands in respect of the execution or delivery of any of
the documents relating the proposed Redomicile Merger or the performance or enforcement of any of them, unless they are executed in or
thereafter brought within the jurisdiction of the Cayman Islands for enforcement purposes or otherwise. We do not intend that any documents
relating the proposed Redomicile Merger be executed in or brought within the jurisdiction of the Cayman Islands. There are no exchange
control regulations or currency restrictions in the Cayman Islands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>People&rsquo;s
Republic of China Taxation </I></B></FONT></P>



<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt; margin-right: 0in; margin-left: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
                                            the Corporate Income Tax Law of the People&rsquo;s Republic of China (the &ldquo;CIT Law&rdquo;)
                                            and its implementation rules, both effective on January 1, 2008, all domestic and foreign
                                            investment companies will be subject to a uniform enterprise income tax at the rate of 25%
                                            and dividends from PRC enterprises to their foreign shareholders will be subject to a withholding
                                            tax at a rate of 10% if the foreign investors are considered as non-resident enterprises
                                            without any establishment or place within the PRC or if the dividends payable have no connection
                                            with the establishment or place of the foreign investors within the PRC, unless any such
                                            foreign investor&rsquo;s jurisdiction of incorporation has a tax treaty with the PRC that
                                            provides for a lower withholding tax rate. In accordance with Caishui (2008) No. 1 issued
                                            by the Ministry of Finance, or MOF, and SAT on February 22, 2008, the accumulative undistributed
                                            profits of foreign investment companies generated before January 1, 2008, and distributed
                                            to foreign investors after year 2008, shall be exempt from withholding tax.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P></DIV>

<!-- Field: Page; Sequence: 91; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt; margin-right: 0in; margin-left: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
CIT Law has introduced the concept of &ldquo;resident enterprises&rdquo; and corresponding tax liability on resident enterprises&rsquo;
worldwide income, whilst &ldquo;non-resident enterprises&rdquo; without any place or establishment in the PRC are required to pay 10%
income tax on their passive incomes from sources within China only. A resident enterprise refers to an enterprise that (i) was established/incorporated
within the PRC, or (ii) was established/incorporated under the laws of a foreign jurisdiction but has its &ldquo;de facto management
body&rdquo; in the PRC. A non-resident enterprise refers to an enterprise which was established/incorporated under the laws of a foreign
jurisdiction and does not have its &ldquo;de facto management body&rdquo; in the PRC, but has an establishment or place in the PRC, or
has China-sourced income even though it does not have any establishment or place in the PRC.</FONT></P></DIV>



<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt; margin-right: 0in; margin-left: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
                                            the implementation rules of the CIT Law, &ldquo;de facto management body&rdquo; is defined
                                            as an organization that has material and overall management and control over the business,
                                            personnel, accounts and properties of an enterprise. In April 2009, the SAT issued a Notice
                                            on Issues Relating to Determination of PRC-Controlled Offshore Enterprises as PRC Resident
                                            Enterprises Based on &ldquo;De Facto Management Body&rdquo; Test, or SAT Circular No. 82,
                                            under which, an offshore enterprise controlled by a PRC enterprise or a PRC enterprise group
                                            will be characterized as a &ldquo;resident enterprise&rdquo; due to the fact that its &ldquo;de
                                            facto management body&rdquo; is located within the PRC, if all of the following conditions
                                            are met at the same time: (i) the senior management personnel responsible for its daily operations
                                            and the place where the senior management departments discharge their responsibilities are
                                            located primarily in the PRC, (ii) its finance and human resources related decisions are
                                            made by or are subject to the approval of institutions or personnel located in the PRC, (iii)
                                            its major assets, books and records, company seals and minutes of its board of directors
                                            and shareholder meetings are located or kept in the PRC, and (iv) senior management personnel
                                            or 50% or more of the members of its board of directors with voting power of the enterprise
                                            reside in the PRC. SAT Circular No. 82 further specifies that the principle of &ldquo;substance
                                            over form&rdquo; shall be adopted in determining whether the &ldquo;de facto management body&rdquo;
                                            is located within China.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently are not treated as a PRC resident enterprise by the Chinese tax authority and as a result, we have not withheld PRC income
taxes from our foreign investors and as a non-resident enterprise, we are subject to PRC withholding tax if we receive dividends directly
from our PRC subsidiaries paid by them using funds out of their profits generated on and after January 1, 2008.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nevertheless,
a significant portion of our operations are currently based in the PRC and are likely to remain based in the PRC after the Redomicile
Merger. Moreover, a significant portion of our management team, who are in charge of finance and human resources related decisions, will
perform their duties mainly in the PRC, and over 50% of our board members habitually reside in the PRC. Our main properties, accounting
books and records, company seals and minutes of board meetings are maintained in China.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
the rules regarding the determination of the &ldquo;de facto management body&rdquo; are relatively new and whether such rules may apply
to us is unclear. Due to lack of further written clarification by the SAT, there is still a uncertainty around the interpretation of
each of the four conditions as specified in SAT Circular No. 82 and the principle of &ldquo;substance over form&rdquo; and the implementation
of SAT Circular No. 82 by Chinese tax authorities in practice. It also remains unclear what percentage of shares of an offshore enterprise
must be held by a PRC entity or group in order for the offshore enterprise to be deemed as an offshore enterprise controlled by a PRC
enterprise or a PRC enterprise group, and whether shares held by PRC resident individuals are counted pursuant to SAT Circular No. 82.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to the lack of clear guidance on the determination of our tax residency under the CIT Law, it remains unclear whether the PRC tax authorities
will treat us as a PRC resident enterprise either before or after the Redomicile Merger or what effect, if any, the Redomicile Merger
will have on the determination. As a result, we cannot express an opinion as to the likelihood that we will be subject to the tax applicable
to resident enterprises or non-resident enterprises under the CIT Law. If CJJD Cayman is treated as a PRC resident enterprise, it will
be subject to PRC tax on its worldwide income at the 25% uniform tax rate, but the dividends distributed from its subsidiaries that are
or deemed to be PRC resident enterprises should be tax-exempt income. In addition, if CJJD Cayman is considered a PRC resident enterprise,
the dividends paid by it to the non-PRC shareholders may be regarded as income from sources within the PRC pursuant to SAT Circular No.
82, and therefore the non-PRC institutional shareholders may be subject to a 10% withholding tax, and the non-PRC individual shareholders
may be subject to a 20% withholding tax unless they are able to claim a lower tax rate pursuant to applicable tax treaties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
if CJJD Cayman is treated as a PRC resident enterprise, there is a possibility that the capital gains realized by its non-PRC shareholders
from the transfer of their shares may be regarded as income from sources within the PRC for PRC tax purposes. If such capital gains are
taxed in China, the applicable income tax rate would be 10% for non-PRC institutional shareholders, and 20% for non-PRC individual shareholders.
If the non-PRC shareholders are U.S. residents that are eligible for PRC-US Tax Treaty benefits, whether capital gains should be taxed
in China is unclear.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Paragraph 5 of Article 12 of the PRC-US Tax Treaty, gains from the alienation of shares of a company which is a PRC resident other
than those mentioned in paragraph 4 (which refers to shares of a company the property of which consists principally of real property
in the PRC) and representing a participation of at least 25% may be taxed in China. Paragraph 6 of Article 12 of the PRC-US Tax Treaty
further specifies that &ldquo;[G]ains derived by a resident of a Contracting State from the alienation of any property other than that
referred to in paragraphs 1 through 5 and arising in the other Contracting State may be taxed in that other Contracting State.&rdquo;
By virtue of this provision, the capital gains realized by U.S. residents may be taxed in the PRC if the capital gains are considered
as &ldquo;arising in&rdquo; the PRC. Under the CIT Law and its implementing rules, the capital gains from transfer of shares may be considered
as &ldquo;arising in&rdquo; the PRC if the enterprise whose shares are transferred is &ldquo;located in&rdquo; China. If CJJD Cayman
is considered a PRC resident enterprise, and if the Chinese tax authorities take the position that a PRC resident enterprise is deemed
to be located in China, the capital gains realized by the U.S. residents from transfer of their shares may be taxed in the PRC depending
on how the PRC-US Tax Treaty is interpreted and implemented by the Chinese tax authorities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15.1pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15.1pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 92; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: white 1pt solid; margin-right: 0in; margin-left: 2.9pt; padding: 3pt 0in 3pt 3pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15.1pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

</DIV>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>United
States Taxation </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
                                            following are the material U.S. federal income tax consequences of the Redomicile Merger
                                            to beneficial owners of Company common stock. This discussion is based on the Code, applicable
                                            Treasury regulations, administrative interpretations and court decisions as in effect as
                                            of the date of this proxy statement/prospectus, all of which may change, possibly with retroactive
                                            effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
discussion addresses only the consequences of the exchange of shares of Company common stock held as capital assets. It does not address
all aspects of U.S. federal income taxation that may be important to a beneficial owner in light of his or her particular circumstances,
including alternative minimum tax and Medicare contribution tax consequences, or tax consequences that may apply to a beneficial owner
subject to special rules, such as:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 0.25in">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid">&#9679;</P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border: white 1pt solid">a financial institution
    or insurance company;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid">&#9679;</P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border: white 1pt solid">a tax-exempt organization;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid">&#9679;</P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border: white 1pt solid">a dealer or broker in
    securities, commodities or foreign currencies;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid">&#9679;</P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border: white 1pt solid">a shareholder that holds
    Company common stock as part of a hedge, appreciated financial position, straddle, conversion or other risk reduction transaction;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid">&#9679;</P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border: white 1pt solid">a U.S. Holder (as defined
    below) whose functional currency is not the U.S. dollar;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid">&#9679;</P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border: white 1pt solid">a shareholder that beneficially
    owns five percent or more of Company common stock;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid">&#9679;</P></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border: white 1pt solid">a shareholder that acquired
    Company common stock pursuant to the exercise of compensatory options or otherwise as compensation.</P></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a partnership holds shares of Company common stock, the tax treatment of a partner will generally depend upon the status of the partner
and the activities of the partnership. A partner of a partnership holding shares of Company common stock should consult its tax advisor
regarding the tax consequences of the Redomicile Merger.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
discussion of material U.S. federal income tax consequences is not a complete analysis or description of all potential U.S. federal income
tax consequences of the Redomicile Merger. This discussion does not address tax consequences that may vary with, or are contingent on,
individual circumstances. In addition, it does not address any non-income tax, non-U.S. tax, or state or local tax consequences. Accordingly,
each Company shareholder should consult its own tax advisor to determine the particular U.S. federal, state, and local income tax or
non-U.S. income tax, or other tax consequences to it of the Redomicile Merger.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Tax
Opinion </B></FONT></P>



<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt; margin-right: 0in; margin-left: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
                                            on certain representations and assumptions described below, all of which must continue to
                                            be true and accurate in all material respects as of the effective time of the Redomicile
                                            Merger, it is the opinion of Pryor Cashman LLP, our tax counsel, that the Redomicile Merger
                                            will be treated for U.S. federal income tax purposes as a reorganization within the meaning
                                            of Section 368(a) of the Code. It is a condition to the obligation of the Company to complete
                                            the Redomicile Merger that counsel confirm its opinion as of the closing date of the Redomicile
                                            Merger. The Company does not intend to waive this condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
opinion described above has relied, and the confirmation opinion as of the closing date of the Redomicile Merger (the &ldquo;closing
date opinion&rdquo;) will rely, on representations made by the Company and CJJD Cayman, including those contained in a certificate of
an officer of the Company and CJJD Cayman. In addition, the opinion has assumed, and our tax counsel&rsquo;s ability to provide the closing
date opinion will depend on, the absence of changes in existing facts or in law between the date of this proxy statement/prospectus and
the closing date of the Redomicile Merger. If any of those representations or assumptions is inaccurate, our tax counsel may not be able
to provide the required closing date opinion or the tax consequences of the Redomicile Merger could differ from those described herein
and in the opinions that our tax counsel have delivered. An opinion of tax counsel neither binds the IRS nor precludes the IRS or the
courts from adopting a contrary position. The Company does not intend to obtain a ruling from the IRS on the tax consequences of the
Redomicile Merger. Consequently, no assurance can be given that the IRS will not assert, or that a court will not sustain, a position
contrary to any of the tax consequences set forth below or any of the tax consequences described in the tax opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the opinion and subject to the qualifications set forth above, in the opinion of our tax counsel the material U.S. federal income
tax consequences of the Redomicile Merger are set forth below.</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>U.S.
Federal Income Tax Consequences of the Redomicile Merger to the Company and CJJD Cayman </B></FONT></P>



<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt; margin-right: 0in; margin-left: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
                                            the Company nor CJJD Cayman will recognize any gain or loss for U.S. federal income tax purposes
                                            as a result of the Redomicile Merger.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P></DIV>

<!-- Field: Page; Sequence: 93; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt; margin-right: 0in; margin-left: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 7874(b) of the Code, CJJD Cayman will be treated as a U.S. corporation for all purposes under the Code because after the Redomicile
Merger, (i) CJJD Cayman will have acquired substantially all of the properties held directly or indirectly by the Company, (ii) CJJD
Cayman will not have substantial business activities in the Cayman Islands, and (iii) the former holders of the Company&rsquo;s common
stock will hold, by reason of owning shares of the Company&rsquo;s common stock, at least 80% or more of the CJJD Cayman ordinary shares.</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>U.S.
Federal Income Tax Consequences of the Redomicile Merger to U.S. Holders </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">This
                                            section applies to beneficial owners of Company common stock that are U.S. Holders. Generally,
                                            a U.S. Holder is a beneficial owner of Company common stock that is for U.S. federal income
                                            tax purposes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a citizen or individual
resident of the United States;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a corporation,
or other entity taxable as a corporation, created or organized in or under the laws of the United States, any state therein or the District
of Columbia;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an estate the income
of which is subject to U.S. federal income taxation regardless of its source; or</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a trust that&nbsp;is
subject to the supervision of a court within the U.S. and the control of one (1)&nbsp;or more U.S. Persons. For purposes of this discussion,
&ldquo;U.S. Person&rdquo; shall have the meaning ascribed to it by Section&nbsp;7701(a)(30) of the Code.</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Holder will not recognize any gain or loss for U.S. federal income tax purposes solely due to the receipt of CJJD Cayman ordinary
shares in the Redomicile Merger. A U.S. Holder&rsquo;s adjusted tax basis in the CJJD Cayman ordinary shares received in the Redomicile
Merger will be the same as such U.S. Holder&rsquo;s adjusted tax basis in the Company common stock surrendered in the Redomicile Merger.
Such U.S. Holder&rsquo;s holding period in the CJJD Cayman ordinary shares received in the Redomicile Merger will include such U.S. Holder&rsquo;s
holding period in the Company common stock surrendered in the Redomicile Merger. Provided, however, that if a U.S. Holder acquired different
blocks of Company common stock at different times or at different prices, the CJJD Cayman ordinary shares received in the Redomicile
Merger will be allocated pro rata to each block of Company common stock, and the basis and holding period of each block of CJJD Cayman
ordinary shares received will be determined on a block-for-block basis depending on the basis and holding period of the blocks of Company
common stock exchanged for such block of CJJD Cayman ordinary shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
U.S. federal income tax consequences of owning and disposing of CJJD Cayman ordinary shares received in the Redomicile Merger will be
the same as the U.S. federal income tax consequences of owning and disposing of Company common stock before the Redomicile Merger. Each
U.S. Holder should consult its own tax advisor to determine the particular U.S. federal, state or local or non-U.S. income or other tax
consequences to it of the ownership and disposition of CJJD Cayman ordinary shares.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>U.S.
Federal Income Tax Consequences of the Redomicile Merger to Non-U.S. Holders </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt; border: white 1pt solid">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
section applies to beneficial owners of Company common stock that are Non-U.S. Holders. Generally, a Non-U.S. Holder is a beneficial
owner of Company common stock that is for U.S. federal income tax purposes:</FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            nonresident alien individual;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            corporation that is not U.S. Holder;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            estate that is not a U.S. Holder; or</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            trust that is not a U.S. Holder.</FONT></TD>
</TR></TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 94; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Special
tax rules may apply to individual beneficial owners who are former citizens or former residents of the United States. Such individuals
should consult their tax advisors regarding the U.S. federal income tax consequences of the Redomicile Merger and of owning or disposing
of CJJD Cayman ordinary shares.</FONT></P>



<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt; margin-right: 0in; margin-left: 0pt">&nbsp;</DIV>

<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt; margin-right: 0in; margin-left: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            receipt of CJJD Cayman ordinary shares in exchange for Company common stock will not be a
                                            taxable transaction to Non-U.S. Holders for U.S. federal income tax purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
U.S. federal income tax consequences of owning and disposing of CJJD Cayman ordinary shares received in the Redomicile Merger will be
the same as the U.S. federal income tax consequences of owning and disposing of Company common stock before the Redomicile Merger, including
that dividends paid by CJJD Cayman to Non-U.S. Holders will generally be subject to U.S. federal withholding tax at a 30% rate (or a
reduced rate specified by an applicable income tax treaty). Each Non-U.S. Holder should consult its own tax advisor to determine the
particular U.S. federal, state or local or non-U.S. income or other tax consequences to it of the ownership and disposition of CJJD Cayman
ordinary shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Anti-money
Laundering&mdash;Cayman Islands</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to comply with legislation or regulations aimed at the prevention of money laundering, CJJD Cayman may be required to adopt and
maintain anti-money laundering procedures, and may require subscribers to provide evidence to verify their identity. Where permitted,
and subject to certain conditions, CJJD Cayman may also delegate the maintenance of our anti-money laundering procedures (including the
acquisition of due diligence information) to a suitable person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD
                                            Cayman reserves the right to request such information as is necessary to verify the identity
                                            of a subscriber. In the event of delay or failure on the part of the subscriber in producing
                                            any information required for verification purposes, CJJD Cayman may refuse to accept the
                                            application, in which case any funds received will be returned without interest to the account
                                            from which they were originally debited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD
Cayman also reserves the right to refuse to make any redemption payment to a shareholder if directors or officers suspect or are advised
that the payment of redemption proceeds to such shareholder might result in a breach of applicable anti-money laundering or other laws
or regulations by any person in any relevant jurisdiction, or if such refusal is considered necessary or appropriate to ensure compliance
with any such laws or regulations in any applicable jurisdiction.</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">If
any person resident in the Cayman Islands knows or suspects or has reason for knowing or suspecting that another person is engaged in
criminal conduct or is involved with terrorism or terrorist property and the information for that knowledge or suspicion came to their
attention in the course of their business in the regulated sector, or other trade, profession, business or employment, the person will
be required to report such knowledge or suspicion to (i) a nominated officer (appointed in accordance with the Proceeds of Crime Act
(As Revised) of the Cayman Islands) or the Financial Reporting Authority of the Cayman Islands, pursuant to the Proceeds of Crime Act
(As Revised), if the disclosure relates to criminal conduct or money laundering or (ii) to a police constable or a nominated officer
(pursuant to the Terrorism Act (As Revised) of the Cayman Islands) or the Financial Reporting Authority, pursuant to the Terrorism Act
(As Revised), if the disclosure relates to involvement with terrorism or terrorist financing and terrorist property. Such a report shall
not be treated as a breach of confidence or of any restriction upon the disclosure of information imposed by any enactment or otherwise.</FONT></P>

<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Data
Protection&thinsp;&mdash;&thinsp;Privacy Notice</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Scope</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
legal basis for this notification is to meet the standards required in respect of, and ensure compliance with, the requirements of the
Cayman Islands&rsquo; Data Protection Act, 2017 or the &ldquo;DPA,&rdquo; which came into effect in the Cayman Islands on 30 September
2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
privacy notice puts investors in CJJD Cayman on notice that through your investment into CJJD Cayman you may provide us with certain
personal information which constitutes personal data within the meaning of the DPL (&ldquo;personal data&rdquo;). CJJD Cayman collects,
uses, discloses, retains and secures personal data to the extent reasonably required only and within the parameters that could be reasonably
expected during the normal course of business. CJJD Cayman will only process, disclose, transfer or retain personal data to the extent
legitimately required to conduct the activities of CJJD Cayman on an ongoing basis or to comply with legal and regulatory obligations
to which CJJD Cayman is subject. CJJD Cayman will only transfer personal data in accordance with the requirements of the DPA, and will
apply appropriate technical and organizational information security measures designed to protect against unauthorized or unlawful processing
of the personal data and against the accidental loss, destruction or damage to the personal data. In our use of this personal data, we
will be characterized as a &ldquo;data controller&rdquo; for the purposes of the DPA, while our affiliates and service providers who
may receive this personal data from us in the conduct of our activities may either act as our &ldquo;data processors&rdquo; for the purposes
of the DPA or may process personal information for their own lawful purposes in connection with services provided to CJJD Cayman.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></DIV>

<!-- Field: Page; Sequence: 95; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are a natural person, this will affect you directly. If you are a corporate investor (including, for these purposes, legal arrangements
such as trusts or exempted limited partnerships) that provides us with personal data on individuals connected to you for any reason in
relation to your investment into CJJD Cayman, this will be relevant for those individuals and you should inform such individuals of the
content.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">What
rights do individuals have in respect of personal data?</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the DPA, individuals must be informed of the purposes for which their personal data is processed and this privacy notice fulfils CJJD
Cayman&rsquo;s obligation in this respect. Individuals have rights under the DPA in certain circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
may include the right to request access to their personal data, the right to request rectification or correction of personal data, the
right to request that processing of personal data be stopped or restricted and the right to require that CJJD Cayman cease processing
personal data for direct marketing purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you consider that your personal data has not been handled correctly, or you are not satisfied with CJJD Cayman&rsquo;s responses to any
requests you have made regarding the use of your personal data, you have the right to complain to the Cayman Islands&rsquo; Ombudsman.
The Ombudsman can be contacted by calling: +1 (345) 946-6283 or by email at info@ombudsman.ky.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contacting
CJJD Cayman</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">For further information on the collection, use, disclosure, transfer or processing of your personal data or the exercise of any of the
rights listed above, please contact us through the address and telephone number of our principal executive office. Our principal website
is&numsp;&numsp;&numsp;&numsp;&numsp;&numsp;&numsp;&numsp; &numsp;&numsp;. The information contained in, or accessible through, our website
is not incorporated into this prospectus or the registration statement of which it forms a part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Economic
Substance</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Cayman Islands has recently enacted the International Tax Co-operation (Economic Substance) Act (2021 Revision), or the Cayman Economic
Substance Act. CJJD Cayman is required to comply with the Cayman Economic Substance Act. As CJJD Cayman is a Cayman Islands company,
compliance obligations include filing annual notifications for CJJD Cayman, which need to state whether CJJD Cayman is carrying out any
relevant activities and if so, whether CJJD Cayman has satisfied economic substance tests to the extent required under the Cayman Economic
Substance Act. As it is a new regime, it is anticipated that the Cayman Economic Substance Act will evolve and be subject to further
clarification and amendments. CJJD Cayman may need to allocate additional resources to keep updated with these developments, and may
have to make changes to our operations in order to comply with all requirements under the Cayman Economic Substance Act. Failure to satisfy
these requirements may subject CJJD Cayman to penalties under the Cayman Economic Substance Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Compensation
of Directors and Officers</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Cayman Islands law, CJJD Cayman is not required to disclose compensation paid to our senior management on an individual basis and CJJD
Cayman have not otherwise publicly disclosed this information elsewhere. The executive officers, directors and management of CJJD Cayman
receive fixed and variable compensation. They also receive benefits in line with market practice. The fixed component of their compensation
is set on market terms and adjusted annually. The variable component consists of cash bonuses and awards of shares (or the cash equivalent).
Cash bonuses are paid to executive officers and members of management based on previously agreed targets for the business. Shares (or
the cash equivalent) are awarded under share options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cayman
Islands Selling Restrictions</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus does not constitute a public offer of the common shares, whether by way of sale or subscription, in the Cayman Islands. The
common shares have not been offered or sold, and will not be offered or sold, directly or indirectly, in the Cayman Islands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
Financial Action Task Force&rsquo;s Increased Monitoring of the Cayman Islands</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2021, the Cayman Islands was added to the Financial Action Task Force (&ldquo;<B>FATF</B>&rdquo;) list of jurisdictions whose
anti-money laundering practices are under increased monitoring, commonly referred to as the &ldquo;FATF grey list.&rdquo; &nbsp;When
the FATF places a jurisdiction under increased monitoring, it means the country has committed to resolve swiftly the identified strategic
deficiencies within agreed timeframes and is subject to increased monitoring during that timeframe. It is unclear how long this designation
will remain in place and what ramifications, if any, the designation will have for CJJD Cayman.</FONT></P>

</DIV>

<DIV STYLE="border: white 1pt solid; padding: 0pt 0in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 96; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><A NAME="main_015"></A>DESCRIPTION
OF SHARE CAPITAL OF CJJD CAYMAN </B></FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
following description of the material terms of CJJD Cayman&rsquo;s ordinary shares following the Redomicile Merger includes a summary
of specified provisions of the amended and restated memorandum and articles of association of CJJD Cayman that will be in effect upon
such time that the Redomicile Merger has been completed. Such amended and restated memorandum and articles of association of CJJD Cayman
are attached as an exhibit to the registration statement of which this proxy statement/prospectus is a part of and incorporated herein
by reference. You are encouraged to read the relevant provisions of the Companies Act and CJJD Cayman&rsquo;s amended and restated memorandum
and articles of association as they relate to the following summary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Authorized
Share Capital </B></FONT></P>



<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt; margin-right: 0in; margin-left: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD
                                            Cayman is authorized to issue 500,000,000 shares of a par value of US$0.001 each. The board
                                            of directors of CJJD Cayman is authorized to issue these shares in different classes and
                                            series and, with respect to each class or series, to determine the designations, powers,
                                            preferences, privileges and other rights, including dividend rights, conversion rights, terms
                                            of redemption and liquidation preferences, any or all of which may be greater than the powers
                                            and rights associated with the ordinary shares, at such times and on such other terms as
                                            they think proper.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the close of business on April 19, 2021, CJJD Cayman had one ordinary share issued and outstanding and no preferred shares issued
and outstanding. Upon the completion of the Redomicile Merger, CJJD Cayman will issue approximately 41,751,790 ordinary shares in the
Redomicile Merger and the one ordinary share issued and outstanding prior to the Redomicile Merger will be cancelled.</FONT></P>

</DIV>

<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt">&nbsp;</DIV>

<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ordinary
                                            Shares </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>General
</I></B></FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt; border: white 1pt solid">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of CJJD Cayman&rsquo;s issued and outstanding ordinary shares will be issued credited as fully paid and non-assessable. CJJD Cayman&rsquo;s
ordinary shares are issued in registered form, and are issued when registered in CJJD Cayman&rsquo;s register of members. CJJD Cayman&rsquo;s
shareholders who are non-residents of the Cayman Islands may freely hold and transfer their ordinary shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Dividends
</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
holders of CJJD Cayman&rsquo;s ordinary shares are entitled to such dividends as may be declared by CJJD Cayman&rsquo;s board of directors,
subject to the Companies Act and the amended and restated memorandum and articles of association of CJJD Cayman. Under Cayman Islands
law, dividends may be declared and paid only out of funds legally available therefor, namely out of either profit or share premium account,
provided that in no circumstances may CJJD Cayman pay a dividend if this would result in CJJD Cayman being unable to pay its debts as
they fall due in the ordinary course of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B><I>Register
of Members </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt; border: white 1pt solid">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Cayman Islands law, CJJD Cayman must keep a register of members and there shall be entered therein:</FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the names and addresses
of the members, a statement of the shares held by each member, and of the amount paid or agreed to be considered as paid, on the shares
of each member;</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the date on which
the name of any person was entered on the register as a member; and</FONT></TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the date on which
any person ceased to be a member.</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt; border: white 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Under Cayman Islands
law, the register of members of CJJD Cayman is prima facie evidence of the matters set out therein (i.e., the register of members will
raise a presumption of fact on the matters referred to above unless rebutted) and a member registered in the register of members shall
be deemed as a matter of Cayman Islands law to have legal title to the shares as set against its name in the register of members. Upon
the closing of this Redomicile Merger, the register of members shall be immediately updated to reflect the issue of ordinary shares by
CJJD Cayman to the Company&rsquo;s stockholders. Once CJJD Cayman&rsquo;s register of members has been updated, the shareholders recorded
in the register of members will be deemed to have legal title to the ordinary shares set against their name in the register of members.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border: white 1pt solid">&nbsp;</P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 97; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B><I>Voting Rights </I></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Each holder of ordinary shares is entitled to
one vote on all matters upon which the ordinary shares are entitled to vote on a show of hands or, on a poll, each holder is entitled
to have one vote for each share registered in his name on the register of members. Voting at any meeting of shareholders is by show of
hands unless a poll is demanded. A poll may be demanded by the chairman of CJJD Cayman&rsquo;s board of directors or by any one or more
shareholders holding at least one-tenth of the votes attaching to the issued and outstanding ordinary shares in CJJD Cayman entitled to
vote at general meetings, present in person or by proxy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">A quorum required for a general meeting of shareholders
consists of one or more shareholders who hold in aggregate at least one-third of the votes attaching to the issued and outstanding ordinary
shares in CJJD Cayman entitled to vote at general meetings, present in person or by proxy or, if a corporation or other non-natural person,
by its duly authorized representative. Although not required by the Companies Act or CJJD Cayman&rsquo;s amended and restated memorandum
and articles of association, CJJD Cayman expects to hold shareholders&rsquo; meetings annually and such meetings may be convened by CJJD
Cayman&rsquo;s board of directors on its own initiative or upon a request to the directors by shareholders holding in aggregate at least
25 percent in par value of CJJD Cayman&rsquo;s issued shares that carry the right to vote at general meetings. An extraordinary general
meeting may also be called by the Chairman of the Board or the President of the Company. Advance notice of at least 10 days is required
for the convening of CJJD Cayman&rsquo;s annual general meeting and other shareholders meetings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">An ordinary resolution to be passed by the shareholders
requires the affirmative vote of a simple majority of the votes attaching to the ordinary shares cast by those shareholders entitled to
vote who are present in person or by proxy in a general meeting, while a special resolution requires the affirmative vote of no less than
two-thirds of the votes attaching to the ordinary shares cast by those shareholders entitled to vote who are present in person or by proxy
in a general meeting. Both ordinary resolutions and special resolutions may also be passed by a unanimous written resolution signed by
all the shareholders of CJJD Cayman, as permitted by the Companies Act and the amended and restated memorandum and articles of association
of CJJD Cayman. A special resolution will be required for important matters such as change of name or making further changes to the amended
memorandum and articles of association of CJJD Cayman.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><B><I>&nbsp;</I></B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Transfer of Ordinary Shares </I></B></P>



<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt; margin-right: 0in; margin-left: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Subject to the restrictions of CJJD Cayman&rsquo;s
amended articles of association, as applicable, any of CJJD Cayman&rsquo;s shareholders may transfer all or any of his or her ordinary
shares by an instrument of transfer in the usual or common form or any other form approved by CJJD Cayman&rsquo;s board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">CJJD Cayman&rsquo;s board of directors may, in
its absolute discretion, decline to register any transfer of any ordinary share which is not fully paid up or on which CJJD Cayman have
a lien. CJJD Cayman&rsquo;s directors may also decline to register any transfer of any ordinary share unless:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

</DIV>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the instrument of transfer is lodged with CJJD Cayman, accompanied by the certificate for
the ordinary shares to which it relates and such other evidence as CJJD Cayman&rsquo;s board of directors may reasonably require to show
the right of the transferor to make the transfer;</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the instrument of transfer is in respect of only one class of ordinary shares;</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the instrument of transfer is properly stamped, if required;</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">in the case of a transfer to joint holders, the number of joint holders to whom the ordinary
share is to be transferred does not exceed four; or</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the ordinary shares transferred are free of any lien in favor of CJJD Cayman.</TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border: white 1pt solid">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">If CJJD Cayman&rsquo;s
directors refuse to register a transfer they shall, within two months after the date on which the instrument of transfer was lodged, send
to each of the transferor and the transferee notice of such refusal. The registration of transfers may, on 14 days&rsquo; notice being
given by advertisement in such one or more newspapers or by electronic means, be suspended and the register closed at such times and for
such periods as CJJD Cayman&rsquo;s board of directors may from time to time determine; provided, however, that the registration of transfers
shall not be suspended and the register shall not be closed for more than 30 days in any year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B><I>Liquidation</I></B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">On a winding up of CJJD
Cayman, if the assets available for distribution among its shareholders shall be more than sufficient to repay the whole of the share
capital at the commencement of the winding up, the surplus will be distributed among its shareholders in proportion to the par value of
the shares held by them at the commencement of the winding up, subject to a deduction from those shares in respect of which there are
monies due, of all monies payable to CJJD Cayman for unpaid calls or otherwise. If CJJD Cayman&rsquo;s assets available for distribution
are insufficient to repay all of the paid-up capital, the assets will be distributed so that the losses are borne by its shareholders
in proportion to the par value of the shares held by them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><B><I>&nbsp;</I></B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Calls on Ordinary Shares and Forfeiture
of Ordinary Shares </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border: white 1pt solid">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">CJJD Cayman&rsquo;s board
of directors may from time to time make calls upon shareholders for any amounts unpaid on their ordinary shares in a notice served to
such shareholders at least 14 days prior to the specified time of payment. The ordinary shares that have been called upon and remain unpaid
are subject to forfeiture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><B><I>&nbsp;</I></B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I></I></B></P>

<!-- Field: Page; Sequence: 98; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Redemption, Repurchase and Surrender
of Ordinary Shares </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border: white 1pt solid">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">CJJD Cayman may issue
shares on terms that are subject to redemption, at CJJD Cayman&rsquo;s option or at the option of the holders, on such terms and in such
manner as may be determined before the issue of such shares, by CJJD Cayman&rsquo;s board of directors or by a special resolution of CJJD
Cayman&rsquo;s shareholders. CJJD Cayman may also repurchase any of its shares provided that the manner and terms of such purchase have
been agreed between the board of directors and the relevant shareholder or are otherwise authorized by its amended and restated memorandum
and articles of association. Under the Companies Act, the redemption or repurchase of any share may be paid out of CJJD Cayman&rsquo;s
profits or out of the proceeds of a fresh issue of shares made for the purpose of such redemption or repurchase, or out of capital (including
share premium account and capital redemption reserve) if CJJD Cayman can, immediately following such payment, pay its debts as they fall
due in the ordinary course of business. In addition, under the Companies Act no such share may be redeemed or repurchased (a) unless it
is fully paid up, (b) if such redemption or repurchase would result in there being no shares outstanding, or (c) if the company has commenced
liquidation. In addition, CJJD Cayman may accept the surrender of any fully paid share for no consideration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><B><I>&nbsp;</I></B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Variations of Rights of Shares </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border: white 1pt solid">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">All or any of the special
rights attached to any class of shares may, subject to the provisions of the Companies Act, be varied either with the written consent
of the holders of not less than two-thirds of the issued shares of that class or with the sanction of a special resolution passed at a
general meeting of the holders of the shares of that class.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid">&nbsp;</P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Inspection of Books and Records </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border: white 1pt solid">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Holders of CJJD Cayman&rsquo;s
ordinary shares have no general right under Cayman Islands law to inspect or obtain copies of CJJD Cayman&rsquo;s list of shareholders
or its corporate records. However, CJJD Cayman will provide its shareholders with annual audited financial statements. See &ldquo;Where
You Can Find Additional Information.&rdquo;</P>



<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B><I>Changes in Capital
</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">CJJD Cayman may from
time to time by ordinary resolution:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">increase its share capital by such sum, to be divided into shares of such classes and amount,
as the resolution shall prescribe;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">consolidate and divide all or any of its share capital into shares of a larger amount than
its existing shares;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="text-align: left; width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">convert all or any of its paid up shares into stock and reconvert that stock into paid up
shares of any denomination;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">sub-divide its existing shares, or any of them into shares of a smaller amount that is fixed
by the amended and restated memorandum and articles of association; and</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">cancel any shares which, at the date of the passing of the resolution, have not been taken
or agreed to be taken by any person and diminish the amount of its share capital by the amount of the shares so cancelled.</TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border: white 1pt solid">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Subject to Companies
Act and confirmation by the Grand Court of the Cayman Islands on an application by CJJD Cayman for an order confirming such reduction,
CJJD Cayman may by special resolution reduce its share capital and any capital redemption reserve in any manner authorized by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><B><I>&nbsp;</I></B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I></I></B></P>

<!-- Field: Page; Sequence: 99; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Issuance of Additional Preferred Shares&nbsp;</I></B></P>



<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt; margin-right: 0in; margin-left: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">CJJD Cayman&rsquo;s amended and restated memorandum
and articles of association authorizes CJJD Cayman&rsquo;s board of directors to issue additional ordinary shares from time to time as
its board of directors shall determine, to the extent of available authorized but unissued shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">CJJD Cayman&rsquo;s amended and restated memorandum
and articles of association authorizes CJJD Cayman&rsquo;s board of directors to establish from time to time one or more series of preferred
shares and to determine, with respect to any series of preferred shares, the terms and rights of that series, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</DIV>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the designation of the series;</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the number of shares of the series;</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the dividend rights, dividend rates, conversion rights, voting rights; and</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
<TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the rights and terms of redemption and liquidation preferences.</TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border: white 1pt solid">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">CJJD Cayman&rsquo;s board
of directors may issue preferred shares without action by its shareholders to the extent authorized but unissued. In addition, the issuance
of preferred shares may be used as an anti-takeover device without further action on the part of the shareholders. Issuance of these shares
may dilute the voting power of holders of ordinary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid"><B>&nbsp;</B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exempted Company</B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">CJJD Cayman is an exempted company duly incorporated
with limited liability under the Companies Act. The Companies Act distinguishes between ordinary resident companies and exempted companies.
Any company, the objects of which are to conduct business mainly outside of the Cayman Islands, may apply to be registered as an exempted
company. The requirements for an exempted company are essentially the same as for an ordinary company except for certain exemptions and
privileges, including (a) an exempted company does not have to file an annual return of its shareholders with the Registrar of Companies,
(b) an exempted company is not required to open its register of members for inspection, (c) an exempted company does not have to hold
an annual general meeting, (d) an exempted company may issue no par value, negotiable or bearer shares, &euro; an exempted company may
register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands, (f) an exempted company may obtain
an undertaking against the imposition of any future taxation (such undertakings are usually given for 20 years in the first instance),
(g) an exempted company may register as a limited duration company and (h) an exempted company may register as a segregated portfolio
company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&ldquo;Limited liability&rdquo; means that the
liability of each shareholder is limited to the amount unpaid by the shareholder on that shareholder&rsquo;s shares of the company (except
in exceptional circumstances, such as fraud, the establishment of an agency relationship or an illegal or improper purpose or other circumstances
in which a court may be prepared to pierce or lift the corporate veil).</P>



<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>Transfer Agent </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; border: white 1pt solid">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The transfer agent and registrar for CJJD
Cayman&rsquo;s ordinary shares is expected to be American Stock Transfer &amp; Trust Company, LLC.</P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 100; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="main_016"></A>COMPARISON OF RIGHTS UNDER NEVADA AND CAYMAN
ISLANDS LAWS </B></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">Your rights as a stockholder of the Company are
governed by the Nevada Revised Statutes (the &ldquo;NRS&rdquo;) and the Company&rsquo;s articles of incorporation and bylaws, as amended
and restated to date. After the Redomicile Merger, you will become a shareholder of CJJD Cayman and your rights will be governed by the
Companies Act and CJJD Cayman&rsquo;s amended and restated memorandum and articles of association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">The principal attributes of the Company&rsquo;s
common stock and CJJD Cayman ordinary shares are similar. However, there are differences between your rights under the NRS and under the
Companies Act. In addition, there are differences between the Company&rsquo;s articles of incorporation and bylaws and CJJD Cayman&rsquo;s
amended and restated memorandum and articles of association. The following discussion is a summary of certain material differences in
your rights that would result from the Redomicile Merger. As such, this summary does not cover all the differences between Companies Act
and the NRS affecting corporations and their shareholders or all of the differences between the Company&rsquo;s articles of incorporation
and bylaws and CJJD Cayman&rsquo;s amended and restated memorandum and articles of association. While we believe this summary is accurate
in all material respects, the following descriptions are qualified in their entirety by reference to the complete text of the relevant
provisions of the Companies Act, the NRS, the Company&rsquo;s articles of incorporation and bylaws and CJJD Cayman&rsquo;s amended and
restated memorandum and articles of association. CJJD Cayman&rsquo;s amended and restated memorandum and articles of association will
be effective prior to the completion of the Redomicile Merger and will replace its existing memorandum and articles of association in
their entirety. A copy of CJJD Cayman&rsquo;s amended and restated memorandum of association and articles of association that will become
effective prior to the consummation of the Redomicile Merger is attached hereto as an exhibit to this Registration Statement on Form F-4
of which this proxy statement/prospectus is a part. We encourage you to read the laws and documents referenced above. The reference of
&ldquo;Memorandum of Association and Articles of Association&rdquo; in the compare table below refers to the amended and restated memorandum
and articles of association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NRS / CJJD&rsquo;s Articles of<BR>
Incorporation and Bylaws</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Companies Act/CJJD Cayman&rsquo;s Amended and Restated Memorandum and Articles of Association</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stockholder Approval of Business Combinations; Fundamental Changes</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Generally, under the NRS, approval of mergers
    and consolidations and sales, leases or exchanges of all of the property or assets of a corporation requires the affirmative vote of the
    holders of a majority of the outstanding shares entitled to vote.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The NRS does not contain a procedure comparable
    to a scheme of arrangement under the Companies Act.</P></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are a number of mechanisms for acquiring
    a Cayman Islands company including: (1) a court-approved &ldquo;scheme of arrangement&rdquo; under the Companies Act; (2) through a tender
    offer by a third party; and (3) through a merger or consolidation between the Cayman Islands company and another company incorporated
    in the Cayman Islands or another jurisdiction (provided that the merger or consolidation is allowed by the laws of that other jurisdiction).</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A scheme of arrangement with one or more class
    or series of shareholders requires the sanction of the scheme of arrangement by the Cayman Islands court and the approval of a majority
    in number of the registered holders of each participating class or series of shares voting on the scheme of arrangement, representing
    75% or more in value of the shares of each participating classes or series voted on such proposal at the relevant meeting excluding any
    shares held by the acquiring party. If a scheme of arrangement receives the approval of shareholders of a company and is subsequently
    sanctioned by the Cayman Islands court, all holders of ordinary shares of the company will be bound by the terms of the scheme of arrangement.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Companies Act provides that when an offer
is made for shares of any class or series of a Cayman Islands company and, within four months of the offer, the holders of not less than
90% of those such class or series accept the offer, the offeror may, for two months after that four-month period, require the remaining
shareholders of the relevant class or series to transfer their shares on the same terms as the original offer. In those circumstances,
non-tendering shareholders will be compelled to sell their shares, unless within one month from the date on which the notice to compulsorily
acquire was given to the non-tendering shareholder, the non-tendering shareholder is able to convince a Cayman Islands court to order
otherwise.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 101; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 25%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NRS/ CJJD&rsquo;s Articles of<BR>
Incorporation and Bylaws</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Companies Act/CJJD Cayman&rsquo;s Amended and Restated Memorandum and Articles of Association</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Authorization of a merger or consolidation requires:
(a) the passing of a special resolution by the shareholders of each constituent company, and (b) such other authorization, if any, as
may be specified in each such company&rsquo;s constitutive documents. In addition, the consent of each holder of a fixed or floating security
of a constituent company must be obtained, unless the court waives such requirement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under CJJD Cayman&rsquo;s amended and restated
articles of association and the Companies Act, there is no requirement for shareholder approval for a sale of all or substantially all
of CJJD Cayman&rsquo;s assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under CJJD Cayman&rsquo;s articles of association and the Companies
Act, there is no requirement for shareholder approval for a sale of all or substantially all of CJJD Cayman&rsquo;s assets.</P>
</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Special Vote Required for Combinations with Interested Shareholders</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The NRS provides generally that a Nevada corporation is prohibited from engaging in mergers, dispositions of 5% or more of the aggregate value of its assets or the disposition of assets representing 10% or more of the earning power or net income of the corporation, certain issuances of stock and other transactions (&ldquo;business combinations&rdquo;) with a person that owns 10% or more of the voting power of the outstanding voting shares of the corporation (an &ldquo;interested shareholder&rdquo;) for a period of three years after the interested stockholder first held 10% or more of the voting power of the outstanding shares. These restrictions on transactions involving an interested stockholder do not apply to (a) a combination approved by the board of directors before that person first became an interested stockholder, (b) a combination with an interested shareholder that resulted in that person becoming an interested stockholder that was approved by the board of directors before that person became an interested stockholder, or (c) a combination that was approved, no earlier than three years after the date that person first became an interested stockholder, by the affirmative vote of holders of at least a majority of the voting power (other than stock owned by the interested shareholder) at a meeting called for that purpose.</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There is no provision in the Companies Act or CJJD Cayman&rsquo;s amended and restated articles of association prohibiting business combinations with interested shareholders.</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>





<!-- Field: Page; Sequence: 102; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: white 1pt solid; padding: 3pt 0in 3pt 3pt; margin-right: 0in; margin-left: -4.5pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 25%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 35%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NRS / CJJD&rsquo;s Articles of <BR>
Incorporation and Bylaws</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 38%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Companies Act/CJJD Cayman&rsquo;s Amended and Restated Memorandum and Articles of Association</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dissenter Rights; Rights to Dissent; Compulsory Acquisition</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With respect to mergers and business combination transactions, under Nevada law, registered holders of shares of any class or series have the right, in certain circumstances, to dissent from a merger of the corporation by demanding payment in cash for the shares equal to the fair value (excluding any appreciation or depreciation as a consequence, or in expectation, of the transaction) of such shares, at a fair value determined by agreement between the dissenting stockholder(s) and the corporation, or if an agreement cannot be reached and an action is timely brought by the corporation, then the court may utilize the services of an appraiser to recommend a decision as to the fair value of such shares. Nevada law further provides that dissenters&rsquo; rights or appraisal rights are not available in a merger to holders of shares of any class or series listed on a U.S. based national securities exchange or held of record by more than 2,000 shareholders, unless the articles of incorporation of the corporation issuing the shares provide otherwise; or the holders of the class or series of stock are required under the plan of merger or exchange to accept for their shares anything except cash, owner&rsquo;s interests or owners interests and cash in lieu of fractional owner&rsquo;s interests of (a) the surviving or acquiring entity, (b) any other entity which at the effective date of the plan of merger or exchange were either listed on a national securities exchange or held of record by at least 2,000 shareholders or (c) some combination of the above. In addition, dissenters&rsquo; rights are not available to any holders of shares of the surviving domestic corporation if the plan of merger did not require the vote of the stockholders of the surviving corporation</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Companies Act and CJJD Cayman&rsquo;s articles
    of association do not specifically provide for appraisal rights. However, in connection with the compulsory transfer of shares to a 90%
    shareholder of a Cayman Islands company as described under &ldquo;Shareholder Approval of Business Combinations; Fundamental Changes,&rdquo;
    a minority shareholder may apply to the Cayman Islands court within one month of receiving notice of the compulsory transfer objecting
    to that transfer. In these circumstances, the burden is on the minority shareholder to show that the court should exercise its discretion
    to prevent the compulsory transfer. The court is unlikely to grant any relief in the absence of bad faith, fraud, unequal treatment of
    shareholders or collusion as between the offeror and the holders of the shares who have accepted the offer as a means of unfairly forcing
    out minority shareholders.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with a merger or a consolidation,
    dissenting shareholders have the right to be paid the fair value of their shares (which, if not agreed between the parties, will be determined
    by the Cayman Islands court) if they follow the required procedures set out in the Companies Act, subject to certain exceptions.</P></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shareholder Consent to Action Without Meeting</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under Nevada law and CJJD&rsquo;s bylaws, stockholders may take any action required or permitted to be taken at a stockholders&rsquo; meeting without a meeting if a written consent thereto is consented to in writing by stockholders holding at least a majority of the voting power; provided that if a different proportion of voting power is required under Nevada law for such an action at a meeting, then that proportion of written consents is required. </FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD Cayman&rsquo;s articles of association permits resolutions, including special resolutions, to be effected by an unanimous written resolution. A special resolution is a resolution that is either (a) passed by a majority of not less than two-thirds of shareholders as, being entitled to do so, vote in person or by proxy at a general meeting, or (b) signed by all the shareholders entitled to vote on that resolution. </FONT></TD>
    </TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></P></DIV>

<!-- Field: Page; Sequence: 103; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt; margin-right: 0in; margin-left: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="padding-bottom: 1.5pt; vertical-align: top; width: 25%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom; width: 35%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NRS / CJJD&rsquo;s Articles of<BR>
    Incorporation and Bylaws</B></P></TD>
    <TD STYLE="padding-bottom: 1.5pt; vertical-align: bottom; text-align: justify; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; text-align: center; width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Companies Act/CJJD Cayman&rsquo;s Amended and Restated Memorandum and Articles of Association</B></FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Distributions and Dividends; Repurchases and Redemptions</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under Nevada law, the Board of Directors, subject
    to any restrictions in the corporation&rsquo;s articles of incorporation, may declare and make distributions (including the payment of
    a dividend) generally out of: (1) operating surplus of the corporation, which is defined as net assets less statutory capital; or (2)
    if no operating surplus exists, out of the net profits of the corporation for the fiscal year in which the dividend is declared and/or
    the preceding fiscal year; subject to criteria set forth in the NRS; provided, however, the Board of Directors may not make distributions
    to its stockholders if, after giving it effect, the corporation would not be able to pay its debts as they become due in the usual course
    of business; or, except as set forth in the articles of incorporation, the corporation&rsquo;s total assets would be less than the sum
    of its total liabilities plus that amount needed if the corporation were dissolved at the time of distribution to satisfy the preferential
    rights upon dissolution of stockholders whose preferential rights are superior to those receiving the distribution.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under Nevada law, if provided in the articles
    of incorporation or in a Board resolution, a corporation may purchase, redeem and dispose of its own shares, except that it may not purchase
    or redeem these shares subject to restrictions on the declaration and making of distributions as set forth above. If a corporation redeems
    its stock, immediately following any such redemption, the corporation must have outstanding one or more series, or one or more classes,
    which shares together must have full voting power and together are entitled to receive the net assets of the corporation upon dissolution
    of the corporation.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">However, at any time, a corporation may purchase
    or redeem any of its shares that are redeemable pursuant to the articles of incorporation or by a Board resolution which are entitled
    upon any distribution of assets to a preference over another class of its stock if these shares will be retired upon acquisition or redemption,
    thereby reducing the capital stock of the corporation.</P></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Companies Act, the board of directors
    may declare the payment of dividends to holders of ordinary shares out of CJJD Cayman&rsquo;s (1) profits available for distribution,
    or (2) &ldquo;share premium account&rdquo;, which represents the excess of the price paid to CJJD Cayman&rsquo;s on the issue of its shares
    over the par or &ldquo;nominal&rdquo; value of those shares and is similar to the U.S. law concept of additional paid in capital.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">However, no dividends may be paid if, after payment,
    CJJD Cayman would not be able to pay its debts as they come due in the ordinary course of business.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dividends on ordinary shares, if any, are at the
    discretion of the directors and depend on, among other things, CJJD Cayman&rsquo;s results of operations, cash requirements and surplus,
    financial condition, contractual restrictions and other factors that the directors deems relevant, as well as CJJD Cayman&rsquo;s ability
    to pay dividends in compliance with the Cayman Islands law. Under the Cayman Islands law, CJJD Cayman is not required to present proposed
    dividends or distributions to its shareholders for approval or adoption. CJJD Cayman may pay dividends in any currency.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The directors are also entitled to issue shares
    with preferred rights to participate in dividends declared by CJJD Cayman. The holders of such preference shares may, depending on their
    terms, rank senior to the ordinary shares with respect to dividends.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the Companies Act, shares of a Cayman Islands
    company may be redeemed or repurchased out of profits of the company, out of the proceeds of a fresh issue of shares made for that purpose
    or out of capital, provided the company&rsquo;s articles authorize this and it has the ability to pay its debts as they come due in the
    ordinary course of business.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CJJD Cayman&rsquo;s articles of association provide
    that CJJD Cayman may make a payment in respect of the redemption or purchase of its own shares otherwise than out of profits or the proceeds
    of a fresh issue of shares.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD ROWSPAN="2" STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Removal of Directors; Terms of Directors</B></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nevada law provides that a director may be removed
    with or without cause by the holders of not less than two-thirds of the voting power of the shares entitled to vote at an election of
    directors, except that: (1) members of a classified Board of Directors may be removed by a vote of the holders of that class or series,
    unless the articles of incorporation provides otherwise; and (2) directors may not be removed in certain situations in the case of a corporation
    having cumulative voting except with the vote of stockholders owning sufficient shares to prevent the director&rsquo;s election to office
    at the time of removal.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CJJD does not have a classified board and does
    not have cumulative voting.</P></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under CJJD Cayman&rsquo;s articles of association,
    the directors of CJJD Cayman are not subject to a term of office and hold office until such time as they are removed from office by ordinary
    resolution of the shareholders or by a resolution of the board of directors.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the office of any director shall
    be vacated if the director (i) becomes bankrupt or makes any arrangement or composition with his creditors, (ii) dies or is found to be
    or becomes of unsound mind, (iii) resigns his office by notice in writing to CJJD Cayman, or (iv) the board of directors resolves that
    his office be vacated.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Directors may be elected by a resolution
of the board of directors, or by an ordinary resolution of the shareholders.</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></P></DIV>

<!-- Field: Page; Sequence: 104; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt; margin-right: 0in; margin-left: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></P>

</DIV>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD ROWSPAN="2" STYLE="vertical-align: top; width: 25%"></TD>
    <TD STYLE="vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 35%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 38%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
  <TR>
    <TD STYLE="padding-bottom: 1.5pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NRS / CJJD&rsquo;s Articles of</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Incorporation and Bylaws</B></P></TD>
    <TD STYLE="padding-bottom: 1.5pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Companies Act/CJJD Cayman&rsquo;s Amended and
    Restated Memorandum and</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Articles of Association</B></P></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Inspection of Books and Records</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nevada law allows any stockholder of record for
    at least six months preceding the demand to inspect, or any person holding, or authorized by those holding, at least 5% of all of the
    corporation&rsquo;s outstanding shares, upon five days written demand, may inspect and make copies during usual business hours, in person
    or by an agent or attorney, of the following: (1) the corporation&rsquo;s stock ledger, including a list of its stockholders and their
    stock holdings; (2) a copy of the corporation&rsquo;s articles of incorporation, and amendments thereto, certified by the Secretary of
    State of Nevada; and (3) a copy of the corporation&rsquo;s bylaws, and amendments thereto, certified by an officer of the corporation.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, Nevada law allows any stockholder
    of record who owns, or has been authorized by the holders of, at least 15% of the outstanding shares of the corporation, upon at least
    five days&rsquo; written demand, to inspect, during usual business hours, the books of account and all financial records of the corporation,
    to make copies of records, and to conduct an audit of such records.</P></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shareholders of a Cayman Islands exempted company
    do not have any general rights to inspect or obtain copies of the list of shareholders or corporate records of a company (other than the
    register of mortgages and charges and the memorandum and articles of association). Under CJJD Cayman&rsquo;s articles of association,
    the directors have the discretion as to whether, to what extent, when, where and under what conditions or regulations the accounts and
    books of the company or any of them shall be open to the inspection of members who are not directors.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Companies Act requires that the register of
    mortgages and charges of a corporation be open to inspection by any shareholder or creditor of the company at all reasonable times.</P></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NRS/ CJJD&rsquo;s Articles of <BR>
Incorporation and Bylaws</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Companies Act/CJJD Cayman&rsquo;s Amended and Restated Memorandum and Articles of Association</B></FONT></TD></TR>
  <TR>
    <TD ROWSPAN="2" STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amendment of Governing Documents</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under Nevada law, unless the articles of incorporation
    requires a greater vote, an amendment to the articles of incorporation requires: (1) the Board of Directors must adopt a resolution setting
    forth the amendment proposed and submit the resolution to the stockholders entitled to vote on the amendment at a special meeting or the
    next annual meeting; (2) the affirmative vote by stockholders having at least a majority of the voting power entitled to vote thereon,
    and (3) if the amendment would adversely affect the rights or change any preference of any class or series of outstanding shares, then
    in addition to the affirmative vote otherwise required, the affirmative vote of a majority of the voting power of each class that is adversely
    affected by the amendment entitled to vote thereon as a class.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under Nevada law, stockholders may adopt the bylaws
    and, in the absence of doing so or in the absence of reserving the right of doing so to the stockholders, the Board of Directors may adopt,
    amend or repeal any bylaw, including any bylaw adopted by the stockholders. The articles of incorporation may grant the authority to adopt,
    amend or repeal bylaws exclusively to the directors of the corporation. The bylaws of CJJD provide that the bylaws can be altered, amended
    or repealed by the Board of Directors.</P></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Companies Act and CJJD Cayman&rsquo;s articles of association provide that CJJD Cayman&rsquo;s memorandum of association and articles of association may only be amended by passing a special resolution of its shareholders to effect such amendment.</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top"></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 105; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border: white 1pt solid"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; width: 25%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NRS/ CJJD&rsquo;s Articles of <BR>
Incorporation and Bylaws</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Companies Act/CJJD Cayman&rsquo;s Amended and Restated Memorandum and Articles of Association</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Indemnification of Directors and Officers</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nevada law provides that a corporation may indemnify
    any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding,
    whether civil, criminal, administrative or investigative, except an action by or in the right of the corporation, by reason of the fact
    that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation
    as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses,
    including attorneys&rsquo; fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection
    with the action, suit or proceeding if the person: (a) is not liable pursuant to NRS 78.138; or (b) acted in good faith and in a manner
    which he or she reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal
    action or proceeding, had no reasonable cause to believe the conduct was unlawful.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CJJD&rsquo;s articles of incorporation and bylaws
    provide generally that CJJD shall indemnify, to the fullest extent authorized by the NRS, each director and officer, as well as persons
    serving at the request of our company as a director, officer, employee or agent of another corporation or of a partnership, joint venture,
    trust or other enterprise, against all expenses, including attorneys&rsquo; fees, judgments, fines and amounts paid in settlement actually
    and reasonably incurred by that person.</P></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cayman Islands law does not limit the extent to
    which a company&rsquo;s articles of association may provide for indemnification of officers and directors, except to the extent any such
    provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud
    or the consequences of committing a crime.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CJJD Cayman&rsquo;s articles of association provide
    that its directors and officers shall be indemnified against all actions, proceedings, costs, charges, expenses, losses, damages and liabilities
    incurred or sustained by such director or officer, other than by reason of such person&rsquo;s own dishonesty, willful default or fraud,
    in or about the conduct of CJJD Cayman&rsquo;s business or affairs or in the execution or discharge of his duties, powers, authorities
    or discretions, including without prejudice to the generality of the foregoing, any costs, expenses, losses or liabilities incurred by
    such director or officer in defending (whether successfully or otherwise) any civil proceedings concerning CJJD Cayman or its affairs
    in any court whether in the Cayman Islands or elsewhere.</P></TD></TR>
  <TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR>
    <TD STYLE="padding-bottom: 1.5pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NRS / CJJD&rsquo;s Articles of</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Incorporation and Bylaws</B></P></TD>
    <TD STYLE="padding-bottom: 1.5pt; vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Companies Act/CJJD Cayman&rsquo;s Amended and Restated Memorandum and Articles of Association</B></FONT></TD></TR>
  <TR>
    <TD ROWSPAN="2" STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Limited Liability of Directors</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as specifically provided in the NRS, or if the articles of incorporation or an amendment thereto provide for greater individual liability, a director or officer is not individually liable to the corporation or its stockholders for any damages as a result of any act or failure to act in his capacity as a director or officer unless it is proven that: (1) the director&rsquo;s or officer&rsquo;s act or failure to act constituted a breach of his or her fiduciary duties as a director or officer; and (2) the breach of those duties involved intentional misconduct, fraud or a knowing violation of law.</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cayman Islands law, in certain circumstances,
    permits a company to limit the liability of a director to the company. The considerations under Cayman Islands law with regard to the
    limitation of a director&rsquo;s liability are similar to those that apply to the enforcement of provisions relating to the indemnification
    of directors discussed above under &ldquo;Indemnification of Directors and Officers.&rdquo; A Cayman Islands court will enforce such a
    limitation except to the extent that enforcement of the relevant provision may be held to be contrary to public policy.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CJJD Cayman&rsquo;s articles of association provide that no current or former director and officer of the company shall be liable to the company for any loss or damage incurred by the company as a result (whether direct or indirect) of the carrying out of their functions unless that liability arises through such person&rsquo;s own dishonesty, willful default or fraud. </FONT></TD></TR>
  </TABLE>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 106; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>


<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NRS
    / CJJD&rsquo;s Articles of <BR>
    Incorporation and Bylaws</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Companies Act/CJJD Cayman&rsquo;s
    Amended and Restated Memorandum and Articles of Association</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shareholder Lawsuits</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: justify; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under Nevada law, a stockholder may bring a derivative action on behalf of CJJD to enforce the rights of CJJD. An individual also may commence a lawsuit separately or bring a class action suit on behalf of such individual and other similarly situated stockholders where the requirements for maintaining a class action under Nevada law have been met. A person may generally institute and maintain such suits only if such person was a stockholder at the time of the transaction which is the subject of the derivative suit or became a stockholder by operation of law from one who was a shareholder at the time of the transaction. Nevada law also requires that the derivative plaintiff must make a demand on the Board of Directors to assert the claim or take suitable actions, and the demand to be refused by the board, before the suit may be prosecuted by the derivative plaintiff, unless such demand would be futile (and if futile, the derivative plaintiff must make clear the reasons why such demand would be futile).</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 38%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the Cayman Islands, the decision to institute
    proceedings on behalf of a company is generally taken by the company&rsquo;s board of directors. In certain limited circumstances, a shareholder
    may be entitled to bring a derivative action on behalf of CJJD Cayman. However, the consideration of such suits has been limited. In this
    regard, the Cayman Islands courts ordinarily would permit a claim to be brought by a minority shareholder, in respect of a cause of action
    vested in a Cayman Islands company, in the name of and seeking relief on behalf of the company only (1) in respect of a cause of action
    arising from an actual or proposed act or omission involving negligence, default, breach of duty or breach of trust by a director of a
    company; (2) where the act complained of is illegal or alleged to constitute a fraud against the company or against any minority shareholder;
    or (3) where the act is beyond the corporate power of the company or otherwise requires approval by a greater percentage of the company&rsquo;s
    shareholders than actually approved it; and, in each case, where the act complained of is not capable of subsequent ratification by any
    majority of the company&rsquo;s shareholders at a general meeting. The cause of action may be against the director, another person or
    both.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A shareholder may also be permitted to bring
an action in his or her own name against a Cayman Islands company, a director or any other person in respect of any direct loss suffered
by such shareholder as a result of any negligence, default, breach of duty or breach of trust. In any such action, however, a loss suffered
by the company will not be regarded as a direct loss suffered by the individual shareholder. A shareholder may also be permitted to bring
an action on the basis that the company&rsquo;s affairs are being, or have been, conducted in a manner that is unfairly prejudicial to
the interests of shareholders generally or to some shareholders in particular.</P></TD></TR>
  </TABLE>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>


<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 107; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="main_017"></A>ENFORCEABILITY OF CIVIL
LIABILITIES </B></P>



<P STYLE="text-indent: 20pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 20pt; margin: 0pt 0; text-align: justify">CJJD Cayman is an exempted company incorporated
in the Cayman Islands because of certain benefits associated with being a Cayman Islands exempted company, such as political and economic
stability, an effective judicial system, a favorable tax system, the absence of foreign exchange control or currency restrictions and
the availability of professional and support services. However, the Cayman Islands has a less developed body of securities laws as compared
to the United States and provides less protection for investors. In addition, Cayman Islands companies do not have standing to sue before
the federal courts of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt; text-align: justify">Substantially all of CJJD Cayman&rsquo;s assets
are located outside the United States. In addition, a majority of CJJD Cayman&rsquo;s directors and officers are nationals or residents
of jurisdictions other than the United States and all or a substantial portion of their assets are located outside the United States.
As a result, it may be difficult for investors to effect service of process within the United States upon CJJD Cayman or these persons,
or to bring an action against CJJD Cayman or against these persons in the United States, in the event that you believe that your rights
have been infringed under the securities laws of the United States or any state in the United States. It may also be difficult for you
to enforce in U.S. courts judgments obtained in U.S. courts based on the civil liability provisions of the U.S. federal securities laws
against CJJD Cayman and its officers and directors. CJJD Cayman has appointed _______________ as its agent to receive service of process
in the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt; text-align: justify">Conyers Dill &amp; Pearman, our counsel as to
Cayman Islands law, has advised us that there is uncertainty as to whether the courts of the Cayman Islands would (1) recognize or enforce
judgments of U.S. courts obtained against CJJD Cayman or its directors or officers, predicated upon the civil liability provisions of
the securities laws of the United States or any state in the United States, or (2) entertain original actions brought in the Cayman Islands
against CJJD Cayman or its directors or officers, predicated upon the securities laws of the United States or any state in the United
States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt; text-align: justify">Conyers Dill &amp; Pearman has informed us that
although there is no statutory enforcement in the Cayman Islands of judgments obtained in the federal or state courts of the United States
(and the Cayman Islands are not a party to any treaties for the reciprocal enforcement or recognition of such judgments), a judgment obtained
in such jurisdiction will be recognized and enforced in the courts of the Cayman Islands at common law, without any re-examination of
the merits of the underlying dispute, by an action commenced on the foreign judgment debt in the Grand Court of the Cayman Islands, provided
such judgment (a) is given by a foreign court of competent jurisdiction, (b) imposes on the judgment debtor a liability to pay a liquidated
sum for which the judgment has been given, (c) is final, (d) is not in respect of taxes, a fine or a penalty, (e) is not inconsistent
with a Cayman Islands judgement of the same matter, (f) is not impeachable on grounds of fraud, and (g) was not obtained in a manner and
is not of a kind the enforcement of which is contrary to natural justice or the public policy of the Cayman Islands. However, the Cayman
Islands courts are unlikely to enforce a judgment obtained from the U.S. courts under civil liability provisions of the U.S. federal securities
law if such judgment is determined by the courts of the Cayman Islands to give rise to obligations to make payments that are penal or
punitive in nature. Because such a determination has not yet been made by a court of the Cayman Islands, it is uncertain whether such
civil liability judgments from U.S. courts would be enforceable in the Cayman Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt; text-align: justify">It is our understanding that the PRC does not
have treaties with the United States and many other countries providing for the reciprocal recognition and enforcement of judgments of
courts and that there is uncertainty as to whether the courts of the PRC would recognize or enforce judgments of United States courts
against CJJD Cayman or the directors or officers of CJJD Cayman predicated upon the civil liability provisions of the securities laws
of the United States or any state in the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt; text-align: justify">Additionally, it is our understanding that it
may be difficult for you to bring an original action against us or against our directors and officers who are nationals or residents of
countries other than the United States in a PRC court in the event that you believe that your rights have been infringed under the U.S.
federal securities laws, PRC laws, Cayman Islands laws or otherwise because we are incorporated under the laws of the Cayman Islands and
it may be difficult for U.S. shareholders, by virtue only of holding our ordinary shares, to establish a connection to the PRC as required
by the PRC Civil Procedures Law in order for a PRC court to have jurisdiction.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border: white 1pt solid"><B>&nbsp;</B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="main_018"></A>LEGAL MATTERS</B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt; text-align: justify">The validity of the ordinary
shares of CJJD Cayman being offered hereby will be passed upon by Conyers Dill &amp; Pearman, our counsel as to the Cayman Islands laws.
Certain legal matters in connection with the Redomicile Merger and as to U.S. federal law have been passed upon for the Company by Pryor
Cashman LLP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; border: white 1pt solid">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border: white 1pt solid"><B><A NAME="main_019"></A>EXPERTS </B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt; text-align: justify">The consolidated financial statements of China
Jo-Jo Drugstores, Inc. as of March 31, 2020 and 2019, and for each of the years in the two-year period ended March 31, 2020, have been
included herein in reliance on the report of BDO China Shu Lun Pan Certified Public Accountants LLP, an independent registered public
accounting firm, and upon the authority of said firm as experts in accounting and auditing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 108; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: white 1pt solid; padding: 0pt 0in 0pt 0pt; margin-right: 0in; margin-left: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="main_020"></A>WHERE YOU CAN FIND MORE INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt; text-align: justify">The Company is subject to the informational requirements
of the Securities Exchange Act of 1934, as amended (&ldquo;Exchange Act&rdquo;). In accordance with the Exchange Act, we file periodic
reports, proxy statements and information statements and other information with the Securities and Exchange Commission (&ldquo;SEC&rdquo;).
You may read and copy any reports or other information that we file or furnish with the SEC at the SEC&rsquo;s Public Reference Room located
at Station Place, 100 F Street, N.E., Washington, D.C. 20549. You may also receive copies of these documents upon payment of a duplicating
fee, by writing to the SEC&rsquo;s Public Reference Room. Please call the SEC at 1-800-SEC-0330 for further information on the operation
of the Public Reference Room in Washington, D.C. and other locations. Our SEC filings are also available via the SEC&rsquo;s website (<I>www.sec.gov</I>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt; text-align: justify">The Company has filed with the SEC a registration
statement on Form F-4 under the Securities Act to register the CJJD Cayman ordinary shares to be issued in connection with the Redomicile
Merger. This proxy statement/prospectus is a part of that registration statement and constitutes a prospectus of CJJD Cayman in addition
to being a consent solicitation of the Company shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt; text-align: justify">You should rely only on the information contained
in this proxy statement/prospectus for your consent of the shareholders of the Company. Neither the Company nor CJJD Cayman has authorized
anyone to provide you with information that differs from that contained in this proxy statement/prospectus. This proxy statement/prospectus
is dated _______, 2021. You should not assume that the information contained in this proxy statement/prospectus is accurate as of any
date other than that date, and neither the mailing of this proxy statement/prospectus to shareholders nor the issuance of shares of CJJD
Cayman ordinary shares in the Redomicile Merger shall create any implication to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt; text-align: justify">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border: white 1pt solid"><B>Information on Website</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt; text-align: justify">Information on the Company&rsquo;s
website is not part of this proxy statement/prospectus and you should not rely on that information in deciding whether to approve of the
proposal described in this proxy statement/prospectus unless that information is also in this proxy statement/prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border: white 1pt solid"><B><A NAME="main_021"></A>OTHER MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 20pt; text-align: justify">As of the date of this proxy statement/prospectus,
the Board has no knowledge of any business which will be presented for consideration at the Special Meeting other than the adoption of
the Merger Agreement. Should any other matters be properly presented, it is intended that the enclosed proxy card will be voted in accordance
with the best judgment of the persons voting the proxies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 60%; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="width: 40%; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______, 2021</FONT></TD>
    <TD STYLE="vertical-align: top; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By Order of the Board of Directors</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 0pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
Lei Liu<BR>
Chief Executive Officer</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 0pt"><P STYLE="margin-top: 0; margin-bottom: 0"></P></TD>
    <TD STYLE="vertical-align: top; padding-left: 0pt"></TD>
    </TR>
  </TABLE>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 109; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INDEX TO FINANCIAL STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0pt; width: 90%; padding-left: 0.125in; text-indent: -0.125in"><A HREF="#fin_001"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Report of Independent Registered Public Accounting Firm</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; width: 10%; padding-left: 0pt; text-align: center; text-indent: 0pt">F-2</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 0pt; padding-left: 0.125in; text-indent: -0.125in"><A HREF="#b_002"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Balance Sheets as of March 31, 2020 and 2019</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center; text-indent: 0pt">F-3</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0pt; padding-left: 0.125in; text-indent: -0.125in"><A HREF="#b_003"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Statements of Operations for the Years Ended March 31, 2020 and 2019</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center; text-indent: 0pt">F-4</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 0pt; padding-left: 0.125in; text-indent: -0.125in"><A HREF="#b_004"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Statements of Changes in Stockholders&rsquo; Equity for the Years Ended March 31, 2020 and 2019</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center; text-indent: 0pt">F-5</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0pt; padding-left: 0.125in; text-indent: -0.125in"><A HREF="#b_005"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Statements of Cash Flows for the Years Ended March 31, 2020 and 2019</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center; text-indent: 0pt">F-6</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 0pt; padding-left: 0.125in; text-indent: -0.125in"><A HREF="#b_006"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Notes to Financial Statements</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center; text-indent: 0pt">F-7</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0pt; padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center; text-indent: 0pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 0pt; padding-left: 0.125in; text-indent: -0.125in"><A HREF="#a_003"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Unaudited condensed consolidated balance sheets as of September 30, 2020 and March 31, 2020</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center; text-indent: 0pt">F-35</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0pt; padding-left: 0.125in; text-indent: -0.125in"><A HREF="#a_004"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Unaudited condensed consolidated statements of operations and comprehensive income (loss) for the three and six months ended September 30, 2020</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center; text-indent: 0pt">F-36</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 0pt; padding-left: 0.125in; text-indent: -0.125in"><A HREF="#a_005"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Unaudited condensed consolidated statements of changes in stockholders&rsquo; equity for the three and six months ended September 30, 2020 and 2019</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center; text-indent: 0pt">F-37</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 0pt; padding-left: 0.125in; text-indent: -0.125in"><A HREF="#a_006"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Unaudited condensed consolidated statements of cash flows for the six months ended September 30, 2020 and 2019</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center; text-indent: 0pt">F-38</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-right: 0pt; padding-left: 0.125in; text-indent: -0.125in"><A HREF="#a_007"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Notes to unaudited condensed consolidated financial statements</FONT></A></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 0pt; padding-left: 0pt; text-align: center; text-indent: 0pt">F-39</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 110; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U><A NAME="fin_001"></A>REPORT OF INDEPENDENT REGISTERED ACCOUNTING
FIRM</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">China Jo-Jo Drugstores, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Carson City, Nevada</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Opinion on the Consolidated Financial
Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have audited the accompanying
consolidated balance sheets of China Jo-Jo Drugstores, Inc. (the &ldquo;Company&rdquo;) as of March 31, 2020 and 2019, the
related consolidated statements of operations and comprehensive loss, stockholders&rsquo; equity, and cash flows for the
years then ended, and the related notes (collectively referred to as the &ldquo;consolidated financial
statements&rdquo;). In our opinion, the consolidated financial statements present fairly, in all
material respects, the financial position of the Company at March 31, 2020 and 2019, and the results of its operations and
its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States
of America.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Change in Accounting Principle</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As discussed in Note 3 to the consolidated
financial statements, effective April 1, 2019, the Company has changed its method of accounting for leases due to the adoption
of ASC 842, Leases.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Basis for Opinion</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These consolidated financial statements
are the responsibility of the Company&rsquo;s management. Our responsibility is to express an opinion on the Company&rsquo;s consolidated
financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight
Board (United States) (&ldquo;PCAOB&rdquo;) and are required to be independent with respect to the Company in accordance with the
U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We conducted our audits in accordance with
the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether
the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required
to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are
required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company&rsquo;s internal control over financial reporting. Accordingly, we express no such opinion.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our audits included performing procedures
to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing
procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and
disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe
that our audits provide a reasonable basis for our opinion.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ BDO China Shu Lun Pan Certified Accountants LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have served as the Company&rsquo;s auditor since year 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shanghai, People&rsquo;s Republic of China</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">July 10, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 111; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PART
I - FINANCIAL INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 11%; text-align: justify; font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
    1.</B></FONT></TD>
    <TD STYLE="width: 89%; text-align: justify; font-size: 11pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FINANCIAL
    STATEMENTS</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="b_002"></A>CHINA
JO-JO DRUGSTORES, INC. AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED
BALANCE SHEETS</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&nbsp;31,</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March&nbsp;31,</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ASSETS</U></FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT ASSETS</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    and cash equivalents</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,176,318</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,322,463</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted
    cash</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,806,288</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,422,739</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    assets available for sale</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">157,159</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">180,928</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
    receivable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,005</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">177,278</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
    accounts receivable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,770,656</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,692,514</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,247,004</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,955,202</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    receivables, net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,069,442</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,438,230</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advances
    to suppliers</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,174,800</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,950,252</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    current assets</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,528,540</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,063,375</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    current assets</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,987,212</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56,202,981</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROPERTY
    AND EQUIPMENT, net</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,633,740</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,727,358</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER ASSETS</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
    investment</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,544,451</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,243</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Farmland
    assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">742,347</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">825,259</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long
    term deposits</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,456,384</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,157,275</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    noncurrent assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,046,763</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,196,197</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    lease right-of-use assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,711,376</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
    assets, net</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,393,960</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,597,323</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    other assets</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,895,281</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,800,297</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt; padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    assets</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99,516,233</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">72,730,636</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-decoration: underline; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LIABILITIES
    AND STOCKHOLDERS&rsquo; EQUITY</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT LIABILITIES</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term
    bank loan</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,410,130</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    payable, trade</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,559,494</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,106,230</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
    payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,605,971</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,951,673</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    payables</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,522,330</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,197,221</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    payables - related parties</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">490,218</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">795,179</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
    deposits</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">708,140</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">771,942</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxes
    payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">119,247</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">125,859</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    liabilities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">753,612</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,264,182</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
    loan payable-current portion</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,287,742</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    portion of operating lease liabilities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">981,090</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    current liabilities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,437,974</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,212,286</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term loan payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,115,958</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long term operating
    lease&nbsp;&nbsp;liabilities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,049,575</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Employee Deposits</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,507</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">81,935</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase
    option and warrants liability</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64,090</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">465,248</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    liabilities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">80,738,104</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,759,469</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMMITMENTS AND
    CONTINGENCIES</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">STOCKHOLDERS&rsquo;
    EQUITY</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    stock; $0.001 par value; 250,000,000 shares authorized; 32,936,786 and 28,936,778 shares issued and outstanding as of March&nbsp;31,
    2020 and March 31, 2019</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,937</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,937</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -10pt; padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
    stock; $0.001 par value; 10,000,000 shares authorized; nil issued and outstanding as of March&nbsp;31, 2020 and March 31,
    2019</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
    paid-in capital</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,209,301</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,905,664</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statutory
    reserves</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,309,109</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,309,109</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    deficit</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(36,400,837</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(30,587,468</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated
    other comprehensive income</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,440,424</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,508,964</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    stockholders&rsquo; equity</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,590,934</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,165,206</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noncontrolling
    interests</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,812,805</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,194,039</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    equity</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,778,129</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,971,167</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt; padding-left: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    liabilities and stockholders&rsquo; equity</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99,516,233</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">72,730,636</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></P>


<!-- Field: Page; Sequence: 112; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="b_003"></A>CHINA
JO-JO DRUGSTORES, INC. AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED
STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-family: Arial, Helvetica, Sans-Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended<BR> March 31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REVENUES,
    NET</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">117,327,689</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107,551,012</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COST
    OF GOODS SOLD</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">91,801,259</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">82,442,969</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GROSS
    PROFIT</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,526,430</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,108,043</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SELLING EXPENSES</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,793,603</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,265,184</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GENERAL AND ADMINISTRATIVE
    EXPENSES</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">8,108,377</P></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,718,989</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IMPAIRMENT
    OF LONG-LIVED ASSETS</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">628,192</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL
    OPERATING EXPENSES</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">32,530,172</P></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,984,173</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOSS FROM OPERATIONS</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">(7,003,742</P></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(876,130</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">OTHER INCOME (EXPENSE):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INTEREST INCOME</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,063,747</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">112,887</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">INTEREST EXPENSE</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(698,518</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">(204,064</P></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(93,311</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CHANGE
    IN FAIR VALUE OF PURCHASE OPTION AND WARRANTS LIABILITY</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">401,158</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(326,452</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOSS BEFORE INCOME
    TAXES</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,441,419</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,183,006</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROVISION
    FOR INCOME TAXES</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,258</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">134,763</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NET LOSS</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,457,677</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,317,769</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADD: NET LOSS ATTRIBUTABLE
    TO NONCONTROLLING INTEREST</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(644,308</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(391,491</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NET LOSS ATTRIBUTABLE
    TO CHINA JO-JO DRUGSTORES, INC.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,813,369</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(926,278</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER COMPREHENSIVE
    LOSS</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOREIGN
    CURRENCY TRANSLATION ADJUSTMENTS</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,068,540</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,077,496</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COMPREHENSIVE LOSS</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,526,217</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,395,265</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WEIGHTED AVERAGE
    NUMBER OF SHARES:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 4pt; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,816,567</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,936,778</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,816,567</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,936,778</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LOSS PER SHARES:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 4pt; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.18</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.03</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.18</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.03</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</FONT></P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></P>


<!-- Field: Page; Sequence: 113; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="b_004"></A>CHINA
JO-JO DRUGSTORES, INC. AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED
STATEMENTS OF CHANGES IN EQUITY</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Additional</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Retained
    Earnings</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">other</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center">p<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">aid-in</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statutory</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT>Accumulated</TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">comprehensive</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">controlling</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">capital</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reserves</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid">deficit</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">income/(loss)</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">interest</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 20%; padding-bottom: 4pt; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BALANCE,
    March&nbsp;31, 2018.</FONT></TD><TD STYLE="width: 1%; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,936,778</FONT></TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 7%; border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,937</FONT></TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43,599,089</FONT></TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,309,109</FONT></TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(29,661,190</FONT></TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="width: 1%; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,586,460</FONT></TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 7%; border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 7%; border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,862,405</FONT></TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    based compensation</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">197,100</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">197,100</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    in capital of Jiuzhou Pharmacy</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,529</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,529</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Start-up
    of&nbsp;Linjia Medical</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">223,629</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">223,629</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale
    of 10% of Jiuxin Medicine</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,101,946</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,027,082</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,864</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(926,278</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(391,491</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,317,769</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
    currency translation loss</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,077,496</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">905</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,076,591</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BALANCE,
    March&nbsp;31, 2019.</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,936,778</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,937</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44,905,664</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,309,109</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(30,587,468</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,508,964</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,194,039</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,971,167</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    based compensation</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,560</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right">34,560</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sale of stock and warrants</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,000,008</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right">4,000</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,269,077</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right">9,273,077</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    loss</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,813,369</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(644,308</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,457,677</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign
    currency translation loss</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,068,540</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,542</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,042,998</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt; text-indent: -10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BALANCE,
    March&nbsp;31, 2020.</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,936,786</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,937</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54,209,301</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,309,109</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(36,400,837</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,440,424</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,812,805</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,778,129</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></P>


<!-- Field: Page; Sequence: 114; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="b_005"></A>CHINA
JO-JO DRUGSTORES, INC. AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED
STATEMENTS OF CASH FLOWS</FONT></P>

<P STYLE="font: 7pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
    the years ended<BR> March 31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CASH FLOWS FROM
    OPERATING ACTIVITIES:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    income</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,457,677</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,317,769</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjustments to
    reconcile net income to net cash used in operating activities:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bad
    debt direct write-off and provision</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">446,354</P></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,357,851</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
    and amortization</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,082,817</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,676,413</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impairment
    of long lived assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">628,192</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    based compensation</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,560</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">197,100</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in fair value of purchase option derivative liability</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(401,158</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">326,452</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in operating assets:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    receivable, trade</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">(1,567,774</P></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(116,810</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
    receivable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">112,803</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">83,910</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories
    and biological assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">979,935</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,390,823</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    receivables</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,010,722</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,308,437</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advances
    to suppliers</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">148,638</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,612,453</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long
    term deposit</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">596,209</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">183,841</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    current assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,278,833</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(83,372</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    noncurrent assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">87,065</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(23,511</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change
    in operating liabilities:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    payable, trade</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(317,755</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(528,353</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    payables and accrued liabilities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(967,751</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(328,473</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer
    deposits</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(22,963</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,011,194</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxes
    payable</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">115</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(216,792</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash used in operating activities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,907,945</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,603,216</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CASH FLOWS FROM
    INVESTING ACTIVITIES:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disposal
    of financial&nbsp;assets&nbsp;available&nbsp;for&nbsp;sale</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,356</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">87,290</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase
    of financial&nbsp;assets&nbsp;available&nbsp;for&nbsp;sale</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(104,360</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisition
    of equipment&nbsp;and building</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(656,297</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5,450,934</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
    in a joint venture</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,567,083</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    intangible assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(871,145</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(29,817</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions
    to leasehold improvements</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(756,444</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,828,360</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash used in investing activities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,836,613</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,326,181</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CASH FLOWS FROM
    FINANCING ACTIVITIES:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
    from short-term bank loan</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,435,620</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
    from third parties loan</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,178,100</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayment
    of&nbsp;&nbsp;third parties loan</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(658,645</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
    from notes payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,974,772</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,030,521</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayment
    of notes payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(46,896,917</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(34,018,811</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase
    in financial liability</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,178</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">81,997</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
    from sale of stock and warrants</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,273,077</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,529</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayment
    of other payables-related parties</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(285,123</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(22,655</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash provided by financing activities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,013,706</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,078,581</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EFFECT
    OF EXCHANGE RATE ON CASH</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,031,744</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,856,174</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">IN<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CREASE (DECREASE)
IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,237,404</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,706,989</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CASH
    AND CASH EQUIVALENTS AND RESTRICTED CASH, beginning of year</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,745,202</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,452,191</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CASH
    AND CASH EQUIVALENTS AND RESTRICTED CASH, end of year</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,982,606</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,745,202</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SUPPLEMENTAL DISCLOSURE
    OF CASH FLOW INFORMATION:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    paid for income taxes</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,198</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56,422</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 4pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    paid for interest</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">108,098</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 7pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 7pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</FONT></P>

<P STYLE="font: 7pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></P>


<!-- Field: Page; Sequence: 115; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="b_006"></A>Note
1 &ndash; DESCRIPTION OF BUSINESS AND ORGANIZATION</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">China
Jo-Jo Drugstores, Inc. (&ldquo;Jo-Jo Drugstores&rdquo; or the &ldquo;Company&rdquo;), was incorporated in Nevada on December 19,
2006, originally under the name &ldquo;Kerrisdale Mining Corporation&rdquo;. On September 24, 2009, the Company changed its name
to &ldquo;China Jo-Jo Drugstores, Inc.&rdquo; in connection with a share exchange transaction as described below.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 17, 2009, the Company completed a share exchange transaction with Renovation Investment (Hong Kong) Co., Ltd. (&ldquo;Renovation&rdquo;),
whereby 7,900,000 shares of common stock were issued to the stockholders of Renovation in exchange for 100% of the capital stock
of Renovation. The completion of the share exchange transaction resulted in a change of control. The share exchange transaction
was accounted for as a reverse acquisition and recapitalization and, as a result, the consolidated financial statements of the
Company (the legal acquirer) are, in substance, those of Renovation (the accounting acquirer), with the assets and liabilities,
and revenues and expenses, of the Company being included effective from the date of the share exchange transaction. Renovation
has no substantive operations of its own except for its holdings of Zhejiang Jiuxin Investment Management Co., Ltd. (&ldquo;Jiuxin
Management&rdquo;), Zhejiang Shouantang Medical Technology Co., Ltd. (&ldquo;Shouantang Technology&rdquo;) and Hangzhou Jiutong
Medical Technology Co., Ltd (&ldquo;Jiutong Medical&rdquo;), Hangzhou Jiuyi Medical Technology Co. Ltd. (&ldquo;Jiuyi Technology&rdquo;),
its wholly-owned subsidiaries.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products in the People&rsquo;s
Republic of China (&ldquo;China&rdquo; or the &ldquo;PRC&rdquo;). The Company&rsquo;s offline retail business is comprised primarily
of pharmacies, which are operated by Hangzhou Jiuzhou Grand Pharmacy Chain Co., Ltd. (&ldquo;Jiuzhou Pharmacy&rdquo;), a company
that the Company controls through contractual arrangements. On March 31, 2017, Jiuxin Management established a subsidiary, Lin&rsquo;An
Jiuzhou Pharmacy Co., Ltd (&ldquo;Lin&rsquo;An Jiuzhou&rdquo;) to operates drugstores in Lin&rsquo;an City.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended March 31, 2020, the Company dissolved eight independent pharmacies. Among the eight dissolved pharmacies, two stores
have merged into Jiuzhou Pharmacy and became Jiuzhou Pharmacy stores in Hangzhou. The other six stores&rsquo; licenses of government
medical insurance, which qualify the stores for government reimbursement, were transferred to six Jiuzhou Pharmacy stores in Hangzhou
City.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 9, 2020, in order to continue expanding and strengthening its local drugstore network, the Company acquired a local drugstores
chain with ten stores at a price of $0.14 (RMB 1). The acquired chain agreed to cease their stores&rsquo; business and liquidate
all of the stores &lsquo;accounts after Jiuzhou Pharmacy acquired them. In March 2020, the chain was dissolved and its government
insurance reimbursement certificates have been transferred to Jiuzhou Pharmacy.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s offline retail business also includes four medical clinics through Hangzhou Jiuzhou Clinic of Integrated Traditional
and Western Medicine (&ldquo;Jiuzhou Clinic&rdquo;) and Hangzhou Jiuzhou Medical and Public Health Service Co., Ltd. (&ldquo;Jiuzhou
Service&rdquo;), both of which are also controlled by the Company through contractual arrangements. In May 2014, Shouantang Technology
established Hangzhou Shouantang Bio-technology Co., Ltd. (&ldquo;Shouantang Bio&rdquo;). In May 2016, Shouantang Bio set up and
held 49% of Hangzhou Kahamadi Bio-technology Co., Ltd. (&ldquo;Kahamadi Bio&rdquo;), a joint venture specializing in brand name
development for nutritional supplements. In 2018, Jiuzhou Pharmacy invested a total of $741,540 (RMB5,100,000) in and held 51%
of Zhejiang Jiuzhou Linjia Medical Investment and Management Co. Ltd (&ldquo;Linjia Medical&rdquo;), which operates two new clinics
in Hangzhou as of March 31, 2020. On March 29, 2019, Jiuzhou Pharmacy formed and currently holds 51% of the equity of Zhejiang
AyiGe Medical Health Management Co., Ltd. (&ldquo;Ayi Health&rdquo;), which is intended to provide technical support such as IT
and customer support to our health management business in the future.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently conducts its online retail pharmacy business through Jiuzhou Pharmacy, which holds the Company&rsquo;s online
pharmacy license. On September 10, 2015, Renovation set up Jiuyi Technology to provide additional technical support such as webpage
development to our online pharmacy business. In November 2015, the technical support function was transferred back to Jiuzhou
Pharmacy, which hosts our online pharmacy.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s wholesale business is primarily conducted through Zhejiang Jiuxin Medicine Co., Ltd. (&ldquo;Jiuxin Medicine&rdquo;),
which is licensed to distribute prescription and non-prescription pharmaceutical products throughout China. Jiuzhou Pharmacy acquired
Jiuxin Medicine on August 25, 2011. On April 20, 2018, 10% of Jiuxin Medicine shares were sold to Hangzhou Kangzhou Biotech Co.
Ltd. for a total proceeds of $79,625 (RMB 507,760).</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></P>


<!-- Field: Page; Sequence: 116; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s herb farming business is conducted by Hangzhou Qianhong Agriculture Development Co., Ltd. (&ldquo;Qianhong Agriculture&rdquo;),
a wholly-owned subsidiary of Jiuxin Management. Due to the complexity of the cultivation business, Qianhong Agriculture has not
grown herbs in fiscal 2020.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements reflect the activities of the Company and each of the following entities:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entity
    Name</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 46%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Background</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Renovation&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
    &nbsp;&nbsp;Incorporated in Hong Kong SAR on September 2, 2008</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiuxin&nbsp;Management</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Established in the PRC on October 14, 2008</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Deemed a wholly foreign owned enterprise (&ldquo;WFOE&rdquo;) under PRC law &nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Registered capital of $14.5 million fully paid</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shouantang Technology</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Established in the PRC on July 16, 2010 by Renovation with registered capital of $20 million</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Registered capital requirement reduced by the SAIC to $11 million in July 2012 and is fully paid &nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Deemed a WFOE under PRC law</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Invests and finances the working capital of Quannuo Technology</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianhong Agriculture&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Established in the PRC on August 10, 2010 by Jiuxin&nbsp;Management</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Registered capital of RMB 10 million fully paid &nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Carries out herb farming business</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiuzhou&nbsp;Pharmacy (1)&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Established in the PRC on September 9, 2003</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Registered capital of RMB 5 million fully paid &nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Operates the &ldquo;Jiuzhou Grand Pharmacy&rdquo; stores in Hangzhou</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIE&nbsp;by&nbsp;contractual&nbsp;arrangements
    (2)</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiuzhou&nbsp;Clinic (1)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Established in the PRC as a general partnership on&nbsp;October 10, 2003</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Operates a medical clinic adjacent to one of Jiuzhou&nbsp;Pharmacy&rsquo;s &nbsp;stores</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIE&nbsp;by&nbsp;contractual arrangements (2)</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiuzhou&nbsp;Service (1)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Established in the PRC on November 2, 2005 &nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Registered capital of RMB 500,000 fully paid</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Operates a medical clinic adjacent to one of Jiuzhou&nbsp;Pharmacy&rsquo;s stores</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIE&nbsp;by&nbsp;contractual
        arrangements (2)</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiuxin Medicine&nbsp;&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Established in PRC on December 31, 2003</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Acquired by Jiuzhou Pharmacy in August 2011 &nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Registered capital of RMB 10 million fully paid</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Carries out pharmaceutical distribution services</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIE by contractual arrangements as a wholly-owned
    subsidiary of Jiuzhou Pharmacy (2)</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiutong Medical&nbsp;&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Established in the PRC on December 20, 2011 by Renovation</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Registered&nbsp;capital of $2.6 million fully paid &nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Currently has no operation</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 117; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entity
    Name</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 46%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Background</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shouantang Bio&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Established in the PRC in October, 2014 by Shouantang Technology&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;100% held by Shouantang Technology&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Registered capital of RMB 1,000,000 fully paid</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Sells nutritional supplements under its own brand name</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiuyi Technology&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Established in the PRC on September 10, 2015</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;100% held by Renovation&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Technical support to online pharmacy</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kahamadi Bio&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Established in the PRC in May 2016</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;49% held by Shouantang Bio</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Registered capital of RMB 10 million</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Develop brand name for nutritional supplements</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49%</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lin&rsquo;An Jiuzhou&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Established in the PRC in March 31, 2017</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;100% held by Jiuxin&nbsp;Management</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Registered capital of RMB 5 million</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Explore retail pharmacy market in Lin&rsquo;An City</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Linjia Medical</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Established
        in the PRC in September27, 2017</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;51%
        held by Jiuzhou Pharmacy</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of RMB 20 million</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operates
        local clinics</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIE by contractual arrangements as a controlled
    subsidiary of Jiuzhou Pharmacy (2)</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ayi Health</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Established
        in the PRC in March 29, 2019</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;51%
        held by Jiuzhou Pharmacy</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of RMB 10 million</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provide
        technical Support for medial service</FONT></P></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIE by contractual arrangements as a controlled
    subsidiary of Jiuzhou Pharmacy (2)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiuzhou Pharmacy,
    Jiuzhou Clinic and Jiuzhou Service had been under the common control of Mr. Lei Liu&nbsp;&nbsp;&nbsp;and Ms. Li Qi, the three
    shareholders (the &ldquo;Owners&rdquo;) since their respective establishment dates, pursuant to agreements among the Owners
    to vote their interests in concert as memorialized in a voting rights agreement. Based on such voting agreement, the Company
    has determined that common control exists among these three companies. The Owners have operated these three companies in conjunction
    with one another since each company&rsquo;s respective establishment date. Jiuxin Medicine is also deemed under the common
    control of the Owners as a subsidiary of Jiuzhou Pharmacy.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To comply with certain
    foreign ownership restrictions of pharmacy and medical clinic operators, Jiuxin Management entered into a series of contractual
    arrangements with Jiuzhou Pharmacy, Jiuzhou Clinic and Jiuzhou Service on August 1, 2009. These contractual arrangements are
    comprised of five agreements: a consulting services agreement, operating agreement, equity pledge agreement, voting rights
    agreement and option agreement. Because such agreements obligate Jiuxin Management to absorb all of the risks of loss from
    the activities of Jiuzhou Pharmacy, Jiuzhou Clinic and Jiuzhou Service, and enable the Company (through Jiuxin Management)
    to receive all of their expected residual returns, the Company accounts for each of the three companies (as well as subsidiaries
    of Jiuzhou Pharmacy) as a variable interest entity (&ldquo;VIE&rdquo;) under the accounting standards of the Financial Accounting
    Standards Board (&ldquo;FASB&rdquo;). Accordingly, the financial statements of Jiuzhou Pharmacy, Jiuzhou Clinic and Jiuzhou
    Service, as well as the subsidiaries under the control of Jiuzhou Pharmacy, Jiuxin Medicine and Shouantang Bio are consolidated
    into the financial statements of the Company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></P>


<!-- Field: Page; Sequence: 118; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
2 &ndash; LIQUIDITY</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s accounts have been prepared in accordance with the accounting principles generally accepted in the United States
of America (&ldquo;US GAAP&rdquo;) on a going concern basis. The going concern basis assumes that assets are realized and liabilities
are extinguished in the ordinary course of business at amounts disclosed in the financial statements. The Company&rsquo;s ability
to continue as a going concern depends upon aligning its sources of funding (debt and equity) with its expenditure requirements
and repayment of the short-term debts as and when they become due.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
drug retail business is a highly competitive industry in the PRC. Several large drugstore chains and a variety of single
stores operate in Hangzhou City and Zhejiang Province. In order to increase the Company&rsquo;s competitive advantages and
gain more local retail pharmacy market share, from fiscal year 2018, we opened fifty-nine new stores in Hangzhou. As a
result, the Company incurred significant incremental expense related to rental, labor hiring and training, and marketing
activities. As the retail pharmaceutical market becomes more competitive in recent years, a new store usually cannot make
profit in its operation until a year later. In fact, the Company incurred significant expenses with limited incremental
revenue in the period it opened new stores. At their openings, except for four stores, almost all of the new stores were
without government insurance reimbursement certificates. In fact, it usually takes more than one year for a new store to
apply for and obtain the local government insurance reimbursement certificate. As of March 31, 2020, the Company had obtained
thirty-six reimbursement certificates for stores opened in fiscal 2018 and thereafter. Historically in a mature store, more
than half of the total revenue were collected from the individual customers&rsquo; government insurance program. The Company is in
the process of actively applying certificates for all of its new stores. In the future, as more and more stores obtain
certificates, the Company expect its new store revenue to increase and eventually contribute positive operating cash
flow.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s principal sources of liquidity consist of existing cash, equity financing, bank facilities from local banks as
well as personal loans from its principal shareholders if necessary. On April 15, 2019, the Company closed a registered direct
offering of 4,000,008 shares of common stock at $2.50 per share with gross proceeds of $10,000,020 from its effective shelf registration
statement on Form S-3 pursuant to a Securities Purchase Agreement dated April 11, 2019 (the &ldquo;2019 Securities Purchase Agreement&rdquo;),
by and among the Company and the investors named therein. On June 3, 2020, the Company closed a registered direct offering of
5,000,004 shares of common stock at $2.00 per share with gross proceeds of $10,000,008 from its effective shelf registration statement
on Form S-3 pursuant to a Securities Purchase Agreement dated June 1, 2020 (the &ldquo;2020 Securities Purchase Agreement&rdquo;),
by and among the Company and the investors named therein.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a credit line agreement from a local bank as displayed in detail in Note 14. As of March 31, 2020, approximately
$0.53 million of the aforementioned bank credit line was available for further borrowing. Additionally, Jiuzhou Pharmacy obtained
a credit line of approximately $7,175,000 (RMB50,000,000) from Haihui Commercial Factoring (Tianjin) Co. Ltd. (&ldquo;Haihui Commercial&rdquo;)
for three years beginning July 26, 2019. As of March 31, 2020, the full amount has been borrowed from
Haihui Commercial. Any borrowing thereunder is guaranteed by a third-party guarantor company, and secured
by the Company&rsquo;s assets pursuant to a collateral agreement, as well as personal guarantees of some of its principal shareholders.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has also obtained additional government insurance reimbursement certificates for its stores opened in the last two years.
As the sales reimbursed from the government account for more than half of sales in a mature store, the certificates may significantly
increase the sales of these stores in the next 12 months. Additionally, with the proceeds from the registered direct financing
closed on April 15, 2019 and June 3, 2020, and increased credit line, the Company believes it can support its operations for at
least the next 12 months.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 119; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
3 &ndash; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Basis
of presentation and consolidation</U></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements are prepared in accordance with accounting principles generally accepted in the
United States of America (&ldquo;US GAAP&rdquo;). The consolidated financial statements include the financial statements of the
Company, its wholly-owned subsidiaries and VIEs. All significant inter-company transactions and balances between the Company,
its subsidiaries and VIEs are eliminated upon consolidation.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>



<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Consolidation
of variable interest entities</U></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with accounting standards regarding consolidation of variable interest entities, VIEs are generally entities that lack
sufficient equity to finance their activities without additional financial support from other parties or whose equity holders
lack adequate decision making ability. All VIEs with which the Company is involved must be evaluated to determine the primary
beneficiary of the risks and rewards of the VIE. The primary beneficiary is required to consolidate the VIE for financial reporting
purposes.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has concluded, based on the contractual arrangements, that Jiuzhou Pharmacy (including its subsidiaries and controlled
entities), Jiuzhou Clinic and Jiuzhou Service are each a VIE and that the Company&rsquo;s wholly-owned subsidiary, Jiuxin Management,
absorbs a majority of the risk of loss from the activities of these companies, thereby enabling the Company, through Jiuxin Management,
to receive a majority of their respective expected residual returns.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Control
and common control are defined under the accounting standards as &ldquo;an individual, enterprise, or immediate family members
who hold more than 50 percent of the voting ownership interest of each entity.&rdquo; Because the Owners collectively own 100%
of Jiuzhou Pharmacy, Jiuzhou Clinic and Jiuzhou Service, and have agreed to vote their interests in concert since the establishment
of each of these three companies as memorialized in the voting rights agreement, the Company believes that the Owners collectively
have control and common control of the three companies. Accordingly, the Company believes that Jiuzhou Pharmacy, Jiuzhou Clinic
and Jiuzhou Service were constructively held under common control by Jiuxin Management as of the time the Contractual Agreements
were entered into, establishing Jiuxin Management as their primary beneficiary. Jiuxin Management, in turn, is owned by Renovation,
which is owned by the Company. <B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Risks
and Uncertainties</U></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
operations of the Company are located in the PRC. Accordingly, the Company&rsquo;s business, financial condition, and results
of operations may be influenced by political, economic, and legal environments in the PRC, as well as by the general state of
the PRC economy. The Company&rsquo;s operations in the PRC are subject to special considerations and significant risks not typically
associated with companies in North America and Western Europe. These include risks associated with, among others, the political,
economic and legal environment and foreign currency exchange. The Company&rsquo;s results may be adversely affected by changes
in the political, regulatory and social conditions in the PRC. Although the Company has not experienced losses from these situations
and believes that it is in compliance with existing laws and regulations including its organization and structure disclosed in
Note 1, this may not be indicative of future results.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has significant cash deposits with suppliers in order to obtain and maintain inventory. The Company&rsquo;s ability to
obtain products and maintain inventory at existing and new locations is dependent upon its ability to post and maintain significant
cash deposits with its suppliers. In the PRC, many vendors are unwilling to extend credit terms for product sales that require
cash deposits to be made. The Company does not generally receive interest on any of its supplier deposits, and such deposits are
subject to loss as a result of the creditworthiness or bankruptcy of the party who holds such funds, as well as the risk from
illegal acts such as conversion, fraud, theft or dishonesty associated with the third party. If these circumstances were to arise,
the Company would find it difficult or impossible, due to the unpredictability of legal proceedings in China, to recover all or
a portion of the amount on deposit with its suppliers.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 120; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Members of the current management team
own controlling interests in the Company and are also the Owners of the VIEs in the PRC. The Company only controls the VIEs through
contractual arrangements which obligate it to absorb the risk of loss and to receive the residual expected returns.&nbsp;&nbsp;As
such, the controlling shareholders of the Company and the VIEs could cancel these agreements or permit them to expire at the end
of the agreement terms, as a result of which the Company would not retain control of the VIEs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Use of estimates</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated
financial statements in conformity with&nbsp;US GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial
statements, and the reported amounts of revenues and expenses during the reporting period. The significant estimates made in
the preparation of the accompanying consolidated financial statements relate to the assessment of the
carrying values of accounts receivable, advances to suppliers and related allowance for doubtful accounts, useful lives of
property and equipment, inventory reserve and fair value of its purchase option derivative liability. Because of the use of
estimates inherent in the financial reporting process, actual results could materially differ from those estimates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Fair value measurements</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company establishes a three-level valuation
hierarchy of valuation techniques based on observable and unobservable inputs, which may be used to measure fair value and include
the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Level 1 &ndash; Quoted prices in active markets for identical
assets or liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 2 &ndash; Inputs other than Level
1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in
markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially
the full term of the assets or liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 3 &ndash; Unobservable inputs that
are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Classification within the hierarchy is
determined based on the lowest level of input that is significant to the fair value measurement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s financial assets and
liabilities, which include financial instruments as defined by FASB ASC 820, include cash and cash equivalents, restricted cash,
financial assets available for sales, accounts receivable, notes receivables, other receivable, accounts payable, notes payable,
other payable, long-term debt and derivatives. The carrying amounts of cash and cash equivalents, restricted cash, accounts receivable,
notes receivables, and accounts payable are a reasonable approximation of fair value due to the short maturities of these instruments
(Level 1). The carrying amount of notes payable approximates fair value based on borrowing rates of similar bank loan currently
available to the Company (Level 2) (See Note 16). The carrying amount of Long-term loan payable approximates fair value based on
borrowing rates of similar bank loan currently available to the Company (Level 2) (See Note 17).The carrying amount of the Company&rsquo;s
derivative instruments is recorded at fair value and is determined based on observable inputs that are corroborated by market data
(Level 2) (See Note 21). The carrying amount of the financial assets available for sale is recorded at fair value and is determined
based on unobservable inputs (Level 3) (See Note 4). The carrying amount of the financial liability is recorded at fair value and
is determined based on unobservable inputs (Level 3) (See Note 22).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 121; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Active Market<BR> for Identical<BR> Assets<BR> (Level 1)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Observable<BR> Inputs<BR> (Level 2)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Unobservable<BR> Inputs<BR> (Level 3)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Total<BR> Carrying<BR> Value</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left">Cash, cash equivalents and restricted cash</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">30,982,606</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">30,982,606</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Financial assets available for sale</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">157,159</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">157,159</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Account receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,770,656</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,770,656</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Notes receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">57,005</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">57,005</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,069,442</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,069,442</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,559,494</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,559,494</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,605,971</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,605,971</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,522,330</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,522,330</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Long-term loan payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,403,700</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,403,700</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Financial liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">70,507</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">70,507</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Warrants liability</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">64,090</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">64,090</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">69,961,533</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">33,073,761</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">227,666</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">103,262,960</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Revenue recognition</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective March 31, 2018, the Company began
recognizing revenue under Accounting Standards Codification (&ldquo;ASC&rdquo;) Topic 606, Revenue from Contracts with Customers
(&ldquo;ASC 606&rdquo;), using the modified retrospective transition method. The impact of adopting the new revenue standard was
not material to the Company&rsquo;s consolidated financial statements. The core principle of this new revenue standard is that
a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the Company expects to be entitled in exchange for those goods or services. The following five steps
are applied to achieve that core principle:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 1: Identify the contract with the customer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 2: Identify the performance obligations in the contract</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 3: Determine the transaction price</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 4: Allocate the transaction price to the performance obligations in the contract</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 5: Recognize revenue when the company satisfies a performance obligation</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to identify the performance obligations
in a contract with a customer, a company must assess the promised goods or services in the contract and identify each promised
good or service that is distinct. A performance obligation meets ASC 606&rsquo;s definition of a &ldquo;distinct&rdquo; good or
service (or bundle of goods or services) if both of the following criteria are met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer (i.e., the good or service is capable of being distinct).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The entity&rsquo;s promise to transfer the good or service to the customer is separately identifiable from other promises in the contract (i.e., the promise to transfer the good or service is distinct within the context of the contract).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 122; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If a good or service is not distinct, the
good or service is combined with other promised goods or services until a bundle of goods or services is identified that is distinct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The transaction price is the amount of
consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer,
excluding amounts collected on behalf of third parties (for example, some sales taxes). The consideration promised in a contract
with a customer may include fixed amounts, variable amounts, or both. Variable consideration is included in the transaction price
only to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur
when the uncertainty associated with the variable consideration is subsequently resolved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The transaction price is allocated to each
performance obligation on a relative standalone selling price basis. The transaction price allocated to each performance obligation
is recognized when that performance obligation is satisfied, at a point in time or over time as appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s revenue is net of value
added tax (&ldquo;VAT&rdquo;) collected on behalf of the PRC tax authorities with respect to the sales of merchandise. VAT collected
from customers, net of VAT paid for purchases, is recorded as a liability in the accompanying consolidated balance sheets until
it is paid to the relevant PRC tax authorities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain contract liabilities primarily
represent the Company&rsquo;s obligation to transfer additional goods or services to a customer for which the Company has received
consideration, for example, membership points. The consideration received remains a contract liability until goods or services
have been provided to the retail customer. The estimated amount based on accrued membership points was deducted from sales revenue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a discussion of the Company&rsquo;s
revenue recognition policies by segment under the new revenue recognition accounting standard:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Pharmacy retail sales</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The physical pharmacies sell prescription
drugs, over-the-counter (&ldquo;OTC&rdquo;) drugs, traditional Chinese medicine, nutritional supplements, medical devices and sundry
products. Revenue from sales of prescription medicine at drugstores is recognized when the prescription is filled and the customer
picks up and pays for the prescription. Revenue from sales of other merchandise at drugstores is recognized at the point of sale,
which is when a customer pays for and receives the merchandise. Usually the majority merchandise, such as prescription and OTC
drugs, are not refundable after the customers leave the counter. Returns of other products, such as sundry products, are minimal.
Sales of drugs reimbursed by the local government medical insurance agency and receivables from the agency are recognized when
a customer pays for the drugs at a store. The Company based on historical experience, a reserve for potential losses from denial
of reimbursement on certain unqualified drugs is made to the receivables from the government agency. Additionally, several onsite
clinics adjacent to pharmacies provide limited medical services. Revenue from medical services is recognized after the service
has been rendered to a customer. As revenue from medical services is minimal compared to pharmacy retail sales, it is included
as part of the pharmacy retail sales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company deduct the membership rewards
directly from the retail revenue, and present such amounts in net sales as opposed to the current reduction of operation expense
classification. Membership rewards, usually membership points, are accumulated
by customers based on their historical spending levels. The Company has determined that there is an additional performance obligation
to those customers at the time of the initial transaction. The customers can then redeem these points against the prices of merchandises
they purchase in the future. At the end of each period, unredeemed membership rewards are reflected as a&nbsp;contract&nbsp;liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Online pharmacy sales</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The online pharmacy sells various health
products except for prescription drugs. Revenue from online pharmacy sales is recognized when merchandise is shipped to customers.
While most deliveries take one day, certain deliveries may take longer depending on a customer&rsquo;s location. Any loss caused
in a shipment will be reimbursed by the Company&rsquo;s courier company. The Company&rsquo;s sales policy allows for the return
of certain merchandises without reason within seven days after a customer&rsquo;s receipt of the applicable merchandise. Historically,
sales returns seven days after merchandise receipts have been minimal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 123; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Wholesale</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Jiuxin Medicine purchases medicine in quantity
and distributes products primarily to local pharmacies and medical products dealers. Revenue from sales of merchandise to non-retail
customers is recognized when the merchandise is transferred to customers. Historically, sales returns have been minimal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s revenue is net of VAT
collected on behalf of PRC tax authorities in respect to the sales of merchandise. VAT collected from customers, net of VAT paid
for purchases, is recorded as a liability in the accompanying consolidated balance sheets until it is paid to the relevant PRC
tax authorities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Disaggregation of Revenue</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table disaggregates the Company&rsquo;s
revenue by major source in each segment for the years ended March 31, 2020 and 2019:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify">For the year ended March 31</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="9">Retail drugstores</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify; text-indent: 10pt">Prescription drugs</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">26,045,423</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">23,516,046</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: 10pt">OTC drugs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,532,248</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,401,328</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt">Nutritional supplements</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,013,622</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,354,108</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: 10pt">TCM</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,325,008</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,529,790</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt">Sundry products</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,312,293</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">941,491</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; text-indent: 10pt">Medical devices</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,852,643</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,591,646</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total retail revenue</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">74,081,237</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">72,334,409</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Online pharmacy</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt">Prescription drugs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,447,469</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: 10pt">OTC drugs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,721,638</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,127,976</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt">Nutritional supplements</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">742,809</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">737,315</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: 10pt">TCM</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">266,638</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">74,262</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt">Sundry products</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,082,601</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,736,070</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; text-indent: 10pt">Medical devices</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,280,060</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,108,836</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total online revenue</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">13,541,215</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">8,784,459</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Drug wholesale</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt">Prescription drugs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">24,857,708</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">16,745,862</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: 10pt">OTC drugs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,196,841</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,964,587</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt">Nutritional supplements</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">205,881</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">290,534</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: 10pt">TCM</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">314,769</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">271,280</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt">Sundry products</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">43,854</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,846</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; text-indent: 10pt">Medical devices</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">86,184</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">135,035</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Total wholesale revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">29,705,237</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">26,432,144</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total revenue</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">117,327,689</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">107,551,012</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Contract Balances</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Contract liabilities primarily
represent the Company&rsquo;s obligation to transfer additional goods or services to a customer for which the Company has
received consideration, for example membership points and membership rewards. The consideration received remains a contract liability until goods
or services have been provided to the retail customer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table provides information
about receivables and contract liabilities from contracts with customers:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31, <BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31,<BR> 2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Trade receivable(included in accounts receivable, net)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">9,770,656</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">8,692,514</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Contract liabilities (included in accrued expenses)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,106,982</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,689,099</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 124; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Restricted cash</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s restricted cash consists
of cash and long-term deposits in a bank as security for its notes payable. The Company has notes payable outstanding with the
bank and is required to keep certain amounts on deposit that are subject to withdrawal restrictions. The notes payable are generally
short term in nature due to their short maturity period of six to nine months; thus, restricted cash is classified as a current
asset.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following represents a reconciliation
of cash and cash equivalents in the Consolidated Condensed Balance Sheets to total cash, cash equivalents and restricted cash in
the Consolidated Condensed Statements of Cash Flows as of March 31, 2020 and March 31, 2019:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31, <BR> 2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">16,176,318</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">9,322,463</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Restricted cash</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">14,806,288</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">15,422,739</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 4pt">Cash, cash equivalents and restricted cash</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">30,982,606</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">24,745,202</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Accounts receivable</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accounts receivable represents the following:
(1) amounts due from banks relating to retail sales that are paid or settled by the customers&rsquo; debit or credit cards, (2)
amounts due from government social security bureaus and commercial health insurance programs relating to retail sales of drugs,
prescription medicine, and medical services that are paid or settled by the customers&rsquo; medical insurance cards, (3) amounts
due from non-bank third party payment instruments such as Alipay and certain e-commerce platforms and (4) amounts due from non-retail
customers for sales of merchandise.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accounts receivable are recorded at net
realizable value consisting of the carrying amount less an allowance for uncollectible accounts, as&nbsp;necessary. In the Company&rsquo;s
retail business, accounts receivable mainly consist of reimbursements due from the government insurance bureaus and commercial
health insurance programs and are usually collected within two or three months. The Company directly writes off delinquent account
balances, which it determines to be uncollectible after confirming with the appropriate bureau or program each month. Additionally,
the Company also makes estimated reserves on related outstanding accounts receivable based on historical trends.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the Company&rsquo;s online pharmacy
business, accounts receivable primarily consist of amounts due from non-bank third party payment instruments such as Alipay and
certain e-commerce platforms. To purchase pharmaceutical products from an e-commerce platforms such as Tmall, customers are required
to submit payment to certain non-bank third party payment instruments, such as Alipay, which, in turn, reimburse the Company within
seven days to a month. Except for customer returns of sold products, the receivables from these payments instruments are rarely
uncollectible.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In its wholesale business, the Company
uses the aging method to estimate the allowance for anticipated uncollectible receivable balances. Under the aging method, bad
debt percentages are determined by management,&nbsp;based on historical experience and the current economic climate, are applied
to customers&rsquo; balances categorized by the number of months the underlying invoices have remained outstanding. At each reporting
period, the allowance balance is adjusted to reflect the amount computed as a result of the aging method. When facts subsequently
become available to indicate that the allowance provided requires an adjustment, a corresponding adjustment is made to the allowance
account as a change in estimate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Advances to suppliers</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advances to suppliers consist of prepayments
to its vendors, such as pharmaceutical manufacturers and other distributors. Since the acquisition of Jiuxin Medicine, the Company
have transferred almost all logistics services of its retail drugstores to Jiuxin Medicine. Jiuzhou Pharmacy only directly purchases
certain non-medical products, such as certain nutritional supplements. As a result, almost all advances to suppliers are made by
Jiuxin Medicine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advances to suppliers for its drug wholesale
business consist of prepayments to its vendors, such as pharmaceutical manufacturers and other distributors.&nbsp;The Company typically
receive products from vendors within three to nine months after making prepayments.&nbsp;The Company continuously monitor delivery
from, and payments to, its vendors while maintaining a provision for estimated credit losses based upon historical experience and
any specific supplier issues, such as discontinuing of inventory supply, that have been identified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 125; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Inventories</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventories are stated at the lower of
cost or net realizable value. Cost is determined using the first in first out (FIFO) method. The Company carries out physical inventory counts on a monthly basis at each store and warehouse location.
Herbs that the Company farms are recorded at their cost, which includes direct costs such as seed selection, fertilizer, labor
costs that are spent in growing herbs on the leased farmland, and indirect costs such as amortization of farmland development cost.
All costs are accumulated until the time of harvest and then allocated to harvested herbs costs when the herbs are sold. The Company
periodically reviews its inventory and records write-downs to inventories for shrinkage losses and damaged merchandise that are
identified. The Company provides a reserve for estimated inventory obsolescence or excess quantities on hand equal to the difference,
if any, between the cost of the inventory and its estimated realizable value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Farmland assets</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Herbs that the Company farms are recorded
at their cost, which includes direct costs such as seed selection, fertilizer, and labor costs that are spent in growing herbs
on the leased farmland, and indirect costs such as amortization of farmland development costs. Since April 2014, amortization of
farmland development costs has been expensed instead of allocated into inventory due to unpredictable future market value of planted
gingko trees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All related costs described in the above
are accumulated until the time of harvest and then allocated to harvested herbs when they are sold.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Property and equipment</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment are stated at cost,
net of accumulated depreciation or amortization. Depreciation is calculated on the straight-line method over the estimated useful
lives of the assets, taking into consideration the assets&rsquo; estimated residual value. Leasehold improvements are amortized
over the shorter of lease term or remaining lease period of the underlying assets. Following are the estimated useful lives of
the Company&rsquo;s property and equipment:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated Useful&nbsp;Life</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3-10 years</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Motor vehicles</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3-5 years</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office equipment &amp; furniture</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3-5 years</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buildings</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35 years</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Maintenance, repairs and minor renewals
are charged to expenses as incurred. Major additions and betterment to property and equipment are capitalized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Intangible assets</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Intangible assets are acquired individually
or as part of a group of assets, and are initially recorded at their fair value.&nbsp;&nbsp;The cost of a group of assets acquired
in a transaction is allocated to the individual assets based on their relative fair values.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimated useful lives of the Company&rsquo;s
intangible assets are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated<BR>
Useful Life</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Land use rights</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50 years</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 years</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">license</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Infinite</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company evaluates intangible assets
for impairment whenever events or changes in circumstances indicate that the assets might be impaired.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Impairment of long lived assets</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company evaluates long lived tangible
and intangible assets for impairment, whenever events or changes in circumstances indicate that the carrying value may not be recoverable
from its estimated future cash flows. Recoverability is measured by comparing the assets&rsquo; net book value to the related projected
undiscounted cash flows from these assets, considering a number of factors including past operating results, budgets, economic
projections, market trends and product development cycles. If the net book value of the asset exceeds the related undiscounted
cash flows, the asset is considered impaired, and a second test is performed to measure the amount of impairment loss. In the year
ended March 31, 2020, the Company evaluated the licenses of insurance applicable drugstores acquired in the past based on their
discounted positive cash value. Due to the stricter government insurance policy in fiscal year 2021, the value of these licenses
has declined. As a result, The Company recorded an impairment of $628,192 as of March 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Notes payable</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the normal course of business, the
Company regularly issues bank acceptance bills as a payment method to settle outstanding accounts payables with various material
suppliers. The Company records such bank acceptance bills as notes payable. Such notes payable are generally short term in nature
due to their short maturity period of six to nine months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 126; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Income taxes</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows FASB ASC Topic 740,
&ldquo;Income Taxes,&rdquo; which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences
of events that have been included in the financial statements or tax returns. Under this method, deferred income taxes are recognized
for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting
amounts at each period end based on enacted tax laws and statutory tax rates, applicable to the periods in which the differences
are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the
amount expected to be realized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accounting standards clarify the accounting
and disclosure requirements for uncertain tax positions and prescribe a recognition threshold and measurement attribute for recognition
and measurement of a tax position taken or expected to be taken in a tax return. The accounting standards also provide guidance
on de-recognition, classification, interest and penalties, accounting in interim periods, disclosures, and transition.&nbsp;No
significant penalties, uncertain tax provisions or interest relating to income taxes were incurred during the periods ended March
31, 2020 and 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Value added tax</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sales revenue represents the invoiced value
of goods, net of VAT. All of the Company&rsquo;s products are sold in the PRC and are subject to a VAT on the gross sales price.
The VAT rates&nbsp;range up to 17%, depending on the type of products sold. The VAT may be offset by VAT paid by the Company on
raw materials and other materials included in the cost of producing or acquiring its finished products. The Company recorded a
VAT payable net of payments in the accompanying financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Stock based compensation</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows the provisions of FASB
ASC 718, &ldquo;Compensation &mdash; Stock Compensation,&rdquo; which establishes accounting standards for non-employee and employee
stock-based awards. Under the provisions of FASB ASC 718, the fair value of stock issued is used to measure the fair value of services
received as the Company believes such approach is a more reliable method of measuring the fair value of the services. For non-employee
stock-based awards, fair value is measured based on the value of the Company&rsquo;s common stock on the date that the commitment
for performance by the counterparty has been reached or the counterparty&rsquo;s performance is complete. The fair value of the
equity instrument is calculated and then recognized as compensation expense over the requisite performance period. For employee
stock-based awards, share-based compensation cost is measured at the grant date based on the fair value of the award and is recognized
as expense with graded vesting on a straight&ndash;line basis over the requisite service period for the entire award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Advertising and promotion costs</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advertising and promotion costs are expensed
as incurred and amounted to $262,553&nbsp;and $1,023,461 for the years ended March 31, 2020 and 2019, respectively. Such costs
consist primarily of print and promotional materials such as flyers to local communities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Foreign currency translation</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company uses the United States dollar
(&ldquo;U.S. dollars&rdquo; or &ldquo;USD&rdquo;) for financial reporting purposes. The Company&rsquo;s subsidiaries and VIEs maintain
their books and records in their functional currency the Renminbi (&ldquo;RMB&rdquo;), the currency of the PRC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 127; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In general, for consolidation purposes,
the Company translates the assets and liabilities of its subsidiaries and VIEs into U.S. dollars using the applicable exchange
rates prevailing at the balance sheet date, and the statements of income and cash flows are translated at average exchange rates
during the reporting period. As a result, amounts related to assets and liabilities reported on the statement of cash flows will
not necessarily agree with changes in the corresponding balances on the balance sheet. Equity accounts are translated at historical
rates. Adjustments resulting from the translation of the financial statements of the subsidiaries and VIEs are recorded as accumulated
other comprehensive income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The balance sheet amounts, with the exception
of equity, at March 31, 2020 and 2019 were translated at 1 RMB to 0.1410 USD and at 1 RMB to 0.1490 USD, respectively. The average
translation rates applied to income and cash flow statement amounts for years ended March 31, 2020 and 2019 were at 1 RMB to 0.1436
USD and at 1 RMB to 0.1491 USD, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Concentrations and credit risk</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B> &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain financial instruments, which subject
the Company to concentration of credit risk, consist of cash and restricted cash. The Company has cash balances at financial institutions
located in Hong Kong and PRC. Balances at financial institutions in Hong Kong may, from time to time, exceed Hong Kong Deposit
Protection Board&rsquo;s insured limits. Since March 31, 2015, balances at financial institutions and state-owned banks within
the PRC are covered by insurance up to RMB 500,000 (USD 79,600) per bank. As of March 31, 2020 and March 31, 2019, the Company
had deposits totaling $30,974,714&nbsp;and $24,730,736 that were covered by such limited insurance, respectively. Any balance over
RMB 500,000 (USD 79,600) per bank in PRC will not be covered. To date, the Company has not experienced any losses in such accounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the fiscal year ended March 31, 2020,
two vendors collectively accounted for 50.4% of the Company&rsquo;s total purchases and two suppliers accounted for more than 10%
of total advances to suppliers.&nbsp;For the fiscal year ended March 31, 2019, two vendors collectively accounted for 40.3% of
the Company&rsquo;s total purchases and two suppliers accounted for more than 10% of total advances to suppliers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the fiscal year ended March 31, 2020,
no customer accounted for more than 10% of the Company&rsquo;s total sales and more than 10% of total accounts receivable. For
the fiscal year ended March 31, 2019, no customer accounted for more than 10% of the Company&rsquo;s total sales or more than 10%
of total accounts receivable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Leases</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2016, the FASB issued ASU 2016-02,
<I>Leases </I>(Topic 842). Lessees are required to recognize a right-of-use asset and a lease liability for virtually all of their
leases (other than leases that meet the definition of a short-term lease). The liability is equal to the present value of lease
payments. The asset is based on the liability, subject to certain adjustments, such as for initial direct costs. For income statement
purposes, a dual model was retained, requiring leases to be classified as either operating or finance leases. Operating leases
result in straight-line expense (similar to operating leases under the prior accounting standard) while finance leases result in
a front-loaded expense pattern (similar to capital leases under the prior accounting standard). Lessor accounting is similar to
the prior model, but updated to align with certain changes to the lessee model (e.g., certain definitions, such as initial direct
costs, have been updated) and the new revenue standard, ASU 2014-9.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 128; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company adopted this new accounting
standard on April 1, 2019 on a modified retrospective basis and applied the new standard to all leases through a cumulative-effect
adjustment to beginning retained earnings. As a result, comparative financial information has not been restated and continues to
be reported under the accounting standards in effect for those periods. The Company elected the package of practical expedients
permitted under the transition guidance within the new standard, which includes, among other things, the ability to carry forward
the existing lease classification. On April 1, 2019, the Company recorded an after-tax transition adjustment to increase retained
earnings by approximately $422,354. The new standard had a material impact on the unaudited condensed consolidated balance sheet,
but did not materially impact the Company&rsquo;s consolidated operating results and had no impact on the Company&rsquo;s cash
flows. The following is a discussion of the Company&rsquo;s lease policy under the new lease accounting standard:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company determines if an arrangement
contains a lease at the inception of a contract. Right-of-use assets represent the Company&rsquo;s right to use an underlying asset
for the lease term and lease liabilities represent the Company&rsquo;s obligation to make lease payments arising from the lease.
Right-of-use assets and lease liabilities are recognized at the commencement date based on the present value of the remaining future
minimum lease payments. As the interest rate implicit in the Company&rsquo;s leases is not readily determinable, the Company utilizes
its incremental borrowing rate, determined by class of underlying asset, to discount the lease payments. The operating lease right-of-use
assets also include lease payments made before commencement and exclude lease incentives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company leases premises for retail
drugstores, and offices under non-cancellable operating leases. Operating lease payments are expensed over the term of lease using
straight line method. A majority of the Company&rsquo;s retail drugstore leases have a 3 to 10 year term. Usually within one to
three months prior to the expiration date of a lease, the Company is required to notify the lessor and has a priority to continue
renting the lease property if a lessor intends to lease property. The lease itself does not have restriction or covenants. If both
parties agree to continue, a new lease contract with new lease terms has to been signed by both parties. Usually the rent may increase
year by year based on the lease contract. Sublease is typically not allowed. Any damage, if made by the lessee, to the property
and equipment within the property has to been fixed or reimbursed by the lessee. The Company does not have any leases entered into
but which have not yet commenced. The Company has historically been able to renew a majority of its drugstores leases. The weighted
average remaining lease term is 3 years and the weighted average discount rate is 4.19%. Under the terms of the lease agreements,
the Company has no legal or contractual asset retirement obligations at the end of the leases. See Note 14 &ldquo;Leases&rdquo;
for additional information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Impact of New Lease Standard on Balance
Sheet Line Items</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of applying the new lease standard
using a modified retrospective method, the following adjustments were made to accounts on the condensed consolidated balance sheet
as of April 1, 2019:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Impact of Change in Accounting Policy</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">As Reported</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Adjusted</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31,<BR> 2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Adjustments</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">April 1, <BR> 2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left; padding-left: 0.75pt">Other current assets</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">2,063,375</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">(717,414</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1,345,961</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.75pt">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">56,202,981</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(717,414</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">55,485,567</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.75pt">Operating lease right-of-use assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,276,388</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,276,388</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.75pt">Total assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">72,730,636</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,558,974</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">87,289,610</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.75pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.75pt">Current portion of operating lease liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,718,610</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,718,610</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.75pt">Total current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">55,212,286</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,718,610</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">59,930,896</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.75pt">Long-term operating lease liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,418,011</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,418,011</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.75pt">Total liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">55,759,469</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,136,621</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">69,896,090</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.75pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.75pt">Retained earnings</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(30,587,468</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">422,354</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(30,165,114</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.75pt">Total shareholders&rsquo; equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,165,206</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">422,354</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,587,560</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.75pt">Total equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,971,167</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">422,354</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,393,521</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Recent Accounting Pronouncements</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accounting pronouncements adopted</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2016, the FASB issued ASU
2016-13, &ldquo;Financial Instruments&mdash;Credit Losses (Topic 326): Measurement of Credit Losses on Financial
Instruments,&rdquo; providing financial statement users with more decision-useful information about the expected credit
losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. For
public business entities that are U.S. Securities and Exchange Commission (SEC) filers, the amendments in this Update are
effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The FASB
has voted to defer the effective date for public companies that are smaller reporting companies to fiscal years beginning
after December 15, 2022. All entities may adopt the amendments in this Update earlier as of the fiscal years beginning after
December 15, 2018, including interim periods within those fiscal years. We are currently evaluating the impact of the
adoption of ASU 2016-13 on our consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 129; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2018, the FASB issued ASU 2018-13
Disclosure Framework &mdash; Changes to the Disclosure Requirements for Fair Value Measurement, which eliminates, adds, and modifies
certain disclosure requirements for fair value measurements under ASC 820. This ASU is to be applied on a prospective basis for
certain modified or new disclosure requirements, and all other amendments in the standard are to be applied on a retrospective
basis. The new standard is effective for interim and annual periods beginning after December 15, 2019, with early adoption permitted.
ASU 2018-13 has no impact on its consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accounting pronouncements not yet effective to adopt</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In July 2017, the FASB issued ASU No.
2017-11, &ldquo;Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), Derivatives and Hedging
(Topic 815): I. Accounting for Certain Financial Instruments with Down Round Features; II. Replacement of the Indefinite
Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable
Noncontrolling Interests with a Scope Exception&rdquo;. Part I of this Update addresses the complexity of accounting for
certain financial instruments with down round features. Part II of this Update addresses the difficulty of navigating Topic
480, Distinguishing Liabilities from Equity, because of the existence of extensive pending content in the FASB Accounting
Standards Codification&reg;. For public business entities, the amendments in Part I of this Update are effective for fiscal
years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted for all
entities, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any
adjustments should be reflected as of the beginning of the fiscal year that includes that interim period. ASU No. 2017-11 has
no impact on its consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In January 2017, the FASB issued ASU No.
2017-04, &ldquo;Intangibles&mdash;Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment&rdquo; (&ldquo;ASU
2017-04&rdquo;), which removes Step 2 from the goodwill impairment test. An entity will apply a one-step quantitative test and
record the amount of goodwill impairment as the excess of a reporting unit&rsquo;s carrying amount over its fair value, not to
exceed the total amount of goodwill allocated to the reporting unit. The new guidance does not amend the optional qualitative assessment
of goodwill impairment. Public business entity that is a U.S. Securities and Exchange Commission filer should adopt the amendments
in this ASU for its annual or any interim goodwill impairment test in fiscal years beginning after December 15, 2019. Early adoption
is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. ASU 2017-4 has no
impact on its consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2019, the FASB issued ASU No.
2019-12, &ldquo;Income Taxes&rdquo; (Topic 740): Simplifying the Accounting for Income Taxes (&ldquo;ASU 2019-12&rdquo;). ASU 2019-12
will simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments
also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance.
For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal
years, beginning after December 15, 2020. For all other entities, the amendments are effective for fiscal years beginning after
December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. The Company do not expect that the
requirements of ASU 2019-12 will have a material impact on its consolidated financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 130; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 4 &ndash; FINANCIAL&nbsp;ASSETS&nbsp;AVAILABLE&nbsp;FOR&nbsp;SALE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2020 and March 31,
2019, financial&nbsp;assets&nbsp;available&nbsp;for&nbsp;sale amounted to $157,159 (RMB 1,114,500) and $180,928 (RMB
1,214,500), respectively. As of March 31, 2020, the fair value of an investment in a limited partner (LP) in a private equity
fund (PE fund), which is intended to invest in retail pharmaceutical business, is $72,551 (RMB514,500). Additionally, the
Company has invested in Inter Mongolia Songlu Pharmaceutical Co. (&ldquo;Songlu Pharmaceutical&rdquo;). As of March 31, 2020,
the fair value of the investment is $84,608 (RMB600,000), which accounts for 0.5% shares of Songlu Pharmaceutical. The
Company has also invested a total of $14,538 (RMB100,000) in a mutual fund, which has been liquidated in the year ended March
31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOTE 5 &ndash; TRADE ACCOUNTS RECEIVABLE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Trade accounts receivable consisted of
the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31,<BR> 2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Accounts receivable</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">12,034,726</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">11,939,364</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Less: allowance for doubtful accounts</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,264,070</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3,246,850</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt">Trade accounts receivable, net</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">9,770,656</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">8,692,514</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended March 31, 2020 and
2019, $212,338 and $146,593 in accounts receivable were directly written off, respectively. As of March 31, 2020, $627,055 were
pledged as collateral for borrowings from financial institutions. As of March 31, 2019, no trade accounts receivables were pledged
as collateral for borrowings from financial institutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note 6 &ndash; OTHER CURRENT ASSETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other current assets consisted of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March&nbsp;31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31,<BR> 2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid rental expenses <SUP>(1)</SUP></FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1,364,975</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1,979,852</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Prepaid and other current assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">163,565</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">83,523</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,528,540</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">2,063,375</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The balance as of March 31, 2020 includes short-term refundable rental security deposits only, while the balance as of March 31, 2019 includes security deposits of $1,444,026 and prepaid rental of $535,826.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note&nbsp;7 &ndash; PROPERTY AND EQUIPMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment consisted of the
following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">March&nbsp;31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">March&nbsp;31,<BR> 2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%">Building</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">5,880,627</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">6,436,297</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Leasehold improvements</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,209,136</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,944,025</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Farmland development cost</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,686,430</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,781,627</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Office equipment and furniture</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,632,955</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,470,084</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Motor vehicles</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">504,327</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">551,927</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,913,475</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,183,960</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Less: Accumulated depreciation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(13,059,852</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(12,111,409</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">Impairment*</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,219,883</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,345,193</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt">Property and equipment, net</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">7,633,740</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">8,727,358</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
variance of impairment from March 31, 2020 to March 31, 2019 is solely caused by exchange rate variance.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Total depreciation expense for property
and equipment was $1,828,514 and $1,221,520 for the year ended March 31, 2020 and 2019, respectively. There were no fixed assets
impaired in the years ended March 31, 2020 and December 31, 2019.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 131; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note&nbsp;8 &ndash; LONG-TERM INVESTMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Long-term investment consists of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31,<BR> 2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kahamadi Bio <SUP>(1)</SUP></FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">6,217</TD><TD STYLE="width: 1%; text-align: left">*</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">24,243</TD><TD STYLE="width: 1%; text-align: left">*</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zhetong Medical <SUP>(2)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,538,234</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt">Advance to suppliers, net</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">2,544,451</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">24,243</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(1) It represents 49% investment in Kahamadi
Bio. The investment is recorded using equity method. Kahamadi Bio suffered loss in the year ended March 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(2) It represents 39% investment in Zhejiang
Zhetong Medical Co., Ltd. Zhetong Medical is established in March 2020 and targeted to acquire or cooperate with potential local
pharmacies. By attracting more funds from local investors, the Company expects to continue growing its local network in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note&nbsp;9 &ndash; ADVANCES TO SUPPLIERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advances to suppliers consist of deposits,
with or advances to, outside vendors for future inventory purchases. Most of the Company&rsquo;s suppliers require a certain amount
of money to be deposited with them as a guarantee that the Company will receive its purchase on a timely basis. This amount is
refundable and bears no interest.&nbsp;&nbsp;As of March 31, 2020 and March 31, 2019, advance to suppliers consist of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31,<BR> 2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Advance to suppliers</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">2,198,863</TD><TD STYLE="width: 1%; text-align: left">*</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">2,477,226</TD><TD STYLE="width: 1%; text-align: left">*</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Less: allowance for doubtful accounts</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,024,063</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)*</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(526,974</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: left">)*</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt">Advance to suppliers, net</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,174,800</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,950,252</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended March 31,
2020 and 2019, none of the advances to suppliers were written off against previous allowance for non-refundable advances, respectively.</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 10 &ndash; INVENTORY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventory consisted of finished goods,
valued at $12,247,004 and $13,955,202 as of March 31, 2020 and March 31, 2019, respectively. The Company constantly monitors its
potential obsolete products and is allowed to return products close to their expiration date to its suppliers. Any loss on damaged
items is immaterial and will be recognized immediately. As a result, no reserves were made for inventory as of March 31, 2020 and
March 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 11 &ndash; FARMLAND ASSETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Farmland assets consist of ginkgo trees
planted in 2012 and expected to be harvested and sold in several years. As of March 31, 2020 and March 31, 2019, farmland assets
are valued as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">March 31,</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">March 31,</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Farmland assets</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">2,177,606</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">2,341,537</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Less: Impairment*</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,435,259</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,516,278</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt">Farmland assets, net</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">742,347</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">825,259</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2018, the book value of the Ginkgo trees planted in Qianhong Agriculture&rsquo;s farmland, including their cultivation cost and land lease amortization expense, is approximately $2,416,839. Based on an independent appraisal report, the value of the Ginkgo trees is approximately $796,286. As a result, the Company recorded an agricultural inventory impairment of $1,620,553 as of March 31, 2018. There are no leasehold impairment expense in fiscal 2019 and 2020.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 132; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note&nbsp;12 &ndash; LONG TERM DEPOSITS,
LANDLORDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2020 and March 31, 2019,
long term deposits amounted to $1,456,384 and $2,157,275, respectively.&nbsp;Long term deposits are sums deposited with, or advanced
to, landlords for the purpose of securing retail store leases that the Company does not anticipate applying or being returned within
the next twelve months. Most of the Company&rsquo;s landlords require a minimum payment of nine months&rsquo; rent, paid up front,
plus additional deposits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note&nbsp;13 &ndash; OTHER NONCURRENT
ASSETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other noncurrent assets consisted of the
following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March&nbsp;31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March&nbsp;31,<BR> 2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Forest land use rights*</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">994,558</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1,103,235</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Others</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">52,205</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">92,962</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,046,763</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,196,197</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The prepayment for lease of forest land use rights is made to a local government in connection with an operating land lease agreement. The land is currently used to cultivate Ginkgo trees. The forest rights certificate from the local village extends the life of the lease to January 31, 2060.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The amortization of the prepayment for
the lease of land use right was approximately $26,975 and $28,071 for the years ended March 31, 2020 and 2019, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s amortizations of the
prepayment for lease of land use right for the next five years and thereafter are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">Years ending March 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left">2020</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">26,975</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">2021</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,975</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,975</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,975</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,975</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Thereafter</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">859,683</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note 14 &ndash; Leases</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company leases most of its retail stores
and corporate offices under operating leases, typically with initial terms of 3 to 10 years. Usually within one to three months
prior to the expiration date of a lease, the Company is required to notify the lessor and has a priority to continue renting the
lease property if a lessor intends to lease property. The lease itself does not have restriction or covenants. If both parties
agree to continue, a new lease contract with new lease terms has to been signed by both parties. Usually the rent may increase
year by year based on the lease contract. Sublease is typically not allowed. Any damage, if made by the lessee, to the property
and equipment within the property has to been fixed or reimbursed by the lessee. The Company does not have any leases entered into
but which have not yet commenced. The net lease cost for the year ended March 31, 2020 is $5,471,063. The Company does not have
finance lease according to the definition of ASU 2016-02, <I>Leases </I>(Topic 842). Supplemental cash flow information related
to leases for the year ended March 31, 2020 is as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>Cash paid for amounts included in the measurement of lease liabilities:</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left; padding-left: 9pt">Operating cash flows paid for operating leases</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">5,471,063</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Right-of-use assets obtained in exchange for lease obligations:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt">Operating leases</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 133; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Supplemental balance sheet information related to leases as
of March 31, 2020 is as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">Operating leases:</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left; padding-bottom: 4pt">Operating lease right-of-use assets</TD><TD STYLE="width: 1%; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 4pt double; text-align: right">21,711,376</TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Current portion of operating lease liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">981,090</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Long-term operating lease liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">19,049,575</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt">Total operating lease liabilities</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">20,030,665</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">Weighted average remaining lease term</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Operating leases</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">Weighted average discount rate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Operating leases</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4.19</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table summarizes the maturity of lease liabilities
under operating leases as of March 31, 2020:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Operating</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">For the year ending March 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Leases</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left">2020</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1,023,767</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">2021</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,687,126</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,292,371</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,748,801</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,531,061</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Thereafter</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,209,053</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt">Total lease payments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,492,179</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Less: imputed interest</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,461,514</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt; padding-left: 9pt">Total lease liabilities</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">20,030,665</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note&nbsp;15 &ndash; INTANGIBLE ASSETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net intangible assets consisted of the
following at:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March&nbsp;31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March&nbsp;31,<BR> 2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">License <SUP>(1)</SUP></FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">2,220,512</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1,909,700</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software<SUP>(2)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,083,024</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">676,336</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Land use rights <SUP>(3)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,375,095</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,452,718</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Total intangible assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,678,631</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,038,754</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Less: accumulated amortization</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(667,633</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(441,431</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: impairment<SUP>(4)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(617,038</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Intangible assets, net</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">3,393,960</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">3,597,323</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Amortization expense of intangibles amounted
to $254,303 and $228,046 for the years ended March 31, 2020 and 2019, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This represents
the fair value of the licenses of insurance applicable drugstores acquired from a variety of drugstores such as Sanhao Pharmacy
and several local stores. The licenses allow patients to pay by using insurance cards at stores. The stores are reimbursed from
the Human Resource and Social Security Department of Hangzhou City. In 2014, the Company acquired Sanhao Pharmacy, a drugstore
chain. In September 2017, the Company acquired several new stores for the purpose of the Municipal Social Medical Reimbursement
Qualification Certificates. On January 9, 2020, the Company acquired a local drugstore chain. The acquired drugstores ceased their
stores&rsquo; business and liquidate all of the stores&rsquo; accounts after Jiuzhou Pharmacy acquired them. In March 2020, the
drugstore chain has dissolved and its certificates were transferred to new stores opened at the same time.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">They are primarily the SAP
    ERP system, the Internet Clinic Diagnosis Terminal system and the Chronic Disease Management system. In 2017, we have installed a
    leading ERP system, SAP from Germany. SAP is a well-known management system used by many fortune 500 companies. It is being
    amortized over three years since its installation. In 2020, we have installed an internet Clinic Diagnosis System used to strengthen
    our ability to perform online diagnosis which may increase more customer spending and a Chronic Disease Management System used to
    better manage and monitor our members&rsquo; health. As of March 31, 2020, the SAP system has a net value of $228,133 (RMB1,617,816),the internet Clinic Diagnosis System has a net value of approximately $379,143 (RMB2,688,709), the Chronic Disease
    Management System has a net value of approximately $16,411 (RMB 116,379).</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 134; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2013, the Company purchased the land use rights of a plot of land in Lin&rsquo;an, Hangzhou, intended for the establishment of an herb processing plant in the future. However, as the Company&rsquo;s farming business in Lin&rsquo;an has not grown, the Company does not expect completion of the plant in the near future.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the year ended March 31, 2020, the company evaluated the licenses of insurance applicable drugstores acquired in the past based on the discounted positive cash value. Due to the stricter government insurance policy in fiscal year 2021, the value of these licenses has declined. As a result, the company recorded an impairment.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note&nbsp;16 &ndash; NOTES PAYABLE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has credit facilities with
Hangzhou United Bank (&ldquo;HUB&rdquo;), Zhejiang Tailong Commercial Bank (&ldquo;ZTCB&rdquo;), Bank of Hangzhou (&ldquo;BOH&rdquo;),
and China Merchant Bank (&ldquo;CMB&rdquo;) that provided working capital in the form of the following bank acceptance notes at
March 31, 2020 and March 31, 2019:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Origination</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Maturity</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">March&nbsp;31,</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">March 31,</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid">Beneficiary</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid">Endorser</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid">date</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid">date</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%">Jiuzhou Pharmacy(1)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: center">HUB</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: center">11/06/18</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: center">05/06/19</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">500,857</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Jiuzhou Pharmacy(1)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">HUB</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">12/12/18</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">06/12/19</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,236,559</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Jiuzhou Pharmacy(1)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">HUB</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">12/20/18</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">06/20/19</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,072,606</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Jiuzhou Pharmacy(1)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">HUB</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">12/29/18</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">06/29/19</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,504,943</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Jiuzhou Pharmacy(1)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">HUB</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">02/14/18</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">08/14/19</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,587,331</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Jiuzhou Pharmacy(1)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">HUB</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">03/06/18</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">09/06/19</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,600,727</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Jiuxin Medicine(1)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">HUB</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">10/11/18</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">04/11/19</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,461,531</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Jiuxin Medicine(1)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">HUB</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">11/06/18</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">05/06/19</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,987,119</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Jiuzhou Pharmacy(1)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">HUB</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">10/09/19</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">04/09/20</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,478,259</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Jiuzhou Pharmacy(1)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">HUB</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">11/06/19</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">05/06/20</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">164,582</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Jiuzhou Pharmacy(1)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">HUB</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">12/05/19</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">06/05/20</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,106,474</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Jiuzhou Pharmacy(1)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">HUB</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">12/31/19</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">06/30/20</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,289,308</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Jiuzhou Pharmacy(1)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">HUB</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">01/06/20</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">07/06/20</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">129,457</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Jiuzhou Pharmacy(1)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">HUB</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">02/19/20</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">08/19/20</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,105,096</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Jiuzhou Pharmacy(1)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">HUB</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">03/10/20</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">09/10/20</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,324,871</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Jiuxin Medicine(1)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">HUB</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">12/26/19</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">06/26/20</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,371,992</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Jiuxin Medicine(1)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">HUB</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">12/31/19</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">06/30/20</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,943,776</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">Jiuxin Medicine(1)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">HUB</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">03/31/20</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">09/30/20</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,692,156</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">26,605,971</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">25,951,673</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2019, the Company had $25,951,673 (RMB 174,203,868) of notes payable from HUB. The Company is required to hold restricted cash in the amount of $15,114,740 (RMB 101,459,590) with HUB as collateral against these bank notes. Included in the restricted cash is a total of $10,446,381 three-year deposit (RMB 70,122,647) deposited into HUB as a collateral for current and future notes payable from HUB. As of March 31, 2020, the Company had $26,605,971 (RMB 188,677,437) of notes payable from HUB. The Company is required to hold restricted cash in the amount of $14,596,179 (RMB 103,509,456) with HUB as collateral against these bank notes. Included in the restricted cash is a total of $8,763,958 three-year deposit (RMB 62,150,000) deposited into HUB as a collateral for current and future notes payable from HUB.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2020, the Company had a
credit line of approximately $12.55 million in the aggregate&nbsp;from HUB. By putting up a three-year deposit of $8.76 million
and the restricted cash of $5.83 million deposited in the banks, the total credit line was $27.14 million. As of March 31, 2020,
the Company had approximately $26.61 million of bank notes payable and approximately $0.53 million bank credit line was still available
for further borrowing. The bank notes are secured by three shops of Jiuzhou Pharmacy and guaranteed by the Company&rsquo;s major
shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 135; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note 17 &ndash; Loan Payable</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 2, 2019 and December 11, 2019,
the Company borrowed $717,810 and $6,460,290 from Haihui Commercial, respectively. After deducting processing fee and deposits
which are refundable at the end of loan period, the Company received $617,317 and $5,878,864 respectively. The Company is required
to pledge accounts receivable of three drugstores to Haihui Commercial. As of March 31, 2020, the remaining loan balance is $6,403,700.
The Company is scheduled to make monthly repayments, among which $2,287,742 is due within a year. The Company has an option to
pay off the debts earlier than the repayment schedule upon approval from Haihui Commercial.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note&nbsp;18 &ndash; TAXES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Income tax</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for income taxes under
the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable
to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis,
operating losses and tax credit carry forwards. Deferred tax assets and liabilities are calculated using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect
on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. Valuation
allowances are provided against deferred income tax assets for amounts which are not considered &ldquo;more likely than not&rdquo;
to be realized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is subject to income taxes
on an entity basis on income arising in or derived from the tax jurisdiction in which each entity is domiciled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="border-bottom: black 1.5pt solid; width: 49%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entity</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 49%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income Tax Jurisdiction</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jo-Jo Drugstores</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United States</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Renovation</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hong Kong, PRC</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All other entities</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mainland, PRC</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended March 31, 2020 and
2019, the components of income tax expense consist of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center">For the year ended</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>Current:</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.75pt">Federal</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.75pt">State</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; padding-bottom: 1.5pt; padding-left: 0.75pt">Foreign</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">16,258</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">134,763</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.75pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,258</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">134,763</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.75pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.75pt">Deferred:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.75pt">Federal</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.75pt">State</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 0.75pt">Foreign</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 0.75pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt; padding-left: 0.75pt">Provision for income taxes</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">16,258</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">134,763</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A reconciliation of the income tax provision
at the federal statutory rate and the effective rate is as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center">For the year</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Ended March 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">U.S. Statutory rates</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">21.0</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">21.0</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Foreign income not recognized in the U.S.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(21.0</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(21.0</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">China income taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25.0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25.0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Change in valuation allowance (1)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(25.0</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(25.0</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Non-deductible expenses-permanent difference (2)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(0.3</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(11.4</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt">Effective tax rate</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(0.3</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)%</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(11.4</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents a non-taxable expense reversal due to overall decrease in allowance for accounts receivable and advances to suppliers.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The (0.3)% and (11.4)% rate adjustments for the years ended March 31, 2020 and 2019 represent expenses that primarily include stock option expenses and other expenses incurred by the Company that are not deductible for PRC income tax.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 136; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The components of the Company&rsquo;s net
deferred tax assets are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">As of<BR> 3/31/2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">As of<BR> 3/31/2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; padding-left: 0.75pt">Allowance</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">948,951</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">986,665</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.75pt">Long-lived assets impairment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">709,230</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">586,298</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.75pt">Accrued expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,443,191</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,569,683</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.75pt">Net operating loss carry forward</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,157,900</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,164,735</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.75pt">Foreign Tax Credit Carryover</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">195,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">195,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt">Total deferred tax assets (liabilities):</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,454,272</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,502,381</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.75pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.75pt">Valuation allowance</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,454,272</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,502,381</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt; padding-left: 0.75pt">Net deferred tax assets (liabilities)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company regularly assesses the realizability
of its deferred tax assets and establishes a valuation allowance if it is more-likely-than-not that some portion of the deferred
tax assets will not be realized. We weigh all available positive and negative evidence, including earnings history and results
of recent operations, scheduled reversals of deferred tax liabilities, projected future taxable income, and tax planning strategies.
Assumptions used to forecast future taxable income often require significant judgment. More weight is given to objectively verifiable
evidence. In the event we determine that we would not be able to realize all or part of our net deferred tax assets in the future,
a valuation allowance will be established against deferred tax assets in the period in which we make such determination. The need
to establish a valuation allowance against deferred tax assets may cause greater volatility in our effective tax rate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2020 and March 31, 2019,
the estimated net operating loss carry forwards for U.S. income tax purposes amounted to $816,908, which may be available to reduce
future years&rsquo; taxable income. These carry forwards will expire if not utilized by 2032. In addition, the Company carries
a foreign tax credit of $195,000. As of March 31, 2020 and March 31, 2019, the estimated net operating loss carry forwards for
Hong Kong income tax purposes amounted to $2,248,203 and $1,960,933, which may be available to reduce future years&rsquo; taxable
income. As of March 31, 2020 and March 31, 2019, the estimated net operating loss carry forwards for China income tax purposes
amounted to $2,461,582 and $2,678,523, which may be available to reduce future years&rsquo; taxable income. These carry forwards
will expire if not utilized in the next five years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recorded net unrecognized tax
benefits of $0.0 million as of March 31, 2020. It is our policy to classify accrued interest and penalties related to unrecognized
tax benefits in the provision for income taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Audit periods remain open for review until
the statute of limitations has passed, which in the PRC is usually 5 years as the Company&rsquo;s most significant tax jurisdiction.
The completion of review or the expiration of the statute of limitations for a given audit period could result in an adjustment
to the Company&rsquo;s liability for income taxes. Any such adjustment could be material to the Company&rsquo;s results of operations
for any given quarterly or annual period based, in part, upon the results of operations for the given period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 137; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 19 &ndash; POSTRETIREMENT BENEFITS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Regulations in the PRC require the Company
to contribute to a defined contribution retirement plan for all permanent employees. The contribution for each employee is based
on a percentage of the employee&rsquo;s current compensation as required by the local government. The Company contributed $1,341,167
and $1,423,449 in employment benefits and pension for the years ended March 31, 2020 and 2019, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 20 &ndash; RELATED PARTY TRANSACTIONS AND ARRANGEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Amounts payable to related parties are
summarized as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March&nbsp;31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31,<BR> 2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to a director and CEO <SUP>(1)</SUP> :</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">490,218</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">795,179</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to foreign exchange restrictions, the Company&rsquo;s director and CEO, Mr. Lei Liu personally lent U.S. dollars to the Company to facilitate its payments of expenses in the United States.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company leases a retail space from
Mr. Lei Liu. The lease expires in September 2020. Rent expenses totaled $26,582 and $27,605 for the twelve months ended March&nbsp;31,
2020 and 2019, respectively. The amounts owed under the lease for the twelve months ended December 31, 2020 and 2019 were not paid
to Mr. Liu as of March 31, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 28, 2018, 10% of Jiuxin Medicine
was sold to Hangzhou Kangzhou Biotech Co. Ltd. for a total proceeds of approximately $75,643 (RMB507, 760). Mr. Lei Liu owns 51%
of Hangzhou Kangzhou Biotech Co. Ltd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 21 &ndash; WARRANTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the registered direct
offering closed on July 19, 2015, the Company issued to an investor a warrant to purchase up to 600,000 shares of common stock
at an exercise price of $3.10 per share. The warrant became exercisable on January 19, 2016 and will expire on January 18, 2021.
In connection with the offering, the Company also issued a warrant to its placement agent of this offering, pursuant to which the
agent may purchase up to 6% of the aggregate number of shares of common stock sold in the offering, i.e. 72,000 shares. Such warrant
has the same terms as the warrant issued to investor in the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The fair value of the warrants issued to
purchase 672,000 shares as described above was estimated by using the binominal pricing model with the following assumptions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Common Stock<BR> Warrants</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Common Stock<BR> Warrants</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March&nbsp;31,<BR> 2020(1)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31,<BR> 2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Stock price</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1.77</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">2.62</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Exercise price</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3.10</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3.10</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Annual dividend yield</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Expected term (years)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.81</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.80</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Risk-free interest rate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.71</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.27</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Expected volatility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">62.08</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">67.69</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2020, the warrants had not been exercised.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon evaluation, the warrants meet the
definition of a derivative under FASB ASC 815, as the Company cannot avoid a net cash settlement under certain circumstances. Accordingly,
the fair value of the warrants was classified as a liability of $465,248 as of March 31, 2019. For the year ended March 31, 2020,
the Company recognized a gain of $401,158 for the investor warrant and placement agent warrant, from the change in fair value of
the warrant liability, respectively. As a result, the warrant liability is carried on the consolidated balance sheets at the fair
value of $64,090 for the investor warrant and placement agent warrant, collectively, as of March 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 138; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note 22 &ndash; Employee
Deposits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To encourage operating team, which consists
of doctors and nurses, to devote their efforts to run clinics, Linjia Medical allows them to put deposits in the clinic where doctors
and nurses work, and take shares in any profit of the clinic. The principal amounts of these deposits are refundable in the event
the doctors and nurses leave the clinic. In order to properly reflect Linjia Medical&rsquo;s liabilities, the Company reclassified
the deposit of $70,507 (RMB500,000) as financial liability as of March 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Note 23 &ndash; STOCKHOLDER&rsquo;S EQUITY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Common stock</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 23, 2017, the Company closed
a private offering with one institutional investor (the &ldquo;Investor&rdquo;) pursuant to which the Company sold to the Investor,
and the Investor purchased from the Company, an aggregate of 4,840,000 shares of the common stock, par value $0.001 per share,
of the Company, at a purchase price of $2.20 per share, for aggregate gross proceeds to the Company of $10,648,000 (the &ldquo;Private
Placement&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Stock warrants </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Concurrent with the registered direct offering
of common stock that closed on April 15, 2019, the Company issued to several investors in a private placement warrants to purchase
up to 3,000,006 shares of common stock. In connection with the offering, the Company also issued a warrant to its placement agent
of this offering, pursuant to which the agent may purchase up to 6% of the aggregate number of shares of common stock sold in the
offering, i.e. 240,000 shares at an exercise price of $3.125 per share. The warrant became exercisable on October 11, 2019 and
will expire on April 11, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon evaluation, the warrants issued in
April 2019 meet the definition of an equity under FASBASC 815. Accordingly, the fair value of the warrants recorded as a part of
additional paid-in capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Stock-based compensation</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for share-based payment
awards granted to employees and directors by recording compensation expense based on estimated fair values. The Company estimates
the fair value of share-based payment awards on the date of grant. The value of the portion of the award that is ultimately expected
to vest is recognized as an expense over the requisite service periods in the Company&rsquo;s consolidated statements of operations.
Share-based awards are attributed to expenses using the straight-line method over the vesting period. The Company determines the
value of each option award that contains a market condition using a Monte Carlo Simulation valuation model, while all other option
awards are valued using the Black-Scholes valuation model as permitted under FASB ASC 718 &ldquo;Compensation - Stock Compensation.&rdquo;
The assumptions used in calculating the fair value of share-based payment awards represent the Company&rsquo;s best estimates.
The Company&rsquo;s estimates of the fair values of stock options granted and the resulting amounts of share-based compensation
recognized may be impacted by certain variables including stock price volatility, employee stock option exercise behaviors, additional
stock option modifications, estimates of forfeitures, and the related income tax impact.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 30, 2018, the Company
granted a total of 3,947,100 shares of restricted common stock to its key employees in its retail drugstores and online
pharmacy under the Company&rsquo;s 2010 Equity Incentive Plan, as amended (the &ldquo;Plan&rdquo;). The stock awards vested
on the grant date. On June 28, 2018, the compensation committee of the Company canceled 225,000 shares granted to the CEO in
order to conform aggregate issuances to the 675,000 share limitation set forth in the Plan. The Tax Cuts and Jobs Act of 2017
removed the 162(m) qualified performance based compensation exemption to the $1 million cap on deductions for compensation to
covered executives. Section 1.3.2 was in the Plan to permit grants under the Plan to fit within that exemption. As that
exemption no longer applies for grants made in 2018 or thereafter, the Plan has been amended to remove the provisions
intended to comply with that exemption, including the one in Section 1.3.2 of the Plan. All $5,328,585 of such expense has
been recorded as a service compensation expense in the year ended March 31, 2018.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Stock option</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 18, 2014, the Company granted
a total of 967,000 shares of stock options under the Plan to a group of a total of 46 grantees including directors, officers and
employees. The exercise price of the stock option is $2.50. The option vests on November 18, 2017, provided that the grantees are
still employed by the Company on such a date. The options will be exercisable for five years from the vesting date, or November
18, 2017 until November 17, 2022. For the years ended March 31, 2020 and 2019, $0 and $0 were recorded as compensation expenses.
As of March 31, 2020, all compensation costs related to stock option compensation arrangements granted have been recognized.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 139; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Statutory reserves</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Statutory reserves represent restricted
retained earnings. Based on their legal formation, the Company is required to set aside 10% of its net income as reported in their
statutory accounts on an annual basis to the Statutory Surplus Reserve Fund (the &ldquo;Reserve Fund&rdquo;). Once the total amount
set aside in the Reserve Fund reaches 50% of the entity&rsquo;s registered capital, further appropriations become discretionary.
The Reserve Fund can be used to increase the entity&rsquo;s registered capital upon approval by relevant government authorities
or eliminate its future losses under PRC GAAP upon a resolution by its board of directors. The Reserve Fund is not distributable
to shareholders, as cash dividends or otherwise, except in the event of liquidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Appropriations to the Reserve Fund are
accounted for as a transfer from unrestricted earnings to statutory reserves. During the years ended March 31, 2020 and 2019, the
Company did not make appropriations to statutory reserves.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no legal requirements in the
PRC to fund the Reserve Fund by transfer of cash to any restricted accounts, and the Company does not do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note 24 &ndash; LOSS PER SHARE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company reports earnings per share
in accordance with the provisions of the FASB&rsquo;s related accounting standard. This standard requires presentation of basic
and diluted earnings per share in conjunction with the disclosure of the methodology used in computing such earnings per share.
Basic earnings per share excludes dilution, but includes vested restricted stocks and is computed by dividing income available
to common stockholders by the weighted average common shares outstanding during the period.&nbsp;&nbsp;Diluted earnings per share
takes into account the potential dilution that could occur if securities or other contracts to issue common stock were exercised
and converted into common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a reconciliation of the
basic and diluted earnings per share computation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">The year ended<BR> March 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Net income attributable to controlling interest</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(5,813,369</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(926,278</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Weighted average shares used in basic computation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,816,567</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">28,936,778</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Diluted effect of stock options and warrants</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Weighted average shares used in diluted computation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,816,567</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">28,936,778</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Income per share &ndash; Basic:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Net income before noncontrolling interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.18</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.03</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Add: Net loss attributable to noncontrolling interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Net income&nbsp;&nbsp;attributable to controlling interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.18</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.03</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Loss per share &ndash; Diluted:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Net income before noncontrolling interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.18</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.03</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Add: Net income attributable to noncontrolling interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Net income attributable to controlling interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.18</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.03</TD><TD STYLE="text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended March 31, 2020, 967,000
shares underlying employee stock options and 600,000 shares underlying outstanding purchase options to an investor, and 72,000
shares underlying outstanding purchase option to an investment placement agent were excluded from the calculation of diluted loss
per share as the options were anti-dilutive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note 25 &ndash; SEGMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company operates within four main reportable
segments: retail drugstores, online pharmacy, drug wholesale and herb farming.&nbsp;&nbsp;The retail drugstores segment sells prescription
and over-the-counter (&ldquo;OTC&rdquo;) medicines, TCM, dietary supplements, medical devices, and sundry items to retail customers.&nbsp;The
online pharmacy sells OTC drugs, dietary supplements, medical devices and sundry items to customers through several third-party
platforms such as Alibaba&rsquo;s Tmall, JD.com and Amazon.com, and the Company&rsquo;s own platform all over China. The drug wholesale
segment includes supplying the Company&rsquo;s own retail&nbsp;drugstores with prescription and OTC medicines, TCM, dietary supplement,
medical devices and sundry items (which sales have been eliminated as intercompany transactions), and also selling them to other
drug vendors and hospitals. The Company&rsquo;s herb farming segment cultivates selected herbs for sales to other drug vendors.
The Company is also involved in online sales and clinic services that do not meet the quantitative thresholds for reportable segments
and are included in the retail drugstores segment. The segments&rsquo; accounting policies are the same as those described in the
summary of significant accounting policies. The Company evaluates performance based on profit or loss from operations before interest
and income taxes not including nonrecurring gains and losses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s reportable business
segments are strategic business units that offer different products and services. Each segment is managed separately because they
require different operations and markets to distinct classes of customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 140; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents summarized
information by segment of the continuing operations for the year ended March 31, 2020:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Retail drugstores</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Online Pharmacy</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Drug wholesale</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Herb<BR>
farming</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,081,237</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,541,215</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,705,237</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">117,327,689</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of goods</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,244,302</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,106,510</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,450,447</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">91,801,259</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross profit</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,836,935</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,434,705</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,254,790</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,526,430</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,434,860</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,148,709</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,210,034</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23,793,603</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General and administrative expenses</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;5,505,303 </FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">243,283</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;2,359,791 </FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;8,108,377 </FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Impairment of long-lived assets</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">628,192</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">628,192</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss&nbsp;from operations</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,731,420</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(957,287</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,315,035</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,003,742</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation and amortization</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,042,951</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,866</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,082,817</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total capital expenditures</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,406,470</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,176</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,409,646</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table presents summarized
information by segment of the continuing operations for the year ended March 31, 2019:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Retail drugstores</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Online Pharmacy</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Drug wholesale</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Herb<BR> farming</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%">Revenue</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">72,334,409</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">8,784,459</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">26,432,144</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">107,551,012</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Cost of goods</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">51,246,983</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,748,519</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,447,467</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">82,442,969</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Gross profit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">21,087,426</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,035,940</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,984,677</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">25,108,043</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Selling expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,930,118</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,735,966</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,599,100</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,265,184</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">General and administrative expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,072,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">347,516</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,701,027</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,718,989</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Impairment of long-lived assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Loss&nbsp;from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(1,915,192</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(1,047,542</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,086,604</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(876,130</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,476,903</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">7,644</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,484,547</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Total capital expenditures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">7,267,847</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,434</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">7,269,281</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 141; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not have long-lived assets
located outside the PRC. In accordance with the enterprise-wide disclosure requirements of FASB&rsquo;s accounting standard, the
Company&rsquo;s net revenue from external customers through its retail drugstores by main product category for the years ended
March 31, 2020 and 2019 were as follows:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center">For the year&nbsp;ended</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Prescription drugs</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">26,045,423</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">23,516,046</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">OTC drugs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,532,248</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,401,328</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Nutritional supplements</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,013,622</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,354,108</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>TCM</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,325,008</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,529,790</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Sundry products</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,312,293</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">941,491</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Medical devices</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,852,643</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,591,646</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">74,081,237</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">72,334,409</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s net revenue from external
customers through online pharmacy by main product category is as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center">For the year&nbsp;ended</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Prescription drugs</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1,447,469</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">OTC drugs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,721,638</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,127,976</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Nutritional supplements</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">742,809</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">737,315</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>TCM</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">266,638</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">74,262</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Sundry products</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,082,601</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,736,070</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Medical devices</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,280,060</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,108,836</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">13,541,215</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">8,784,459</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company&rsquo;s net revenue from external customers through
wholesale by main product category is as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center">For the years&nbsp;ended</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">March 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Prescription drugs</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">24,857,708</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">16,745,862</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">OTC drugs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,196,841</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,964,587</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Nutritional supplements</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">205,881</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">290,534</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>TCM</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">314,769</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">271,280</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Sundry products</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">43,854</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,846</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Medical devices</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">86,184</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">135,035</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">29,705,237</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">26,432,144</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 142; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Note 26 &ndash; SUBSEQUENT EVENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 29, 2020, an Investor exercised
part of its warrants by purchasing 25,000 shares of common stocks at $3.10 per share. Total proceeds to the Company is $77,500.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 3, 2020, the Company closed a registered
direct offering of 5,000,004 shares of common stock at $2.00 per share with gross proceeds of $10,000,008 from its effective shelf
registration statement on Form S-3 pursuant to a Securities Purchase Agreement dated June 1, 2020 (the &ldquo;2020 Securities Purchase
Agreement&rdquo;), by and among the Company and the investors named therein. Concurrently, the Company issued unregistered warrants
to the investors in a private placement to purchase up to an aggregate of 3,750,003 shares of common stock at an exercise price
of $2.60 per share (the &ldquo;2020 Warrants&rdquo;). The 2020 Warrants shall be initially exercisable six months following issuance
and expire five and one-half years from the issuance date. H.C. Wainwright &amp; Co., LLC (the &ldquo;Placement Agent&rdquo;) (or
its designees) shall also receive warrants to purchase such number of shares of common stock as is equal to 6.5% of the aggregate
number of shares of common stock sold in the offering, or 300,000 warrants, with substantially the same terms as the 2020 Warrants
being issued to the investors, except that, among other things, the Placement Agent&rsquo;s warrants will expire on June 1, 2025
and warrants&rsquo; exercise price shall be $2.57.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The recent outbreak of COVID-19, which
was declared as a pandemic by the World Health Organization on March 11, 2020, has led to an adverse impacts on the World&rsquo;s
economy. At the outbreak of COVID-19, the company has reduced the store hours, supply and customer service. To stay safe, people tend not to shop and entertain as much
as in the past. The retail business such as restaurants, hotels and cinema have declined. The peak is in February
2020. However, as the spread of COVID-19 is effectively controlled in China, the business has come back to normal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 143; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CHINA
JO-JO DRUGSTORES, INC. AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a_003"></A>CONDENSED
CONSOLIDATED BALANCE SHEETS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(UNAUDITED)</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; text-align: justify"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 9.5pt">December&nbsp;31,</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center"><FONT STYLE="font-size: 9.5pt">March&nbsp;31,</FONT></TD><TD STYLE="white-space: nowrap"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 9.5pt">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 9.5pt">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 9.5pt"><U>ASSETS</U></FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 9.5pt">CURRENT ASSETS</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; width: 76%; text-align: justify"><FONT STYLE="font-size: 9.5pt">Cash and cash equivalents</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9.5pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-size: 9.5pt">12,116,508</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9.5pt">$</FONT></TD><TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-size: 9.5pt">16,176,318</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Restricted cash</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">12,925,216</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">14,806,288</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Financial assets available for sale</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">170,604</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">157,159</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Notes receivable</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">57,005</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Trade accounts receivable</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">11,521,988</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">9,770,656</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Inventories</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">14,933,245</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">12,247,004</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Other receivables, net</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">5,084,145</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">5,069,442</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Advances to suppliers</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">4,511,821</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">1,174,800</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Other current assets</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">1,821,838</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">1,528,540</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Total current assets</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">63,085,365</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">60,987,212</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 9.5pt">PROPERTY AND EQUIPMENT, net</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">6,727,485</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">7,633,740</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 9.5pt">OTHER ASSETS</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Long-term investment</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">4,295,979</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">2,544,451</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Farmland assets</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">830,595</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">742,347</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Long term deposits</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">1,551,248</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">1,456,384</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Other noncurrent assets</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">1,136,261</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">1,046,763</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Operating lease right-of-use assets</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">21,389,539</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">21,711,376</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Intangible assets, net</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">3,541,672</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">3,393,960</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Total other assets</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">32,745,294</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">30,895,281</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.375in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Total assets</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-size: 9.5pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-size: 9.5pt">102,558,144</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-size: 9.5pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-size: 9.5pt">99,516,233</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-decoration: underline; text-align: justify"><FONT STYLE="font-size: 9.5pt">LIABILITIES AND STOCKHOLDERS&rsquo;
    EQUITY</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 9.5pt">CURRENT LIABILITIES</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Short-term bank loan</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">2,296,155</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">1,410,130</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Accounts payable, trade</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">18,064,997</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">21,559,494</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Notes payable</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">25,736,161</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">26,605,971</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Other payables</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">2,744,874</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">2,522,330</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Other payables - related parties</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">689,274</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">490,218</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Customer deposits</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">841,686</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">708,140</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Taxes payable</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">690,906</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">119,247</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Accrued liabilities</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">681,316</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">753,612</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Long-term loan payable-current portion</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">2,480,264</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">2,287,742</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Current portion of operating lease liabilities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">1,650,085</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">981,090</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Total current liabilities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">55,875,718</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">57,437,974</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Long-term loan payable</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">2,589,643</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">4,115,958</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Long-term operating lease&nbsp;liabilities</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">17,993,514</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">19,049,575</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Employee Deposits</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">15,308</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">70,507</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Purchase option and warrants liability</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">64,090</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Total liabilities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">76,474,183</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">80,738,104</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 9.5pt">COMMITMENTS AND CONTINGENCIES</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 9.5pt">STOCKHOLDERS&rsquo; EQUITY</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Common stock;
    $0.001 par value; 250,000,000 shares authorized; 41,751,790 and 32,936,786 shares issued and outstanding as of December 31,
    2020 and March 31, 2020, respectively</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">41,752</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">32,937</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.25in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Preferred stock;
    $0.001 par value; 10,000,000 shares authorized; nil issued and outstanding as of December 31 and March 31, 2020, respectively</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Additional paid-in capital</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">67,506,686</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">54,209,301</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Statutory reserves</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">1,309,109</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">1,309,109</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Accumulated deficit</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">(44,382,384</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">)</FONT></TD><TD><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 9.5pt">(36,400,837</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 9.5pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Accumulated other comprehensive income</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">3,649,357</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">1,440,424</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Total stockholders&rsquo; equity</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">28,124,520</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">20,590,934</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Noncontrolling interests</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">(2,040,559</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">(1,812,805</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Total equity</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">26,083,961</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 9.5pt">18,778,129</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.375in; text-align: justify"><FONT STYLE="font-size: 9.5pt">Total liabilities and stockholders&rsquo;
    equity</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-size: 9.5pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-size: 9.5pt">102,558,144</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 4pt"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left"><FONT STYLE="font-size: 9.5pt">$</FONT></TD><TD STYLE="border-bottom: Black 4pt double; text-align: right"><FONT STYLE="font-size: 9.5pt">99,516,233</FONT></TD><TD STYLE="padding-bottom: 4pt; text-align: left"><FONT STYLE="font-size: 9.5pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 4pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these condensed consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 144; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CHINA
JO-JO DRUGSTORES, INC. AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a_004"></A>CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(UNAUDITED)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">For the three months ended<BR> December&nbsp;31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">For the nine months ended<BR> December&nbsp;31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left">REVENUES, NET</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">35,538,759</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">33,363,282</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">97,435,616</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">86,997,845</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">COST OF GOODS SOLD</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">27,451,509</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">26,079,910</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">74,355,395</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">66,959,671</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">GROSS PROFIT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,087,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,283,372</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,080,221</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,038,174</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">SELLING EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,262,590</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,676,400</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,010,509</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,130,799</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">GENERAL AND ADMINISTRATIVE EXPENSES</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">6,192,294</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,054,060</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">10,374,019</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">5,729,607</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">TOTAL OPERATING EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,454,884</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,730,460</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,384,528</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,860,406</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">INCOME (LOSS) FROM OPERATIONS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,367,634</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">552,912</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,304,307</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,822,232</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">OTHER INCOME (EXPENSE):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">INTEREST INCOME</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">193,207</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">272,773</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">544,462</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">661,160</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">INTEREST EXPENSE</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(109,896</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(354,975</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>OTHER</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(43,525</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(302,408</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(118,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(437,118</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">CHANGE IN FAIR VALUE OF DERIVATIVE LIABILITIES</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">36,306</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(65,172</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">64,090</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">345,248</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">INCOME (LOSS) BEFORE INCOME TAXES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,291,542</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">458,105</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,168,730</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,252,942</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">PROVISION FOR INCOME TAXES</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,976</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,184</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">40,571</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">16,274</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">NET INCOME (LOSS)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,293,518</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">455,921</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,209,301</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,269,216</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">LESS: NET LOSS ATTRIBUTABLE TO NONCONTROLLING INTEREST</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(37,199</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(75,861</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(227,754</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(441,084</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -9pt; padding-left: 9pt">NET INCOME (LOSS) ATTRIBUTABLE TO CHINA JO-JO DRUGSTORES, INC.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,256,319</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">531,782</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,981,547</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,828,132</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Foreign currency translation adjustments</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,083,903</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">358,868</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,208,933</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(582,705</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 4pt">COMPREHENSIVE GAIN (LOSS)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(5,209,615</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">814,789</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(6,000,368</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(3,851,921</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>WEIGHTED AVERAGE NUMBER OF SHARES:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt; text-indent: 20pt">Basic</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">41,339,834</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">32,936,786</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">40,462,971</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">32,776,786</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt; text-indent: 20pt">Diluted</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">41,339,834</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">32,936,786</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">40,462,971</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">32,776,786</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>EARNINGS (LOSS) PER SHARE</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt; text-indent: 20pt">Basic</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(0.15</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">0.02</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(0.20</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(0.09</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt; text-indent: 20pt">Diluted</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(0.15</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">0.02</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(0.20</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(0.09</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these condensed consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 145; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CHINA
JO-JO DRUGSTORES, INC. AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a_005"></A>CONDENSED
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&rsquo; EQUITY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(UNAUDITED)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">Accumulated</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Common Stock</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center">Additional</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Retained Earnings</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; text-align: center">other</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; text-align: center">Non-</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Number of</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Paid-in</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Statutory</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Accumulated</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">comprehensive</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">controlling</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">shares</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">capital</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">reserves</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">deficit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">income/(loss)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">interest</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; width: 20%; text-align: left">BALANCE, March&nbsp;31, 2019.</TD><TD STYLE="width: 1%; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; border-bottom: Black 4pt double; text-align: right">28,936,778</TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; border-bottom: Black 4pt double; text-align: right">28,937</TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; border-bottom: Black 4pt double; text-align: right">44,905,664</TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; border-bottom: Black 4pt double; text-align: right">1,309,109</TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; border-bottom: Black 4pt double; text-align: right">(30,587,468</TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="width: 1%; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; border-bottom: Black 4pt double; text-align: right">2,508,964</TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; border-bottom: Black 4pt double; text-align: right">(1,194,039</TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="width: 1%; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; border-bottom: Black 4pt double; text-align: right">16,971,167</TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Stock based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,560</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,560</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Sale of stock and warrants</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,000,008</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,269,077</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,273,077</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Net loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,134,951</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(243,219</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,378,170</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Foreign currency translation loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(403,620</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(403,620</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">BALANCE, June&nbsp;30, 2019.</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">32,936,786</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">32,937</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">54,209,301</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,309,109</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(32,722,419</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">2,105,344</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(1,437,258</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">23,497,014</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Net loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,224,963</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(122,004</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,346,967</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Foreign currency translation gain</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(526,630</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(526,630</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">BALANCE, September 30, 2019.</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">32,936,786</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">32,937</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">54,209,301</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,309,109</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(33,947,382</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,578,714</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(1,559,262</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">21,623,417</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Net income(loss)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">531,782</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(75,861</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">455,921</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Foreign currency translation gain</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">348,128</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">348,128</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">BALANCE, December 31, 2019.</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">32,936,786</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">32,937</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">54,209,301</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,309,109</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(33,415,600</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,926,842</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(1,635,123</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">22,427,466</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">BALANCE, March&nbsp;31, 2020.</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">32,936,786</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">32,937</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">54,209,301</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,309,109</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(36,400,837</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,440,424</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(1,812,805</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">18,778,129</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Exercise of warrants</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">77,475</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">77,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Sale of stock and warrants</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,000,004</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,282,100</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,287,100</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Net loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(231,509</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(157,083</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(388,592</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Foreign currency translation gain</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">93,569</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">93,569</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">BALANCE, June&nbsp;30, 2020.</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">37,961,790</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">37,962</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">63,568,876</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,309,109</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(36,632,346</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,533,993</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(1,969,888</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">27,847,706</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Net loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,493,719</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(33,472</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,527,191</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Foreign currency translation gain</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,031,461</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,031,461</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">BALANCE, September 30, 2020.</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">37,961,790</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">37,962</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">63,568,876</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,309,109</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(38,126,065</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">2,565,454</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(2,003,360</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">27,351,976</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Issuance of incentive common stocks award</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,790,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,790</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,937,810</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,941,600</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Net loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,256,319</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(37,199</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,293,518</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Foreign currency translation gain </TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,083,903</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,083,903</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">BALANCE, December 31, 2020.</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">41,751,790</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">41,752</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">67,506,686</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,309,109</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(44,382,384</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">3,649,357</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(2,040,559</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">26,083,961</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these condensed consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 146; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CHINA
JO-JO DRUGSTORES, INC. AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="a_006"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(UNAUDITED)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">For&nbsp;the&nbsp;nine&nbsp;months&nbsp;ended<BR> December&nbsp;31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">CASH FLOWS FROM OPERATING ACTIVITIES:</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Net loss</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(8,209,301</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(3,269,216</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Adjustments to reconcile net income to net cash provided by operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt">Bad debt direct write-off and provision</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,065</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(29,038</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 9pt">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,657,001</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,572,925</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt">Stock based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,941,600</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,560</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 9pt">Change in fair value of purchase option derivative liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(64,090</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(345,248</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt">Changes in operating assets and liabilities&#65306;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 9pt">Accounts receivable, trade</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,203,132</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,581,208</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt">Notes receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">58,848</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">122,175</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 9pt">Inventories and biological assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,558,139</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,484,432</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt">Other receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">625,207</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,353,544</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 9pt">Advances to suppliers</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,050,898</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(222,928</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt">Other current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(79,851</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,758,533</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 9pt">Long term deposit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">28,275</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">597,084</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt">Other noncurrent assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">52</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,744</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 9pt">Accounts payable, trade</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,077,172</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,397,104</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt">Other payables and accrued liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(118,323</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(917,398</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 9pt">Customer deposits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">69,385</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">458,415</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 9pt">Taxes payable</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">525,005</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">312,192</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 9pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 0.25in">Net cash used in operating activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(12,448,468</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(11,274,690</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">CASH FLOWS FROM INVESTING ACTIVITIES:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: 10pt">Disposal of financial&nbsp;assets&nbsp;available&nbsp;for&nbsp;sale</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,370</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt">Acquisition of equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(41,565</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(561,677</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 9pt">Purchases of intangible assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(62,644</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(461,013</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt">Investment in a joint venture</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,458,633</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 9pt">Additions to leasehold improvements</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(261,759</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(705,856</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 0.25in">Net cash used in investing activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,824,601</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,714,176</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">CASH FLOWS FROM FINANCING ACTIVITIES:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: 10pt">Proceeds from short-term bank loan</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">727,855</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt">Proceeds from third parties&rsquo; loan</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,085,406</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: 10pt">Repayment of&nbsp;&nbsp;third parties&rsquo; loan</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,789,379</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt">Proceeds from notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39,320,707</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">36,537,832</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 9pt">Repayment of notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(42,312,460</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(39,784,592</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt">Decrease in Employee Deposits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(58,228</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,185</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 9pt">Exercise of warrants</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">77,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt">Net Proceeds from equity financing</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,287,100</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,273,077</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 9pt">Repayment of other payables-related parties</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">168,990</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(406,506</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 0.25in">Net cash provided by financing activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">5,422,085</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">12,698,032</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">EFFECT OF EXCHANGE RATE ON CASH</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,910,102</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(559,998</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">(DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED
                                     CASH</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,940,882</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(850,832</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">30,982,606</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">24,745,202</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, end of period</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">25,041,724</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">23,894,370</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;Cash paid for interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">354,975</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt; padding-left: 9pt">Cash paid for income taxes</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">35,954</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">17,215</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these condensed consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 147; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A NAME="a_007"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
1 &ndash; DESCRIPTION OF BUSINESS AND ORGANIZATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">China
Jo-Jo Drugstores, Inc. (&ldquo;Jo-Jo Drugstores&rdquo; or the &ldquo;Company&rdquo;), was incorporated in Nevada on December 19,
2006, originally under the name &ldquo;Kerrisdale Mining Corporation&rdquo;. On September 24, 2009, the Company changed its name
to &ldquo;China Jo-Jo Drugstores, Inc.&rdquo; in connection with a share exchange transaction as described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 17, 2009, the Company completed
a share exchange transaction with Renovation Investment (Hong Kong) Co., Ltd. (&ldquo;Renovation&rdquo;), whereby 7,900,000 shares
of common stock were issued to the stockholders of Renovation in exchange for 100% of the capital stock of Renovation. The completion
of the share exchange transaction resulted in a change of control. The share exchange transaction was accounted for as a reverse
acquisition and recapitalization and, as a result, the consolidated financial statements of the Company (the legal acquirer) are,
in substance, those of Renovation (the accounting acquirer), with the assets and liabilities, and revenues and expenses, of the
Company being included effective from the date of the share exchange transaction. Renovation has no substantive operations of
its own except for its holdings of Zhejiang Jiuxin Investment Management Co., Ltd. (&ldquo;Jiuxin Management&rdquo;), Zhejiang
Shouantang Medical Technology Co., Ltd. (&ldquo;Shouantang Technology&rdquo;), Hangzhou Jiutong Medical Technology Co., Ltd (&ldquo;Jiutong
Medical&rdquo;), and Hangzhou Jiuyi Medical Technology Co. Ltd. (&ldquo;Jiuyi Technology&rdquo;), its wholly-owned subsidiaries.&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products in the People&rsquo;s
Republic of China (&ldquo;China&rdquo; or the &ldquo;PRC&rdquo;). The Company&rsquo;s offline retail business is comprised primarily
of pharmacies, which are operated by Hangzhou Jiuzhou Grand Pharmacy Chain Co., Ltd. (&ldquo;Jiuzhou Pharmacy&rdquo;), a company
that the Company controls through contractual arrangements. On March 31, 2017, Jiuxin Management established a subsidiary, Lin&rsquo;An
Jiuzhou Pharmacy Co., Ltd (&ldquo;Lin&rsquo;An Jiuzhou&rdquo;) to operate drugstores in Lin&rsquo;an City.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 9, 2020, in order to continue
expanding and strengthening its local drugstore network, Jiuzhou Pharmacy acquired a local drugstores chain with ten stores at
a price of $0.14 (RMB 1). The acquired chain agreed to cease all business and liquidate all accounts of the stores that were acquired.
In March 2020, the chain was dissolved, and its government insurance reimbursement certificates have been transferred to new stores
owned by Jiuzhou Pharmacy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s offline retail business
includes four medical clinics through Hangzhou Jiuzhou Clinic of Integrated Traditional and Western Medicine (General Partnership)
(&ldquo;Jiuzhou Clinic&rdquo;) and Hangzhou Jiuzhou Medical and Public Health Service Co., Ltd. (&ldquo;Jiuzhou Service&rdquo;),
both of which are controlled by the Company through contractual arrangements. In May 2014, Shouantang Technology established
Hangzhou Shouantang Bio-technology Co., Ltd. (&ldquo;Shouantang Bio&rdquo;). In May 2016, Shouantang Bio set up and held 49% of
Hangzhou Kahamadi Bio-technology Co., Ltd. (&ldquo;Kahamadi Bio&rdquo;), a joint venture specializing in brand name development for
nutritional supplements. In 2018, Jiuzhou Pharmacy invested a total of $741,540 (RMB5,100,000) in and held 51% of Zhejiang Jiuzhou
Linjia Medical Investment and Management Co. Ltd (&ldquo;Linjia Medical&rdquo;), which has ceased its operation as of December 31,
2020. On March 29, 2019, Jiuzhou Pharmacy formed and held 51% of the equity of Zhejiang AyiGe Medical Health Management Co., Ltd.
(&ldquo;Ayi Health&rdquo;), which was intended to provide technical support such as IT and customer support to our health management
business. However, as the health management business did not progress as planned, on November 19, 2020, Ayi Health was
dissolved.&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently conducts its online retail pharmacy business through Jiuzhou Pharmacy, which holds the Company&rsquo;s online
pharmacy license. On September 10, 2015, Renovation set up Jiuyi Technology to provide additional technical support such as webpage
development to our online pharmacy business. In November 2015, the technical support function was transferred back to Jiuzhou
Pharmacy, which hosts our online pharmacy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s wholesale business is primarily conducted through Zhejiang Jiuxin Medicine Co., Ltd. (&ldquo;Jiuxin Medicine&rdquo;),
which is licensed to distribute prescription and non-prescription pharmaceutical products throughout China. Jiuzhou Pharmacy acquired
Jiuxin Medicine on August 25, 2011. On April 20, 2018, 10% of Jiuxin Medicine shares were sold to Hangzhou Kangzhou Biotech Co.
Ltd. for total proceeds of $79,625 (RMB 507,760).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s herb farming business is conducted by Hangzhou Qianhong Agriculture Development Co., Ltd. (&ldquo;Qianhong Agriculture&rdquo;),
a wholly-owned subsidiary of Jiuxin Management. Due to the complexity of the cultivation business, Qianhong Agriculture has not
grown herbs in the nine months ended December 31, 2020.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 148; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying condensed consolidated financial statements reflect the activities of the Company and each of the following entities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 18%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entity Name</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 49%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Background</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 31%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Renovation&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Incorporated in Hong Kong SAR on September 2, 2008</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiuxin&nbsp;Management</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Established in the PRC on October
        14, 2008</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Deemed
        a wholly foreign owned enterprise (&ldquo;WFOE&rdquo;) under PRC law &nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Registered
        capital of $23.5 million fully paid</P></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shouantang Technology</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Established
        in the PRC on July 16, 2010 by Renovation with registered capital of $20 million</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Registered
        capital requirement reduced by the SAIC to $11 million in July 2012 and is fully paid &nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Deemed
        a WFOE under PRC law</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Invests
        and finances the working capital of Quannuo Technology</P></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Qianhong Agriculture&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Established
        in the PRC on August 10, 2010 by Jiuxin&nbsp;Management</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Registered
        capital of RMB 10 million fully paid &nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Carries
        out herb farming business</P></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiuzhou&nbsp;Pharmacy (1)&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Established
        in the PRC on September 9, 2003</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Registered
        capital of RMB 5 million fully paid &nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Operates
        the &ldquo;Jiuzhou Grand Pharmacy&rdquo; stores in Hangzhou</P></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIE&nbsp;by&nbsp;contractual&nbsp;arrangements (2)</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiuzhou&nbsp;Clinic (1)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Established
        in the PRC as a general partnership on&nbsp;October 10, 2003</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Operates
        a medical clinic adjacent to one of Jiuzhou&nbsp;Pharmacy&rsquo;s stores</P></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIE&nbsp;by&nbsp;contractual arrangements (2)</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiuzhou&nbsp;Service (1)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Established
        in the PRC on November 2, 2005 &nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Registered
        capital of RMB 500,000 fully paid</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Operates
        a medical clinic adjacent to one of Jiuzhou&nbsp;Pharmacy&rsquo;s stores</P></TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">VIE&nbsp;by&nbsp;contractual arrangements (2)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiuxin Medicine&nbsp;&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Established in PRC on December
        31, 2003</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Acquired
        by Jiuzhou Pharmacy in August 2011</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;10%
        of shares sold On April 20, 2018&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Registered
        capital of RMB 10 million fully paid</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Carries
        out pharmaceutical distribution services</P></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIE by contractual arrangements as a wholly-owned subsidiary of Jiuzhou Pharmacy (2)</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiutong Medical&nbsp;&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Established
        in the PRC on December 20, 2011 by Renovation</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Registered&nbsp;capital of $2.6
        million fully paid &nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#9679;&nbsp;&nbsp; &nbsp;&nbsp;Currently has no operation</P></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 149; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 18%; border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entity Name</FONT></TD>
    <TD STYLE="width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 49%; border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Background</FONT></TD>
    <TD STYLE="width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 31%; border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ownership</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shouantang Bio&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Established
        in the PRC in October, 2014 by Shouantang Technology&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;100% held by Shouantang Technology&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Registered capital of RMB 1,000,000 fully paid</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Sells nutritional supplements under its own brand name</P></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiuyi Technology&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Established in the PRC on September 10, 2015</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;100% held by Renovation&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Currently has no operation</P></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kahamadi Bio&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Established in the PRC in May 2016</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;49% held by Shouantang Bio</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Registered capital of RMB 10 million</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Develop brand name for nutritional supplements</P></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49%</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lin&rsquo;An Jiuzhou&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Established in the PRC on March 31, 2017</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;100% held by Jiuxin&nbsp;Management</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Registered capital of RMB 5 million</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#9679;&nbsp;&nbsp;
        &nbsp;&nbsp;Explore retail pharmacy market in Lin&rsquo;An City</P></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Linjia Medical</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Established
        in the PRC on September 27, 2017</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;51%
        held by Jiuzhou Pharmacy</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Registered
        capital of RMB 20 million</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operates
        local clinics</P></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VIE by contractual arrangements as a controlled subsidiary of Jiuzhou Pharmacy (2)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Jiuzhou Pharmacy, Jiuzhou Clinic and Jiuzhou Service have been
under the common control of Mr. Lei Liu, Ms. Li Qi, and another shareholder (the &ldquo;Owners&rdquo;) since their respective establishment
dates, pursuant to agreements among the Owners to vote their interests in concert as memorialized in a voting rights agreement.
Based on such voting rights agreement, the Company has determined that these three entities are under the common control of the
Owners. The Owners have operated these three companies in conjunction with one another since each company&rsquo;s respective establishment
date. Jiuxin Medicine is also deemed under the common control of the Owners as a subsidiary of Jiuzhou Pharmacy.</P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">To comply with certain foreign ownership restrictions of pharmacy
and medical clinic operators, Jiuxin Management entered into a series of contractual arrangements with Jiuzhou Pharmacy, Jiuzhou
Clinic and Jiuzhou Service on August 1, 2009. These contractual arrangements are comprised of five agreements: a consulting services
agreement, an operating agreement, an equity pledge agreement, a voting rights agreement and an option agreement. Because such
agreements obligate Jiuxin Management to absorb all of the risks of loss from the activities of Jiuzhou Pharmacy, Jiuzhou Clinic
and Jiuzhou Service, and enable the Company (through Jiuxin Management) to receive all of their expected residual returns, the
Company accounts for each of the three companies (as well as subsidiaries of Jiuzhou Pharmacy) as a variable interest entity (&ldquo;VIE&rdquo;)
under the accounting standards of the Financial Accounting Standards Board (&ldquo;FASB&rdquo;). Accordingly, the financial statements
of Jiuzhou Pharmacy, Jiuzhou Clinic and Jiuzhou Service, as well as the subsidiaries under the control of Jiuzhou Pharmacy, Jiuxin
Medicine and Shouantang Bio are consolidated into the financial statements of the Company.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 150; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
2 &ndash; LIQUIDITY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s accounts have been prepared in accordance with the accounting principles generally accepted in the United States
of America (&ldquo;US GAAP&rdquo;) on a going concern basis. The going concern basis assumes that assets are realized and liabilities
are extinguished in the ordinary course of business at amounts disclosed in the financial statements. The Company&rsquo;s ability
to continue as a going concern depends upon aligning its sources of funding (debt and equity) with its expenditure requirements
and repayment of the short-term debts as and when they become due.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The drug retail business is a highly competitive
industry in the PRC. Several large drugstore chains and a variety of single stores operate in Hangzhou City and Zhejiang Province.
In order to increase the Company&rsquo;s competitive advantages and gain more local retail pharmacy market share, from fiscal
year 2018, we opened fifty-nine new stores in Hangzhou. As a result, the Company incurred significant incremental expense related
to rental, labor hiring and training, and marketing activities. As the retail pharmaceutical market becomes more competitive in
recent years, a new store usually cannot make profit in its operation until a year later. In fact, the Company incurred significant
expenses with limited incremental revenue in the period it opened new stores. At their openings, except for four stores, almost
all of the new stores were without government insurance reimbursement certificates. In fact, it usually takes more than one year
for a new store to apply for and obtain the local government insurance reimbursement certificate. As of December 31, 2020, the
Company had obtained forty-six reimbursement certificates for stores opened in fiscal 2018 and thereafter. Historically in a mature
store, more than half of the total revenue were generated from the individual customers&rsquo; government insurance program. The
Company is in the process of actively applying certificates for all of its new stores. In the future, as more and more stores
obtain certificates, the Company expect the income of its new stores to increase and eventually contribute positive operating
cash flow.&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s principal sources
of liquidity consist of existing cash, equity financing, and bank facilities from local banks as well as personal loans from its
principal shareholders when necessary. On April 15, 2019, the Company closed a registered direct offering of 4,000,008 shares
of common stock at $2.50 per share with gross proceeds of $10,000,020 from its effective shelf registration statement on Form
S-3 pursuant to a Securities Purchase Agreement dated April 11, 2019 (the &ldquo;2019 Securities Purchase Agreement&rdquo;), by
and among the Company and the investors named therein. On June 3, 2020, the Company closed a registered direct offering of 5,000,004
shares of common stock at $2.00 per share with gross proceeds of $10,000,008 from its effective shelf registration statement on
Form S-3 pursuant to a Securities Purchase Agreement dated June 1, 2020 (the &ldquo;2020 Securities Purchase Agreement&rdquo;),
by and among the Company and the investors named therein.&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The spread of COVID-19 in the winter
has negatively impacted the local economy. In order to relieve the operation difficulty, the Government has continued its tax
cut policy such as lower certain tax rate. On the other side, local banks are encouraged to provide low interest rate loans
to local enterprises. The Company has a credit line agreement from a local bank as described in detail in Note 16. As of
December 31, 2020, approximately $0.57 million of the aforementioned bank credit line was available for further borrowing.
Additionally, Jiuzhou Pharmacy obtained a credit line of approximately $7,653,850 (RMB50,000,000) from Haihui Commercial
Factoring (Tianjin) Co. Ltd. (&ldquo;Haihui Commercial&rdquo;) for three years beginning July 26, 2019. As of December 31,
2020, the full amount has been borrowed from Haihui Commercial. Any borrowing thereunder is guaranteed by a third-party
guarantor company and secured by the Company&rsquo;s assets pursuant to a collateral agreement, as well as personal
guarantees of some of its principal shareholders.

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has also obtained additional
government insurance reimbursement certificates for its stores opened in the last two years. In a mature store, more than half
of the revenue are generated by customers utilizing the government insurance program. With these certificates, mature stores are
able to attract more customers who are eligible for the insurance program, and its sales may significantly increase in the next
12 months. Additionally, with the proceeds from the registered direct financing closed on April 15, 2019 and June 3, 2020, and
the increased credit line, the Company believes it can support its operations for at least the next 12 months ended December 31, 2021.&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 151; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
3 &ndash; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Basis
of presentation and consolidation</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted
in the United States of America (&ldquo;US GAAP&rdquo;). The consolidated financial statements include the financial statements
of the Company, its wholly-owned subsidiaries and VIEs. All significant inter-company transactions and balances between the Company,
its subsidiaries and VIEs are eliminated upon consolidation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Consolidation
of variable interest entities</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with accounting standards regarding consolidation of variable interest entities, VIEs are generally entities that lack
sufficient equity to finance their activities without additional financial support from other parties or whose equity holders
lack adequate decision making ability. All VIEs with which the Company is involved must be evaluated to determine the primary
beneficiary of the risks and rewards of the VIE. The primary beneficiary is required to consolidate the VIE for financial reporting
purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has concluded, based on the contractual arrangements, that Jiuzhou Pharmacy (including its subsidiaries and controlled
entities), Jiuzhou Clinic and Jiuzhou Service are each a VIE and that the Company&rsquo;s wholly-owned subsidiary, Jiuxin Management,
absorbs a majority of the risk of loss from the activities of these companies, thereby enabling the Company, through Jiuxin Management,
to receive a majority of their respective expected residual returns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Control and common control are defined
under the accounting standards as &ldquo;an individual, enterprise, or immediate family members who hold more than 50 percent
of the voting ownership interest of each entity.&rdquo; Because the Owners collectively own 100% of Jiuzhou Pharmacy, Jiuzhou
Clinic and Jiuzhou Service, and have agreed to vote their interests in concert since the establishment of each of these three
companies as memorialized in the voting rights agreement, the Company believes that the Owners collectively have control and common
control of the three companies. Accordingly, the Company believes that Jiuzhou Pharmacy, Jiuzhou Clinic and Jiuzhou Service were
constructively held under common control by Jiuxin Management as of the time the contractual agreements were entered into, establishing
Jiuxin Management as their primary beneficiary. Jiuxin Management, in turn, is owned by Renovation, which is owned by the Company.
&nbsp;&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Risks
and Uncertainties</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company operates in the PRC. Accordingly,
the Company&rsquo;s business, financial condition, and results of operations may be influenced by political, economic, and legal
environments in the PRC, as well as by the general state of the PRC economy. The Company&rsquo;s operations in the PRC are subject
to special considerations and significant risks not typically associated with companies in North America and Western Europe. These
include risks associated with, among others, the political, economic and legal environment and foreign currency exchange. The
Company&rsquo;s financial performance may be adversely affected by changes in the political, regulatory and social conditions
in the PRC. Although the Company has not experienced losses from these situations and believes that it is in compliance with existing
laws and regulations including its organization and structure disclosed in Note 1, this may not be indicative of future results.&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has significant cash deposits with suppliers in order to obtain and maintain inventory. The Company&rsquo;s ability to
obtain products and maintain inventory at existing and new locations is dependent upon its ability to post and maintain significant
cash deposits with its suppliers. In the PRC, many vendors are unwilling to extend credit terms for product sales that require
cash deposits to be made. The Company does not generally receive interest on any of its supplier deposits, and such deposits are
subject to loss as a result of the creditworthiness or bankruptcy of the party who holds such funds, as well as the risk from
illegal acts such as conversion, fraud, theft or dishonesty associated with the third party. If these circumstances were to arise,
the Company would find it difficult or impossible, due to the unpredictability of legal proceedings in China, to recover all or
a portion of the amount on deposit with its suppliers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Members
of the current management team own controlling interests in the Company and are also the Owners of the VIEs in the PRC. The Company
only controls the VIEs through contractual arrangements which obligate it to absorb the risk of loss and to receive the residual
expected returns.&nbsp;&nbsp;As such, the controlling shareholders of the Company and the VIEs could cancel these agreements or
permit them to expire at the end of the agreement terms, as a result of which the Company would not retain control of the VIEs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Use
of estimates</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with&nbsp;US GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the
financial statements, and the reported amounts of revenues and expenses during the reporting period. The significant estimates
made in the preparation of the accompanying consolidated financial statements relate to the assessment of the carrying values
of accounts receivable, advances to suppliers and related allowance for doubtful accounts, useful lives of property and equipment,
inventory reserve and fair value of its purchase option derivative liability. Because of the use of estimates inherent in the
financial reporting process, actual results could materially differ from those estimates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 152; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Fair
value measurements</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company establishes a three-level valuation hierarchy of valuation techniques based on observable and unobservable inputs, which
may be used to measure fair value and include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 &ndash; Quoted prices in active markets for identical assets or liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 &ndash; Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets
or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable
market data for substantially the full term of the assets or liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 &ndash; Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of
the assets or liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Classification
within the hierarchy is determined based on the lowest level of input that is significant to the fair value measurement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s financial assets and liabilities, which include financial instruments as defined by FASB ASC 820, include cash,
cash equivalents and restricted cash, financial assets available for sales, trade accounts receivable, notes receivables, other
receivable, accounts payable, other payable, notes payable, long-term loan payable, employee deposits and warrants liability.
The carrying amounts of cash and cash equivalents, restricted cash, accounts receivable, notes receivables, and accounts payable
are a reasonable approximation of fair value due to the short maturities of these instruments (Level 1). The carrying amount of
notes payable approximates fair value based on borrowing rates of similar bank loan currently available to the Company (Level
2) (See Note 16). The carrying amount of Long-term loan payable approximates fair value based on borrowing rates of similar bank
loan currently available to the Company (Level 2) (See Note 17). The carrying amount of the Company&rsquo;s derivative instruments
is recorded at fair value and is determined based on observable inputs that are corroborated by market data (Level 2) (See Note
21). The carrying amount of the financial assets available for sale is recorded at fair value and is determined based on unobservable
inputs (Level 3) (See Note 4). The carrying amount of the employee deposits is recorded at fair value and is determined based
on unobservable inputs (Level 3) (See Note 22).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">(amount in absolute value)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Active Market<BR> for Identical<BR> Assets<BR> (Level 1)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Observable<BR> Inputs<BR> (Level 2)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Unobservable<BR> Inputs<BR> (Level 3)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Total<BR> Carrying<BR> Value</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: justify">Cash, cash equivalents and restricted cash</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">25,041,724</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">25,041,724</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Financial assets available for sale</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">170,604</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">170,604</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Trade accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,521,988</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,521,988</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Notes receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Other receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,084,145</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,084,145</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,064,997</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,064,997</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Notes payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,736,161</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,736,161</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Other payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,744,874</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,744,874</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Long-term loan payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,069,907</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,069,907</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Employee Deposits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,308</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,308</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Warrants liability</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">62,457,728</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">30,806,068</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">185,912</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">93,449,708</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Revenue
recognition</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective March 31, 2018, the Company
began recognizing revenue under Accounting Standards Codification (&ldquo;ASC&rdquo;) Topic 606, Revenue from Contracts with Customers
(&ldquo;ASC 606&rdquo;), using the modified retrospective transition method. The impact of adopting the new revenue standard was
not material to the Company&rsquo;s consolidated financial statements. The core principle of this new revenue standard is that
a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the company expects to be entitled in exchange for those goods or services. The following five steps
are applied to achieve that core principle:&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
    1: Identify the contract with the customer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
    2: Identify the performance obligations in the contract</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
    3: Determine the transaction price</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
    4: Allocate the transaction price to the performance obligations in the contract</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step
    5: Recognize revenue when the company satisfies a performance obligation</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 153; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to identify the performance obligations in a contract with a customer, a company must assess the promised goods or services
in the contract and identify each promised good or service that is distinct. A performance obligation meets ASC 606&rsquo;s definition
of a &ldquo;distinct&rdquo; good or service (or bundle of goods or services) if both of the following criteria are met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    customer can benefit from the good or service either on its own or together with other resources that are readily available
    to the customer (i.e., the good or service is capable of being distinct).</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    entity&rsquo;s promise to transfer the good or service to the customer is separately identifiable from other promises in the
    contract (i.e., the promise to transfer the good or service is distinct within the context of the contract).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a good or service is not distinct, the good or service is combined with other promised goods or services until a bundle of goods
or services is identified that is distinct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised
goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). The consideration
promised in a contract with a customer may include fixed amounts, variable amounts, or both. Variable consideration is included
in the transaction price only to the extent that it is probable that a significant reversal in the amount of cumulative revenue
recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transaction price is allocated to each performance obligation on a relative standalone selling price basis. The transaction price
allocated to each performance obligation is recognized when that performance obligation is satisfied, at a point in time or over
time as appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s revenue is net of value added tax (&ldquo;VAT&rdquo;)
collected on behalf of the PRC tax authorities with respect to the sales of merchandise. VAT collected from customers, and net
of VAT paid for purchases, is recorded as a liability in the accompanying consolidated balance sheets until it is paid to the relevant
PRC tax authorities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
contract liabilities primarily represent the Company&rsquo;s obligation to transfer additional goods or services to a customer
for which the Company has received consideration, for example, membership points. The consideration received remains a contract
liability until goods or services have been provided to the retail customer. The estimated amount based on accrued membership
points was deducted from sales revenue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a discussion of the Company&rsquo;s revenue recognition policies by segment under the new revenue recognition accounting
standard:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Pharmacy
retail sales</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The physical pharmacies sell prescription
drugs, over-the-counter (&ldquo;OTC&rdquo;) drugs, traditional Chinese medicine, nutritional supplements, medical devices and
sundry products. Revenue from sales of prescription medicine at drugstores is recognized when a prescription is filled and a customer
picks up and pays for the prescription. Revenue from sales of other merchandise at drugstores is recognized at the point of sale,
which is when a customer pays for and receives the merchandise. Usually the majority merchandise, such as prescription and OTC
drugs, are not refundable after customers leave the counter. Returns of other products, such as sundry products, are minimal.
Sales of drugs reimbursed by the local government medical insurance agency and receivables from the agency are recognized when
a customer pays for the drugs at a store. Based on historical experience, the Company made a reserve for potential losses from
denial of reimbursement on certain unqualified drugs to the receivables from the government agency. Additionally, several onsite
clinics adjacent to pharmacies provide limited medical services. Revenue from medical services is recognized after the service
has been rendered to a customer. As revenue from medical services is minimal compared to pharmacy retail sales, it is included
as part of the pharmacy retail sales.&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company deducts the membership rewards
directly from the retail revenue, and presents such amounts in net sales as opposed to the current reduction of operation expense
classification. Membership rewards, usually membership points, are accumulated by customers based on their historical spending
levels. The Company determines if there is an additional performance obligation to the customers at the time of the initial transaction.
The customers can then redeem these points during their future purchase. At the end of each quarter and fiscal year, unredeemed
membership rewards are reflected as a&nbsp;contract&nbsp;liability.&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 154; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Online
pharmacy sales</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The online pharmacy segment sells various
health products except for prescription drugs. Revenue from online pharmacy sales is recognized when merchandise is shipped to
customers. While most deliveries take one day, certain deliveries may take longer depending on a customer&rsquo;s location. Any
loss caused in a shipment will be reimbursed by the Company&rsquo;s courier company. The Company&rsquo;s sales policy allows for
return of certain merchandises without reason within seven days after a customer&rsquo;s receipt of the applicable merchandise.
Historically, sales returns beyond seven days of the receipt of merchandise have been minimal.<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Wholesale</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiuxin
Medicine purchases medicine in quantity and distributes products primarily to local pharmacies and medical products dealers. Revenue
from sales of merchandise to non-retail customers is recognized when the merchandise is transferred to customers. Historically,
sales returns have been minimal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Disaggregation
of Revenue</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables disaggregate the Company&rsquo;s revenue by major source in each segment for the three and nine months ended
December 31, 2020 and 2019:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">For the three months ended December 31</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="9" STYLE="text-align: justify">Retail drugstores</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify; text-indent: 10pt">Prescription drugs</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">7,013,958</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">7,496,469</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: 10pt">OTC drugs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,451,389</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,260,883</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt">Nutritional supplements</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,624,313</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,602,407</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: 10pt">TCM</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,191,877</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,416,126</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt">Sundry products</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">301,658</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">188,484</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; text-indent: 10pt">Medical devices</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,483,645</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">611,597</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total retail revenue</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">20,066,840</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">21,575,966</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Online pharmacy</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt">Prescription drugs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,227,332</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: 10pt">OTC drugs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,415,029</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,981,871</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt">Nutritional supplements</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">318,869</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">245,249</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: 10pt">TCM</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">174,476</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">42,331</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt">Sundry products</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">548,018</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">729,179</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; text-indent: 10pt">Medical devices</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">915,414</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">966,393</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total online revenue</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">6,599,138</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">3,965,023</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Drug wholesale</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt">Prescription drugs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">7,450,847</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">6,358,031</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: 10pt">OTC drugs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,326,118</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,310,927</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt">Nutritional supplements</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,452</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">47,736</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: 10pt">TCM</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">57,244</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">67,507</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt">Sundry products</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,530</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,789</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; text-indent: 10pt">Medical devices</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">20,590</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">18,303</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Total wholesale revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">8,872,781</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">7,822,293</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total revenue</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">35,538,759</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">33,363,282</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 155; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">For the nine months ended December 31</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="9" STYLE="text-align: justify">Retail drugstores</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify; text-indent: 10pt">Prescription drugs</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">20,403,438</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">19,214,689</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: 10pt">OTC drugs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,887,032</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,964,312</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt">Nutritional supplements</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,636,347</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,510,514</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: 10pt">TCM</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,195,267</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,474,676</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt">Sundry products</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,062,321</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">777,432</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; text-indent: 10pt">Medical devices</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,623,405</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,370,604</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total retail revenue</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">56,807,810</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">56,312,227</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Online pharmacy</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt">Prescription drugs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5,855,491</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: 10pt">OTC drugs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,720,874</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,133,128</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt">Nutritional supplements</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">747,962</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">488,956</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: 10pt">TCM</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">270,024</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">77,981</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt">Sundry products</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,506,232</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,542,372</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; text-indent: 10pt">Medical devices</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,758,401</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,517,455</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total online revenue</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">16,858,984</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">8,759,892</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Drug wholesale</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt">Prescription drugs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">19,267,262</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">18,054,557</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: 10pt">OTC drugs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,804,608</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,433,730</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt">Nutritional supplements</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">102,397</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">104,475</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; text-indent: 10pt">TCM</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">164,544</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">247,465</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 10pt">Sundry products</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,887</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,809</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; text-indent: 10pt">Medical devices</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">406,124</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">54,690</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Total wholesale revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">23,768,822</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">21,925,726</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total revenue</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">97,435,616</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">86,997,845</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Contract
Balances</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Contract liabilities primarily represent
the Company&rsquo;s obligation to transfer additional goods or services to a retail customer for which the Company has received
consideration, for example membership points and membership rewards. The consideration received remains a contract liability until
goods or services have been provided to the retail customer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information about receivables and contract liabilities from contracts with customers:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; text-align: center">December&nbsp;31, <BR> 2020</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; text-align: center">March&nbsp;31, <BR> 2020</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Trade receivable (included in accounts receivable, net)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">11,521,988</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">9,770,656</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Contract liabilities (included in accrued expenses)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,138,349</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,106,982</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Restricted
cash</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s restricted cash consists
of cash and long-term deposits in a bank as security for its notes payable. The Company has notes payable outstanding with a bank
and is required to keep certain amounts on deposit that are subject to withdrawal restrictions. Notes payable are generally short
term in nature due to their short maturity period of six to nine months; thus, restricted cash is classified as a current asset.&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 156; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following represents a reconciliation of cash and cash equivalents in the Consolidated Condensed Balance Sheets to total cash,
cash equivalents and restricted cash in the Consolidated Condensed Statements of Cash Flows as of December 31, 2020&nbsp;and&nbsp;March&nbsp;31,
2020:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; text-align: center">December&nbsp;31,<BR> 2020</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; text-align: center">March&nbsp;31,<BR> 2020</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Cash and cash equivalents</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">12,116,508</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">16,176,318</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Restricted cash</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">12,925,216</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">14,806,288</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt">Cash, cash equivalents and restricted cash</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">25,041,724</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; font-weight: bold; text-align: right">30,982,606</TD><TD STYLE="padding-bottom: 4pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Accounts
receivable</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable represents the following: (1) amounts due from banks relating to retail sales that are paid or settled by the customers&rsquo;
debit or credit cards, (2) amounts due from government social security bureaus and commercial health insurance programs relating
to retail sales of drugs, prescription medicine, and medical services that are paid or settled by the customers&rsquo; medical
insurance cards, (3) amounts due from non-bank third party payment instruments such as Alipay and certain e-commerce platforms
and (4) amounts due from non-retail customers for sales of merchandise.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable are recorded at net realizable value consisting of the carrying amount less an allowance for uncollectible accounts,
as&nbsp;necessary. In the Company&rsquo;s retail business, accounts receivable mainly consist of reimbursements due from the government
insurance bureaus and commercial health insurance programs and are usually collected within two or three months. The Company directly
writes off delinquent account balances, which it determines to be uncollectible after confirming with the appropriate bureau or
program each month. Additionally, the Company also makes estimated reserves on related outstanding accounts receivable based on
historical trends.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the Company&rsquo;s online pharmacy
business, accounts receivable primarily consist of amounts due from non-bank third party payment instruments such as Alipay and
certain e-commerce platforms. To purchase pharmaceutical products from e-commerce platforms such as Tmall, customers are required
to submit payments to certain non-bank third party payment instruments, such as Alipay, which, in turn, reimburse the Company
within seven days to a month. Except for customer returns of sold products, the receivables from these payment instruments are
rarely uncollectible.&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
its wholesale business, the Company uses the aging method to estimate the allowance for anticipated uncollectible receivable balances.
Under the aging method, bad debt percentages are determined by management,&nbsp;based on historical experience and the current
economic climate, are applied to customers&rsquo; balances categorized by the number of months the underlying invoices have remained
outstanding. At each reporting period, the allowance balance is adjusted to reflect the amount computed as a result of the aging
method. When facts subsequently become available to indicate that the allowance provided requires an adjustment, a corresponding
adjustment is made to the allowance account as a change in estimate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three months ended December 31,
2020, bad debt direct write-off and provision in cash flows amounted to $293,141, an increase of $1,089,429, as compared to reversal
of bad debt allowance of $796,288 for the same period a year ago. For the nine months ended December 31, 2020, bad debt direct
write-off and provision in cash flows amounted to $7,065, an increase of $36,103, as compared to reversal of bad debt allowance
of $29,038 for the same period a year ago.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Advances
to suppliers</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advances to suppliers consist of prepayments
to vendors, such as pharmaceutical manufacturers and other distributors. Since the acquisition of Jiuxin Medicine, the Company
has transferred almost all logistics services of its retail drugstores to Jiuxin Medicine. Jiuzhou Pharmacy only directly purchases
certain non-medical products, such as nutritional supplements. As a result, almost all advances to suppliers are made by Jiuxin
Medicine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Advances to suppliers for our drug wholesale
business consist of prepayments to vendors, such as pharmaceutical manufacturers and other distributors.&nbsp;The Company typically
receives products from vendors within three to nine months after making prepayments.&nbsp;The Company continuously monitors delivery
from, and payments to, its vendors while maintaining a provision for estimated credit losses based upon historical experience
and any specific supplier issues, such as discontinuing of inventory supply, that have been identified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 157; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Inventories</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories
are stated at the lower of cost or net realizable value. Cost is determined using the first in first out (FIFO) method. The Company
carries out physical inventory counts on a monthly basis at each store and warehouse location. Herbs that the Company farms are
recorded at their cost, which includes direct costs such as seed selection, fertilizer, labor costs that are spent in growing
herbs on the leased farmland, and indirect costs such as amortization of farmland development cost. All costs are accumulated
until the time of harvest and then allocated to harvested herbs costs when the herbs are sold. The Company periodically reviews
its inventory and records write-downs to inventories for shrinkage losses and damaged merchandise that are identified. The Company
provides a reserve for estimated inventory obsolescence or excess quantities on hand equal to the difference, if any, between
the cost of the inventory and its estimated realizable value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Farmland
assets</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Herbs
that the Company farms are recorded at their cost, which includes direct costs such as seed selection, fertilizer, and labor costs
that are spent in growing herbs on the leased farmland, and indirect costs such as amortization of farmland development costs.
Since April 2014, amortization of farmland development costs has been expensed instead of allocated into inventory due to unpredictable
future market value of planted gingko trees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
related costs described in the above are accumulated until the time of harvest and then allocated to harvested herbs when they
are sold.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Property
and equipment</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are stated at cost, net of accumulated depreciation or amortization. Depreciation is calculated on the straight-line
method over the estimated useful lives of the assets, taking into consideration the assets&rsquo; estimated residual value. Leasehold
improvements are amortized over the shorter of lease term or remaining lease period of the underlying assets. Following are the
estimated useful lives of the Company&rsquo;s property and equipment:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    Useful&nbsp;Life</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold
    improvements</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3-10
    years</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Motor
    vehicles</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3-5
    years</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
    equipment &amp; furniture</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3-5
    years</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buildings</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35
    years</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maintenance,
repairs and minor renewals are charged to expenses as incurred. Major additions and betterment to property and equipment are capitalized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Intangible
assets</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets are acquired individually or as part of a group of assets, and are initially recorded at their fair value.&nbsp;&nbsp;The
cost of a group of assets acquired in a transaction is allocated to the individual assets based on their relative fair values.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated useful lives of the Company&rsquo;s intangible assets are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated<BR>
    Useful Life</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 88%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Land
    use rights</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50
    years</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3
    years</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">License</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Infinite</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates intangible assets for impairment whenever events or changes in circumstances indicate that the assets might
be impaired.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 158; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Impairment
of long-lived assets</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates long lived tangible and intangible assets for impairment, whenever events or changes in circumstances indicate
that the carrying value may not be recoverable from its estimated future cash flows. Recoverability is measured by comparing the
assets&rsquo; net book value to the related projected undiscounted cash flows from these assets, considering a number of factors
including past operating results, budgets, economic projections, market trends and product development cycles. If the net book
value of the asset exceeds the related undiscounted cash flows, the asset is considered impaired, and a second test is performed
to measure the amount of impairment loss. There were no fixed assets and farmland assets impaired for the nine months ended December
31, 2020 and 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Notes
payable</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the normal course of business, the Company regularly issues bank acceptance bills as a payment method to settle outstanding accounts
payables with various material suppliers. The Company records such bank acceptance bills as notes payable. Such notes payable
are generally short term in nature due to their short maturity period of six to nine months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Income
taxes</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes following the liability method pursuant to FASB ASC 740 &ldquo;Income Taxes&rdquo;. Under this
method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases
of assets and liabilities using enacted tax rates that will be in effect in the period in which the differences are expected to
reverse. The Company records a valuation allowance to offset deferred tax assets if, based on the weight of available evidence,
it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred
taxes of a change in tax rate is recognized in income in the period that includes the enactment date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also follows FASB ASC 740, which addresses the determination of whether tax benefits claimed or expected to be claimed
on a tax return should be recorded in the financial statements. The Company may recognize the tax benefit from an uncertain tax
position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities,
based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should
be measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement.
ASC 740 also provides guidance on recognition, classification, interest and penalties on income taxes, accounting in interim periods
and requires increased disclosures. As of December 31, 2020 and March 31, 2020, the Company did not have a liability for unrecognized
tax benefits. It is the Company&rsquo;s policy to include penalties and interest expense related to income taxes as a component
of other expense and interest expense, respectively, as necessary. The Company&rsquo;s historical tax years will remain open for
examination by the local authorities until the statute of limitations has passed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
ASC 740-270, entities calculate the income tax provision for an interim period by distinguishing between elements recognized in
the income tax provision through (1) applying an estimated annual effective tax rate (ETR) to a measure of year-to-date operating
results referred to as &ldquo;ordinary income (or loss),&rdquo; and (2) discretely recognizing specific events (referred to as
&ldquo;discrete items&rdquo;) as they occur. Entities should revise the ETR, as necessary, as of the end of each successive interim
period during its fiscal year based on changes to any of these estimates and judgments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ETR expected to apply for the full fiscal year is applied to year-to-date ordinary income (or loss) at the end of each interim
period to compute the year-to-date income tax (or benefit) applicable to ordinary income or loss. Income tax expense (or benefit)
related to each discrete item is individually determined and recognized in the interim period when the discrete item occurs. As
a result, the income tax provision (or benefit) for an interim period might include elements that apply to ordinary income or
loss, as well as elements related to discrete items. Discrete items include significant items that are unusual or that occur infrequently.
Determining which items are unusual or infrequent often requires a significant degree of judgment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
ASC 740-270-30-36, entities subject to income taxes in multiple jurisdictions should apply one overall ETR instead of separate
ETRs for each jurisdiction when calculating the interim-period income tax or benefit related to consolidated ordinary income (or
loss) for the year-to-date interim period, except in certain circumstances. The income tax provision or benefit for each interim
period is the difference between the year-to-date amount for the current period and the year-to-date amount for the prior period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 159; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Value
added tax</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
revenue represents the invoiced value of goods, net of VAT. All of the Company&rsquo;s products are sold in the PRC and are subject
to a VAT on the gross sales price. The VAT rates range up to 13%, depending on the type of products sold. The VAT may be offset
by VAT paid by the Company on raw materials and other materials included in the cost of producing or acquiring its finished products.
The Company recorded a VAT payable net of payments in the accompanying financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Stock
based compensation</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows the provisions of FASB ASC 718, &ldquo;Compensation &mdash; Stock Compensation,&rdquo; which establishes accounting
standards for non-employee and employee stock-based awards. Under the provisions of FASB ASC 718, the fair value of stock issued
is used to measure the fair value of services received as the Company believes such approach is a more reliable method of measuring
the fair value of the services. For non-employee stock-based awards, fair value is measured based on the value of the Company&rsquo;s
common stock on the date that the commitment for performance by the counterparty has been reached or the counterparty&rsquo;s
performance is complete. The fair value of the equity instrument is calculated and then recognized as compensation expense over
the requisite performance period. For employee stock-based awards, share-based compensation cost is measured at the grant date
based on the fair value of the award and is recognized as expense with graded vesting on a straight&ndash;line basis over the
requisite service period for the entire award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Advertising
and promotion costs</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising
and promotion costs are expensed as incurred and amounted to $91,703 and $60,781 for the three months ended December 31, 2020
and 2019, respectively. Advertising and promotion costs are expensed as incurred and amounted to $229,079 and $217,768 for the
nine months ended December 31, 2020 and 2019, respectively. Such costs consist primarily of print and promotional materials such
as flyers to local communities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Foreign
currency translation</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company uses the United States dollar (&ldquo;U.S. dollars&rdquo; or &ldquo;USD&rdquo;) for financial reporting purposes. The
Company&rsquo;s subsidiaries and VIEs maintain their books and records in their functional currency the Renminbi (&ldquo;RMB&rdquo;),
the currency of the PRC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, for consolidation purposes, the Company translates the assets and liabilities of its subsidiaries and VIEs into U.S.
dollars using the applicable exchange rates prevailing at the balance sheet date, and the statements of income and cash flows
are translated at average exchange rates during the reporting period. As a result, amounts related to assets and liabilities reported
on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the balance sheet. Equity
accounts are translated at historical rates. Adjustments resulting from the translation of the financial statements of the subsidiaries
and VIEs are recorded as accumulated other comprehensive income.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
balance sheet amounts, with the exception of equity, at December 31, 2020 and at March 31, 2020 were translated at 1 RMB to 0.1531
USD and at 1 RMB to 0.1410 USD, respectively. The average translation rates applied to income and cash flow statement amounts
for the nine months ended December 31, 2020 and 2019 were at 1 RMB to 0.1456 USD and at 1 RMB to 0.1437 USD, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 160; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Concentrations
and credit risk</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
financial instruments, which subject the Company to concentration of credit risk, consist of cash and restricted cash. The Company
has cash balances at financial institutions located in Hong Kong and PRC. Balances at financial institutions in Hong Kong may,
from time to time, exceed Hong Kong Deposit Protection Board&rsquo;s insured limits. Since March 31, 2015, balances at financial
institutions and state-owned banks within the PRC are covered by insurance up to RMB 500,000 (USD 76,550) per bank. As of December
31, 2020, and March 31, 2020, the Company had deposits totaling $25,001,532 and $30,974,714 that were covered by such limited
insurance, respectively. Any balance over RMB 500,000 (USD 76,550) per bank in PRC will not be covered. To date, the Company has
not experienced any losses in such accounts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three months ended December 31, 2020, two largest vendors accounted for 44.8% of the Company&rsquo;s total purchases and one
vendor accounted for 24.4% of the Company&rsquo;s total advances to suppliers. For the three months ended December 31, 2019, two
largest vendors accounted for 45.1% of the Company&rsquo;s total purchases and one vendor accounted for 24.4% of the Company&rsquo;s
total advances to suppliers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the nine months ended December 31, 2020, two vendors accounted for 32.8% of the Company&rsquo;s total purchases and two vendors
accounted for more than 10% of total advances to suppliers. For the nine months ended December 31, 2019, two vendors accounted
for 48.7% of the Company&rsquo;s total purchases and two vendors accounted for more than 10% of total advances to suppliers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three months ended December 31, 2020 and 2019, no customer accounted for more than 10% of the Company&rsquo;s total sales
and more than 10% of total accounts receivable. For the nine months ended December 31, 2020 and 2019, no customer accounted for
more than 10% of the Company&rsquo;s total sales or more than 10% of total accounts receivable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Leases</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2016, the FASB issued ASU 2016-02, <I>Leases </I>(Topic 842). Lessees are required to recognize a right-of-use asset
and a lease liability for virtually all of their leases (other than leases that meet the definition of a short-term lease). The
liability is equal to the present value of lease payments. The asset is based on the liability, subject to certain adjustments,
such as for initial direct costs. For income statement purposes, a dual model was retained, requiring leases to be classified
as either operating or finance leases. Operating leases result in straight-line expense (similar to operating leases under the
prior accounting standard) while finance leases result in a front-loaded expense pattern (similar to capital leases under the
prior accounting standard). Lessor accounting is similar to the prior model, but updated to align with certain changes to the
lessee model (e.g., certain definitions, such as initial direct costs, have been updated) and the new revenue standard, ASU 2014-9.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted this new accounting standard on April 1, 2019 on a modified retrospective basis and applied the new standard to
all leases through a cumulative-effect adjustment to beginning retained earnings. As a result, comparative financial information
has not been restated and continues to be reported under the accounting standards in effect for those periods. The Company elected
the package of practical expedients permitted under the transition guidance within the new standard, which includes, among other
things, the ability to carry forward the existing lease classification. On April 1, 2019, the Company recorded an after-tax transition
adjustment to increase retained earnings by approximately $422,354. The new standard had a material impact on the unaudited condensed
consolidated balance sheet, but did not materially impact the Company&rsquo;s consolidated operating results and had no impact
on the Company&rsquo;s cash flows. The following is a discussion of the Company&rsquo;s lease policy under the new lease accounting
standard:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 161; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&rsquo;s
right to use an underlying asset for the lease term and lease liabilities represent the Company&rsquo;s obligation to make lease
payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date based on the
present value of the remaining future minimum lease payments. As the interest rate implicit in the Company&rsquo;s leases is not
readily determinable, the Company utilizes its incremental borrowing rate, determined by class of underlying asset, to discount
the lease payments. The operating lease right-of-use assets also include lease payments made before commencement and exclude lease
incentives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company leases premises for retail
drugstores, and offices under non-cancellable operating leases. Operating lease payments are expensed over the term of lease using
straight line method. A majority of the Company&rsquo;s retail drugstore leases have a 3 to 10 year term. Usually within one to
three months prior to the expiration date of a lease, the Company is required to notify the lessor and has a priority to continue
renting the lease property if a lessor intends to lease property. The lease itself does not have restriction or covenants. If
both parties agree to continue, a new lease contract with new lease terms has to been signed by both parties. Usually, the rent
may increase year by year based on the lease contract. Sublease is typically not allowed. Any damage, if made by the lessee, to
the property and equipment within the property has to been fixed or reimbursed by the lessee. The Company does not have any leases
entered into that have not yet commenced. The Company has historically been able to renew a majority of its drugstores&rsquo;
leases. The weighted average remaining lease term is 2.6 years and the weighted average discount rate is 4.19%. Under the terms
of its lease agreements, the Company has no legal or contractual asset retirement obligations at the end of the leases. Due to the spread of COVID-19, the Company was able to renegotiate with certain landlords and was able to lower its rent payment. However,
the reduction in rent is immaterial. .If any reduction is successfully implemented, as the amount is immaterial, the Company simply adjusts
rent expense as reduced payments are made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Recent
Accounting Pronouncements</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting
pronouncements adopted</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In June 2016, the FASB issued ASU 2016-13,
&ldquo;Financial Instruments&mdash;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,&rdquo; providing
financial statement users with more decision-useful information about the expected credit losses on financial instruments and
other commitments to extend credit held by a reporting entity at each reporting date. For public business entities that are U.S.
Securities and Exchange Commission (SEC) filers, the amendments in this Update are effective for fiscal years beginning after
December 15, 2019, including interim periods within those fiscal years. The FASB has voted to defer the effective date for public
companies that are smaller reporting companies to fiscal years beginning after December 15, 2022. All entities may adopt the amendments
in this Update earlier as of the fiscal years beginning after December 15, 2018, including interim periods within those fiscal
years. We are currently evaluating the impact of the adoption of ASU 2016-13 on the Company&rsquo;s consolidated financial statements.&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2018, the FASB issued ASU 2018-13
Disclosure Framework &mdash; Changes to the Disclosure Requirements for Fair Value Measurement, which eliminates, adds, and modifies
certain disclosure requirements for fair value measurements under ASC 820. This ASU is to be applied on a prospective basis for
certain modified or new disclosure requirements, and all other amendments in the standard are to be applied on a retrospective
basis. The new standard is effective for interim and annual periods beginning after December 15, 2019, with early adoption permitted.
ASU 2018-13 has no impact on the Company&rsquo;s consolidated financial statements.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2017, the FASB issued ASU No. 2017-04, &ldquo;Intangibles&mdash;Goodwill and Other (Topic 350): Simplifying the Test for
Goodwill Impairment&rdquo; (&ldquo;ASU 2017-04&rdquo;), which removes Step 2 from the goodwill impairment test. An entity will
apply a one-step quantitative test and record the amount of goodwill impairment as the excess of a reporting unit&rsquo;s carrying
amount over its fair value, not to exceed the total amount of goodwill allocated to the reporting unit. The new guidance does
not amend the optional qualitative assessment of goodwill impairment. Public business entity that is a U.S. Securities and Exchange
Commission filer should adopt the amendments in this ASU for its annual or any interim goodwill impairment test in fiscal years
beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing
dates after January 1, 2017. The Company adopted ASU 2017-04 on January 1, 2020. The adoption of the ASU 2017-04 did not have
a material impact on the Company&rsquo;s consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 162; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting
pronouncements not yet effective to adopt</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2019, the FASB issued ASU No. 2019-12, &ldquo;Income Taxes&rdquo; (Topic 740): Simplifying the Accounting for Income
Taxes (&ldquo;ASU 2019-12&rdquo;). ASU 2019-12 will simplify the accounting for income taxes by removing certain exceptions to
the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of
Topic 740 by clarifying and amending existing guidance. For public business entities, the amendments in this Update are effective
for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. For all other entities, the
amendments are effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning
after December 15, 2022. The Company does not expect that the requirements of ASU 2019-12 will have a material impact on its consolidated
financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
4 &ndash; FINANCIAL&nbsp;ASSETS&nbsp;AVAILABLE&nbsp;FOR&nbsp;SALE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020 and March 31, 2020, financial&nbsp;assets&nbsp;available&nbsp;for&nbsp;sale amounted to $170,604 (RMB
1,114,500) and $157,159 (RMB 1,114,500), respectively. As of December 31, 2020, the fair value of an investment in a limited
partner (LP) in a private equity fund (PE fund), which is intended to invest in retail pharmaceutical business, is $78,758
(RMB 514,500). Additionally, the Company has invested in Inner Mongolia Songlu Pharmaceutical Co. (&ldquo;Songlu
Pharmaceutical&rdquo;). As of December 31, 2020, the fair value of the investment is $91,846 (RMB 600,000), which accounts
for 0.5% shares of Songlu Pharmaceutical.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
5 &ndash; TRADE ACCOUNTS RECEIVABLE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
accounts receivable consisted of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">December&nbsp;31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">March&nbsp;31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Accounts receivable</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">14,015,488</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">12,034,726</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Less: allowance for doubtful accounts</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,493,500</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,264,070</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Trade accounts receivable, net</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">11,521,988</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">9,770,656</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three months ended December 31, 2020 and 2019, $16,433 and $47,110 in accounts receivable were written off, respectively.
For the nine months ended December 31, 2020 and 2019, $71,856 and $184,838 in accounts receivable were written off, respectively.
As of December 31, 2020, $813,567 were pledged as collateral for borrowings from financial institutions. As of March 31, 2020,
$627,055 were pledged as collateral for borrowings from financial institutions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
6 &ndash; OTHER CURRENT ASSETS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
current assets consisted of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">December&nbsp;31,<BR> 2020</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">March&nbsp;31,<BR> 2020</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rental deposits <SUP>(1)</SUP></FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1,488,133</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1,364,975</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Prepaid and other current assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">333,705</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">163,565</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,821,838</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,528,540</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    balance as of December 31, 2020 and March 31, 2020 includes short-term refundable rental security deposits.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 163; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
7 &ndash; PROPERTY AND EQUIPMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment consisted of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; text-align: justify">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">December&nbsp;31,<BR> 2020</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center">March&nbsp;31,<BR> 2020</TD><TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Building</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">6,383,729</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">5,880,627</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Leasehold improvements</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,827,485</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,209,136</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Farmland development cost</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,830,708</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,686,430</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Office equipment and furniture</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,006,533</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,632,955</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Motor vehicles</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">378,704</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">504,327</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,427,159</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,913,475</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Less: Accumulated depreciation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(15,296,761</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(13,059,852</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Impairment*</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,402,913</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(2,219,883</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Property and equipment, net</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">6,727,485</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">7,633,740</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    variance of impairment from March 31, 2020 to December 31, 2020 is solely caused by exchange rate variance.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expenses for property and equipment totaled $350,544 and $413,411 for the three months ended December 31, 2020 and 2019, respectively.
Depreciation expenses for property and equipment totaled $1,458,703 and $1,352,400 for the nine months ended December 31, 2020
and 2019, respectively. There were no fixed assets impaired in the nine months ended December 31, 2020 and December 31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note&nbsp;8
&ndash; LONG-TERM INVESTMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term
investment consists of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">December&nbsp;31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">March&nbsp;31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kahamadi Bio <SUP>(1)</SUP></FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">9,823</TD><TD STYLE="width: 1%; text-align: left">*</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">6,217</TD><TD STYLE="width: 1%; text-align: left">*</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Zhetong Medical <SUP>(2)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,286,156</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,538,234</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Long-term investment</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">4,295,979</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">2,544,451</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
    represents 49% investment in Kahamadi Bio. The investment is recorded using the equity method. Kahamadi Bio made a profit
    of $2,923 in the nine months ended December 31, 2020.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">It represents 39% investment in Zhejiang Zhetong Medical Co.,
Ltd. (&ldquo;Zhetong Medical&rdquo;). Zhetong Medical was established in March 2020 to target potential acquisitions or to cooperate
with local pharmacies. By attracting more funds from local investors, the Company expects to continue growing its local network
in the future. In the nine months ended December 31, 2020, Jiuzhou Pharmacy injected funds of approximately $1,747,922 into Zhetong
Medical. The investment is recorded based on equity method.</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
9 &ndash; ADVANCES TO SUPPLIERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advances
to suppliers consist of deposits, with or advances to, outside vendors for future inventory purchases. Most of the Company&rsquo;s
suppliers require a certain amount of money to be deposited with them as a guarantee that the Company will receive its purchase
on a timely basis. This amount is refundable and bears no interest. As of December 31, 2020 and March 31, 2020, advance to suppliers
consist of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">December&nbsp;31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">March&nbsp;31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Advance to suppliers</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">5,595,191</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">2,198,863</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Less: reserve for vendor non-performance on advances</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,083,370</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,024,063</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Advance to suppliers, net</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">4,511,821</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,174,800</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the nine months ended December 31, 2020 and 2019, none of
the advances to suppliers were written off against previous allowance for unrefundable advances, respectively. The increase in
advance to suppliers is primarily due to deposits made to purchase Ejiao. Ejiao is a traditional chinese nutritional supplement,
which is popular in the local market. In order to retain the sufficient quantity of Ejiao for our stores, we advanced approximately
$3.06 million to suppliers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 164; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
10 &ndash; INVENTORY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
consisted of finished goods, valued at $14,933,245 and $12,247,004 as of December 31, 2020 and March 31, 2020, respectively. The
Company constantly monitors its potential obsolete products and is allowed to return products close to their expiration dates
to its suppliers. Any loss on damaged items is immaterial and will be recognized immediately. As a result, no reserves were made
for inventory as of December 31, 2020 and March 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
11 &ndash; FARMLAND ASSETS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Farmland
assets consist of ginkgo trees planted in 2012 and expected to be harvested and sold in several years. As of December 31, 2020
and March 31, 2020, farmland assets are valued as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">December&nbsp;31,</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">March&nbsp;31,</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Farmland assets</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">2,388,644</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">2,177,606</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Less: Impairment*</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,558,049</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,435,259</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Farmland assets, net</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">830,595</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">742,347</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">The difference
between the recorded impairment loss as of December 31, 2020 and March 31, 2020 is primarily due to the exchange rate variance
over years. There is no leasehold impairment expense in the nine months ended December 31, 2020 and 2019.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
12 &ndash; LONG TERM REFUNDABLE DEPOSITS, LANDLORDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020 and March 31, 2020, long term deposits amounted to $1,551,248 and $1,456,384, respectively. Long term deposits
are money deposited with, or advanced to, landlords for the purpose of securing retail store leases that the Company does not
anticipate being returned within the next twelve months. Most of the Company&rsquo;s landlords require a minimum payment of nine
months&rsquo; rent, paid up front, plus additional deposits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
13 &ndash; OTHER NONCURRENT ASSETS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
noncurrent assets consisted of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">December&nbsp;31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">March&nbsp;31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Forest land use rights*</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1,039,159</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">994,558</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Others</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">97,102</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">52,205</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,136,261</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,046,763</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    prepayment for lease of forest land use rights is a payment made to a local government in connection with entering into an
    operating land lease agreement. The land is currently used to cultivate Ginkgo trees. The forest rights certificate from the
    local village extends the life of the lease to January 31, 2060.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amortization of the prepayment for the lease of forest land use right was approximately $12,834 and $12,652 for the three months
ended December 31, 2020 and 2019, respectively. The amortization of the prepayment for the lease of forest land use right was
approximately $38,501 and $37,957 for the nine months ended December 31, 2020 and 2019, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s amortizations of the prepayment for lease of land use right for the next five years and thereafter are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">For the year ending December 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: justify">2021</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">51,335</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">51,335</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">51,335</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">51,335</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">2025</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">51,335</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Thereafter</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">782,484</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 165; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
14 &ndash; LEASES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company leases most of its retail
stores and corporate offices under operating leases, typically with initial terms of 3 to 10 years. Usually within one to three
months prior to the expiration date of a lease, the Company is required to notify the lessor and has a priority to continue renting
the lease property if a lessor intends to lease property. The lease itself does not have restriction or covenants. If both parties
agree to continue, a new lease contract with new lease terms has to been signed by both parties. Usually, the rent may increase
year by year based on the lease contract. Sublease is typically not allowed. Any damage, if made by the lessee, to the property
and equipment within the property has to been fixed or reimbursed by the lessee. The Company does not have any leases entered
into that have not yet commenced. The net lease cost for the nine months ended December 31, 2020 is $4,875,040. The Company does
not have any finance lease according to the definition of ASU 2016-02, <I>Leases </I>(Topic 842). Supplemental cash flow information
related to leases for the&nbsp;nine months ended&nbsp;December 31, 2020&nbsp;is as follows:&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">Cash paid for amounts included in the measurement of lease liabilities:</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: justify; padding-left: 9pt">Operating cash flows paid for operating leases</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">4,875,040</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 1.5pt">Right-of-use assets obtained in exchange for lease obligations:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt">Operating leases</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplemental
balance sheet information related to leases as of&nbsp;December 31, 2020&nbsp;is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify">Operating leases:</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: justify; padding-bottom: 4pt">Operating lease right-of-use assets</TD><TD STYLE="width: 1%; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 4pt double; text-align: right">21,389,539</TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Current portion of operating lease liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,650,085</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Long-term operating lease liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">17,993,514</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total operating lease liabilities</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">19,643,599</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">Weighted average remaining lease term</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Operating leases</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.6</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify">Weighted average discount rate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Operating leases</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4.77</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the maturity of lease liabilities under operating leases as of December 31, 2020:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Operating</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid">For the year ending December 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Leases</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: justify">2021</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1,637,434</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,561,458</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,664,506</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,389,697</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">2025</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,063,584</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Thereafter</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,662,802</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 9pt">Total lease payments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,979,481</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Less: imputed interest</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,335,882</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt; padding-left: 9pt">Total lease liabilities</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">19,643,599</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 166; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
15 &ndash; INTANGIBLE ASSETS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
intangible assets consisted of the following at:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">December&nbsp;31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">March&nbsp;31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">License <SUP>(1)</SUP></FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">2,441,250</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">2,220,512</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software<SUP>(2)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,210,785</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,083,024</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Land use rights <SUP>(3)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,492,738</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,375,095</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Total intangible assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,144,773</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,678,631</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Less: accumulated amortization</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(933,273</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(667,633</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: impairment<SUP>(4)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(669,828</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(617,038</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Intangible assets, net</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">3,541,672</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">3,393,960</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
expense of intangibles amounted to $48,301 and $107,666 for the three months ended December 31, 2020 and 2019, respectively. Amortization
expense of intangibles amounted to $198,298 and $210,555 for the nine months ended December 31, 2020 and 2019, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">This represents the fair value of the licenses of insurance
applicable drugstores acquired previously, such as Sanhao Pharmacy and several local stores. If a store has such license, patients
are allowed pay by using insurance cards at that store. The stores are then reimbursed from the Human Resource and Social Security
Department of Hangzhou City. In 2014, the Company acquired Sanhao Pharmacy, a drugstore chain. In September 2017, the Company acquired
several new stores for the purpose of the Municipal Social Medical Reimbursement Qualification Certificates. On January 9, 2020,
Jiuzhou Pharmacy acquired a local drugstore chain. The acquired drugstores ceased all business and liquidated all accounts after
being acquired. In March 2020, the drugstore chain has dissolved and its certificates were transferred to new stores owned by Jiuzhou
Pharmacy.</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">These balances primarily include the SAP ERP system, the Internet
Clinic Diagnosis Terminal system and the Chronic Disease Management system. In 2017, the Company installed a leading ERP system,
SAP from Germany. SAP is a well-known management system used by many fortune 500 companies. It is being amortized over three years
since its installation. In 2020, the Company installed an internet Clinic Diagnosis System for online diagnosis which may increase
customer spending, and a Chronic Disease Management System to better manage and monitor its members&rsquo; health. As of December
31, 2020, the SAP system has a net value of $769,881 (RMB 5,029,372), the internet Clinic Diagnosis System has a net value of approximately
$411,580 (RMB 2,688,709), and the Chronic Disease Management System has a net value of approximately $17,815 (RMB 116,379).</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">In July 2013, the Company purchased the land use rights of a
plot of land in Lin&rsquo;an, Hangzhou, intended to establish an herb processing plant in the future. However, as the Company&rsquo;s
farming business in Lin&rsquo;an has not grown, the Company does not expect to complete this project in the near future.</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    the year ended March 31, 2020, the Company evaluated the licenses of insurance applicable drugstores acquired in the past
    based on the discounted positive cash value. Due to the stricter government insurance policy in the fourth quarter of fiscal
    year 2020, the value of these licenses has declined. As a result, the Company recorded an impairment in the fourth quarter of fiscal 2020. There are no
    impairment expenses in the nine months ended December 31, 2020 and 2019.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 167; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
16 &ndash; NOTES PAYABLE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has credit facilities with Hangzhou United Bank (&ldquo;HUB&rdquo;) that provided working capital in the form of the following
bank acceptance notes at December 31, 2020 and March 31, 2020:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Origination</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Maturity</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">December&nbsp;31,</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">March&nbsp;31,</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficiary<SUP>(1)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center">Endorser</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center">date</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center">date</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 43%; text-align: justify">Jiuzhou Pharmacy</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HUB</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/09/19</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">04/09/20</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">3,478,259</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Jiuzhou Pharmacy</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HUB</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/06/19</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05/06/20</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">164,582</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Jiuzhou Pharmacy</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HUB</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/05/19</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/05/20</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,106,474</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Jiuzhou Pharmacy</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HUB</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/19</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/30/20</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,289,308</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Jiuzhou Pharmacy</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HUB</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">01/06/20</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/06/20</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">129,457</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Jiuzhou Pharmacy</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HUB</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/19/20</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">08/19/20</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,105,096</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Jiuzhou Pharmacy</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HUB</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/10/20</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09/10/20</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,324,871</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Jiuxin Medicine</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HUB</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/26/19</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/26/20</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,371,992</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Jiuxin Medicine</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HUB</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/19</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/30/20</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,943,776</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Jiuxin Medicine</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HUB</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/31/20</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09/30/20</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,692,156</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Jiuzhou Pharmacy</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HUB</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">08/11/20</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/11/21</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,359,247</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Jiuzhou Pharmacy</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HUB</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">08/31/20</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/01/21</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">474,539</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Jiuzhou Pharmacy</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HUB</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">09/08/20</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/08/21</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,848,532</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Jiuzhou Pharmacy</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HUB</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10/10/20</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">04/10/21</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">824,202</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Jiuzhou Pharmacy</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HUB</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11/09/20</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">05/09/21</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,739,133</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Jiuzhou Pharmacy</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HUB</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/17/20</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/17/21</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,238,393</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Jiuzhou Pharmacy</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HUB</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/25/20</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/25/21</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">995,001</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Jiuzhou Pharmacy</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HUB</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/30/20</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/30/21</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,305,535</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Jiuzhou Pharmacy</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HUB</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/07/20</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/07/21</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,429,269</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Jiuxin Medicine</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HUB</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/30/20</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/30/21</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,522,310</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">25,736,161</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">26,605,971</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 31, 2020, the Company had $25,736,161 (RMB 168,125,591) of notes payable from HUB. The Company is required to
    hold restricted cash in the amount of $12,683,907 (RMB 82,859,654) with HUB as collateral against these bank notes. Included
    in the restricted cash is a total of $6,888,465 three-year deposit (RMB 45,000,000) deposited into HUB as a collateral for
    current and future notes payable from HUB.&nbsp;&nbsp;As of March 31, 2020, the Company had $26,605,971 (RMB 188,677,437)
    of notes payable from HUB. The Company is required to hold restricted cash in the amount of $14,596,179 (RMB 103,509,456)
    with HUB as collateral against these bank notes. Included in the restricted cash is a total of $8,763,958 three-year deposit
    (RMB 62,150,000) deposited into HUB as a collateral for current and future notes payable from HUB.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, the Company had a credit line of approximately $13.62 million in the aggregate&nbsp;from HUB. By putting
up a three-year deposit of $6.89 million and the additional short-term deposits of $5.80 million deposited in the banks, the total
credit line was $26.31 million. As of December 31, 2020, the Company had approximately $25.74 million of bank notes payable and
approximately $0.57 million bank credit line was still available for further borrowing. The bank notes are secured by three drugstores
of Jiuzhou Pharmacy and guaranteed by the Company&rsquo;s major shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 168; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
17 &ndash; LONG-TERM LOAN PAYABLE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 2, 2019 and December 11, 2019,
the Company borrowed $717,810 and $6,460,290 from Haihui Commercial Factoring (Tianjin) Co. Ltd. (&ldquo;Haihui Commercial&rdquo;),
respectively. After deducting processing fee and deposits which are refundable at the end of loan period, the Company received
$617,317 and $5,878,864 respectively. The Company is required to pledge accounts receivable of three drugstores to Haihui Commercial.
As of December 31, 2020, the remaining loan balance is $5,069,907. The Company is scheduled to make monthly repayments, among
which $2,480,264 is due within a year. The Company has an option to pay off the debts earlier than the repayment schedule upon
approval from Haihui Commercial.&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
18 &ndash; TAXES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Income
tax</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
tax expense includes a provision for federal, state and foreign taxes based on the annual estimated effective tax rate applicable
to the Company and its subsidiaries, adjusted for items which are considered discrete to the period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The effective tax rate based on forecasted
annual results for the FYE 2021 is (1.1)%. The effective tax rates on income before income taxes for the nine months ended December
31, 2020 was (0.5)%. The (0.5)% rate adjustments for the nine months ended December 31, 2020 represent expenses that primarily
include stock option expenses and legal, accounting and other expenses incurred by the Company that are not deductible for PRC
income tax. The effective tax rate is based on forecasted annual results and these amounts may fluctuate significantly through
the rest of the year as a result of the unpredictable impact of COVID-19 on the Company&rsquo;s operating activities.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
effective tax rate on income before income taxes for the nine months ended December 31, 2019 was (0.5)%. The (0.5)% rate adjustments
for the nine months ended December 31, 2019 represent expenses that primarily include stock option expenses and legal, accounting
and other expenses incurred by the Company that are not deductible for PRC income tax.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
reconciliation of the income tax provision at the federal statutory rate and the effective rate is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center">For the nine months Ended<BR> December 31</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">U.S. Statutory rates</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">21.0</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">21.0</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Foreign income not recognized in the U.S.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(21.0</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(21.0</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">China income taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25.0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25.0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Change in valuation allowance</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(25.0</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(25.0</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Non-deductible expenses-permanent difference</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(0.5</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(0.5</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Effective tax rate</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(0.5</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)%</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(0.5</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has recorded $0 unrecognized benefit as of December 31, 2020. On the information currently available, the Company does
not anticipate a significant increase or decrease to its unrecognized benefit within the next 12 months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
19 &ndash; POSTRETIREMENT BENEFITS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulations
in the PRC require the Company to contribute to a defined contribution retirement plan for all permanent employees. The contribution
for each employee is based on a percentage of the employee&rsquo;s current compensation as required by the local government. The
Company contributed $309,950 and $364,477 in employment benefits and pension for the three months ended December 31, 2020 and
2019, respectively. The Company contributed $769,740 and $1,045,798 in employment benefits and pension for the nine months ended
December 31, 2020 and 2019, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 169; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
20 &ndash; RELATED PARTY TRANSACTIONS AND ARRANGEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
payable to related parties are summarized as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">December&nbsp;31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">March&nbsp;31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to a director and CEO <SUP>(1)</SUP> :</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">689,274</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">490,218</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
    to foreign exchange restrictions, the Company&rsquo;s director and CEO, Mr. Lei Liu personally lent U.S. dollars to the Company
    to facilitate its payments of expenses in the United States.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company leases from Mr. Lei Liu a
retail space; the lease expires in September 2022. Rent expenses totaled $6,993 and $6,572 for the three months ended December
31, 2020 and 2019, respectively. Rent expenses totaled $20,216 and $19,956 for the nine months ended December 31, 2020 and 2019,
respectively. The amounts owed under the lease for the nine months ended December 31, 2020 and 2019 were not paid to Mr. Liu as
of December 31, 2020.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On April 28, 2018, 10% of Jiuxin Medicine was sold to Hangzhou
Kangzhou Biotech Co. Ltd. for a total proceed of approximately $75,643 (RMB507, 760). Mr. Lei Liu owns 51% of Hangzhou Kangzhou
Biotech Co. Ltd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
21 &ndash; WARRANTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the registered direct
offering closed on July 19, 2015, the Company issued to an investor a warrant to purchase up to 600,000 shares of common stock
at an exercise price of $3.10 per share. The warrant became exercisable on January 19, 2016 and expired on January 18, 2021. In
connection with the offering, the Company also issued a warrant to its placement agent of this offering, pursuant to which the
agent may purchase up to 6% of the aggregate number of shares of common stock sold in the offering, i.e. 72,000 shares. Such warrant
has the same terms as the warrant issued to the investor in the offering.<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 1, 2020, one investor exercised 25,000 warrants at the price of $3.10 per share in cash. As of December 31, 2020, 647,000
warrants had not been exercised. The fair value of the warrants issued to purchase 647,000 and 672,000 shares as of December 31,
2020 and March 31, 2020, as described above was estimated by using the binominal pricing model with the following assumptions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Common Stock<BR> Warrants</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Common Stock<BR> Warrants</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">December 31,<BR> 2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">March 31, <BR>2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: justify">Stock price</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1.01</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1.77</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Exercise price</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3.10</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3.10</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Annual dividend yield</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Expected term (years)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.05</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.81</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Risk-free interest rate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.08</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.71</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Expected volatility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">86.36</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">62.08</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
evaluation, the warrants meet the definition of a derivative under FASB ASC 815, as the Company cannot avoid a net cash settlement
under certain circumstances. Accordingly, the fair value of the warrants was classified as a liability of $64,090 as of March
31, 2020. For the three months ended December 31, 2020 and December 31, 2019, the Company recognized a gain of $36,306 and a loss
of $65,172 for the investor warrant and placement agent warrant, from the change in fair value of the warrant liability. For the
nine months ended December 31, 2020 and December 31, 2019, the Company recognized a gain of $64,090 and a gain of $345,248 for
the investor warrant and placement agent warrant, from the change in fair value of the warrant liability. As a result, the warrant
liability is carried on the consolidated balance sheets at the fair value of $0 and $64,090 for the investor warrant and placement
agent warrant, collectively, as of December 31, 2020 and March 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 170; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
22 &ndash; EMPLOYEE DEPOSITS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To encourage the operating team, which
consists of doctors and nurses, to devote their efforts to run clinics, Linjia Medical allows them to put deposits in the clinic
where doctors and nurses work, and take shares in any profit of the clinic. The principal amounts of these deposits are refundable
in the event the doctors and nurses leave the clinic. In order to properly reflect Linjia Medical&rsquo;s liabilities, the Company
reclassified the deposit of $15,308 (RMB100,000) and $70,507 (RMB500,000) as financial liability as of December 31, 2020 and March
31, 2020.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
23 &ndash; STOCKHOLDER&rsquo;S EQUITY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Common
stock</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 15, 2019, the Company closed a registered direct offering of 4,000,008 shares of common stock at $2.50 per share with gross
proceeds of $10,000,020 from its effective shelf registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 1, 2020, an investor exercised 25,000 warrants at the price of $3.10 per share in cash. The Company issued 25,000 shares
of common stock as a result.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 3, 2020, the Company closed a registered direct offering of 5,000,004 shares of common stock at $2.00 per share with gross
proceeds of $10,000,008 from its effective shelf registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Stock
warrants</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concurrent
with the registered direct offering of common stock that closed on April 15, 2019, the Company issued to several investors in
a private placement warrants to purchase up to 3,000,006 shares of common stock. In connection with the offering, the Company
also issued a warrant to its placement agent of this offering, pursuant to which the agent may purchase up to 6% of the aggregate
number of shares of common stock sold in the offering, i.e. 240,000 shares at an exercise price of $3.125 per share. The warrant
became exercisable on October 11, 2019 and will expire on April 11, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concurrent
with the registered direct offering of common stock that closed on June 3, 2020, the Company issued to several investors in a
private placement warrants to purchase up to 3,750,003 shares of common stock. In connection with the offering, the Company also
issued warrants to its placement agent of this offering, pursuant to which the agent may purchase up to 6.5% of the aggregate
number of shares of common stock sold in the offering, i.e. 300,000 shares at an exercise price of $2.57 per share. The warrant
becomes exercisable on December 2, 2020 and will expire on June 2, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
evaluation, both the warrants issued in April 2019 and June 2020 meet the definition of an equity transaction under FASBASC 815.
Accordingly, the fair value of the warrants is recorded as a part of additional paid-in capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Stock-based
compensation</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for share-based payment awards granted to employees and directors by recording compensation expense based on
estimated fair values. The Company estimates the fair value of share-based payment awards on the date of grant. The value of the
portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the
Company&rsquo;s consolidated statements of operations. Share-based awards are attributed to expenses using the straight-line method
over the vesting period. The Company determines the value of each option award that contains a market condition using a Monte
Carlo Simulation valuation model, while all other option awards are valued using the Black-Scholes valuation model as permitted
under FASB ASC 718 &ldquo;Compensation - Stock Compensation.&rdquo; The assumptions used in calculating the fair value of share-based
payment awards represent the Company&rsquo;s best estimates. The Company&rsquo;s estimates of the fair values of stock options
granted and the resulting amounts of share-based compensation recognized may be impacted by certain variables including stock
price volatility, employee stock option exercise behaviors, additional stock option modifications, estimates of forfeitures, and
the related income tax impact. On December 31, 2020, the Company granted a total of 3,790,000 shares of restricted common stock
to its key employees in its retail drugstores and online pharmacy under the Company&rsquo;s 2010 Equity Incentive Plan, as amended
(the &ldquo;Plan&rdquo;). The stock awards vested on the grant date. All $3,941,600 of such expense has been recorded as a service
compensation expense in the quarter ended December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Stock
option</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 18, 2014, the Company granted
a total of 967,000 shares of stock options under the Plan to a group of a total of 46 grantees including directors, officers and
employees. The exercise price of the stock option is $2.50. The option vested on November 18, 2017, provided that the grantees
are still employed by the Company on such a date. The options are exercisable for five years from the vesting date, or November
18, 2017 until November 17, 2022. For the nine months ended December 31, 2020 and 2019, none was recorded as compensation expense.
As of December 31, 2020, all compensation costs related to stock option compensation arrangements granted have been recognized.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 171; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Statutory
reserves</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statutory
reserves represent restricted retained earnings. Based on their legal formation, the Company is required to set aside 10% of its
net income as reported in their statutory accounts on an annual basis to the Statutory Surplus Reserve Fund (the &ldquo;Reserve
Fund&rdquo;). Once the total amount set aside in the Reserve Fund reaches 50% of the entity&rsquo;s registered capital, further
appropriations become discretionary. The Reserve Fund can be used to increase the entity&rsquo;s registered capital upon approval
by relevant government authorities or eliminate its future losses under PRC GAAP upon a resolution by its board of directors.
The Reserve Fund is not distributable to shareholders, as cash dividends or otherwise, except in the event of liquidation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appropriations
to the Reserve Fund are accounted for as a transfer from unrestricted earnings to statutory reserves. During the nine months ended
December 31, 2020 and 2019, the Company did not make appropriations to statutory reserves.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no legal requirements in the PRC to fund the Reserve Fund by transfer of cash to any restricted accounts, and the Company
does not do so.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
24 &ndash; LOSS PER SHARE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company reports earnings per share in accordance with the provisions of the FASB&rsquo;s related accounting standard. This standard
requires presentation of basic and diluted earnings per share in conjunction with the disclosure of the methodology used in computing
such earnings per share. Basic earnings per share excludes dilution, but includes vested restricted stocks and is computed by
dividing income available to common stockholders by the weighted average common shares outstanding during the period. Diluted
earnings per share takes into account the potential dilution that could occur if securities or other contracts to issue common
stock were exercised and converted into common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a reconciliation of the basic and diluted (loss) earnings per share computation:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Three months ended<BR> December&nbsp;31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Nine months ended<BR> December&nbsp;31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: justify">Net Loss(income) attributable to controlling interest</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(6,256,319</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">531,782</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(7,981,547</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(2,828,132</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Weighted average shares used in basic computation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">41,339,834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,936,786</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">40,462,971</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,776,786</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Diluted effect of purchase options and warrants</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Weighted average shares used in diluted computation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">41,339,834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,936,786</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">40,462,971</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,776,786</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Loss(income) per share &ndash; Basic:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Net loss(income) attributable to controlling interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.15</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.02</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.20</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.09</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Loss(income) per share &ndash; Diluted:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Net loss (income) attributable to controlling interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.15</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.02</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.20</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.09</TD><TD STYLE="text-align: left">)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three and nine months ended December 31, 2020, 967,000 shares underlying employee stock options and 575,000 shares underlying
outstanding purchase options to an investor, and 72,000 shares underlying outstanding purchase option to an investment placement
agent were excluded from the calculation of diluted loss per share as the options were anti-dilutive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
25 &ndash; SEGMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company operates within four main reportable segments: retail drugstores, online pharmacy, drug wholesale and herb farming. The
retail drugstores segment sells prescription and over-the-counter (&ldquo;OTC&rdquo;) medicines, TCM, dietary supplements, medical
devices, and sundry items to retail customers. The online pharmacy sells OTC drugs, dietary supplements, medical devices and sundry
items to customers through several third-party platforms such as Alibaba&rsquo;s Tmall, JD.com and Amazon.com, and the Company&rsquo;s
own platform all over China. The drug wholesale segment includes supplying the Company&rsquo;s own retail drugstores with prescription
and OTC medicines, TCM, dietary supplement, medical devices and sundry items (which sales have been eliminated as intercompany
transactions), and also selling them to other drug vendors and hospitals. The Company&rsquo;s herb farming segment cultivates
selected herbs for sales to other drug vendors. The Company is also involved in online sales and clinic services that do not meet
the quantitative thresholds for reportable segments and are included in the retail drugstores segment. The segments&rsquo; accounting
policies are the same as those described in the summary of significant accounting policies. The Company evaluates performance
based on profit or loss from operations before interest and income taxes not including nonrecurring gains and losses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s reportable business segments are strategic business units that offer different products and services. Each segment
is managed separately because they require different operations and markets to distinct classes of customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 172; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents summarized information by segment of the continuing operations for the three months ended December 31,
2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Retail<BR>
 drugstores</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Online<BR>
 Pharmacy</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Drug<BR>
 wholesale</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Herb<BR> farming</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Total</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: justify">Revenue</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">20,066,840</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">6,599,138</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">8,872,781</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">35,538,759</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Cost of goods</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,525,740</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,065,897</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,859,872</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">27,451,509</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Gross profit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">6,541,100</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">533,241</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,012,909</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,087,250</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Selling expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,864,838</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">790,595</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">607,157</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,262,590</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">General and administrative expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,557,075</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">64,983</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">570,236</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,192,294</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Income (Loss) from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(5,880,813</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(322,337</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(164,484</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,367,634</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">384,166</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,679</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">398,845</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Total capital expenditures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">68,367</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">68,367</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents summarized information by segment of the continuing operations for the three months ended December 31,
2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Retail<BR> drugstores</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Online <BR> Pharmacy</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Drug <BR> wholesale</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Herb<BR> farming</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Total</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: justify">Revenue</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">21,575,965</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">3,965,023</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">7,822,294</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">33,363,282</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Cost of goods</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,388,580</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,639,995</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,051,335</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,079,910</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Gross profit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">6,187,385</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">325,028</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">770,959</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,283,372</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Selling expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,836,140</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">507,393</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">332,867</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,676,400</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">General and administrative expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,403,350</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">61,193</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(410,483</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,054,060</TD><TD STYLE="text-align: left"></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Income (Loss) from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(52,105</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(243,558</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">848,575</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">552,912</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">459,184</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">36,402</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">495,586</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Total capital expenditures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">277,480</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">277,480</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents summarized information by segment of the continuing operations for the nine months ended December 31,
2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Retail<BR>
 drugstores</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Online<BR>
 Pharmacy</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Drug<BR>
 wholesale</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Herb<BR> farming</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Total</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: justify">Revenue</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">56,807,810</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">16,858,984</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">23,768,822</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">97,435,616</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Cost of goods</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,254,501</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,039,033</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,061,861</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">74,355,395</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Gross profit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">18,553,309</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,819,951</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,706,961</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,080,221</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Selling expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,278,931</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,117,354</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,614,224</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,010,509</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">General and administrative expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,097,483</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">186,104</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,090,432</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,374,019</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Loss from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(6,823,105</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(483,507</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(997,695</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,304,307</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,626,020</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,980</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,657,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Total capital expenditures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">387,223</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">387,223</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents summarized information by segment of the continuing operations for the nine months ended December 31,
2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Retail<BR> drugstores</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Online<BR> pharmacy</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Drug<BR> wholesale</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Herb<BR> farming</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Total</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: justify">Revenue</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">56,312,226</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">8,759,892</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">21,925,727</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">86,997,845</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Cost of goods</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39,542,348</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,769,309</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,648,014</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">66,959,671</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Gross profit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">16,769,878</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">990,583</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,277,713</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,038,174</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Selling expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,067,432</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,442,927</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,620,440</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,130,799</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">General and administrative expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,396,589</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">176,792</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,156,226</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,729,607</TD><TD STYLE="text-align: left"></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Loss from operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(2,694,143</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(629,136</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(498,953</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,822,232</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,495,216</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">67,740</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,562,956</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Total capital expenditures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,267,614</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,267,614</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 173; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not have long-lived assets located outside the PRC. In accordance with the enterprise-wide disclosure requirements
of FASB&rsquo;s accounting standard.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s net revenue from external customers through
its retail drugstores by main product categories for the three and nine months ended December 31, 2020 and 2019 were as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Three months ended<BR> December&nbsp;31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Nine months ended<BR> December&nbsp;31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: justify">Prescription drugs</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">7,013,958</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">7,496,469</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">20,403,438</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">19,214,689</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">OTC drugs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,451,389</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,260,883</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,887,032</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,964,312</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Nutritional supplements</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,624,313</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,602,407</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,636,347</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,510,514</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">TCM</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,191,877</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,416,126</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,195,267</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,474,676</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Sundry products</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">301,658</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">188,484</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,062,321</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">777,432</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Medical devices</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,483,645</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">611,597</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,623,405</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,370,604</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">20,066,840</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">21,575,966</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">56,807,810</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">56,312,227</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s net revenue from external
customers through online pharmacy by main product categories is as follows:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Three months ended<BR> December&nbsp;31,</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Nine months ended<BR> December&nbsp;31,</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2020</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2019</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2020</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">2019</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: justify">Prescription drugs</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">2,227,332</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">5,855,491</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">OTC drugs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,415,029</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,981,871</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,720,874</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,133,128</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Nutritional supplements</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">318,869</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">245,249</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">747,962</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">488,956</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">TCM</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">174,476</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">42,331</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">270,024</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">77,981</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Sundry products</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">548,018</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">729,179</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,506,232</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,542,372</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Medical devices</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">915,414</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">966,393</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,758,401</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,517,455</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">6,599,138</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">3,965,023</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">16,858,984</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">8,759,892</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company&rsquo;s net revenue from external
customers through wholesale by main product categories is as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Three months ended<BR> December&nbsp;31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Nine months ended<BR> December&nbsp;31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: justify">Prescription drugs</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">7,450,847</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">6,358,031</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">19,267,262</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">18,054,557</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">OTC drugs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,326,118</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,310,927</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,804,608</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,433,730</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Nutritional supplements</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,452</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">47,736</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">102,397</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">104,475</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">TCM</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">57,244</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">67,507</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">164,544</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">247,465</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Sundry products</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,530</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,789</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,887</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,809</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Medical devices</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">20,590</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">18,303</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">406,124</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">54,690</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">8,872,781</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">7,822,293</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">23,768,822</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">21,925,726</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
26 <FONT STYLE="text-transform: uppercase">&ndash; Subsequent Events</FONT></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 4, 2021, Jiuxin Investments sold
Lin&rsquo;An Jiuzhou, its subsidiary, to a local online medicine operator for a total proceeds of $130,135 (RMB850,000). Lin&rsquo;An
Jiuzhou has suffered an accumulated loss of $833,831 as of January 31, 2021. After spinning off its Lin&rsquo;An subsidiary, the Company
will focus more on its Hangzhou pharmacies.&nbsp;The disposal of Lin&rsquo;an Jiuzhou&rsquo;s operation is insignificant to our pharmacy
business.<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 174; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: right; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: right; padding-bottom: 0pt"><A NAME="main_022"></A><B>Annex
A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; padding-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt"><B>AGREEMENT AND PLAN OF MERGER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">This AGREEMENT AND PLAN OF
MERGER (this &ldquo;<B>Agreement</B>&rdquo;) is entered into as of _______, 2021, by and among China Jo-Jo Drugstores, Inc., a Nevada
corporation (&ldquo;<B>CJJD</B>&rdquo;), and China Jo-Jo Drugstores Holdings, Inc., an exempted company incorporated under the laws of
the Cayman Islands and a wholly owned subsidiary of CJJD (&ldquo;<B>CJJD Cayman</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">RECITALS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">1. The Boards of Directors
of each of CJJD and CJJD Cayman have unanimously determined that it is advisable and in the best interests of their respective shareholders
or stockholders to reorganize so that CJJD will merge with and into CJJD Cayman (the &ldquo;<B>Merger</B>&rdquo;), with CJJD Cayman surviving
and changing its name to China Jo-Jo Drugstores, Inc., an exempted company incorporated under the laws of the Cayman Islands;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">2.
The respective Boards of Directors of CJJD and CJJD Cayman have each unanimously approved the Merger, this Agreement, the Plan of
Merger (as defined below) and, to the extent applicable, the other transactions described herein, pursuant to which CJJD Cayman will
be the surviving company of the Merger, all upon the terms and subject to the conditions set forth in this Agreement and the Plan of
Merger, and whereby each issued and outstanding share of common stock, par value $0.001 per share, of CJJD (&ldquo;<B>CJJD Common
Stock</B>&rdquo;), shall be converted into the right to receive one ordinary share, par value US$0.001 per share, of CJJD Cayman (a
&ldquo;<B>CJJD Cayman Ordinary Share</B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">3. The Merger requires, among
other things, the approval of this Agreement and the Plan of Merger by the affirmative vote of the holders of a majority of the issued
and outstanding shares of CJJD Common Stock; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">4. The parties intend that
the Merger qualify as a &ldquo;reorganization&rdquo; within the meaning of Section 368(a) of the Internal Revenue Code of 1986, as amended
(the &ldquo;<B>Code</B>&rdquo;), and that this Agreement shall be, and is hereby, adopted as a &ldquo;plan of reorganization&rdquo; for
purposes of Section 368(a) of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>


<DIV STYLE="border: white 1pt solid; margin-top: 0pt; margin-bottom: 0pt; padding-right: 0pt; padding-top: 0pt; padding-bottom: 0pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">NOW THEREFORE, in consideration
of the foregoing and of the covenants and agreements contained herein, and of other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the parties hereto hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">ARTICLE I<BR>
The Merger&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">Section
1.01. <I>The Merger</I>. Subject to the terms and conditions of this Agreement, and in accordance with the Nevada Revised Statutes (the
&ldquo;<B>NRS</B>&rdquo;) and the Cayman Islands Companies Act (the &ldquo;<B>Act</B>&rdquo;), at the Effective Time (as defined in Section
1.02), CJJD shall be merged with and into CJJD Cayman in accordance with this Agreement and the Plan of Merger, and the separate corporate
existence of CJJD shall thereupon cease. Pursuant to and simultaneously upon the consummation of the Merger at the Effective Time, in
accordance with the NRS and the Act, (i) CJJD Cayman shall continue as the surviving company in the Merger (sometimes hereinafter referred
to as the &ldquo;<B>Surviving Company</B>&rdquo;), (ii) the corporate identity, existence, powers, rights and immunities of CJJD Cayman
as the Surviving Company shall continue unimpaired by the Merger, and (iii) CJJD Cayman shall succeed to and shall possess all the assets,
properties, rights, privileges, powers, franchises, immunities and purposes, and be subject to all the debts, liabilities, obligations,
restrictions and duties of CJJD, all without further act or deed.</P>

</DIV>

<DIV STYLE="border: white 1pt solid; margin-top: 0pt; margin-bottom: 0pt; padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 1.02. <I>Filing Plan
of Merger; Effective Time</I>. As soon as practicable following the satisfaction or, to the extent permitted by applicable law, waiver
of the conditions set forth in Article V, if this Agreement shall not have been terminated prior thereto as provided in Section 6.01,
CJJD Cayman and CJJD shall cause a plan of merger (the &ldquo;<B>Plan of Merger</B>&rdquo;) in the form set out in <U>Annex A</U> to be
properly executed and filed with the Registrar of Companies of the Cayman Islands (the &ldquo;<B>Cayman Registrar</B>&rdquo;) in accordance
with the Act and otherwise make all other filings, submissions or recordings as required by the NRS and the Act. The Merger shall become
effective upon the date on which the Plan of Merger is registered by the Cayman Registrar (or on such later date as may be specified in
the Plan of Merger) in accordance with the Act (the &ldquo;<B>Effective Time</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">ARTICLE II<BR>
Memorandum and Articles of Association,<BR>
Directors and Officers of Surviving Company, and Certain Representations&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 2.01. <I>Name of Surviving
Company</I>. The name of the Surviving Company shall be &ldquo;China Jo-Jo Drugstores, Inc.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 2.02. <I>Memorandum
and Articles of Association of Surviving Company</I>. At the Effective Time, in accordance with the terms of the Plan of Merger, the Surviving
Company will adopt the memorandum and articles of association in the form set out in <U>Annex B</U>, as the memorandum and articles of
association of the Surviving Company until thereafter amended as provided by law and such memorandum and articles of association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 2.03. <I>Directors
of Surviving Company</I>. From and after the Effective Time, the directors of CJJD Cayman immediately prior to the Effective Time shall
be the directors of the Surviving Company, each such director to serve in such capacity until his or her earlier death, resignation or
removal or until his or her successor is duly elected or appointed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt"></P></DIV>

<!-- Field: Page; Sequence: 175; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: white 1pt solid; margin-top: 0pt; margin-bottom: 0pt; padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 2.04. <I>Officers of
Surviving Company</I>. From and after the Effective Time, the officers of CJJD Cayman immediately prior to the Effective Time shall be
the officers of the Surviving Company, each such officer to serve in such capacity until his or her earlier death, resignation or removal
or until his or her successor is duly elected or appointed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 2.05. <I>Directors
and Officers of CJJD Cayman.</I> Immediately prior to the Effective Time, CJJD, in its capacity as the sole shareholder of CJJD Cayman,
agrees to take or cause to be taken all such actions as are necessary to cause at least those persons serving as the directors and officers
of CJJD immediately prior to the Effective Time to be elected or appointed as the directors and officers of CJJD Cayman (to the extent
the officers and directors of CJJD Cayman and CJJD are not already identical), each such person to have the same office(s) with CJJD Cayman
(and the same class designations and committee memberships in the case of directors) as he or she held with CJJD, with the directors to
serve until the earlier of the next meeting of the CJJD Cayman shareholders at which an election of directors is required for the class
to which they have been elected or until their successors are elected or appointed (or their earlier death, disability or retirement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 2.06. <I>Representation
of CJJD</I>. CJJD hereby represents and warrants that it is the owner of all of the outstanding share capital of CJJD Cayman, free and
clear of any adverse claims.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">ARTICLE III<BR>
Conversion, Issuance and Repurchase of Shares&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 3.01. <I>Effect on
Capital Stock</I>. At the Effective Time, by virtue of the Merger and without any action on the part of the holder of any shares of either
CJJD or CJJD Cayman:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">(a) <I>Conversion of CJJD Share;
Issuance of CJJD Cayman Ordinary Share</I>. Each issued and outstanding share of CJJD Common Stock shall be automatically converted into
the right to receive one validly issued, fully paid and non-assessable CJJD Cayman Ordinary Share, and CJJD Cayman shall issue to each
holder of such right that number of CJJD Cayman Ordinary Shares, credited as fully paid, to which each such holder is entitled. Each treasury
share of CJJD Common Stock shall be automatically converted into a treasury share of CJJD Cayman.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">(b) <I>Cancellation of CJJD
Capital Stock</I>. The certificates for CJJD Common Stock exchanged for CJJD Cayman Ordinary Shares will be cancelled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">(c) <I>Cancellation of CJJD
Cayman Ordinary Share</I>. The one CJJD Cayman Ordinary Share that was held by CJJD prior to the Merger shall be cancelled, and no consideration
shall be paid or payable to the holder of such CJJD Cayman Ordinary Share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">(d) <I>Stock-Based Compensation
Plans</I>. CJJD shall assign, and CJJD Cayman shall assume, CJJD&rsquo;s rights and obligations under the stock-based benefit and compensation
plans and programs and agreements providing for the grant or award of restricted stock, stock units, stock options, stock appreciation
rights, performance shares, performance units, dividend equivalent rights and share awards to the employees, directors and consultants
of CJJD and its affiliates (collectively, the &ldquo;<B>Stock Plans</B>&rdquo;) in accordance with Article IV of this Agreement. To the
extent a Stock Plan provides for awards of incentive stock options pursuant to Section 422 of the Code, approval of such plan by CJJD,
as the sole shareholder of CJJD Cayman, shall be deemed, as of the Effective Time, to constitute approval of the members of CJJD Cayman
for purposes of Section 422(b) of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">(e) <I>Convertible Securities</I>.
CJJD shall assign, and CJJD Cayman shall assume, CJJD&rsquo;s rights and obligations under its securities, including but not limited to
convertible debentures, warrants and options, that may be convertible into or exercisable into CJJD Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 3.02. <I>Exchange of
CJJD Cayman Shares.</I>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">(a) <I>Uncertificated Shares</I>.
At the Effective Time, each outstanding share of CJJD Common Stock held in uncertificated, book entry form will be exchanged for one CJJD
Cayman Ordinary Share in accordance with Sections 3.01(a) and (b) without further act or deed by the holder thereof, and record of such
ownership shall be kept in uncertificated, book entry form in CJJD's register of members by CJJD Cayman&rsquo;s transfer agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">(b) <I>Certificated Shares</I>.
At the Effective Time, each outstanding share of CJJD Common Stock held in certificated form will be converted into the right to receive
one CJJD Cayman Ordinary Share in accordance with Sections 3.01(a) and (b) without further act or deed by the holder thereof, and the
holder thereof will cease to be, and will have no rights as, a stockholder of CJJD. Following the consummation of the Merger, CJJD&rsquo;s
exchange agent will send a letter of transmittal to each such holder, explaining the procedure for surrendering such holder&rsquo;s CJJD
Common Stock certificates in exchange for share certificates representing CJJD Cayman Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">(c) <I>Shareholder Rights at
Effective Time</I>. At the Effective Time, holders of CJJD Common Stock will cease to be, and will have no rights as, stockholders of
CJJD, other than the right to receive any dividend or other distribution with a record date prior to the Effective Time that may have
been declared or made by CJJD on such shares of CJJD Common Stock in accordance with the terms of this Agreement or prior to the date
of this Agreement and that remain unpaid at the Effective Time. After the Effective Time, there shall be no further registration of transfers
on the stock transfer books of the Surviving Company of the shares of CJJD Common Stock that were outstanding immediately prior to the
Effective Time. Upon and after the Effective Time, registered shareholders in CJJD Cayman&rsquo;s register of members will have and be
entitled to exercise any voting and other rights with respect to and to receive any dividend and other distributions upon CJJD Cayman
Ordinary Shares registered in their respective names in the register of members.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 3.03. <I>Dissenters&rsquo;
Rights</I>. There are no dissenters&rsquo; rights or appraisal rights available to holders of CJJD Common Stock under the Nevada Revised
Statutes or under the Act in connection with the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">&nbsp;</P></DIV>

<!-- Field: Page; Sequence: 176; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: white 1pt solid; margin-top: 0pt; margin-bottom: 0pt; padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">ARTICLE
IV<BR>
Employee Benefit and Compensation Plans and Agreements; Other Contracts&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 4.01. <I>Assumption
of Equity Plans</I>. At the Effective Time, CJJD shall assign, and CJJD Cayman shall assume, the rights and obligations of CJJD under
each Stock Plan. To the extent any Stock Plan or any applicable agreement relating thereto provides for the issuance, delivery or purchase
of, or otherwise relates to, CJJD Common Stock, from and after the Effective Time, such Stock Plan or applicable agreement shall be deemed
to have been amended to provide for the issuance, delivery or purchase of, or otherwise relate to, CJJD Cayman Ordinary Shares, and all
options or awards issued, or benefits available or based upon the value of a specified number of shares of CJJD Common Stock, under such
Stock Plan after the Effective Time shall entitle the holder thereof to purchase, receive, acquire, hold or realize the benefits measured
by the value of, as appropriate, an equivalent number of CJJD Cayman Ordinary Shares in accordance with the terms of such Stock Plan and
any applicable agreement relating thereto. The outstanding options or other awards or benefits available under the terms of the Stock
Plans at and following the Effective Time shall, to the extent permitted by law and otherwise reasonably practicable, otherwise be exercisable,
payable, issuable or available upon the same terms and conditions as under such Stock Plans and the agreements relating thereto immediately
prior to the Effective Time. Other than as set forth above, the Merger will not affect the underlying terms or conditions of any outstanding
equity awards, which shall remain subject to their original terms and conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 4.02. <I>Assumption
of Benefit Plans</I>. At the Effective Time, the obligations of CJJD under or with respect to every plan, trust, program and benefit then
in effect or administered by CJJD for the benefit of the directors, officers and employees of CJJD or any of its subsidiaries (collectively,
the &ldquo;Assumed Benefit Plans&rdquo; and, together with the Assumed Equity Plans, the &ldquo;<B>Assumed Plans</B>&rdquo;) shall become
the lawful obligations of CJJD Cayman and shall be implemented and administered in the same manner and without interruption until the
same are amended or otherwise lawfully altered or terminated. Effective at the Effective Time, CJJD Cayman hereby expressly adopts and
assumes all obligations of CJJD under the Assumed Plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 4.03. <I>Assumption
of Contracts</I>. At the Effective Time, the obligations of CJJD under or with respect to contracts or agreements (collectively, the &ldquo;<B>Assumed
Contracts</B>&rdquo;) shall become the lawful obligations of CJJD Cayman and shall be performed in the same manner and without interruption
until the same are amended or otherwise lawfully altered or terminated. Effective at the Effective Time, CJJD Cayman hereby expressly
adopts and assumes all obligations of CJJD under the Assumed Contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 4.04. <I>Other Actions</I>.
Such amendments or other actions that are deemed necessary or appropriate by CJJD and CJJD Cayman to effect the Merger, including to facilitate
the assumption by CJJD Cayman of the Assumed Plans and the Assumed Contracts, and any other amendments or actions that CJJD and CJJD Cayman
shall deem advisable, shall be adopted and entered into with respect to the Assumed Plans, the Assumed Contracts and any other change
in control arrangements between the CJJD and its executive officers and key employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">ARTICLE V<BR>
Conditions Precedent&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">The respective obligations
of each party to effect the Merger are subject to the satisfaction or waiver of the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">(a) <I>Stockholder Approval</I>.
This Agreement shall have been adopted and approved by the affirmative vote of holders owning a majority of the issued and outstanding
shares of CJJD Common Stock entitled to vote thereon at the record date for such actions as set by the Board of Directors of CJJD.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">(b) <I>No Prohibition</I>.
None of the parties hereto shall be subject to any decree, order or injunction of any court of competent jurisdiction, whether in the
U.S., the Cayman Islands or any other country that prohibits the consummation of the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">(c) <I>Effective Registration
Statement</I>. The registration statement on Form F-4 filed with the Securities and Exchange Commission by CJJD Cayman in connection with
the offer and issuance of the CJJD Cayman Ordinary Shares to be issued pursuant to the Merger shall have become effective under the Securities
Act of 1933, as amended, and no stop order with respect thereto shall be in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">(d) <I>NASDAQ Listing</I>.
The CJJD Cayman Ordinary Shares to be issued pursuant to the Merger shall have been authorized for listing on the NASDAQ Stock Market,
subject to official notice of issuance and satisfaction of other standard conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">(e) <I>Consents and Authorizations</I>.
Other than the filing of the Plan of Merger provided for under Article I, all material consents and authorizations of, filings or registrations
with, and notices to, any governmental or regulatory authority required of CJJD, CJJD Cayman, or any of their respective subsidiaries
to consummate the Merger and the other transactions contemplated hereby, including, without limitation, any filings required under (i)
applicable U.S. state securities and &ldquo;Blue Sky&rdquo; laws, and (ii) applicable Cayman Islands securities laws, shall have been
obtained or made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">(f) <I>Representations and
Warranties</I>. The representations and warranties of the parties set forth herein shall be true and correct in all material respects,
and the covenants of the parties set forth herein (other than those to be performed after the Effective Time) shall have been performed
in all material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">(g) <I>Opinion</I>. CJJD shall
have received an opinion of Pryor Cashman LLP in form and substance reasonably satisfactory to CJJD, on the basis of certain facts, representations
and assumptions set forth in such opinion, dated the Effective Time, to the effect that the Merger will be treated for U.S. federal income
tax purposes as a reorganization within the meaning of Section 368(a) of the Code. The parties to this Agreement agree to use commercially
reasonable efforts to make such representations as are requested by such counsel for the purpose of rendering such opinion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt"></P></DIV>

<!-- Field: Page; Sequence: 177; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: white 1pt solid; margin-top: 0pt; margin-bottom: 0pt; padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">ARTICLE VI<BR>
Termination, Amendment and Waiver&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 6.01. <I>Termination</I>.
This Agreement may be terminated and the Merger abandoned at any time prior to the Effective Time, whether before or after approval by
the stockholders of CJJD, by action of the Board of Directors of CJJD.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 6.02. <I>Effect of
Termination</I>. In the event of termination of this Agreement as provided in Section 6.01, this Agreement shall forthwith become void
and have no effect, without any liability or obligation on the part of CJJD or CJJD Cayman.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 6.03. <I>Amendment</I>.
This Agreement may be amended by the parties hereto at any time before or after any required approval or adoption by the stockholders
of CJJD of this Agreement or matters presented in connection with this Agreement; provided, however, that after any such approval or adoption,
there shall be made no amendment requiring further approval or adoption by such stockholders under applicable law until such further approval
or adoption is obtained. This Agreement may not be amended except by an instrument in writing signed on behalf of each of the parties
hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 6.04. <I>Waiver</I>.
At any time prior to the Effective Time, the parties may waive compliance with any of the agreements or covenants contained in this Agreement,
or may waive any of the conditions to consummation of the Merger contained in this Agreement. Any agreement on the part of a party to
any such waiver shall be valid only if set forth in an instrument in writing signed on behalf of such party. The failure of any party
to this Agreement to assert any of its rights under this Agreement or otherwise shall not constitute a waiver of such rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">ARTICLE VII<BR>
Covenants&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 7.01. <I>Rule 16b-3
Approval</I>. CJJD and CJJD Cayman shall take all such steps as may reasonably be required to cause the transactions contemplated by Section
3.01 and any other dispositions of CJJD equity securities (including derivative securities) or acquisitions of CJJD Cayman equity securities
(including derivative securities) in connection with this Agreement by each individual who (i) is a director or officer of CJJD, or (ii)
at the Effective Time, is or will become a director or officer of CJJD Cayman, to be exempt under Rule 16b-3 promulgated under the Securities
Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 7.02. <I>CJJD Cayman
Vote</I>. Prior to or concurrent with seeking the approval and adoption of this Agreement by the stockholders owning a majority of the
outstanding shares of CJJD Common Stock, CJJD in its capacity as the sole shareholder of CJJD Cayman shall pass shareholder resolutions
of CJJD Cayman which approve and adopt this Agreement and which approve and authorize the Merger and the Plan of Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 7.03. <I>Further Assurances</I>.
CJJD Cayman shall use its reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things
necessary and reasonably appropriate to consummate and make effective, in the most expeditious manner practicable, the Merger and the
other transactions provided for herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">ARTICLE VIII<BR>
General Provisions</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 8.01. <I>Assignment;
Binding Effect; Benefit</I>. Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned by any
of the parties hereto (whether by operation of law or otherwise) without the prior written consent of the other parties. Subject to the
preceding sentence, this Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors
and assigns. Notwithstanding anything contained in this Agreement to the contrary, except for the provisions of Article IV (collectively,
the &ldquo;<B>Third Party Provisions</B>&rdquo;), nothing in this Agreement, expressed or implied, is intended to confer on any person
other than the parties hereto or their respective successors and assigns any rights, remedies, obligations or liabilities under or by
reason of this Agreement. The Third Party Provisions may be enforced only by the specifically intended beneficiaries thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 8.02. <I>Entire Agreement</I>.
This Agreement and any documents delivered by the parties in connection herewith constitute the entire agreement among the parties with
respect to the subject matter hereof and supersede all prior agreements and understandings among the parties with respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 8.03. <I>Governing
Law</I>. To the fullest extent permitted by law, this Agreement shall be governed by and construed in accordance with the laws of the
State of Nevada without regard to its rules of conflict of laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 8.04. <I>Counterparts</I>.
This Agreement may be executed by the parties hereto in separate counterparts, each of which when so executed and delivered shall be an
original, but all such counterparts shall together constitute one and the same instrument. Each counterpart may consist of a number of
copies hereof, each signed by less than all, but together signed by all of the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 8.05. <I>Headings</I>.
Headings of the Articles and Sections of this Agreement are for the convenience of the parties only and shall be given no substantive
or interpretative effect whatsoever.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Section 8.06. <I>Severability</I>.
If any provision of this Agreement is determined by any court or arbitrator of competent jurisdiction to be invalid, illegal or unenforceable
in any respect, such provision will be enforced to the maximum extent possible given the intent of the parties hereto. If such clause
or provision cannot be so enforced, such provision shall be stricken from this Agreement and the remainder of this Agreement shall be
enforced as if such invalid, illegal or unenforceable clause or provision had (to the extent not enforceable) never been contained in
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt"></P></DIV>

<!-- Field: Page; Sequence: 178; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: white 1pt solid; margin-top: 0pt; margin-bottom: 0pt; padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">IN WITNESS WHEREOF, CJJD and
CJJD Cayman have caused this Agreement to be signed by their respective officers thereunto duly authorized, all as of the date first written
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; padding-bottom: 0pt">&nbsp;</P>

</DIV>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 40%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>China Jo-Jo Drugstores, Inc.,<BR>
a Nevada corporation</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 20%; text-align: center; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 40%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>China Jo-Jo Drugstores Holdings, Inc.,<BR>
a Cayman Islands company</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; width: 36%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 20%; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; width: 36%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Liu Liu</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Liu Lei</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Chief Executive Officer</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: President</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 179; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<DIV STYLE="border: white 1pt solid; margin-top: 0pt; padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt; margin-bottom: 0pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt"><B>Form of Plan of Merger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt"><B>The
Companies Act (2021 Revision) of the Cayman Islands</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt"><B>Plan of Merger </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">&nbsp;</P>

</DIV>

<DIV STYLE="border: white 1pt solid; margin-top: 0pt; margin-bottom: 0pt; padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">This plan of merger (the &ldquo;<B>Plan
of Merger</B>&rdquo;) is made on [<B><I>insert date</I></B>], 2021 between China Jo-Jo Drugstores Holdings, Inc., a Cayman Islands exempted
company (the &ldquo;<B>Surviving Company</B>&rdquo;), and China Jo-Jo Drugstores, Inc., a Nevada corporation (the &ldquo;<B>Merging Company</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Whereas the Surviving Company
is a Cayman Islands exempted company and is entering into this Plan of Merger pursuant to the provisions of Part XVI of the Companies
Act (2021 Revision) (the &ldquo;<B>Act</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Whereas the Merging Company
is a Nevada corporation and is entering into this Plan of Merger pursuant to the provisions of Part XVI of the Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Whereas the directors of the
Merging Company and the directors of the Surviving Company deem it desirable and in the commercial interests of the Merging Company and
the Surviving Company, respectively, that the Merging Company be merged with and into the Surviving Company and that the undertaking,
property and liabilities of the Merging Company vest in the Surviving Company (the &ldquo;<B>Merger</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Terms not otherwise defined
in this Plan of Merger shall have the meanings given to them under the Agreement and Plan of Merger dated [<B><I>insert date</I></B>],
2021 and made between the Surviving Company and the Merging Company (the &ldquo;<B>Merger Agreement</B>&rdquo;) a copy of which is annexed
at Annexure 1 hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

</DIV>

<DIV STYLE="border: white 1pt solid; margin-top: 0pt; margin-bottom: 0pt; padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Now
therefore this Plan of Merger provides as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">&nbsp;</P>

</DIV>

<DIV STYLE="border: white 1pt solid; margin-top: 0pt; padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt; margin-bottom: 0pt">

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">1</TD><TD>The constituent companies (as defined in the Act) to this Merger are the Surviving Company and the Merging Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: -0.25in; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">2</TD><TD>The surviving company (as defined in the Act) is the Surviving Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: -0.25in; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">3</TD><TD STYLE="text-align: justify">The registered office of the Surviving Company is c/o Conyers Trust Company (Cayman) Limited, Cricket Square, P.O. Box 2681, Grand
Cayman, KY1-1111, Cayman Islands, and the registered office of the Merging Company is c/o National Registered Agents, Inc., 701 S CARSON
ST STE 200, Carson City, NV, 89701.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: -0.25in; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">4</TD><TD>Immediately prior to the Effective Date (as defined below), the share capital of the Surviving Company will be US$510,000 divided
into 500,000,000 ordinary shares of a par value of US$0.001 each and 10,000,000 preferred shares of a par value of US$0.001 each and the
Surviving Company will have one ordinary share in issue.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: -0.25in; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">5</TD><TD STYLE="text-align: justify">Immediately prior to the Effective Date (as defined below), the number of the authorized capital stock of the Merging Company will
be 250,000,000 shares of common stock with a par value of US$0.001 each, and 10,000,000 shares of preferred stock with a par value of
US$0.001 each, and the Merging Company will have 41,751,790 shares of common stock in issue.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: -0.25in; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">6</TD><TD>The date on which it is intended that the Merger is to take effect is _______, 2021 (the &ldquo;<B>Effective Date</B>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: -0.25in; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">7</TD><TD>Upon the Effective Date, the Surviving Company will change its name to &ldquo;China Jo-Jo Drugstores, Inc.&rdquo;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: -0.25in; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">8</TD><TD>The terms and conditions of the Merger are such that, on the Effective Date:</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">8.1</TD><TD STYLE="text-align: justify">each share of common stock issued and outstanding in the Merging
Company on the Effective Date shall be converted into or exchanged for one ordinary share in the Surviving Company (which shall be issued
by the Surviving Company credited as fully paid) and each ordinary share issued and outstanding in the Surviving Company immediately
prior to the Effective Date shall be cancelled, and no consideration shall be paid or payable to the holder of such share;</TD>
</TR></TABLE>

<DIV STYLE="border: white 1pt solid; margin-top: 0pt; padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt; margin-bottom: 0pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">9</TD><TD STYLE="text-align: justify">The rights and restrictions attaching to the shares in the Surviving
Company are set out in the Amended and Restated Memorandum and Articles of Association of the Surviving Company in the form annexed at
Annexure 2 hereto.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">10</TD><TD STYLE="text-align: justify">The Memorandum and Articles of Association of the Surviving
Company shall be amended and restated by the deletion in their entirety and the substitution in their place of the Amended and Restated
Memorandum and Articles of Association in the form annexed at Annexure 2 hereto on the Effective Date.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">11</TD><TD STYLE="text-align: justify">There are no amounts or benefits which are or shall be paid
or payable to any director of either constituent company or the Surviving Company consequent upon the Merger.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">12</TD><TD STYLE="text-align: justify">The Surviving Company has granted no fixed or floating security
interests that are outstanding as at the date of this Plan of Merger.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; padding-bottom: 0pt"></P></DIV></DIV>

<!-- Field: Page; Sequence: 180; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: white 1pt solid; margin-top: 0pt; padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt; margin-bottom: 0pt"><DIV STYLE="border: white 1pt solid; margin-top: 0pt; padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt; margin-bottom: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">13</TD><TD STYLE="text-align: justify">The names of each director of the surviving company (as defined
in the Act) are:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">13.1</TD><TD STYLE="text-align: justify">&nbsp;Lei Liu;</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">13.2</TD><TD STYLE="text-align: justify">&nbsp;Li Qi;</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">13.3</TD><TD STYLE="text-align: justify">&nbsp;Caroline Wang;</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">13.4</TD><TD STYLE="text-align: justify">&nbsp;Jiangliang He;</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">13.5</TD><TD STYLE="text-align: justify">&nbsp;Genghua Gu; and</TD>
</TR></TABLE>

<DIV STYLE="border: white 1pt solid; margin-top: 0pt; padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt; margin-bottom: 0pt">

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">13.6</TD><TD>&nbsp;Pingfan Wu.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: -0.25in; padding-bottom: 0pt">&nbsp;</P>



<P STYLE="margin-left: 0.25in; border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; padding-bottom: 0pt">Unless otherwise indicated, the address for
each of the director listed above is c/o China Jo-Jo Drugstores, Inc., Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou
City, Zhejiang Province, People&rsquo;s Republic of China, 310008.</P>

<DIV STYLE="border: white 1pt solid; margin-top: 0pt; padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt; margin-bottom: 0pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: -0.25in; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">14</TD><TD STYLE="text-align: justify">This Plan of Merger has been approved by the board of directors
of the Surviving Company pursuant to section 233(3) of the Act.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: -0.25in; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">15</TD><TD STYLE="text-align: justify">This Plan of Merger has been authorized by the sole shareholder
of the Surviving Company pursuant to section 233(6) of the Act.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: -0.25in; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">16</TD><TD STYLE="text-align: justify">All necessary approvals have been obtained from the members,
officers and management of the Merging Company pursuant to the Nevada Revised Statutes.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: -0.25in; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in">17</TD><TD>At any time prior to the Effective Date, this Plan of Merger may be:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: -0.25in; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in">17.1</TD><TD>&nbsp;terminated by the board of directors of either the Surviving Company or the Merging Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: -0.25in; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">17.2</TD><TD>&nbsp;amended by the board of directors of both the Surviving Company and the Merging Company to:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: -0.25in; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">change the Effective Date provided that such changed date shall
not be a date later than the ninetieth day after the date of registration of this Plan of Merger with the Registrar of Companies; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: -0.25in; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">effect any other changes to this Plan of Merger which the directors
of both the Surviving Company and the Merging Company deem advisable, provided that such changes do not materially adversely affect any
rights of the shareholders of the Surviving Company or the Merging Company, as determined by the directors of both the Surviving Company
and the Merging Company, respectively.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: -0.25in; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">18</TD><TD STYLE="text-align: justify">This Plan of Merger may be executed in counterparts.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-indent: -0.25in; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">19</TD><TD STYLE="text-align: justify">This Plan of Merger shall be governed by and construed in accordance
with the laws of the Cayman Islands.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><I>[remainder of page intentionally
left blank; signature page follows]</I></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt"></P></DIV></DIV></DIV></DIV>

<!-- Field: Page; Sequence: 181; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0in; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; padding-bottom: 0pt">In witness whereof the parties hereto have caused this Plan of Merger
to be executed on the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNED </B>by<B><BR>
</B><B>&nbsp;</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 46%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liu Lei</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-right: 5pt; padding-left: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-right: 5pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Duly authorized for</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-right: 5pt; padding-left: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and on behalf of</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-right: 5pt; padding-left: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>China Jo-Jo Drugstores, Inc.,</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>a Nevada corporation</B></P></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-right: 5pt; padding-left: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNED </B>by<B><BR>
</B><B>&nbsp;</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liu Lei</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-right: 5pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Duly authorized for</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-right: 5pt; padding-left: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and on behalf of</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-right: 5pt; padding-left: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>China Jo-Jo Drugstores Holdings, Inc.,</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>a Cayman Islands exempted company</B></P></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; padding-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 182; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Annexure 1<BR>
<BR>
Merger Agreement&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 183; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Annexure 2<BR>
<BR>
Amended and Restated Memorandum and Articles of Association</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 184; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: white 1pt solid; margin-top: 0pt; padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt; margin-bottom: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Annex B<BR>
<BR>
Form of Amended and Restated Memorandum and Articles of Association</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>of</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>China Jo-Jo Drugstores Holdings, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P></DIV>

<!-- Field: Page; Sequence: 185; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><B>Item 20. Indemnification
of Directors and Officers</B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<DIV STYLE="border: white 1pt solid; margin-right: 0in; padding-right: 0in">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">The articles of association
of the Registrant provide for the indemnification of its directors and officers. Specifically, under the indemnification provisions, the
Registrant will indemnify its directors and officers to the fullest extent permitted by law against liabilities that are incurred by the
directors or officers while executing the duties of their respective offices. The directors and officers, however, will not be entitled
to the indemnification if they incurred the liabilities through their own fraud, willful neglect or willful default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Registrant is an exempted
company with limited liability incorporated in the Cayman Islands. As such, it is subject to and governed by the laws of the Cayman Islands
with respect to the indemnification provisions. Although the Companies Act (2021 Revision) of the Cayman Islands does not specifically
restrict a Cayman Islands company&rsquo;s ability to indemnify its directors or officers, it does not expressly provide for such indemnification
either. Certain English case law (which is likely to be persuasive in the Cayman Islands), however, indicate that the indemnification
is generally permissible, unless there had been fraud, willful default or reckless disregard on the part of the director or officer in
question.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Registrant maintains insurance
policies that indemnify its directors and officers against various liabilities arising under the Securities Act of 1933 and the Securities
Exchange Act of 1934 that might be incurred by any director or officer in his or her capacity as such.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Item 21. Exhibits and Financial
Statement Schedules </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 15pt"><B>&nbsp;</B></P>

</DIV>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit No.</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 90%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#main_022">Agreement and Plan of Merger (included in Annex A of the proxy statement/prospectus)</A></FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify; vertical-align: top"><A HREF="ea140501ex3-1_chinajojo.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Memorandum of Association and Articles of Association of China Jo-Jo Drugstores Holdings, Inc.</FONT></A></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="ea140501ex5-1_chinajojo.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal Opinion of Conyers Dill &amp; Pearman</FONT></A></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="ea140501ex8-1_chinajojo.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax Opinion of Pryor Cashman LLP</FONT></A></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="ea140501ex21-1_chinajojo.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">List of Subsidiaries</FONT></A></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="ea140501ex5-1_chinajojo.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Conyers Dill &amp; Pearman (included in Exhibit 5.1)</FONT></A></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="ea140501ex8-1_chinajojo.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Pryor Cashman LLP (included in Exhibit 8.1)</FONT></A></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.3</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="ea140501ex23-3_chinajojo.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Independent Registered Public Accounting Firm</FONT></A></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#d_001">Power of Attorney (included on signature page)</A></FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><A HREF="ea140501ex99-1_chinajojo.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Proxy Card</FONT></A></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 22. Undertakings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The undersigned registrant hereby undertakes: (1) to file, during any
period in which offers or sales are being made, a post-effective amendment to this registration statement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(i) To include any prospectus required by Section 10(a)(3) of the Securities
Act of 1933.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-indent: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(ii) To reflect in the prospectus any facts or events arising after
the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate,
represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase
or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered)
and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with
the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change
in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration Fee&rdquo; table in the effective registration
statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-indent: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(iii) To include any material information with respect to the plan
of distribution not previously disclosed in the registration statement or any material change to such information in the registration
statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-indent: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(2) That, for the purpose
of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial
bona fide offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">(3) To remove from registration
by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">(4) To file a post-effective
amendment to the registration statement to include any financial statements required by Item 8.A of Form 20-F at the start of any delayed
offering or throughout a continuous offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 186; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">(5) That, for the purpose of
determining liability under the Securities Act of 1933 to any purchaser:</P>





<DIV STYLE="border: white 1pt solid; margin-top: 0pt; padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt; margin-bottom: 0pt"><DIV STYLE="border: white 1pt solid; margin-top: 0pt; padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt; margin-bottom: 0pt"><DIV STYLE="border: white 1pt solid; margin-top: 0pt; padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt; margin-bottom: 0pt"><DIV STYLE="border: white 1pt solid; margin-top: 0pt; padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt; margin-bottom: 0pt"><DIV STYLE="border: white 1pt solid; margin-top: 0pt; padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt; margin-bottom: 0pt"><DIV STYLE="border: white 1pt solid; margin-top: 0pt; padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt; margin-bottom: 0pt"><DIV STYLE="border: white 1pt solid; margin-top: 0pt; padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt; margin-bottom: 0pt"><DIV STYLE="border: white 1pt solid; padding-right: 0in"><P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">(i)
Inapplicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">(ii) If the registrant is subject
to Rule 430C, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration
statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included
in the registration statement as of the date it is first used after effectiveness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">Provided, however, that no
statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated
or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as
to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration
statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first
use.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">(6) That, for the purpose of
determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">The undersigned registrant
undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless
of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means
of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or
sell such securities to such purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">(i) Any preliminary prospectus
or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">(ii) Any free writing prospectus
relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">(iii) The portion of any other
free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided
by or on behalf of the undersigned registrant; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">(iv) Any other communication
that is an offer in the offering made by the undersigned registrant to the purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">The undersigned registrant
hereby undertakes as follows: that prior to any public reoffering of the securities registered hereunder through use of a prospectus which
is a part of this registration statement, by any person or party who is deemed to be an underwriter within the meaning of Rule 145(c),
the issuer undertakes that such reoffering prospectus will contain the information called for by the applicable registration form with
respect to reofferings by persons who may be deemed underwriters, in addition to the information called for by the other items of the
applicable form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">The registrant undertakes that
every prospectus: (1) that is filed pursuant to the immediately preceding paragraph, or (2) that purports to meet the requirements of
Section 10(a)(3) of the Act and is used in connection with an offering of securities subject to Rule 415, will be filed as a part of an
amendment to the registration statement and will not be used until such amendment is effective, and that, for purposes of determining
any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide
offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">Insofar as indemnification
for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant
pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange
Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a
claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director,
officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director,
officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel
the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">The undersigned registrant
hereby undertakes to respond to requests for information that is incorporated by reference into the prospectus pursuant to Item 4, 10(b),
11, or 13 of this Form, within one business day of receipt of such request, and to send the incorporated documents by first class mail
or other equally prompt means. This includes information contained in documents filed subsequent to the effective date of the registration
statement through the date of responding to the request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15pt; padding-bottom: 0pt">&nbsp;</P>

</DIV>

<P STYLE="border: white 1pt solid; padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15.1pt; padding-bottom: 0pt">The
undersigned registrant hereby undertakes to supply by means of a post-effective amendment all information concerning a transaction, and
the company being acquired involved therein, that was not the subject of and included in the registration statement when it became effective.</P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15.1pt; padding-bottom: 0pt"></P></DIV></DIV></DIV></DIV></DIV></DIV></DIV>

<!-- Field: Page; Sequence: 187; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="border: White 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="border: White 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt"><B>SIGNATURES</B></P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="border: white 1pt solid; padding-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15.1pt; padding-bottom: 0pt">Pursuant
to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereunto duly authorized in the city of Hangzhou, the People&rsquo;s Republic of China, on May 17, 2021.</P>

<P STYLE="border: white 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 15.1pt; padding-bottom: 0pt">&nbsp;</P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CHINA JO-JO DRUGSTORES HOLDINGS,
    INC.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 34%">/s/ Lei Liu</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lei Liu</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; background-color: white; padding-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; background-color: white; padding-bottom: 0pt"><A NAME="d_001"></A><B>POWER OF ATTORNEY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 24.5pt; background-color: white; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; background-color: white; padding-bottom: 0pt">Each
of the undersigned individuals hereby severally constitutes and appoints each of Lei Liu and Ming Zhao as the attorney-in-fact for the
undersigned, in any and all capacities, with full power of substitution, to sign any and all pre- or post-effective amendments to this
registration statement, any subsequent registration statement for the same offering which may be filed pursuant to Rule&nbsp;413 or 462
under the Securities Act of 1933, as amended, and any and all pre- or post-effective amendments thereto, and to file the same with exhibits
thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact
full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises,
as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact
may lawfully do or cause to be done by virtue hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">Pursuant to the requirements
of the Securities Act, this registration statement has been signed by the following persons in the capacities and on the dates indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT></TD>
    <TD STYLE="width: 2%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="width: 2%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="width: 16%; border-bottom: black 1.5pt solid; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <I>Lei Liu</I></FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and Director </FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 17, 2021</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lei Liu </FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <I>Ming Zhao</I></FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer </FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 17, 2021</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ming Zhao </FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Financial Officer and Principal Accounting Officer)</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/&nbsp;<I>Li Qi</I></FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Li Qi </FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 17, 2021</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <I>Caroline Wang</I>&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Caroline Wang</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director </FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 17, 2021</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ &nbsp;<I>Jiangliang He</I></FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jiangliang He </FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director </FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 17, 2021</FONT></TD></TR>
  <TR>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <I>Genghua Gu</I>&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Genghua Gu </FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 17, 2021</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ &nbsp;<I>Pingfan Wu</I></FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pingfan Wu </FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 17, 2021</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; padding-bottom: 0pt">&nbsp;&nbsp;</P>


<!-- Field: Page; Sequence: 188; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<DIV STYLE="border: white 1pt solid; margin-top: 0pt; padding-top: 0pt; padding-right: 0pt; padding-bottom: 0pt; margin-bottom: 0pt">

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt"><B>SIGNATURE OF AUTHORIZED REPRESENTATIVE OF THE
REGISTRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Pursuant to the Securities Act
of 1933, as amended, the undersigned, the duly authorized representative in the United States of China Jo-Jo Drugstores Holdings, Inc.,
has signed this registration statement in New York, NY, United States, on May 17, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: justify; padding-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AUTHORIZED U.S. REPRESENTATIVE</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pryor Cashman LLP</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ <I>Elizabeth Fei Chen</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Elizabeth Fei Chen</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Partner</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; text-align: center; padding-bottom: 0pt">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; padding-top: 0pt; margin-top: 0pt; padding-right: 0pt; margin-bottom: 0pt; padding-bottom: 0pt">&nbsp;</P>



<!-- Field: Page; Sequence: 189; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ea140501ex3-1_chinajojo.htm
<DESCRIPTION>AMENDED AND RESTATED MEMORANDUM OF ASSOCIATION AND ARTICLES OF ASSOCIATION OF CHINA JO-JO DRUGSTORES HOLDINGS, INC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
3.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex3-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 3.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 3.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 3.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies Act (Revised)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
Limited by Shares</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDED
AND RESTATED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MEMORANDUM
AND ARTICLES OF ASSOCIATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OF</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CHINA
JO-JO DRUGSTORES HOLDINGS, INC. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(adopted
by a Special Resolution of the Shareholders of the Company dated 12 May 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grand
Cayman</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cayman
Islands</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>conyers.com</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
COMPANIES ACT (REVISED)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXEMPTED
COMPANY LIMITED BY SHARES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDED
AND RESTATED </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MEMORANDUM
OF ASSOCIATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CHINA
JO-JO DRUGSTORES HOLDINGS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(adopted
by a Special Resolution of the Shareholders of the Company dated 12 May 2021) </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
name of the Company is China Jo-Jo Drugstores Holdings, Inc.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="padding-right: 0pt; font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-left: 0pt"></TD><TD STYLE="padding-right: 0pt; font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Registered Office of the Company shall be at the offices of Conyers Trust Company (Cayman)
                                            Limited at SIX, Cricket Square, P.O. Box 2681, Grand Cayman KY1-1111, Cayman Islands.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="padding-right: 0pt; font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-left: 0pt"></TD><TD STYLE="padding-right: 0pt; font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the following provisions of this Memorandum, the objects for which the Company is established
                                            are unrestricted.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="padding-right: 0pt; font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-left: 0pt"></TD><TD STYLE="padding-right: 0pt; font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
                                            to the following provisions of this Memorandum, the Company shall have and be capable of
                                            exercising all the functions of a natural person of full capacity irrespective of any question
                                            of corporate benefit, as provided by Section 27(2) of the Companies Act.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="padding-right: 0pt; font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-left: 0pt"></TD><TD STYLE="padding-right: 0pt; font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing
                                            in this Memorandum shall permit the Company to carry on a business for which a licence is
                                            required under the laws of the Cayman Islands unless duly licensed.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="padding-right: 0pt; font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-left: 0pt"></TD><TD STYLE="padding-right: 0pt; font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD><TD STYLE="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company shall not trade in the Cayman Islands with any person, firm or corporation except
                                            in furtherance of the business of the Company carried on outside the Cayman Islands; provided
                                            that nothing in this clause shall be construed as to prevent the Company effecting and concluding
                                            contracts in the Cayman Islands, and exercising in the Cayman Islands all of its powers necessary
                                            for the carrying on of its business outside the Cayman Islands.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="padding-right: 0pt; font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-left: 0pt"></TD><TD STYLE="padding-right: 0pt; font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD><TD STYLE="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            liability of each member is limited to the amount from time to time unpaid on such member&rsquo;s
                                            shares.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="padding-right: 0pt; font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-left: 0pt"></TD><TD STYLE="padding-right: 0pt; font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD><TD STYLE="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            share capital of the Company is US$510,000 divided into 500,000,000 Ordinary Shares of a
                                            par value of US$0.001 each and 10,000,000 preferred shares of a par value of US$0.001 each,
                                            with the power for the Company, insofar as is permitted by law, to redeem or purchase any
                                            of its shares and to increase or reduce the said share capital subject to the provisions
                                            of the Companies Act (Revised) and the Articles of Association of the Company and to issue
                                            any part of its capital, whether original, redeemed or increased, with or without any preference,
                                            priority or special privilege or subject to any postponement of rights or to any conditions
                                            or restrictions; and so that, unless the conditions of issue shall otherwise expressly declare,
                                            every issue of shares, whether declared to be preference or otherwise, shall be subject to
                                            the power hereinbefore contained.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="padding-right: 0pt; font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-left: 0pt"></TD><TD STYLE="padding-right: 0pt; font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD><TD STYLE="padding-left: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company may exercise the power contained in the Companies Act to deregister in the Cayman
                                            Islands and be registered by way of continuation in another jurisdiction.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
COMPANIES ACT (REVISED)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXEMPTED
COMPANY LIMITED BY SHARES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDED
AND RESTATED </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLES
OF ASSOCIATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CHINA
JO-JO DRUGSTORES HOLDINGS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(adopted
by a Special Resolution of the Shareholders of the Company dated 12 May 2021)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>TABLE
A</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">The regulations in Table A in the Schedule to the Companies Act (Revised) do not apply to the Company.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>INTERPRETATION</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.&#9;(1)&#9;In
these Articles, unless the context otherwise requires, the words standing in the first column of the following table shall bear the meaning
set opposite them respectively in the second column.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>WORD</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>MEANING</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Audit
    Committee&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    audit committee of the Company formed by the Board pursuant to Article 100) hereof, or any successor audit committee.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Auditor&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    independent auditor of the Company which shall be a firm of independent accountants.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Articles&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">these
    Articles in their present form or as supplemented or amended or substituted from time to time.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Board&rdquo;
    or &ldquo;Directors&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    board of directors of the Company or the directors present at a meeting of directors of the Company at which a quorum is present.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;capital&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    share capital from time to time of the Company.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;clear
    days&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    relation to the period of a notice, that period excluding the day when the notice is given or deemed to be given and the day for
    which it is given or on which it is to take effect.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;clearing
    house&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    clearing house recognised by the laws of the jurisdiction in which the shares of the Company (or depositary receipts therefor) are
    listed or quoted on a stock exchange or interdealer quotation system in such jurisdiction.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5in; text-align: justify; text-indent: -2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Company&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">China
    Jo-Jo Drugstores Holdings, Inc.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Compensation
    Committee&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    compensation committee of the Company formed by the Board pursuant to Article 100 hereof, or any successor audit committee.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;competent
    regulatory</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    competent regulatory authority in the&nbsp;&nbsp;territory </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">authority&rdquo;
    where the shares of the Company (or depositary receipts therefor) are listed or quoted on a stock exchange or interdealer quotation
    system in such territory.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;debenture&rdquo;
    and</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">include
    debenture stock and debenture </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;debenture
    holder&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">stockholder
    respectively.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Designated
    Stock</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    NASDAQ Stock Market.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Exchange&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;dollars&rdquo;
    and &ldquo;$&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dollars,
    the legal currency of the United States of America.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Exchange
    Act&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    United States Securities Exchange Act of 1934, as amended.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Electronic&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    that term defined in the Electronic Transactions Act (Revised).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Electronic
    Record&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    that term defined in the Electronic Transactions Act (Revised).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Electronic
    Signature&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    that term defined in the Electronic Transactions Act (Revised).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;financial
    year&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">fiscal
    year of the Company ended March 31.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;FINRA&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
    Industry Regulatory Authority in the United States.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;FINRA
    Rules&rdquo; the rules set forth by FINRA.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;head
    office&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">such
    office of the Company as the Directors may from time to time determine to be the principal office of the Company.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Law&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Companies Act, Cap. 22 (Act 3 of 1961, as consolidated and revised) of the Cayman Islands.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Member&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    duly registered holder from time to time of the shares in the capital of the Company, including any shareholders holding shares through
    brokers&rsquo; accounts and registered under CEDE &amp; Co.</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;month&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    calendar month.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Nomination
    Committee&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    nomination committee of the Company formed by the Board pursuant to Article 100 hereof, or any successor audit committee.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Notice&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">written
    notice unless otherwise specifically stated and as further defined in these Articles.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Office&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    registered office of the Company for the time being.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;ordinary
    resolution&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    resolution shall be an ordinary resolution when it has been passed by a simple majority of votes cast by such Members as, being entitled
    so to do, vote in person or, in the case of any Member being a corporation, by its duly authorised representative or, where proxies
    are allowed, by proxy at a general meeting duly called and held in accordance with these Articles.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
    Shares</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    ordinary share of US$0.0001 par value in the capital of the Company having the rights attaching to it set out herein.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;paid
    up&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">paid
    up or credited as paid up.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;preferred
    share&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    preferred share(s) issued as a separate class or in separate classes to the Ordinary Shares, the terms of which and the rights attaching
    thereto being at the absolute discretion of the Directors as they see fit.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Register&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    principal register and where applicable, any branch register of Members of the Company to be maintained at such place within or outside
    the Cayman Islands as the Board shall determine from time to time.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Registration
    Office&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    respect of any class of share capital such place as the Board may from time to time determine to keep a branch register of Members
    in respect of that class of share capital and where (except in cases where the Board otherwise directs) the transfers or other documents
    of title for such class of share capital are to be lodged for registration and are to be registered.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;SEC&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    United States Securities and Exchange Commission.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Seal&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">common
    seal or any one or more duplicate seals of the Company (including a securities seal) for use in the Cayman Islands or in any place
    outside the Cayman Islands.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Secretary&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    person, firm or corporation appointed by the Board to perform any of the duties of secretary of the Company and includes any assistant,
    deputy, temporary or acting secretary.</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;special
    resolution&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    resolution shall be a special resolution when it has been passed by a majority of not less than two-thirds of votes cast by such
    Members as, being entitled so to do, vote in person or, in the case of such Members as are corporations, by their respective duly
    authorised representative or, where proxies are allowed, by proxy at a general meeting duly called and held in accordance with these
    Articles.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    special resolution shall be effective for any purpose for which an ordinary resolution is expressed to be required under any provision
    of these Articles or the Statutes.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Statutes&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Law and every other law of the Legislature of the Cayman Islands for the time being in force applying to or affecting the Company,
    its Memorandum of Association and/or these Articles.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;year&rdquo;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    calendar year.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            these Articles, unless there is something within the subject or context inconsistent with
                                            such construction:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">words
                                            importing the singular include the plural and vice versa;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">words
                                            importing a gender include both gender and the neuter;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">words
                                            importing persons include companies, associations and bodies of persons whether corporate
                                            or not;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
words:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;may&rdquo;
shall be construed as permissive;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;shall&rdquo;
                                            or &ldquo;will&rdquo; shall be construed as imperative;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">expressions
                                            referring to writing shall, unless the contrary intention appears, be construed as including
                                            printing, lithography, photography and other modes of representing words or figures in a
                                            visible form, and including where the representation takes the form of electronic display,
                                            provided that both the mode of service of the relevant document or notice and the Member&rsquo;s
                                            election comply with all applicable Statutes, rules and regulations;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">references
                                            to any law, ordinance, statute or statutory provision shall be interpreted as relating to
                                            any statutory modification or re-enactment thereof for the time being in force;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">save
                                            as aforesaid words and expressions defined in the Statutes shall bear the same meanings in
                                            these Articles if not inconsistent with the subject in the context;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">references
                                            to a document being executed include references to it being executed under hand or under
                                            seal or by Electronic Signature or by any other method and references to a notice or document
                                            include a notice or document recorded or stored in any digital, electronic, electrical, magnetic
                                            or other retrievable form or medium and information in visible form whether having physical
                                            substance or not.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SHARE
CAPITAL</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.&#9;(1)&#9;The
share capital of the Company at the date on which these Articles come into effect shall be US$510,000 divided into 500,000,000 Ordinary
Shares of a par value of US$0.001 each and 10,000,000 preferred shares of a par value of US$0.001 each.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Subject to the Law, the Company&rsquo;s Memorandum and Articles of Association and, where applicable, the rules of the Designated
Stock Exchange and/or any competent regulatory authority, the Company shall have the power to purchase or otherwise acquire its own
shares and such power shall be exercisable by the Board in such manner, upon such terms and subject to such conditions as it in its
absolute discretion thinks fit and any determination by the Board of the manner of purchase shall be deemed authorised by these
Articles for purposes of the Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)&nbsp;No
share shall be issued to bearer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ALTERATION
OF CAPITAL</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.&#9;The
Company may from time to time by ordinary resolution in accordance with the Law alter the conditions of its Memorandum of Association
to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">increase
                                            its capital by such sum, to be divided into shares of such amounts, as the resolution shall
                                            prescribe;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">consolidate
                                            and divide all or any of its capital into shares of larger amount than its existing shares;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">without
                                            prejudice to the powers of the Board under Article 12, divide its shares into several classes
                                            and without prejudice to any special rights previously conferred on the holders of existing
                                            shares attach thereto respectively any preferential, deferred, qualified or special rights,
                                            privileges, conditions or such restrictions which in the absence of any such determination
                                            by the Company in general meeting, as the Directors may determine provided always that, for
                                            the avoidance of doubt, where a class of shares has been authorized by the Company no resolution
                                            of the Company in general meeting is required for the issuance of shares of that class and
                                            the Directors may issue shares of that class and determine such rights, privileges, conditions
                                            or restrictions attaching thereto as aforesaid, and further provided that where the Company
                                            issues shares which do not carry voting rights, the words &ldquo;non-voting&rdquo; shall
                                            appear in the designation of such shares and where the equity capital includes shares with
                                            different voting rights, the designation of each class of shares, other than those with the
                                            most favourable voting rights, must include the words &ldquo;restricted voting&rdquo; or
                                            &ldquo;limited voting&rdquo;;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sub-divide
                                            its shares, or any of them, into shares of smaller amount than is fixed by the Company&rsquo;s
                                            Memorandum of Association (subject, nevertheless, to the Law), and may by such resolution
                                            determine that, as between the holders of the shares resulting from such sub-division, one
                                            or more of the shares may have any such preferred, deferred or other rights or be subject
                                            to any such restrictions as compared with the other or others as the Company has power to
                                            attach to unissued or new shares; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cancel
                                            any shares which, at the date of the passing of the resolution, have not been taken, or agreed
                                            to be taken, by any person, and diminish the amount of its capital by the amount of the shares
                                            so cancelled or, in the case of shares, without par value, diminish the number of shares
                                            into which its capital is divided.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.&#9;The
Board may settle as it considers expedient any difficulty which arises in relation to any consolidation and division under the last preceding
Article and in particular but without prejudice to the generality of the foregoing may issue certificates in respect of fractions of
shares or arrange for the sale of the shares representing fractions and the distribution of the net proceeds of sale (after deduction
of the expenses of such sale) in due proportion amongst the Members who would have been entitled to the fractions, and for this purpose
the Board may authorise some person to transfer the shares representing fractions to their purchaser or resolve that such net proceeds
be paid to the Company for the Company&rsquo;s benefit. Such purchaser will not be bound to see to the application of the purchase money
nor will his title to the shares be affected by any irregularity or invalidity in the proceedings relating to the sale.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.&#9;The
Company may from time to time by special resolution, subject to any confirmation or consent required by the Law, reduce its share capital
or any capital redemption reserve or other undistributable reserve in any manner permitted by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.&#9;Except
so far as otherwise provided by the conditions of issue, or by these Articles, any capital raised by the creation of new shares shall
be treated as if it formed part of the original capital of the Company, and such shares shall be subject to the provisions contained
in these Articles. The Directors may pay, out of the capital or any other monies of the Company, all expenses incurred in or about the
formation and establishment of the Company including the expenses of registration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SHARE
RIGHTS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.&#9;Subject
to the provisions of the Law, the rules of the Designated Stock Exchange and the Company&rsquo;s Memorandum and Articles of Association
and to any special rights conferred on the holders of any shares or class of shares, and without prejudice to Article 12 hereof, any
share in the Company (whether forming part of the present capital or not) may be issued with or have attached thereto such rights or
restrictions whether in regard to dividend, voting, return of capital or otherwise as the Board may determine, including without limitation
on terms that they may be, or at the option of the Company or the holder are, liable to be redeemed on such terms and in such manner,
including out of capital, as the Board may deem fit. The Board may make calls on the Members in respect of any monies unpaid on their
shares including any premium and each Member shall (subject to receiving at least fourteen (14) clear days&rsquo; notice specifying when
and where payment is to be made), pay to the Company the amount called on his shares. Members registered as the joint holders of a share
shall be jointly and severally liable to pay all calls in respect of the share. If a call remains unpaid after it has become due and
payable the person from whom it is due and payable shall pay interest on the amount unpaid from the day it became due and payable until
it is paid at the rate fixed by the terms of allotment of the share or in the notice of the call or if no rate is fixed, at the rate
of ten (10) percent per annum. The directors may, at their discretion, waive payment of the interest wholly or in part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.&#9;Subject
to the Law, any preferred shares may be issued or converted into shares that, at a determinable date or at the option of the Company
or the holder, are liable to be redeemed on such terms and in such manner as the Company before the issue or conversion may by ordinary
resolution of the Members determine. Where the Company purchases for redemption a redeemable share, purchases not made through the market
or by tender shall be limited to a maximum price as may from time to time be determined by the Board, either generally or with regard
to specific purchases. If purchases are by tender, tenders shall comply with applicable laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>VARIATION
OF RIGHTS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.&#9;Subject
to the Law and without prejudice to Article 8, all or any of the special rights for the time being attached to the shares or any class
of shares may, unless otherwise provided by the terms of issue of the shares of that class, from time to time (whether or not the Company
is being wound up) be varied, modified or abrogated with the sanction of a special resolution passed at a separate general meeting of
the holders of the shares of that class. To every such separate general meeting all the provisions of these Articles relating to general
meetings of the Company shall, <I>mutatis mutandis</I>, apply, but so that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            necessary quorum (whether at a separate general meeting or at its adjourned meeting) shall
                                            be a person or persons or (in the case of a Member being a corporation) its duly authorized
                                            representative together holding or representing by proxy not less than one-third in nominal
                                            value of the issued voting shares of that class;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">every
                                            holder of shares of the class shall be entitled on a poll to one vote for every such share
                                            held by him; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            holder of shares of the class present in person or by proxy or authorised representative
                                            may demand a poll.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.&#9;The
special rights conferred upon the holders of any shares or class of shares shall not, unless otherwise expressly provided in the rights
attaching to or the terms of issue of such shares, be deemed to be varied, modified or abrogated by the creation or issue of further
shares ranking <I>pari passu</I> therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SHARES</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.&#9;(1)&#9;Subject
to the Law, these Articles and, where applicable, the rules of the Designated Stock Exchange and without prejudice to any special rights
or restrictions for the time being attached to any shares or any class of shares, the unissued shares of the Company (whether forming
part of the original or any increased capital) shall be at the disposal of the Board, which may offer, allot, grant options over or otherwise
dispose of them to such persons, at such times and for such consideration and upon such terms and conditions as the Board may in its
absolute discretion determine but so that no shares shall be issued at a discount, except in accordance with the provisions of Law. In
particular and without prejudice to the generality of the foregoing, the Board is hereby empowered to authorize by resolution or resolutions
from time to time the issuance of one or more classes or series of preferred shares and to fix the designations, powers, preferences
and relative, participating, optional and other rights, if any, and the qualifications, limitations and restrictions thereof, if any,
including, without limitation, the number of shares constituting each such class or series, dividend rights, conversion rights, redemption
privileges, voting powers, full or limited or no voting powers, and liquidation preferences, and to increase or decrease the size of
any such class or series (but not below the number of shares of any class or series of preferred shares then outstanding) to the extent
permitted by Law. Without limiting the generality of the foregoing, the resolution or resolutions providing for the establishment of
any class or series of preferred shares may, to the extent permitted by law, provide that such class or series shall be superior to,
rank equally with or be junior to the preferred shares of any other class or series.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Neither the Company nor the Board shall be obliged, when making or granting any allotment of, offer of, option over or disposal of
shares, to make, or make available, any such allotment, offer, option or shares to Members or others with registered addresses in
any particular territory or territories being a territory or territories where, in the absence of a registration statement or other
special formalities, this would or might, in the opinion of the Board, be unlawful or impracticable. Members affected as a result of
the foregoing sentence shall not be, or be deemed to be, a separate class of members for any purpose whatsoever.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
The Board may issue options, warrants or convertible securities or securities of similar nature conferring the right upon the
holders thereof to subscribe for, purchase or receive any class of shares or securities in the capital of the Company on such terms
as it may from time to time determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.&#9;The
Company may in connection with the issue of any shares exercise all powers of paying commission and brokerage conferred or permitted
by the Law. Subject to the Law, the commission may be satisfied by the payment of cash or by the allotment of fully or partly paid shares
or partly in one and partly in the other.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.&#9;Except
as required by law, no person shall be recognised by the Company as holding any share upon any trust and the Company shall not be bound
by or required in any way to recognise (even when having notice thereof) any equitable, contingent, future or partial interest in any
share or any fractional part of a share or (except only as otherwise provided by these Articles or by law) any other rights in respect
of any share except an absolute right to the entirety thereof in the registered holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.&#9;Subject
to the Law and these Articles, the Board may at any time after the allotment of shares but before any person has been entered in the
Register as the holder, recognise a renunciation thereof by the allottee in favour of some other person and may accord to any allottee
of a share a right to effect such renunciation upon and subject to such terms and conditions as the Board considers fit to impose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SHARE
CERTIFICATES</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.&#9;If
shares are issued in the form of a physical share certificate, every share certificate shall be issued under the Seal or a facsimile
thereof or with the Seal printed thereon and shall specify the number and class and distinguishing numbers (if any) of the shares to
which it relates, and the amount paid up thereon and may otherwise be in such form as the Directors may from time to time determine.
No certificate shall be issued representing shares of more than one class. The Board may by resolution determine, either generally or
in any particular case or cases, that any signatures on any such certificates (or certificates in respect of other securities) need not
be autographic but may be affixed to such certificates by some mechanical means or may be printed thereon. Alternatively, shares can
be issued via book-entry form evidenced by a Statement of Account duly maintained and recorded by the Company&rsquo;s transfer agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.&#9;(1)&#9;In
the case of a share held jointly by several persons, the Company shall not be bound to issue more than one certificate therefor and delivery
of a certificate to one of several joint holders shall be sufficient delivery to all such holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Where a share stands in the names of two or more persons, the person first named in the Register shall as regards service of notices
and, subject to the provisions of these Articles, all or any other matters connected with the Company, except the transfer of the
shares, be deemed the sole holder thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.&#9;Every
person whose name is entered, upon an allotment of shares, as a Member in the Register shall be entitled, upon payment of such fee as
the Directors may from time to time determine, to receive one certificate for all such shares of any one class or several certificates
each for one or more of such shares of such class upon payment for every certificate of such fee as the Directors may from time to time
determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.&#9;Where
applicable, share certificates shall be issued within the relevant time limit as prescribed by the Law or as the Designated Stock Exchange
may from time to time determine, whichever is the shorter, after allotment or, except in the case of a transfer which the Company is
for the time being entitled to refuse to register and does not register, after lodgment of a transfer with the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.&#9;Upon
every transfer of shares the certificate (if any) held by the transferor shall be given up to be cancelled, and shall forthwith be cancelled
accordingly, and, subject to Article 18, a new certificate shall be issued to the transferee in respect of the shares transferred to
him. If any of the shares included in the certificate so given up shall be retained by the transferor a new certificate for the balance
shall be issued to him at the aforesaid fee payable by the transferor to the Company in respect thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.&#9;If
a share certificate shall be damaged or defaced or alleged to have been lost, stolen or destroyed a new certificate representing the
same shares may be issued to the relevant Member upon request and on payment of such fee as the Company may determine and, subject to
compliance with such terms (if any) as to evidence and indemnity and to payment of the costs and reasonable out-of-pocket expenses of
the Company in investigating such evidence and preparing such indemnity as the Board may think fit and, in case of damage or defacement,
on delivery of the old certificate to the Company provided always that where share warrants have been issued, no new share warrant shall
be issued to replace one that has been lost unless the Board has determined that the original has been destroyed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>REGISTER
OF MEMBERS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.&#9;(1)&#9;The
Company shall keep in one or more books a Register of its Members and shall enter therein the following particulars, that is to say:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            name and address of each Member, the number and class of shares held by him and the amount
                                            paid or agreed to be considered as paid on such shares;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            date on which each person was entered in the Register; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            date on which any person ceased to be a Member.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
The Company may keep an overseas or local or other branch register of Members resident in any place, and the Board may make and vary
such regulations as it determines in respect of the keeping of any such register and maintaining a Registration Office in connection
therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.&#9;The
Register and branch register of Members, as the case may be, shall be open to inspection for such times and on such days as the Board
shall determine by Members without charge or by any other person, upon a maximum payment of $2.50 or such other sum specified by the
Board, at the Office or Registration Office or such other place at which the Register is kept in accordance with the Law. The Register
including any overseas or local or other branch register of Members may, subject to compliance with any notice requirement of the Designated
Stock Exchange, be closed at such times or for such periods not exceeding in the whole thirty (30) days in each year as the Board may
determine and either generally or in respect of any class of shares.</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>RECORD
DATES</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.&#9;For
the purpose of determining the Members entitled to notice of or to vote at any general meeting, or any adjournment thereof, or entitled
to express consent to corporate action in writing without a meeting, or entitled to receive payment of any dividend or other distribution
or allotment of any rights, or entitled to exercise any rights in respect of any change, conversion or exchange of shares or for the
purpose of any other lawful action, the Board may fix, in advance, a date as the record date for any such determination of Members, which
date shall not be more than sixty (60) days nor less than ten (10) days before the date of such meeting, nor more than sixty (60) days
prior to any other such action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Board does not fix a record date for any general meeting, the record date for determining the Members entitled to a notice of or
to vote at such meeting shall be at the close of business on the day next preceding the day on which notice is given, or, if in accordance
with these Articles notice is waived, at the close of business on the day next preceding the day on which the meeting is held. If corporate
action without a general meeting is to be taken, the record date for determining the Members entitled to express consent to such corporate
action in writing, when no prior action by the Board is necessary, shall be the first date on which a signed written consent setting
forth the action taken or proposed to be taken is delivered to the Company by delivery to its head office. The record date for determining
the Members for any other purpose shall be at the close of business on the day on which the Board adopts the resolution relating thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
determination of the Members of record entitled to notice of or to vote at a meeting of the Members shall apply to any adjournment of
the meeting; provided, however, that the Board may fix a new record date for the adjourned meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>TRANSFER
OF SHARES</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.&#9;Subject
to these Articles and the requirements of the Designated Stock Exchange, any Member may transfer all or any of his shares by an instrument
of transfer in the usual or common form or in a form prescribed by the Designated Stock Exchange or in any other form approved by the
Board and may be under hand or, if the transferor or transferee is a clearing house or a central depository house or its nominee(s),
by hand or by machine imprinted signature or by Electronic Signature or by such other manner of execution as the Board may approve from
time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.&#9;The
instrument of transfer shall be executed by or on behalf of the transferor and the transferee provided that the Board may dispense with
the execution of the instrument of transfer by the transferee in any case which it thinks fit in its discretion to do so. Without prejudice
to the last preceding Article, the Board may also resolve, either generally or in any particular case, upon request by either the transferor
or transferee, to accept mechanically executed transfers. The transferor shall be deemed to remain the holder of the share until the
name of the transferee is entered in the Register in respect thereof. Nothing in these Articles shall preclude the Board from recognising
a renunciation of the allotment or provisional allotment of any share by the allottee in favour of some other person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.&#9;(1)&#9;The
Board may, in its absolute discretion, and without giving any reason therefor, refuse to register a transfer of any share made in accordance
with Article 46 but only where such share is not a fully paid up share (and being transferred to a person of whom it does not approve),
or any share issued under any share incentive scheme for employees or pursuant to any other agreement, contract or other such arrangement,
upon which a restriction on transfer imposed thereby still subsists, and it may also, without prejudice to the foregoing generality,
refuse to register a transfer of any share to more than four joint holders.</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
The Board in so far as permitted by any applicable law may, in its absolute discretion, at any time and from time to time transfer
any share upon the Register to any branch register or any share on any branch register to the Register or any other branch register.
In the event of any such transfer, the shareholder requesting such transfer shall bear the cost of effecting the transfer unless the
Board otherwise determines.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)&nbsp;Unless
the Board otherwise agrees (which agreement may be on such terms and subject to such conditions as the Board in its absolute discretion
may from time to time determine, and which agreement the Board shall, without giving any reason therefore, be entitled in its absolute
discretion to give or withhold), no shares upon the Register shall be transferred to any branch register nor shall shares on any branch
register be transferred to the Register or any other branch register and all transfers and other documents of title shall be lodged for
registration, and registered, in the case of any shares on a branch register, at the relevant Registration Office, and, in the case of
any shares on the Register, at the Office or such other place at which the Register is kept in accordance with the Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.&#9;Without
limiting the generality of the last preceding Article, the Board may decline to recognise any instrument of transfer unless:-</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            fee of such maximum sum as the Designated Stock Exchange may determine to be payable or such
                                            lesser sum as the Board may from time to time require is paid to the Company in respect thereof;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            instrument of transfer is in respect of only one class of share;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            instrument of transfer is lodged at the Office or such other place at which the Register
                                            is kept in accordance with the Law or the Registration Office (as the case may be) accompanied
                                            by the relevant share certificate(s) and such other evidence as the Board may reasonably
                                            require to show the right of the transferor to make the transfer (and, if the instrument
                                            of transfer is executed by some other person on his behalf, the authority of that person
                                            so to do);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            applicable, the instrument of transfer is duly and properly stamped; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            transfer is not to more than four joint holders;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.&#9;If
the Board refuses to register a transfer of any share, it shall, within one month after the date on which the transfer was lodged with
the Company, send to each of the transferor and transferee notice of the refusal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30.&#9;The
registration of transfers of shares or of any class of shares may, on fourteen (14) days&rsquo; calendar notice being given by advertisement
in such one or more newspapers or by electronic means, be suspended and the register closed at such times and for such periods as the
Board may from time to time determine, provided, however, that the registration of transfers shall not be suspended nor the register
closed for more than thirty (30) calendar days in any year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>TRANSMISSION
OF SHARES</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.&#9;If
a Member dies, the survivor or survivors where the deceased was a joint holder, and his legal personal representatives where he was a
sole or only surviving holder, will be the only persons recognised by the Company as having any title to his interest in the shares;
but nothing in this Article will release the estate of a deceased Member (whether sole or joint) from any liability in respect of any
share which had been solely or jointly held by him.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.&#9;Any
person becoming entitled to a share in consequence of the death or bankruptcy or winding-up of a Member may, upon such evidence as to
his title being produced as may be required by the Board, elect either to become the holder of the share or to have some person nominated
by him registered as the transferee thereof. If he elects to become the holder he shall notify the Company in writing either at the Registration
Office or Office, as the case may be, to that effect. If he elects to have another person registered he shall execute a transfer of the
share in favour of that person. The provisions of these Articles relating to the transfer and registration of transfers of shares shall
apply to such notice or transfer as aforesaid as if the death or bankruptcy of the Member had not occurred and the notice or transfer
were a transfer signed by such Member.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.&#9;A
person becoming entitled to a share by reason of the death or bankruptcy or winding-up of a Member shall be entitled to the same dividends
and other advantages to which he would be entitled if he were the registered holder of the share. However, the Board may, if it thinks
fit, withhold the payment of any dividend payable or other advantages in respect of such share until such person shall become the registered
holder of the share or shall have effectually transferred such share, but, subject to the requirements of Article 75(2) being met, such
a person may vote at meetings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>UNTRACEABLE
MEMBERS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34.&#9;(1)&#9;Without
prejudice to the rights of the Company under paragraph (2) of this Article, the Company may cease sending cheques for dividend entitlements
or dividend warrants by post if such cheques or warrants have been left uncashed on two consecutive occasions. However, the Company may
exercise the power to cease sending cheques for dividend entitlements or dividend warrants after the first occasion on which such a cheque
or warrant is returned undelivered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
The Company shall have the power to sell, in such manner as the Board thinks fit, any shares of a Member who is untraceable, but no
such sale shall be made unless:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            cheques or warrants in respect of dividends of the shares in question, being not less than
                                            three in total number, for any sum payable in cash to the holder of such shares in respect
                                            of them sent during the relevant period in the manner authorised by the Articles have remained
                                            uncashed;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">so
                                            far as it is aware at the end of the relevant period, the Company has not at any time during
                                            the relevant period received any indication of the existence of the Member who is the holder
                                            of such shares or of a person entitled to such shares by death, bankruptcy or operation of
                                            law; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Company, if so required by the rules governing the listing of shares on the Designated Stock
                                            Exchange, has given notice to, and caused advertisement in newspapers to be made in accordance
                                            with the requirements of, the Designated Stock Exchange of its intention to sell such shares
                                            in the manner required by the Designated Stock Exchange, and a period of three (3) months
                                            or such shorter period as may be allowed by the Designated Stock Exchange has elapsed since
                                            the date of such advertisement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purpose of the foregoing, the &ldquo;relevant period&rdquo; means the period commencing twelve (12) years before the date of publication
of the advertisement referred to in paragraph (c) of this Article and ending at the expiry of the period referred to in that paragraph.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
To give effect to any such sale the Board may authorise some person to transfer the said shares and an instrument of transfer signed
or otherwise executed by or on behalf of such person shall be as effective as if it had been executed by the registered holder or
the person entitled by transmission to such shares, and the purchaser shall not be bound to see to the application of the purchase
money nor shall his title to the shares be affected by any irregularity or invalidity in the proceedings relating to the sale. The
net proceeds of the sale will belong to the Company and upon receipt by the Company of such net proceeds it shall become indebted to
the former Member for an amount equal to such net proceeds. No trust shall be created in respect of such debt and no interest shall
be payable in respect of it and the Company shall not be required to account for any money earned from the net proceeds which may be
employed in the business of the Company or as it thinks fit. Any sale under this Article shall be valid and effective
notwithstanding that the Member holding the shares sold is dead, bankrupt or otherwise under any legal disability or
incapacity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>GENERAL
MEETINGS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35.&#9;An
annual general meeting of the Company shall be held at any such time, place and with such regularity as may be determined by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36.&#9;Each
general meeting, other than an annual general meeting, shall be called an extraordinary general meeting. Extraordinary general meetings
may be held at such times and in any location in the world as may be determined by the Board. To the extent that Members hold in aggregate
less than thirty percent (30%) of the outstanding voting shares in the Company, they cannot:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Call
                                            general meetings or annual general meetings; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Include
                                            matters for consideration at shareholder meetings.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37.&#9;(1)&#9;Only
a majority of the Board may call extraordinary general meetings, which extraordinary general meetings shall be held at such times and
locations (as permitted hereby) as such person or persons shall determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(2) The Board shall, on the requisition of Members holding at the date of the deposit of the requisition not less than thirty percent
(30%) of such of the paid-up share capital of the Company as at the date of the deposit carries the right to vote at general meetings,
forthwith proceed to convene an extraordinary general meeting. To be effective the requisition shall state the objects of the meeting,
shall be in writing, signed by the requisitionists, and shall be deposited at the registered office. The requisition may consist of several
documents in like form each signed by one or more requisitionists.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(3) If the Board does not, within twenty-one days from the date of the
requisition, duly proceed to call an extraordinary general meeting, the requisitionists, or any of them representing more than one half
of the total voting rights of all of them, may themselves convene an extraordinary general meeting; but any meeting so called shall not
be held more than ninety days after the requisition. An extraordinary general meeting called by requisitionists shall be called in the
same manner, as nearly as possible, as that in which general meetings are to be called by the Board.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>NOTICE
OF GENERAL MEETINGS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38.&#9;(1)&#9;Any
general meeting (whether an annual general meeting or an extraordinary general meeting) may be called by not less than (i) ten (10) clear
days&rsquo; Notice in the case of an annual general meeting or (ii) fourteen (14) clear days&rsquo; Notice in the case of an extraordinary
general meeting, save that any such annual or extraordinary general meeting may be called by shorter notice, subject to the Law, if it
is so agreed:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            the case of a meeting called as an annual general meeting, by all the Members entitled to
                                            attend and vote thereat; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            the case of any other meeting, by a majority in number of the Members having the right to
                                            attend and vote at the meeting, being a majority together holding not less than twenty five
                                            per cent. (25%) in nominal value of the issued shares giving that right.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
The Notice shall specify the time and place of the meeting and, in the case of special business, the general nature of the business
to be conducted and further, in the case of any matter for which approval by special resolution shall be required, the intention to
propose such a special resolution. The Notice convening an annual general meeting shall specify the meeting as such. Notice of every
general meeting shall be given to all Members other than to such Members as, under the provisions of these Articles or the terms of
issue of the shares they hold, are not entitled to receive such notices from the Company, to all persons entitled to a share in
consequence of the death or bankruptcy or winding-up of a Member and to each of the Directors and the Auditors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 35.45pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
A Member may give notice to the Company of business proposed to be brought before an annual general meeting provided that such
notice of proposal of business must be delivered to, or mailed and received at the principal executive offices of the Company not
less than ninety (90) days and not more than one hundred and twenty (120) days prior to the one-year anniversary of the preceding
year&rsquo;s annual general meeting; <U>provided</U>, <U>however</U>, that if the date of the annual general meeting is more than
thirty (30) days before or more than sixty (60) days after such anniversary date, such notice by the Member, to be timely, must be
so delivered, or so mailed and received, not later than the ninetieth (90th) day prior to such annual general meeting or, if later,
the tenth (10th) day following the day on which &ldquo;public disclosure&rdquo; of the date of such meeting was first made by the
Company (such notice within such time periods, &ldquo;<U>Timely Notice</U>&rdquo;). In no event shall any adjournment or
postponement of an annual general meeting, or the announcement thereof, commence a new time period (or extend any time period) for
the giving of Timely Notice as described above. For purposes of these Articles, &ldquo;<U>public disclosure</U>&rdquo; shall mean
disclosure in a press release reported by a national news service or in a document publicly filed by the Company with the SEC
pursuant to Sections 13, 14 or 15(d) of the Exchange Act or publicly filed according to applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39.&#9;The
accidental omission to give Notice of a meeting or (in cases where instruments of proxy are sent out with the Notice) to send such instrument
of proxy to, or the non-receipt of such Notice or such instrument of proxy by, any person entitled to receive such Notice shall not invalidate
any resolution passed or the proceedings at that meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>PROCEEDINGS
AT GENERAL MEETINGS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40.&#9;(1)&#9;All
business shall be deemed special that is transacted at an extraordinary general meeting, and also all business that is transacted at
an annual general meeting, with the exception of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            declaration and sanctioning of dividends;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">consideration
                                            and adoption of the accounts and balance sheet and the reports of the Directors and Auditors
                                            and other documents required to be annexed to the balance sheet;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            election of Directors; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">adoption
                                            of the Company&rsquo;s equity incentive plan and its amendments.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
No business other than the appointment of a chairman of a meeting shall be transacted at any general meeting unless a quorum is
present at the commencement of the business. At any general meeting of the Company, one (1) Member entitled to vote and present in
person or by proxy or (in the case of a Member being a corporation) by its duly authorised representative representing not less than
one-third in nominal value of the total issued voting shares in the Company throughout the meeting shall form a quorum for all
purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41.&#9;If
within fifteen (15) minutes from the time appointed for the meeting a quorum is not present, the meeting, if convened upon the requisition
of shareholders, shall be cancelled. In any other case it shall stand adjourned to the same time and place seven days or to such other
time or place as is determined by the Directors. If at such adjourned meeting a quorum is not present within half an hour from the time
appointed for holding the meeting, the meeting shall be dissolved. The Chairman may, with the consent of a meeting at which a quorum
is present, adjourn the meeting. When a meeting is adjourned for seven (7) days or more, notice of the adjourned meeting shall be given
in accordance with the articles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42.&#9;The
chairman of the Board shall preside as chairman at every general meeting. If at any meeting the chairman is not present within fifteen
(15) minutes after the time appointed for holding the meeting, or is not willing to act as chairman, the Directors present shall choose
one of their number to act, or if one Director only is present he shall preside as chairman if willing to act. If no Director is present,
or if each of the Directors present declines to take the chair, or if the chairman chosen shall retire from the chair, the Members present
in person or (in the case of a Member being a corporation) by its duly authorised representative or by proxy and entitled to vote shall
elect one of their number to be chairman.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43.&#9;The
chairman may adjourn the meeting from time to time and from place to place, but no business shall be transacted at any adjourned meeting
other than the business which might lawfully have been transacted at the meeting had the adjournment not taken place. When a meeting
is adjourned for fourteen (14) days or more, at least seven (7) clear days&rsquo; notice of the adjourned meeting shall be given specifying
the time and place of the adjourned meeting but it shall not be necessary to specify in such notice the nature of the business to be
transacted at the adjourned meeting and the general nature of the business to be transacted. Save as aforesaid, it shall be unnecessary
to give notice of an adjournment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44.&#9;If
an amendment is proposed to any resolution under consideration but is in good faith ruled out of order by the chairman of the meeting,
the proceedings on the substantive resolution shall not be invalidated by any error in such ruling. In the case of a resolution duly
proposed as a special resolution, no amendment thereto (other than a mere clerical amendment to correct a patent error) may in any event
be considered or voted upon.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>VOTING</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45.&#9;Subject
to any special rights or restrictions as to voting for the time being attached to any shares by or in accordance with these Articles,
at any general meeting on a show of hands every Member present in person (or being a corporation, is present by a duly authorised representative),
or by proxy shall have one vote and on a poll every Member present in person or by proxy or, in the case of a Member being a corporation,
by its duly authorised representative shall have one vote for every share of which he is the holder but so that no amount paid up or
credited as paid up on a share in advance of calls or instalments is treated for the foregoing purposes as paid up on the share. Notwithstanding
anything contained in these Articles, where more than one proxy is appointed by a Member which is a clearing house or a central depository
house (or its nominee(s)), each such proxy shall have one vote on a show of hands. A resolution put to the vote of a meeting shall be
decided on a show of hands unless (before or on the declaration of the result of the show of hands or on the withdrawal of any other
demand for a poll) a poll is demanded:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            the chairman of such meeting; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            at least three Members present in person or (in the case of a Member being a corporation)
                                            by its duly authorised representative or by proxy for the time being entitled to vote at
                                            the meeting; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            a Member or Members present in person or (in the case of a Member being a corporation) by
                                            its duly authorised representative or by proxy and representing not less than one-tenth of
                                            the total voting rights of all Members having the right to vote at the meeting; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
                                            a Member or Members present in person or (in the case of a Member being a corporation) by
                                            its duly authorised representative or by proxy and holding shares in the Company conferring
                                            a right to vote at the meeting being shares on which an aggregate sum has been paid up equal
                                            to not less than one-tenth of the total sum paid up on all shares conferring that right;
                                            or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            required by the rules of the Designated Stock Exchange, by any Director or Directors who,
                                            individually or collectively, hold proxies in respect of shares representing five per cent.
                                            (5%) or more of the total voting rights at such meeting.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
demand by a person as proxy for a Member or in the case of a Member being a corporation by its duly authorised representative shall be
deemed to be the same as a demand by a Member.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">46.&#9;Unless
a poll is duly demanded and the demand is not withdrawn, a declaration by the chairman that a resolution has been carried, or carried
unanimously, or by a particular majority, or not carried by a particular majority, or lost, and an entry to that effect made in the minute
book of the Company, shall be conclusive evidence of the facts without proof of the number or proportion of the votes recorded for or
against the resolution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">47.&#9;If
a poll is duly demanded the result of the poll shall be deemed to be the resolution of the meeting at which the poll was demanded. There
shall be no requirement for the chairman to disclose the voting figures on a poll.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48.&#9;A
poll demanded on the election of a chairman, or on a question of adjournment, shall be taken forthwith. A poll demanded on any other
question shall be taken in such manner (including the use of ballot or voting papers or tickets) and either forthwith or at such time
(being not later than thirty (30) days after the date of the demand) and place as the chairman directs. It shall not be necessary (unless
the chairman otherwise directs) for notice to be given of a poll not taken immediately.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49.&#9;The
demand for a poll shall not prevent the continuance of a meeting or the transaction of any business other than the question on which
the poll has been demanded, and, with the consent of the chairman, it may be withdrawn at any time before the close of the meeting or
the taking of the poll, whichever is the earlier.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.&#9;On
a poll votes may be given either personally or by proxy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51.&#9;A
person entitled to more than one vote on a poll need not use all his votes or cast all the votes he uses in the same way.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52.&#9;All
questions submitted to a meeting shall be decided by a simple majority of votes except where a greater majority is required by these
Articles or by the Law. In the case of an equality of votes, whether on a show of hands or on a poll, the chairman of such meeting shall
be entitled to a second or casting vote in addition to any other vote he may have.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53.&#9;Where
there are joint holders of any share any one of such joint holders may vote, either in person or by proxy, in respect of such share as
if he were solely entitled thereto, but if more than one of such joint holders be present at any meeting the vote of the senior holder
who tenders a vote, whether in person or by proxy, shall be accepted to the exclusion of the votes of the other joint holders, and for
this purpose seniority shall be determined by the order in which the names stand in the Register in respect of the joint holding. Several
executors or administrators of a deceased Member in whose name any share stands shall for the purposes of this Article be deemed joint
holders thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54.&#9;(1)&#9;A
Member who is a patient for any purpose relating to mental health or in respect of whom an order has been made by any court having jurisdiction
for the protection or management of the affairs of persons incapable of managing their own affairs may vote, whether on a show of hands
or on a poll, by his receiver, committee, <I>curator bonis</I> or other person in the nature of a receiver, committee or <I>curator bonis
</I>appointed by such court, and such receiver, committee, <I>curator bonis</I> or other person may vote on a poll by proxy, and may
otherwise act and be treated as if he were the registered holder of such shares for the purposes of general meetings, provided that such
evidence as the Board may require of the authority of the person claiming to vote shall have been deposited at the Office, head office
or Registration Office, as appropriate, not less than forty-eight (48) hours before the time appointed for holding the meeting, or adjourned
meeting or poll, as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;Any
person entitled under Article 53 to be registered as the holder of any shares may vote at any general meeting in respect thereof in the
same manner as if he were the registered holder of such shares, provided that forty-eight (48) hours at least before the time of the
holding of the meeting or adjourned meeting, as the case may be, at which he proposes to vote, he shall satisfy the Board of his entitlement
to such shares, or the Board shall have previously admitted his right to vote at such meeting in respect thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55.&#9;No
Member shall, unless the Board otherwise determines, be entitled to attend and vote and to be reckoned in a quorum at any general meeting
unless he is duly registered and all calls or other sums presently payable by him in respect of shares in the Company have been paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56.&#9;If:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            objection shall be raised to the qualification of any voter; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            votes have been counted which ought not to have been counted or which might have been rejected;
                                            or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            votes are not counted which ought to have been counted;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
objection or error shall not vitiate the decision of the meeting or adjourned meeting on any resolution unless the same is raised or
pointed out at the meeting or, as the case may be, the adjourned meeting at which the vote objected to is given or tendered or at which
the error occurs. Any objection or error shall be referred to the chairman of the meeting and shall only vitiate the decision of the
meeting on any resolution if the chairman decides that the same may have affected the decision of the meeting. The decision of the chairman
on such matters shall be final and conclusive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>PROXIES</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57.&#9;Any
Member entitled to attend and vote at a meeting of the Company shall be entitled to appoint another person as his proxy to attend and
vote instead of him. A Member who is the holder of two or more shares may appoint more than one proxy to represent him and vote on his
behalf at a general meeting of the Company or at a class meeting. A proxy need not be a Member. In addition, a proxy or proxies representing
either a Member who is an individual or a Member which is a corporation shall be entitled to exercise the same powers on behalf of the
Member which he or they represent as such Member could exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58.&#9;The
instrument appointing a proxy shall be in writing under the hand of the appointor or of his attorney duly authorised in writing or, if
the appointor is a corporation, either under its seal or under the hand of an officer, attorney or other person authorised to sign the
same. In the case of an instrument of proxy purporting to be signed on behalf of a corporation by an officer thereof it shall be assumed,
unless the contrary appears, that such officer was duly authorised to sign such instrument of proxy on behalf of the corporation without
further evidence of the facts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">59.&#9;The
instrument appointing a proxy and (if required by the Board) the power of attorney or other authority (if any) under which it is signed,
or a certified copy of such power or authority, shall be delivered to such place or one of such places (if any) as may be specified for
that purpose in or by way of note to or in any document accompanying the notice convening the meeting (or, if no place is so specified
at the Registration Office or the Office, as may be appropriate) not less than forty-eight (48) hours before the time appointed for holding
the meeting or adjourned meeting at which the person named in the instrument proposes to vote or, in the case of a poll taken subsequently
to the date of a meeting or adjourned meeting, not less than twenty-four (24) hours before the time appointed for the taking of the poll
and in default the instrument of proxy shall not be treated as valid. No instrument appointing a proxy shall be valid after the expiration
of twelve (12) months from the date named in it as the date of its execution, except at an adjourned meeting or on a poll demanded at
a meeting or an adjourned meeting in cases where the meeting was originally held within twelve (12) months from such date. Delivery of
an instrument appointing a proxy shall not preclude a Member from attending and voting in person at the meeting convened and in such
event, the instrument appointing a proxy shall be deemed to be revoked.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">60.&#9;Instruments
of proxy shall be in any common form or in such other form as the Board may approve (provided that this shall not preclude the use of
the two-way form) and the Board may, if it thinks fit, send out with the notice of any meeting forms of instrument of proxy for use at
the meeting. The instrument of proxy shall be deemed to confer authority to demand or join in demanding a poll and to vote on any amendment
of a resolution put to the meeting for which it is given as the proxy thinks fit. The instrument of proxy shall, unless the contrary
is stated therein, be valid as well for any adjournment of the meeting as for the meeting to which it relates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">61.&#9;A
vote given in accordance with the terms of an instrument of proxy shall be valid notwithstanding the previous death or insanity of the
principal, or revocation of the instrument of proxy or of the authority under which it was executed, provided that no intimation in writing
of such death, insanity or revocation shall have been received by the Company at the Office or the Registration Office (or such other
place as may be specified for the delivery of instruments of proxy in the notice convening the meeting or other document sent therewith)
two (2) hours at least before the commencement of the meeting or adjourned meeting, or the taking of the poll, at which the instrument
of proxy is used.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62.&#9;Anything
which under these Articles a Member may do by proxy he may likewise do by his duly appointed attorney and the provisions of these Articles
relating to proxies and instruments appointing proxies shall apply <I>mutatis mutandis</I> in relation to any such attorney and the instrument
under which such attorney is appointed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>CORPORATIONS
ACTING BY REPRESENTATIVES</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">63.&#9;(1)&#9;Any
corporation which is a Member may by resolution of its directors or other governing body authorise such person as it thinks fit to act
as its representative at any meeting of the Company or at any meeting of any class of Members. The person so authorised shall be entitled
to exercise the same powers on behalf of such corporation as the corporation could exercise if it were an individual Member and such
corporation shall for the purposes of these Articles be deemed to be present in person at any such meeting if a person so authorised
is present thereat.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;If
a clearing house (or its nominee(s)) or a central depository, being a corporation, is a Member, it may authorise such persons as it thinks
fit to act as its representatives at any meeting of the Company or at any meeting of any class of Members provided that the authorisation
shall specify the number and class of shares in respect of which each such representative is so authorised. Each person so authorised
under the provisions of this Article shall be deemed to have been duly authorised without further evidence of the facts and be entitled
to exercise the same rights and powers on behalf of the clearing house or central depository (or its nominee(s)) as if such person was
the registered holder of the shares of the Company held by the clearing house or central depository (or its nominee(s)) including the
right to vote individually on a show of hands.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)&nbsp;Any
reference in these Articles to a duly authorised representative of a Member being a corporation shall mean a representative authorised
under the provisions of this Article.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ACTION
BY WRITTEN RESOLUTIONS OF MEMBERS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64.&#9;Members
may pass a resolution in writing without holding a meeting if the following conditions are met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)&nbsp;all
Members entitled to vote are given notice of the resolution as if the same were being proposed at a meeting of Members;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;all
Members entitled so to vote :</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sign
                                            a document; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sign
                                            several documents in the like form each signed by one or more of those Members; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)&nbsp;the
signed document or documents is or are delivered to the Company, including, if the Company so nominates, by delivery of an Electronic
Record by Electronic means to the address specified for that purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
written resolution shall be as effective as if it had been passed at a meeting of the Members entitled to vote duly convened and held.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>BOARD
OF DIRECTORS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">65.&#9;(1)&#9;Unless
otherwise determined by the Company in general meeting, the number of Directors shall not be less than two (2). There shall be no maximum
number of Directors unless otherwise determined from time to time by the Members in general meeting. The Directors shall be elected or
appointed in the first place by the subscribers to the Memorandum of Association or by a majority of them and thereafter in accordance
with Article 65(3). At any one time, at least majority of the Board of Directors shall be Independent Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
[INTENTIONALLY LEFT BLANK]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)&nbsp;Subject to the Articles and the Law, the Company may by ordinary resolution elect any person to be a Director either to fill a
casual vacancy or as an addition to the existing Board. Any Director so appointed shall hold office until his death, resignation,
removal by an ordinary resolution or removal by a resolution of all the remaining Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)&nbsp;The
Directors by the affirmative vote of a simple majority of the remaining Directors present and voting at a Board meeting, shall have the
power from time to time and at any time to appoint any person as a Director to fill a casual vacancy on the Board or as an addition to
the existing Board, whether or not that person has previously served on the Board, subject to these Articles, applicable law and the
listing rules of the Designated Stock Exchange. Any Director so appointed shall hold office until death, resignation, removal by an ordinary
resolution or removal by a resolution of all the remaining Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)&nbsp;No
Director shall be required to hold any shares of the Company by way of qualification and a Director who is not a Member shall be entitled
to receive notice of and to attend and speak at any general meeting of the Company and of all classes of shares of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)
Subject to any provision to the contrary in these Articles, a Director may be removed by way of an ordinary resolution of the
Members at any time before the expiration of his period of office notwithstanding anything in these Articles or in any agreement
between the Company and such Director (but without prejudice to any claim for damages under any such agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)&nbsp;A
vacancy on the Board created by the removal of a Director under the provisions of subparagraph (6) above may be filled by the election
or appointment by ordinary resolution of the Members at the meeting at which such Director is removed or by the affirmative vote of a
simple majority of the remaining Directors present and voting at a Board meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)&nbsp;The
Company may from time to time in general meeting by ordinary resolution increase or reduce the number of Directors but so that the number
of Directors shall never be less than two (2).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)&nbsp;The
Directors shall, as soon as may be after each appointment or election of Directors, elect amongst the Directors a chairman (the &ldquo;Chairman&rdquo;)
and if more than one Director is proposed for this office, the election to such office shall take place in such manner as the Directors
may determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>RETIREMENT
OF DIRECTORS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">66.&#9;(1)&#9;Notwithstanding
any other provisions in the Articles, the Directors of each Class shall retire from office once they have come to terms, provided that
notwithstanding anything herein, the chairman of the Board shall not, whilst holding such office, be subject to retirement or be taken
into account in determining the number of Directors to retire.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;A
retiring Director shall be eligible for re-election and shall continue to act as a Director throughout the meeting at which he retires.
The Directors to retire shall include (so far as necessary to ascertain the number of directors to retire) any Director who wishes to
retire and not to offer himself for re-election. Any further Directors so to retire shall be those of the other Directors subject to
retirement who have been longest in office since their last re-election or appointment and so that as between persons who became or were
last re-elected Directors on the same day those to retire shall (unless they otherwise agree among themselves) be determined by lot and,
without limitation, the Directors to retire at the first annual general meeting shall be so determined.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">67.&#9;No
person other than a Director retiring at the meeting shall, unless recommended by the Directors for election, be eligible for election
as a Director at any general meeting unless a Notice signed by a Member (other than the person to be proposed) duly qualified to attend
and vote at the meeting for which such notice is given of his intention to propose such person for election and also a Notice signed
by the person to be proposed of his willingness to be elected shall have been lodged at the head office or at the Registration Office
provided that the minimum length of the period, during which such Notice(s) are given, shall be at least seven (7) days and that the
period for lodgment of such Notice(s) shall commence no earlier than the day after the despatch of the notice of the general meeting
appointed for such election and end no later than seven (7) days prior to the date of such general meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>DISQUALIFICATION
OF DIRECTORS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">68.&#9;The
office of a Director shall be vacated if the Director:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)&nbsp;resigns
his office by notice in writing delivered to the Company at the Office or tendered at a meeting of the Board;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">(2)</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">becomes of unsound mind or dies;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)&nbsp;without
special leave of absence from the Board, is absent from meetings of the Board for six consecutive months and the Board resolves that
his office be vacated;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)&nbsp;becomes
bankrupt or has a receiving order made against him or suspends payment or compounds with his creditors;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">(5)</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">is prohibited by law from being a Director; or</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)&nbsp;ceases
to be a Director by virtue of any provision of the Statutes or is removed from office pursuant to these Articles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ALTERNATE
DIRECTORS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">69.&#9;Any
Director may at any time by Notice delivered to the Office or head office or at a meeting of the Directors appoint any person (including
another Director) to be his alternate Director. Any person so appointed shall have all the rights and powers of the Director or Directors
for whom such person is appointed in the alternative provided that such person shall not be counted more than once in determining whether
or not a quorum is present. An alternate Director may be removed at any time by the body which appointed him and, subject thereto, the
office of alternate Director shall continue until the happening of any event which, if we were a Director, would cause him to vacate
such office or if his appointer ceases for any reason to be a Director. Any appointment or removal of an alternate Director shall be
effected by Notice signed by the appointor and delivered to the Office or head office or tendered at a meeting of the Board. An alternate
Director may also be a Director in his own right and may act as alternate to more than one Director. An alternate Director shall, if
his appointor so requests, be entitled to receive notices of meetings of the Board or of committees of the Board to the same extent as,
but in lieu of, the Director appointing him and shall be entitled to such extent to attend and vote as a Director at any such meeting
at which the Director appointing him is not personally present and generally at such meeting to exercise and discharge all the functions,
powers and duties of his appointor as a Director and for the purposes of the proceedings at such meeting the provisions of these Articles
shall apply as if he were a Director save that as an alternate for more than one Director his voting rights shall be cumulative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70.&#9;An
alternate Director shall only be a Director for the purposes of the Law and shall only be subject to the provisions of the Law insofar
as they relate to the duties and obligations of a Director when performing the functions of the Director for whom he is appointed in
the alternative and shall alone be responsible to the Company for his acts and defaults and shall not be deemed to be the agent of or
for the Director appointing him. An alternate Director shall be entitled to contract and be interested in and benefit from contracts
or arrangements or transactions and to be repaid expenses and to be indemnified by the Company to the same extent <I>mutatis mutandis
</I>as if he were a Director but he shall not be entitled to receive from the Company any fee in his capacity as an alternate Director
except only such part, if any, of the remuneration otherwise payable to his appointor as such appointor may by Notice to the Company
from time to time direct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">71.&#9;Every
person acting as an alternate Director shall have one vote for each Director for whom he acts as alternate (in addition to his own vote
if he is also a Director). If his appointor is for the time being absent from the People&rsquo;s Republic of China or otherwise not available
or unable to act, the signature of an alternate Director to any resolution in writing of the Board or a committee of the Board of which
his appointor is a member shall, unless the notice of his appointment provides to the contrary, be as effective as the signature of his
appointor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">72.&#9;An
alternate Director shall ipso facto cease to be an alternate Director if his appointor ceases for any reason to be a Director, however,
such alternate Director or any other person may be re-appointed by the Directors to serve as an alternate Director PROVIDED always that,
if at any meeting any Director retires but is re-elected at the same meeting, any appointment of such alternate Director pursuant to
these Articles which was in force immediately before his retirement shall remain in force as though he had not retired.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>DIRECTORS&rsquo;
FEES AND EXPENSES</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">73.&#9;The
Directors shall receive such remuneration as the Board may from time to time determine. Each Director shall be entitled to be repaid
or prepaid all traveling, hotel and incidental expenses reasonably incurred or expected to be incurred by him in attending meetings of
the Board or committees of the board or general meetings or separate meetings of any class of shares or of debenture of the Company or
otherwise in connection with the discharge of his duties as a Director.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">74.&#9;Each
Director shall be entitled to be repaid or prepaid all travelling, hotel and incidental expenses reasonably incurred or expected to be
incurred by him in attending meetings of the Board or committees of the Board or general meetings or separate meetings of any class of
shares or of debentures of the Company or otherwise in connection with the discharge of his duties as a Director.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75.&#9;Any
Director who, by request, goes or resides abroad for any purpose of the Company or who performs services which in the opinion of the
Board go beyond the ordinary duties of a Director may be paid such extra remuneration (whether by way of salary, commission, participation
in profits or otherwise) as the Board may determine and such extra remuneration shall be in addition to or in substitution for any ordinary
remuneration provided for by or pursuant to any other Article.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>DIRECTORS&rsquo;
INTERESTS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">76.&#9;A
Director may:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">hold
                                            any other office or place of profit with the Company (except that of Auditor) in conjunction
                                            with his office of Director for such period and upon such terms as the Board may determine.
                                            Any remuneration (whether by way of salary, commission, participation in profits or otherwise)
                                            paid to any Director in respect of any such other office or place of profit shall be in addition
                                            to any remuneration provided for by or pursuant to any other Article;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">act
                                            by himself or his firm in a professional capacity for the Company (otherwise than as Auditor)
                                            and he or his firm may be remunerated for professional services as if he were not a Director;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">continue
                                            to be or become a director, managing director, joint managing director, deputy managing director,
                                            executive director, manager or other officer or member of any other company promoted by the
                                            Company or in which the Company may be interested as a vendor, shareholder or otherwise and
                                            (unless otherwise agreed) no such Director shall be accountable for any remuneration, profits
                                            or other benefits received by him as a director, managing director, joint managing director,
                                            deputy managing director, executive director, manager or other officer or member of or from
                                            his interests in any such other company. Subject as otherwise provided by these Articles
                                            the Directors may exercise or cause to be exercised the voting powers conferred by the shares
                                            in any other company held or owned by the Company, or exercisable by them as Directors of
                                            such other company in such manner in all respects as they think fit (including the exercise
                                            thereof in favour of any resolution appointing themselves or any of them directors, managing
                                            directors, joint managing directors, deputy managing directors, executive directors, managers
                                            or other officers of such company) or voting or providing for the payment of remuneration
                                            to the director, managing director, joint managing director, deputy managing director, executive
                                            director, manager or other officers of such other company and any Director may vote in favour
                                            of the exercise of such voting rights in manner aforesaid notwithstanding that he may be,
                                            or about to be, appointed a director, managing director, joint managing director, deputy
                                            managing director, executive director, manager or other officer of such a company, and that
                                            as such he is or may become interested in the exercise of such voting rights in manner aforesaid.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9;Notwithstanding
the foregoing, no &ldquo;Independent Director&rdquo; as defined in FINRA Rules or in Rule 10A-3 under the Exchange Act, and with respect
of whom the Board has determined constitutes an &ldquo;Independent Director&rdquo; for purposes of compliance with applicable law or
the Company&rsquo;s listing requirements, shall without the consent of the Audit Committee take any of the foregoing actions or any other
action that would reasonably be likely to affect such Director&rsquo;s status as an &ldquo;Independent Director&rdquo; of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">77.&#9;Subject
to the Law and to these Articles, no Director or proposed or intending Director shall be disqualified by his office from contracting
with the Company, either with regard to his tenure of any office or place of profit or as vendor, purchaser or in any other manner whatsoever,
nor shall any such contract or any other contract or arrangement in which any Director is in any way interested be liable to be avoided,
nor shall any Director so contracting or being so interested be liable to account to the Company or the Members for any remuneration,
profit or other benefits realised by any such contract or arrangement by reason of such Director holding that office or of the fiduciary
relationship thereby established provided that such Director shall disclose the nature of his interest in any contract or arrangement
in which he is interested in accordance with Article 102 herein. Any such transaction that would reasonably be likely to affect a Director&rsquo;s
status as an &ldquo;Independent Director&rdquo;, or that would constitute a &ldquo;related party transaction&rdquo; as defined by Item
7.N of Form 20F promulgated by the SEC, shall require the approval of the Audit Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">78.&#9;A
Director who to his knowledge is in any way, whether directly or indirectly, interested in a contract or arrangement or proposed contract
or arrangement with the Company shall declare the nature of his interest at the meeting of the Board at which the question of entering
into the contract or arrangement is first considered, if he knows his interest then exists, or in any other case at the first meeting
of the Board after he knows that he is or has become so interested. For the purposes of this Article, a general Notice to the Board by
a Director to the effect that:</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">he
                                            is a member or officer of a specified company or firm and is to be regarded as interested
                                            in any contract or arrangement which may after the date of the Notice be made with that company
                                            or firm; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">he
                                            is to be regarded as interested in any contract or arrangement which may after the date of
                                            the Notice be made with a specified person who is connected with him;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shall
be deemed to be a sufficient declaration of interest under this Article in relation to any such contract or arrangement, provided that
no such Notice shall be effective unless either it is given at a meeting of the Board or the Director takes reasonable steps to secure
that it is brought up and read at the next Board meeting after it is given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">79.&#9;Following
a declaration being made pursuant to the last preceding two Articles, subject to any separate requirement for Audit Committee approval
under applicable law or the listing rules of the Company&rsquo;s Designated Stock Exchange, and unless disqualified by the chairman of
the relevant Board meeting, a Director may vote in respect of any contract or proposed contract or arrangement in which such Director
is interested and may be counted in the quorum at such meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>GENERAL
POWERS OF THE DIRECTORS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">80.&#9;(1)&#9;The
business of the Company shall be managed and conducted by the Board, which may pay all expenses incurred in forming and registering the
Company and may exercise all powers of the Company (whether relating to the management of the business of the Company or otherwise) which
are not by the Statutes or by these Articles required to be exercised by the Company in general meeting, subject nevertheless to the
provisions of the Statutes and of these Articles and to such regulations being not inconsistent with such provisions, as may be prescribed
by the Company in general meeting, but no regulations made by the Company in general meeting shall invalidate any prior act of the Board
which would have been valid if such regulations had not been made. The general powers given by this Article shall not be limited or restricted
by any special authority or power given to the Board by any other Article.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;Any
person contracting or dealing with the Company in the ordinary course of business shall be entitled to rely on any written or oral contract
or agreement or deed, document or instrument entered into or executed as the case may be by any two of the Directors acting jointly on
behalf of the Company and the same shall be deemed to be validly entered into or executed by the Company as the case may be and shall,
subject to any rule of law, be binding on the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)&nbsp;Without
prejudice to the general powers conferred by these Articles it is hereby expressly declared that the Board shall have the following powers:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            give to any person the right or option of requiring at a future date that an allotment shall
                                            be made to him of any share at par or at such premium as may be agreed;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            give to any Directors, officers or employees of the Company an interest in any particular
                                            business or transaction or participation in the profits thereof or in the general profits
                                            of the Company either in addition to or in substitution for a salary or other remuneration;
                                            and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            resolve that the Company be deregistered in the Cayman Islands and continued in a named jurisdiction
                                            outside the Cayman Islands subject to the provisions of the Law.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">81.&#9;Reserved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">82.&#9;The
Board may by power of attorney appoint any company, firm or person or any fluctuating body of persons, whether nominated directly or
indirectly by the Board, to be the attorney or attorneys of the Company for such purposes and with such powers, authorities and discretions
(not exceeding those vested in or exercisable by the Board under these Articles) and for such period and subject to such conditions as
it may think fit, and any such power of attorney may contain such provisions for the protection and convenience of persons dealing with
any such attorney as the Board may think fit, and may also authorise any such attorney to sub-delegate all or any of the powers, authorities
and discretions vested in him. Such attorney or attorneys may, if so authorised under the Seal of the Company, execute any deed or instrument
under their personal seal with the same effect as the affixation of the Company&rsquo;s Seal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">83.&#9;The
Board may entrust to and confer upon a managing director, joint managing director, deputy managing director, an executive director or
any Director any of the powers exercisable by it upon such terms and conditions and with such restrictions as it thinks fit, and either
collaterally with, or to the exclusion of, its own powers, and may from time to time revoke or vary all or any of such powers but no
person dealing in good faith and without notice of such revocation or variation shall be affected thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">84.&#9;All
cheques, promissory notes, drafts, bills of exchange and other instruments, whether negotiable or transferable or not, and all receipts
for moneys paid to the Company shall be signed, drawn, accepted, endorsed or otherwise executed, as the case may be, in such manner as
the Board shall from time to time by resolution determine. The Company&rsquo;s banking accounts shall be kept with such banker or bankers
as the Board shall from time to time determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">85.&#9;(1)&#9;The
Board may establish or concur or join with other companies (being subsidiary companies of the Company or companies with which it is associated
in business) in establishing and making contributions out of the Company&rsquo;s moneys to any schemes or funds for providing pensions,
sickness or compassionate allowances, life assurance or other benefits for employees (which expression as used in this and the following
paragraph shall include any Director or ex-Director who may hold or have held any executive office or any office of profit under the
Company or any of its subsidiary companies) and ex-employees of the Company and their dependants or any class or classes of such person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;The
Board may pay, enter into agreements to pay or make grants of revocable or irrevocable pensions or other benefits to employees and ex-employees
and their dependants, or to any of such persons, including pensions or benefits additional to those, if any, to which such employees
or ex-employees or their dependants are or may become entitled under any such scheme or fund as mentioned in the last preceding paragraph.
Any such pension or benefit may, as the Board considers desirable, be granted to an employee either before and in anticipation of or
upon or at any time after his actual retirement, and may be subject or not subject to any terms or conditions as the Board may determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>BORROWING
POWERS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">86.&#9;The
Board may exercise all the powers of the Company to raise or borrow money and to mortgage or charge all or any part of the undertaking,
property and assets (present and future) and uncalled capital of the Company and, subject to the Law, to issue debentures, bonds and
other securities, whether outright or as collateral security for any debt, liability or obligation of the Company or of any third party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">87.&#9;Debentures,
bonds and other securities may be made assignable free from any equities between the Company and the person to whom the same may be issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">88.&#9;Any
debentures, bonds or other securities may be issued at a discount (other than shares (with the exception of any share discount conducted
in accordance with Law)), premium or otherwise and with any special privileges as to redemption, surrender, drawings, allotment of shares,
attending and voting at general meetings of the Company, appointment of Directors and otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">89.&#9;(1)&#9;Where
any uncalled capital of the Company is charged, all persons taking any subsequent charge thereon shall take the same subject to such
prior charge, and shall not be entitled, by notice to the Members or otherwise, to obtain priority over such prior charge.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;The
Board shall cause a proper register to be kept, in accordance with the provisions of the Law, of all charges specifically affecting the
property of the Company and of any series of debentures issued by the Company and shall duly comply with the requirements of the Law
in regard to the registration of charges and debentures therein specified and otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>PROCEEDINGS
OF THE DIRECTORS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">90.&#9;The
Board may meet for the despatch of business, adjourn and otherwise regulate its meetings as it considers appropriate. Questions arising
at any meeting shall be determined by a majority of votes. In the case of any equality of votes the chairman of the meeting shall have
an additional or casting vote.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">91.&#9;A
meeting of the Board may be convened by the Secretary on request of a Director or by any Director. The Secretary shall convene a meeting
of the Board. Notice of a meeting of the Board shall be deemed to be duly given to a Director if it is given to such Director in writing
or verbally (including in person or by telephone) or via electronic mail or by telephone or in such other manner as the Board may from
time to time determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">92.&#9;(1)&#9;The
quorum necessary for the transaction of the business of the Board may be fixed by the Board and, unless so fixed at any other number,
shall be two (2). An alternate Director shall be counted in a quorum in the case of the absence of a Director for whom he is the alternate
provided that he shall not be counted more than once for the purpose of determining whether or not a quorum is present.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;Directors
may participate in any meeting of the Board by means of a conference telephone or other communications equipment through which all persons
participating in the meeting can communicate with each other simultaneously and instantaneously and, for the purpose of counting a quorum,
such participation shall constitute presence at a meeting as if those participating were present in person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)&nbsp;Any
Director who ceases to be a Director at a Board meeting may continue to be present and to act as a Director and be counted in the quorum
until the termination of such Board meeting if no other Director objects and if otherwise a quorum of Directors would not be present.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">93.&#9;The
continuing Directors or a sole continuing Director may act notwithstanding any vacancy in the Board but, if and so long as the number
of Directors is reduced below the minimum number fixed by or in accordance with these Articles, the continuing Directors or Director,
notwithstanding that the number of Directors is below the number fixed by or in accordance with these Articles as the quorum or that
there is only one continuing Director, may act for the purpose of filling vacancies in the Board or of summoning general meetings of
the Company but not for any other purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">94.&#9;The
Chairman of the Board shall be the chairman of all meetings of the Board. If the Chairman of the Board is not present at any meeting
within five (5) minutes after the time appointed for holding the same, the Directors present may choose one of their number to be chairman
of the meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">95.&#9;A
meeting of the Board at which a quorum is present shall be competent to exercise all the powers, authorities and discretions for the
time being vested in or exercisable by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">96.&#9;(1)&#9;The
Board may delegate any of its powers, authorities and discretions to committees (including, without limitation, the Audit Committee),
consisting of such Director or Directors and other persons as it thinks fit, and they may, from time to time, revoke such delegation
or revoke the appointment of and discharge any such committees either wholly or in part, and either as to persons or purposes. Any committee
so formed shall, in the exercise of the powers, authorities and discretions so delegated, conform to any regulations which may be imposed
on it by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;All
acts done by any such committee in conformity with such regulations, and in fulfilment of the purposes for which it was appointed, but
not otherwise, shall have like force and effect as if done by the Board, and the Board (or if the Board delegates such power, the committee)
shall have power to remunerate the members of any such committee, and charge such remuneration to the current expenses of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">97.&#9;The
meetings and proceedings of any committee consisting of two or more members shall be governed by the provisions contained in these Articles
for regulating the meetings and proceedings of the Board so far as the same are applicable and are not superseded by any regulations
imposed by the Board under the last preceding Article, indicating, without limitation, any committee charter adopted by the Board for
purposes or in respect of any such committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">98.&#9;A
resolution in writing signed by all the Directors except such as are temporarily unable to act through ill-health or disability shall
(provided that such number is sufficient to constitute a quorum and further provided that a copy of such resolution has been given or
the contents thereof communicated to all the Directors for the time being entitled to receive notices of Board meetings in the same manner
as notices of meetings are required to be given by these Articles) be as valid and effectual as if a resolution had been passed at a
meeting of the Board duly convened and held. Such resolution may be contained in one document or in several documents in like form each
signed by one or more of the Directors and for this purpose a facsimile signature of a Director shall be treated as valid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.&#9;All
acts bona fide done by the Board or by any committee or by any person acting as a Director or members of a committee, shall, notwithstanding
that it is afterwards discovered that there was some defect in the appointment of any member of the Board or such committee or person
acting as aforesaid or that they or any of them were disqualified or had vacated office, be as valid as if every such person had been
duly appointed and was qualified and had continued to be a Director or member of such committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>COMMITTEES</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Without
prejudice to the freedom of the Directors to establish any other committees, for so long as the shares of the Company (or depositary
receipts therefor) are listed or quoted on the Designated Stock Exchange, the Board shall establish and maintain an Audit Committee,
a Compensation Committee and a Nomination Committee as committees of the Board, the composition and responsibilities of which shall comply
with the FINRA Rules, the rules and regulations of the SEC and the rules and regulations of the Designated Stock Exchange, as appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.&nbsp;&nbsp;&nbsp;&nbsp;&#9;The
Board shall adopt a formal written audit committee charter, a formal written compensation committee charter and a formal written Nomination
Committee Charter and review and assess the adequacy of each formal written charter on an annual basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">102.&nbsp;&nbsp;&nbsp;&#9;For
so long as the shares of the Company (or depositary receipts therefor) are listed or quoted on the Designated Stock Exchange, the Company
shall conduct an appropriate review of all related party transactions on an ongoing basis and shall utilize the Audit Committee for the
review and approval of potential conflicts of interest.&nbsp; Specifically, the Audit Committee shall approve any transaction or transactions
between the Company and any of the following parties: (i) any Member owning an interest in the voting power of the Company or any subsidiary
of the Company that gives such Member significant influence over the Company or any subsidiary of the Company, (ii) any director or executive
officer of the Company or any subsidiary of the Company and any relative of such director or executive officer, (iii) any person in which
a substantial interest in the voting power of the Company is owned, directly or indirectly, by any person described in (i) or (ii) or
over which such a person is able to exercise significant influence, and (iv) any affiliate (other than a subsidiary) of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">103.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Board may, from time to time, appoint such other committees as may be permitted by Law. Such other committees appointed by the Board
shall consist of one (1) or more members of the Board and shall have such powers and perform such duties as may be provided in a resolution
of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>OFFICERS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">104.&#9;(1)&#9;The
officers of the Company shall consist of the chief executive officer, the chief financial officer, the Directors and Secretary, and such
additional officers (who may or may not be Directors) as the Board may from time to time determine, all of whom shall be deemed to be
officers for the purposes of the Law and these Articles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;The
officers shall receive such remuneration as the Directors may from time to time determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">105.&#9;(1)&#9;The
Secretary and additional officers, if any, shall be appointed by the Board and shall hold office on such terms and for such period as
the Board may determine. If thought fit, two or more persons may be appointed as joint Secretaries. The Board may also appoint from time
to time on such terms as it thinks fit one or more assistant or deputy Secretaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;The
Secretary shall attend all meetings of the Members and shall keep correct minutes of such meetings and enter the same in the proper books
provided for the purpose. He shall perform such other duties as are prescribed by the Law or these Articles or as may be prescribed by
the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">106.&#9;The
officers of the Company shall have such powers and perform such duties in the management, business and affairs of the Company as may
be delegated to them by the Directors from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107.&#9;A
provision of the Law or of these Articles requiring or authorising a thing to be done by or to a Director and the Secretary shall not
be satisfied by its being done by or to the same person acting both as Director and as or in place of the Secretary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>REGISTER
OF DIRECTORS AND OFFICERS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">108.&#9;The
Company shall cause to be kept in one or more books at its Office a Register of Directors and Officers in which there shall be entered
the full names and addresses of the Directors and Officers and such other particulars as required by the Law or as the Directors may
determine. The Company shall send to the Registrar of Companies in the Cayman Islands a copy of such register, and shall from time to
time notify to the said Registrar of any change that takes place in relation to such Directors and Officers as required by the Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>MINUTES</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">109.&#9;(1)&#9;The
Board shall cause minutes to be duly entered in books provided for the purpose:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
                                            all elections and appointments of officers;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
                                            the names of the Directors present at each meeting of the Directors and of any committee
                                            of the Directors;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
                                            all resolutions and proceedings of each general meeting of the Members, meetings of the Board
                                            and meetings of committees of the Board and where there are managers, of all proceedings
                                            of meetings of the managers.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Minutes
                                            shall be kept by the Secretary at the Office.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SEAL</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">110.&#9;(1)&#9;The
Company shall have one or more Seals, as the Board may determine. For the purpose of sealing documents creating or evidencing securities
issued by the Company, the Company may have a securities seal which is a facsimile of the Seal of the Company with the addition of the
word &ldquo;Securities&rdquo; on its face or in such other form as the Board may approve. The Board shall provide for the custody of
each Seal and no Seal shall be used without the authority of the Board or of a committee of the Board authorised by the Board in that
behalf. Subject as otherwise provided in these Articles, any instrument to which a Seal is affixed shall be signed autographically by
one Director and the Secretary or by two Directors or by such other person (including a Director) or persons as the Board may appoint,
either generally or in any particular case, save that as regards any certificates for shares or debentures or other securities of the
Company the Board may by resolution determine that such signatures or either of them shall be dispensed with or affixed by some method
or system of mechanical signature or by Electronic Signature. Every instrument executed in manner provided by this Article shall be deemed
to be sealed and executed with the authority of the Board previously given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;Where
the Company has a Seal for use abroad, the Board may by writing under the Seal appoint any agent or committee abroad to be the duly authorised
agent of the Company for the purpose of affixing and using such Seal and the Board may impose restrictions on the use thereof as may
be thought fit. Wherever in these Articles reference is made to the Seal, the reference shall, when and so far as may be applicable,
be deemed to include any such other Seal as aforesaid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>AUTHENTICATION
OF DOCUMENTS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">111.&#9;Any
Director or the Secretary or any person appointed by the Board for the purpose may authenticate any documents affecting the constitution
of the Company and any resolution passed by the Company or the Board or any committee, and any books, records, documents and accounts
relating to the business of the Company, and to certify copies thereof or extracts therefrom as true copies or extracts, and if any books,
records, documents or accounts are elsewhere than at the Office or the head office the local manager or other officer of the Company
having the custody thereof shall be deemed to be a person so appointed by the Board. A document purporting to be a copy of a resolution,
or an extract from the minutes of a meeting, of the Company or of the Board or any committee which is so certified shall be conclusive
evidence in favour of all persons dealing with the Company upon the faith thereof that such resolution has been duly passed or, as the
case may be, that such minutes or extract is a true and accurate record of proceedings at a duly constituted meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>DESTRUCTION
OF DOCUMENTS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">112.&#9;(1)&#9;The
Company shall be entitled to destroy the following documents at the following times:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            share certificate which has been cancelled at any time after the expiry of one (1) year from
                                            the date of such cancellation;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            dividend mandate or any variation or cancellation thereof or any notification of change of
                                            name or address at any time after the expiry of two (2) years from the date such mandate
                                            variation cancellation or notification was recorded by the Company;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            instrument of transfer of shares which has been registered at any time after the expiry of
                                            seven (7) years from the date of registration;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            allotment letters after the expiry of seven (7) years from the date of issue thereof; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">copies
                                            of powers of attorney, grants of probate and letters of administration at any time after
                                            the expiry of seven (7) years after the account to which the relevant power of attorney,
                                            grant of probate or letters of administration related has been closed;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
it shall conclusively be presumed in favour of the Company that every entry in the Register purporting to be made on the basis of any
such documents so destroyed was duly and properly made and every share certificate so destroyed was a valid certificate duly and properly
cancelled and that every instrument of transfer so destroyed was a valid and effective instrument duly and properly registered and that
every other document destroyed hereunder was a valid and effective document in accordance with the recorded particulars thereof in the
books or records of the Company. Provided always that: (1) the foregoing provisions of this Article shall apply only to the destruction
of a document in good faith and without express notice to the Company that the preservation of such document was relevant to a claim;
(2) nothing contained in this Article shall be construed as imposing upon the Company any liability in respect of the destruction of
any such document earlier than as aforesaid or in any case where the conditions of proviso (1) above are not fulfilled; and (3) references
in this Article to the destruction of any document include references to its disposal in any manner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;Notwithstanding
any provision contained in these Articles, the Directors may, if permitted by applicable law, authorise the destruction of documents
set out in sub-paragraphs (a) to (e) of paragraph (1) of this Article and any other documents in relation to share registration which
have been microfilmed or electronically stored by the Company or by the share registrar on its behalf provided always that this Article
shall apply only to the destruction of a document in good faith and without express notice to the Company and its share registrar that
the preservation of such document was relevant to a claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>DIVIDENDS
AND OTHER PAYMENTS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">113.&#9;Subject
to the Law, the Company in general meeting or the Board may from time to time declare dividends in any currency to be paid to the Members
but no dividend shall be declared in excess of the amount recommended by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">114.&#9;Dividends
may be declared and paid out of the profits of the Company, realised or unrealised, or from any reserve set aside from profits which
the Directors determine is no longer needed. The Board may also declare and pay dividends out of share premium account or any other fund
or account which can be authorised for this purpose in accordance with the Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">115.&#9;Except
in so far as the rights attaching to, or the terms of issue of, any share otherwise provide:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            dividends shall be declared and paid according to the amounts paid up on the shares in respect
                                            of which the dividend is paid, but no amount paid up on a share in advance of calls shall
                                            be treated for the purposes of this Article as paid up on the share; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            dividends shall be apportioned and paid pro rata according to the amounts paid up on the
                                            shares during any portion or portions of the period in respect of which the dividend is paid.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">116.&#9;The
Board may from time to time pay to the Members such interim dividends as appear to the Board to be justified by the profits of the Company
and in particular (but without prejudice to the generality of the foregoing) if at any time the share capital of the Company is divided
into different classes, the Board may pay such interim dividends in respect of those shares in the capital of the Company which confer
on the holders thereof deferred or non-preferential rights as well as in respect of those shares which confer on the holders thereof
preferential rights with regard to dividend and provided that the Board acts bona fide the Board shall not incur any responsibility to
the holders of shares conferring any preference for any damage that they may suffer by reason of the payment of an interim dividend on
any shares having deferred or non-preferential rights and may also pay any fixed dividend which is payable on any shares of the Company
half-yearly or on any other dates, whenever such profits, in the opinion of the Board, justifies such payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">117.&#9;The
Board may deduct from any dividend or other moneys payable to a Member by the Company on or in respect of any shares all sums of money
(if any) presently payable by him to the Company on account of calls or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">118.&#9;No
dividend or other moneys payable by the Company on or in respect of any share shall bear interest against the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">119.&#9;Any
dividend, interest or other sum payable in cash to the holder of shares may be paid by cheque or warrant sent through the post addressed
to the holder at his registered address or, in the case of joint holders, addressed to the holder whose name stands first in the Register
in respect of the shares at his address as appearing in the Register or addressed to such person and at such address as the holder or
joint holders may in writing direct. Every such cheque or warrant shall, unless the holder or joint holders otherwise direct, be made
payable to the order of the holder or, in the case of joint holders, to the order of the holder whose name stands first on the Register
in respect of such shares, and shall be sent at his or their risk and payment of the cheque or warrant by the bank on which it is drawn
shall constitute a good discharge to the Company notwithstanding that it may subsequently appear that the same has been stolen or that
any endorsement thereon has been forged. Any one of two or more joint holders may give effectual receipts for any dividends or other
moneys payable or property distributable in respect of the shares held by such joint holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">120.&#9;All
dividends or bonuses unclaimed for one (1) year after having been declared may be invested or otherwise made use of by the Board for
the benefit of the Company until claimed. Any dividend or bonuses unclaimed after a period of six (6) years from the date of declaration
shall be forfeited and shall revert to the Company. The payment by the Board of any unclaimed dividend or other sums payable on or in
respect of a share into a separate account shall not constitute the Company a trustee in respect thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a Member fails to pay any call the Board may give to such Member not less than fourteen (14) clear days&rsquo; notice requiring payment
and specifying the amount unpaid including any interest which may have accrued, any expenses which have been incurred by the Company
due to that person&rsquo;s default and the place where payment is to be made. The notice shall also contain a warning that if the notice
is not complied with, the shares in respect of which the call is made will be liable to be forfeited. If such notice is not complied
with, the Board may, before the payment required by the notice has been received, resolve that any share the subject of that notice be
forfeited (which forfeiture shall include all dividends or other monies payable in respect of the forfeited share and not paid before
such forfeiture).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
forfeited share may be sold, re-allotted or otherwise disposed of on such terms and in such manner as the directors determine and at
any time before a sale, re-allotment or disposition the forfeiture may be cancelled on such terms as the directors think fit. A person
whose shares have been forfeited shall cease to be a Member in respect of the forfeited shares, but shall, notwithstanding such forfeit,
remain liable to pay to the Company all monies which at the date of forfeiture were payable to the Company in respect of the shares,
together with all expenses and interest from the date of forfeiture or surrender until payment, but his liability shall cease if and
when the Company receives payment in full of the unpaid amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
declaration, whether statutory or under oath, made by a Director or the Secretary shall be conclusive evidence that the person making
the declaration is a Director or Secretary of the Company and that the particular shares have been forfeited or surrendered on a particular
date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the execution of an instrument of transfer, if necessary, the declaration shall constitute good title to the shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">121.&#9;Whenever
the Board or the Company in general meeting has resolved that a dividend be paid or declared, the Board may further resolve that such
dividend be satisfied wholly or in part by the distribution of specific assets of any kind and in particular of paid up shares, debentures
or warrants to subscribe securities of the Company or any other company, or in any one or more of such ways, and where any difficulty
arises in regard to the distribution the Board may settle the same as it thinks expedient, and in particular may issue certificates in
respect of fractions of shares, disregard fractional entitlements or round the same up or down, and may fix the value for distribution
of such specific assets, or any part thereof, and may determine that cash payments shall be made to any Members upon the footing of the
value so fixed in order to adjust the rights of all parties, and may vest any such specific assets in trustees as may seem expedient
to the Board and may appoint any person to sign any requisite instruments of transfer and other documents on behalf of the persons entitled
to the dividend, and such appointment shall be effective and binding on the Members. The Board may resolve that no such assets shall
be made available to Members with registered addresses in any particular territory or territories where, in the absence of a registration
statement or other special formalities, such distribution of assets would or might, in the opinion of the Board, be unlawful or impracticable
and in such event the only entitlement of the Members aforesaid shall be to receive cash payments as aforesaid. Members affected as a
result of the foregoing sentence shall not be or be deemed to be a separate class of Members for any purpose whatsoever.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">122.&#9;(1)&#9;Whenever
the Board or the Company in general meeting has resolved that a dividend be paid or declared on any class of the share capital of the
Company, the Board may further resolve either:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            such dividend be satisfied wholly or in part in the form of an allotment of shares credited
                                            as fully paid up, provided that the Members entitled thereto will be entitled to elect to
                                            receive such dividend (or part thereof if the Board so determines) in cash in lieu of such
                                            allotment. In such case, the following provisions shall apply:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            basis of any such allotment shall be determined by the Board;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Board, after determining the basis of allotment, shall give not less than ten (10) days&rsquo;
                                            Notice to the holders of the relevant shares of the right of election accorded to them and
                                            shall send with such notice forms of election and specify the procedure to be followed and
                                            the place at which and the latest date and time by which duly completed forms of election
                                            must be lodged in order to be effective;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            right of election may be exercised in respect of the whole or part of that portion of the
                                            dividend in respect of which the right of election has been accorded; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            dividend (or that part of the dividend to be satisfied by the allotment of shares as aforesaid)
                                            shall not be payable in cash on shares in respect whereof the cash election has not been
                                            duly exercised (&ldquo;the non-elected shares&rdquo;) and in satisfaction thereof shares
                                            of the relevant class shall be allotted credited as fully paid up to the holders of the non-elected
                                            shares on the basis of allotment determined as aforesaid and for such purpose the Board shall
                                            capitalise and apply out of any part of the undivided profits of the Company (including profits
                                            carried and standing to the credit of any reserves or other special account, share premium
                                            account or capital redemption reserve) as the Board may determine, such sum as may be required
                                            to pay up in full the appropriate number of shares of the relevant class for allotment and
                                            distribution to and amongst the holders of the non-elected shares on such basis; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            the Members entitled to such dividend shall be entitled to elect to receive an allotment
                                            of shares credited as fully paid up in lieu of the whole or such part of the dividend as
                                            the Board may think fit. In such case, the following provisions shall apply:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            basis of any such allotment shall be determined by the Board;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Board, after determining the basis of allotment, shall give not less than ten (10) days&rsquo;
                                            Notice to the holders of the relevant shares of the right of election accorded to them and
                                            shall send with such notice forms of election and specify the procedure to be followed and
                                            the place at which and the latest date and time by which duly completed forms of election
                                            must be lodged in order to be effective;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            right of election may be exercised in respect of the whole or part of that portion of the
                                            dividend in respect of which the right of election has been accorded; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            dividend (or that part of the dividend in respect of which a right of election has been accorded)
                                            shall not be payable in cash on shares in respect whereof the share election has been duly
                                            exercised (&ldquo;the elected shares&rdquo;) and in lieu thereof shares of the relevant class
                                            shall be allotted credited as fully paid up to the holders of the elected shares on the basis
                                            of allotment determined as aforesaid and for such purpose the Board shall capitalise and
                                            apply out of any part of the undivided profits of the Company (including profits carried
                                            and standing to the credit of any reserves or other special account, share premium account
                                            or capital redemption reserve) as the Board may determine, such sum as may be required to
                                            pay up in full the appropriate number of shares of the relevant class for allotment and distribution
                                            to and amongst the holders of the elected shares on such basis.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#9;The
                                            shares allotted pursuant to the provisions of paragraph (1) of this Article shall rank <I>pari
                                            passu</I> in all respects with shares of the same class (if any) then in issue save only
                                            as regards participation in the relevant dividend or in any other distributions, bonuses
                                            or rights paid, made, declared or announced prior to or contemporaneously with the payment
                                            or declaration of the relevant dividend unless, contemporaneously with the announcement by
                                            the Board of their proposal to apply the provisions of sub-paragraph (a) or (b) of paragraph
                                            (2) of this Article in relation to the relevant dividend or contemporaneously with their
                                            announcement of the distribution, bonus or rights in question, the Board shall specify that
                                            the shares to be allotted pursuant to the provisions of paragraph (1) of this Article shall
                                            rank for participation in such distribution, bonus or rights.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Board may do all acts and things considered necessary or expedient to give effect to any
                                            capitalisation pursuant to the provisions of paragraph (1) of this Article, with full power
                                            to the Board to make such provisions as it thinks fit in the case of shares becoming distributable
                                            in fractions (including provisions whereby, in whole or in part, fractional entitlements
                                            are aggregated and sold and the net proceeds distributed to those entitled, or are disregarded
                                            or rounded up or down or whereby the benefit of fractional entitlements accrues to the Company
                                            rather than to the Members concerned). The Board may authorise any person to enter into on
                                            behalf of all Members interested, an agreement with the Company providing for such capitalisation
                                            and matters incidental thereto and any agreement made pursuant to such authority shall be
                                            effective and binding on all concerned.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)&nbsp;The
Company may upon the recommendation of the Board by ordinary resolution resolve in respect of any one particular dividend of the Company
that notwithstanding the provisions of paragraph (1) of this Article a dividend may be satisfied wholly in the form of an allotment of
shares credited as fully paid up without offering any right to shareholders to elect to receive such dividend in cash in lieu of such
allotment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)&nbsp;The
Board may on any occasion determine that rights of election and the allotment of shares under paragraph (1) of this Article shall not
be made available or made to any shareholders with registered addresses in any territory where, in the absence of a registration statement
or other special formalities, the circulation of an offer of such rights of election or the allotment of shares would or might, in the
opinion of the Board, be unlawful or impracticable, and in such event the provisions aforesaid shall be read and construed subject to
such determination. Members affected as a result of the foregoing sentence shall not be or be deemed to be a separate class of Members
for any purpose whatsoever.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)&nbsp;Any
resolution declaring a dividend on shares of any class, whether a resolution of the Company in general meeting or a resolution of the
Board, may specify that the same shall be payable or distributable to the persons registered as the holders of such shares at the close
of business on a particular date, notwithstanding that it may be a date prior to that on which the resolution is passed, and thereupon
the dividend shall be payable or distributable to them in accordance with their respective holdings so registered, but without prejudice
to the rights inter se in respect of such dividend of transferors and transferees of any such shares. The provisions of this Article
shall <I>mutatis mutandis</I> apply to bonuses, capitalisation issues, distributions of realised capital profits or offers or grants
made by the Company to the Members.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>RESERVES</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">123.&#9;(1)&#9;The
Board shall establish an account to be called the share premium account and shall carry to the credit of such account from time to time
a sum equal to the amount or value of the premium paid on the issue of any share in the Company. Unless otherwise provided by the provisions
of these Articles, the Board may apply the share premium account in any manner permitted by the Law. The Company shall at all times comply
with the provisions of the Law in relation to the share premium account.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;Before
recommending any dividend, the Board may set aside out of the profits of the Company such sums as it determines as reserves which shall,
at the discretion of the Board, be applicable for any purpose to which the profits of the Company may be properly applied and pending
such application may, also at such discretion, either be employed in the business of the Company or be invested in such investments as
the Board may from time to time think fit and so that it shall not be necessary to keep any investments constituting the reserve or reserves
separate or distinct from any other investments of the Company. The Board may also without placing the same to reserve carry forward
any profits which it may think prudent not to distribute.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>CAPITALISATION</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">124.&#9;The
Company may, upon the recommendation of the Board, at any time and from time to time pass an ordinary resolution to the effect that it
is desirable to capitalise all or any part of any amount for the time being standing to the credit of any reserve or fund (including
a share premium account and capital redemption reserve and the profit and loss account) whether or not the same is available for distribution
and accordingly that such amount be set free for distribution among the Members or any class of Members who would be entitled thereto
if it were distributed by way of dividend and in the same proportions, on the footing that the same is not paid in cash but is applied
either in or towards paying up the amounts for the time being unpaid on any shares in the Company held by such Members respectively or
in paying up in full unissued shares, debentures or other obligations of the Company, to be allotted and distributed credited as fully
paid up among such Members, or partly in one way and partly in the other, and the Board shall give effect to such resolution provided
that, for the purposes of this Article, a share premium account and any capital redemption reserve or fund representing unrealised profits,
may be applied only in paying up in full unissued shares of the Company to be allotted to such Members credited as fully paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">125.&#9;The
Board may settle, as it considers appropriate, any difficulty arising in regard to any distribution under the last preceding Article
and in particular may issue certificates in respect of fractions of shares or authorise any person to sell and transfer any fractions
or may resolve that the distribution should be as nearly as may be practicable in the correct proportion but not exactly so or may ignore
fractions altogether, and may determine that cash payments shall be made to any Members in order to adjust the rights of all parties,
as may seem expedient to the Board. The Board may appoint any person to sign on behalf of the persons entitled to participate in the
distribution any contract necessary or desirable for giving effect thereto and such appointment shall be effective and binding upon the
Members.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ACCOUNTING
RECORDS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">126.&#9;The
Board shall cause true accounts to be kept of the sums of money received and expended by the Company, and the matters in respect of which
such receipt and expenditure take place, and of the property, assets, credits and liabilities of the Company and of all other matters
required by the Law or necessary to give a true and fair view of the Company&rsquo;s affairs and to explain its transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">127.&#9;The
accounting records shall be kept at the Office or, at such other place or places as the Board decides and shall always be open to inspection
by the Directors. No Member (other than a Director) shall have any right of inspecting any accounting record or book or document of the
Company except as conferred by law or authorised by the Board or the Company in general meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">128.&#9;Subject
to Article 129, a printed copy of the Directors&rsquo; report, accompanied by the balance sheet and profit and loss account, including
every document required by law to be annexed thereto, made up to the end of the applicable financial year and containing a summary of
the assets and liabilities of the Company under convenient heads and a statement of income and expenditure, together with a copy of the
Auditors&rsquo; report, shall be sent to each person entitled thereto at least ten (10) days before the date of the general meeting and
laid before the Company at the annual general meeting held in accordance with Article 35 provided that this Article shall not require
a copy of those documents to be sent to any person whose address the Company is not aware or to more than one of the joint holders of
any shares or debentures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">129.&#9;&#9;Subject
to due compliance with all applicable Statutes, rules and regulations, including, without limitation, the rules of the Designated Stock
Exchange, and to obtaining all necessary consents, if any, required thereunder, the requirements of Article 128 shall be deemed satisfied
in relation to any person by sending to the person in any manner not prohibited by the Statutes, summarised financial statements derived
from the Company&rsquo;s annual accounts and the directors&rsquo; report which shall be in the form and containing the information required
by applicable laws and regulations, provided that any person who is otherwise entitled to the annual financial statements of the Company
and the directors&rsquo; report thereon may, if he so requires by notice in writing served on the Company, demand that the Company sends
to him, in addition to summarised financial statements, a complete printed copy of the Company&rsquo;s annual financial statement and
the directors&rsquo; report thereon.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">130.&#9;&#9;The
requirement to send to a person referred to in Article 128 the documents referred to in that article or a summary financial report in
accordance with Article 129 shall be deemed satisfied where, in accordance with all applicable Statutes, rules and regulations, including,
without limitation, the rules of the Designated Stock Exchange, the Company publishes copies of the documents referred to in Article
128 and, if applicable, a summary financial report complying with Article 129, on the Company&rsquo;s computer network or in any other
permitted manner (including by sending any form of electronic communication), and that person has agreed or is deemed to have agreed
to treat the publication or receipt of such documents in such manner as discharging the Company&rsquo;s obligation to send to him a copy
of such documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>AUDIT</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">131.&nbsp;Subject
to applicable law and rules of the Designated Stock Exchange:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)&nbsp;At
the annual general meeting or at a subsequent extraordinary general meeting, the Members shall verify the appointment by the Audit Committee
of an auditor to audit the accounts of the Company and such auditor shall hold office until the Audit Committee appoint another auditor.
Such auditor may be a Member but no Director or officer or employee of the Company shall, during his continuance in office, be eligible
to act as an auditor of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;The
Audit Committee may appoint the Auditor. The Audit Committee may remove the Auditor at any time before the expiration of its term of
engagement and the Audit Committee shall appoint another Auditor in its place for the remainder of its term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">132.&#9;Subject
to the Law the accounts of the Company shall be audited at least once in every year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">133.&#9;The
remuneration of the Auditor shall be fixed by the Audit Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">134.&#9;
[INTENTIONALLY LEFT BLANK]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">135.&#9;The
Auditor shall at all reasonable times have access to all books kept by the Company and to all accounts and vouchers relating thereto;
and he may call on the Directors or officers of the Company for any information in their possession relating to the books or affairs
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">136.&#9;The
statement of income and expenditure and the balance sheet provided for by these Articles shall be examined by the Auditor and compared
by him with the books, accounts and vouchers relating thereto; and he shall make a written report thereon stating whether such statement
and balance sheet are drawn up so as to present fairly the financial position of the Company and the results of its operations for the
period under review and, in case information shall have been called for from Directors or officers of the Company, whether the same has
been furnished and has been satisfactory. The financial statements of the Company shall be audited by the Auditor in accordance with
generally accepted auditing standards. The Auditor shall make a written report thereon in accordance with generally accepted auditing
standards and the report of the Auditor shall be submitted to the Members in general meeting. The generally accepted auditing standards
referred to herein may be those of a country or jurisdiction other than the Cayman Islands. If so, the financial statements and the report
of the Auditor should disclose this fact and name such country or jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>NOTICES</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">137.&#9;Any
Notice or document, whether or not, to be given or issued under these Articles from the Company to a Member shall be in writing or by
cable, telex or facsimile transmission message or other form of electronic transmission or communication and any such Notice and document
may be served or delivered by the Company on or to any Member either personally or by sending it through the post in a prepaid envelope
addressed to such Member at his registered address as appearing in the Register or at any other address supplied by him to the Company
for the purpose or, as the case may be, by transmitting it to any such address or transmitting it to any telex or facsimile transmission
number or electronic number or address or website supplied by him to the Company for the giving of Notice to him or which the person
transmitting the notice reasonably and bona fide believes at the relevant time will result in the Notice being duly received by the Member
or may also be served by advertisement in appropriate newspapers in accordance with the requirements of the Designated Stock Exchange
or, to the extent permitted by the applicable laws, by placing it on the Company&rsquo;s website and giving to the member a notice stating
that the notice or other document is available there (a &ldquo;notice of availability&rdquo;). The notice of availability may be given
to the Member by any of the means set out above. In the case of joint holders of a share all notices shall be given to that one of the
joint holders whose name stands first in the Register and notice so given shall be deemed a sufficient service on or delivery to all
the joint holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">138.&#9;Any
Notice or other document:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            served or delivered by post, shall where appropriate be sent by airmail and shall be deemed
                                            to have been served or delivered on the day following that on which the envelope containing
                                            the same, properly prepaid and addressed, is put into the post; in proving such service or
                                            delivery it shall be sufficient to prove that the envelope or wrapper containing the notice
                                            or document was properly addressed and put into the post and a certificate in writing signed
                                            by the Secretary or other officer of the Company or other person appointed by the Board that
                                            the envelope or wrapper containing the Notice or other document was so addressed and put
                                            into the post shall be conclusive evidence thereof;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            sent by electronic communication, shall be deemed to be given immediately upon the time of
                                            the transmission on the day on which it is transmitted from the server of the Company or
                                            its agent. A Notice placed on the Company&rsquo;s website is deemed given by the Company
                                            to a Member on the day following that on which a notice of availability is deemed served
                                            on the Member;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            served or delivered in any other manner contemplated by these Articles, shall be deemed to
                                            have been served or delivered at the time of personal service or delivery or, as the case
                                            may be, at the time of the relevant despatch or transmission; and in proving such service
                                            or delivery a certificate in writing signed by the Secretary or other officer of the Company
                                            or other person appointed by the Board as to the act and time of such service, delivery,
                                            despatch or transmission shall be conclusive evidence thereof; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">may
                                            be given to a Member in the English language or such other language as may be approved by
                                            the Directors, subject to due compliance with all applicable Statutes, rules and regulations.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">139.&#9;(1)&#9;Any
Notice or other document delivered or sent by post to or left at the registered address of any Member in pursuance of these Articles
shall, notwithstanding that such Member is then dead or bankrupt or that any other event has occurred, and whether or not the Company
has notice of the death or bankruptcy or other event, be deemed to have been duly served or delivered in respect of any share registered
in the name of such Member as sole or joint holder unless his name shall, at the time of the service or delivery of the Notice or document,
have been removed from the Register as the holder of the share, and such service or delivery shall for all purposes be deemed a sufficient
service or delivery of such Notice or document on all persons interested (whether jointly with or as claiming through or under him) in
the share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;A
Notice may be given by the Company to the person entitled to a share in consequence of the death, mental disorder or bankruptcy of a
Member by sending it through the post in a prepaid letter, envelope or wrapper addressed to him by name, or by the title of representative
of the deceased, or trustee of the bankrupt, or by any like description, at the address, if any, supplied for the purpose by the person
claiming to be so entitled, or (until such an address has been so supplied) by giving the notice in any manner in which the same might
have been given if the death, mental disorder or bankruptcy had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)&nbsp;Any
person who by operation of law, transfer or other means whatsoever shall become entitled to any share shall be bound by every Notice
in respect of such share which prior to his name and address being entered on the Register shall have been duly given to the person from
whom he derives his title to such share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SIGNATURES</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">140.&#9;For
the purposes of these Articles, a cable or telex or facsimile or electronic transmission message purporting to come from a holder of
shares or, as the case may be, a Director, or, in the case of a corporation which is a holder of shares from a director or the secretary
thereof or a duly appointed attorney or duly authorised representative thereof for it and on its behalf, shall in the absence of express
evidence to the contrary available to the person relying thereon at the relevant time be deemed to be a document or instrument in writing
signed by such holder or Director in the terms in which it is received.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>WINDING
UP</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">141.&nbsp;A
resolution that the Company be wound up by the court or be wound up voluntarily shall be a special resolution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">142.&#9;(1)&#9;Subject
to any special rights, privileges or restrictions as to the distribution of available surplus assets on liquidation for the time being
attached to any class or classes of shares (i) if the Company shall be wound up and the assets available for distribution amongst the
Members of the Company shall be more than sufficient to repay the whole of the capital paid up at the commencement of the winding up,
the excess shall be distributed <I>pari passu</I> amongst such members in proportion to the amount paid up on the shares held by them
respectively and (ii) if the Company shall be wound up and the assets available for distribution amongst the Members as such shall be
insufficient to repay the whole of the paid-up capital such assets shall be distributed so that, a nearly as may be, the losses shall
be borne by the Members in proportion to the capital paid up, or which ought to have been paid up, at the commencement of the winding
up on the shares held by them respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;If
the Company shall be wound up (whether the liquidation is voluntary or by the court) the liquidator may, with the authority of a special
resolution and any other sanction required by the Law, divide among the Members in specie or kind the whole or any part of the assets
of the Company and whether or not the assets shall consist of properties of one kind or shall consist of properties to be divided as
aforesaid of different kinds, and may for such purpose set such value as he deems fair upon any one or more class or classes of property
and may determine how such division shall be carried out as between the Members or different classes of Members. The liquidator may,
with the like authority, vest any part of the assets in trustees upon such trusts for the benefit of the Members as the liquidator with
the like authority shall think fit, and the liquidation of the Company may be closed and the Company dissolved, but so that no contributory
shall be compelled to accept any shares or other property in respect of which there is a liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>INDEMNITY</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">143.&#9;(1)&#9;The
Directors, Secretary and other officers for the time being of the Company and the liquidator or trustees (if any) for the time being
acting in relation to any of the affairs of the Company and everyone of them, and everyone of their heirs, executors and administrators,
shall be indemnified and secured harmless out of the assets and profits of the Company from and against all actions, costs, charges,
losses, damages and expenses which they or any of them, their or any of their heirs, executors or administrators, shall or may incur
or sustain by or by reason of any act done, concurred in or omitted in or about the execution of their duty, or supposed duty, in their
respective offices or trusts; and none of them shall be answerable for the acts, receipts, neglects or defaults of the other or others
of them or for joining in any receipts for the sake of conformity, or for any bankers or other persons with whom any moneys or effects
belonging to the Company shall or may be lodged or deposited for safe custody, or for insufficiency or deficiency of any security upon
which any moneys of or belonging to the Company shall be placed out on or invested, or for any other loss, misfortune or damage which
may happen in the execution of their respective offices or trusts, or in relation thereto; PROVIDED THAT this indemnity shall not extend
to any matter in respect of any fraud or dishonesty which may attach to any of said persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --> -</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;Each
Member agrees to waive any claim or right of action he might have, whether individually or by or in the right of the Company, against
any Director on account of any action taken by such Director, or the failure of such Director to take any action in the performance of
his duties with or for the Company; PROVIDED THAT such waiver shall not extend to any matter in respect of any fraud or dishonesty which
may attach to such Director.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>AMENDMENT
TO MEMORANDUM AND ARTICLES OF ASSOCIATION</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>AND
NAME OF COMPANY</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">144.&#9;No
Article shall be rescinded, altered or amended and no new Article shall be made until the same has been approved by a special resolution
of the Members. A special resolution shall be required to alter the provisions of the Memorandum of Association or to change the name
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>INFORMATION</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">145.&#9;No
Member shall be entitled to require discovery of or any information respecting any detail of the Company&rsquo;s trading or any matter
which is or may be in the nature of a trade secret or secret process which may relate to the conduct of the business of the Company and
which in the opinion of the Directors it will be inexpedient in the interests of the members of the Company to communicate to the public.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>MERGERS
AND CONSOLIDATIONS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">146.&#9;Subject
to the Law and these Articles, the Company shall, with the approval of a special resolution, have the power to merge or consolidate with
one or more constituent companies (as defined in the Law) upon such terms as the Directors may determine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>TRANSFERS
BY WAY OF CONTINUATION</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">147.&#9;Subject
to the Law and these Articles, the Company may by Special Resolution resolve to be registered by way of continuation in a jurisdiction
outside the Islands or such other jurisdiction in which it is for the time being incorporated, registered or existing. In furtherance
of a resolution adopted pursuant to this Article, the Directors may cause an application to be made to the Registrar of Companies to
deregister the Company in the Islands or such other jurisdiction in which it is for the time being incorporated, registered or existing
and may cause all such further steps as they consider appropriate to be taken to effect the transfer by way of continuation of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;-
42 -</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ea140501ex5-1_chinajojo.htm
<DESCRIPTION>LEGAL OPINION OF CONYERS DILL & PEARMAN
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="vertical-align: middle; width: 50%; text-align: left; font-size: 10pt"><IMG SRC="ex5-1_001.jpg" ALT=""></TD>
    <TD STYLE="width: 50%">
    <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 2.25pt 0pt 0">CONYERS DILL &amp; PEARMAN</P>
    <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 2.25pt 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.15pt 0pt 0">SIX, 2<SUP>nd</SUP> Floor, Cricket Square</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.15pt 0pt 0">PO Box 2681, Grand Cayman KY1-1111</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.15pt 0pt 0">Cayman Islands</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.15pt 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.15pt 0pt 0">T +1 345 945 3901</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.15pt 0pt 0">&nbsp;</P>
    <P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 2.15pt 0pt 0">conyers.com</P></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">17 May 2021</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><BR>+1 345 814 7786<BR>
cora.miller@conyers.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>China Jo-Jo Drugstores
Holdings, Inc. &nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">c/o Conyers Trust Company
(Cayman) Limited&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Cricket Square, Hutchings
Drive&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">P.O. Box 2681&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Grand Cayman, KY1-111&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Cayman Islands&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Dear Mesdames and Sirs:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>Re: China Jo-Jo Drugstores Holdings,
Inc. (the &ldquo;Company&rdquo;)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in">We have acted as Cayman
Islands legal advisers to the Company in connection with the Company&rsquo;s registration statement on Form F-4 and proxy statement, including
all amendments or preliminary or final supplements thereto (the&nbsp;&ldquo;<B>Registration Statement</B>&rdquo;), filed with the Securities
and Exchange Commission (the&nbsp;&ldquo;<B>Commission</B>&rdquo;) under the U.S. Securities Act of 1933, as amended (the&nbsp;Act) to
date (the &ldquo;<B>Registration Statement</B>&rdquo;) and the prospectus contained in the Registration Statement dated May 14, 2021 (the
&ldquo;<B>Prospectus</B>&rdquo;), in respect of 41,751,790 ordinary shares of the Company with a nominal or par value US$0.001 (the&nbsp;&ldquo;<B>Shares</B>&rdquo;)
and warrants to purchase 8,257,009 Shares (the &ldquo;<B>Warrants</B>&rdquo; and together with the Shares, the &ldquo;<B>Securities</B>&rdquo;)
to be issued by the Company in connection with that certain agreement and plan of merger dated May 14, 2021 made between the Company and
China Jo-Jo Drugstores, Inc., a Nevada corporation (the &ldquo;<B>Plan of Merger</B>&rdquo;), as contained in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><B>DOCUMENTS REVIEWED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">For the purposes of giving this opinion,
we have examined the following documents:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in">1.1.</TD>
  <TD STYLE="text-align: justify">the Registration Statement;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in">1.2.</TD>
  <TD STYLE="text-align: justify">the Prospectus;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in">1.3.</TD>
  <TD STYLE="text-align: justify">the Plan of Merger;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in">1.4.</TD>
  <TD STYLE="text-align: justify">a copy of the Certificate of Incorporation and the Amended and Restated Memorandum and Articles of Association of the Company adopted
by special resolution dated May 12, 2021 (the &ldquo;<B>Memorandum and Articles</B>&rdquo;);</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in">1.5.</TD>
  <TD STYLE="text-align: justify">a copy of the written resolutions of the board of directors of the Company dated May 14, 2021 (the &ldquo;<B>Resolutions</B>&rdquo;);</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in">1.6.</TD>
  <TD STYLE="text-align: justify">a copy of a Certificate of Good Standing issued by the Registrar of Companies in relation to the Company on May 14, 2021 (the &ldquo;<B>Certificate
Date</B>&rdquo;); and</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in">1.7.</TD>
  <TD STYLE="text-align: justify">such other documents and made such enquiries as to questions of law as we have deemed necessary in order to render the opinion set forth
below.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><B>ASSUMPTIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">We have assumed:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in">2.1</TD>
  <TD STYLE="text-align: justify">the genuineness and authenticity of all signatures and the conformity to the originals of all copies (whether or not certified) examined
by us and the authenticity and completeness of the originals from which such copies were taken;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in">2.2</TD>
  <TD STYLE="text-align: justify">the accuracy and completeness of all factual representations made in the Registration Statement, the Prospectus and the other documents
reviewed by us;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in">2.3</TD>
  <TD STYLE="text-align: justify">that the Resolutions were passed at one or more duly convened, constituted and quorate meetings or by unanimous written resolutions,
remain in full force and effect and have not been rescinded or amended;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in">2.4</TD>
  <TD STYLE="text-align: justify">that there is no provision of the law of any jurisdiction, other than the Cayman Islands, which would have any implication in relation
to the opinions expressed herein;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in">2.5</TD>
  <TD STYLE="text-align: justify">the Company has or will receive consideration in money or money&rsquo;s worth for the issue of the Shares, and none of the Shares were
or will be issued for less than par value;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in">2.6</TD>
  <TD STYLE="text-align: justify">no invitation has been or will be made by or on behalf of the Company to the public in the Cayman Islands to subscribe for any of the
Shares;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in">2.7</TD>
  <TD STYLE="text-align: justify">the Memorandum and Articles will not be amended in any manner that would affect the opinions set forth herein;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in">2.8</TD>
  <TD STYLE="text-align: justify">that the Company will have sufficient authorised capital to effect the issue of any of the Shares at the time of issuance; and</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in">2.9</TD>
  <TD STYLE="text-align: justify">prior to, at the time of, and immediately following the approval of the transactions contemplated by the Registration Statement, the
Company was, or will be, able to pay its debts as they fell, or fall, due and has entered, or will enter, into the transactions contemplated
by the Registration Statement for proper value and not with an intention to defraud or wilfully defeat an obligation owed to any creditor
or with a view to giving a creditor a preference.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">conyers.com | <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><B>QUALIFICATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in">3.1</TD>
  <TD STYLE="text-align: justify">We have made no investigation of and express no opinion in relation to the laws of any jurisdiction other than the Cayman Islands. This
opinion is to be governed by and construed in accordance with the laws of the Cayman Islands and is limited to and is given on the basis
of the current law and practice in the Cayman Islands.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in">3.2</TD>
  <TD STYLE="text-align: justify">This opinion is issued solely for your benefit and use in connection with the matter described herein and is not to be relied upon by
any other person, firm or entity or in respect of any other matter.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in">3.3</TD>
  <TD STYLE="text-align: justify">Under Cayman Islands law, the register of members (shareholders) is <I>prima facie</I> evidence of title to shares and this register
would not record a third party interest in such shares. However, there are certain limited circumstances where an application may be
made to a Cayman Islands court for a determination on whether the register of members reflects the correct legal position. Further, the
Cayman Islands court has the power to order that the register of members maintained by a company should be rectified where it considers
that the register of members does not reflect the correct legal position. As far as we are aware, such applications are rarely made in
the Cayman Islands and there are no circumstances or matters of fact known to us on the date of this opinion letter which would properly
form the basis for an application for an order for rectification of the register of members of the Company, but if such an application
were made in respect of the Shares, then the validity of such shares may be subject to re-examination by a Cayman Islands court.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><B>OPINION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On the basis of and subject to the foregoing,
we are of the opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in">4.1</TD>
  <TD STYLE="text-align: justify">The Company is duly incorporated and existing under the laws of the Cayman Islands and, based on the Certificate of Good Standing, is
in good standing as at the Certificate Date. Pursuant to the Companies Act (&ldquo;<B>Act</B>&rdquo;), a company is deemed to be in good
standing if all fees and penalties under the Act have been paid and the Registrar of Companies has no knowledge that the Company is in
default under the Act.</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in">4.2</TD>
  <TD STYLE="text-align: justify">When issued and recorded in the register of members of the Company in accordance with the Memorandum and Articles and paid for as contemplated
by the Registration Statement and Plan of Merger, the Securities will be validly issued, fully paid and non-assessable (which term means
when used herein that no further sums are required to be paid by the holders thereof in connection with the issue of such shares).</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">conyers.com | <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">We hereby consent to the
filing of this opinion as an exhibit to the Registration Statement and to the references to our firm under the captions &ldquo;Proposal
No. 1, Adoption of the Merger Agreement&rdquo;, &ldquo;Enforceability of Civil Liabilities&rdquo; and &ldquo;Legal Matters&rdquo; in
the prospectus forming a part of the Registration Statement. In giving this consent, we do not hereby admit that we are experts within
the meaning of Section 11 of the Securities Act or that we are within the category of persons whose consent is required under Section
7 of the Securities Act or the Rules and Regulations of the Commission promulgated thereunder.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Yours faithfully,&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Conyers Dill &amp; Pearman</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">conyers.com | 4</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8.1
<SEQUENCE>4
<FILENAME>ea140501ex8-1_chinajojo.htm
<DESCRIPTION>TAX OPINION OF PRYOR CASHMAN LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 8.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex8-1_001.jpg" ALT="">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">May 14, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">China Jo-Jo Drugstores Holdings, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Gong Shu District, Hangzhou City</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">People&rsquo;s Republic of China 310008</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are acting as United States
federal income tax counsel to China Jo-Jo Drugstores Holdings, Inc., a Cayman Islands exempted company (the &ldquo;<B>CJJD Cayman</B>&rdquo;),
in connection with the preparation and filing on May 14, 2021 by CJJD Cayman with the Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;)
of the Registration Statement on Form F-4 (the &ldquo;<B>Registration Statement</B>&rdquo;) under the Securities Act of 1933, as amended
(the &ldquo;<B>Securities Act</B>&rdquo;), with respect to the registration by CJJD Cayman of ordinary shares, US$0.001 par value per
share in relation to the agreement and plan of merger, dated as of May 14, 2021 (the &ldquo;<B>Merger Agreement</B>&rdquo;) by and among
CJJD Cayman and China Jo-Jo Drugstores, Inc., a Nevada Corporation (the &ldquo;<B>Company</B>&rdquo;). Any capitalized terms used but
not defined herein shall have the meaning ascribed to such terms in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white">In
providing our opinion, we have examined the Merger Agreement, the Registration Statement, and such other documents as we have deemed necessary
or appropriate for purposes of this opinion. In our examination, we have assumed, without independent verification, (i)&nbsp;the authenticity
of original documents, (ii)&nbsp;the accuracy of copies and the genuineness of signatures, (iii)&nbsp;that the execution and delivery
by each party to a document and the performance by such party of its obligations thereunder have been authorized by all necessary measures
and do not violate or result in a breach of or default under such party&rsquo;s certificate or instrument of formation and&nbsp;by-laws&nbsp;or
the laws of such party&rsquo;s jurisdiction of organization, (iv)&nbsp;that each agreement represents the entire agreement between the
parties with respect to the subject matter thereof, (v)&nbsp;that the parties to each agreement have complied, and will comply, with all
of their respective covenants, agreements and undertakings contained therein, (vi)&nbsp;that the transactions provided for by each agreement
were and will be carried out in accordance with their terms, (vii)&nbsp;that the Redomicile Merger will be consummated in compliance with
the Merger Agreement, and (viii)&nbsp;that the parties have no plan or intention to waive or modify, and have not waived or modified,
any of the material terms or conditions in the Merger Agreement. If any of the above described assumptions is untrue for any reason or
if the transaction is consummated in a manner that is different from the manner described in the Merger Agreement or the Registration
Statement, this opinion may be adversely affected. We have not undertaken any independent investigation of any factual matter set forth
in any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><IMG SRC="ex8-1_002.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">China Jo-Jo Drugstores Holdings, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">May 14, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white">Based
upon and subject to the foregoing, and our consideration of such other matters of fact and law as we have considered necessary or appropriate,
we hereby confirm that, subject to the assumptions, exceptions, limitations and qualifications set forth herein and in the Registration
Statement, the discussion set forth in the Registration Statement under the caption &ldquo;<I>Material U.S. Federal Income Tax Considerations</I>,&rdquo;
insofar as it expresses conclusions as to the application of United States federal income tax law, is our opinion as to the material United
States federal income tax consequences of the Merger to holders of shares of, and warrants to acquire, common stock in the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white">We
express no opinion on any issue relating to the tax consequences of the transactions contemplated by the Merger Agreement or the Registration
Statement other than the opinion set forth above. Our opinion set forth above is based on the Code, Treasury Regulations promulgated thereunder,
published pronouncements of the Internal Revenue Service and judicial precedents, all as of the date hereof. The foregoing authorities
may be repealed, revoked or modified, and any such change may have retroactive effect. Any change in applicable laws or facts and circumstances
surrounding the Merger, or any inaccuracy in the statements, facts, assumptions and representations on which we have relied may affect
the validity of the opinion set forth herein. We assume no responsibility to inform CJJD Cayman of any such change or inaccuracy that
may occur or come to our attention. In addition, our opinion is being delivered prior to the consummation of the Merger and therefore
is prospective and dependent on future events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white">This
opinion is furnished to you solely in connection with the Registration Statement and this opinion is not to be relied upon for any other
purpose without our prior written consent. We hereby consent to use of this opinion as an exhibit to the Registration Statement and to
the use of our name therein. In giving this consent, we do not admit that we come within the category of persons whose consent is required
under Section&nbsp;7 of the Securities Act or the rules and regulations of the SEC thereunder, nor do we admit that we are experts with
respect to any part of the Registration Statement within the meaning of the term &ldquo;experts&rdquo; as used in the Securities Act or
the rules and regulations of the SEC thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%; font-size: 10pt">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">/s/ PRYOR CASHMAN LLP</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>5
<FILENAME>ea140501ex21-1_chinajojo.htm
<DESCRIPTION>LIST OF SUBSIDIARIES
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>EXHIBIT 21.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">China Jo-Jo Drugstores Holdings, Inc.<BR>
<BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Subsidiaries of Registrant</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.3
<SEQUENCE>6
<FILENAME>ea140501ex23-3_chinajojo.htm
<DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 23.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex23-3_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We hereby consent to the
included in the Prospectus constituting a part of this Registration Statement of our report dated July 10, 2020 relating to the consolidated
financial statements of China Jo-Jo Drugstores, Inc. appearing in its Annual Report on Form 10-K for the fiscal year ended March 31,
2020 filed with the Securities and Exchange Commission on July 10, 2020. We also consent to the reference to us under the caption &ldquo;Experts&rdquo;
in the Prospectus<FONT STYLE="font-family: Times New Roman, Times, Serif">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BDO CHINA SHU LUN PAN Certified Public Accountants LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="ex23-3_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shanghai, People&rsquo;s Republic of China</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">May 14, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>ea140501ex99-1_chinajojo.htm
<DESCRIPTION>FORM OF PROXY CARD
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD COLSPAN="4" STYLE="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CHINA JO-JO DRUGSTORES, INC.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>THIS
    PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Special
MEETING OF STOCKHOLDERS &#8211; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2021 AT &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ET
</FONT>&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">(
    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2021 AT BEIJING TIME)</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P></TD>
    <TD ROWSPAN="20" STYLE="padding-right: 5.65pt; padding-left: 5.65pt; text-align: center"><IMG SRC="ex99-1_005.jpg" ALT=""><FONT STYLE="font-size: 10pt"></FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="5" STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 62.4pt">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="3" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><B>CONTROL ID:</B></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="3" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><B>REQUEST ID:</B></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: bottom; padding-right: 5.65pt; padding-left: 5.65pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="3" STYLE="padding-bottom: 32pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-bottom: 32pt; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 32pt; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 32pt; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 32pt; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="3" ROWSPAN="3" STYLE="padding-bottom: 32pt; vertical-align: bottom; padding-right: 5.65pt; padding-left: 5.65pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 32pt; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 32pt; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="3" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD ROWSPAN="4" STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD ROWSPAN="4" STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD ROWSPAN="4" STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD ROWSPAN="4" STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD ROWSPAN="4" STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="4" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">The undersigned hereby appoints Lei Liu as proxy of the undersigned, with full power of substitution, to vote all the shares of common stock of China Jo-Jo Drugstores, Inc. held of record by the undersigned on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, at the special meeting of shareholders to be held on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2021 at &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;pm E.T. (&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2021 at &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, Beijing time), or any adjournment thereof. The meeting will be held at the company&rsquo;s principal executive offices located at Hai Wai Hai Tongxin Mansion Floor 6, Gong Shu District, Hangzhou City, Zhejiang Province, P. R. China, 310008.</TD></TR>
  <TR>
    <TD COLSPAN="4" STYLE="padding-bottom: 32pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="3" ROWSPAN="2" STYLE="padding-bottom: 32pt; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="4" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>(CONTINUED AND TO BE SIGNED ON REVERSE SIDE.)</B></FONT></TD></TR>
  <TR>
    <TD COLSPAN="4" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="4" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="4" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B><U>VOTING INSTRUCTIONS</U></B></FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="4" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>If you vote by phone, fax or internet, please DO NOT mail your proxy card.</B></FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="4" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="3" ROWSPAN="5" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.65pt 0pt 28.1pt"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.65pt 0pt 28.1pt"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.65pt 0pt 28.1pt"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.1pt">&nbsp;</P></TD></TR>
  <TR>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><IMG SRC="ex99-1_001.jpg" ALT="mail" STYLE="height: 34px; width: 34px"></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt"><B>MAIL:</B></FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Please mark, sign, date, and return this Proxy Card promptly using the enclosed envelope.</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><IMG SRC="ex99-1_002.jpg" ALT="fax" STYLE="height: 34px; width: 34px"></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt"><B>FAX:</B></FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Complete the reverse portion of this Proxy Card and Fax to <B>202-521-3464.</B></FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><IMG SRC="ex99-1_003.jpg" ALT="internet" STYLE="height: 34px; width: 34px"></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt"><B>INTERNET:</B></FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">https://www.iproxydirect.com/CJJD</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><IMG SRC="ex99-1_004.jpg" ALT="phone" STYLE="height: 34px; width: 34px"></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt"><B>PHONE:</B></FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">1-866-752-VOTE(8683)</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="5" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="5" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="5" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="5" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="5" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 11%">&nbsp;</TD>
    <TD STYLE="width: 9%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 32%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 21%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD COLSPAN="3" STYLE="padding-right: 0.7pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SPECIAL MEETING OF THE STOCKHOLDERS OF<BR>
    CHINA JO-JO DRUGSTORES, INC.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P></TD>
    <TD COLSPAN="8" STYLE="padding-left: 0.5in; text-align: right; text-indent: -0.5in"><FONT STYLE="font-size: 10pt"><B>PLEASE COMPLETE, DATE, SIGN AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. <BR>
PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE: </B></FONT><B><FONT STYLE="font-family: Wingdings">&yacute;</FONT></B></TD></TR>
  <TR>
    <TD COLSPAN="3" STYLE="padding-right: 0.7pt; padding-left: 0.5in; text-align: center; text-indent: -0.5in">PROXY SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS</TD>
    <TD COLSPAN="8" STYLE="padding-left: 0.5in; text-align: right; text-indent: -0.5in">&nbsp;</TD></TR>
  <TR STYLE="background-color: #F3F3F3">
    <TD STYLE="white-space: nowrap; width: 7%; border-top: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Proposal 1</B></FONT></TD>
    <TD STYLE="width: 45%; border-top: Black 1pt solid; padding-top: 3pt; padding-bottom: 3pt; padding-left: 4.55pt"><FONT STYLE="font-size: 10pt"><B>- The Board of Directors recommends you vote FOR the following proposal:</B></FONT></TD>
    <TD STYLE="width: 2%; border-top: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&agrave;</FONT></TD>
    <TD STYLE="width: 6%; border-top: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>FOR </B></FONT></TD>
    <TD STYLE="width: 1%; border-top: Black 1pt solid; padding-right: 0.7pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 5%; border-top: Black 1pt solid; padding-right: 0.7pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>AGAINST</B></FONT></TD>
    <TD STYLE="width: 1%; border-top: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 7%; border-top: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>ABSTAIN</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 2%; border-top: Black 1pt solid; padding-left: 0.5in; text-indent: -0.5in">&nbsp;</TD>
    <TD STYLE="width: 10%; border-top: Black 1pt solid; padding-left: 0.5in; text-align: right; text-indent: -0.5in">&nbsp;</TD>
    <TD STYLE="width: 14%; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-left: 0.5in; text-align: center; text-indent: -0.5in">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; padding-left: 0.5in; text-align: center; layout-grid-mode: line; font-weight: bold">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0.7pt">To approve and adopt of the agreement and plan of merger (the &ldquo;Merger Agreement&rdquo;) by and between the Company and China Jo-Jo Drugstores Holdings, Inc., an exempted company incorporated under the laws of the Cayman Islands and a wholly owned subsidiary of the Company (&ldquo;CJJD Cayman&rdquo;), which included a plan of merger required to be filed with the Register of Companies of the Cayman Islands, substantially in the form as attached as Annex A to the Merger Agreement (the &ldquo;Plan of Merger&rdquo;), pursuant to which the Company will merge with and into CJJD Cayman, with CJJD Cayman as the surviving company upon the merger becoming effective, and whereby each issued and outstanding share of the common stock of the Company will be converted into the right to receive one ordinary share of CJJD Cayman (the &ldquo;Redomicile Merger&rdquo;).</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.5in; text-align: center; layout-grid-mode: line; font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: center">&#9744;</TD>
    <TD STYLE="padding-right: 0.7pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; text-align: center">&#9744;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&#9744;</TD>
    <TD STYLE="vertical-align: top; padding-left: 0.5in; text-indent: -0.5in">&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-align: right; text-indent: -0.5in">&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-align: center; text-indent: -0.5in">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; padding-left: 0.5in; text-align: center; layout-grid-mode: line; font-weight: bold">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.5in; text-align: center; layout-grid-mode: line; font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-left: 0.5in; text-indent: -0.5in">&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-align: right; text-indent: -0.5in">&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-align: center; text-indent: -0.5in">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding-top: 3pt; padding-left: 0.5in; text-align: center; layout-grid-mode: line; font-weight: bold">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-right: 0.7pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; padding-left: 0.5in; text-align: center; layout-grid-mode: line; font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-right: 0.7pt; text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding-left: 0.5in; text-indent: -0.5in">&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-align: right; text-indent: -0.5in">&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-align: center; text-indent: -0.5in">&nbsp;</TD></TR>
  <TR STYLE="background-color: #F3F3F3">
    <TD STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; padding-top: 3pt; padding-bottom: 3pt">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 0.7pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 0.7pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-top: Black 1pt solid; padding-left: 0.5in; text-indent: -0.5in">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; padding-left: 0.5in; text-align: right; text-indent: -0.5in">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; padding-left: 0.5in; text-align: center; text-indent: -0.5in">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-top: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: right">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; padding-right: 0.7pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="white-space: nowrap; border-top: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>MARK &ldquo;X&rdquo; HERE
IF YOU PLAN TO ATTEND THE MEETING: &#9744;</B></FONT></TD></TR>
  <TR>
    <TD COLSPAN="2" ROWSPAN="2" STYLE="padding-right: 0.7pt; padding-bottom: 8pt; text-align: justify">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top; padding-right: 0.7pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="padding-right: 0.7pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">MARK HERE FOR
ADDRESS CHANGE &#9744; New Address (if applicable):</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">____________________________<BR>
    ____________________________<BR>
    ____________________________</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>IMPORTANT: </B>Please sign exactly as your
    name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney,
    trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized
    officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: ________________________, 2021</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; padding-left: 11.45pt">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="5" ROWSPAN="5" STYLE="padding-right: 0.7pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">(Print Name of Stockholder and/or Joint Tenant)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="6" STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Signature of Stockholder)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="6" STYLE="text-align: center"><FONT STYLE="font-size: 10pt">(Second Signature if held jointly)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !/ &4# 2(  A$! Q$!_\0
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M\3BL3A')-7C;>W2]G;39J[]%8_5'X:_%[P=\5]/N-7\&78O[&RF$%U,WRJ)
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M  3V^%-[?/YUQX.FU3P*9#R63P].+9,[N>!G!/7\**YS_@@G\.[WP'_P3Y\
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1A8(?)5A_>.2/2BDHI'KG_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !6 G # 2(  A$! Q$!_\0
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M:P^)7CSP]J_B;P=HTLC-;>(-/T">*'6H=(U7C3KG4=-:5)GL(W:Y\H,/+^\
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M*<4J=-**=%TTI>ZVVI-RNFM;7;5X/I> G&?(ZB2Y4DVY/73HGMTZ[_-?R?\
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MI#M[+C/7OFBBFHI2<EO*U_D IV8&$.1U( )_ <9_,8[<57>5T)&Q""52-O-
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MB^&W@3Q?\0;C3[G5(?!GA[4-?ETNV,:)J<=E"6:T\QXW=68,7!"M@)G:P&"
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MTW3;S3XO[2,\LNH+,;\+<W,R3/C>P,21E$A/E@ >Z#H/H*^?OV:_@?)^S_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZD]<>HYS2*%C4;$1?,.Y@%!!9N"<G)R<=?TYHHH &CC.[Y?O*%./E& <\!<
M<_XT%$+!]HW#.#W ]/?\:** $5(U82K&IE.,R/\ ?(QR._!],_0BE,<;,&V*
M&!^4@=#GK_G%%% "HH4,%  !&X<\G@YZGO@_GUSFE[X^OZ8_QHHH **** "B
EBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" (R U(# 2(  A$! Q$!_\0
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M/K3PQ>Z/<_$SX=_"_7FUGPAHP![M_P ,T?M9_P#21[XR_P#A@OV2/_G+4?\
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M;C59/#]P=9^S#38+BYB /(/^&:/VL_\ I(]\9?\ PP7[)'_SEJ/^&:/VL_\
MI(]\9?\ PP7[)'_SEJZ#0_\ @H?^P[XET'X9>*- _:D^#>K>'/C+?:M8?"[7
M++Q?8S:5XVDT+6M/\.:U=Z)?*?L\VD:7X@U73M$OM=E>+1+;5;N&PEU!;EC$
M.*^#_P#P4X_8]^,M]^U?:Z7\3+/P99_L9_$3Q5\/_C+K_P 1[G1/"WARVMO!
MOACP#XDUSXA:/K!UN^MO^%>Q7/Q!L?"L&J>(CX;UNX\5:)X@L4\/?8(-*U/5
MP#5_X9H_:S_Z2/?&7_PP7[)'_P Y:C_AFC]K/_I(]\9?_#!?LD?_ #EJ[;3_
M -O+]C34_A]XA^*L'[2_P?MOAYX2\::!\.O%GBO5O&6F:%IOA;QUXKATRX\+
M>%/$G]M2Z?<Z%K?B6VUG2;G0++5(+676+?4;.?3A<0W$3LGB#]O+]C?PE%\.
MIO%7[1WPL\,Q?%?1])\0^ V\0>(X-&_MCP_K^O+X7T+7[D:BELV@:)K7B,R:
M'I&K^(QI&GZEJ=IJ%G97,TVF:@EL <5_PS1^UG_TD>^,O_A@OV2/_G+4?\,T
M?M9_])'OC+_X8+]DC_YRU>\:5^TU^S[KOQDUC]GS1_B_X#U+XU:!#-+K'PXL
M]>M)O$EA);:=;:Q=:?-;(QB_MFUT:[AUF[T))GUJUT8R:M<6$>GP3W,?N= '
MP9^S!XB^-FC?M%?M/_ 3XL_&O5OCKI?PR\$_LX^.O!_BOQ)X$^'?@?Q'82_%
MG_A<UGXET2ZA^&GAWPMH6IZ9!+\-](O=+GN=(&IVTM]J,$]Y=0?9EA^\Z^%/
M@_\ \I!/VW?^R'?L0_\ I?\ M55]UT %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MNWUG6/A[X>77O"T?@:ST^P\6^*DL]$EU'Q/!<16'@K^QQ:W"?J+T_7K[G/\
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M-YHHFACDEC22X=HH$D=$>>18I)FCB4D&2188I9F1 2(HY)" B,0 ?E9^S/\
M\$_-3^''P_?Q[\6-=^($_P"T+J?QO_:'_:E?X;?!/]K?]J/X._L\>'O'_P ?
M?C%XL^.A^$>J>'/AQXW\"> _C1X6\+:]XDC\*ZG\0_BS\&-8N/&\<>KZ]>^
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!X<3P]KGC&R^(7[4>@Z'\*+75+ZRL/&WQDU"RT&U\4^H_![]J3QA^T'\0O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %'3I110 4444
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M]"Q0!]UT5\*?\/&/V<_^A7_;)_\ %;W_  44_P#H6*/^'C'[.?\ T*_[9/\
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M_AXQ^SG_ -"O^V3_ .*WO^"BG_T+%'_#QC]G/_H5_P!LG_Q6]_P44_\ H6*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&-;NV@N5C8@LBSQ)*$8C@E0^"1P2"15J@ HHHH **** /A7_ ()?_P#*-O\
M8&_[,Y_9N_'_ (M#X2Z_YZU]U5\*_P#!+[_E&W^P-_V9S^S=_P"JB\(U]U4
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?!W_!4[_E&)_P %
M'/\ LP[]KW_UGSXAU]XU\'?\%3O^48G_  4<_P"S#OVO?_6?/B'0!]XT444
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M#P3!J^C1Z]XVG_9V\::CX+UG5-!U"0-INGVGB.YTZ6_TV/409K.W/E7H\U&
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %?!W_!4[_E&)_P4<_[,._:]
M_P#6?/B'7WC7R?\ MZ?"WQM\<OV&?VS_ (*?#32[?6_B/\8/V3_VBOA;\/\
M1;O4['1;35_&WQ ^$'C'PGX4TNZUC4Y8--TFWO\ 7=7L+2;4]0GAL;".5KJ[
MEC@BD=0#ZPHKX6?]J']I\.XC_P"":W[2;QAF$;/\9_V'HW9 3L9XU_:DE5&9
M<%D620*25#N!N+?^&HOVHO\ I&I^TC_X>G]A_P#^BAH ^ZZ*^%/^&HOVHO\
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M3/XG^#T?A/49]&O=1U[0H;W5?!4FFZI=K]^_\-1?M1?](U/VD?\ P]/[#_\
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M-WI%Q=6K(\3K<017CRPLLD;"1%*NA 8?A7K/[+/[9WQ1_P""??@C_@DUXT^
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M& _ ?_1PW[=?_B;_ .TC_P#-_1_PP'X#'_-PW[=?;_F]_P#:1_\ F_\ Y\4
M?==%?"G_  [^^&G?X[_MUD]S_P -Z_M:#)[G"_%H*,GG"JJCHJ@  '_#OWX:
M?]%V_;K_ /$]OVMO_GMT ?==%?"G_#OOX6OQ/\;_ -NN=1RJ_P##P#]L:TVM
M_>WZ=\9[*5N,C9)(\?.[9O564_X=\?"/_HLW[=?_ (L/_;=_^?Q0!]UT5\*?
M\.]_A'_T6;]NO_Q8?^V[_P#/XI/^'>?P8;YI?BS^W7-(?O2?\/(OV^K?=S@'
MR;/]HZVMDVH ,101AL;GW2,\C 'W917PI_P[R^"?_15?VZ__ !91_P %!/\
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M_&_R?V0/V?(MVW.-VSX>+NQDXSG&3CJ:F_X=<?\ !,O_ *1T_L)_^(B_L_\
M_P [Z@#[LII90<%E!'4$C([^OI7PK_PZW_X)E?\ 2.G]A/\ \1%_9_\ _G?5
M9C_X)B?\$UH46.+_ ()Z?L.11ID+''^R9\!$1026(5%\ !1EB2< 9))ZDT ?
M<.]/[R_]]#_&F23PQ(TDLT4<:@%GDD1$4$@ LS$* 20!DCD@=37Q)_P[(_X)
MM?\ 2/C]A_\ \1/^ W_S T^/_@F9_P $WHG62+_@GW^Q%'(I)5X_V4?@.CJ2
M""59? 08$@D'!'!(Z&@#[._M73/^@E8?^!EO_P#'*/[5TO\ Z"-A_P"!EM_\
M<[?_ *J^.O\ AVS_ ,$ZO^C!OV*__$6/@9_\PE'_  [9_P""=7_1@W[%?_B+
M'P,_^82@#Z\E\0Z! _ESZYH\+X#;)=3LHWVG.&VO.#@X.#C!P<=*C_X2?PU_
MT,.A_P#@VL/_ )(KY0B_X)R_\$]H$\N']A#]C2%,EMD7[+_P1C3<<9.U/ X&
M3@9.,G S4G_#NO\ X)]_]&*_L<?^(Q_!/_YB* /JB3Q7X7B1I)?$F@11KC<\
MFL:<B*"P4%F:Y"@$D 9(R2!U.*J_\)SX)_Z'#PM_X4&D_P#R77S)'_P3O_X)
M_P 3K)%^PQ^QW%(N2LD?[,OP51U)!4E67P2&&02#@C()'0U9_P"'?G[!?_1D
M?[(G_B-GP:_^8N@#Z2_X3GP3_P!#AX6_\*#2?_DNH)OB'X MRJW'CGP= S#<
MJS>)M%B+*#@LH>]4D \9'&>*^=/^'?G[!?\ T9'^R)_XC9\&O_F+JQ#^P-^P
MI;@K!^Q9^R7 K'++#^SE\'HPQQC)">#5!..,GG% 'OO_  LOX<?]% \$_P#A
M5:%_\GT?\++^''_10/!/_A5:%_\ )]>#_P##!W[#G_1F7[*/_B.WPA_^8^C_
M (8-_8;_ .C,OV4?_$=OA#_\Q] 'MA^+GPH4E3\3OAZ"I((/C3PV""#@@@ZE
MD$$$$'D'@TG_  MWX3_]%/\ AY_X6OAO_P"6=>/C]AW]BI0%'[('[+@"@  ?
ML_\ PG   P  /"6     . .!2_\ ##W[%?\ T:!^R[_X8#X3_P#S)4 >L3_&
M;X06P4S_ !6^&T._.SS?'7A>+?MQNV^9JJAMNY=V#QD9ZC,/_"[_ (+?]%>^
M%_\ X7_A3_Y;5YG#^Q-^QE;EC!^R/^S%"7QO\GX"?"J,MMSMW;/"B[MNXXSG
M&3CK4W_#%_['?_1I_P"S3_X8GX7?_,M0!Z-_PN_X+?\ 17OA?_X7_A3_ .6U
M4S^T!\!E)4_&WX1@J<$'XD^#001P00=9R"#U![UPO_#%_P"QW_T:=^S3_P"&
M)^%W_P RU6Q^Q_\ LE  #]ES]G0    ?!+X:   8  'AG  '  X XH Z[_AH
M'X"_]%M^$7_AR?!O_P NJCE_:&^ 4*&2;XX_!Z&,$ R2_$SP7&BYX&6?6@N2
MQ  )&<^O!Y;_ (9 _9+_ .C7?V=?_#)_#3_YF:DB_9%_9/A<20_LP_L\Q2 $
M!XO@M\-HW (P0&3PT& (.#@\@X- &W_PTE^SIU_X7[\%?_#J>!O4'_H.^U+_
M ,-)_LZ?]%]^"O\ X=/P-_\ +VLS_AE+]ES_ *-L^ 7_ (9WX=__ #.4?\,I
M?LM_]&V? +_PSOP[_P#F<H MR_M/?LU6[[)_VAO@; [*'"3?%KP#&Q4Y4,%?
MQ #M)4@$#!*GN#47_#4O[,?_ $<9\"/_  [WP_\ _FAIT7[+G[,T"[(/V=?@
M5"FXMLB^$?P_C7<< MM3P^!N( !.,G STJ3_ (9B_9K_ .C>O@=_X:;P%_\
M*"@"NW[4W[,*JS/^T;\!PJJS,S?%[X? *@&YBQ/B' 4 9)/  R>!53_AK?\
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M[:SLK/3K2WL-/M+:PL;2%+>TLK."*UM+6"-0L<%O;P(D,,,:@*D<:*B* %4
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MJB@#XE_X:3_:;_Z1V_'K_P //^QW_P#1"T?\-)_M-_\ 2.WX]?\ AY_V._\
MZ(6OMJB@#XD/[2/[3K<)_P $[OCJ'_A,_P :OV/XXAW.]X?C_<RKD A=D$F6
MV@[5+.J?\-'?M2_](\OC)_X?/]D[_P"?37VY10!\1_\ #1W[4O\ TCR^,G_A
M\_V3O_GTT']H[]J4_P#./+XR?^'S_9/_ /GT_F._0\5]N44 ?F9I_P"W)^T;
M?_'3Q=\#8O\ @GI\7#KOA/X1?#CXLWFWXY_LPB[73?B)XU^*W@W3XI5D^*R:
M0UL;CX7:A+!+:ZU<:AYK7,=]I=E;K87>H>K_ /#1W[4O_2/+XR?^'S_9._\
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ME1_PT+^UQ_TC\\<_^)$?LZ__ #95]OT4 ?$'_#0O[7'_ $C\\<_^)$?LZ_\
MS94?\-"_M<?](_/'/_B1'[.O_P V5?;]% 'Q!_PT+^UQ_P!(_/'/_B1'[.O_
M ,V5'_#0O[7'_2/SQS_XD1^SK_\ -E7V_10!\/?\- _M?DDQ_P#!/[Q4JDYQ
M<?M(_ ..7/<E(->NXPI_A(F)/.57N?\ #0'[8?\ T8!XC_\ $E/@1_\ +6ON
M&B@#X>_X: _;#_Z, \1_^)*? C_Y:T?\- ?MA_\ 1@'B/_Q)3X$?_+6ON&B@
M#X>_X: _;#_Z, \1_P#B2GP(_P#EK1_PT!^V'_T8!XC_ /$E/@1_\M:^X:*
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M%=^#/^&2],U6'X&_%/Q!IX\$:=!<Z9XCG\764^M>$M3?]6O^"/O@OQM\/?\
M@G9^SWX0^(O@?XD_#?QEI1^*[:QX*^,-CK%C\3]#_M'XV_$C5=/B\;_V[<7V
MIZCK]UI=]97]YK\VIZQ#XE:Z'B"RUS6['4[?5KP ]W^-/[<O[-/P"\:-\.O'
M_BWQGJ?C:Q\/1>+_ !9X=^$OP1^.O[05_P#"[P9=R/'IOC;XW#X!_#7XEP_
MCP3K@M=7F\-^,?C++X%\,^);3PQXSOM U34K/P1XNGT7OO@S^T9\.OCOXE^.
MGAGP ^KW4_P ^)ND?"OQAJMY:V*Z%K.O:Y\*/AO\9-,U/P9J=AJ>H1Z]X;NO
M!GQ2\+2Q:LZ6)EOVOH8K:2U@@O;K\XOACXUU7]BG]K/_ (*!W7QJ^#G[1_B_
M3?VI/CAX#^.WP-^*/P-_9N^-_P"T?H'C/PA9_ /X4?".3X5>(]6^!_@3X@#X
M2^)_AQXM\ :K';VGQ?E\ ^#M3T#Q?8>*/#?B&^M(O&TOA[XM^*W[.7Q0AUC_
M (*1_M.^#/@[^T-IO[0NG?\ !2G]C?QU^SQJNAZ+\6_[8NOAXG@7]@KP[\3]
M3\#>$?#<ESX9\;>!;G08?BEX/^,.L^'].\2>%M0T[P[XMTSQ)K$T'@^2320#
M^A3X4_%2'XK6OCRZA^'_ ,5/A[_P@?Q4\??"J2#XK>![[P-=>+I? .L'2)/B
M!X#AOIIV\4?"OQ>1_:7@+QO:F*Q\4Z01J%K!%&=M>J5_,YX<^!GQZ^)O[1OP
M@\&_%;P#^TQ?_!37/^"QG_!3_6_B9::G;?''PSX*U']G>_\ V9?BU<?!R[\8
MZO82Z-92_L_>*?B';^$M-\"IJFH#X6^-M8GT_P -Z2FM1ZH^F7GE7C'PU^T9
MHOP"^%W[/'BWX'_&&]^&WA#XZ?\ !33P]X&\>?$;]EO]O;]LO5O#_@GX=?M4
M>)- _9#^&EM\&/V>_C)\"_$D$?CCX):^E[\$?VI/C%\1+;X<>%_ _@G2M,T7
M6MGBL>(K8 _JXHKXX_X)Y77Q:O?V%/V1)_CU9>--.^-/_#//PIM_BA8_$?3=
M9TCQ_;>-K3P?I=KX@B\9Z=XB5==MO$XU"&8ZTNKAM0DU SRW4DLLC2/]CT %
M%%% !1110 44?3_/\Z^3_BA^W%^RY\&_'VK?"_X@_%%=+\?:!IFAZQKWAG2?
M!GQ"\87NB:?XFBO)_#\^L2^#/"?B"TTQ]7M]/O;BPMKVY@NKBV@>X2 P[78
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M:T?\/*OV,/\ HJVM_P#AF_CG_P#.UH ^ZZ*^%/\ AY5^QA_T5;6__#-_'/\
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M: /NNBOA3_AY5^QA_P!%6UO_ ,,W\<__ )VM'_#RK]C#_HJVM_\ AF_CG_\
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MP1I4OP_^)&@?LX_"/XS^&?VW?C!^QO\ $+XE_$KXD^)-$_9>T&3X:? ;P_\
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MP/\ #_Q=^&7Q8\/^(/ ^AP^%_A-\;OB+JWBSP[KGA+3O&/A_XAFQ\0?!74?
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M/X,\4>(9S$+B\\0^%=,\,>'K+P_K7FIJ6D0:-IR6-S!]EC*V]7_:>_9K\/\
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M3/VR/^S ?^":G_K17_!6"@#VC_AB_P#8[_Z-._9I_P##$_"[_P"9:C_AB_\
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MN?4?#'@WQ;-I<MTDITB^E5+.8 BT#_@GK^RCX?3P[./ GBCQ#XA\-_'SP?\
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MK7QM_:6MOCEI_P 'KNV^)WAWP)X<70_C]>:K>^._!/N7[97[ OQG^,7Q,_;
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M_P $]SIG]LIX9U;4WTM=2^P7_P#9S7RVZWYT^_%H9C970B /TTHHHH ****
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M6_C1XAUR'XB>(/[%L?#7PC^&GAK_ (0C3],T(:_X^N_"'Q ^(WBKX:>.>+/
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MCG_H[+]F?_P^_P +?_FJH _CE_8JM/&'[57P=\/_ +!WA_Q/X1\=?&KXJ_\
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MG^(__$*/^"-'_P!*YK]SZ* /PP_X<&_LP?\ 13_$?_B%'_!&C_Z5S7:?#O\
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M_P ) -)_MO\ L'1/[6^R?;_[(TSS_L</T!0 5\T_ME_![Q3^T%^RA^T/\$?
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M% 'Q/_PL/_@H3_T:I^RK_P")K_$K_P"@DH_X6'_P4)_Z-4_95_\ $U_B5_\
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MB@#X _;(_P"3BO\ @D[_ -G_ /Q'_P#767_!2ROO^O@#]LC_ ).*_P""3O\
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MXRL[S7OA_8_##XF>*?3_ -HK_@GIH]AK7[4/@RR_8=\/^(?V/?A!_P %+_\
M@F_^T+\(O@KX3_9K\)>-O EG\$YOA]\ _#_[:D_[/WP7T7PS>1W_ (;U>;1/
M$.H?&#P)\,?"U[J/C348_'COX8\3:SX@U2TU'^J7VQ_A]/Q_I0!@8'0<"@#^
M5GXX?!'XF^+/VR/ACX_^&'[)'C#X?>(?A5^V'^Q3I_P'\0?#[]C&>TETC]@_
M1;3X03>,->U#]K+QK?:?K_P(\":1H/B#XE?#;Q=^QM\.3\/XO"UOH.N6^M_
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MK^&EMKR4Z[I=I;ZA87%SJ&E_:[2"&^LY99D2YA9_YY?V=OV)?VDH=*_X)V?
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M[7_$WB;7[^WTO1-!T72X'N]0U;5M1NY(K6QL+&VBDN+JZN)$AAB1I)&55)H
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MCK2_VAOASX(_82TGQ'HOQ(\5^&+KPWXMO?VN_"/B'3OC4MG8V7B<_'KPA?\
MBV[\1VTNAVOQ.T76O$H!_2%\0/C/\./A=XJ^#7@OQOKLND>)/C_\1+_X4_"F
MPCT?6M37Q)XYTOX;>/\ XN7NCS7FEZ?>V6AQP^ ?ACXVUL:EK]QIFER/I*Z;
M%>/JFH:=9W7J?Z?Y]J_DJ^"?@;3/CUX$_P"":[_\-*_&KXA:K\7/^"G/C_XG
M_%?P[X)_;4^-W[0GCC]C;P-XX_X)U_MH2>"?V6;']H_QC\1?B-\4O!.J:%X
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M\*?#O_E)?^UY_P!F0?\ !/#_ -7I_P %-Z^ZZ "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /A7_@EY_RC3_X)[?\
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MXU_X*+>)/VM_!WQ'TVZ_;*^)GP^UC3?&^C^./V)_VHO@;\,-!U_XQ^#OAO\
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M (]_9W_8@^.'BC5=<^(NJ_"/Q-J>GW7Q8^&GP6T;1]/FT^TN[^[UC^T-/TX
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MM_RC3H_X8W_:*_Z2Q?M__P#AN?\ @EE_]+3K[_HH ^ /^&-_VBO^DL7[?_\
MX;G_ ()9?_2TZ/\ AC?]HK_I+%^W_P#^&Y_X)9?_ $M.OO\ HH ^ /\ AC?]
MHK_I+%^W_P#^&Y_X)9?_ $M.C_AC?]HK_I+%^W__ .&Y_P""67_TM.OO^B@#
MX _X8W_:*_Z2Q?M__P#AN?\ @EE_]+3H_P"&-_VBO^DL7[?_ /X;G_@EE_\
M2TZ^_P"B@#X _P"&-_VBO^DL7[?_ /X;G_@EE_\ 2TZ/^&-_VBO^DL7[?_\
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MC?\ !4W_ *,W_8 _\66?M%?_ $IVOO\ HH _*7XU_M6?\%)?@/X.T;QOXO\
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M_@OP'X<\)>%I]2.MG_A)]8TO5_&,NF:/>^)+S3;?[(KX _X6-_P5-_Z,W_8
M_P#%EG[17_TIVC_A8W_!4W_HS?\ 8 _\66?M%?\ TIV@ _X)._\ *++_ ()I
M_P#9@'[&_P#ZSK\.:U?^"GO_ "CL_;9_[-E^,/Z^"]6KTO\ 8B^"GBK]FO\
M8O\ V1/V<_'6H>']6\;? ']F#X!?!3QCJGA.ZU&^\*ZEXJ^%?PI\)^!?$.H>
M&;[6-*T'5[SP_>:OH5Y<:-=:IH>C:C<:=);37VE:=<O+9P]G^TE\%-._:1_9
M_P#C/\ =6\1:OX0T[XR_#/QE\-KSQ7H%MIE[K?AN#Q?H=YHKZYI-GK5K?:1=
MW^E_:Q>VMKJEG=:?<30)%=V\L#.A /;**^%6_9Y_;)9F(_X*$^)D!)(1?V9O
M@&54$Y"J7T=F(7H-S,V!RQ.24_X9X_;*_P"DA?B?_P 1F^ /_P IJ /??VB_
MV?/AO^U'\(/%/P4^*UGJT_A+Q1)H6H)J'AS6+OPYXK\+^)_"7B#2_%W@KQMX
M-\1V!%[X>\8>"?%^AZ)XI\,:U;;WT_6M*LYY(;B!9;>7YE\0?L':Y\2_!%KX
M)^//[7O[1/QO@TOXG?L[_%'0=1\1:1\ /!\NCZQ^SE\7_"/QIT"VCTOX9?!7
MP9H%^/&/B;P;IVF^--4U/2KO6Y?#TUSI_AS4/#LQCNX]W_AGC]LK_I(7XG_\
M1F^ /_RFH_X9X_;*_P"DA?B?_P 1F^ /_P IJ ,#X=?\$X?A)\-?BS\+_C!H
MWCCXFWFN_"GX_?MT?M#Z)I.I7GA&30]2\6?M]>+-:\8?%'1M8CMO"-MJ<GAS
MPAJ6N747P^AL-3L-4M+9(4\2ZIXF=2Y\_L_^"2/[.)\-GP7XB\3?%+Q9X-O?
MA5_P4$^#GB#P[JNL>&;2W\1^#?\ @H[\<[[X\_&I;V_T3PII>KV&J^&?$&HW
M6A?#C4M#O]+DT;0FCEU=-=UV"'6(_7_^&>/VRO\ I(7XG_\ $9O@#_\ *:C_
M (9X_;*_Z2%^)_\ Q&;X _\ RFH ]?\ V>?@9XS^">F:I8^-/VDOC/\ M%W%
MUI?A3P_HM]\6[7X6:6/"^@>$+?5(;&#3-.^%'PX^'&E7NMZQ)K%Q-XK\6:Y9
MZIX@\1?8="M[J]CMM%M8C]&5\*?\,\?ME?\ 20OQ/_XC-\ ?_E-1_P ,\?ME
M?])"_$__ (C-\ ?_ )34 ?==?"GAW_E)G\7_ /LQ3]G'_P!7_P#M44?\,\?M
ME?\ 20OQ/_XC-\ ?_E-73_ S]F+QY\-_C1X_^.WQ4_:'\2_';QMXV^%WP^^$
M=HFI_#SX>_#S2/#?A?X?^+?B-XRM9;2S\#Z9:2ZCJ>JZK\2-2CO;G4;F6&&T
MTZPBL[:&1[R:X /L2OA3_@F1_P F!?LI?]DBT#_T9=U]UU^>'@__ ()ZQ_#G
MPUI/@?X<?ME_MK>!? GAN"6P\*^#=#\>_!ZXT;POHQNI[FTT/29]?^!>M:W)
MINFK.;6P_M75]3ODM(X8I[VX:/>0#]#_ //^?U_ST^$5_P""=7[.^I>,X_%O
MQ#N/BQ\:]/TO1/BOX=\'_#WXX?%GQE\4OAKX"T?XW:#>^$/B5:^%?"GBK4+V
M(2Z]X&U76_ ,&H:_=:]J>B>!_$/B/POH5YINE:_J]O>/_P"&*O&/_1^W[=?_
M (6_P(_^AXH_X8J\8_\ 1^W[=?\ X6_P(_\ H>* ,NQ_X)O? =?@QX\_9\\2
M^,?VB/B)\(_'7PWL?A OA/XC?'_XC>+K;P;\.-.GTZ:U\-^"KG4-6^VZ9(J:
M-H=F_B34I]8\7R6&C6EH_B!H9]16^]G^._[(_P $OVC]8^"FO?%'0M5U'5/@
M%X[TWQ[X"N=(\1:OH)FN=.O=%U6;PKXL33+F!/%_P]UO6O"_A'6_$W@771=^
M'?$6J^#_  Q<ZM970TF!*\L_X8J\8_\ 1^W[=?\ X6_P(_\ H>*/^&*O&/\
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M;Y[-[DB:220&7YW=P6,7_"V?A7_T4OX?_P#A9>'/_EE1_P +8^%?_12_A_\
M^%EX<_\ EE0!Z!16%H?BCPSXGCN)?#7B+0O$,5HZ1W<NAZOI^K1VTDJL\<=P
M]A<7"PO(JLR)(59U5BH(!-;M !1110 4444 %%%% !1110 4444 %%%% !11
M2'OCKC@=N] "T4A(')[ GTXX]<#OW_"DW#_)7_XJH<XK=I>LHKOW:["O;O\
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M'PW_ -%$_:%_\2&^+W]?%-?1-%'UW&?]!-3_ , PW_S$/^S\)_SY7_@S$_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI:_&/]H3X/>*O%&J0WOAC6)U\+_#/PSX\\1W5O!;QV.F76HWME83@&[\&O\
M@GM^SY\#/$'PJ\5>#V^(VI>(_@_XQ_:D\>^&-;\9_$'6_%VJZCXK_;%\66WC
M?XXZQXMU+5S-?>*;W7?$=JNH:?=ZM<37>G2S7+FXN);B65L^S_X)M_LL0?#O
MX'_"F^\,>(]>\ ? &+X]V?@SP[KGBS5+RUU/2_VEO"'Q%\"_%O1_%\L9M[G7
M],USPQ\4_&&G6D+S6TNE"\MIK.>.:SA<>L?#7]I"U^*?BV.[\,^&;!_V?M=_
M9S^%G[0O@+]H"X^('A&VMO%UA\2KOQ7<2:%<?"N\N;3XD>$+'P]X2T7P[XKD
M\;^*=)T_PQK"^*9="T^<:SX6\06]M[9X*^(/@+XE:1)X@^'/C?PAX_T"&^FT
MR77/!7B71O%6D1:E;PV]Q<:?)J6A7M_9)?007=K--:-.)XH;FWD>-4FC9@#\
MZM+_ ."1O[+G]B>-]&\>>)?V@/C(_CK]G+P]^RI>:U\5_C-K^OZ]X>^#?@GQ
M'IGC#X>:;X,U#2K?0!X5\5_#[Q=I%CXL\,?$32X8O'A\4P1^)==\1:WKL%MJ
M$'5/_P $P/V?-7NOBMK?CWQ;\=/BGXR^-MO^SC;?$OQU\0?BC=:GXDUV#]E/
MXN:U\:?@S;6,.DZ7HGAKPM8Z%XOUZ]CU#2O"/A[0M)UK2R8[^QDU*[U+5+[]
M&J* "BBB@#X4^'?_ "DO_:\_[,@_X)X?^KT_X*;U]UU\*?#O_E)?^UY_V9!_
MP3P_]7I_P4WK[KH **** "BBB@ HHHH **** "BBB@ HKX&_;"O?BCK7Q?\
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M%O["O_T$5'_#'?QA_P"DD_[=?_@M_85_^@BH ^ZZ*^%/^&._C#_TDG_;K_\
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M_P#ME? #]NC]K/XD^(_&/PJ\!>*-1^.'@?1FD^!'P,^&VBZK?Z=XN^)'Q_\
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M\,>"O!XUH^%_"FC0:G<>'_"?A_3[V]AFO4TRV>X=* /LFBBB@ HHHH ****
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M/#/BWX8?#WP#\=_%?[+?[9WB'XW?M)_LLZ5:Z*/#6C^'].^(GP+63X:&[O/
MG@+X#>*+OQHV@&?P]X&N_$.GZ%^EG[&7P9^(>F_M9_M4?M)7'[-5_P#L8_!_
MXI?"7]FOX5>&O@1K^J_!&Y\7^.?B/\'M2^-.L^-/V@O%'A_]G3QY\4?A5X87
M5?"GQ.^'7P>\..GC_6O'/B'2?A(\WBC3/#V@Z3X'@O\ ]2** "BBB@ HHHH
M^%/AW_RDO_:\_P"S(/\ @GA_ZO3_ (*;U]UU\*_#P$?\%+OVNR00#^P__P $
M\""1C(_X7K_P4W&1ZC((R.X(Z@U]U4 %%%% !1110 4444 %%%% !1110!\*
M?M(?\G>?\$Z/^RF_M$?^LO?$JONNOA3]I#_D[S_@G1_V4W]HC_UE[XE5]UT
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M#?P'K,_AVQ\/>!YK3Q/IP\)#4K76;Z(:4=4L8WFH ^G/B5_P44^"7B'X(?M
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M]ES_ &Q/_6Q/CS7W77PI_P $WO\ DU+2?^RY_MB?^MB?'F@#[KHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \8^-W[/?P@_:,
MT+PUX=^,7A$^*M.\&>+4\=^$9K7Q!XH\)ZUX8\7KX7\4^"6U_0/$O@S6_#WB
M/2+^X\'>-_&'A:]>PU6!+_P_XFUO2+U+BPU&Y@D^>_\ AVQ^Q_\ ]")\0?\
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M4 %%%% !1110 4444 %%%% !1110 4444 ?!7_!*O_E%_P#\$W_^S"OV/O\
MUGKX=U]<_$CXI_#'X.>%YO&_Q>^(W@/X5^"[?4-*TFX\7_$CQ?X?\#^%X-4U
MR_@TO1--FU_Q/J.EZ3%J&L:G<VVG:59O=K<:A?W$%G:1S7$L<;?(W_!*O_E%
M_P#\$W_^S"OV/O\ UGKX=U\Z?\%K? WA7XG_ +,W[/OPR\=:9;ZYX*^)'_!2
M/_@FQX"\7:%='%OK?A?Q;^V1\)="\0Z3-@AFAU#1[Z\MI0O/E.YZ T ?J%\2
M?BM\+_@UX8E\;?%_XD> OA3X,AU'3-(F\7?$GQAX>\#>&(M6UJ[CL-&TR37_
M !1J.EZ4FH:M?3166F6378N;^[ECMK6*69U0]]_G\^E?Q&_MH^*?B+^TE^PA
M\>_V;_CI8ZU=3_\ !&[X#^,?#WQZ\0>)$,6B?$?]J.3QW)\'?V2/&UG/>0VT
M7B.5_P!E;1==_:-U:\2%DT+6_CE\-2]Q+J\;SP?HIJG[47[;7CK]O#XI>!=.
M_:!_9P^"FI_#+]M[P1\*O ?P3^+/[5]_\.?%WCG]F^+4?AS<7DFC?L61_L5>
M.?$/QPG^,/@;7O&^J>#OB_X?_:B\.6EGXKO;>22]\):'\+-:T%@#^AGXA?%G
MX<_"B3P''\0_%>F^%9/B?\1/#WPF\ KJ"W9/B?XC^*[?5+KP[X4L3:6]R%U'
M5;;1M3EMVN1!:JME+YMQ&3&&H_!7XV_"K]HKX:^'OC#\$O&^C_$;X9>*Y=>M
M_#GC+0&N6TK5YO"WB76/!_B%+4W=M:7&=+\3>']9T>Y\R!!]KT^X$>^()(_\
MN_B+]H*;XV_$K]A_Q!\4OVM?$&I_M(S_ /!:F[\&?$7]AR?4? ,^D? +PO\
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MQ/CS7W77PI_P3>_Y-2TG_LN?[8G_ *V)\>: /NNBBB@ HHHH **** "BBB@
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M:"PO=(TR\L5G>Y6RNK"UN+1;F1Y9)+@6\L3PB=Y)YW>4)YC/-*S,3(Y/Q/\
M\*E_X*'?]'K?L[?^(+^)?_HR*/\ A4O_  4._P"CUOV=O_$%_$O_ -&10!]N
MW&F:;=2V<]UI]C<S:<[2:?-<6EO-+8.P16>SDDC9[5V5$#- 4)"("<*,..G:
M>8YXC8V9BNK5+*YC-K 8[BRBCDBCM)TV;9;6.*::-+>0-$D<LB*@5V!^(/\
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MW,\T&EIJ>H_8H#%;-?W;1&XD]XH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/"O_ $,WA_\ \'.G?_)-?*G_  [E_P"">W_1B'[&G_B+_P $?_F'H_X=R_\
M!/;_ *,0_8T_\1?^"/\ \P] 'U7_ ,)9X5_Z&;P__P"#G3O_ ))H_P"$L\*_
M]#-X?_\ !SIW_P DU\J?\.Y?^">W_1B'[&G_ (B_\$?_ )AZ/^'<O_!/;_HQ
M#]C3_P 1?^"/_P P] 'U7_PEGA7_ *&;P_\ ^#G3O_DFC_A+/"O_ $,WA_\
M\'.G?_)-?*G_  [E_P"">W_1B'[&G_B+_P $?_F'H_X=R_\ !/;_ *,0_8T_
M\1?^"/\ \P] 'U7_ ,)9X5_Z&;P__P"#G3O_ ))H_P"$L\*_]#-X?_\ !SIW
M_P DU\J?\.Y?^">W_1B'[&G_ (B_\$?_ )AZ/^'<O_!/;_HQ#]C3_P 1?^"/
M_P P] 'U7_PEGA7_ *&;P_\ ^#G3O_DFC_A+/"O_ $,WA_\ \'.G?_)-?*G_
M  [E_P"">W_1B'[&G_B+_P $?_F'H_X=R_\ !/;_ *,0_8T_\1?^"/\ \P]
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M (B_\$?_ )AZ/^'<O_!/;_HQ#]C3_P 1?^"/_P P] 'U7_PEGA7_ *&;P_\
M^#G3O_DFC_A+/"O_ $,WA_\ \'.G?_)-?*G_  [E_P"">W_1B'[&G_B+_P $
M?_F'H_X=R_\ !/;_ *,0_8T_\1?^"/\ \P] 'U7_ ,)9X5_Z&;P__P"#G3O_
M ))H_P"$L\*_]#-X?_\ !SIW_P DU\J?\.Y?^">W_1B'[&G_ (B_\$?_ )AZ
M/^'<O_!/;_HQ#]C3_P 1?^"/_P P] 'U7_PEGA7_ *&;P_\ ^#G3O_DFC_A+
M/"O_ $,WA_\ \'.G?_)-?*G_  [E_P"">W_1B'[&G_B+_P $?_F'H_X=R_\
M!/;_ *,0_8T_\1?^"/\ \P] 'U7_ ,)9X5_Z&;P__P"#G3O_ ))H_P"$L\*_
M]#-X?_\ !SIW_P DU\J?\.Y?^">W_1B'[&G_ (B_\$?_ )AZ/^'<O_!/;_HQ
M#]C3_P 1?^"/_P P] 'U7_PEGA7_ *&;P_\ ^#G3O_DFC_A+/"O_ $,WA_\
M\'.G?_)-?*G_  [E_P"">W_1B'[&G_B+_P $?_F'H_X=R_\ !/;_ *,0_8T_
M\1?^"/\ \P] 'U7_ ,)9X5_Z&;P__P"#G3O_ ))H_P"$L\*_]#-X?_\ !SIW
M_P DU\J?\.Y?^">W_1B'[&G_ (B_\$?_ )AZ/^'<O_!/;_HQ#]C3_P 1?^"/
M_P P] 'U7_PEGA7_ *&;P_\ ^#G3O_DFC_A+/"O_ $,WA_\ \'.G?_)-?*G_
M  [E_P"">W_1B'[&G_B+_P $?_F'H_X=R_\ !/;_ *,0_8T_\1?^"/\ \P]
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M (B_\$?_ )AZ/^'<O_!/;_HQ#]C3_P 1?^"/_P P] 'U7_PEGA7_ *&;P_\
M^#G3O_DFC_A+/"O_ $,WA_\ \'.G?_)-?*G_  [E_P"">W_1B'[&G_B+_P $
M?_F'H_X=R_\ !/;_ *,0_8T_\1?^"/\ \P] 'U7_ ,)9X5_Z&;P__P"#G3O_
M ))H_P"$L\*_]#-X?_\ !SIW_P DU\J?\.Y?^">W_1B'[&G_ (B_\$?_ )AZ
M/^'<O_!/;_HQ#]C3_P 1?^"/_P P] 'U7_PEGA7_ *&;P_\ ^#G3O_DFC_A+
M/"O_ $,WA_\ \'.G?_)-?*G_  [E_P"">W_1B'[&G_B+_P $?_F'H_X=R_\
M!/;_ *,0_8T_\1?^"/\ \P] 'U7_ ,)9X5_Z&;P__P"#G3O_ ))H_P"$L\*_
M]#-X?_\ !SIW_P DU\J?\.Y?^">W_1B'[&G_ (B_\$?_ )AZ/^'<O_!/;_HQ
M#]C3_P 1?^"/_P P] 'U7_PEGA7_ *&;P_\ ^#G3O_DFC_A+/"O_ $,WA_\
M\'.G?_)-?*G_  [E_P"">W_1B'[&G_B+_P $?_F'H_X=R_\ !/;_ *,0_8T_
M\1?^"/\ \P] 'U7_ ,)9X5_Z&;P__P"#G3O_ ))H_P"$L\*_]#-X?_\ !SIW
M_P DU\J?\.Y?^">W_1B'[&G_ (B_\$?_ )AZ/^'<O_!/;_HQ#]C3_P 1?^"/
M_P P] 'U7_PEGA7_ *&;P_\ ^#G3O_DFC_A+/"O_ $,WA_\ \'.G?_)-?*G_
M  [E_P"">W_1B'[&G_B+_P $?_F'H_X=R_\ !/;_ *,0_8T_\1?^"/\ \P]
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M (B_\$?_ )AZ/^'<O_!/;_HQ#]C3_P 1?^"/_P P] 'U7_PEGA7_ *&;P_\
M^#G3O_DFC_A+/"O_ $,WA_\ \'.G?_)-?*G_  [E_P"">W_1B'[&G_B+_P $
M?_F'H_X=R_\ !/;_ *,0_8T_\1?^"/\ \P] 'U7_ ,)9X5_Z&;P__P"#G3O_
M ))H_P"$L\*_]#-X?_\ !SIW_P DU\J?\.Y?^">W_1B'[&G_ (B_\$?_ )AZ
M/^'<O_!/;_HQ#]C3_P 1?^"/_P P] 'U7_PEGA7_ *&;P_\ ^#G3O_DFC_A+
M/"O_ $,WA_\ \'.G?_)-?*G_  [E_P"">W_1B'[&G_B+_P $?_F'H_X=R_\
M!/;_ *,0_8T_\1?^"/\ \P] 'U7_ ,)9X5_Z&;P__P"#G3O_ ))H_P"$L\*_
M]#-X?_\ !SIW_P DU\J?\.Y?^">W_1B'[&G_ (B_\$?_ )AZ/^'<O_!/;_HQ
M#]C3_P 1?^"/_P P] 'U7_PEGA7_ *&;P_\ ^#G3O_DFC_A+/"O_ $,WA_\
M\'.G?_)-?*G_  [E_P"">W_1B'[&G_B+_P $?_F'H_X=R_\ !/;_ *,0_8T_
M\1?^"/\ \P] 'U7_ ,)9X5_Z&;P__P"#G3O_ ))H_P"$L\*_]#-X?_\ !SIW
M_P DU\J?\.Y?^">W_1B'[&G_ (B_\$?_ )AZ/^'<O_!/;_HQ#]C3_P 1?^"/
M_P P] 'U7_PEGA7_ *&;P_\ ^#G3O_DFC_A+/"O_ $,WA_\ \'.G?_)-?*G_
M  [E_P"">W_1B'[&G_B+_P $?_F'H_X=R_\ !/;_ *,0_8T_\1?^"/\ \P]
M'U7_ ,)9X5_Z&;P__P"#G3O_ ))H_P"$L\*_]#-X?_\ !SIW_P DU\J?\.Y?
M^">W_1B'[&G_ (B_\$?_ )AZ/^'<O_!/;_HQ#]C3_P 1?^"/_P P] 'UC!XD
M\.W4T5O:Z_HMS/,VR&"#5;&::5ST2**.=GD8\X5%)XZ5M5^-_P"W#^Q7^QQ\
M)?A3\)/B%\*OV3/V9OAEX]\/_M[_ /!+?^P?&_P^^ _PL\&>+]$_M7_@IA^R
M7HFJ?V1XE\.>%=-UK3?[2T;4]1TB_P#L=[#]LTR_O;"X\RUNYXI/V0H ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJWC_ .(_B>'1+"#3X]<\<^-]=EFUGQ9XIU-8!=ZWX@U262^U2_EGN[EC)*U
M'=T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1_*FBCF3=LDC1PR@ NT444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% 'P1_P4C_ .3>?AW_ -G[_P#!*C_UZ'^Q[7WO7P1_
MP4C_ .3>?AW_ -G[_P#!*C_UZ'^Q[7WO0 4444 %%%% !1110 4444 %%%%
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M+\T5_:[_ &KO OP?^ OC;4_CM\4M7\,?MCW_ .UO_P $Z_V7?B+XKT?3TO\
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M/B'?6D_A7P7I6D^#&.A>%]1MM"MM5T^ZOM1Y[]HS]L[Q=X=\;_\ !3S3[_\
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MXL^(O#'@?1=1^(?AOXC>*?@EKG[0MK\/?B7\"_CS\(?%UE\*O#'C2S^'>O\
MB35-#^+GPQ\":KI/V7QC?6NG:9H^LV.F^(_$FF7%OXI\.Z+J?A:XBUA@#ZOH
MKX/US_@I;^QSX?\  /PH^*MUX_\ '^H_##XS?#7P+\8_"GQ%\+?LY_M+>-?
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M@ HHHH **** "N-^(O\ R3[QW_V)OB?_ -,E]795QOQ%_P"2?>._^Q-\3_\
MIDOJ /GC_@G]_P F&_L2_P#9HW[-W_JF_!E?7-?(W_!/[_DPW]B7_LT;]F[_
M -4WX,KV#XR:/\<];\)167[/GQ&^$_PP\=C5;2:;Q'\9?@OXP^.WA.30HXKE
M;_3H_!7@GX]?LZ:Q%JUS.]G)::TWCZ:SLHH+F&;0;][N*>R /6:*^ /^%<_\
M%3?^CR/V /\ Q6G^T5_]-BH_X5S_ ,%3?^CR/V /_%:?[17_ --BH ^_Z*^
M/^%<_P#!4W_H\C]@#_Q6G^T5_P#38J/^%<_\%3?^CR/V /\ Q6G^T5_]-BH
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M?C^=?AX ?OA1_6OQ:_9@N_VD_$?_  4V^-J>*_VR;[XH?"O0/V.?V*/B!/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'P
M1_P4C_Y-Y^'?_9^__!*C_P!>A_L>U][U\$?\%(_^3>?AW_V?O_P2H_\ 7H?[
M'M?>] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$WCK_A&=5M/A]\1O%5_'!:7'Z-4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'P1_P %(_\ DWGX=_\
M9^__  2H_P#7H?['M?>]?!'_  4C_P"3>?AW_P!G[_\ !*C_ ->A_L>U][T
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M%7@SPCX;^%/@CQO9WGB#P];^/?BEXW?PU?VVM?NY110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?!'
M_!2/_DWGX=_]G[_\$J/_ %Z'^Q[7WO7P1_P4C_Y-Y^'?_9^__!*C_P!>A_L>
MU][T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %<;\1?^2?>._P#L3?$__IDOJ[*L_5M,M=:T
MK4]'O@YLM6T^]TR[$3^7(;6_MI+6X$<@!*.8I7"/@[6PV#B@#Y6_X)_?\F&_
ML2_]FC?LW?\ JF_!E?7-?G5X#_8%\;_#+P-X*^&O@?\ X*'_ +<^A>"?AWX0
M\,^ _!VB1P?L37J:/X4\'Z)8^'?#NEB^U/\ 8NO=3OSI^CZ;9VC7^IWM[J5Z
MT1NM0O+N\FFN).K_ .&//B__ -))/VZO_!?^PS_]!+0!]U45\*_\,>?%_P#Z
M22?MU?\ @O\ V&?_ *"6C_ACSXO_ /223]NK_P %_P"PS_\ 02T ?=5%?"O_
M  QY\7_^DDG[=7_@O_89_P#H):/^&//B_P#]))/VZO\ P7_L,_\ T$M 'W51
M7PK_ ,,>?%__ *22?MU?^"_]AG_Z"6C_ (8\^+__ $DD_;J_\%_[#/\ ]!+0
M!]U45\*_\,>?%_\ Z22?MU?^"_\ 89_^@EH_X8\^+_\ TDD_;J_\%_[#/_T$
MM 'W517PK_PQY\7_ /I))^W5_P""_P#89_\ H):/^&//B_\ ]))/VZO_  7_
M +#/_P!!+0!]U45\*_\ #'GQ?_Z22?MU?^"_]AG_ .@EH_X8\^+_ /TDD_;J
M_P#!?^PS_P#02T ?=5%?"O\ PQY\7_\ I))^W5_X+_V&?_H):/\ ACSXO_\
M223]NK_P7_L,_P#T$M 'W517PK_PQY\7_P#I))^W5_X+_P!AG_Z"6C_ACSXO
M_P#223]NK_P7_L,__02T ?=5%?"O_#'GQ?\ ^DDG[=7_ (+_ -AG_P"@EH_X
M8\^+_P#TDD_;J_\ !?\ L,__ $$M 'W517PK_P ,>?%__I))^W5_X+_V&?\
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M &&?_H):/^&//B__ -))/VZO_!?^PS_]!+0!]U45\*_\,>?%_P#Z22?MU?\
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MH]]J-A=_H!0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
-110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ex3-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex3-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  F 0X# 2(  A$! Q$!_\0
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M'8_%7A:^TAV"O,F8G/\ !(.5/YC\LU:]R1#]^#*_P]FCG^'N@O%C9]BC7CU
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MWY\2ZXNIB0)Y $K/Y>,[OO*.N1^52_$OPO>^+_"R:98S013"Y27=.2%P P[
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ex8-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex8-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  _ L@# 2(  A$! Q$!_\0
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M]V45_#[_ ,$Q]1_X+Z_\%0/V:_$/[2/PX_X*O^%_A7I>C_$KQ5\+[3PEXV^
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M_P#P5:BLOB-\=?\ @E\__!:N6?\ 8;UB?]FW]KN7XFV?[%\DWCBS\(^(-/\
MB3HEO\*=/\/W^FQ_$&>QL_%^B-!>>*5TH>*H+?4KE=&EOK"QU:_NM'_OIK^
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MWNN^"O%_A[Q=K,_ACXA>&$N"?*U[P/XC-G=H0\4-P&N= U1FT_5;VUF^\?\
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M_P '/GPR\-?%C_@G[\)O!OB&VLT;Q'^W)^RQX+L?$$NDV6JZCX7C^(?BO4O
MNL:OI,-X%5KE-'U^\62T\^"+4(_]$N9%B<LOYE?\%8?^"9O@O_@C]:?LN?\
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MK**Z@U'7M,_9>EUR_AN$@$L5YK,KR2:I<QNLU^\DC7+R%VS_ %C5_'?^S_\
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MZIXJ_8L^(=C\/O&_P[^'/C>7PI'%XW^(GQ&>^?Q'\(?"=SX>\,ZAXLT72/$
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MPIXWGT"6=XI9WT.Z\0Z7?W6D-/+!;RS_ -GS6WG2V\$DFYX(F3\]_P#AG/\
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MMKTW]_<_;+=(H;GS8XHE3Z'K\@/^&<_^"T?_ $DV_94_\5W7?_T4='_#.?\
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M<_\ @M'_ -)-OV5/_%=UW_\ 11T!9?S1_P#)O_D3]?Z*_(#_ (9S_P""T?\
MTDV_94_\5W7?_P!%'1_PSG_P6C_Z2;?LJ?\ BNZ[_P#HHZ LOYH_^3?_ ")^
MHOQ%^&_A'XK>&CX0\<66H:CH#:SX=\0-::;X@\0^&IVU;PGKNG^)O#UT=2\,
M:KH^J%=,U_2M-U6.V^V_9+BYLH%O(+B -$W!_$W]F/X ?&:Z\67_ ,4/A1X0
M\::CXZ^%EU\$_%VIZOI['5-?^%EUKT?BE/!U_J5M+;WSZ?IOB>,>(_#]PEQ'
MJ/AK7I+C6/#U[I>HW5S<2_GM_P ,Y_\ !:/_ *2;?LJ?^*[KO_Z*.C_AG/\
MX+1_])-OV5/_ !7==_\ T4= 6_O+_P F_P#D3]"M)_9H^"6D^$/"G@=_!$7B
M+0?!7CKPS\3_  [)X[UWQ/\ $7Q%;?$;P9>VVH>%/'%[XQ\>:UXC\7ZSXI\/
MW5G9MI.M:UKFH7ME#:6MI!*EI;0P1^B> ?A[X(^%OABU\%_#KPOH_@WPG8ZC
MXAU:S\/Z#9QV&EVVI>*_$6J^+?$=Y#:Q?)'-K/B77-7UJ^90!+?ZA<S8!D('
MY8_\,Y_\%H_^DFW[*G_BNZ[_ /HHZ/\ AG/_ (+1_P#23;]E3_Q7==__ $4=
M 6_O+_R;_(_0>[_9D^!VH^-_B[\0]5\"6NM>)_CWX!T?X6?&)]=U;Q!KFA_$
M#X=^'[?Q'::'X0U[PEJVJWGA-]&TNU\8>++>UM[71+9O)\2:VDLDJZE="3F[
M?]CK]GB!?#!;P->WMYX-\4?#GQAX=UG4_&WCW5/$-EK7P@M-8T_X6"?Q%?\
MB>XUO5M(\ 6/B'7;?PYX=UF_U#P_;-K6KW<^F7-_JFH7=S\.?\,Y_P#!:/\
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M,?#!\5-X9^(-]\/=(NIM+\$^(_'FD>)/$WABP$-MH^L6D=K:B'XP_P"&<_\
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M?![Q'\(?#'PQ^&_Q$@^*&@>'9_A7I7PJ^(7CGQ-XITB\^!>O:AXB\:^(]/\
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MX=Z<=6\065KXXOM.^&/QZTN_\ IK>J^&KCQA\1?!=YH-QJ5E9^--)LO#^_\
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M?C:7QL/$?F'PE]E'C,W$\VEFY%J-"^P.)/["-\BW0!^[Y_U;\]3W7X@?MT?
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<=PZG=:C,NL2:C/;7$%I<Q65L4$NW3^OZ=S__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ex8-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex8-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  = 2<# 2(  A$! Q$!_\0
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M3+H:/XO\'W]^\>M>$]<M=.OX[FPO;$RQW(MUN/B>\_X+N^)?A1\.?@?^T/\
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M%X531=3MY_%&CVDO[I?M-?\ !,OX0>"_^"3WC3_@FQ^S'=Z?\"OAMXVT;2?
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MGGLY7\"O<6]Q/!<0S2_FIX7_ .":6N?MM? O]M_XX_LX^(C\)O\ @H!^R?\
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';^2LO1'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ex23-3_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-3_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !& BH# 2(  A$! Q$!_\0
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M*<_BP'XTRR\4Z%J*QM9ZI;SB21HD*-]YU7<5'N%YKR.^E&HZPVMV(:2UGNE
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M>&WC!B9%P00O/7G//Y"H+OQC=VVA0ZA]EB=Y=X50W!Q@ ]<\$_\ ZJ .M-K
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M>[=Y:;AWP,T"&-1\L:#G/ QSZUDV?B2UO;Z.T6.5)';:-Y7&<,>QYX4]*VJ
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M#NX'7V-=<L:QK)\S ,2Q)8\?0]A0!S3W6A1,XDT@QR;C$_[M<[SE57(/);!
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MC"@, J#L .PKNJ*32>IM1Q%6B[TY6/./^%,Z!_S\W?\ WT*/^%,Z!_S\W?\
MWT*]'HHL=']IXS_GX_Z^1YQ_PIG0/^?F[_[Z%'_"F= _Y^;O_OH5Z/118?\
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M3LZ5;H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *,444 &**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
%** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ex23-3_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-3_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  6 9D# 2(  A$! Q$!_\0
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MM6\1^%(=7T]%M;N/3?M-H%@(9.3^,&OZ/+^UW\!?#_Q*U'1='\%Z'\-_B?\
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M$KC4]3U+XMZI\)]'L9VTCP1JVJ>&[?0%30[35[SQ'XBUZ1N8^+W[!?QN\?\
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M+J:4TDW96T_4D"A %'10%'T' _E3)88YQME!(QCC\O;M1169J1"W50%4X50
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'D*6BB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  Q 0P# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_C^?./\
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M%?M6>'-4OO!7@3XA>)-&M/"&L>-_%GAZ%FO?A?\ %#0K>&UTC3?B9+9PM?\
MA/Q+HT-KH/Q&LU6&&W37KC2[OQ7-7)Z4\/5Q>5XZ&84L.N?$X=T98;&T*=[>
MV="5U4I+>4J3;BM9);&E'/*U+%4,%F^ GEM7%2Y,+B(UHXG UZEOX7UB"2HU
MF]H5K*5GRR:V_K+IH8GM]>1P/\]J 2!G'4YQTP#Z\?GGUYQS7^8)^W#^U'^T
MU^RG_P %P_VQ_P!H+]GKQ'XPD\1_ WX_^(O&6IZ.MYXAU?P5+\/DL/"6D>*=
M&\=Z#;7+62?#[7(M:M?#^N7,D,":5/JNG:C8W=AJMIIMY!ED^4U,XJXJC2K4
MZ,\/AI8B/M%>-2:FJ<:3G=*'/)V4W=*ZTU-L[SREDE+"UZU"I6IXC%0P\O9N
MTZ<91<Y55!QDZG)%-N"LVE*SNC_3]HKXB_X)]?MW?!S_ (*)_LT^#/VB?@_=
M_9HM3C_L3X@>!+ZYAG\1_"_XC:=;VS>(_ WB)8PI:6PEN([O1]5$,-MXB\.W
MNE:_911VVH)%']N9R 0>/?T[_0C_ /7[>;5I5:%6I1K4Y4JM*<J=2G--2C.+
MLTT_SV:::;33/7HUZ.)I4J]"I&K1K0C4I5(.\9PDKQ::ONKW3LTTTU=-"%E]
M1G..3CD<^H_KGT/2F^8N,DX'&6) 7GW)&/;(!]L\#^)G_@ZDUS7='_:T_P""
M8,.CZ]KVD0W=]XP%Y#I.L:IID-X!\6/@RJ_:X;&Y@BN JR21J9D<JKNH(#$'
M^TGQ1X7T'QIX9U_PAXITR#6_#7BK0]4\.>(-'NPYM=4T36K"?3=5TZY\MXY/
M)O+*YG@E,<D<FV0M&ZR!6'5B<']6PF6XMU.=9A"O4Y%"SI*A7]BU>4DJCDDY
MJRBKKE5]UPX7,OK6,S3!QHN$LMJ4:?/*=XUI5J"KQ:2A>"5U%OW^KZ6.@SZC
M'.!SG/\ @../U -+7\"N@^,/B[_P;>?\%9Y?"'Q"\5_$#QO_ ,$\_P!J!D&F
M:SXEUW6_%*V?PQEU=H=*\1";4)[S?\2/V<-9U?\ LSQA#;*M_P"*OAUJ3:H+
M07?B32!8_P!Z^C:OI7B'2-+U[0=3L-9T/6]-LM7T?6-*NX+_ $S5M*U*UBO-
M.U+3KZU>2WO+&^LYH;JTNK>1X+BWEBEAD>-E8Z9CETL"L+5IU8XK"8VA&OAL
M3"+A&>EJM&<6Y.G6HSO&I3D[[25XM,G+,TCF#Q5*="6%QF!Q$L/BL+.:G*'V
MJ5:$N6'M*%>#4Z=115U=.TDT:1(')I"R@9) !.,DX'TYZY_QY%?,?[8W[67P
MI_8B_9R^)W[2_P 8]4%GX.^&^A/?1Z7!/ FL^+_$MXXL?"O@;PU#,<77B+Q;
MKD]GH^FQ;6BMVN7U&]:#3;&\N8/Y2/\ @AO^SA\??^"EW[7WQ+_X+(?MF:IX
ME?P5:^/M3?\ 9\^'(U_7H/!&K>.=$_XD]C?Z+H+WD=E=?#;X#Z1!!X4\)M):
MR1>(_B%#J&O7LT^J>&-1.H+#9>ZV#QF/K55A\+A5&$9N#G+$8J=W3PM&*<;R
M<4Y3FWRTXZN[T#%YHJ&-P>7T:+Q.+Q7-4G!34(X;"0TGBJ\K2M#F:A3A92JS
MNHV2;/[4\@<]"?<<GKC)ZCWZ#H.>BY'<@>Q(S_.OR0_X+NWEYI__  2-_;AO
M-/O+S3KNW^%>G/!>:?=W%E>6Y/CSPDOF6]W:R17$+%6()CE4E"R'*LRM_(Y_
MP2?_ ."$^J?\%,/V3+?]IG5?VY?B]\';VX^)'COP ?!NE>&;[QE9I'X+N;&V
MBU4:U?\ Q+T"<RZB+PO):G3REN4"K+("V.C!99A\1@*N88O'K!4:6*AA;+"U
M<4Y5)TO:Q:]E)-*R:O9K2_4Y,?G&*PV8T<MP>7/'5JN%GBVWB:>%C"G"HJ;5
MZL9*4KM.R:?D?Z*6X>H'U(_H306'J#^(_7G^6:_C;_XA(7Y)_P""G'QQ/K_Q
M:S'X\_&@?J?SI/\ B$@<$'_AYS\<<GH#\+3U_P##SXR,@C!ZCL.M?4LCZ9^W
MO;_A)QBN^BUGU_ID_P!I9]?_ ))Z/K_:V$_^0_X'F?V2%@!GTZXR1^>.>H]A
MW(J%[JWC;;+/!&^ =CS(C;6/#;68'![$CGD8'2OD_P#86_99/[%?[)WP8_9?
M/Q'UCXM?\*BT'5=$;XB>(-,_L75_$YU3Q/KGB4W=[I7]K:]]BDMCK7]GQQ'6
M+XF&UC<RKN\I/XN/^"Z/P>D_:5_X. OV=OV:KSQUXI\!Z%\</ ?[-7PWU+Q'
MX:NYGO\ P_;^)_%/Q$L;C5]/TR6[M]-NKVW7#*ETOER;1YF0H%<^6Y=3S'&5
ML/\ 6O8T:%#%8EXE493YJ.&BIN:HWC-<\'S<M^:-N5JYT9IFM;+<%0Q/U15J
M]>OA<,L-[>--1K8J4H*+K<LXM0DK.7(DT[JUF?W[?;;/_G[MO^_\7_Q=21SQ
M2Y\J6.7:<'RY$?&?NY*L<9P>O\@37\?A_P"#17X5?]) ?VD\<Y_XI3PF>_.3
M_:VT$GTR >,#!(YWQ/\ \&H_C;P-IT_B7]F3_@IA\:?"/Q.TM?M.AW/BW1=5
MT'2Y[VWP\"3^)_AOXXTCQ#H,9=54:A;Z;KDEODR#3[C;Y3="P622LH9[)-V2
ME5RO%1@F^LY1G)Q2TYFHR:OL[,YWF6?03E+A^$XJ[:HYMAI5&D_L1G1A%R=G
M9.<;Z*^J9_92"#G'X^H/O2U_''_P2C_X*F?MP_L[?MWR?\$DO^"I>HW?C#QO
M?:G)X3^%/Q<UZ[@U;Q5:>*IM&E\3^$-+U?QE;6MK_P ++\ ?%#04,G@?QEJU
ML/%VGZY-8:%K]Q=&[FMO#G]6G[0_QS\#?LR? OXL_M!?$R\EL_ ?P<\!>)/'
MWB>6UC66^GT[PYILU^=-TR!FC2XU;5YXH-+TJV:2-)]2O+:%I(U?<O%CLNQ.
M!Q-/#34*KKPIU,+5H2]I2Q-*LU&E4I25G:4FHN,DIQDG&233.[+\VPV886IB
MH*IA_J\ZM+%4<1'V=;"U:";JTZL=5[L4Y*46XRC:2=FCV8'EACH?7.<_GCZ?
MRK)B\0:%/>&P@UG29K]6*&RCU&TDO P(#+]F25IMPR/EV!N<8YY_@D^"T7_!
M5K_@Y0^)GQ+\7WW[0NK?L@_L/> O$R>')O#?@J_\06_A:SN[F-=3LO NF^'_
M  SJ?A;4OC1\0[#P]J%CJOB_Q/XZ\0V'AG1WU&S&E6-A#?6/A]/N6Y_X-"?@
M[#8"XT']O+]H;3/&"(LB>(+GP7X.N[$7H&[[1_9MAJ6CZN$,F&*)XF%P.]T6
M^<^C4RC X-^QS+.*=#&)1=7#8;"5L7]7<DI*%:K&<*:J)-<T8.7*[W=U9^93
MSS,<='ZQE632Q&!<I*GB<5C*.#>)C%N/M,/2E3JS=.4HR4)5/9\ZLTK.Z_L+
MW<].0.<8[=N_ Y/'(].M.ZXP3^G^!_3BOX_/V6?V#?\ @MY_P31_;"_9N\-:
M9^U!XH_:R_8/\9_%C0/"'Q8BAUC5?%\?@CP1K)O(;G4_$'PU^)MQX@\1_#NW
MMY+>TE?Q7\,O%.K:3IA:/^WY;2SE:"3^P+!XP<#'8 _CV_E7F8W"TL+4IJCC
M,/CJ56FZD*N']I&R4N5PJTZD8SI54[-P=]&FFTSU\OQU7&4ZCKX+$8"M1J>S
MJ4<0X2NW%24Z52DY1JTI7M&:M=III/0_S_-3\.6W_!6/_@YV\3>!OBHJ^)?@
MG^SMX]\3Z&?"EWOO=$N/AS^R?;/"GAI[29S$^C>.OC9.^H^);8@17^G^(-2M
M9$='4+_H JB(J+&H1%"*J( %15&%4*  J@8&   ,<"OX$?\ @FWJ=K^S+_P=
M!_M.?#CQ[*NE7/Q0^(W[7'@;P[<ZF3;"ZO?B'J]K\</ OEM-@-)XE\.Z3;Q:
M: 1]LGO[6&$O),BG^_ '(![8'/X\^GY]/PKV.)KQK97AX:86EDV!EADOA?M8
M<]::Z-RJN7.UL_=>R/!X3M.CF^)J6^MUL[S".);=YI4JOLZ$)-KF2A147&.V
MMTM1W]1Z_P OSZU4O;*TU"TNK&^M;>]LKV":UO+.[ACN+6[M;B)X;BVN;>57
MAGM[B%WAGAE1HY8I'1U96(-K/_UCV.<]_8?3G SWI,A1V!]A_G\,]Z^9T6M[
M;.^O2S3NFK;*UMG:VI]8TNMFM=+73NFG=6:LTVGW3:=]C^6#]B/_ ((?_M0?
M\$__ /@K#XT_:C^ GCOX*:?^Q-XXU;XB:%J7PI;Q-XYM/B'9_"/QW8?\)'I'
MA.+0D\#S^%KFX^'?Q)MM'?PQY_BLAO#.CJ&O+>ZOKFU/V#_P<=_M->)?V:O^
M"7'Q:_X0S4I]&\5_'GQ-X5_9VT_5K.>6VO\ 3M%^((U6_P#'DMK)$\<L<E]\
M/?#?BK11.A#6[:L)D99DB(_3?1OVX?V0?$/QWN_V7]!_:0^#^M?M$6&JZOH5
M]\&=*\;Z+?\ Q%LM9\/:3/KFNZ;=>&K:XEU&"\T;2+6YU#5(985>QMX)VNEB
M,3"OP\_X.NOAWK'B_P#X)E:#XMTNVN;JT^%7[2GPO\4^(_(1WCL] \0:-XS^
M'PU"YV#"11:_XPT"V#N%13=@%D.,_18.O6S'/,G>:12O/!T>:5'V3KT:;?L)
MU+J/M7+EA!5I+WXI)M[OY?'X?#Y9P_G:RF3?[O&U53A6]K&A6JQBZ].ERR?L
M%%2G-THM.#<G97T]D_X-LOV/?"'[-G_!-KX9?%2+1[2/XI?M86X^-'CWQ UL
MBZC+X;N[B\L?A;X5BN3F4:'X?\%)9ZI;60*Q1Z[XE\0W@4-?$G^@;H._3' Y
MYZX]/SP,#'2OR?\ ^"&_Q9\/?&'_ ()3?L5ZYX?O+6Y?PI\'='^%GB.VMY4>
M72O%?PJGN? 6N:?>1HQ-O<-<:$M_'%*%D>ROK2Y ,-Q&[_K!SD=..Y'./RQW
M]?7CL/,S2=6IF6/EB')U7C,0I*=TX\M248QY7;E48*,4EHNFZ/6R>E0HY3EU
M/#\JHK!8>47!II\U*,Y2NK\TI3E-R>K;U;;3%)&.3QWZ=^/T_IWK^*#_ (.Q
M/V6+3X?WW[,?_!1KX4++X.^*FE_$+2?A'XW\4Z$%L=0O-<T2PU#Q_P# [QI+
M/;I'(WB+PA?^$?$&C0:K(\MW-ID^@V#N+70[2.+^U_''H>.1UX]>!^6*_D\_
MX.Z?BUX:\-_L,? GX0W-S$WBOXD_M(:7XOTNQ,B"X7PU\*_ GB^7Q)JGE'+^
M1;ZEXQ\,6#S ;1+J<<>#N)7NX9E4AGF C3U56I*A7C>T9X:M"<:\*BU3I\BN
M[Z72>C2//XJA2ED&8SJ63HTE6HS2O*&)I5*<J$H/1JHIOECROF=VM4[']%G[
M&?QU'[3O[)?[-_[0A2*&Z^,GP5^''Q!U2WMT$4%IKGB3PMIE_K]G;H"P6"TU
MJ74+:'&/W<2Y"'*C^/;]C7PGX9^('_!T9_P4%\!^-M"TWQ3X,\:^$OVH?"?B
MWPQK5K'?:-XB\-:[X>^%VGZSHFK6,X:&\T[4K*>6VNK:56CDC<@KP"/ZH?\
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M _XUT_!_KS^UKX*SCK_R2OXO@_H/KUYK^J48QQWYSZ_7Z]Z_.[_@I7_P3?\
MA/\ \%//@AX9^!/QA\;?$;P%X;\+_$C2_B99ZM\,KCPU;ZY<:OI/A[Q-X;@L
M;M_%/A[Q)IYTV2T\4WUQ*L5C'=&Y@M62Y6-98I>'*,51P.:8#%UW)4:&(C4J
M.,'4DHQC4O:*UD[R5DCT\]PE?'Y1F&$PT8RKXC#RITHRE&$7)RINSG+2*M%Z
MO38[3_@F?_RCL_87_P"S2?V>_P#U5GA?\?KV_6OM[V/?/Y?Y->1_ 3X/Z%^S
MY\$OA%\"?"^IZOK/AKX._#;P7\,= U;7VLY-<U/2/ _A[3_#>G7VL/86EC8M
MJ5U9Z=%/>M9V5G:M</(8+:&+;&OKG^?>N*O-5*]:I'X:E:K4C>][3JU)Q;6Z
MTDM&]-NAW86,J>'H4Y?'3H4:<TG=*4*5.,K.VJO%Z[/=:-'Y#_\ !>C(_P""
M0G[<IST^%&G8Q[>//"&#_+OW)["OSM_X-@OB[\*/ W_!+O3=$\9?$[X>>$]9
M_P"&@_C7='2/$WC;PUH.J+:SZCHHM[HV.J:I:78@GV.T4C0JDJC=&S+@G]\?
MVQ?V8/"'[:'[-'Q>_9>\?Z_XF\+^#?C%X;@\-Z]K_@V72H?%&F6<&KZ9K2W&
MCR:UINKZ4ER;G2X8F-]IMW$89)0(@Y5U_G)D_P"#0;]@^9BTW[1'[5TK%0"T
MNI_!J1R%X W'X5,<8Z X &>^,>WE]?+9Y/B,MQV*KX6<\QI8N-2CA98F\*=!
MT^5I-)7D^][+L?/9CA\TIYWA\TP&#H8RG'+ZN#G"MC(85QE.O&:DN9-R7*M&
MM+NQ_3*/VCOV?> ?CK\&B.^/B;X)'X8.NXP.G4].AYPO_#1O[/F3_P 7U^#>
MWC_FIW@DC.> !_;G&1R2>X)Q7\RH_P"#0#]@HX_XR#_:K /0F_\ @SCCV_X5
M1G].*3_B$!_8*!X_:#_:K[_\Q#X,9^G_ "2G..>>1CCMTGZEP]_T.L;IU_LF
M7XVJ??;_ #+^O<27?_"%@]+6_P"%BGUZ[=KZ>7HS^KG0?$.@>*=)L?$/AG6]
M)\0Z%J41FT[6M"U&SU?2=0A61X3+8ZCI\UQ9740EBEB:2WF=!+&\9(=&"_Q"
M?\%-O^5IC]@/IG[?^R%CTS_PFWQ$Z>W]*_KS_8Q_95\$_L2?LQ?"/]ECX<:Y
MXF\3>"O@]H5_X?T#7O&#Z1)XFU*VU#Q!JWB.:?5GT'3-%TDSB]UFYB0V6EV<
M8@BA#(T@>23XN^/G_!'CX#_M"?\ !0OX,_\ !1OQ/\2_B[HWQ7^"DOPSF\.^
M"-!O/!T?PZU0_"W5M:UC1?[9M]0\):AXD<:A<:W<Q:F;+Q!9EX(H1:?97\QY
M,<JQ6&P.+QLZE2<J-3 9AA*,U2;E.=:"A0<X1UI\]KSNVJ;=F[7-<YPF,S#!
MX&-.G!5J68Y;BZT/:Q484Z-652LHU):3<5;E25Y]//\ 7/ (_E[?GGD=\]Z_
M/#_@IS_P3O\ A7_P4J_9>\4_ ;Q\MIHGBZT,WBCX-?$TV276J?#'XEVEI/#I
M.MPA0MQ=^'M52630_&>@AQ#KGAV\NHE\G4K72]0L/T/ X[CG.,Y_#)'3^?KB
ME_E_G_)KR\/5JX:K2KT9NG6HSA4ISCHXSC9I[V=VFG%W33<6FG8]K$8>EBJ-
M;#UX1JT:\)4ZE.:3C*,DUJFG9J]TUK&23331_&Y_P0E_X*-_%;]E?XTZS_P1
M:_X*$BX\(?$SX9>([KP1^SGXJ\2W[S0>?"GVO3_@M)KUT5CUCPWX@TJ2W\1_
ML^^) YM]:T&^C\&6TNY?".FM_6K\9/%VM^ OA!\5O'/ANTMK_P 1>"_AMXZ\
M5Z!87=M=7MK>ZSX<\,ZIJ^EV5U:64D-[=V]Q?6<$$]K9SPW4\3O';RQS,K+^
M;'_!13_@B]^R/_P4F\<?#GXJ_%B^^)_PR^+/PULVTG3/B;\$?$6A^$?%^MZ'
M;WJZKH6E>(;W5_#7B..]/A#6_-UGPAJEK%8:QH5W>Z@MO?M;W7DQ_I_\.O"F
MI>!O G@_P;K/C3Q/\1]4\+^'M*T&\\?>-3I+>,/%TNE6D5H-=\42Z%IFC:/<
M:_J20K<ZM=Z?I.G6]Y>M-<K:0M*R#TLSQ&"QE7#X[#P=+$5O>S'">S<:*KQG
M%SJT)ZQ]GB4I2E!/FI5)RM&VAY658;,,'3Q. Q%15L/0;AEV-<U.N\/.,N2E
MB(.TW5PK:C&H[QJP4;R<M5_/M_P3\_X.7?V&/VK?#'AW0?VA?$FF?L@?'5[.
MRM-=T+XCZ@T/PEUO6O+CBO+GP5\5)HDT>PL9KLL\>B>/&\,ZYI^\6(EUHVS:
MC<?NAIG[2G[.NM:2-?TCX]_!;5-!\HS_ -M:;\4/ ]_I1MPA8S#4+;7);01;
M?G\SS/+V_,6QG/P5^UO_ ,$1O^":W[9^KZIXL^*_[.NA^'?B)J\CSZC\3/A#
M?W_PK\9ZG=.7,E[KDWA66UT'Q3?REMTMYXJT'6[MRJAI2F5/Y5:C_P &AW_!
M/&XU1KG3_C/^UAIFE-*&_L@>*/A)?%4W$^5_:%S\)C=$8^4R.&D(P=VX9.TH
M<.XE^TA7S++92NYX>6&ACJ4)=J-:$XU'!_951>ZFD^QS*?$^%3IRPV6YG%-Q
MA7CBIX"K*-VTZU*I%TN>*>OLW[VK;3>OAG_!R3_P5>_9+^)'[+>K?L)_ #Q_
MX8^/_P 6_B3X]^']WXOU'X;7=MXQ\*?#?1_!?BG3O%<-J?%.C->Z5J_CWQ'K
MFEZ9H&D>&/#EQJ>HVMI=:O<:K_9LZ:=:ZI^U_P#P0J_93^(W['O_  3,_9_^
M%7Q=TN\\/?$O6E\7_%/Q=X3U%!'J'@V\^)_BG4_%FG>%=2A.]K;6-&T&^TFW
MUZR?;)8:]_:=C(OF6[,U?]BO_@A3_P $X_V%O%.D_$3X7?!^^\=?%;0)DN/#
M_P 4/C5KTGQ%\4^&;J,,$O\ PK8SVNF^#O"NJ1[F\G6O#_A73M:B4E(M01'=
M6_86EC\?@WE]'*<MC7>'IXAXNOBL7&"K8C$RIJ'NT8-PHTH+2*^*5[O2S;R[
M+,:\RKYSF<Z$<74PT<%0PN$E-T,/A5/VEIU9Q4JU:4M922Y5LGT"BBBO$>Z^
M?Y'T;_5!1113(CT_[<_]N"D[CZ'^:T44&@M%%%);+T7Y$2W7JOS84444I=/G
M_P"DR"'PKU_4****H;W_ / ?SD)W'T/\UI:**"AH^\W_  '^5.HHI/IZ_P"8
M!2-T/T/\J**'^J !T_%OYFEHHIDQWEZ_H%%%%!,OB_[=?Y,****!+XO^W?\
MVT0=6^O]!2T45*Z_/_TIE=8>C_(1>@^@_E2T45184444">S$'3\6_F:6BBIC
>U_Q/\Q2V?H_R$'3\6_F:C?J/I_4T44UN_7]$4?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X1"<17AI9@  34T *@    @ !@$Q  (
M   1   (8E$0  $    ! 0   %$1  0    !   N(U$2  0    !   N(X=I
M  0    !   (=.H<  <   @,    5@     <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     $%D;V)E($EM86=E4F5A9'D    !ZAP !P  " P
M  B&     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                          #_
MX0F;:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@8F5G
M:6X])^^[OR<@:60])U<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"<_/@T*/'@Z
M>&UP;65T82!X;6QN<SIX/2)A9&]B93IN<SIM971A+R(^/')D9CI21$8@>&UL
M;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS>6YT
M87@M;G,C(CX\<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB=75I9#IF868U
M8F1D-2UB83-D+3$Q9&$M860S,2UD,S-D-S4Q.#)F,6(B('AM;&YS.GAM<#TB
M:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(^/'AM<#I#<F5A=&]R5&]O
M;#Y!9&]B92!);6%G95)E861Y/"]X;7 Z0W)E871O<E1O;VP^/"]R9&8Z1&5S
M8W)I<'1I;VX^/"]R9&8Z4D1&/CPO>#IX;7!M971A/@T*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" \/WAP86-K970@96YD/2=W)S\^_]L 0P " 0$" 0$" @("
M @(" @,% P,# P,&! 0#!0<&!P<'!@<'" D+"0@("@@'!PH-"@H+# P,# <)
M#@\-# X+# P,_]L 0P$" @(# P,& P,&# @'" P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\  $0@ *P J P$B
M  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*"__$ +40
M  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A""-"L<$5
M4M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U155E=865IC
M9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2U
MMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$
M !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (! @0$ P0'
M!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6
M)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS
M='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#
MQ,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1
M #\ _?RJ^J:I:Z'IEQ?7UQ;V=G9Q-////((XH(U!9G9C@*H ))/  KF/CQ\?
M/!O[,7PKU;QMX^\0Z=X7\+Z)'YEW?WC[47)PJ*HRTDCL0J1H&=V(5020*^2;
M3X;^+/\ @J=K,.M?&2WOOAO^S_!*ESHWPOO9A::QXU (>*[\0@-NAMC\KII@
M/S<&X+8$( +>J_\ !0KXR_M%ZE<>+?V:_A=H_COX/^#Y7:_UC7;V33+KXDE2
M4E@\.9 0I%\S"\N<03N@CC^4F8?1O[*?[7?@C]LOX;-XD\%:A<2?8KAM/U?2
M=0MVL]6\.WR?ZVROK5_WEO<1G@HPY&&4LI5CV^EZKH6AZ9;V-C<Z39V=G$L%
MO;P21QQ01J JHJC 50   . !7SG^U7^Q\OB[XEK\8/@SXPT3X;_'33[=+>34
M92)=&\9VL?W=.UJW0@SPXX2=<3VY(:-B 8V /J*BO ?V./V\-._:3U75/!7B
MC19_AQ\9_"<"3>(?!6HW"RS1Q,=JWUC,,)?:?(P^2YB&.BN(W^6O?J /S;_;
MM\-?$KQQ_P %?]$UWPCHFC?$^Q^!OPXT[Q=:_#K6W\N#4KF\U/4;>:^T^1F$
M,&K116D8ADG5T(+IF(MY@P?^";O[*O[.G_!33QI^TG\3/&WPC\.^*]:O/BU=
MP1KXP\/B/7-(MUTG2@+2X@F'F0&.;[0-AXW;R"0<GZ9\)_\ *;3QY_V1/P]_
MZ?-:K7_:M_85U#QE\2H_B_\ !OQ!:?#?XZ:;;K;-J4L#2Z-XRM4^[IVM6Z8,
M\'4).N)[<D-&Q *,P,W_ (<D_LB_]&Z_"7_PGX/\*Q?B3_P1A_9%\/?#K7]0
M;]GWX0V:V.FW%P9Y-#@C6 )$S;RQ "@8SDD8QG-:7PV_X*T_#_2_ GBQ?C5)
M;_ WXA?#6U2X\7>%]>N@\D,;MLCNM/D4?\3&TGD^2&2W5F9V6,HLAV5R.D_!
M;QU_P5:U.W\0?&#2=:^'O[/<4J7.B?#"YS;ZMXU"L&CN_$.TYCMN%9-,!Y.#
M<%B/*" _/'4O'_CSXZ_\$?O@1\0/ ?A5_ FB_LS^%O#T\'Q-U2TDMM?UO4P;
M2SN=.T5=RNNGG>Z7%S-NBGV>6D4@!D7]Z*^1/^"WFF6VB_\ !)KXH6=G;P6E
MG:6FEPP00QB..&-=3LPJ*HX50   . !7UW0!\CV'BC3/#'_!;#QP^I:EI^G+
M+\%/#RH;JX2'>1KFM9QN(SCVKZ8_X6UX5_Z&;P__ .#&'_XJN)^._P"PK\%O
MVHO$]KK?Q(^$_P //'FL6-J+*WO=?\/VNH7$$ 9G$2O*C$(&=FV@XRQ/>N)_
MX= ?LI_]&W_!'_PB]/\ _C5 '<?$;P9\%_B_XZ\)^)_%5G\.O$/B+P+=/>^'
MM1U VMQ<Z/,R[6>!V)*$\'C^)5;[RJ1VG_"VO"O_ $,WA_\ \&,/_P 57B?_
M  Z _93_ .C;_@C_ .$7I_\ \:H_X= ?LI_]&W_!'_PB]/\ _C5 'GO_  6]
M^(_AW6?^"7/Q4M;/7M%NKF:+3A'%#?1.[G^U+0X #9/X5]G5\\Z=_P $D/V6
E](U""[M?V=O@K;W5K(LT,L?@VP5XG4Y5E(BR"" 017T-0!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>ex99-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_002.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X1"<17AI9@  34T *@    @ !@$Q  (
M   1   (8E$0  $    ! 0   %$1  0    !   N(U$2  0    !   N(X=I
M  0    !   (=.H<  <   @,    5@     <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     $%D;V)E($EM86=E4F5A9'D    !ZAP !P  " P
M  B&     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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2-(=N%[8))K[JHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>ex99-1_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_003.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X1"<17AI9@  34T *@    @ !@$Q  (
M   1   (8E$0  $    ! 0   %$1  0    !   N(U$2  0    !   N(X=I
M  0    !   (=.H<  <   @,    5@     <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     $%D;V)E($EM86=E4F5A9'D    !ZAP !P  " P
M  B&     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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-5-_'UE10 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>ex99-1_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_004.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X1"<17AI9@  34T *@    @ !@$Q  (
M   1   (8E$0  $    ! 0   %$1  0    !   N(U$2  0    !   N(X=I
M  0    !   (=.H<  <   @,    5@     <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     $%D;V)E($EM86=E4F5A9'D    !ZAP !P  " P
M  B&     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                          #_
MX0F;:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@8F5G
M:6X])^^[OR<@:60])U<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"<_/@T*/'@Z
M>&UP;65T82!X;6QN<SIX/2)A9&]B93IN<SIM971A+R(^/')D9CI21$8@>&UL
M;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS>6YT
M87@M;G,C(CX\<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB=75I9#IF868U
M8F1D-2UB83-D+3$Q9&$M860S,2UD,S-D-S4Q.#)F,6(B('AM;&YS.GAM<#TB
M:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(^/'AM<#I#<F5A=&]R5&]O
M;#Y!9&]B92!);6%G95)E861Y/"]X;7 Z0W)E871O<E1O;VP^/"]R9&8Z1&5S
M8W)I<'1I;VX^/"]R9&8Z4D1&/CPO>#IX;7!M971A/@T*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" \/WAP86-K970@96YD/2=W)S\^_]L 0P " 0$" 0$" @("
M @(" @,% P,# P,&! 0#!0<&!P<'!@<'" D+"0@("@@'!PH-"@H+# P,# <)
M#@\-# X+# P,_]L 0P$" @(# P,& P,&# @'" P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\  $0@ *P K P$B
M  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*"__$ +40
M  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A""-"L<$5
M4M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U155E=865IC
M9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2U
MMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$
M !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (! @0$ P0'
M!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6
M)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS
M='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#
MQ,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1
M #\ _<3]H?\ :.\%_LI_"R^\9^/=<M]!T"Q9(O-=&EFNIG.V*W@A0-)//(WR
MI%&K.Y. ":^==0_:W_:E\9>'+[QSX/\ V<]!TWP3IL+7<'A_QEXK?3O&GB*!
M06)AM8+>>WLY64?)#<S;RQ ?RCG$UCX/L?C+_P %F/%"^,E?6(_A'\/]"UKP
M)I]P0;/2;G4KK5H+_4$BQAKHK9P1+*<F--ZKCS&S]>4 ?!?[;'_!2OQ-9? W
MX%_$CX8ZPOA/X3_%/3Y-5U3QK/X*N/%UQHS/;P2V%B^G6]Q$ZM.9+@/+N81M
M:[, N".2_9__ ."MOQ(U_P 036EC<_"G]HRULXO/N])\'6]]X)\?P6Z@L]Q'
MH&L.1>JJ@Y$-Q&2<!0Q(!^9OC[\/X] ^/7_"A=!T&'QOX^^$OQ \4WG@7PA?
M^&=*U_0+OPYK5K8:S(T\&I7EG )[26[:W@*3><$+JJ%'8KYCJ?PG\*?%OQI_
MPA>N>!=+_9U^+5GJ, TF\TJUO] \/QZI,VVQ@U+1Y)))-&:YE4QVVKZ3<2Q-
M,0GG%L6\E ?N3^S7^T_X)_:X^&,/BWP)K*ZMI9GDLKJ*2)[>\TJ[B.)K2[MY
M LMO<1MP\4BJR\'&"">_K\2?V1?VX?$?PJ\?Z]\4/$L-]I?Q(^%,UMH_QJT^
M:-(YO&WA5;HV#:O=Q0CRFUC0[GB:>-56>T8."([F%(_VTBE6>)9(V5T<!E93
MD,#T(-2!\F?M470_9N_X*2? _P"+$_[KPU\0K&Z^$/B&X8_N[2YN)5OM$E;T
M#74-U:@GC?J$0[U[3^V3>_%#3?V7?'%S\%X="NOBA;:5++X>@UB,R6MQ<*,^
M61O0;V4,$WL$$A3?\NZK_P"T_P#LZ>'?VM?@%XH^'?BJ.X.B^*+,VSS6S^7<
MV,JL)(+J!_X)X9DCEC?^%XT/:O)OV$_VI_$&MZSJ7P2^,,EO9_';X=VB->RK
M'Y%MXYTO/EP>(+ =&BFP!-&O-O<;XV !C+ 'G_[$W[(G[//[7O['O]K:QIO_
M  O!O&VLR:[XJU+XBZ;!<:\OB".%+.XBNK<H%L+BU2%;86\*HL*1!5R#O;XS
M_;G_ &4V\/\ Q<F_9YM]/\::\O\ ;FG)\+'N+:]U&ZD\*ZU;3VNOZ/\ V@58
M-::9/#%?QFXDWVYCL\-^[C)_0#X^?LA>-/A?\9]1^-'[/=UH^G^-M8V'QAX,
MU:9K?P_\1$C4*KR2(K&RU)$ 6.\1&# *DR2)@IR?PK_X)46/QE\)OXT_:$U'
MQ9KOQF\47$NJ7USHGC?5]-M/" D8F#3-+%K<1+'#:Q[(_,"[IW1Y')WX# _-
M?3OB98^,_P!HZW^+GBZW\4VW@KQ=\.+?P1\9=6E\,Z@D.F^)-1\+WMGJ5A/$
M(-[2&ZTO1T<HK()'A!;+C/[*_P#!/3_A)!^P1\$U\865_IWBR/P+HJ:Q;7R%
M+J"[%A")EE4\K('#;@>0<@\UX%\<OAO\:_\ @FU\(?$WQ,\#_&+7_BQX"\!:
M;/K^M^"/B2L6H7T^GVR&:Z^P:U&L=Q'.L*.8Q=BY5F 4E<[J^SO"?B:U\:>%
MM-UBQ9VL=6M8KRW9UVL8Y$#J2.QP1Q0!H5Y#^UU^QGX:_:[\.Z2U]>:KX7\9
M>$KEM0\)^,-$E%OK/A>[*[3)!(00T;K\DL$@:*9/E=6X(]>HI ?']A^V_P#$
M[]C11I'[2G@?4-4T&S&R'XJ^ =(GU+1+N,<"74M.B\R\TR4C&\JLUMDDB51\
MH]S^#/[:?P@_:)TB.^\"_%#P#XMMY #_ ,2O7;:Y=/9T5RR-ZJP!'<5Z;7D/
MQ=_X)]_ GX_:O)J/C;X-?"_Q5J4QW/>ZIX8LKFZ<^\K1E_UH \+_ &M/&\7_
M  4A^+1_9N\#W U/P%I5[!=?&;Q%:ONL[6RC99D\-Q2J</>7K*BSJI_<6OF[
M\/+&M?:$,2V\2QQJL<<8"JJC 4#H *YGX._!/P?^SUX L_"O@3POH/@_PUIY
<=K;2]'L8[.TA+L6=A'& N68DDXR223744 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>ex99-1_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 'P !H# 2(  A$! Q$!_\0
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MZYIV@1+#HECJ4%K'%=6ND1*JB/3H)%,=F@4;8%0$ YKMZ "OP4_;2_X*/_M
M_ +XZ^-? '@KX@?L6Z-X=\."T:ST'XK?$#4]&^(DJR0)+(+C2[:!X8WN"Q%D
MN29/ER.>?WKK\ /VR/B!I5O^TKJZ:3\-?^">TL/AS5[6+Q=/^TAXB\/Z9\7?
M%DUND,KSZ':ZC#]H2V>(B+2IF6=))5P..* /VU^#?C"\^(/PJ^'WC?49+"6_
M\5>%-'UN]DTOS3IK75_:1SSFP:94E>S$K,+=W56DB"/CYJ]*KAOAEKMGXF^'
MW@[7]/TRUT6RU7P_IMW:Z58^5]AL(7MT"6UB84CA:RC"XM'B1$>W\MU4 BNY
MH *_GC_;+^(O[,VM_MB6?A.3]B#4_P!NK]H_PGK^F1)9:3\(K2*+X9:#+);3
M6]UK'Q1U18M#F2S#M>06E\US(L:-M4$;:_H<KX2O?VTO@AX,^.GQ.^%>H^'Y
M?"%WX.T.Y\1^+/B5KAT#PWX8US5K.!)[G0;+4;RZAU'6-7MK1DF=FA\A4(2)
MW.10!]$_"WXL>$O&MSJW@K3++_A&_%O@2QT>+Q3X&<VSS>$_MUJCV.GM+8_Z
M&Z1Q+Y<?D!$VQ_*@7%>R5Y_\/;OP+XHT:T^)7@G3]*6W^(&GV&MR:Y8V-M;W
MFN6SPXLY[VZBC66\V1_+$\KN F-AVD5Z!0 5_,)^V1#^PSXF_;<^);_ML?L\
M_$KXKZWX/U/PT_PNU[X:?#/QY)HD6C?9HI+G2_%VJ:%>QZ5XGOTU +*\L]NR
M+:8@<L@*U_3W7\S'[?WQ[_:!\&_M,_$#P]\//VDOVCO!&GVDE@ND^"OA_P#L
MM:;\1?"*W,EO&5A3QE<Q^?<M=RG%TP)%MN(4\4 ?T6_#&\\-ZA\//!=[X/TA
M] \+7/AS2I/#^B2V9TZ32](-K&+&QDL2 ;1[> )&UNP#1,I5N0:[JO*?@7>Z
M[J/P<^&=_P")_P"TCXAO/!FA7.M-J]DFFZI)J4UC%)=2WVGQ_)8W,TK-+):K
MQ;E_*_AKU:@ K\2?VMO%O[>.M_M,:+\*/A!XA\.?!GX):=J4GQ ^(/QKU*Y\
M&:AXAU7P[90H-+^&G@7PYJUQ%<'5M8NU8ZIJM^NR*!@D)S@U^VU?RW?ME?L@
M>-?BM^VW\8;K2?@9\ _C5=WYTKQ?8?\ ";_M!^,_#OQ T'P_';0P7<]QX0T+
M5XK72= BNH]VF%K2)'^?>SDF@#^ESX<7VL:EX$\*W^OS+<:S=:-9RZA.BP*)
MIRF#*5MF>W#R*%>00LT7F%]A*XKM:\Q^"VCW7A[X3?#S0[VPM=*NM*\)Z-8S
MZ;8WKZC96$EO:1H;2TOY6>2\MX,>7#<2,TDL:J[L6)->G4 %?C'^U)_P3F_:
M6^(O[0VJ?&']FC]JOP]^S_I7C^R?3OBA:O\ "S1O$?CC5;&Z6*VU&VTCQG<R
M?;[>QDLT(LK"<-:Z?=O]H@C!)K]G*_G%_;J^+G[8/[,?[5?B+XD?"Z#X:^-_
M 7Q-@M/AE:Z]\4_V@D\#^%_AIJ.L""*RTJS^'TT)%YKEG*[:B+NP:2[O8B()
M!'PU '] GPV\&1_#OP#X0\#1ZMJ&NKX5T'3M%.M:K()=2U62S@6.74+V0<-<
M74H>9\?*I?:O %=M7G/PA3Q''\+_  $OB_6M/\1>*/\ A%M(;7M;TE_,TS4M
M3DM(WNKFPDR3):-(Q6"0G<\:JS<DUZ-0 5_+_P#M^?%K_@G%\//V[K'Q7^T'
M=?M3_$[XB?#^VO[CPC\./ OP2\2_$SX,>"_B%JEK%'>^*W^Q6O\ 9.H>+[2R
M:)@+PW2:7$5D78.:_J K^<C]LCQ=^R_JO[3W[0'@7XY_$'Q!\ ='NOA_!#I?
MCA_C1H_A;4;SQKI-Q'JES>> ? L:_P!M6=WJ]J\>GW&ORB>#6HO]"ACRG !^
M\OP1O]&U7X1_#O5?#R:M'H>J>%-)U+2DUVP;2]86RO[=;N#^TM-8!K&[*3 S
M6I \ACY8 "XKU*O&_P!GF309?@;\*7\+7NM:EX=/@;P^-%U'Q%))-KE_IZ6,
M26UYJ<TRK)+=7,:B9Y'52^\-M .*]DH \5_:+UC7_#WP1^)6O>&?'>C_  RU
MK1_"VI:E:>/M?TUM8TCPL;.$SR:M>Z6A#W\5M&C'[*GS3,0B@DX/\QGPC_9K
M^)G_  5*U-_CEH/[8_[*OQT\0?"S7H/#]UX@\6_LB?9/$^CW5I*+NUCQK8MK
MV2TE\LSZ?=.DT# !XS@8K^F/]IWP-X^^)7P*^(G@?X77_A[2_'WB'0Y;'POJ
M/BW3O[7\,V6JLZ/;W&N:6/\ D(:=&R[KBT_Y;+\M?AMX2_8J_P""['@C6I]<
M\+_M?_L/^')K_3+'2=6M_#G[.=[HT>HV5C*)(1*EE/!"][''N@@NY%9XT(&2
MHP0#^A/X?:)K'AKP1X5\/^(;ZRU/6]&T+3M-U34--LUT_3[R]M+=(9[BRL4
M2SM9'4M#;* L,96,<+785Q'PVLO%NF^ ?"-AX]O[?5/&MIH.GP>*=2M$,=I?
MZ['"JZC=VL9R8K:XN1)+!$23'$R(22M=O0 4444 %%%% 'E_Q<^+WA#X*>$Y
M/&?C4:XVC17,5JX\/Z%J/B&_\V8D)MT_3(IKEDR/F<)M7N17P/\ %+_@KM^R
MK\*O#=OXFUC3_C%>V<^N:+H7E6WPH\6PRK/K=]'802@W-@BR+%)*K/$A,KKG
M8I(K]1GC20;9$1U_NNH8?DP(K*U'P_H.KP);:MHFD:I;1SPW,=OJ.FV5[ ES
M;N'@N$BN898UG@<!X95421N R,IYH C\->(-/\5^']&\2Z4+D:;KNG6FJ6(O
M;66RNQ:WD*SP_:+2=5FMIMCCS(9562-LJP!!%;=( % 50%4      #H !P .
&P%+0!__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
